data_2kkl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kkl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.531 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 mt -128.16 151.12 49.62 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.513 -0.992 . . . . 0.0 109.702 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.65 143.48 41.39 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.1 mp -120.23 150.72 40.22 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.335 -0.853 . . . . 0.0 109.868 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.3 mt -117.11 132.58 56.64 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 t -119.08 132.11 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.406 -0.809 . . . . 0.0 109.887 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.78 102.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.542 -0.724 . . . . 0.0 109.134 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.71 -42.91 97.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.679 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -150.21 136.93 19.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.165 -0.96 . . . . 0.0 109.888 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.87 173.27 29.27 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.07 -43.17 60.75 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.224 1.949 . . . . 0.0 112.39 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -102.81 66.15 0.92 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.36 144.75 49.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.278 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.49 -9.7 66.87 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.8 m -66.13 145.64 55.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.404 -1.057 . . . . 0.0 109.665 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.61 146.96 51.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.58 -0.7 . . . . 0.0 109.475 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -125.33 134.49 52.2 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tt -101.98 124.23 47.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.504 -0.748 . . . . 0.0 109.471 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.56 111.74 24.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.32 -0.862 . . . . 0.0 109.271 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -86.22 55.42 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.612 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 51.26 -169.09 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.655 0.74 . . . . 0.0 110.855 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 68.57 -142.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.491 0.663 . . . . 0.0 110.32 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.45 127.85 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.2 m -121.61 116.64 24.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.559 -0.713 . . . . 0.0 109.123 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 p -83.09 165.33 19.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.359 -0.838 . . . . 0.0 109.553 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.51 140.86 51.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.55 -27.25 16.35 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -67.85 143.71 55.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -1.108 . . . . 0.0 109.864 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.59 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -92.14 -40.43 0.36 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.651 -0.655 . . . . 0.0 109.857 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 65.8 Cg_exo -53.32 -133.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.785 2.323 . . . . 0.0 113.356 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -73.83 101.37 3.73 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.283 -0.885 . . . . 0.0 109.751 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.9 m -166.54 129.25 1.88 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 109.25 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.75 -41.17 97.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 109.992 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 87' ' ' ILE . 96.7 mt -82.68 126.01 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.732 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -129.5 86.94 2.48 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.0 mt -102.18 96.16 6.8 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.354 -0.841 . . . . 0.0 109.514 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 65.9 t0 -87.92 97.3 10.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.317 -0.865 . . . . 0.0 109.62 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 62.9 m-20 -159.97 173.22 16.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.127 -0.983 . . . . 0.0 109.661 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.5 m -63.61 -41.42 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.464 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.594 ' HG1' ' H ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -79.32 -178.11 6.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.831 . . . . 0.0 110.211 -179.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.594 ' H ' ' HG1' ' A' ' 93' ' ' THR . 4.8 t 61.64 93.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 121.63 0.728 . . . . 0.0 109.597 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.4 m -62.87 -167.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 0.0 109.897 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -63.48 -40.5 97.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.0 109.836 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -132.28 40.93 3.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.474 -0.766 . . . . 0.0 109.265 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -44.06 -35.75 2.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.749 . . . . 0.0 110.03 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.16 152.58 38.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -139.88 149.29 43.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.488 -0.758 . . . . 0.0 109.039 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.24 140.63 49.11 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.471 -0.768 . . . . 0.0 109.057 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -131.28 137.12 48.7 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.377 -0.827 . . . . 0.0 109.061 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.6 tp -95.66 127.65 41.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.244 -0.91 . . . . 0.0 109.789 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 105' ' ' ASN . 40.6 tt0 -142.11 145.11 33.91 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.202 -0.936 . . . . 0.0 109.142 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.443 ' OD1' ' CG ' ' A' ' 107' ' ' GLU . 11.2 p30 45.39 41.39 6.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.754 . . . . 0.0 109.571 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m120 56.8 33.98 23.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.536 -0.727 . . . . 0.0 109.994 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.443 ' CG ' ' OD1' ' A' ' 105' ' ' ASN . 73.9 mm-40 -138.47 129.87 27.45 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.273 -0.892 . . . . 0.0 109.264 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -71.27 148.16 47.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 109.953 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.91 166.66 24.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.349 -0.845 . . . . 0.0 109.511 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.3 p -123.77 131.12 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.5 t -123.68 136.8 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 122.238 1.018 . . . . 0.0 109.065 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -101.93 112.92 25.72 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.124 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.503 2.221 0 O-C-N 120.829 -1.169 . . . . 0.0 108.246 177.691 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.392 0.615 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -141.11 161.41 37.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.363 -0.836 . . . . 0.0 108.86 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.39 134.99 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.353 -0.842 . . . . 0.0 109.334 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 56.97 36.54 27.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.59 -0.694 . . . . 0.0 109.539 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 58.33 45.83 16.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.522 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -144.71 119.86 5.92 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.999 -1.063 . . . . 0.0 108.679 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.58 115.99 4.19 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.537 1.492 . . . . 0.0 111.771 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.55 158.68 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.322 -0.861 . . . . 0.0 109.975 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.18 -42.09 99.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.7 t -162.85 157.64 21.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 109.1 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.2 156.04 40.86 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.999 -1.063 . . . . 0.0 109.712 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -90.82 129.71 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.228 -0.92 . . . . 0.0 109.53 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.1 mt -80.76 153.32 27.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 0.0 110.105 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.54 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.22 156.01 40.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.411 -0.805 . . . . 0.0 109.131 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -54.86 134.03 48.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.34 -0.85 . . . . 0.0 110.742 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.72 14.68 67.23 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 83.5 m-20 -91.66 152.4 20.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.135 -1.215 . . . . 0.0 109.711 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -114.02 131.15 56.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.602 -0.686 . . . . 0.0 109.24 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 144' ' ' LEU . 55.2 t -122.29 132.59 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -120.64 120.65 36.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.465 -0.772 . . . . 0.0 109.299 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.14 128.63 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.58 -0.7 . . . . 0.0 109.842 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 53.61 -128.9 40.35 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.1 -1.43 39.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.577 -0.955 . . . . 0.0 109.291 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -97.09 145.16 26.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.457 -0.777 . . . . 0.0 109.262 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -116.22 126.12 53.18 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' VAL . 5.2 mp -128.62 154.55 46.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.573 -0.705 . . . . 0.0 109.437 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.72 130.97 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 109.156 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -87.22 119.41 27.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.9 mt -132.98 150.92 52.12 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.791 -0.568 . . . . 0.0 109.468 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 74.0 p . . . . . 0 N--CA 1.498 1.955 0 O-C-N 121.568 -0.707 . . . . 0.0 109.269 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.9 mp -95.08 157.08 16.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.277 -1.131 . . . . 0.0 109.304 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.422 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -127.18 166.91 16.8 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -137.39 159.68 41.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.466 -0.771 . . . . 0.0 109.758 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.0 mt -112.35 135.47 53.0 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.36 137.48 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.57 0.7 . . . . 0.0 109.509 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.45 131.32 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.485 -0.759 . . . . 0.0 109.896 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -96.35 -32.53 12.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 109.172 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -132.21 155.35 48.41 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.762 0.791 . . . . 0.0 110.221 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.35 164.82 14.44 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.76 -15.6 40.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.686 2.257 . . . . 0.0 111.001 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -92.05 13.94 17.37 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.17 135.15 13.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.814 . . . . 0.0 110.369 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.73 -18.5 47.01 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -65.7 144.26 57.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -1.153 . . . . 0.0 109.824 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -138.79 148.72 44.15 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.358 -0.839 . . . . 0.0 109.904 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.99 137.29 50.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.544 -0.722 . . . . 0.0 109.175 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.429 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 40.8 tp -98.76 128.89 45.14 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.339 -0.85 . . . . 0.0 109.794 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.5 mt -85.97 78.91 9.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 108.986 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -98.21 10.89 39.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.469 -0.769 . . . . 0.0 109.074 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -125.11 148.43 48.55 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.5 -0.75 . . . . 0.0 109.817 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.98 95.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.542 -0.724 . . . . 0.0 109.91 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.424 HG21 HD12 ' A' ' 76' ' ' ILE . 96.9 mt -123.53 126.15 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.465 -0.772 . . . . 0.0 109.058 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.5 m -123.85 119.45 29.72 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.626 -0.671 . . . . 0.0 109.249 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 m -82.86 153.87 24.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 109.482 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.22 177.2 4.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.578 -0.701 . . . . 0.0 109.984 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.94 -129.1 20.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -98.99 122.03 41.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.347 -1.09 . . . . 0.0 110.241 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.703 ' HD1' ' HG ' ' A' ' 85' ' ' SER . 4.8 t-80 -174.15 94.63 0.32 Allowed Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 85' ' ' SER . 38.4 Cg_exo -53.87 150.78 28.79 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.504 2.136 . . . . 0.0 112.995 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 1.2 m-20 77.24 -19.12 0.45 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.703 ' HG ' ' HD1' ' A' ' 82' ' ' HIS . 11.2 m -74.69 148.01 40.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.825 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 71' ' ' LEU . 34.2 t70 -62.92 -46.35 88.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.445 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -100.99 112.0 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.84 . . . . 0.0 109.348 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 22.9 p90 -130.91 90.13 2.85 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.3 94.94 7.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.419 -0.801 . . . . 0.0 109.063 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 43.7 t0 -87.02 98.94 11.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.459 -0.776 . . . . 0.0 109.413 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 64.5 m-20 -158.32 172.88 17.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 109.586 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.77 -44.67 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.506 -0.746 . . . . 0.0 109.818 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.6 p -78.28 -171.0 2.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.992 -1.068 . . . . 0.0 110.509 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 t 62.5 115.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.618 0.723 . . . . 0.0 109.9 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 p -69.84 170.71 10.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.6 -0.687 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -58.19 -32.99 68.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.291 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.51 59.8 1.55 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -63.55 -40.16 96.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.513 -0.742 . . . . 0.0 109.262 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.4 156.0 39.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.075 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -137.03 140.6 42.21 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.6 146.87 27.91 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -136.18 147.24 47.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.285 -0.884 . . . . 0.0 109.817 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.5 tp -101.97 127.25 48.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.611 -0.681 . . . . 0.0 109.407 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -157.29 144.41 18.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.488 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 56.36 35.12 25.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.736 -0.603 . . . . 0.0 109.704 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 58.14 31.99 21.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.492 -0.755 . . . . 0.0 109.748 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -142.63 143.13 32.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.363 -0.835 . . . . 0.0 109.455 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -92.45 149.16 21.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 109.64 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -144.11 170.75 15.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.351 -0.843 . . . . 0.0 109.554 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.79 131.04 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.6 t -126.95 130.52 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.496 ' CB ' ' H ' ' A' ' 119' ' ' THR . 26.9 t0 -103.38 128.55 50.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.568 -0.708 . . . . 0.0 109.509 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.907 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.496 ' H ' ' CB ' ' A' ' 112' ' ' ASP . 26.0 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -124.76 157.29 36.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.67 -0.644 . . . . 0.0 109.542 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.82 134.55 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.509 0.671 . . . . 0.0 109.939 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.0 m120 47.47 -108.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.759 -0.588 . . . . 0.0 109.934 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -128.32 17.13 6.56 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.611 -0.681 . . . . 0.0 109.329 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -124.32 83.31 57.09 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.524 -0.735 . . . . 0.0 109.449 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.81 136.4 75.13 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.609 2.206 . . . . 0.0 112.466 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.9 m -151.37 159.28 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.188 -0.945 . . . . 0.0 110.071 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -62.87 -43.66 98.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.503 -0.748 . . . . 0.0 109.584 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.6 m -135.85 151.25 49.84 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.324 -0.86 . . . . 0.0 109.223 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.73 152.45 35.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.095 -1.003 . . . . 0.0 110.128 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.6 t -95.95 132.14 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.744 . . . . 0.0 109.317 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.52 146.56 40.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 109.769 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.421 ' H ' ' HB2' ' A' ' 135' ' ' ASP . . . -135.43 153.49 51.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.702 . . . . 0.0 109.517 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.638 ' N ' HD21 ' A' ' 133' ' ' ASN . 0.0 OUTLIER -45.41 104.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.74 . . . . 0.0 110.591 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.32 44.52 4.03 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 132' ' ' ALA . 15.1 t0 -87.87 163.51 16.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.213 -1.169 . . . . 0.0 109.656 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -113.35 116.99 30.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -124.62 133.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -132.51 118.96 19.92 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 139' ' ' ILE . 96.8 mt -124.0 128.22 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.589 -0.694 . . . . 0.0 109.961 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 53.52 -128.99 40.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -95.72 -9.76 31.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.485 -1.009 . . . . 0.0 109.019 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -94.45 142.68 27.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -118.16 130.53 56.16 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.19 149.26 46.55 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.622 -0.674 . . . . 0.0 109.785 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.4 p -124.94 136.88 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 77.0 t80 -83.01 117.66 22.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 70.7 mt -135.34 146.53 48.5 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.419 0.628 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.829 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.586 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.27 143.23 33.73 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.417 -1.049 . . . . 0.0 110.054 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.22 159.36 42.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.64 163.35 31.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.461 -0.774 . . . . 0.0 109.786 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -120.14 136.49 54.59 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.8 t -123.11 133.47 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.571 0.701 . . . . 0.0 109.989 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.96 113.43 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.533 -0.729 . . . . 0.0 109.57 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -65.81 -45.6 81.75 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.589 -0.694 . . . . 0.0 109.555 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -156.95 144.43 18.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.2 -176.62 34.36 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -54.4 -38.79 89.4 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.993 2.462 . . . . 0.0 112.004 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -106.17 22.32 15.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -39.69 107.62 0.07 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.789 -0.569 . . . . 0.0 110.427 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.6 -20.59 3.1 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.2 p -69.06 158.09 35.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.042 -1.269 . . . . 0.0 110.977 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -143.44 158.14 43.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.472 -0.767 . . . . 0.0 109.713 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.62 143.75 50.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.713 . . . . 0.0 109.648 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.4 tp -108.42 126.54 53.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.9 mt -98.68 112.16 24.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.342 -0.849 . . . . 0.0 109.355 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 66.7 t0 -132.34 36.47 3.6 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -140.0 155.06 47.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.273 -0.892 . . . . 0.0 109.885 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.04 91.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.551 -0.718 . . . . 0.0 110.203 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -128.31 129.09 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.342 -0.849 . . . . 0.0 109.852 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.9 m -124.66 125.96 44.95 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.5 m -87.31 161.61 17.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 109.527 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.41 152.54 37.78 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.621 -0.674 . . . . 0.0 109.962 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.5 -130.37 10.2 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.522 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 96.7 mtt180 -100.43 134.39 43.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -1.06 . . . . 0.0 110.043 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 50.6 m-70 -165.4 152.23 9.22 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.07 -15.88 47.78 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.126 1.884 . . . . 0.0 110.893 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 85' ' ' SER . 34.5 t70 -142.13 -124.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.564 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.471 ' H ' ' CG ' ' A' ' 84' ' ' ASP . 3.5 m 59.02 138.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.765 0.793 . . . . 0.0 110.179 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.18 -41.13 99.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.459 -0.776 . . . . 0.0 109.87 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -88.11 120.47 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -129.97 86.75 2.44 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.593 -0.692 . . . . 0.0 109.208 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.9 mt -96.52 99.63 11.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.287 -0.883 . . . . 0.0 109.163 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -90.76 94.92 9.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -153.75 152.52 30.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.282 -0.886 . . . . 0.0 109.805 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.6 p -66.42 -34.72 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.0 p -64.97 -31.42 72.64 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.858 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.4 t -98.16 126.26 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.111 -0.993 . . . . 0.0 110.196 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.9 t -76.58 168.52 19.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 110.242 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -60.84 -42.87 98.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.452 -0.78 . . . . 0.0 109.819 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -124.06 54.31 1.35 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.42 -0.8 . . . . 0.0 109.08 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.01 -41.72 97.37 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.557 -0.714 . . . . 0.0 109.551 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.73 157.44 42.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.05 -1.031 . . . . 0.0 109.971 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -136.11 149.18 48.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -112.14 144.03 42.2 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -132.86 138.18 46.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.537 -0.727 . . . . 0.0 109.247 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD1' ' O ' ' A' ' 107' ' ' GLU . 39.3 tp -88.99 129.79 35.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.44 -0.787 . . . . 0.0 109.997 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -169.54 158.66 7.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.402 -0.811 . . . . 0.0 108.928 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 59.24 31.81 21.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.591 -0.693 . . . . 0.0 109.652 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 52.47 32.53 11.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.444 -0.785 . . . . 0.0 109.607 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.555 ' O ' ' CG ' ' A' ' 108' ' ' PHE . 77.3 mm-40 -143.75 -119.71 0.09 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.322 -0.861 . . . . 0.0 108.852 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 107' ' ' GLU . 56.5 m-85 -162.92 150.98 13.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 109.222 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -137.26 151.2 48.43 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.08 131.62 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.17 131.08 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.478 0.656 . . . . 0.0 109.31 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 119' ' ' THR . 89.2 m-20 -90.78 147.08 23.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.794 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.373 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.542 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 33.4 m . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.101 0.476 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.583 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 1.6 m-85 -127.22 138.84 53.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.598 -0.688 . . . . 0.0 109.452 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.9 134.24 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 m120 47.76 -171.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.433 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -65.4 -18.82 65.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.2 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -104.99 104.47 46.88 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.568 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.84 142.13 28.01 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.043 1.828 . . . . 0.0 112.447 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.6 163.09 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.252 -0.905 . . . . 0.0 110.454 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -66.76 -38.58 86.88 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.1 p -158.45 160.17 36.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.981 -1.074 . . . . 0.0 109.8 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -169.05 164.3 11.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.061 -1.025 . . . . 0.0 110.315 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.65 130.46 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.583 -0.698 . . . . 0.0 109.447 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.97 150.06 34.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 110.731 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.54 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -147.05 152.18 38.12 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.735 . . . . 0.0 109.358 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -55.52 134.36 50.72 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.669 0.747 . . . . 0.0 111.183 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.5 13.69 64.96 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 84.4 m-20 -89.99 163.88 14.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.253 -1.145 . . . . 0.0 110.17 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -121.12 132.95 55.16 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.58 131.67 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -114.53 119.02 35.41 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.414 HG21 HD12 ' A' ' 139' ' ' ILE . 35.1 mm -111.66 124.16 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.654 0.74 . . . . 0.0 109.638 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.72 -124.6 7.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -96.56 -1.9 46.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.515 -0.991 . . . . 0.0 108.59 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -95.51 142.48 27.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.575 -0.703 . . . . 0.0 109.847 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -107.44 133.74 51.5 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.637 -0.664 . . . . 0.0 109.882 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -138.34 161.14 37.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.422 -0.799 . . . . 0.0 109.132 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.95 132.39 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -90.03 117.56 28.92 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.1 mt -134.86 163.64 29.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.716 -0.615 . . . . 0.0 110.125 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.633 -0.667 . . . . 0.0 109.897 -179.576 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.67 151.6 42.93 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.446 -1.032 . . . . 0.0 109.847 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.84 156.19 42.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.42 153.55 49.58 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.98 0.895 . . . . 0.0 110.13 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.63 134.9 54.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -122.97 135.36 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.875 0.845 . . . . 0.0 109.902 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.37 135.6 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.676 0.75 . . . . 0.0 110.101 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -84.65 -74.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.399 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.668 HH21 ' NH1' ' A' ' 143' ' ' ARG . 88.2 mtm180 -129.11 147.65 50.99 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.433 -0.792 . . . . 0.0 110.0 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.97 177.66 26.78 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -65.83 -19.04 58.93 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.664 2.243 . . . . 0.0 110.922 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 66' ' ' ALA . 35.5 m120 -84.47 -80.77 0.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.875 . . . . 0.0 109.508 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 58.8 131.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.974 0.892 . . . . 0.0 110.901 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.62 41.43 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.8 m -69.87 146.3 51.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -1.145 . . . . 0.0 111.011 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -145.5 156.53 43.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 109.786 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -129.54 144.35 51.23 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.5 tp -104.06 127.94 51.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.685 -0.634 . . . . 0.0 109.301 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -100.07 74.04 1.76 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.025 -1.047 . . . . 0.0 109.177 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 32.1 p-10 -94.67 3.87 54.54 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -106.6 153.07 22.89 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.281 -0.887 . . . . 0.0 110.059 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.06 94.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.454 -0.779 . . . . 0.0 109.808 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 76' ' ' ILE . 97.2 mt -125.55 126.86 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.6 m -126.46 120.66 30.31 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 p -84.76 166.49 16.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.962 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.38 170.89 7.64 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.932 0.872 . . . . 0.0 110.215 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.29 -131.3 29.91 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -110.77 130.65 55.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -1.06 . . . . 0.0 110.104 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -170.08 136.14 1.27 Allowed Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -42.57 -58.47 1.26 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.485 2.123 . . . . 0.0 112.653 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -96.1 92.72 6.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.935 . . . . 0.0 109.88 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.48 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 82.9 p -171.13 121.09 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 108.972 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -68.1 -34.32 76.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.421 -0.799 . . . . 0.0 109.298 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.43 HD11 HG21 ' A' ' 87' ' ' ILE . 96.6 mt -78.94 130.19 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.861 -1.149 . . . . 0.0 109.761 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 62.4 m-85 -129.07 89.33 2.85 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.427 -0.796 . . . . 0.0 109.401 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.7 mt -101.18 103.35 14.39 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -92.52 87.66 6.05 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.626 0.727 . . . . 0.0 109.881 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.46 ' OD2' ' CZ ' ' A' ' 142' ' ' PHE . 65.2 m-20 -150.22 149.53 30.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.963 . . . . 0.0 109.757 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.2 m -72.79 -26.27 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.733 0.778 . . . . 0.0 109.568 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.2 p -71.66 -17.21 62.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 109.382 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.0 t -110.94 126.78 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.325 -0.859 . . . . 0.0 109.415 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 p -77.08 168.63 19.76 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.797 0.808 . . . . 0.0 110.667 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -63.67 -38.08 89.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.477 -0.764 . . . . 0.0 109.878 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -129.97 50.56 2.17 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.117 -0.989 . . . . 0.0 109.115 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -62.63 -40.8 98.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.078 -1.014 . . . . 0.0 108.969 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.99 159.89 43.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.898 -1.126 . . . . 0.0 110.107 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -134.55 150.53 50.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.498 -0.751 . . . . 0.0 109.436 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.27 140.05 48.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.575 -0.703 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -134.56 136.86 43.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.433 -0.792 . . . . 0.0 109.189 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 38.5 tp -102.63 127.68 49.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -155.66 143.74 19.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.19 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 56.24 39.73 30.15 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.547 0.689 . . . . 0.0 110.135 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.2 m120 55.22 31.79 17.2 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.597 0.713 . . . . 0.0 109.382 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -139.79 130.96 26.5 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.237 -0.914 . . . . 0.0 109.753 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -83.62 146.27 28.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -147.58 167.15 25.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.152 -0.967 . . . . 0.0 109.379 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.21 135.59 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.9 t -125.63 130.84 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 119' ' ' THR . 15.0 m-20 -95.23 134.35 38.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.497 1.908 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.281 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.52 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 29.0 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.602 0.715 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -127.89 145.34 50.98 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.786 . . . . 0.0 109.379 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.4 p -109.59 157.05 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.847 0.832 . . . . 0.0 109.752 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.464 ' ND2' ' CD ' ' A' ' 136' ' ' GLU . 90.8 m-20 -53.21 -39.6 63.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.828 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -57.41 -83.41 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.941 -1.099 . . . . 0.0 109.631 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -143.35 147.39 39.94 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.076 -1.015 . . . . 0.0 109.553 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.18 120.73 8.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.603 2.202 . . . . 0.0 111.894 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.69 163.18 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.186 -0.946 . . . . 0.0 110.203 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 128' ' ' SER . 47.8 p-10 -66.94 -33.03 74.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.55 -0.719 . . . . 0.0 109.487 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.548 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 86.4 p -152.23 160.19 43.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.047 . . . . 0.0 109.278 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.39 156.51 30.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.029 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.1 130.15 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.491 -0.755 . . . . 0.0 109.941 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.6 mt -76.49 151.38 36.45 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.849 0.833 . . . . 0.0 110.209 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.553 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.77 155.71 39.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.507 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -51.33 124.02 10.91 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.921 0.867 . . . . 0.0 110.972 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.07 16.22 59.71 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.553 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 28.9 m-20 -87.75 155.48 19.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.925 -1.338 . . . . 0.0 110.565 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 56.6 mp0 -113.61 128.2 56.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.661 -0.649 . . . . 0.0 109.499 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 144' ' ' LEU . 54.8 t -125.45 131.48 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.403 ' O ' ' NE2' ' A' ' 138' ' ' GLN . 4.9 pp0? -123.2 132.83 54.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.706 -0.621 . . . . 0.0 109.776 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 139' ' ' ILE . 96.4 mt -121.18 117.08 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.668 0.747 . . . . 0.0 109.052 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 61.26 -127.84 43.07 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -93.27 -5.33 50.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -1.161 . . . . 0.0 109.02 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.46 ' CZ ' ' OD2' ' A' ' 91' ' ' ASP . 57.8 m-85 -96.13 133.7 40.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.184 -0.947 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.668 ' NH1' HH21 ' A' ' 62' ' ' ARG . 83.3 mtp180 -103.27 139.4 38.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.592 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 137' ' ' VAL . 4.7 mp -135.51 166.47 23.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 109.47 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.0 p -128.69 133.67 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.652 0.739 . . . . 0.0 109.567 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -96.1 115.52 27.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -0.828 . . . . 0.0 109.249 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.57 147.88 51.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.626 0.727 . . . . 0.0 109.668 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.541 0.686 . . . . 0.0 109.632 -179.755 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.582 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -122.37 142.97 49.95 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.558 -0.966 . . . . 0.0 109.223 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.13 155.18 41.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.38 157.12 40.82 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.186 0.517 . . . . 0.0 109.733 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.4 mt -117.04 128.7 55.42 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.01 134.08 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.642 0.734 . . . . 0.0 109.538 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.6 t -78.36 111.69 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.677 -0.64 . . . . 0.0 109.898 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -64.88 -43.62 92.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.577 -0.702 . . . . 0.0 110.219 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -137.21 151.77 49.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.534 -0.729 . . . . 0.0 110.287 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.06 172.29 22.61 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.21 -20.83 55.81 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.956 2.437 . . . . 0.0 112.006 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' O ' ' C ' ' A' ' 66' ' ' ALA . 93.1 m-20 -98.65 -35.74 10.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.446 -0.784 . . . . 0.0 109.357 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . 35.42 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.313 0.578 . . . . 0.0 110.789 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.48 -15.13 3.66 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.9 m -62.86 144.49 56.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -1.008 . . . . 0.0 110.766 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -137.57 156.04 48.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.603 -0.686 . . . . 0.0 109.354 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -126.32 146.75 49.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.626 -0.671 . . . . 0.0 109.315 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.78 126.56 51.97 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.3 mt -100.53 124.47 46.12 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.452 0.644 . . . . 0.0 109.669 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -154.39 56.63 0.7 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -161.08 175.57 12.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.491 -0.756 . . . . 0.0 109.547 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.13 -65.53 1.0 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.495 -0.753 . . . . 0.0 110.297 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mm -108.56 124.56 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.765 . . . . 0.0 110.212 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.411 ' OG1' ' CD ' ' A' ' 74' ' ' GLN . 31.5 m -127.97 127.08 42.62 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 p -84.65 165.02 18.27 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.562 -0.711 . . . . 0.0 109.936 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.79 164.93 12.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.631 -0.668 . . . . 0.0 110.026 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.445 ' N ' ' NE2' ' A' ' 98' ' ' HIS . . . 70.99 -127.73 15.51 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.535 ' O ' ' ND1' ' A' ' 82' ' ' HIS . 96.9 mtt180 -101.87 137.01 40.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.399 -1.059 . . . . 0.0 110.491 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 173.13 153.79 0.25 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.3 144.41 51.07 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.733 2.289 . . . . 0.0 113.059 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 55.5 t0 57.09 28.6 15.17 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.451 -0.781 . . . . 0.0 109.348 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 18.3 t -98.19 119.81 37.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.34 -0.85 . . . . 0.0 109.572 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -65.03 -36.45 84.41 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.42 -0.8 . . . . 0.0 109.318 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -78.24 128.45 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.892 . . . . 0.0 110.212 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 91.6 m-85 -126.85 86.98 2.58 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.8 mt -108.21 106.45 16.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.619 0.723 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 55.6 t0 -86.51 90.82 8.35 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.501 ' OD2' ' CE2' ' A' ' 142' ' ' PHE . 71.1 m-20 -151.33 130.66 12.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.876 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.14 -24.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.4 p -75.18 -13.81 60.49 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.554 -0.717 . . . . 0.0 109.182 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.451 ' O ' ' OG ' ' A' ' 95' ' ' SER . 89.5 t -101.75 -15.1 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 94' ' ' VAL . 79.4 p 50.23 174.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.592 0.71 . . . . 0.0 110.792 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -59.88 -65.66 0.64 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 109.935 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -102.17 134.53 45.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.648 -0.658 . . . . 0.0 109.779 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.445 ' NE2' ' N ' ' A' ' 80' ' ' GLY . 4.8 p80 -154.3 -35.42 0.1 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.67 158.52 43.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.823 . . . . 0.0 109.928 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -137.16 151.2 48.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.653 -0.654 . . . . 0.0 109.67 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.5 142.63 43.53 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -134.65 141.03 46.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.796 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.9 tp -102.44 127.13 49.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.683 -0.635 . . . . 0.0 109.32 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 106' ' ' ASN . 80.5 tt0 -155.99 -70.69 0.11 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.557 -0.714 . . . . 0.0 109.355 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -72.05 32.71 0.06 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.497 -0.752 . . . . 0.0 109.529 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.531 ' H ' ' C ' ' A' ' 104' ' ' GLU . 16.2 p30 44.02 30.19 0.4 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.658 0.742 . . . . 0.0 109.53 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 108' ' ' PHE . 96.1 mt-10 -144.47 10.24 1.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 107' ' ' GLU . 94.1 m-85 58.17 144.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.255 0.55 . . . . 0.0 110.494 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -133.76 163.7 28.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.3 132.18 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.737 -0.602 . . . . 0.0 109.487 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.7 t -128.65 133.6 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.98 114.67 21.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.317 -0.864 . . . . 0.0 109.487 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 111.006 -179.049 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 121.334 0.588 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.423 ' OH ' ' NH1' ' A' ' 123' ' ' ARG . 31.4 p90 -141.54 157.98 44.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.513 -0.742 . . . . 0.0 109.12 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.1 p -121.02 128.86 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.451 0.643 . . . . 0.0 109.888 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 54.35 38.54 29.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.65 -0.656 . . . . 0.0 109.614 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.423 ' NH1' ' OH ' ' A' ' 120' ' ' TYR . 31.0 mmt180 60.47 44.01 12.45 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.436 0.636 . . . . 0.0 110.21 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -147.63 87.21 6.01 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.522 -0.736 . . . . 0.0 109.127 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.4 130.45 38.61 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.378 2.052 . . . . 0.0 112.076 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.5 m -147.34 154.4 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.326 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.89 -39.81 94.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.6 p -157.26 157.35 34.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.229 -0.919 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.37 149.99 14.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.288 -0.883 . . . . 0.0 109.806 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.65 135.98 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.501 -0.749 . . . . 0.0 110.434 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.28 148.89 37.25 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.358 -0.839 . . . . 0.0 109.856 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.03 154.72 44.28 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.571 0.701 . . . . 0.0 109.773 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.552 ' ND2' ' H ' ' A' ' 148' ' ' THR . 24.4 t-20 -55.97 115.07 2.19 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.581 0.705 . . . . 0.0 110.751 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 146' ' ' PHE . . . 84.13 15.34 69.78 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 136' ' ' GLU . 67.7 t0 -64.23 145.74 55.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -1.211 . . . . 0.0 109.996 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 135' ' ' ASP . 98.4 mt-10 -93.49 122.12 35.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 52.8 t -122.05 132.89 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -122.67 124.92 44.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 141' ' ' LYS . 96.6 mt -124.42 129.95 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.307 0.575 . . . . 0.0 109.947 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.69 -88.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 139' ' ' ILE . 63.3 mttp -141.88 -4.33 1.07 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.461 -1.023 . . . . 0.0 108.624 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.501 ' CE2' ' OD2' ' A' ' 91' ' ' ASP . 62.2 m-85 -96.94 140.49 31.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.767 . . . . 0.0 109.924 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -105.0 129.48 53.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.658 -0.651 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.07 149.68 50.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.22 129.06 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.6 0.714 . . . . 0.0 109.119 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 134' ' ' GLY . 76.0 t80 -90.08 127.67 36.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.764 -0.585 . . . . 0.0 109.582 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.625 ' N ' ' CD2' ' A' ' 147' ' ' LEU . 0.6 OUTLIER -143.41 174.95 10.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.823 0.821 . . . . 0.0 110.06 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.552 ' H ' ' ND2' ' A' ' 133' ' ' ASN . 18.9 p . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.525 0.678 . . . . 0.0 109.482 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.421 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.52 160.75 20.17 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.509 -0.995 . . . . 0.0 109.526 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.81 154.93 51.04 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.35 152.66 48.67 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.454 -0.779 . . . . 0.0 109.616 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.0 mt -113.7 134.41 54.76 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.8 134.98 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.62 110.84 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.576 -0.703 . . . . 0.0 109.632 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -64.55 -44.98 89.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.861 . . . . 0.0 109.68 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -141.88 148.34 38.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.363 -0.835 . . . . 0.0 109.898 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.52 178.69 27.43 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.68 -40.48 84.22 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.326 2.017 . . . . 0.0 111.497 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -114.02 48.24 1.11 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.09 95.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.512 -0.743 . . . . 0.0 109.387 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.53 -17.04 0.58 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.2 t -62.56 150.23 41.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.492 -1.005 . . . . 0.0 109.513 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -130.3 156.2 45.05 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.633 -0.667 . . . . 0.0 109.292 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.17 146.07 50.83 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.533 -0.73 . . . . 0.0 109.286 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 tp -105.66 125.36 50.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.642 -0.661 . . . . 0.0 109.557 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.54 77.85 2.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.406 -0.809 . . . . 0.0 109.0 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.01 12.85 18.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 0.0 109.405 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -126.51 140.63 52.31 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.93 88.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.521 -0.737 . . . . 0.0 110.446 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 mm -106.18 118.47 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.303 -0.873 . . . . 0.0 109.764 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.9 m -123.22 122.85 39.41 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.5 t -87.65 167.3 14.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.175 -0.953 . . . . 0.0 109.543 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.51 146.88 46.99 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.556 -0.715 . . . . 0.0 109.097 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.71 -125.22 8.01 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 99.8 mtt180 -103.32 133.33 48.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.436 -1.037 . . . . 0.0 110.556 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 0.7 OUTLIER 175.11 120.12 0.12 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.08 -14.76 23.44 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.59 1.526 . . . . 0.0 111.287 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 66.5 t0 -96.74 -24.13 16.09 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.727 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.5 t -74.55 139.92 44.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.446 -0.784 . . . . 0.0 110.659 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.59 -41.29 96.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 109.687 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.74 129.51 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.344 -0.848 . . . . 0.0 110.303 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CZ ' ' OD2' ' A' ' 90' ' ' ASP . 84.4 t80 -129.25 84.84 2.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.7 mt -108.54 109.34 20.55 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.559 -0.713 . . . . 0.0 109.916 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.517 ' OD2' ' CZ ' ' A' ' 88' ' ' PHE . 97.9 m-20 -99.95 -93.38 0.27 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.511 -0.743 . . . . 0.0 109.352 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.468 ' CG ' ' CE1' ' A' ' 142' ' ' PHE . 1.5 p30 39.75 -165.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.645 0.736 . . . . 0.0 110.783 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.479 ' O ' ' OG1' ' A' ' 93' ' ' THR . 28.9 m -71.84 161.55 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 92' ' ' VAL . 72.5 p 54.56 -139.77 0.98 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.279 0.562 . . . . 0.0 110.676 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.2 t 42.72 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.493 -0.754 . . . . 0.0 109.649 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -69.36 173.33 5.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.47 -0.769 . . . . 0.0 110.816 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -60.39 -43.91 96.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.48 -0.762 . . . . 0.0 109.358 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -123.23 64.14 1.0 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.36 -35.08 25.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.536 -0.728 . . . . 0.0 109.69 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.45 149.62 30.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 109.803 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -141.49 134.23 28.68 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -100.98 145.8 28.23 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.507 -0.746 . . . . 0.0 109.786 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -131.63 132.18 43.81 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.9 tp -90.75 130.57 36.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.307 -0.871 . . . . 0.0 109.622 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 106' ' ' ASN . 49.1 tp10 -131.97 140.81 49.1 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.582 -0.699 . . . . 0.0 109.319 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 51.63 -85.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.469 -0.769 . . . . 0.0 110.085 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 104' ' ' GLU . 16.9 t-20 -155.75 20.57 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.456 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -134.02 139.95 46.37 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.548 -0.72 . . . . 0.0 109.373 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -77.34 147.13 36.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.513 -0.742 . . . . 0.0 109.981 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -124.85 160.89 27.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.33 134.15 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.8 t -127.33 135.48 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.5 ' CG ' ' H ' ' A' ' 119' ' ' THR . 50.2 t0 -84.0 111.73 19.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.188 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.425 -0.797 . . . . 0.0 109.304 -179.874 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.5 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 23.8 m . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.107 0.479 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -132.9 157.62 44.63 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.462 -0.774 . . . . 0.0 109.223 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.94 128.42 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.561 -0.712 . . . . 0.0 109.375 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 54.55 38.24 29.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.918 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 63.1 46.69 4.53 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.506 0.67 . . . . 0.0 109.833 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -148.6 88.98 5.15 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.091 -1.005 . . . . 0.0 109.24 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -55.06 132.35 51.8 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.226 1.951 . . . . 0.0 112.393 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.1 m -151.5 156.12 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.276 -0.89 . . . . 0.0 109.863 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.29 -40.63 96.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.824 . . . . 0.0 109.379 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.7 t -161.51 156.0 22.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.258 -0.901 . . . . 0.0 109.347 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.43 156.47 38.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.6 t -88.6 130.19 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.342 -0.849 . . . . 0.0 109.247 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.52 149.2 34.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.838 . . . . 0.0 110.218 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.526 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.41 163.81 37.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.416 -0.802 . . . . 0.0 109.267 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.497 ' ND2' ' OG1' ' A' ' 148' ' ' THR . 18.1 m120 -56.53 138.49 51.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.285 -0.884 . . . . 0.0 110.43 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.36 13.55 81.6 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 27.5 m-20 -83.03 145.15 29.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.25 . . . . 0.0 109.623 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -112.87 126.53 55.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.42 132.47 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.6 -0.688 . . . . 0.0 109.333 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 140' ' ' GLY . 13.3 tm0? -119.42 127.8 53.44 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.57 127.46 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.531 0.681 . . . . 0.0 110.052 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.506 ' O ' ' NE2' ' A' ' 138' ' ' GLN . . . 54.51 -104.65 0.27 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -116.78 -24.85 7.52 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.616 -0.932 . . . . 0.0 109.465 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.468 ' CE1' ' CG ' ' A' ' 91' ' ' ASP . 25.2 m-85 -76.33 142.77 41.14 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.347 -0.846 . . . . 0.0 110.077 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -107.85 137.08 46.5 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -136.54 155.49 49.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.389 -0.819 . . . . 0.0 109.415 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.3 p -119.82 131.14 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -94.8 120.54 35.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.397 -0.814 . . . . 0.0 109.985 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.3 mt -134.18 150.43 51.08 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.497 ' OG1' ' ND2' ' A' ' 133' ' ' ASN . 4.5 p . . . . . 0 N--CA 1.498 1.929 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.9 mt -124.6 145.96 49.32 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.654 -0.91 . . . . 0.0 110.36 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.37 166.51 31.64 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.588 0.708 . . . . 0.0 109.85 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -125.83 146.19 49.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.843 0.83 . . . . 0.0 110.236 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.6 mt -125.43 140.9 52.39 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.672 0.749 . . . . 0.0 109.575 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -140.99 143.37 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.745 0.784 . . . . 0.0 110.341 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.6 t -73.76 131.09 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.792 0.806 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -95.22 -32.0 13.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -151.71 140.55 20.95 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.781 0.8 . . . . 0.0 109.966 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.37 167.48 11.66 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.05 -17.71 40.67 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.823 2.349 . . . . 0.0 111.384 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.38 19.52 13.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.43 143.05 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.865 0.84 . . . . 0.0 110.369 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.96 -14.28 61.6 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.4 t -68.16 138.61 55.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.644 -0.915 . . . . 0.0 110.892 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -134.52 143.48 47.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.74 0.781 . . . . 0.0 110.231 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -128.91 136.58 50.6 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.633 0.73 . . . . 0.0 109.652 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt -110.25 123.52 49.93 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.885 0.85 . . . . 0.0 109.74 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.5 mt -90.3 113.38 25.22 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.552 0.691 . . . . 0.0 109.59 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -147.21 70.88 1.2 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.674 0.75 . . . . 0.0 109.197 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -171.07 -121.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.651 -0.656 . . . . 0.0 109.763 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.14 127.6 1.51 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.751 0.786 . . . . 0.0 109.805 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.407 HD11 HG23 ' A' ' 76' ' ' ILE . 14.2 mm 63.57 82.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.632 0.729 . . . . 0.0 109.385 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.4 m -99.41 123.38 43.64 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.781 0.801 . . . . 0.0 110.136 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.1 t -91.44 166.43 12.87 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.538 0.685 . . . . 0.0 109.411 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.54 154.95 26.27 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.774 0.797 . . . . 0.0 110.019 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 101.83 -118.97 6.31 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.551 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 84.9 mtp180 -124.08 130.62 52.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.78 -0.835 . . . . 0.0 110.352 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 3.1 m-70 176.3 149.37 0.31 Allowed Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.05 -30.99 20.09 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.88 2.386 . . . . 0.0 112.158 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -93.0 -0.25 57.25 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.0 t -94.74 118.93 32.53 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.717 0.77 . . . . 0.0 109.803 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.01 -39.94 94.17 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.335 0.588 . . . . 0.0 109.44 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.526 ' CD1' ' N ' ' A' ' 87' ' ' ILE . 1.9 mp -82.56 125.57 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.718 . . . . 0.0 109.987 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CE2' ' OD1' ' A' ' 90' ' ' ASP . 34.0 t80 -124.82 102.3 7.5 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.811 0.815 . . . . 0.0 108.922 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.8 mt -107.34 112.67 25.61 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.821 0.819 . . . . 0.0 110.038 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD1' ' CE2' ' A' ' 88' ' ' PHE . 99.9 m-20 -91.52 81.31 5.37 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.496 0.665 . . . . 0.0 109.435 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 92' ' ' VAL . 66.9 t0 -156.16 140.76 16.91 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.71 0.767 . . . . 0.0 110.071 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.542 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 33.4 m -67.62 -22.64 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.9 p -65.72 -29.08 69.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.575 -0.703 . . . . 0.0 109.165 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -103.34 128.84 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 121.887 0.851 . . . . 0.0 110.033 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 p -72.66 172.41 10.7 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.881 0.848 . . . . 0.0 111.03 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -59.19 -43.75 92.22 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.911 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 99' ' ' ALA . 95.1 mtt-85 -108.29 -51.81 2.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 59.5 -72.56 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.423 0.63 . . . . 0.0 109.951 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -142.32 163.51 32.65 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.712 0.768 . . . . 0.0 109.919 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -132.03 146.11 51.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.803 0.811 . . . . 0.0 110.062 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.35 140.51 48.59 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.432 0.634 . . . . 0.0 109.392 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -128.1 142.91 51.07 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.805 0.812 . . . . 0.0 110.212 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.6 tp -103.56 123.1 46.31 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.548 0.69 . . . . 0.0 109.361 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -92.25 -127.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.444 0.64 . . . . 0.0 110.141 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.64 -40.8 92.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.805 -0.559 . . . . 0.0 109.641 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -174.82 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -140.91 136.59 32.42 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.653 0.74 . . . . 0.0 109.478 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -79.41 146.88 32.57 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.694 0.759 . . . . 0.0 110.228 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.26 160.87 31.63 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.426 0.631 . . . . 0.0 109.488 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -123.82 127.06 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.885 0.85 . . . . 0.0 109.595 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.74 133.95 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.685 0.755 . . . . 0.0 109.404 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -80.61 151.84 28.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.635 0.731 . . . . 0.0 110.451 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.812 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.914 0.864 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.427 ' OH ' ' OE1' ' A' ' 138' ' ' GLN . 51.0 p90 -138.97 160.71 39.11 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.379 0.609 . . . . 0.0 109.584 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 123' ' ' ARG . 10.4 p -105.92 128.24 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 121.858 0.837 . . . . 0.0 109.99 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 53.42 -83.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.321 0.581 . . . . 0.0 109.707 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 121' ' ' VAL . 64.3 ttt180 -156.91 42.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -147.64 85.15 6.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.94 133.95 61.36 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.44 2.093 . . . . 0.0 112.177 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -145.92 162.98 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.905 0.86 . . . . 0.0 110.574 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -65.44 -34.08 77.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.2 p -153.2 159.9 42.73 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.571 0.7 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.62 155.91 30.92 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.709 0.766 . . . . 0.0 110.388 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.3 t -105.78 130.12 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.852 0.834 . . . . 0.0 109.641 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -75.79 146.35 40.04 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.625 0.726 . . . . 0.0 109.835 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.546 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.58 155.35 40.15 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.019 0.914 . . . . 0.0 110.289 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.422 ' OD1' ' OG1' ' A' ' 148' ' ' THR . 33.1 m-20 -48.41 122.93 5.88 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.937 0.875 . . . . 0.0 110.755 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.62 18.79 54.11 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 16.1 m-20 -87.66 151.93 22.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.694 -0.886 . . . . 0.0 110.301 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -114.86 129.92 56.79 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.734 0.778 . . . . 0.0 109.721 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.64 131.03 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.709 0.766 . . . . 0.0 109.133 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.427 ' OE1' ' OH ' ' A' ' 120' ' ' TYR . 57.0 tt0 -117.26 126.69 53.15 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.795 0.807 . . . . 0.0 109.883 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.18 129.1 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.573 0.701 . . . . 0.0 109.619 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 48.0 -107.28 0.23 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -111.31 -21.05 12.05 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.51 148.14 33.56 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.684 0.754 . . . . 0.0 110.76 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -115.33 126.98 55.11 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.718 0.77 . . . . 0.0 109.453 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.11 155.92 44.7 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.625 0.726 . . . . 0.0 110.173 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.9 p -126.75 135.37 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.715 0.769 . . . . 0.0 109.763 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -92.73 118.77 31.42 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.861 0.838 . . . . 0.0 109.673 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 93.0 mt -134.58 148.83 50.53 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.627 0.727 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.422 ' OG1' ' OD1' ' A' ' 133' ' ' ASN . 5.1 p . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.624 0.726 . . . . 0.0 109.759 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.905 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.25 146.1 46.39 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.396 -1.061 . . . . 0.0 109.942 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.58 157.15 40.63 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 pp -141.49 157.67 44.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.225 -0.922 . . . . 0.0 109.673 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mp -116.18 151.75 35.07 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.17 133.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.37 134.59 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.409 -0.807 . . . . 0.0 110.398 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -112.23 50.72 0.84 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 141' ' ' LYS . 3.6 tpt180 -120.42 173.43 7.15 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.72 -57.63 3.04 Favored Glycine 0 N--CA 1.49 2.241 0 O-C-N 120.92 -1.112 . . . . 0.0 111.443 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -85.07 12.67 3.0 Favored 'Trans proline' 0 N--CA 1.515 2.761 0 C-N-CA 123.917 3.078 . . . . 0.0 114.366 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -148.62 17.08 1.02 Allowed 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.335 -1.478 . . . . 0.0 108.663 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.78 153.39 32.92 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.382 0.611 . . . . 0.0 109.896 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.47 -21.63 43.34 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.7 m -66.17 141.24 58.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.29 -1.123 . . . . 0.0 109.263 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -133.81 146.95 51.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.679 -0.638 . . . . 0.0 109.359 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.18 102.24 4.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.41 -0.806 . . . . 0.0 108.878 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -85.63 137.72 32.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 109.4 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.3 mt -95.91 97.45 9.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.526 -0.734 . . . . 0.0 109.82 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 51.5 t0 -109.92 17.54 21.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -127.35 152.92 46.85 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.505 -0.747 . . . . 0.0 109.997 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.41 -47.89 83.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.636 -0.665 . . . . 0.0 110.452 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.24 126.12 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.299 -0.876 . . . . 0.0 109.618 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 92.6 m -121.96 120.95 35.92 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 p -85.29 163.13 18.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.387 -0.82 . . . . 0.0 109.853 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.58 177.83 4.5 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.478 -0.764 . . . . 0.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.88 -129.64 10.4 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.367 -0.92 . . . . 0.0 110.887 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.558 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 85.1 mtt85 -96.63 114.75 26.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.447 -1.031 . . . . 0.0 110.231 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 32.3 m-70 -170.58 80.33 0.57 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.81 -38.39 67.43 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.282 1.988 . . . . 0.0 111.266 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.56 -39.85 95.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.441 -0.787 . . . . 0.0 109.28 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 t -72.09 158.27 36.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.352 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -62.45 -40.55 96.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.514 -0.741 . . . . 0.0 109.883 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 93.2 mt -94.49 117.09 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.07 -1.019 . . . . 0.0 109.671 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 16.5 p90 -130.33 88.26 2.62 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.19 92.33 9.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.029 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -95.71 92.65 6.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.419 -0.801 . . . . 0.0 109.488 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -159.99 176.93 11.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.82 -44.38 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.312 -0.867 . . . . 0.0 109.994 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.6 p -71.61 173.6 7.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.63 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t 61.81 108.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.679 0.752 . . . . 0.0 109.707 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -61.1 -150.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.551 0.691 . . . . 0.0 110.752 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -60.31 -45.69 92.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.483 -0.76 . . . . 0.0 109.364 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 99' ' ' ALA . 36.4 ptt85 179.99 -54.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' A' ' 97' ' ' ARG . 46.8 p-80 43.09 15.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.675 -0.641 . . . . 0.0 110.141 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -154.7 143.13 20.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.861 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -149.42 147.67 28.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.34 143.31 39.02 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.51 -0.744 . . . . 0.0 109.547 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -128.71 137.59 51.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.655 -0.653 . . . . 0.0 109.509 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.2 tp -91.64 126.89 36.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.382 -0.824 . . . . 0.0 108.78 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 106' ' ' ASN . 83.7 tt0 -119.83 129.87 54.63 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.467 -0.771 . . . . 0.0 109.763 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 m120 50.79 -86.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.518 -0.739 . . . . 0.0 109.957 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 104' ' ' GLU . 9.0 m120 -148.35 23.6 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.171 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -134.97 139.05 44.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.698 . . . . 0.0 109.561 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -75.5 149.0 38.54 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.646 -0.659 . . . . 0.0 109.716 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -135.92 165.33 25.9 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 109.092 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.69 132.28 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -129.78 132.73 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 119' ' ' THR . 88.8 m-20 -103.71 139.28 39.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.432 -0.792 . . . . 0.0 109.391 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 -179.298 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.52 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 21.3 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.157 0.503 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -119.62 150.25 40.62 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.623 -0.673 . . . . 0.0 109.326 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 122' ' ' ASN . 11.7 p -120.37 130.84 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.595 -0.69 . . . . 0.0 110.01 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 124' ' ' GLU . 91.0 m-20 45.58 -172.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.637 0.732 . . . . 0.0 110.781 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -59.67 -2.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.59 -0.694 . . . . 0.0 110.051 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 122' ' ' ASN . 27.1 mt-10 -109.6 95.16 18.49 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.421 -0.799 . . . . 0.0 109.436 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.28 127.82 8.54 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.834 1.69 . . . . 0.0 111.795 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.04 162.25 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.309 -0.869 . . . . 0.0 110.363 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -74.66 -22.44 58.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.531 -0.731 . . . . 0.0 109.553 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.4 p -162.54 160.34 25.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.632 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -173.06 166.14 4.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.166 -0.959 . . . . 0.0 109.677 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.79 130.66 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.453 -0.779 . . . . 0.0 109.516 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.73 148.7 34.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 109.91 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.537 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -151.02 152.74 33.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 108.945 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -51.87 134.13 31.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.371 -0.831 . . . . 0.0 110.441 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.19 11.4 64.82 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 79.4 m-20 -89.09 148.64 23.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.269 -1.136 . . . . 0.0 109.724 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -112.22 128.06 56.14 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.93 130.6 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.645 -0.659 . . . . 0.0 109.301 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -126.01 122.45 35.9 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.595 -0.691 . . . . 0.0 109.214 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 95.4 mt -123.82 129.73 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.638 -0.664 . . . . 0.0 109.914 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.36 -108.02 2.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.527 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 88.7 tttt -126.16 -26.1 3.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.913 . . . . 0.0 109.255 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -74.34 146.58 42.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -103.84 139.7 38.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.493 -0.754 . . . . 0.0 109.269 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.53 137.43 40.26 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.814 . . . . 0.0 109.589 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.8 p -109.49 130.18 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -89.72 111.45 22.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.923 . . . . 0.0 109.971 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.8 mt -140.12 159.85 41.26 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.612 0.72 . . . . 0.0 109.813 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.543 -0.723 . . . . 0.0 110.356 -179.345 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 tp -149.95 141.65 23.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.92 -1.341 . . . . 0.0 109.237 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.17 165.93 23.64 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.55 0.69 . . . . 0.0 109.739 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.03 154.75 47.88 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.623 0.725 . . . . 0.0 109.744 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.3 mt -114.37 136.81 52.58 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.35 131.56 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.609 0.719 . . . . 0.0 109.782 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.0 t -73.21 133.63 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.593 0.711 . . . . 0.0 109.72 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -86.29 -74.02 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.906 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -121.61 149.24 43.45 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.757 0.789 . . . . 0.0 110.09 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.54 175.09 25.3 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.42 -18.43 43.87 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.864 2.376 . . . . 0.0 111.727 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' ALA . 92.5 m-20 -88.93 -74.93 0.45 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.186 -0.947 . . . . 0.0 109.38 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 60.59 132.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.473 -0.767 . . . . 0.0 110.521 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.99 -20.24 50.85 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 m -71.54 144.79 49.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -1.143 . . . . 0.0 110.777 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -146.69 151.66 37.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 109.64 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -130.32 145.66 51.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -109.66 146.25 35.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.563 -0.71 . . . . 0.0 109.22 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.6 mt -97.65 115.82 28.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.882 . . . . 0.0 110.17 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -89.45 53.33 2.58 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.963 0.887 . . . . 0.0 108.693 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 43.31 -165.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.174 0.988 . . . . 0.0 111.199 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 59.95 -144.5 0.52 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.663 0.745 . . . . 0.0 110.479 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.407 HD11 HG23 ' A' ' 76' ' ' ILE . 96.7 mt -111.12 127.21 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.734 -0.604 . . . . 0.0 109.5 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.6 m -120.24 120.58 36.51 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.531 ' HG ' ' CG ' ' A' ' 82' ' ' HIS . 17.2 p -83.03 162.29 21.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.429 -0.795 . . . . 0.0 109.885 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.73 -179.46 3.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.34 -0.85 . . . . 0.0 110.137 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.45 -124.17 28.91 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -105.62 127.26 52.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.43 -1.041 . . . . 0.0 109.963 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.531 ' CG ' ' HG ' ' A' ' 78' ' ' SER . 36.6 t-80 -173.94 135.09 0.62 Allowed Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' A' ' 85' ' ' SER . 49.3 Cg_endo -68.92 150.32 73.1 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.391 2.061 . . . . 0.0 113.394 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t0 65.24 -8.3 0.26 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.821 -0.549 . . . . 0.0 110.087 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 83' ' ' PRO . 46.7 t -73.84 133.98 43.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.991 -1.068 . . . . 0.0 110.191 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.26 -41.1 97.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.544 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.84 126.02 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.722 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -129.66 85.87 2.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.511 -0.743 . . . . 0.0 109.148 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.2 mt -104.83 93.66 4.85 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.455 -0.778 . . . . 0.0 109.331 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -99.96 83.34 2.7 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.526 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 24.3 p30 -155.4 172.57 17.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.127 -0.983 . . . . 0.0 109.958 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.541 ' C ' ' H ' ' A' ' 94' ' ' VAL . 5.3 t -62.81 169.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.534 -0.729 . . . . 0.0 110.703 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 92' ' ' VAL . 4.4 p 65.74 -7.38 0.36 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 92' ' ' VAL . 82.2 t -125.87 122.19 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.475 -0.766 . . . . 0.0 109.254 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.3 p -86.65 -162.09 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.824 0.821 . . . . 0.0 110.498 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -62.57 -38.65 90.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.837 . . . . 0.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -152.81 81.69 1.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.077 -1.015 . . . . 0.0 108.947 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -65.95 -39.76 90.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.737 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.62 160.97 36.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.841 . . . . 0.0 109.621 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -137.88 144.96 41.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.506 -0.746 . . . . 0.0 109.196 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.52 140.35 48.21 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -136.95 142.15 42.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.815 . . . . 0.0 109.625 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 53.8 tp -95.53 126.9 41.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.514 -0.742 . . . . 0.0 109.385 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.413 ' HG2' ' H ' ' A' ' 105' ' ' ASN . 53.5 tt0 -94.12 -128.46 0.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.236 -0.915 . . . . 0.0 110.012 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.413 ' H ' ' HG2' ' A' ' 104' ' ' GLU . 9.0 m120 -64.48 -41.57 96.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.825 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -174.05 25.83 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.02 -1.05 . . . . 0.0 109.092 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -137.41 142.4 41.67 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.234 -0.917 . . . . 0.0 110.059 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -76.64 145.63 38.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.499 -0.75 . . . . 0.0 110.05 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -139.27 162.16 35.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.279 -0.888 . . . . 0.0 109.221 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.57 132.57 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.6 t -127.37 132.84 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.669 0.747 . . . . 0.0 109.475 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 1.5 m-20 -78.01 138.06 38.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.561 -0.712 . . . . 0.0 109.584 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.341 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.621 0.724 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -140.46 157.67 45.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.181 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 122' ' ' ASN . 7.6 p -107.29 156.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.69 -0.631 . . . . 0.0 109.638 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 121' ' ' VAL . 6.5 m120 -41.23 -39.35 1.32 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.517 0.675 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -65.63 -90.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.984 . . . . 0.0 109.967 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -142.62 146.39 38.22 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.297 -0.877 . . . . 0.0 109.8 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.96 133.88 34.9 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.257 1.971 . . . . 0.0 112.636 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.6 m -144.24 157.31 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.082 -1.011 . . . . 0.0 110.64 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -72.96 -16.85 61.52 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.679 0.752 . . . . 0.0 109.049 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.6 p -158.61 161.23 37.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.968 . . . . 0.0 109.434 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.63 153.96 25.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.942 -1.099 . . . . 0.0 109.84 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.2 t -98.78 126.81 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.386 -0.821 . . . . 0.0 109.57 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 76.8 mt -79.53 146.44 32.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 110.303 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.526 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -151.96 151.17 30.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.175 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.471 ' ND2' ' HG1' ' A' ' 148' ' ' THR . 22.1 t-20 -46.93 124.99 6.87 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.461 -0.774 . . . . 0.0 110.998 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.53 13.6 59.57 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 32.9 m-20 -87.57 154.68 20.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.043 -1.269 . . . . 0.0 109.693 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -115.35 135.86 53.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.446 -0.784 . . . . 0.0 109.553 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.07 132.1 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.0 109.144 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -120.27 122.19 40.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 0.0 109.445 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.62 126.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.52 0.676 . . . . 0.0 109.232 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.2 -134.3 48.46 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -91.86 -7.95 47.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -1.032 . . . . 0.0 109.38 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.526 ' CE1' ' OD2' ' A' ' 91' ' ' ASP . 82.5 m-85 -95.28 143.86 26.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 0.0 110.516 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -108.16 136.9 47.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.622 -0.674 . . . . 0.0 109.202 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.29 154.27 51.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.59 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.89 136.53 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.436 0.636 . . . . 0.0 109.289 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -92.46 113.48 25.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.677 -0.639 . . . . 0.0 109.297 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.4 mt -137.06 147.77 46.34 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.756 . . . . 0.0 109.784 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.471 ' HG1' ' ND2' ' A' ' 133' ' ' ASN . 68.3 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 110.016 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.394 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.34 151.79 33.98 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.497 -1.001 . . . . 0.0 109.846 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -146.4 156.25 43.17 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -137.99 171.75 13.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.805 . . . . 0.0 109.326 -179.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 mt -118.76 134.3 55.24 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.77 130.05 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -70.07 134.91 29.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.537 -0.727 . . . . 0.0 109.986 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -104.55 36.3 2.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.626 -0.672 . . . . 0.0 109.338 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 66' ' ' ALA . 77.8 mtp85 -126.85 144.27 51.02 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.429 -0.794 . . . . 0.0 109.93 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.76 -57.21 15.09 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -46.43 -36.93 18.8 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.314 2.009 . . . . 0.0 111.781 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.401 ' ND2' ' CE1' ' A' ' 142' ' ' PHE . 41.0 m-20 -119.66 25.31 10.09 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.581 -0.699 . . . . 0.0 109.18 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . -66.46 140.52 58.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.313 -0.867 . . . . 0.0 109.801 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.413 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 101.21 -18.87 53.48 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 m -64.12 136.55 57.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.38 -1.071 . . . . 0.0 109.739 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' NH1' ' O ' ' A' ' 67' ' ' GLY . 90.6 mtm-85 -140.58 146.82 38.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.728 . . . . 0.0 109.098 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 57' ' ' LEU . 88.0 m-85 -129.01 136.58 50.5 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.511 -0.743 . . . . 0.0 109.324 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 tp -103.84 129.73 51.34 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.494 -0.754 . . . . 0.0 109.163 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.55 70.46 3.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.357 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 67.1 t0 -95.18 34.67 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -141.52 150.81 42.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.341 -0.85 . . . . 0.0 109.96 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.76 81.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.684 -0.635 . . . . 0.0 110.299 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.39 125.27 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.407 -0.808 . . . . 0.0 109.32 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.0 m -122.65 122.14 38.09 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.42 ' OG ' ' OE2' ' A' ' 100' ' ' GLU . 7.1 m -87.15 153.12 21.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 109.727 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -118.34 122.38 42.73 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.637 -0.665 . . . . 0.0 109.341 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.22 -124.38 2.52 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.476 ' C ' ' CG ' ' A' ' 82' ' ' HIS . 62.8 ttm-85 -119.72 121.92 40.28 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.532 -0.981 . . . . 0.0 109.222 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.614 ' N ' ' CD2' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -170.05 161.54 6.67 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.12 -78.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.45 2.1 . . . . 0.0 112.077 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -81.37 97.41 7.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.325 -0.86 . . . . 0.0 109.743 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 p -166.51 126.96 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.767 . . . . 0.0 109.019 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.35 -37.72 84.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.48 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.3 mm -87.86 120.31 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.0 109.649 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CE2' ' OD2' ' A' ' 90' ' ' ASP . 69.3 t80 -130.28 85.72 2.32 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.19 107.86 18.96 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.444 -0.785 . . . . 0.0 109.507 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD2' ' CE2' ' A' ' 88' ' ' PHE . 97.9 m-20 -90.38 87.32 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 109.276 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -151.71 150.1 29.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.379 -0.826 . . . . 0.0 109.641 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.37 -25.05 26.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.041 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.412 ' HG1' ' N ' ' A' ' 94' ' ' VAL . 72.0 p -65.27 -33.94 77.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.479 -0.763 . . . . 0.0 109.647 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.412 ' N ' ' HG1' ' A' ' 93' ' ' THR . 25.1 t -101.68 118.02 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.3 -0.875 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.7 m -70.81 174.7 5.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.342 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -60.67 -43.72 97.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.564 -0.71 . . . . 0.0 109.356 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -127.04 55.23 1.58 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.564 -0.71 . . . . 0.0 109.114 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -60.7 -41.87 96.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.5 -0.75 . . . . 0.0 109.761 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.45 158.58 44.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.357 -0.839 . . . . 0.0 109.08 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.42 ' OE2' ' OG ' ' A' ' 78' ' ' SER . 28.0 tp10 -133.13 148.63 52.12 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.518 -0.739 . . . . 0.0 109.227 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -113.84 135.48 53.92 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -128.59 141.26 51.42 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.465 -0.772 . . . . 0.0 109.655 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.1 tp -98.93 127.23 44.81 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 106' ' ' ASN . 49.2 tp10 -123.39 132.76 54.07 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.578 -0.701 . . . . 0.0 109.701 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 51.97 -84.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 109.859 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' GLU . 63.8 t30 -153.51 25.74 0.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -134.73 138.58 44.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.489 -0.757 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -77.04 146.98 37.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -0.779 . . . . 0.0 109.74 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -132.92 157.62 44.66 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.29 136.54 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.35 133.5 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 44.5 p-10 -95.87 115.69 27.8 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.247 -0.908 . . . . 0.0 109.769 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.466 -0.772 . . . . 0.0 108.935 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 93.8 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.356 0.598 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -147.49 162.7 38.54 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 p -120.74 128.13 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.435 -0.791 . . . . 0.0 109.844 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.1 m120 55.38 38.5 30.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.509 -0.745 . . . . 0.0 110.01 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 59.26 40.16 21.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.459 -0.776 . . . . 0.0 109.492 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -144.59 87.36 7.58 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.0 108.494 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.1 135.09 67.3 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.498 2.132 . . . . 0.0 112.202 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.3 m -141.79 162.96 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.307 -0.871 . . . . 0.0 110.014 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.64 -40.54 97.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.503 -0.748 . . . . 0.0 109.366 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.2 p -157.58 161.35 38.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.098 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.37 150.58 23.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.006 -1.058 . . . . 0.0 109.908 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.6 t -95.0 132.26 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.494 -0.754 . . . . 0.0 109.239 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.64 151.44 37.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.389 -0.819 . . . . 0.0 109.943 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.544 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -147.4 159.34 43.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.345 -0.847 . . . . 0.0 109.636 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -57.25 132.36 52.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 110.637 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.34 14.93 72.9 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 29.4 m-20 -83.18 148.84 27.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.242 -1.152 . . . . 0.0 109.581 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -113.29 128.12 56.37 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.42 131.73 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -120.06 118.45 30.65 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.539 -0.725 . . . . 0.0 109.229 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.31 129.36 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.611 -0.68 . . . . 0.0 109.744 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 59.98 -131.41 50.32 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -102.43 -16.32 16.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.587 -0.949 . . . . 0.0 109.18 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.401 ' CE1' ' ND2' ' A' ' 65' ' ' ASN . 79.0 m-85 -80.47 147.81 30.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.455 -0.778 . . . . 0.0 109.895 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.16 137.24 43.24 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.476 -0.765 . . . . 0.0 109.2 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.5 150.67 46.64 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.336 -0.853 . . . . 0.0 109.24 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.02 132.78 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.463 -0.773 . . . . 0.0 108.943 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.449 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 74.1 t80 -93.29 117.48 30.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 109.513 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.0 mt -129.06 139.76 51.89 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 69.7 p . . . . . 0 N--CA 1.496 1.849 0 O-C-N 121.446 -0.784 . . . . 0.0 109.993 -179.524 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.444 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.3 mt -96.54 172.31 8.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.155 -1.203 . . . . 0.0 110.243 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.71 157.66 43.65 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.598 ' CD2' HH21 ' A' ' 69' ' ' ARG . 5.1 mp -131.87 150.3 52.19 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.341 -0.849 . . . . 0.0 110.022 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.5 mt -117.39 134.89 54.3 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.61 132.53 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.654 0.74 . . . . 0.0 109.259 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.1 132.53 33.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.491 -0.755 . . . . 0.0 109.779 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -93.31 -15.12 26.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.373 -0.829 . . . . 0.0 109.284 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -165.87 141.77 5.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.034 . . . . 0.0 109.925 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.91 176.82 24.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.23 -40.23 83.13 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.423 2.082 . . . . 0.0 111.764 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -108.43 53.58 0.68 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.96 143.47 42.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.463 -0.773 . . . . 0.0 110.13 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.13 1.56 75.64 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.2 m -71.84 152.33 42.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.466 -1.02 . . . . 0.0 109.941 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.598 HH21 ' CD2' ' A' ' 57' ' ' LEU . 17.8 ptm180 -133.81 144.37 48.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.516 -0.74 . . . . 0.0 109.279 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -121.16 138.31 54.27 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.487 -0.758 . . . . 0.0 109.385 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 tp -99.48 125.71 45.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.388 -0.82 . . . . 0.0 109.13 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -99.34 75.05 1.96 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.282 -0.886 . . . . 0.0 109.13 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 64.3 t0 -99.07 17.3 20.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.392 -0.817 . . . . 0.0 109.053 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -119.26 144.45 46.77 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.562 -0.711 . . . . 0.0 109.658 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.82 99.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 110.076 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.4 mt -124.81 126.78 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.431 -0.793 . . . . 0.0 109.012 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 m -124.52 124.05 41.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.564 -0.71 . . . . 0.0 109.364 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -96.67 156.57 16.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 109.334 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.91 147.81 35.04 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.69 -48.44 1.01 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -88.01 141.11 28.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.151 -1.205 . . . . 0.0 109.989 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.615 ' N ' ' CD2' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -88.72 -44.49 0.45 Allowed Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.419 -0.801 . . . . 0.0 109.817 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 32.5 Cg_exo -57.25 137.19 80.59 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.374 2.049 . . . . 0.0 112.701 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 44.76 46.43 8.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.603 -0.686 . . . . 0.0 109.709 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.9 m -156.07 116.89 3.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.325 -0.859 . . . . 0.0 109.74 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.24 -38.29 90.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.3 mm -78.2 128.09 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.427 -0.796 . . . . 0.0 109.819 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -129.99 85.92 2.35 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.4 98.05 7.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 46.7 p-10 -91.46 94.62 9.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.701 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -154.3 158.14 39.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.18 -0.95 . . . . 0.0 109.926 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.7 m -69.13 -32.47 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.534 -0.729 . . . . 0.0 109.761 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p -65.83 -29.96 70.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.901 . . . . 0.0 110.341 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -99.84 125.9 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -0.994 . . . . 0.0 109.562 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.0 m -79.39 -170.15 2.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.643 -0.661 . . . . 0.0 110.19 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -60.28 -45.45 93.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.758 . . . . 0.0 109.614 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 99' ' ' ALA . 79.7 mtp85 -108.17 -47.83 3.47 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.8 t60 52.81 -80.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.619 -0.675 . . . . 0.0 110.074 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -127.71 155.8 43.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.541 -0.724 . . . . 0.0 109.131 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -136.02 154.23 51.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 109.094 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -118.73 143.66 46.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -130.19 144.29 51.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.4 -0.813 . . . . 0.0 109.511 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.6 tp -104.46 123.96 48.4 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.511 -0.743 . . . . 0.0 109.437 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -95.19 -117.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 92.5 m-20 -65.07 -50.3 66.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 110.13 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 68.6 m-20 -169.03 23.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.572 -0.705 . . . . 0.0 109.282 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.54 136.68 43.22 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -77.0 146.62 37.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.49 -0.756 . . . . 0.0 110.126 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -123.37 156.62 35.06 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 p -117.75 131.15 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.76 143.13 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.485 -0.759 . . . . 0.0 109.731 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -99.58 112.82 24.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 0.0 108.938 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.172 -0.955 . . . . 0.0 110.742 -178.795 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.199 0.523 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -138.78 153.19 48.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.429 -0.794 . . . . 0.0 109.387 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.1 p -120.25 129.36 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.664 0.745 . . . . 0.0 109.52 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.512 ' CG ' ' H ' ' A' ' 123' ' ' ARG . 6.8 t-20 55.37 -167.09 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.585 0.707 . . . . 0.0 110.229 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.512 ' H ' ' CG ' ' A' ' 122' ' ' ASN . 11.0 mmp_? -72.6 -4.63 31.99 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.691 -0.631 . . . . 0.0 109.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -107.81 99.53 30.46 Favored Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -76.19 128.46 10.58 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.021 1.814 . . . . 0.0 112.056 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.59 160.79 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.299 -0.876 . . . . 0.0 110.478 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.89 -42.21 97.51 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.556 -0.715 . . . . 0.0 109.266 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 m -157.94 158.43 34.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 109.467 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -168.05 159.09 10.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.035 -1.041 . . . . 0.0 109.859 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.19 131.53 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.763 . . . . 0.0 109.954 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.6 150.31 36.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.866 . . . . 0.0 109.864 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.96 156.76 46.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.418 -0.801 . . . . 0.0 109.567 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -55.83 135.03 52.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.52 -0.737 . . . . 0.0 110.667 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.99 19.16 65.77 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 136' ' ' GLU . 64.4 t0 -96.76 133.73 40.96 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.308 -1.113 . . . . 0.0 109.986 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.488 ' N ' ' OD1' ' A' ' 135' ' ' ASP . 98.4 mt-10 -94.35 130.45 40.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.319 -0.863 . . . . 0.0 109.224 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.5 t -124.51 132.53 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.565 -0.71 . . . . 0.0 109.126 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -126.22 127.53 45.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.42 127.47 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.496 -0.753 . . . . 0.0 109.698 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.48 -95.35 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -128.43 -18.37 4.01 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.643 -0.916 . . . . 0.0 109.123 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -74.76 141.44 44.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -0.859 . . . . 0.0 109.63 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -105.28 131.83 52.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.432 -0.792 . . . . 0.0 109.814 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.75 152.62 51.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.506 -0.746 . . . . 0.0 109.161 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.43 131.39 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -92.5 111.39 22.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.44 -0.788 . . . . 0.0 109.271 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.77 143.17 50.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.467 0.651 . . . . 0.0 109.715 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 0.0 109.775 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.633 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.92 148.21 26.93 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.187 -1.184 . . . . 0.0 109.931 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.26 176.87 8.02 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.614 0.721 . . . . 0.0 109.315 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -157.33 172.58 18.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.886 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.47 149.3 52.21 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 68.2 t -124.61 131.56 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.571 -0.705 . . . . 0.0 109.804 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.6 t -73.05 119.88 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.487 -0.758 . . . . 0.0 109.333 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -92.92 -16.64 24.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 109.122 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -155.5 132.68 10.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.599 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.15 172.14 22.52 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.97 -42.44 66.76 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.518 2.146 . . . . 0.0 112.003 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -100.66 49.71 0.89 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.471 -0.768 . . . . 0.0 109.09 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.09 141.98 26.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.539 -0.726 . . . . 0.0 110.234 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.65 -18.48 56.86 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -68.64 149.88 48.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.284 -1.127 . . . . 0.0 110.695 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -139.06 135.81 34.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -111.58 115.46 29.2 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.416 -0.802 . . . . 0.0 109.07 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 tt -94.5 133.23 38.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 110.244 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.75 131.17 35.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.578 -0.701 . . . . 0.0 109.608 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -136.33 26.74 3.17 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.61 155.46 47.43 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.299 -0.876 . . . . 0.0 109.783 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.69 84.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.932 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 76' ' ' ILE . 96.8 mt -123.14 126.31 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.419 -0.801 . . . . 0.0 109.156 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.4 m -119.69 124.03 45.24 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.712 . . . . 0.0 109.549 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 m -86.87 155.43 20.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.476 -0.765 . . . . 0.0 109.193 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.41 131.7 53.73 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.448 -0.783 . . . . 0.0 109.364 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.3 -138.91 6.31 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 72.7 ttp85 -113.37 125.58 54.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.509 -0.995 . . . . 0.0 110.042 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 11.8 m-70 -168.94 152.17 5.17 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.14 -19.5 50.91 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.201 1.934 . . . . 0.0 111.589 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 85' ' ' SER . 84.5 m-20 -117.95 -129.95 0.3 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.543 -0.723 . . . . 0.0 109.744 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 84' ' ' ASP . 6.1 m 57.87 138.18 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.74 0.781 . . . . 0.0 110.602 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.34 -43.53 97.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.492 -0.755 . . . . 0.0 109.355 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.418 HG23 HD13 ' A' ' 87' ' ' ILE . 93.5 mt -100.81 115.25 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.332 -0.855 . . . . 0.0 109.228 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.516 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 26.3 p90 -130.23 98.1 4.62 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.9 mt -97.0 123.8 40.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.581 ' CG ' ' H ' ' A' ' 91' ' ' ASP . 31.0 t0 -95.25 -151.62 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.538 -0.726 . . . . 0.0 109.8 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.581 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 34.5 t70 58.82 171.53 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.686 0.755 . . . . 0.0 110.351 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.447 ' N ' ' CG ' ' A' ' 91' ' ' ASP . 71.9 t -91.25 114.21 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.599 -0.688 . . . . 0.0 110.151 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER 172.29 -31.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.099 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.9 t -115.52 131.99 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 121.704 0.764 . . . . 0.0 109.689 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -77.06 -175.78 3.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.589 -0.695 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -62.11 -39.16 91.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.756 . . . . 0.0 109.65 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -139.77 57.81 1.62 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.155 -0.966 . . . . 0.0 109.16 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -61.66 -40.11 93.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.452 -0.78 . . . . 0.0 109.639 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.39 156.33 43.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.106 -0.996 . . . . 0.0 110.097 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -137.25 145.9 44.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.57 145.65 38.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.542 -0.724 . . . . 0.0 109.181 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.2 mtp85 -130.78 144.65 51.6 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.6 -0.687 . . . . 0.0 109.283 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.0 tp -105.17 126.44 52.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.589 -0.694 . . . . 0.0 109.686 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -158.05 149.89 21.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.014 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 55.51 35.2 24.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.446 -0.784 . . . . 0.0 109.415 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 54.9 31.62 16.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.677 -0.639 . . . . 0.0 109.716 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -143.53 138.97 29.54 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -77.08 145.69 37.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.528 -0.733 . . . . 0.0 109.618 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -130.94 159.0 38.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.708 . . . . 0.0 109.195 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.28 128.05 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.1 t -125.96 132.81 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 53.3 p-10 -95.9 144.94 25.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.435 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 109.969 -179.352 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.522 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 45.2 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.236 0.541 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 119' ' ' THR . 38.4 m-85 -144.28 152.11 40.34 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.214 -0.929 . . . . 0.0 109.585 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.4 p -129.08 138.91 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.48 -0.763 . . . . 0.0 109.454 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 58.98 38.34 24.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.596 -0.69 . . . . 0.0 109.839 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 48.58 35.9 6.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.0 109.945 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -145.49 148.22 36.33 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 108.642 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.427 ' O ' ' OE2' ' A' ' 124' ' ' GLU . 25.7 Cg_endo -61.43 139.9 84.8 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.367 2.044 . . . . 0.0 112.095 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' N ' ' A' ' 127' ' ' ASP . 2.0 p -147.76 161.19 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.33 -0.856 . . . . 0.0 108.996 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 128' ' ' SER . 67.3 t0 -124.73 66.83 1.09 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 127' ' ' ASP . 3.5 p 84.82 116.87 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.15 0.5 . . . . 0.0 109.809 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.84 43.32 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.25 -0.906 . . . . 0.0 109.931 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.1 t -79.21 133.23 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -0.779 . . . . 0.0 110.519 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.52 147.88 37.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.384 -0.823 . . . . 0.0 109.617 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.537 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -142.15 148.42 38.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.254 -0.903 . . . . 0.0 109.186 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 49.9 p-10 -48.48 132.23 17.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.772 . . . . 0.0 111.021 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.23 13.1 66.56 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 79.8 m-20 -89.48 150.28 22.55 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.097 -1.237 . . . . 0.0 110.042 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -111.74 136.99 50.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.599 -0.688 . . . . 0.0 109.515 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -128.27 134.74 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.515 -0.741 . . . . 0.0 109.221 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -124.15 117.4 24.56 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.84 128.35 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.479 -0.763 . . . . 0.0 109.524 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 142' ' ' PHE . . . 61.62 45.29 96.61 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.541 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? 70.2 -29.33 0.18 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.571 -0.958 . . . . 0.0 110.119 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 140' ' ' GLY . 72.8 m-85 -66.64 137.12 56.49 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.65 -0.656 . . . . 0.0 110.273 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -106.85 124.61 49.87 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.287 -0.883 . . . . 0.0 109.191 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.7 mp -126.37 147.64 49.72 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.533 -0.729 . . . . 0.0 109.327 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 10.4 p -108.59 126.61 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -89.76 120.49 31.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.557 -0.714 . . . . 0.0 109.879 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.8 mt -131.89 150.46 52.15 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.463 0.649 . . . . 0.0 109.762 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.499 1.993 0 O-C-N 121.695 -0.628 . . . . 0.0 109.377 -179.734 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.549 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -138.55 163.61 31.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.456 -1.026 . . . . 0.0 109.636 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.73 156.83 42.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.508 -0.745 . . . . 0.0 109.949 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.423 ' C ' ' CD1' ' A' ' 57' ' ' LEU . 3.9 pp -142.7 169.9 16.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.355 -0.841 . . . . 0.0 110.626 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.9 mt -124.49 144.01 50.34 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -130.42 132.49 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.743 0.782 . . . . 0.0 109.61 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.3 t -75.71 132.62 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.69 0.757 . . . . 0.0 109.993 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.527 ' NZ ' ' OE2' ' A' ' 136' ' ' GLU . 51.9 mtmt -86.78 -73.78 0.45 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.724 -0.61 . . . . 0.0 110.017 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.583 HH21 ' NH1' ' A' ' 143' ' ' ARG . 61.7 ttp180 -117.33 134.69 54.52 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.433 -0.792 . . . . 0.0 110.356 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.26 173.9 21.6 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.47 -19.74 48.63 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.882 2.388 . . . . 0.0 111.726 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -97.37 19.77 12.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 109.047 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.22 139.32 29.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.389 -0.819 . . . . 0.0 110.373 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.78 -22.27 40.18 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.3 m -71.9 149.39 45.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.367 -1.078 . . . . 0.0 110.831 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -145.78 152.31 39.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.327 -0.858 . . . . 0.0 110.232 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -121.55 131.76 54.31 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.463 0.649 . . . . 0.0 109.444 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 46.8 tp -100.42 128.87 46.37 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 0.0 109.263 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.08 128.27 42.83 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.836 0.826 . . . . 0.0 110.428 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 67.6 t0 -155.24 41.03 0.42 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -141.39 152.61 44.47 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.353 -0.842 . . . . 0.0 109.553 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.46 -48.02 83.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.687 -0.633 . . . . 0.0 109.987 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.42 121.33 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.45 -0.781 . . . . 0.0 109.372 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -116.92 118.9 33.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.583 0.706 . . . . 0.0 109.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 m -86.16 155.28 20.82 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.554 0.692 . . . . 0.0 109.895 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.69 169.75 8.34 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.905 0.859 . . . . 0.0 110.339 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.31 -119.9 5.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.532 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 74.1 ttp85 -118.63 121.6 40.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.888 . . . . 0.0 109.884 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 41.7 m-70 -167.9 151.28 5.79 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.82 145.02 79.48 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.787 2.324 . . . . 0.0 112.783 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 54.82 31.1 14.93 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.511 0.672 . . . . 0.0 109.584 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 t -99.14 123.45 43.44 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.209 -0.932 . . . . 0.0 110.555 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 71' ' ' LEU . 54.3 m-20 -65.85 -39.57 90.88 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -85.01 125.51 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 109.841 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -127.19 86.11 2.46 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.2 mt -115.26 94.29 4.66 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -92.79 109.68 21.12 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.525 0.679 . . . . 0.0 109.622 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -158.58 163.1 37.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.958 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.3 -44.21 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.63 0.729 . . . . 0.0 110.285 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.5 p -68.22 -29.4 68.23 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.344 -0.848 . . . . 0.0 109.996 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.4 t -92.46 112.1 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.131 -0.981 . . . . 0.0 109.97 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.9 m -77.58 176.73 8.67 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.686 0.755 . . . . 0.0 110.444 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.53 -41.84 99.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.646 -0.658 . . . . 0.0 110.017 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -124.18 49.2 1.81 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.377 -0.827 . . . . 0.0 109.005 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.08 -39.93 94.1 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.511 0.672 . . . . 0.0 109.45 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.99 154.89 40.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.957 -1.089 . . . . 0.0 110.272 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -136.58 151.6 49.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.497 0.665 . . . . 0.0 109.848 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -121.09 138.83 54.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -130.71 141.21 50.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.635 0.731 . . . . 0.0 109.718 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.06 123.87 38.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 106' ' ' ASN . 80.7 tt0 -115.13 120.38 39.58 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.862 0.839 . . . . 0.0 109.867 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.464 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 21.3 t-20 52.09 -84.52 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.426 0.631 . . . . 0.0 110.372 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -144.03 20.36 1.77 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 108.503 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -130.16 137.47 50.13 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.714 0.769 . . . . 0.0 109.721 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -82.08 147.47 29.09 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.433 0.635 . . . . 0.0 109.76 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -136.06 157.87 45.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.518 -0.739 . . . . 0.0 109.769 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.84 127.35 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.1 t -131.03 131.26 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 119' ' ' THR . 42.9 t0 -100.38 126.48 46.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.697 0.76 . . . . 0.0 109.447 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.644 0.735 . . . . 0.0 109.228 -179.88 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.549 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 28.4 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.62 0.724 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.434 ' OH ' ' NE2' ' A' ' 138' ' ' GLN . 22.7 p90 -119.57 150.51 40.17 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.579 0.704 . . . . 0.0 109.905 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 122' ' ' ASN . 9.6 p -121.28 130.07 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.974 0.892 . . . . 0.0 109.29 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 124' ' ' GLU . 14.0 m120 41.9 -168.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.098 0.951 . . . . 0.0 111.324 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.05 -0.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.757 -0.59 . . . . 0.0 110.163 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 122' ' ' ASN . 17.2 tt0 -113.25 93.09 24.6 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.384 -0.822 . . . . 0.0 109.42 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.04 122.36 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.74 2.293 . . . . 0.0 112.361 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.0 m -136.72 165.07 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.447 -0.783 . . . . 0.0 109.891 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.83 -37.81 88.78 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.591 0.71 . . . . 0.0 109.3 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.4 p -155.54 161.34 40.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.903 . . . . 0.0 110.065 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.06 156.26 24.34 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.597 0.713 . . . . 0.0 110.166 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.36 129.75 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.624 0.726 . . . . 0.0 110.098 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.88 143.04 38.08 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.906 0.86 . . . . 0.0 110.592 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.544 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.86 147.18 27.65 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.596 0.712 . . . . 0.0 109.279 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 20.5 p30 -43.17 130.19 4.65 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.057 0.932 . . . . 0.0 111.667 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.06 13.47 68.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 81.2 m-20 -89.95 150.03 22.33 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.986 -1.302 . . . . 0.0 109.673 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 61' ' ' LYS . 84.0 tt0 -108.5 129.25 55.29 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.696 0.76 . . . . 0.0 110.05 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.9 t -126.11 131.25 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.434 ' NE2' ' OH ' ' A' ' 120' ' ' TYR . 56.6 tt0 -121.5 120.92 36.31 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.465 0.65 . . . . 0.0 109.772 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 139' ' ' ILE . 39.7 mm -110.71 122.2 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.75 0.786 . . . . 0.0 109.284 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 56.3 -129.74 48.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -95.06 -6.59 41.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.544 -0.974 . . . . 0.0 109.059 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -89.88 139.92 30.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 0.0 109.519 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.583 ' NH1' HH21 ' A' ' 62' ' ' ARG . 85.0 mtt85 -102.95 136.52 42.61 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.674 0.75 . . . . 0.0 110.027 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.53 157.37 46.69 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.55 133.52 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.671 0.748 . . . . 0.0 109.431 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -87.27 111.51 21.11 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.595 0.712 . . . . 0.0 109.978 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.7 mt -136.19 157.7 46.19 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.426 0.631 . . . . 0.0 109.335 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.4 p . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.496 0.665 . . . . 0.0 109.718 -179.423 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 55' ' ' LEU . 2.6 mm? -102.09 167.54 9.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.563 -0.963 . . . . 0.0 110.272 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.19 176.96 7.5 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -130.55 146.6 52.1 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.023 0.916 . . . . 0.0 110.712 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mt -116.4 134.33 55.0 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.2 t -122.43 135.08 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.586 0.708 . . . . 0.0 109.187 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.3 t -69.18 133.39 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.58 0.705 . . . . 0.0 110.184 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -95.17 -28.61 14.96 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.548 0.689 . . . . 0.0 109.196 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -147.73 138.19 23.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.194 -0.941 . . . . 0.0 110.072 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.65 174.4 15.9 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.17 -13.1 25.84 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.958 2.439 . . . . 0.0 111.132 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ALA . 97.9 m-20 -97.88 16.69 20.1 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . -39.78 133.04 1.62 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.884 0.849 . . . . 0.0 110.924 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.34 -14.24 65.42 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -66.39 146.71 54.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.437 -1.037 . . . . 0.0 110.971 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -134.96 142.11 46.42 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.269 0.557 . . . . 0.0 109.604 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.98 125.42 49.36 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.621 0.724 . . . . 0.0 109.95 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 tt -102.16 132.97 47.74 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.281 0.563 . . . . 0.0 110.044 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -87.72 157.74 18.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.512 -0.743 . . . . 0.0 110.344 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 66.7 t0 -173.51 33.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -156.58 147.17 21.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.452 -0.78 . . . . 0.0 109.88 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.23 136.81 46.46 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.802 0.811 . . . . 0.0 110.83 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 85.3 mt 55.11 100.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.542 0.687 . . . . 0.0 109.873 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -103.7 126.06 50.59 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.607 0.717 . . . . 0.0 109.571 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -92.94 143.64 26.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.491 0.662 . . . . 0.0 109.923 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -101.97 170.06 8.37 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.75 0.786 . . . . 0.0 110.282 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . 92.02 -129.47 9.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.52 ' O ' ' CD2' ' A' ' 82' ' ' HIS . 8.7 ptp180 -103.8 110.83 23.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.932 . . . . 0.0 109.612 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 81' ' ' ARG . 80.3 m-70 -161.87 90.56 1.43 Allowed Pre-proline 0 N--CA 1.486 1.341 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 58.6 Cg_exo -52.12 145.72 33.13 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.679 2.253 . . . . 0.0 112.507 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 7.0 t0 81.5 -22.32 0.27 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -71.97 146.98 47.39 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.79 0.805 . . . . 0.0 110.891 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -62.62 -42.86 99.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.64 -0.663 . . . . 0.0 109.845 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.03 114.05 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 109.563 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.501 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 22.0 p90 -129.85 97.87 4.62 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.577 0.703 . . . . 0.0 109.414 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 80' ' ' GLY . 96.1 mt -102.03 96.75 7.22 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.763 0.792 . . . . 0.0 108.871 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 30.0 p30 -85.34 90.61 7.97 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.515 0.674 . . . . 0.0 109.764 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -146.06 150.05 35.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.485 -0.759 . . . . 0.0 109.477 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.08 -32.32 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.551 0.691 . . . . 0.0 109.912 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.6 p -66.43 -32.51 73.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.459 -0.776 . . . . 0.0 109.786 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.32 128.47 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.306 -0.871 . . . . 0.0 109.917 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.643 ' HG ' ' H ' ' A' ' 96' ' ' ARG . 25.2 t -78.29 -170.96 2.2 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.666 0.745 . . . . 0.0 110.594 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.643 ' H ' ' HG ' ' A' ' 95' ' ' SER . 95.3 mtt180 -61.66 -41.62 97.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.516 -0.74 . . . . 0.0 109.036 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -142.21 62.41 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -62.3 -40.81 97.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.507 -0.745 . . . . 0.0 109.084 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.32 151.07 44.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 0.0 109.777 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -140.83 136.57 32.52 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.656 0.741 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -99.43 146.69 26.05 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.396 0.617 . . . . 0.0 109.356 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -130.81 131.74 44.82 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.483 0.659 . . . . 0.0 109.342 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.1 tp -102.93 123.51 46.7 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.437 ' HG2' ' H ' ' A' ' 105' ' ' ASN . 44.6 tt0 -93.18 -132.04 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.625 -0.672 . . . . 0.0 109.827 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.437 ' H ' ' HG2' ' A' ' 104' ' ' GLU . 90.9 m-20 -64.35 -44.34 91.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.321 -0.862 . . . . 0.0 109.616 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 3.9 m120 -169.79 24.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.78 131.53 51.27 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.654 0.74 . . . . 0.0 109.514 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.409 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 63.9 m-85 -78.94 146.43 33.48 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.486 0.66 . . . . 0.0 109.836 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 93.4 m-20 -144.61 159.38 42.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 p -126.93 131.98 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.483 0.658 . . . . 0.0 109.343 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.04 133.46 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.633 0.73 . . . . 0.0 109.414 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -96.53 114.09 25.72 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.569 0.699 . . . . 0.0 109.215 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.649 0.738 . . . . 0.0 110.385 -179.263 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.657 0.741 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -137.57 157.73 45.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.622 -0.674 . . . . 0.0 109.411 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.86 129.57 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.752 0.787 . . . . 0.0 109.965 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.9 m120 52.65 49.56 20.08 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.701 0.762 . . . . 0.0 109.719 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 52.29 26.17 3.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.968 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -123.95 101.22 35.95 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.82 127.01 13.71 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.323 2.015 . . . . 0.0 112.274 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.4 p -144.36 138.69 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.474 -0.766 . . . . 0.0 109.946 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -66.49 -40.17 89.14 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.474 0.654 . . . . 0.0 109.449 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 87.7 p -156.87 154.26 29.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.13 157.14 27.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.854 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 82.3 t -91.61 128.13 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.729 0.776 . . . . 0.0 109.796 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.67 152.29 35.84 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.754 0.788 . . . . 0.0 110.411 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.534 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.4 155.73 40.92 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.51 0.671 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.405 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 43.0 p-10 -51.77 132.57 31.44 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.883 0.849 . . . . 0.0 111.084 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.45 18.19 66.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 23.5 m-20 -83.57 149.38 26.61 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.223 -1.163 . . . . 0.0 110.073 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 57.6 mp0 -108.84 123.97 49.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.624 -0.672 . . . . 0.0 109.435 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.4 t -125.17 132.32 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.38 125.18 44.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 141' ' ' LYS . 36.3 mm -111.34 127.51 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.737 0.779 . . . . 0.0 109.308 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 54.91 -92.19 0.01 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 139' ' ' ILE . 60.8 pttt -129.9 -18.46 3.4 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -76.99 142.61 39.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 110.036 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -105.65 132.49 51.73 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.684 0.754 . . . . 0.0 110.13 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.54 155.35 50.56 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.446 0.641 . . . . 0.0 109.578 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.39 134.39 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.559 0.695 . . . . 0.0 109.802 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -94.12 120.73 34.79 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.74 152.85 51.65 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.799 0.809 . . . . 0.0 109.613 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.587 0.708 . . . . 0.0 109.693 -179.734 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.4 mt -125.56 149.58 48.22 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.433 -1.039 . . . . 0.0 110.636 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.43 156.31 40.39 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.39 151.47 41.18 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.097 0.951 . . . . 0.0 110.188 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.0 mt -117.88 142.51 47.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.2 t -127.32 130.7 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.56 -0.713 . . . . 0.0 109.816 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.41 130.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 121.649 0.738 . . . . 0.0 110.061 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.21 -76.47 0.12 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.559 -0.713 . . . . 0.0 109.756 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -123.62 148.53 46.34 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.625 0.726 . . . . 0.0 110.16 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.53 175.28 30.31 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.89 -21.23 50.64 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.887 2.391 . . . . 0.0 111.346 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -110.31 23.8 13.82 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -39.96 145.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.643 0.735 . . . . 0.0 110.923 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.6 -1.3 88.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.6 m -72.38 146.23 47.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -1.073 . . . . 0.0 110.742 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -134.38 147.6 50.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.682 . . . . 0.0 109.571 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -128.77 146.92 50.77 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.492 -0.755 . . . . 0.0 109.55 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.1 tp -105.25 127.64 53.04 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.559 0.695 . . . . 0.0 109.756 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -92.88 77.81 4.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 54.8 t0 -108.59 16.81 22.63 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -124.51 140.02 53.34 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.571 0.7 . . . . 0.0 109.622 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.54 85.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.618 -0.676 . . . . 0.0 109.869 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.407 HD11 HG23 ' A' ' 76' ' ' ILE . 97.1 mt -112.91 121.09 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.531 -0.731 . . . . 0.0 109.354 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.6 m -126.83 124.0 38.62 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -97.67 155.25 17.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.448 -0.782 . . . . 0.0 109.625 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.6 158.37 20.9 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.672 0.748 . . . . 0.0 110.219 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.68 -120.95 5.29 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -93.87 111.32 23.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.342 -1.093 . . . . 0.0 109.944 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -175.05 88.71 0.31 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 46.1 Cg_exo -54.91 148.27 47.75 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.574 2.183 . . . . 0.0 112.526 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 10.3 t0 82.14 -7.75 1.32 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.492 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 66.7 m -78.48 147.12 34.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.345 -0.847 . . . . 0.0 110.618 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.17 -38.71 92.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.511 -0.743 . . . . 0.0 109.153 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.08 126.75 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.341 -0.849 . . . . 0.0 109.907 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 50.3 m-85 -125.2 98.78 5.79 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.413 0.625 . . . . 0.0 109.316 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.561 ' C ' ' H ' ' A' ' 91' ' ' ASP . 49.0 mt -107.87 146.81 31.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.61 -0.681 . . . . 0.0 109.608 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 41.4 t0 -60.48 -1.16 0.32 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 89' ' ' LEU . 2.6 p30 47.22 31.92 1.9 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.643 0.735 . . . . 0.0 110.444 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.9 m -68.88 -24.79 28.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 109.885 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 140' ' ' GLY . 60.6 p -138.22 13.27 2.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.392 -0.817 . . . . 0.0 109.234 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.73 131.35 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.584 0.706 . . . . 0.0 109.582 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.3 p -66.67 -162.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.636 0.731 . . . . 0.0 110.887 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.38 -40.85 92.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 109.77 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 99' ' ' ALA . 93.3 mtm-85 -133.24 -41.7 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 t60 60.6 -67.27 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.954 -0.466 . . . . 0.0 109.939 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -140.99 154.3 45.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.079 -1.013 . . . . 0.0 109.412 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -138.7 142.34 38.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.555 -0.715 . . . . 0.0 109.551 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -99.88 140.31 34.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.421 -0.799 . . . . 0.0 109.446 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.406 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 50.5 mmm-85 -130.48 141.53 50.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.636 -0.665 . . . . 0.0 109.547 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.8 tp -115.24 119.54 36.69 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.571 0.7 . . . . 0.0 109.183 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -160.16 -34.04 0.06 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.562 -0.712 . . . . 0.0 109.124 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 107' ' ' GLU . 13.7 m120 -88.58 41.85 1.04 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 0.0 109.232 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 57.48 1.64 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 109.973 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 105' ' ' ASN . 96.1 mt-10 -142.99 157.22 44.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.167 -0.958 . . . . 0.0 109.906 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -74.25 141.65 45.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.515 -0.741 . . . . 0.0 110.14 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 102' ' ' ARG . 39.6 p30 -139.66 173.76 11.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.458 -0.776 . . . . 0.0 109.548 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.3 134.64 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.687 -0.633 . . . . 0.0 109.847 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -127.02 130.81 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.72 155.19 24.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.414 -0.804 . . . . 0.0 110.127 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.399 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.456 ' CG2' ' N ' ' A' ' 120' ' ' TYR . 44.2 m . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.637 0.732 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.456 ' N ' ' CG2' ' A' ' 119' ' ' THR . 44.2 p90 -142.48 162.28 35.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.545 -0.722 . . . . 0.0 109.956 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 123' ' ' ARG . 8.4 p -114.68 131.42 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.654 0.74 . . . . 0.0 109.722 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 43.59 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.582 -0.699 . . . . 0.0 110.385 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 121' ' ' VAL . 15.0 ptp180 -143.68 41.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 109.059 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -146.71 82.43 8.68 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.369 -0.832 . . . . 0.0 109.185 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.58 128.9 32.31 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.806 2.338 . . . . 0.0 112.811 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.3 m -150.81 161.87 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 109.945 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.62 -38.01 89.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 109.557 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -153.22 152.65 31.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 109.511 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.5 152.13 32.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.212 -0.93 . . . . 0.0 110.072 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.27 130.16 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.461 -0.775 . . . . 0.0 109.913 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.96 148.93 34.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.793 0.806 . . . . 0.0 110.272 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.437 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -148.98 156.36 42.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.494 -0.754 . . . . 0.0 109.317 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.711 ' ND2' ' H ' ' A' ' 148' ' ' THR . 31.8 t-20 -57.72 136.14 56.85 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.776 0.798 . . . . 0.0 111.301 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.3 10.46 77.55 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.437 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 89.5 m-20 -89.62 156.42 18.6 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.228 -1.16 . . . . 0.0 110.275 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -108.78 136.57 48.12 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.704 -0.623 . . . . 0.0 109.376 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.72 133.25 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.647 -0.658 . . . . 0.0 109.458 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -123.14 114.77 20.76 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 140' ' ' GLY . 96.7 mt -132.78 122.43 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.448 -0.782 . . . . 0.0 109.74 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . 35.14 72.8 0.11 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 142' ' ' PHE . 6.2 tmtt? 64.16 -63.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.911 -0.758 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 140' ' ' GLY . 33.1 m-85 -36.31 123.19 0.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.504 0.669 . . . . 0.0 110.595 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -101.56 132.46 47.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.725 -0.609 . . . . 0.0 109.46 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -138.06 156.43 47.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.56 -0.712 . . . . 0.0 109.423 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.09 137.9 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.619 -0.676 . . . . 0.0 109.424 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -90.82 114.48 26.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.589 -0.694 . . . . 0.0 109.262 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.6 mt -134.01 149.4 51.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.774 0.797 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.711 ' H ' ' ND2' ' A' ' 133' ' ' ASN . 82.4 p . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.568 -0.707 . . . . 0.0 109.52 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.13 151.77 19.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.399 -1.06 . . . . 0.0 110.289 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -127.02 162.63 25.56 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.23 153.8 45.66 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.917 0.865 . . . . 0.0 110.509 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.7 mt -114.3 141.21 47.89 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.8 132.72 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.585 0.707 . . . . 0.0 109.794 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.8 t -72.06 132.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.606 0.717 . . . . 0.0 109.686 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -81.9 -77.16 0.23 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.543 -0.723 . . . . 0.0 109.188 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -133.94 139.16 45.95 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.806 0.813 . . . . 0.0 109.836 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.62 -177.74 37.77 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.51 -38.63 90.07 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.758 2.305 . . . . 0.0 111.919 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 66' ' ' ALA . 98.7 m-20 -75.53 -78.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.662 -0.648 . . . . 0.0 110.102 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 59.63 122.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.442 -0.787 . . . . 0.0 110.391 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.14 -19.58 53.55 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.6 t -67.63 144.78 55.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.295 -1.121 . . . . 0.0 110.554 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -134.54 145.07 48.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.627 -0.671 . . . . 0.0 109.732 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.22 139.3 48.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.54 -0.725 . . . . 0.0 109.6 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pp -106.41 145.41 31.77 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.5 0.667 . . . . 0.0 109.833 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.34 123.92 44.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.373 -0.83 . . . . 0.0 109.635 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -93.94 37.93 1.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 109.157 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 55.93 -168.09 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.718 0.77 . . . . 0.0 111.034 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 62.76 -141.37 0.39 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.526 0.679 . . . . 0.0 110.667 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.436 HG23 HD12 ' A' ' 76' ' ' ILE . 93.4 mt -113.57 127.82 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.741 -0.599 . . . . 0.0 109.705 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.1 m -120.84 124.95 46.29 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.502 0.668 . . . . 0.0 109.27 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.5 m -94.42 161.63 14.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.518 -0.739 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.57 151.68 31.31 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.606 0.717 . . . . 0.0 109.848 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.85 -58.02 1.53 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -77.62 145.83 36.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -1.091 . . . . 0.0 110.691 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.495 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -86.02 -47.35 0.57 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.505 -0.747 . . . . 0.0 109.742 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 72.9 Cg_exo -51.97 133.71 46.89 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.325 2.017 . . . . 0.0 113.172 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' PRO . 45.7 t0 41.8 49.88 3.96 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.726 0.774 . . . . 0.0 109.718 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 t -157.01 114.25 3.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.62 -37.66 88.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.533 -0.73 . . . . 0.0 109.9 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.432 HG21 HD13 ' A' ' 87' ' ' ILE . 23.5 mm -73.22 131.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.416 -0.802 . . . . 0.0 110.12 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -129.78 86.54 2.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.705 -0.622 . . . . 0.0 109.541 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -123.12 93.52 3.98 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 97.2 m-20 -94.68 104.18 16.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.431 -0.793 . . . . 0.0 109.468 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 62.3 m-20 -159.52 168.58 25.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.243 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.34 -35.99 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.507 0.67 . . . . 0.0 109.827 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.2 p -65.77 -26.78 67.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.41 128.83 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.487 -0.758 . . . . 0.0 109.499 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.4 m -88.95 -164.07 1.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.605 0.717 . . . . 0.0 110.03 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -62.92 -43.64 98.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.497 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' A' ' 99' ' ' ALA . 84.7 mtp180 -108.39 -57.83 2.07 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 57.69 -73.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.864 -0.522 . . . . 0.0 109.655 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -132.12 155.24 48.5 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.651 0.738 . . . . 0.0 109.439 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -139.37 146.25 39.98 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.05 139.18 48.9 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -128.85 139.26 52.24 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.02 121.53 36.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.493 -0.754 . . . . 0.0 109.541 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -99.44 -124.99 0.16 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -84.59 88.18 7.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.829 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 52.71 27.0 4.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.64 -0.663 . . . . 0.0 110.051 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -142.19 131.12 23.02 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.019 -1.051 . . . . 0.0 110.02 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -76.73 147.75 37.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.636 -0.665 . . . . 0.0 110.206 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -139.67 159.78 41.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.104 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.0 p -126.44 132.73 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.702 -0.624 . . . . 0.0 109.435 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.9 135.82 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.509 0.671 . . . . 0.0 109.244 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -85.3 115.29 22.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.496 -0.753 . . . . 0.0 109.378 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.617 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.2 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.489 0.661 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.37 149.95 49.81 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 122' ' ' ASN . 9.9 p -130.52 156.69 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.604 -0.685 . . . . 0.0 110.009 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 121' ' ' VAL . 97.5 m-20 -40.61 173.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.995 0.902 . . . . 0.0 111.063 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 60.46 -105.12 0.2 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.856 -0.528 . . . . 0.0 109.992 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -125.62 145.5 51.6 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.779 -0.576 . . . . 0.0 109.602 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -49.24 139.12 28.35 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.355 2.037 . . . . 0.0 113.053 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -137.85 160.08 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.489 -0.757 . . . . 0.0 109.977 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -69.13 -37.68 78.45 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.661 -0.649 . . . . 0.0 109.525 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p -156.28 161.83 40.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.048 -1.032 . . . . 0.0 110.456 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.33 165.55 31.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.45 -0.781 . . . . 0.0 109.579 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.0 t -93.46 130.24 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.441 -0.787 . . . . 0.0 109.719 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.6 mt -77.33 147.2 36.31 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.645 0.736 . . . . 0.0 110.467 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.88 164.17 34.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.614 0.721 . . . . 0.0 109.698 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 18.5 p30 -64.0 127.34 30.97 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.66 0.743 . . . . 0.0 110.714 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.41 16.33 69.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -85.69 160.23 19.61 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.154 -1.204 . . . . 0.0 109.928 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -112.15 124.37 52.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.522 -0.736 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.1 t -127.35 132.67 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -121.7 113.96 20.46 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.5 130.05 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.462 0.648 . . . . 0.0 109.795 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 142' ' ' PHE . . . 67.29 36.01 88.84 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 140' ' ' GLY . 15.0 tptp 71.37 -19.18 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.677 -0.896 . . . . 0.0 109.475 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.54 ' H ' ' C ' ' A' ' 140' ' ' GLY . 95.6 m-85 -73.96 143.34 45.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.882 . . . . 0.0 109.961 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -99.71 120.68 40.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 109.17 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.33 153.39 47.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.6 -0.687 . . . . 0.0 109.944 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.09 138.72 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.581 0.705 . . . . 0.0 109.554 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -89.9 120.34 31.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.675 . . . . 0.0 109.397 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 66.3 mt -134.72 152.87 52.1 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.396 0.617 . . . . 0.0 109.878 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.569 0.699 . . . . 0.0 109.567 179.988 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mp -100.72 149.76 23.46 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.158 -1.201 . . . . 0.0 110.178 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -149.05 165.85 30.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.444 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.04 155.16 47.35 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.67 0.748 . . . . 0.0 109.818 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -116.14 136.69 52.79 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -120.48 135.28 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.672 0.749 . . . . 0.0 109.744 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.3 116.52 20.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.527 -0.733 . . . . 0.0 110.007 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -66.76 -45.15 79.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.43 -0.794 . . . . 0.0 109.918 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -154.29 151.55 29.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.017 . . . . 0.0 110.396 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.42 -176.53 28.11 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.53 -38.37 74.94 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.894 2.396 . . . . 0.0 112.274 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -82.17 -76.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.572 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 70.27 118.07 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.563 0.697 . . . . 0.0 110.249 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.27 -15.65 62.87 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.8 t -67.21 145.46 55.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -1.144 . . . . 0.0 110.546 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -133.4 151.81 51.86 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.667 -0.645 . . . . 0.0 109.676 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -128.17 142.05 51.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.505 -0.747 . . . . 0.0 109.052 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.4 tp -102.27 128.29 48.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.608 -0.683 . . . . 0.0 109.969 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -92.5 75.02 5.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 109.161 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 35.6 p-10 -95.07 5.52 51.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 109.134 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -115.09 139.43 49.89 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.512 -0.742 . . . . 0.0 109.81 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.61 -50.72 72.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.589 -0.695 . . . . 0.0 110.004 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.9 mm -110.14 120.87 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.346 -0.847 . . . . 0.0 108.828 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.4 m -125.69 115.04 19.48 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.369 0.604 . . . . 0.0 109.688 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.1 m -84.31 151.52 24.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.37 -0.831 . . . . 0.0 109.022 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.61 162.23 13.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.216 -0.928 . . . . 0.0 110.348 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.8 -132.18 11.0 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.545 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 94.9 mtt180 -102.97 131.32 50.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.477 -1.013 . . . . 0.0 110.226 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 23.9 m-70 -172.92 153.93 2.67 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.17 -54.38 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.33 2.02 . . . . 0.0 111.305 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 84' ' ' ASP . 50.3 p-10 -96.79 88.7 4.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.453 -0.78 . . . . 0.0 109.806 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.6 p -166.33 126.79 1.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.991 . . . . 0.0 109.381 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.11 -39.95 95.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.847 . . . . 0.0 109.649 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.6 mt -87.76 127.45 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.104 -0.997 . . . . 0.0 109.594 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -129.28 85.75 2.35 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.2 mt -101.51 94.53 5.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 108.808 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -88.47 85.52 6.87 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.498 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 12.2 p-10 -155.29 170.11 22.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.36 -0.838 . . . . 0.0 109.655 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 94' ' ' VAL . 4.1 t -71.9 171.9 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.597 -0.689 . . . . 0.0 110.504 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 92' ' ' VAL . 2.7 p 66.24 -5.93 0.53 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.668 -0.645 . . . . 0.0 109.627 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.505 ' H ' ' C ' ' A' ' 92' ' ' VAL . 94.4 t -109.44 -19.2 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 94' ' ' VAL . 1.4 m 44.5 -173.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.826 0.822 . . . . 0.0 110.827 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -70.11 -43.79 70.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.932 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.424 ' CG ' ' NE2' ' A' ' 82' ' ' HIS . 79.3 mtp85 -140.91 88.98 2.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.836 . . . . 0.0 109.421 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -99.53 -30.57 12.08 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.92 151.44 33.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -140.85 150.32 43.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.478 -0.763 . . . . 0.0 109.503 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.34 145.66 37.09 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -132.99 136.28 45.97 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 57.4 tp -96.78 124.75 40.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 109.743 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -107.18 -109.93 0.3 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.518 -0.739 . . . . 0.0 109.571 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -91.84 79.35 5.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.065 . . . . 0.0 109.38 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.0 m120 55.89 34.68 24.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.558 -0.713 . . . . 0.0 109.538 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.24 131.51 13.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.912 . . . . 0.0 109.044 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -83.73 150.35 25.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.172 -0.955 . . . . 0.0 110.357 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -122.31 157.77 31.03 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.9 p -120.87 127.73 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.593 -0.692 . . . . 0.0 109.222 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -130.72 137.55 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.755 -0.59 . . . . 0.0 109.543 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 49.4 p-10 -84.55 95.68 8.92 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.275 -0.891 . . . . 0.0 109.277 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.429 -179.823 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.316 0.579 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.422 ' OH ' ' OE1' ' A' ' 138' ' ' GLN . 44.2 p90 -146.22 158.81 43.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.98 . . . . 0.0 109.245 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.55 133.85 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.717 -0.615 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 124' ' ' GLU . 97.7 m-20 57.69 38.43 27.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.779 -0.575 . . . . 0.0 110.006 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 56.79 0.06 0.07 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.525 -0.734 . . . . 0.0 110.634 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 122' ' ' ASN . 72.3 mt-10 -107.28 147.65 35.61 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.266 -0.896 . . . . 0.0 109.44 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.92 148.08 0.23 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.265 1.977 . . . . 0.0 112.227 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 12.9 p -124.69 135.15 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.769 0.795 . . . . 0.0 109.663 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 128' ' ' SER . 65.7 t0 -148.58 59.85 1.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 128' ' ' SER . 2.8 p 80.97 95.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.526 0.679 . . . . 0.0 109.506 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.09 151.22 49.45 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.397 -0.814 . . . . 0.0 109.501 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.6 t -81.5 131.49 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.47 -0.769 . . . . 0.0 109.957 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.03 151.7 35.45 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.478 -0.764 . . . . 0.0 110.267 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.543 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -152.63 153.8 34.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -0.899 . . . . 0.0 109.934 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -49.23 129.84 18.61 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.66 0.743 . . . . 0.0 111.383 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.16 15.13 61.23 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 92.2 m-20 -91.08 150.86 21.24 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.744 -1.445 . . . . 0.0 109.86 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -108.84 130.86 55.42 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.473 -0.767 . . . . 0.0 109.122 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -124.45 133.1 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.604 -0.685 . . . . 0.0 109.248 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.456 ' OE1' ' CZ ' ' A' ' 143' ' ' ARG . 57.3 tt0 -121.07 124.66 45.35 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.49 129.84 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.49 0.662 . . . . 0.0 110.027 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 50.46 -98.38 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -127.4 -19.3 4.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.623 -0.928 . . . . 0.0 108.888 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.498 ' CE1' ' OD2' ' A' ' 91' ' ' ASP . 13.6 m-85 -74.82 143.31 43.99 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.406 -0.809 . . . . 0.0 109.874 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.456 ' CZ ' ' OE1' ' A' ' 138' ' ' GLN . 28.1 mmt180 -103.32 137.17 41.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.496 -0.753 . . . . 0.0 109.653 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.86 151.96 44.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.809 -0.557 . . . . 0.0 109.794 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.0 p -124.28 134.28 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 67.2 t80 -93.04 108.63 20.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.5 mt -140.22 150.75 44.53 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.622 0.725 . . . . 0.0 109.414 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.519 -0.738 . . . . 0.0 110.062 -179.398 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.24 131.69 56.39 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.621 -0.929 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.15 155.03 44.48 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.4 153.27 48.07 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.827 0.823 . . . . 0.0 110.399 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -114.35 127.08 55.68 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.54 134.05 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.661 0.743 . . . . 0.0 109.809 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.77 128.95 34.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.581 -0.699 . . . . 0.0 109.789 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -88.45 -35.56 16.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.166 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -150.18 132.49 15.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.636 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.43 169.48 11.92 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 66' ' ' ALA . 54.4 Cg_exo -52.12 -39.42 70.82 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.755 2.303 . . . . 0.0 111.816 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -81.81 30.63 0.37 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 64' ' ' PRO . . . -63.17 134.26 55.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.524 -0.735 . . . . 0.0 110.278 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.73 -15.61 58.61 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -65.57 144.53 56.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.525 -0.985 . . . . 0.0 110.076 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -136.87 148.9 47.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.642 -0.661 . . . . 0.0 109.698 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -128.79 153.5 47.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.603 -0.686 . . . . 0.0 109.181 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.8 tp -110.16 143.57 40.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.835 -0.541 . . . . 0.0 109.903 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.9 mt -116.59 78.96 1.25 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.513 -0.742 . . . . 0.0 109.686 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 67.1 t0 -110.31 41.01 1.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -135.93 150.33 49.26 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.704 . . . . 0.0 109.428 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.85 79.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.409 -0.807 . . . . 0.0 109.67 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.62 127.51 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.8 m -122.8 124.98 44.54 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.0 t -97.63 168.16 10.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.335 -0.853 . . . . 0.0 110.443 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -116.16 -178.93 3.52 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.652 0.739 . . . . 0.0 109.753 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.34 -134.74 39.25 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.588 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 38.1 mmt180 -74.58 133.9 42.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.436 -1.037 . . . . 0.0 109.818 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 1.2 m80 166.96 85.92 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.15 -36.47 66.65 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.992 1.795 . . . . 0.0 110.964 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -94.82 72.34 3.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.351 -0.843 . . . . 0.0 109.591 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.4 t -169.13 148.3 3.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.072 -1.018 . . . . 0.0 109.41 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.29 -41.5 98.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.354 -0.842 . . . . 0.0 109.681 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.85 123.64 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 109.912 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CZ ' ' OD2' ' A' ' 90' ' ' ASP . 89.3 t80 -130.4 85.73 2.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.12 128.61 53.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.376 -0.828 . . . . 0.0 109.694 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD2' ' CZ ' ' A' ' 88' ' ' PHE . 94.6 m-20 -135.1 86.06 2.22 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 63.3 m-20 -158.92 178.99 9.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.88 . . . . 0.0 110.032 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.528 ' C ' ' H ' ' A' ' 94' ' ' VAL . 2.8 t -63.42 166.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.611 -0.681 . . . . 0.0 110.847 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 92' ' ' VAL . 3.0 p 66.06 -4.76 0.62 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' A' ' 92' ' ' VAL . 55.3 t -123.99 129.5 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.3 m -107.59 -139.24 0.37 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 109.958 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -63.42 -42.53 98.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.546 -0.721 . . . . 0.0 110.662 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -156.89 94.02 1.4 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 109.005 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -61.29 -39.04 88.95 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.438 -0.789 . . . . 0.0 109.438 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.55 162.08 41.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 110.573 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -133.39 145.56 50.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -113.87 141.89 46.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.333 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.71 135.81 50.68 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.748 0.785 . . . . 0.0 109.834 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 107' ' ' GLU . 47.2 tp -98.42 128.49 44.82 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.39 -126.62 0.15 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.152 -0.967 . . . . 0.0 110.94 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 8.0 m120 -64.53 -48.91 73.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 110.529 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 5.5 m120 -168.82 21.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.33 -0.856 . . . . 0.0 109.665 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.466 ' O ' ' CD1' ' A' ' 103' ' ' LEU . 96.8 mt-10 -116.37 -126.92 0.29 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.35 -0.844 . . . . 0.0 109.057 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.439 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 13.7 m-85 -164.23 155.35 15.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.017 -1.052 . . . . 0.0 108.933 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 58.6 m-20 -143.45 149.51 37.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.149 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.32 130.51 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.44 131.54 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.355 0.597 . . . . 0.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -100.25 118.16 35.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.53 -0.731 . . . . 0.0 109.356 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.355 -0.841 . . . . 0.0 110.215 -179.091 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.227 0.537 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -124.12 142.15 51.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.61 -0.681 . . . . 0.0 109.188 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 p -124.13 132.08 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.606 0.717 . . . . 0.0 109.622 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 124' ' ' GLU . 98.1 m-20 52.6 -171.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.819 0.819 . . . . 0.0 110.894 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -71.37 6.84 1.56 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.394 -0.817 . . . . 0.0 108.871 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 122' ' ' ASN . 3.9 pt-20 -120.44 84.74 36.22 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.45 134.38 60.84 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.373 2.049 . . . . 0.0 112.009 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -151.04 156.15 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.132 -0.98 . . . . 0.0 109.809 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.45 -41.88 96.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.1 p -158.11 143.5 16.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.399 -0.813 . . . . 0.0 109.546 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -172.93 167.52 5.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.289 -0.882 . . . . 0.0 110.056 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.8 t -78.05 144.31 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.981 0.896 . . . . 0.0 109.96 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.566 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -136.8 158.06 45.31 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.544 0.688 . . . . 0.0 110.444 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.06 -172.02 4.06 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.629 0.728 . . . . 0.0 109.201 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 47.2 p-10 -50.78 141.52 12.96 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.834 0.826 . . . . 0.0 111.538 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.17 21.36 57.2 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -110.08 151.88 26.67 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.446 -1.032 . . . . 0.0 109.267 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -113.46 138.09 50.6 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.8 t -125.61 132.27 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -118.71 125.45 49.7 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.46 128.95 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.65 0.738 . . . . 0.0 109.518 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.67 -120.98 4.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -98.45 -16.31 19.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.421 -1.046 . . . . 0.0 108.808 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -80.37 145.47 32.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 0.0 110.214 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -115.85 126.68 54.29 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.03 158.43 36.98 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.65 -0.656 . . . . 0.0 109.762 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.83 135.47 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -90.24 109.87 20.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.924 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.44 143.59 39.74 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.401 0.62 . . . . 0.0 109.374 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 110.396 -179.54 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.4 mt -131.57 154.01 49.28 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.118 0.961 . . . . 0.0 110.535 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.77 158.89 42.94 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.16 151.0 51.16 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.309 1.052 . . . . 0.0 110.929 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -115.25 136.4 53.14 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.221 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.8 t -121.75 132.97 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.855 0.836 . . . . 0.0 109.859 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.7 t -69.8 102.82 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.927 0.87 . . . . 0.0 109.538 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HZ3' ' NH2' ' A' ' 143' ' ' ARG . 88.6 tttt -66.07 -43.87 86.11 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.632 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -130.97 136.82 48.89 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.945 0.879 . . . . 0.0 109.797 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.9 168.62 16.45 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.11 -34.66 68.63 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.88 2.387 . . . . 0.0 111.471 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 66' ' ' ALA . 87.3 m-20 -66.89 -45.52 77.77 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . 31.52 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.455 0.645 . . . . 0.0 110.838 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.01 -24.62 4.5 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.4 p -70.02 160.68 31.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.779 -0.836 . . . . 0.0 110.849 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.566 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -152.46 164.04 38.35 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.937 0.875 . . . . 0.0 110.556 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -128.24 142.35 51.19 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.887 0.851 . . . . 0.0 109.723 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -104.48 127.52 52.2 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.822 0.82 . . . . 0.0 110.406 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.3 mt -91.37 116.49 28.88 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.898 0.856 . . . . 0.0 109.966 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -157.69 19.7 0.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -129.65 138.89 51.46 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.895 0.855 . . . . 0.0 109.821 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.79 134.62 51.28 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.78 0.8 . . . . 0.0 110.458 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 mm 53.09 93.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.6 m -106.08 118.13 35.81 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.029 0.918 . . . . 0.0 110.169 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 85' ' ' SER . 12.2 m -85.67 159.33 19.84 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.639 0.733 . . . . 0.0 109.909 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 96' ' ' ARG . . . -106.89 170.09 8.15 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.865 0.841 . . . . 0.0 110.388 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.5 -70.67 2.62 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.621 ' NH1' ' NH2' ' A' ' 96' ' ' ARG . 79.7 mtp85 -71.74 142.59 49.77 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.714 0.769 . . . . 0.0 110.118 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.525 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -86.43 -46.07 0.56 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.837 -0.539 . . . . 0.0 109.91 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 54.3 Cg_exo -54.24 135.0 63.43 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.257 1.971 . . . . 0.0 112.725 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 54.48 33.21 18.31 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 78' ' ' SER . 1.6 t -159.65 117.63 2.72 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.932 0.872 . . . . 0.0 109.876 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.23 -37.85 88.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.404 HD13 HG23 ' A' ' 87' ' ' ILE . 96.7 mt -80.57 125.36 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.58 0.705 . . . . 0.0 109.702 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.4 ' CD1' ' CB ' ' A' ' 82' ' ' HIS . 57.4 t80 -130.01 86.19 2.38 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.965 0.888 . . . . 0.0 109.566 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 90' ' ' ASP . 96.8 mt -79.7 146.71 32.28 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.763 0.792 . . . . 0.0 109.787 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 89' ' ' LEU . 64.7 t0 -55.88 -109.12 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.454 0.645 . . . . 0.0 110.267 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 93' ' ' THR . 58.6 m-20 -162.23 -103.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.461 0.648 . . . . 0.0 109.486 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 t 53.01 -77.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.151 0.501 . . . . 0.0 109.904 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 91' ' ' ASP . 11.8 p -115.17 9.23 15.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.656 -0.653 . . . . 0.0 109.375 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.1 131.09 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 121.918 0.866 . . . . 0.0 109.862 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.47 ' HG ' ' H ' ' A' ' 96' ' ' ARG . 7.5 t -89.33 -155.74 0.37 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.813 0.816 . . . . 0.0 110.94 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.621 ' NH2' ' NH1' ' A' ' 81' ' ' ARG . 79.3 mtp85 -63.7 -41.22 98.14 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.312 0.577 . . . . 0.0 109.894 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 99' ' ' ALA . 33.5 ptt180 -166.41 56.36 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.433 0.635 . . . . 0.0 109.593 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -62.85 -6.42 3.74 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 97' ' ' ARG . . . -143.56 147.49 34.51 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.939 0.876 . . . . 0.0 109.673 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -143.93 138.94 28.87 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.057 0.932 . . . . 0.0 109.925 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -106.38 145.81 31.25 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.717 0.77 . . . . 0.0 109.302 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -132.93 143.98 49.84 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.985 0.897 . . . . 0.0 110.177 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.0 tp -106.83 121.77 45.05 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.839 0.828 . . . . 0.0 109.569 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 104' ' ' GLU . 9.8 pm0 -107.12 -116.51 0.26 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.444 0.64 . . . . 0.0 109.876 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.469 ' H ' ' CG ' ' A' ' 104' ' ' GLU . 47.7 p-10 -87.38 80.82 8.04 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.604 0.716 . . . . 0.0 110.437 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 54.22 31.42 14.07 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.421 0.629 . . . . 0.0 109.508 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -141.4 130.41 23.24 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.66 0.743 . . . . 0.0 109.562 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -93.31 148.72 21.79 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.465 0.65 . . . . 0.0 109.647 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -147.25 172.34 13.99 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.637 0.732 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.3 p -124.66 131.65 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-O 121.966 0.888 . . . . 0.0 109.576 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.97 133.29 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.712 0.768 . . . . 0.0 109.5 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -89.05 113.82 24.98 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.553 0.692 . . . . 0.0 109.515 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 121.718 0.771 . . . . 0.0 109.578 -179.731 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.455 0.645 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -121.7 144.15 48.94 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.825 0.821 . . . . 0.0 109.611 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 122' ' ' ASN . 3.2 p -101.99 154.4 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.42 0.628 . . . . 0.0 109.954 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 123' ' ' ARG . 37.9 p-10 -34.04 -45.3 0.2 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.106 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.499 ' N ' ' OD1' ' A' ' 122' ' ' ASN . 99.8 mtt180 -74.5 -114.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.64 -0.662 . . . . 0.0 110.919 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -102.36 147.29 33.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.679 -0.638 . . . . 0.0 109.989 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.77 137.7 78.39 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.793 2.329 . . . . 0.0 113.022 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.07 161.23 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.789 0.804 . . . . 0.0 110.558 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.46 -18.35 61.13 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.8 p -158.16 159.24 35.94 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.721 0.772 . . . . 0.0 109.901 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.69 155.28 31.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.88 0.847 . . . . 0.0 110.219 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.5 t -99.64 128.91 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.708 0.765 . . . . 0.0 109.622 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.24 143.21 35.52 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.789 0.804 . . . . 0.0 110.552 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.53 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -153.25 150.36 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.611 0.72 . . . . 0.0 109.635 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -39.95 122.87 1.54 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.773 0.797 . . . . 0.0 111.145 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.44 13.11 68.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 28.0 m-20 -85.9 149.15 25.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.516 -0.991 . . . . 0.0 109.861 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -112.47 141.96 45.59 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.867 0.842 . . . . 0.0 110.219 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.2 t -121.74 133.66 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.804 0.812 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -128.45 112.66 14.61 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.829 0.823 . . . . 0.0 109.472 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 139' ' ' ILE . 96.8 mt -131.13 128.59 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.871 0.843 . . . . 0.0 109.654 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 56.07 -134.46 50.27 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -95.45 -13.59 24.46 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.56 130.53 35.86 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.832 0.825 . . . . 0.0 110.073 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.467 ' NH2' ' HZ3' ' A' ' 61' ' ' LYS . 85.7 mtp180 -105.99 135.56 47.22 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.714 0.768 . . . . 0.0 109.752 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.69 149.33 51.49 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.658 0.742 . . . . 0.0 109.714 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.32 132.18 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.721 0.772 . . . . 0.0 109.239 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -94.49 111.94 23.7 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.941 0.877 . . . . 0.0 110.008 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.7 mt -138.14 150.52 46.89 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.805 0.812 . . . . 0.0 109.989 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.702 0.763 . . . . 0.0 110.354 -179.723 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.52 136.81 42.55 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.512 -0.993 . . . . 0.0 109.46 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.64 160.64 26.7 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.38 150.22 50.2 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.486 -0.759 . . . . 0.0 109.858 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.34 136.08 53.47 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.5 133.79 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.11 112.46 3.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.425 -0.797 . . . . 0.0 109.464 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.52 ' O ' ' NE ' ' A' ' 62' ' ' ARG . 24.2 tptp -64.71 -47.07 79.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.453 -0.78 . . . . 0.0 109.505 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 61' ' ' LYS . 4.7 mmp_? -143.61 155.26 44.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 109.847 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.43 167.18 11.55 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.56 -19.51 54.39 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.544 2.163 . . . . 0.0 111.873 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -106.25 33.44 3.84 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.452 -0.78 . . . . 0.0 109.192 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.79 145.88 11.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 109.922 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.21 53.68 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.3 m -69.96 145.89 51.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -1.053 . . . . 0.0 109.907 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -141.81 156.1 45.57 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -129.51 146.97 51.27 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.449 -0.782 . . . . 0.0 109.511 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.519 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 53.9 tp -106.44 124.93 50.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.541 -0.724 . . . . 0.0 109.114 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.7 68.73 5.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.152 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.3 p30 -98.75 5.84 47.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.438 -0.789 . . . . 0.0 109.727 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -119.45 135.55 54.7 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.457 -0.777 . . . . 0.0 109.335 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.68 136.06 54.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.514 -0.741 . . . . 0.0 110.659 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.1 mm 60.23 85.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.439 0.637 . . . . 0.0 109.992 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.4 m -102.93 121.84 43.34 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.418 ' O ' ' OG ' ' A' ' 85' ' ' SER . 11.5 m -85.52 162.17 19.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.711 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.37 127.08 44.94 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.86 -141.9 9.64 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -104.48 132.47 50.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.437 -1.037 . . . . 0.0 110.401 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.653 ' ND1' ' N ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 174.15 151.1 0.25 Allowed Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.63 -23.29 49.51 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.14 1.893 . . . . 0.0 112.104 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 85' ' ' SER . 73.0 m-20 -103.3 -146.84 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 109.732 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 84' ' ' ASP . 8.7 t 59.6 128.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.612 0.72 . . . . 0.0 110.389 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 71' ' ' LEU . 48.0 t0 -64.7 -39.69 94.09 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.03 124.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.422 -0.799 . . . . 0.0 109.223 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -130.2 86.25 2.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.723 -0.61 . . . . 0.0 109.482 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.65 99.68 11.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -84.39 92.57 8.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.658 -0.651 . . . . 0.0 109.766 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.413 ' OD2' ' OG1' ' A' ' 93' ' ' THR . 43.3 t0 -154.38 151.76 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 109.593 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 m -71.21 -26.91 27.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.314 -0.867 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.413 ' OG1' ' OD2' ' A' ' 91' ' ' ASP . 66.1 p -65.7 -33.85 76.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.499 -0.751 . . . . 0.0 109.737 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.97 121.53 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.293 -0.879 . . . . 0.0 109.374 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.8 m -77.3 179.77 6.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 0.0 110.34 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -58.03 -44.27 87.23 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -135.68 78.63 1.73 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.49 -0.757 . . . . 0.0 109.03 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -94.68 -18.93 20.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.518 -0.739 . . . . 0.0 109.219 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -153.13 152.32 31.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.483 -0.76 . . . . 0.0 109.184 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -139.6 139.6 36.81 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -106.43 119.79 40.19 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.578 -0.702 . . . . 0.0 109.165 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -107.61 134.93 49.89 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 109.398 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.9 tp -103.4 126.68 50.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.386 -0.821 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.428 ' CG ' ' H ' ' A' ' 105' ' ' ASN . 27.0 tp10 -99.57 -131.2 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.512 -0.743 . . . . 0.0 109.08 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.428 ' H ' ' CG ' ' A' ' 104' ' ' GLU . 42.6 t-20 -65.54 -49.43 68.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.402 -0.811 . . . . 0.0 109.902 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.421 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 2.5 t-20 177.51 46.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 108' ' ' PHE . 80.5 mm-40 -134.32 -6.25 2.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.981 -1.074 . . . . 0.0 109.251 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 107' ' ' GLU . 62.3 m-85 56.71 151.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.724 0.773 . . . . 0.0 110.209 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 88.8 m-20 -143.49 159.89 41.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.379 -0.826 . . . . 0.0 109.487 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.85 137.42 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.8 t -133.8 157.27 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.405 -0.809 . . . . 0.0 109.763 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 36.5 p-10 -84.7 13.63 5.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.674 -0.641 . . . . 0.0 109.582 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 112' ' ' ASP . 9.4 p . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 121.419 0.628 . . . . 0.0 110.394 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.442 0.639 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -141.91 160.36 40.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.1 p -112.17 129.2 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.293 -0.88 . . . . 0.0 110.486 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.536 ' CG ' ' H ' ' A' ' 123' ' ' ARG . 5.9 t-20 59.47 -167.44 0.16 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.682 0.753 . . . . 0.0 110.824 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.536 ' H ' ' CG ' ' A' ' 122' ' ' ASN . 96.0 mtt-85 -72.71 -12.75 61.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.884 -0.51 . . . . 0.0 109.9 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -86.41 116.53 66.22 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.27 -0.894 . . . . 0.0 109.2 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.22 121.63 5.8 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.507 1.472 . . . . 0.0 111.768 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.53 156.74 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 128' ' ' SER . 38.4 p-10 -72.96 -36.76 67.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.416 -0.803 . . . . 0.0 109.606 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.53 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 99.5 p -160.55 161.83 32.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.413 -0.805 . . . . 0.0 108.852 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -165.53 157.68 15.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.918 -1.114 . . . . 0.0 110.386 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 87.3 t -81.31 134.0 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.462 -0.774 . . . . 0.0 109.638 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.9 mt -80.8 148.07 30.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 109.696 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.548 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -146.28 160.72 41.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.345 -0.847 . . . . 0.0 109.611 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.423 ' OD1' ' OG1' ' A' ' 148' ' ' THR . 51.3 m-20 -57.54 136.79 56.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.737 . . . . 0.0 110.628 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.53 18.62 70.49 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 84.8 m-20 -93.5 155.25 17.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.162 -1.199 . . . . 0.0 109.642 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 56.4 mp0 -113.33 137.43 51.52 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.4 t -122.94 133.6 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -124.12 116.71 23.2 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.592 -0.692 . . . . 0.0 109.304 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 139' ' ' ILE . 96.6 mt -126.31 128.07 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.612 -0.68 . . . . 0.0 109.811 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 52.82 -134.23 39.85 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -95.49 -4.59 44.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.6 -0.941 . . . . 0.0 109.076 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -95.84 132.34 41.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.553 -0.717 . . . . 0.0 109.506 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -103.36 133.8 47.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.34 154.88 47.2 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.9 134.18 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.687 -0.633 . . . . 0.0 109.368 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -92.0 112.44 24.38 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.2 mt -134.2 148.65 50.92 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.457 0.646 . . . . 0.0 110.101 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 133' ' ' ASN . 35.8 p . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.796 -0.565 . . . . 0.0 109.984 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.492 0.663 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -84.37 2.24 41.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 109.288 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 63.6 ttm-85 -159.71 119.76 2.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 0.0 109.108 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.54 154.06 39.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.805 . . . . 0.0 109.756 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.42 61.45 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 109.359 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 31' ' ' SER . 7.2 p90 -112.99 125.31 54.27 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.305 -0.872 . . . . 0.0 109.12 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.8 mt 45.86 13.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -0.976 . . . . 0.0 110.047 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 29' ' ' PHE . 13.5 m -73.1 146.15 45.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.172 -0.955 . . . . 0.0 110.03 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 33' ' ' LEU . 97.2 mt-10 53.48 25.93 5.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.302 -0.874 . . . . 0.0 109.762 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.533 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.4 mm? 40.48 -111.35 0.12 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.721 -0.612 . . . . 0.0 110.42 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -125.39 -59.18 1.4 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.545 -0.722 . . . . 0.0 109.342 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.461 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . -179.31 53.02 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.529 -0.732 . . . . 0.0 109.393 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 35.4 Cg_endo -64.33 146.86 90.61 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.671 2.247 . . . . 0.0 112.379 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.41 -75.68 0.36 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.825 . . . . 0.0 109.959 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -82.74 152.83 25.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 0.0 110.186 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.95 -33.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.71 58.35 8.53 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 66.0 p -82.0 166.79 19.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.153 . . . . 0.0 109.974 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -133.59 -86.44 0.43 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.494 -0.754 . . . . 0.0 109.788 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 p -76.25 154.97 34.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 110.263 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -175.91 -73.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.3 m -106.24 -4.9 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.575 -0.703 . . . . 0.0 109.31 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.4 m -149.2 86.04 1.48 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.185 -0.947 . . . . 0.0 109.436 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.51 4.93 84.1 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 37.3 t -71.56 -0.46 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -1.084 . . . . 0.0 108.945 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -51.34 -80.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.759 . . . . 0.0 110.031 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' A' ' 51' ' ' LEU . . . -130.66 -2.66 4.8 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 50' ' ' GLY . 0.4 OUTLIER 23.79 66.58 0.38 Allowed Pre-proline 0 N--CA 1.506 2.344 0 CA-C-O 121.07 0.462 . . . . 0.0 111.015 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 19.3 Cg_exo -48.91 -41.81 38.83 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.934 1.756 . . . . 0.0 112.72 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 55' ' ' LEU . 27.7 Cg_exo -61.64 150.79 84.07 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.152 1.901 . . . . 0.0 112.354 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.17 80.23 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 53' ' ' PRO . 67.0 mt -128.16 151.12 49.62 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.513 -0.992 . . . . 0.0 109.702 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.65 143.48 41.39 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 11.1 mp -120.23 150.72 40.22 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.335 -0.853 . . . . 0.0 109.868 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.3 mt -117.11 132.58 56.64 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 t -119.08 132.11 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.406 -0.809 . . . . 0.0 109.887 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.78 102.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.542 -0.724 . . . . 0.0 109.134 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.71 -42.91 97.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.679 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -150.21 136.93 19.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.165 -0.96 . . . . 0.0 109.888 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.87 173.27 29.27 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.07 -43.17 60.75 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.224 1.949 . . . . 0.0 112.39 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -102.81 66.15 0.92 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.36 144.75 49.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.278 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.49 -9.7 66.87 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.8 m -66.13 145.64 55.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.404 -1.057 . . . . 0.0 109.665 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.61 146.96 51.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.58 -0.7 . . . . 0.0 109.475 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -125.33 134.49 52.2 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tt -101.98 124.23 47.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.504 -0.748 . . . . 0.0 109.471 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.56 111.74 24.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.32 -0.862 . . . . 0.0 109.271 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -86.22 55.42 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.612 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 51.26 -169.09 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.655 0.74 . . . . 0.0 110.855 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 68.57 -142.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.491 0.663 . . . . 0.0 110.32 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.45 127.85 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.2 m -121.61 116.64 24.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.559 -0.713 . . . . 0.0 109.123 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 p -83.09 165.33 19.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.359 -0.838 . . . . 0.0 109.553 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.51 140.86 51.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.55 -27.25 16.35 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -67.85 143.71 55.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -1.108 . . . . 0.0 109.864 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.59 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -92.14 -40.43 0.36 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.651 -0.655 . . . . 0.0 109.857 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 65.8 Cg_exo -53.32 -133.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.785 2.323 . . . . 0.0 113.356 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -73.83 101.37 3.73 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.283 -0.885 . . . . 0.0 109.751 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.9 m -166.54 129.25 1.88 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 109.25 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.75 -41.17 97.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 109.992 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 87' ' ' ILE . 96.7 mt -82.68 126.01 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.732 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -129.5 86.94 2.48 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.0 mt -102.18 96.16 6.8 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.354 -0.841 . . . . 0.0 109.514 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 65.9 t0 -87.92 97.3 10.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.317 -0.865 . . . . 0.0 109.62 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 62.9 m-20 -159.97 173.22 16.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.127 -0.983 . . . . 0.0 109.661 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.5 m -63.61 -41.42 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.464 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.594 ' HG1' ' H ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -79.32 -178.11 6.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.831 . . . . 0.0 110.211 -179.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.594 ' H ' ' HG1' ' A' ' 93' ' ' THR . 4.8 t 61.64 93.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 121.63 0.728 . . . . 0.0 109.597 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.4 m -62.87 -167.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 0.0 109.897 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -63.48 -40.5 97.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.0 109.836 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -132.28 40.93 3.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.474 -0.766 . . . . 0.0 109.265 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -44.06 -35.75 2.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.749 . . . . 0.0 110.03 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.16 152.58 38.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -139.88 149.29 43.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.488 -0.758 . . . . 0.0 109.039 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.24 140.63 49.11 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.471 -0.768 . . . . 0.0 109.057 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -131.28 137.12 48.7 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.377 -0.827 . . . . 0.0 109.061 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.6 tp -95.66 127.65 41.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.244 -0.91 . . . . 0.0 109.789 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 105' ' ' ASN . 40.6 tt0 -142.11 145.11 33.91 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.202 -0.936 . . . . 0.0 109.142 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' OD1' ' CG ' ' A' ' 107' ' ' GLU . 11.2 p30 45.39 41.39 6.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.754 . . . . 0.0 109.571 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m120 56.8 33.98 23.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.536 -0.727 . . . . 0.0 109.994 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.443 ' CG ' ' OD1' ' A' ' 105' ' ' ASN . 73.9 mm-40 -138.47 129.87 27.45 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.273 -0.892 . . . . 0.0 109.264 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -71.27 148.16 47.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 109.953 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.91 166.66 24.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.349 -0.845 . . . . 0.0 109.511 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.3 p -123.77 131.12 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.5 t -123.68 136.8 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 122.238 1.018 . . . . 0.0 109.065 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -101.93 112.92 25.72 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.124 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.1 m -96.09 0.55 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 120.829 -1.169 . . . . 0.0 108.246 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.63 142.73 34.18 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' LEU . 9.7 m -69.73 144.44 52.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.332 -1.099 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 9.1 mp 38.2 -98.85 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.744 -0.598 . . . . 0.0 110.92 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.427 ' OD1' ' O ' ' A' ' 117' ' ' ASN . 32.4 p30 -78.31 152.71 32.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.13 -140.54 6.09 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -61.97 138.15 58.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -1.137 . . . . 0.0 110.255 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -141.11 161.41 37.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.363 -0.836 . . . . 0.0 108.86 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.39 134.99 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.353 -0.842 . . . . 0.0 109.334 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 56.97 36.54 27.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.59 -0.694 . . . . 0.0 109.539 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 58.33 45.83 16.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.522 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -144.71 119.86 5.92 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.999 -1.063 . . . . 0.0 108.679 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.58 115.99 4.19 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.537 1.492 . . . . 0.0 111.771 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.55 158.68 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.322 -0.861 . . . . 0.0 109.975 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.18 -42.09 99.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.7 t -162.85 157.64 21.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 109.1 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.2 156.04 40.86 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.999 -1.063 . . . . 0.0 109.712 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -90.82 129.71 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.228 -0.92 . . . . 0.0 109.53 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.1 mt -80.76 153.32 27.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 0.0 110.105 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.54 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.22 156.01 40.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.411 -0.805 . . . . 0.0 109.131 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -54.86 134.03 48.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.34 -0.85 . . . . 0.0 110.742 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.72 14.68 67.23 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 83.5 m-20 -91.66 152.4 20.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.135 -1.215 . . . . 0.0 109.711 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -114.02 131.15 56.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.602 -0.686 . . . . 0.0 109.24 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 144' ' ' LEU . 55.2 t -122.29 132.59 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -120.64 120.65 36.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.465 -0.772 . . . . 0.0 109.299 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.14 128.63 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.58 -0.7 . . . . 0.0 109.842 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 53.61 -128.9 40.35 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.1 -1.43 39.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.577 -0.955 . . . . 0.0 109.291 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -97.09 145.16 26.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.457 -0.777 . . . . 0.0 109.262 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -116.22 126.12 53.18 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' VAL . 5.2 mp -128.62 154.55 46.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.573 -0.705 . . . . 0.0 109.437 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.72 130.97 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 109.156 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -87.22 119.41 27.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.9 mt -132.98 150.92 52.12 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.791 -0.568 . . . . 0.0 109.468 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 74.0 p -127.99 160.0 33.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.568 -0.707 . . . . 0.0 109.269 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -74.06 100.53 1.14 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.546 ' ND1' ' N ' ' A' ' 150' ' ' HIS . 0.0 OUTLIER -80.9 157.18 25.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 0.0 109.929 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -87.46 -3.42 59.01 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.508 HE21 ' CE1' ' A' ' 150' ' ' HIS . 88.4 mt-30 50.49 18.37 0.45 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.73 . . . . 0.0 109.358 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -73.4 -125.45 0.1 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.67 135.36 57.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -1.117 . . . . 0.0 110.552 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.9 p30 -94.62 10.94 32.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.416 -0.802 . . . . 0.0 109.424 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.84 133.4 47.34 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.537 -0.727 . . . . 0.0 109.861 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -148.26 -88.91 0.08 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.385 -0.822 . . . . 0.0 108.88 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' A' ' 158' ' ' HIS . 0.3 OUTLIER -152.7 117.58 5.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.132 -0.98 . . . . 0.0 109.571 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -163.61 138.16 6.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 108.833 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.448 ' NE2' ' O ' ' A' ' 162' ' ' HIS . 76.9 t60 -113.14 107.42 15.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.433 -0.792 . . . . 0.0 109.285 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.428 ' H ' ' CD2' ' A' ' 161' ' ' HIS . 8.5 p80 -107.5 45.85 0.97 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.479 -0.763 . . . . 0.0 108.954 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.448 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 62.8 t-80 -146.3 140.19 26.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.362 -0.836 . . . . 0.0 110.098 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.644 179.843 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 26' ' ' ARG . 14.3 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.5 t80 57.57 -77.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.716 -0.615 . . . . 0.0 109.846 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 24' ' ' VAL . 60.0 ttt85 -148.89 105.79 3.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.145 -0.972 . . . . 0.0 109.414 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 46.02 -147.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 110.076 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -135.12 -30.19 1.06 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -97.47 -8.97 28.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.286 -0.884 . . . . 0.0 109.576 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.01 -4.07 53.27 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.217 -0.927 . . . . 0.0 108.796 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.6 t -66.3 146.18 54.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 110.172 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -147.94 98.47 2.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.306 -0.871 . . . . 0.0 108.754 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.17 149.9 40.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.506 -0.746 . . . . 0.0 110.211 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.0 t0 64.41 79.2 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.659 0.742 . . . . 0.0 109.587 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -51.49 165.79 0.4 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.698 -0.626 . . . . 0.0 109.535 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.1 -6.11 16.98 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.704 2.269 . . . . 0.0 111.352 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.34 128.34 1.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.819 . . . . 0.0 110.0 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 40' ' ' GLY . 56.1 tt0 -74.35 -79.03 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.569 -0.707 . . . . 0.0 109.588 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.9 1.17 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.385 -0.822 . . . . 0.0 108.999 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.511 ' H ' ' C ' ' A' ' 38' ' ' GLN . . . 70.68 59.12 5.39 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 p -95.26 -2.36 49.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -1.157 . . . . 0.0 108.73 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -52.67 140.03 24.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.416 -0.802 . . . . 0.0 110.038 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.7 t -66.22 144.18 56.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 110.716 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.89 14.53 0.73 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.52 -43.39 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.316 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 m -62.08 141.76 57.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.32 -0.863 . . . . 0.0 109.924 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.55 174.69 20.46 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.74 130.52 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.473 -1.016 . . . . 0.0 109.269 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -78.43 146.52 34.45 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.454 -0.779 . . . . 0.0 110.492 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 51' ' ' LEU . . . 78.27 -119.65 5.22 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.553 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 0.2 OUTLIER 77.04 46.59 0.12 Allowed Pre-proline 0 C--N 1.299 -1.627 0 O-C-N 121.971 -0.723 . . . . 0.0 109.733 -178.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 51' ' ' LEU . 27.3 Cg_exo -51.36 -42.84 52.88 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 121.512 1.474 . . . . 0.0 111.687 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' C ' ' H ' ' A' ' 55' ' ' LEU . 43.1 Cg_exo -56.76 145.71 81.45 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.65 1.567 . . . . 0.0 112.802 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.97 28.68 0.94 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 53' ' ' PRO . 10.9 mp -95.08 157.08 16.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.277 -1.131 . . . . 0.0 109.304 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -127.18 166.91 16.8 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -137.39 159.68 41.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.466 -0.771 . . . . 0.0 109.758 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.0 mt -112.35 135.47 53.0 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.36 137.48 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.57 0.7 . . . . 0.0 109.509 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.45 131.32 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.485 -0.759 . . . . 0.0 109.896 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -96.35 -32.53 12.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 109.172 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -132.21 155.35 48.41 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.762 0.791 . . . . 0.0 110.221 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.35 164.82 14.44 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.76 -15.6 40.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.686 2.257 . . . . 0.0 111.001 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -92.05 13.94 17.37 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.17 135.15 13.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.814 . . . . 0.0 110.369 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.73 -18.5 47.01 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -65.7 144.26 57.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -1.153 . . . . 0.0 109.824 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -138.79 148.72 44.15 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.358 -0.839 . . . . 0.0 109.904 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.99 137.29 50.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.544 -0.722 . . . . 0.0 109.175 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.429 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 40.8 tp -98.76 128.89 45.14 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.339 -0.85 . . . . 0.0 109.794 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.5 mt -85.97 78.91 9.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 108.986 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -98.21 10.89 39.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.469 -0.769 . . . . 0.0 109.074 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -125.11 148.43 48.55 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.5 -0.75 . . . . 0.0 109.817 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.98 95.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.542 -0.724 . . . . 0.0 109.91 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.424 HG21 HD12 ' A' ' 76' ' ' ILE . 96.9 mt -123.53 126.15 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.465 -0.772 . . . . 0.0 109.058 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.5 m -123.85 119.45 29.72 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.626 -0.671 . . . . 0.0 109.249 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 m -82.86 153.87 24.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 109.482 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.22 177.2 4.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.578 -0.701 . . . . 0.0 109.984 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.94 -129.1 20.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -98.99 122.03 41.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.347 -1.09 . . . . 0.0 110.241 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.703 ' HD1' ' HG ' ' A' ' 85' ' ' SER . 4.8 t-80 -174.15 94.63 0.32 Allowed Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 85' ' ' SER . 38.4 Cg_exo -53.87 150.78 28.79 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.504 2.136 . . . . 0.0 112.995 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 1.2 m-20 77.24 -19.12 0.45 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.703 ' HG ' ' HD1' ' A' ' 82' ' ' HIS . 11.2 m -74.69 148.01 40.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.825 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 71' ' ' LEU . 34.2 t70 -62.92 -46.35 88.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.445 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -100.99 112.0 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.84 . . . . 0.0 109.348 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 22.9 p90 -130.91 90.13 2.85 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.3 94.94 7.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.419 -0.801 . . . . 0.0 109.063 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 43.7 t0 -87.02 98.94 11.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.459 -0.776 . . . . 0.0 109.413 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 64.5 m-20 -158.32 172.88 17.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 109.586 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.77 -44.67 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.506 -0.746 . . . . 0.0 109.818 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.6 p -78.28 -171.0 2.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.992 -1.068 . . . . 0.0 110.509 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 t 62.5 115.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.618 0.723 . . . . 0.0 109.9 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 p -69.84 170.71 10.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.6 -0.687 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -58.19 -32.99 68.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.291 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.51 59.8 1.55 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -63.55 -40.16 96.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.513 -0.742 . . . . 0.0 109.262 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.4 156.0 39.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.075 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -137.03 140.6 42.21 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.6 146.87 27.91 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -136.18 147.24 47.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.285 -0.884 . . . . 0.0 109.817 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.5 tp -101.97 127.25 48.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.611 -0.681 . . . . 0.0 109.407 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -157.29 144.41 18.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.488 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 56.36 35.12 25.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.736 -0.603 . . . . 0.0 109.704 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 58.14 31.99 21.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.492 -0.755 . . . . 0.0 109.748 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -142.63 143.13 32.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.363 -0.835 . . . . 0.0 109.455 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -92.45 149.16 21.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 109.64 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -144.11 170.75 15.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.351 -0.843 . . . . 0.0 109.554 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.6 p -125.79 131.04 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.6 t -126.95 130.52 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.496 ' CB ' ' H ' ' A' ' 119' ' ' THR . 26.9 t0 -103.38 128.55 50.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.568 -0.708 . . . . 0.0 109.509 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.9 m -91.68 10.28 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.12 148.58 50.94 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.7 m -82.62 -88.05 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.513 -0.992 . . . . 0.0 110.117 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.96 -48.12 80.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.796 . . . . 0.0 109.729 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -92.86 175.41 6.81 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.184 -0.947 . . . . 0.0 110.102 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.68 160.22 27.47 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.496 ' H ' ' CB ' ' A' ' 112' ' ' ASP . 26.0 m -63.59 142.48 58.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -1.084 . . . . 0.0 109.871 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -124.76 157.29 36.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.67 -0.644 . . . . 0.0 109.542 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.82 134.55 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.509 0.671 . . . . 0.0 109.939 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.0 m120 47.47 -108.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.759 -0.588 . . . . 0.0 109.934 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -128.32 17.13 6.56 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.611 -0.681 . . . . 0.0 109.329 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -124.32 83.31 57.09 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.524 -0.735 . . . . 0.0 109.449 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.81 136.4 75.13 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.609 2.206 . . . . 0.0 112.466 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.9 m -151.37 159.28 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.188 -0.945 . . . . 0.0 110.071 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -62.87 -43.66 98.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.503 -0.748 . . . . 0.0 109.584 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.6 m -135.85 151.25 49.84 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.324 -0.86 . . . . 0.0 109.223 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.73 152.45 35.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.095 -1.003 . . . . 0.0 110.128 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.6 t -95.95 132.14 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.744 . . . . 0.0 109.317 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.52 146.56 40.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 109.769 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.421 ' H ' ' HB2' ' A' ' 135' ' ' ASP . . . -135.43 153.49 51.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.702 . . . . 0.0 109.517 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.638 ' N ' HD21 ' A' ' 133' ' ' ASN . 0.0 OUTLIER -45.41 104.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.74 . . . . 0.0 110.591 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.32 44.52 4.03 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.421 ' HB2' ' H ' ' A' ' 132' ' ' ALA . 15.1 t0 -87.87 163.51 16.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.213 -1.169 . . . . 0.0 109.656 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -113.35 116.99 30.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -124.62 133.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -132.51 118.96 19.92 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.417 HD11 HG22 ' A' ' 139' ' ' ILE . 96.8 mt -124.0 128.22 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.589 -0.694 . . . . 0.0 109.961 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 53.52 -128.99 40.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -95.72 -9.76 31.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.485 -1.009 . . . . 0.0 109.019 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -94.45 142.68 27.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -118.16 130.53 56.16 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.19 149.26 46.55 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.622 -0.674 . . . . 0.0 109.785 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.4 p -124.94 136.88 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 77.0 t80 -83.01 117.66 22.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 70.7 mt -135.34 146.53 48.5 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.419 0.628 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.9 p -111.21 131.79 54.84 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -72.71 2.85 29.67 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -123.9 108.96 13.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.551 -0.97 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -83.61 143.18 30.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 109.756 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -173.49 166.38 4.67 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.393 -0.817 . . . . 0.0 109.67 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.69 -17.83 55.94 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -135.02 -11.86 2.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.472 -1.017 . . . . 0.0 109.036 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 155' ' ' ASP . 53.4 p-10 -70.43 145.33 51.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.085 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' A' ' 156' ' ' LEU . 10.1 mp -77.72 142.83 38.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.271 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -87.37 -9.48 54.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.59 -0.694 . . . . 0.0 109.467 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -82.58 137.41 34.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 0.0 109.962 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -145.32 137.61 25.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.093 -1.005 . . . . 0.0 109.269 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -85.29 165.21 17.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.207 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -64.2 -12.35 39.7 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.527 -0.733 . . . . 0.0 109.566 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.629 ' HD1' ' CG ' ' A' ' 163' ' ' HIS . 60.8 t-80 -70.55 173.41 7.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.334 -0.854 . . . . 0.0 110.658 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.629 ' CG ' ' HD1' ' A' ' 162' ' ' HIS . 66.0 m80 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.908 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.449 0.643 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -73.87 150.14 41.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.704 0.764 . . . . 0.0 110.809 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -67.34 144.78 55.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.597 0.713 . . . . 0.0 110.257 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.87 138.74 53.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 0.0 110.235 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -87.77 109.84 20.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 110.025 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -171.47 -26.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.2 pp -105.8 -25.81 12.03 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 t -101.66 72.17 1.36 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.423 -0.798 . . . . 0.0 109.42 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -96.47 124.09 40.35 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.795 0.807 . . . . 0.0 109.524 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 35' ' ' ALA . 83.1 mt -87.45 -3.45 59.01 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.1 t0 56.63 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.547 -0.721 . . . . 0.0 110.552 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -92.25 151.74 41.86 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.659 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.93 144.76 77.88 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.501 2.134 . . . . 0.0 112.373 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 42.5 -141.31 0.13 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.611 0.719 . . . . 0.0 110.504 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 39' ' ' ALA . 1.5 pp0? -100.57 -4.56 28.32 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 38' ' ' GLN . . . 43.73 97.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.65 0.738 . . . . 0.0 110.253 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.16 149.5 50.15 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.552 ' C ' ' H ' ' A' ' 43' ' ' SER . 73.6 m -83.51 -76.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.431 -1.04 . . . . 0.0 109.87 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 60.47 -1.05 0.23 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.0 109.144 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 41' ' ' THR . 12.4 p -71.63 158.02 36.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.038 -1.038 . . . . 0.0 110.412 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -175.02 27.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.13 137.69 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.409 -0.807 . . . . 0.0 109.952 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 m -71.34 150.97 44.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.226 -0.921 . . . . 0.0 110.499 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.58 -87.0 0.07 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.441 ' CG2' ' H ' ' A' ' 49' ' ' GLU . 3.5 m -60.63 -108.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.366 -1.079 . . . . 0.0 110.835 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.441 ' H ' ' CG2' ' A' ' 48' ' ' VAL . 64.7 tt0 58.99 37.4 24.54 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.38 97.05 0.11 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.9 tp -172.1 71.14 0.45 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.243 -1.151 . . . . 0.0 108.95 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.43 179.26 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.656 2.237 . . . . 0.0 112.105 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.07 147.16 91.64 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.397 2.065 . . . . 0.0 112.81 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.35 -20.86 43.8 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.5 mp -105.27 143.23 33.73 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.417 -1.049 . . . . 0.0 110.054 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.22 159.36 42.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.64 163.35 31.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.461 -0.774 . . . . 0.0 109.786 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -120.14 136.49 54.59 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.8 t -123.11 133.47 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.571 0.701 . . . . 0.0 109.989 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.96 113.43 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.533 -0.729 . . . . 0.0 109.57 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -65.81 -45.6 81.75 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.589 -0.694 . . . . 0.0 109.555 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -156.95 144.43 18.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.2 -176.62 34.36 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -54.4 -38.79 89.4 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.993 2.462 . . . . 0.0 112.004 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -106.17 22.32 15.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -39.69 107.62 0.07 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.789 -0.569 . . . . 0.0 110.427 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.6 -20.59 3.1 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.2 p -69.06 158.09 35.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.042 -1.269 . . . . 0.0 110.977 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -143.44 158.14 43.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.472 -0.767 . . . . 0.0 109.713 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.62 143.75 50.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.713 . . . . 0.0 109.648 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.4 tp -108.42 126.54 53.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.9 mt -98.68 112.16 24.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.342 -0.849 . . . . 0.0 109.355 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 66.7 t0 -132.34 36.47 3.6 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -140.0 155.06 47.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.273 -0.892 . . . . 0.0 109.885 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.04 91.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.551 -0.718 . . . . 0.0 110.203 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -128.31 129.09 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.342 -0.849 . . . . 0.0 109.852 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.9 m -124.66 125.96 44.95 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.5 m -87.31 161.61 17.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 109.527 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.41 152.54 37.78 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.621 -0.674 . . . . 0.0 109.962 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.5 -130.37 10.2 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.522 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 96.7 mtt180 -100.43 134.39 43.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -1.06 . . . . 0.0 110.043 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 50.6 m-70 -165.4 152.23 9.22 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.07 -15.88 47.78 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.126 1.884 . . . . 0.0 110.893 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 85' ' ' SER . 34.5 t70 -142.13 -124.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.564 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.471 ' H ' ' CG ' ' A' ' 84' ' ' ASP . 3.5 m 59.02 138.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.765 0.793 . . . . 0.0 110.179 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.18 -41.13 99.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.459 -0.776 . . . . 0.0 109.87 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -88.11 120.47 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -129.97 86.75 2.44 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.593 -0.692 . . . . 0.0 109.208 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.9 mt -96.52 99.63 11.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.287 -0.883 . . . . 0.0 109.163 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -90.76 94.92 9.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -153.75 152.52 30.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.282 -0.886 . . . . 0.0 109.805 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.6 p -66.42 -34.72 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.0 p -64.97 -31.42 72.64 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.858 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.4 t -98.16 126.26 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.111 -0.993 . . . . 0.0 110.196 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.9 t -76.58 168.52 19.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 110.242 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -60.84 -42.87 98.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.452 -0.78 . . . . 0.0 109.819 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -124.06 54.31 1.35 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.42 -0.8 . . . . 0.0 109.08 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.01 -41.72 97.37 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.557 -0.714 . . . . 0.0 109.551 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.73 157.44 42.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.05 -1.031 . . . . 0.0 109.971 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -136.11 149.18 48.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -112.14 144.03 42.2 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -132.86 138.18 46.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.537 -0.727 . . . . 0.0 109.247 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD1' ' O ' ' A' ' 107' ' ' GLU . 39.3 tp -88.99 129.79 35.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.44 -0.787 . . . . 0.0 109.997 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -169.54 158.66 7.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.402 -0.811 . . . . 0.0 108.928 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 59.24 31.81 21.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.591 -0.693 . . . . 0.0 109.652 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 52.47 32.53 11.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.444 -0.785 . . . . 0.0 109.607 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.555 ' O ' ' CG ' ' A' ' 108' ' ' PHE . 77.3 mm-40 -143.75 -119.71 0.09 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.322 -0.861 . . . . 0.0 108.852 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 107' ' ' GLU . 56.5 m-85 -162.92 150.98 13.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 109.222 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -137.26 151.2 48.43 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.08 131.62 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.17 131.08 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.478 0.656 . . . . 0.0 109.31 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 119' ' ' THR . 89.2 m-20 -90.78 147.08 23.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.794 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 m -133.17 3.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.41 -136.72 6.61 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 116' ' ' LEU . 28.6 t -55.84 179.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.537 -0.978 . . . . 0.0 110.724 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.4 ' N ' ' OG ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -62.38 -50.47 71.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.504 -0.747 . . . . 0.0 109.493 -179.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -65.18 -40.97 94.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 109.511 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.06 -140.51 22.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.542 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 33.4 m -64.3 163.69 12.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.068 . . . . 0.0 109.789 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.583 ' CD1' ' N ' ' A' ' 120' ' ' TYR . 1.6 m-85 -127.22 138.84 53.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.598 -0.688 . . . . 0.0 109.452 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.9 134.24 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 m120 47.76 -171.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.433 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -65.4 -18.82 65.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.2 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -104.99 104.47 46.88 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.568 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.84 142.13 28.01 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.043 1.828 . . . . 0.0 112.447 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.6 163.09 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.252 -0.905 . . . . 0.0 110.454 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -66.76 -38.58 86.88 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.1 p -158.45 160.17 36.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.981 -1.074 . . . . 0.0 109.8 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -169.05 164.3 11.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.061 -1.025 . . . . 0.0 110.315 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.65 130.46 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.583 -0.698 . . . . 0.0 109.447 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.97 150.06 34.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 110.731 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.54 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -147.05 152.18 38.12 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.735 . . . . 0.0 109.358 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -55.52 134.36 50.72 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.669 0.747 . . . . 0.0 111.183 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.5 13.69 64.96 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 84.4 m-20 -89.99 163.88 14.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.253 -1.145 . . . . 0.0 110.17 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -121.12 132.95 55.16 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.58 131.67 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -114.53 119.02 35.41 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.414 HG21 HD12 ' A' ' 139' ' ' ILE . 35.1 mm -111.66 124.16 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.654 0.74 . . . . 0.0 109.638 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.72 -124.6 7.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -96.56 -1.9 46.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.515 -0.991 . . . . 0.0 108.59 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -95.51 142.48 27.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.575 -0.703 . . . . 0.0 109.847 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -107.44 133.74 51.5 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.637 -0.664 . . . . 0.0 109.882 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -138.34 161.14 37.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.422 -0.799 . . . . 0.0 109.132 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.95 132.39 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -90.03 117.56 28.92 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.1 mt -134.86 163.64 29.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.716 -0.615 . . . . 0.0 110.125 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 150' ' ' HIS . 25.6 p -137.43 -162.01 1.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.633 -0.667 . . . . 0.0 109.897 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.43 74.54 0.02 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 148' ' ' THR . 12.7 p80 -76.19 129.47 36.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.171 -1.193 . . . . 0.0 110.24 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -78.28 139.27 38.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -0.835 . . . . 0.0 110.209 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -115.96 -71.44 0.74 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 57.34 63.2 5.52 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -64.28 144.59 57.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.093 -1.24 . . . . 0.0 109.846 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 157' ' ' GLU . 46.6 t0 57.34 22.21 7.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.485 -0.759 . . . . 0.0 109.442 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.487 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 74.4 mt 38.98 27.61 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.441 0.639 . . . . 0.0 109.82 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 155' ' ' ASP . 10.5 tm-20 -72.72 127.48 32.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.845 . . . . 0.0 110.205 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 156' ' ' LEU . 35.5 p-80 -174.23 44.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -60.08 -44.29 94.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.504 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -155.06 151.7 28.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.071 -1.018 . . . . 0.0 109.953 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -154.04 148.92 26.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.591 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.455 ' O ' ' OXT' ' A' ' 163' ' ' HIS . 33.9 t-80 -151.41 140.24 20.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.219 -0.926 . . . . 0.0 109.682 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.455 ' OXT' ' O ' ' A' ' 162' ' ' HIS . 58.0 t-80 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 117.753 -1.118 . . . . 0.0 110.205 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.715 0.769 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -82.64 -76.38 0.27 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.765 0.793 . . . . 0.0 109.666 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -72.67 136.31 45.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.359 -0.838 . . . . 0.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.34 147.79 52.82 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.926 0.87 . . . . 0.0 110.439 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -75.77 -4.42 40.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.523 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.505 ' CE1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -88.74 162.57 16.17 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.954 -1.091 . . . . 0.0 109.701 -179.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.505 ' O ' ' CE1' ' A' ' 29' ' ' PHE . 33.9 mt -58.78 81.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.474 -0.767 . . . . 0.0 109.8 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 29' ' ' PHE . 7.0 t -103.45 -134.98 0.33 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.802 0.811 . . . . 0.0 109.832 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.43 ' OE1' ' OG ' ' A' ' 31' ' ' SER . 39.9 mp0 -80.04 106.88 12.38 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.019 0.914 . . . . 0.0 109.996 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.457 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 10.1 mp -70.65 143.36 51.45 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.817 0.818 . . . . 0.0 109.585 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -48.88 113.54 0.81 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.875 . . . . 0.0 110.86 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.412 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . -171.72 56.32 0.23 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.443 -0.785 . . . . 0.0 109.063 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 49.7 Cg_endo -68.96 156.15 66.26 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.851 2.367 . . . . 0.0 112.184 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.86 144.75 56.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 110.629 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -158.6 -68.44 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.765 0.793 . . . . 0.0 109.287 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -44.3 112.69 0.44 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.099 0.952 . . . . 0.0 110.559 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 41' ' ' THR . . . -85.61 -0.73 87.88 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 40' ' ' GLY . 3.1 p 38.33 55.36 1.79 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.907 0.86 . . . . 0.0 110.167 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.85 134.96 55.18 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.838 0.828 . . . . 0.0 110.336 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.4 m 49.32 -111.15 0.45 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.634 -0.666 . . . . 0.0 110.052 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -175.31 -27.77 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.15 139.18 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 0.0 110.483 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.3 m 56.07 87.53 0.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.966 0.889 . . . . 0.0 110.078 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.09 -60.77 0.83 Allowed Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.8 t -64.83 -45.67 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.214 -1.168 . . . . 0.0 110.296 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 43.99 79.21 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.139 -0.976 . . . . 0.0 110.397 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.14 117.24 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.66 139.59 21.77 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.616 -0.931 . . . . 0.0 109.819 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -50.36 160.29 1.62 Allowed 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.532 2.155 . . . . 0.0 112.09 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.45 144.2 49.68 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.666 2.244 . . . . 0.0 112.976 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.61 14.05 68.84 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.67 151.6 42.93 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.446 -1.032 . . . . 0.0 109.847 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.84 156.19 42.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.42 153.55 49.58 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.98 0.895 . . . . 0.0 110.13 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.63 134.9 54.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -122.97 135.36 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.875 0.845 . . . . 0.0 109.902 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.37 135.6 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.676 0.75 . . . . 0.0 110.101 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -84.65 -74.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.399 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.668 HH21 ' NH1' ' A' ' 143' ' ' ARG . 88.2 mtm180 -129.11 147.65 50.99 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.433 -0.792 . . . . 0.0 110.0 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.97 177.66 26.78 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -65.83 -19.04 58.93 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.664 2.243 . . . . 0.0 110.922 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 66' ' ' ALA . 35.5 m120 -84.47 -80.77 0.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.875 . . . . 0.0 109.508 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 58.8 131.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.974 0.892 . . . . 0.0 110.901 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.62 41.43 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.8 m -69.87 146.3 51.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -1.145 . . . . 0.0 111.011 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -145.5 156.53 43.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 109.786 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -129.54 144.35 51.23 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.5 tp -104.06 127.94 51.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.685 -0.634 . . . . 0.0 109.301 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -100.07 74.04 1.76 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.025 -1.047 . . . . 0.0 109.177 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 73' ' ' ASP . 32.1 p-10 -94.67 3.87 54.54 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -106.6 153.07 22.89 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.281 -0.887 . . . . 0.0 110.059 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.06 94.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.454 -0.779 . . . . 0.0 109.808 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 76' ' ' ILE . 97.2 mt -125.55 126.86 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.6 m -126.46 120.66 30.31 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 p -84.76 166.49 16.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.962 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.38 170.89 7.64 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.932 0.872 . . . . 0.0 110.215 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.29 -131.3 29.91 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -110.77 130.65 55.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -1.06 . . . . 0.0 110.104 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -170.08 136.14 1.27 Allowed Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -42.57 -58.47 1.26 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.485 2.123 . . . . 0.0 112.653 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -96.1 92.72 6.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.935 . . . . 0.0 109.88 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.48 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 82.9 p -171.13 121.09 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 108.972 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -68.1 -34.32 76.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.421 -0.799 . . . . 0.0 109.298 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.43 HG21 HD11 ' A' ' 87' ' ' ILE . 96.6 mt -78.94 130.19 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.861 -1.149 . . . . 0.0 109.761 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 62.4 m-85 -129.07 89.33 2.85 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.427 -0.796 . . . . 0.0 109.401 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.7 mt -101.18 103.35 14.39 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -92.52 87.66 6.05 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.626 0.727 . . . . 0.0 109.881 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.46 ' OD2' ' CZ ' ' A' ' 142' ' ' PHE . 65.2 m-20 -150.22 149.53 30.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.963 . . . . 0.0 109.757 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.2 m -72.79 -26.27 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.733 0.778 . . . . 0.0 109.568 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.2 p -71.66 -17.21 62.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 109.382 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.0 t -110.94 126.78 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.325 -0.859 . . . . 0.0 109.415 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 p -77.08 168.63 19.76 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.797 0.808 . . . . 0.0 110.667 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -63.67 -38.08 89.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.477 -0.764 . . . . 0.0 109.878 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -129.97 50.56 2.17 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.117 -0.989 . . . . 0.0 109.115 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -62.63 -40.8 98.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.078 -1.014 . . . . 0.0 108.969 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.99 159.89 43.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.898 -1.126 . . . . 0.0 110.107 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -134.55 150.53 50.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.498 -0.751 . . . . 0.0 109.436 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.27 140.05 48.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.575 -0.703 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -134.56 136.86 43.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.433 -0.792 . . . . 0.0 109.189 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 38.5 tp -102.63 127.68 49.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -155.66 143.74 19.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.19 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 56.24 39.73 30.15 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.547 0.689 . . . . 0.0 110.135 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.2 m120 55.22 31.79 17.2 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.597 0.713 . . . . 0.0 109.382 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -139.79 130.96 26.5 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.237 -0.914 . . . . 0.0 109.753 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -83.62 146.27 28.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -147.58 167.15 25.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.152 -0.967 . . . . 0.0 109.379 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.21 135.59 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.9 t -125.63 130.84 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.52 ' CG ' ' H ' ' A' ' 119' ' ' THR . 15.0 m-20 -95.23 134.35 38.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.37 -3.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -88.44 129.86 9.82 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.493 ' C ' ' H ' ' A' ' 117' ' ' ASN . 2.9 t 39.87 24.53 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.075 0.94 . . . . 0.0 109.791 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 114' ' ' GLY . 4.6 tp 55.81 9.56 0.45 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.927 0.87 . . . . 0.0 108.78 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 115' ' ' SER . 66.1 t30 -155.98 114.77 3.46 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.341 -0.85 . . . . 0.0 109.188 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.501 ' O ' ' CZ ' ' A' ' 120' ' ' TYR . . . -149.11 -67.18 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.52 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 29.0 m -67.44 137.03 55.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.331 -1.099 . . . . 0.0 110.489 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.501 ' CZ ' ' O ' ' A' ' 118' ' ' GLY . 22.5 m-85 -127.89 145.34 50.98 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.786 . . . . 0.0 109.379 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.4 p -109.59 157.05 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.847 0.832 . . . . 0.0 109.752 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.464 ' ND2' ' CD ' ' A' ' 136' ' ' GLU . 90.8 m-20 -53.21 -39.6 63.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.828 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -57.41 -83.41 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.941 -1.099 . . . . 0.0 109.631 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -143.35 147.39 39.94 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.076 -1.015 . . . . 0.0 109.553 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.18 120.73 8.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.603 2.202 . . . . 0.0 111.894 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.69 163.18 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.186 -0.946 . . . . 0.0 110.203 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 128' ' ' SER . 47.8 p-10 -66.94 -33.03 74.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.55 -0.719 . . . . 0.0 109.487 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.548 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 86.4 p -152.23 160.19 43.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.047 . . . . 0.0 109.278 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.39 156.51 30.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.029 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.1 130.15 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.491 -0.755 . . . . 0.0 109.941 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.6 mt -76.49 151.38 36.45 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.849 0.833 . . . . 0.0 110.209 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.553 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.77 155.71 39.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.507 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -51.33 124.02 10.91 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.921 0.867 . . . . 0.0 110.972 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.07 16.22 59.71 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.553 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 28.9 m-20 -87.75 155.48 19.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.925 -1.338 . . . . 0.0 110.565 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 56.6 mp0 -113.61 128.2 56.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.661 -0.649 . . . . 0.0 109.499 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 144' ' ' LEU . 54.8 t -125.45 131.48 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.403 ' O ' ' NE2' ' A' ' 138' ' ' GLN . 4.9 pp0? -123.2 132.83 54.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.706 -0.621 . . . . 0.0 109.776 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 139' ' ' ILE . 96.4 mt -121.18 117.08 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.668 0.747 . . . . 0.0 109.052 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 61.26 -127.84 43.07 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -93.27 -5.33 50.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -1.161 . . . . 0.0 109.02 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.46 ' CZ ' ' OD2' ' A' ' 91' ' ' ASP . 57.8 m-85 -96.13 133.7 40.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.184 -0.947 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.668 ' NH1' HH21 ' A' ' 62' ' ' ARG . 83.3 mtp180 -103.27 139.4 38.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.592 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 137' ' ' VAL . 4.7 mp -135.51 166.47 23.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 109.47 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.0 p -128.69 133.67 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.652 0.739 . . . . 0.0 109.567 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -96.1 115.52 27.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -0.828 . . . . 0.0 109.249 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.57 147.88 51.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.626 0.727 . . . . 0.0 109.668 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.556 ' C ' ' H ' ' A' ' 150' ' ' HIS . 6.3 p -134.41 167.46 20.71 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.541 0.686 . . . . 0.0 109.632 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 150' ' ' HIS . . . -69.84 34.26 0.38 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.556 ' H ' ' C ' ' A' ' 148' ' ' THR . 84.9 t60 58.02 146.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.598 -0.943 . . . . 0.0 111.039 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.435 ' O ' ' CD2' ' A' ' 150' ' ' HIS . 98.8 mttt -77.1 147.94 36.34 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.875 0.845 . . . . 0.0 110.616 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -70.24 165.05 23.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.922 0.868 . . . . 0.0 111.045 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.14 111.22 0.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -150.83 -35.07 0.15 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.281 -1.129 . . . . 0.0 108.292 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.5 p-10 -68.15 148.08 51.41 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.247 -0.908 . . . . 0.0 110.53 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 74.5 mt -69.27 141.9 54.25 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.92 0.867 . . . . 0.0 110.524 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -76.79 143.66 39.68 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.986 0.898 . . . . 0.0 110.107 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -74.51 141.31 44.89 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.695 0.759 . . . . 0.0 110.514 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -152.78 -158.81 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.319 -0.863 . . . . 0.0 109.979 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 55.4 79.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.977 0.894 . . . . 0.0 109.862 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -154.64 146.55 23.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.549 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -144.6 124.6 13.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.265 -0.897 . . . . 0.0 108.994 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.484 ' ND1' ' O ' ' A' ' 163' ' ' HIS . 61.3 t-80 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.457 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' ' O ' ' A' ' 26' ' ' ARG . 43.5 p90 -87.33 -11.68 48.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 109.241 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 25' ' ' PHE . 91.1 mtm-85 55.62 116.26 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.632 0.729 . . . . 0.0 110.892 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.14 -136.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.582 -0.699 . . . . 0.0 110.41 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -78.94 -3.46 44.99 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.267 -0.896 . . . . 0.0 109.663 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 3.0 p90 -148.64 -125.4 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.559 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 32' ' ' GLU . 89.6 mt 60.42 130.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.663 0.744 . . . . 0.0 110.384 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.5 t 47.86 -86.94 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.18 0.514 . . . . 0.0 110.079 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' LEU . 45.7 tp10 56.46 72.18 0.52 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.326 -0.859 . . . . 0.0 110.086 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 mt 58.08 -178.3 0.07 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.715 0.769 . . . . 0.0 111.494 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -86.86 111.6 20.94 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.427 0.632 . . . . 0.0 109.643 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.447 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -78.29 -178.23 1.01 Allowed Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.434 -0.791 . . . . 0.0 109.587 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.447 ' CD ' ' CB ' ' A' ' 35' ' ' ALA . 35.8 Cg_exo -59.84 144.83 99.39 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.918 2.412 . . . . 0.0 112.944 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 39' ' ' ALA . . . -86.53 -11.12 52.53 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 51.8 -83.24 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.583 -0.698 . . . . 0.0 110.127 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . -62.74 -21.28 65.69 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.284 -0.885 . . . . 0.0 109.472 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.91 25.36 41.51 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 98.7 m -63.23 -43.37 98.26 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.407 -1.055 . . . . 0.0 109.711 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -50.35 139.83 14.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 110.992 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 p 45.63 70.25 0.38 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.684 -0.635 . . . . 0.0 110.188 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.76 -64.46 1.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.703 -0.623 . . . . 0.0 109.379 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.48 128.23 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.931 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.1 p -78.63 162.85 25.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.444 -0.785 . . . . 0.0 110.545 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.61 -174.49 48.19 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 50' ' ' GLY . 15.1 t -85.17 118.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.549 -0.971 . . . . 0.0 109.827 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' VAL . 46.0 tt0 39.7 -93.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.779 -0.576 . . . . 0.0 110.668 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . -107.64 -44.38 1.23 Allowed Glycine 0 N--CA 1.497 2.754 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 50' ' ' GLY . 0.4 OUTLIER 42.72 78.5 0.38 Allowed Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.327 -1.102 . . . . 0.0 109.566 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.38 169.94 20.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.108 1.872 . . . . 0.0 112.485 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -56.82 147.42 72.72 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.395 2.063 . . . . 0.0 112.872 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.24 -15.02 54.85 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -122.37 142.97 49.95 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.558 -0.966 . . . . 0.0 109.223 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.13 155.18 41.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.38 157.12 40.82 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.186 0.517 . . . . 0.0 109.733 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.4 mt -117.04 128.7 55.42 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.01 134.08 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.642 0.734 . . . . 0.0 109.538 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.6 t -78.36 111.69 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.677 -0.64 . . . . 0.0 109.898 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -64.88 -43.62 92.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.577 -0.702 . . . . 0.0 110.219 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -137.21 151.77 49.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.534 -0.729 . . . . 0.0 110.287 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.06 172.29 22.61 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.21 -20.83 55.81 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.956 2.437 . . . . 0.0 112.006 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' O ' ' C ' ' A' ' 66' ' ' ALA . 93.1 m-20 -98.65 -35.74 10.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.446 -0.784 . . . . 0.0 109.357 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . 35.42 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.313 0.578 . . . . 0.0 110.789 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.48 -15.13 3.66 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.9 m -62.86 144.49 56.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -1.008 . . . . 0.0 110.766 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -137.57 156.04 48.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.603 -0.686 . . . . 0.0 109.354 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -126.32 146.75 49.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.626 -0.671 . . . . 0.0 109.315 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.78 126.56 51.97 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 79.3 mt -100.53 124.47 46.12 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.452 0.644 . . . . 0.0 109.669 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -154.39 56.63 0.7 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.429 ' N ' ' CD ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -161.08 175.57 12.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.491 -0.756 . . . . 0.0 109.547 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.13 -65.53 1.0 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.495 -0.753 . . . . 0.0 110.297 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mm -108.56 124.56 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.765 . . . . 0.0 110.212 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.411 ' OG1' ' CD ' ' A' ' 74' ' ' GLN . 31.5 m -127.97 127.08 42.62 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 p -84.65 165.02 18.27 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.562 -0.711 . . . . 0.0 109.936 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -109.79 164.93 12.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.631 -0.668 . . . . 0.0 110.026 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.445 ' N ' ' NE2' ' A' ' 98' ' ' HIS . . . 70.99 -127.73 15.51 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.535 ' O ' ' ND1' ' A' ' 82' ' ' HIS . 96.9 mtt180 -101.87 137.01 40.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.399 -1.059 . . . . 0.0 110.491 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 173.13 153.79 0.25 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.3 144.41 51.07 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.733 2.289 . . . . 0.0 113.059 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 55.5 t0 57.09 28.6 15.17 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.451 -0.781 . . . . 0.0 109.348 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 18.3 t -98.19 119.81 37.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.34 -0.85 . . . . 0.0 109.572 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -65.03 -36.45 84.41 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.42 -0.8 . . . . 0.0 109.318 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -78.24 128.45 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.892 . . . . 0.0 110.212 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 91.6 m-85 -126.85 86.98 2.58 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.8 mt -108.21 106.45 16.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.619 0.723 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 55.6 t0 -86.51 90.82 8.35 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.501 ' OD2' ' CE2' ' A' ' 142' ' ' PHE . 71.1 m-20 -151.33 130.66 12.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.876 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.14 -24.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.4 p -75.18 -13.81 60.49 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.554 -0.717 . . . . 0.0 109.182 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.451 ' O ' ' OG ' ' A' ' 95' ' ' SER . 89.5 t -101.75 -15.1 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 94' ' ' VAL . 79.4 p 50.23 174.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.592 0.71 . . . . 0.0 110.792 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -59.88 -65.66 0.64 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 109.935 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -102.17 134.53 45.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.648 -0.658 . . . . 0.0 109.779 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.445 ' NE2' ' N ' ' A' ' 80' ' ' GLY . 4.8 p80 -154.3 -35.42 0.1 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.67 158.52 43.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.823 . . . . 0.0 109.928 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -137.16 151.2 48.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.653 -0.654 . . . . 0.0 109.67 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.5 142.63 43.53 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -134.65 141.03 46.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.796 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.9 tp -102.44 127.13 49.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.683 -0.635 . . . . 0.0 109.32 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 106' ' ' ASN . 80.5 tt0 -155.99 -70.69 0.11 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.557 -0.714 . . . . 0.0 109.355 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -72.05 32.71 0.06 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.497 -0.752 . . . . 0.0 109.529 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.531 ' H ' ' C ' ' A' ' 104' ' ' GLU . 16.2 p30 44.02 30.19 0.4 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.658 0.742 . . . . 0.0 109.53 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 108' ' ' PHE . 96.1 mt-10 -144.47 10.24 1.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 107' ' ' GLU . 94.1 m-85 58.17 144.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.255 0.55 . . . . 0.0 110.494 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -133.76 163.7 28.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.3 132.18 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.737 -0.602 . . . . 0.0 109.487 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.7 t -128.65 133.6 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.98 114.67 21.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.317 -0.864 . . . . 0.0 109.487 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.04 -177.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 111.006 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.2 -3.64 65.92 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.7 p -74.09 158.89 33.42 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 110.429 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.5 tt -69.86 106.58 3.2 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.404 -0.81 . . . . 0.0 109.854 -179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 63.2 t-20 -155.24 110.17 3.0 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.346 -0.846 . . . . 0.0 108.902 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.38 48.52 4.06 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -63.81 136.06 57.11 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.358 -1.084 . . . . 0.0 110.402 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.423 ' OH ' ' NH1' ' A' ' 123' ' ' ARG . 31.4 p90 -141.54 157.98 44.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.513 -0.742 . . . . 0.0 109.12 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.1 p -121.02 128.86 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.451 0.643 . . . . 0.0 109.888 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 54.35 38.54 29.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.65 -0.656 . . . . 0.0 109.614 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.423 ' NH1' ' OH ' ' A' ' 120' ' ' TYR . 31.0 mmt180 60.47 44.01 12.45 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.436 0.636 . . . . 0.0 110.21 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -147.63 87.21 6.01 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.522 -0.736 . . . . 0.0 109.127 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.4 130.45 38.61 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.378 2.052 . . . . 0.0 112.076 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.5 m -147.34 154.4 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.326 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.89 -39.81 94.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.6 p -157.26 157.35 34.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.229 -0.919 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.37 149.99 14.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.288 -0.883 . . . . 0.0 109.806 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.65 135.98 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.501 -0.749 . . . . 0.0 110.434 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.28 148.89 37.25 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.358 -0.839 . . . . 0.0 109.856 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.03 154.72 44.28 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.571 0.701 . . . . 0.0 109.773 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.552 ' ND2' ' H ' ' A' ' 148' ' ' THR . 24.4 t-20 -55.97 115.07 2.19 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.581 0.705 . . . . 0.0 110.751 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 146' ' ' PHE . . . 84.13 15.34 69.78 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 136' ' ' GLU . 67.7 t0 -64.23 145.74 55.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -1.211 . . . . 0.0 109.996 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 135' ' ' ASP . 98.4 mt-10 -93.49 122.12 35.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 52.8 t -122.05 132.89 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -122.67 124.92 44.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 141' ' ' LYS . 96.6 mt -124.42 129.95 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.307 0.575 . . . . 0.0 109.947 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.69 -88.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 139' ' ' ILE . 63.3 mttp -141.88 -4.33 1.07 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.461 -1.023 . . . . 0.0 108.624 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.501 ' CE2' ' OD2' ' A' ' 91' ' ' ASP . 62.2 m-85 -96.94 140.49 31.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.767 . . . . 0.0 109.924 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -105.0 129.48 53.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.658 -0.651 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.07 149.68 50.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.22 129.06 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.6 0.714 . . . . 0.0 109.119 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 134' ' ' GLY . 76.0 t80 -90.08 127.67 36.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.764 -0.585 . . . . 0.0 109.582 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.625 ' N ' ' CD2' ' A' ' 147' ' ' LEU . 0.6 OUTLIER -143.41 174.95 10.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.823 0.821 . . . . 0.0 110.06 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.59 ' HG1' ' H ' ' A' ' 150' ' ' HIS . 18.9 p -145.34 -151.58 0.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.525 0.678 . . . . 0.0 109.482 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -73.69 8.35 11.0 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.59 ' H ' ' HG1' ' A' ' 148' ' ' THR . 86.1 t60 54.03 77.12 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.216 -1.167 . . . . 0.0 109.919 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -85.69 143.09 28.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.28 -0.888 . . . . 0.0 110.591 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.36 143.06 53.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.563 -0.711 . . . . 0.0 110.238 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -74.88 -124.65 0.14 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 54.91 -165.77 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.625 -0.927 . . . . 0.0 110.84 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -61.55 149.11 40.03 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.803 0.811 . . . . 0.0 110.92 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.03 144.97 55.85 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.604 0.716 . . . . 0.0 110.669 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -61.81 148.73 42.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.515 -0.741 . . . . 0.0 110.299 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -76.34 155.28 34.3 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.723 -0.611 . . . . 0.0 110.307 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -133.88 138.14 45.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.513 -0.742 . . . . 0.0 109.416 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -90.46 129.76 36.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.441 -0.787 . . . . 0.0 110.221 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -66.53 -35.56 80.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.6 -0.687 . . . . 0.0 109.617 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 82.8 t60 58.11 86.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.49 -0.757 . . . . 0.0 109.716 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 82.4 t60 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.63 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 25' ' ' PHE . 7.5 p . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 26' ' ' ARG . 72.1 t80 54.13 108.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.371 -0.831 . . . . 0.0 110.225 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 25' ' ' PHE . 62.8 ttm-85 56.89 149.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.71 0.767 . . . . 0.0 110.251 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.02 137.75 58.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.877 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 9.7 p-10 -95.35 -0.74 52.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 0.0 109.602 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -105.16 -17.66 14.4 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -94.44 -10.39 32.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -89.9 -12.97 37.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -111.38 117.06 32.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.449 -0.782 . . . . 0.0 109.335 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.69 -41.96 98.07 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.762 -0.586 . . . . 0.0 110.617 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.92 114.12 25.2 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.117 -0.99 . . . . 0.0 109.973 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.437 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . . . -166.09 -62.95 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.447 -0.783 . . . . 0.0 109.399 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 35' ' ' ALA . 22.4 Cg_endo -59.51 -28.7 88.14 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.073 1.849 . . . . 0.0 111.45 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' PRO . . . 39.27 -153.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.6 0.714 . . . . 0.0 110.926 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.578 ' CD ' ' H ' ' A' ' 38' ' ' GLN . 2.9 pm0 -95.51 10.96 34.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.433 -0.792 . . . . 0.0 109.136 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 63.29 18.92 11.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.0 109.938 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.16 -135.4 4.45 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.5 p 48.09 -162.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.997 . . . . 0.0 110.817 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.38 -168.74 0.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.689 0.757 . . . . 0.0 111.163 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.418 ' O ' ' OG ' ' A' ' 43' ' ' SER . 7.8 t 51.38 22.12 1.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.714 . . . . 0.0 109.252 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.94 -5.42 59.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.404 -0.81 . . . . 0.0 109.368 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.88 138.49 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.322 -0.861 . . . . 0.0 109.877 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 p -75.95 162.16 28.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 95.77 0.98 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 50' ' ' GLY . 33.6 m -77.61 138.35 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -1.112 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -50.69 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.411 -0.805 . . . . 0.0 110.661 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . 58.63 165.06 0.1 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.75 85.61 3.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.454 -1.027 . . . . 0.0 108.54 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 54' ' ' GLY . 24.4 Cg_exo -55.58 -42.43 67.83 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.44 2.094 . . . . 0.0 113.783 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -73.6 23.7 0.33 Allowed 'Trans proline' 0 N--CA 1.489 1.242 0 CA-C-N 120.058 1.056 . . . . 0.0 112.048 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 52' ' ' PRO . . . 49.76 81.68 0.05 OUTLIER Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.52 160.75 20.17 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.509 -0.995 . . . . 0.0 109.526 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.81 154.93 51.04 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.35 152.66 48.67 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.454 -0.779 . . . . 0.0 109.616 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.0 mt -113.7 134.41 54.76 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.8 134.98 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.62 110.84 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.576 -0.703 . . . . 0.0 109.632 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -64.55 -44.98 89.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.861 . . . . 0.0 109.68 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -141.88 148.34 38.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.363 -0.835 . . . . 0.0 109.898 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.52 178.69 27.43 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.68 -40.48 84.22 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.326 2.017 . . . . 0.0 111.497 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -114.02 48.24 1.11 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.09 95.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.512 -0.743 . . . . 0.0 109.387 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.53 -17.04 0.58 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.2 t -62.56 150.23 41.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.492 -1.005 . . . . 0.0 109.513 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -130.3 156.2 45.05 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.633 -0.667 . . . . 0.0 109.292 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.17 146.07 50.83 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.533 -0.73 . . . . 0.0 109.286 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 tp -105.66 125.36 50.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.642 -0.661 . . . . 0.0 109.557 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.54 77.85 2.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.406 -0.809 . . . . 0.0 109.0 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.01 12.85 18.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 0.0 109.405 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -126.51 140.63 52.31 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.93 88.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.521 -0.737 . . . . 0.0 110.446 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 mm -106.18 118.47 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.303 -0.873 . . . . 0.0 109.764 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.9 m -123.22 122.85 39.41 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.5 t -87.65 167.3 14.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.175 -0.953 . . . . 0.0 109.543 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -122.51 146.88 46.99 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.556 -0.715 . . . . 0.0 109.097 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.71 -125.22 8.01 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 99.8 mtt180 -103.32 133.33 48.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.436 -1.037 . . . . 0.0 110.556 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 0.7 OUTLIER 175.11 120.12 0.12 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.08 -14.76 23.44 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.59 1.526 . . . . 0.0 111.287 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 66.5 t0 -96.74 -24.13 16.09 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.727 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.5 t -74.55 139.92 44.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.446 -0.784 . . . . 0.0 110.659 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.59 -41.29 96.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 109.687 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.74 129.51 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.344 -0.848 . . . . 0.0 110.303 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CZ ' ' OD2' ' A' ' 90' ' ' ASP . 84.4 t80 -129.25 84.84 2.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.7 mt -108.54 109.34 20.55 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.559 -0.713 . . . . 0.0 109.916 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.517 ' OD2' ' CZ ' ' A' ' 88' ' ' PHE . 97.9 m-20 -99.95 -93.38 0.27 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.511 -0.743 . . . . 0.0 109.352 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.468 ' CG ' ' CE1' ' A' ' 142' ' ' PHE . 1.5 p30 39.75 -165.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.645 0.736 . . . . 0.0 110.783 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.479 ' O ' ' OG1' ' A' ' 93' ' ' THR . 28.9 m -71.84 161.55 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 110.057 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 92' ' ' VAL . 72.5 p 54.56 -139.77 0.98 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.279 0.562 . . . . 0.0 110.676 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.2 t 42.72 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.493 -0.754 . . . . 0.0 109.649 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -69.36 173.33 5.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.47 -0.769 . . . . 0.0 110.816 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -60.39 -43.91 96.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.48 -0.762 . . . . 0.0 109.358 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -123.23 64.14 1.0 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.36 -35.08 25.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.536 -0.728 . . . . 0.0 109.69 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -150.45 149.62 30.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 109.803 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -141.49 134.23 28.68 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -100.98 145.8 28.23 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.507 -0.746 . . . . 0.0 109.786 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -131.63 132.18 43.81 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.9 tp -90.75 130.57 36.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.307 -0.871 . . . . 0.0 109.622 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 106' ' ' ASN . 49.1 tp10 -131.97 140.81 49.1 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.582 -0.699 . . . . 0.0 109.319 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 51.63 -85.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.469 -0.769 . . . . 0.0 110.085 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 104' ' ' GLU . 16.9 t-20 -155.75 20.57 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.456 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -134.02 139.95 46.37 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.548 -0.72 . . . . 0.0 109.373 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -77.34 147.13 36.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.513 -0.742 . . . . 0.0 109.981 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -124.85 160.89 27.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.33 134.15 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.8 t -127.33 135.48 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.518 ' OD2' ' N ' ' A' ' 118' ' ' GLY . 50.2 t0 -84.0 111.73 19.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.188 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.0 t -94.23 109.48 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.425 -0.797 . . . . 0.0 109.304 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.12 -177.9 39.68 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 116' ' ' LEU . 39.6 t -69.7 135.49 49.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -1.095 . . . . 0.0 109.907 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 116' ' ' LEU . 3.8 mm? 43.93 -170.85 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.327 -0.858 . . . . 0.0 110.684 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 118' ' ' GLY . 58.6 t-20 -71.95 147.75 46.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.769 . . . . 0.0 110.341 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 117' ' ' ASN . . . -148.98 -72.59 0.01 OUTLIER Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.5 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 23.8 m -62.28 139.59 58.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.174 -1.192 . . . . 0.0 109.874 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -132.9 157.62 44.63 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.462 -0.774 . . . . 0.0 109.223 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.8 p -118.94 128.42 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.561 -0.712 . . . . 0.0 109.375 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 54.55 38.24 29.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.918 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 63.1 46.69 4.53 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.506 0.67 . . . . 0.0 109.833 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -148.6 88.98 5.15 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.091 -1.005 . . . . 0.0 109.24 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.414 ' C ' HD22 ' A' ' 117' ' ' ASN . 37.1 Cg_exo -55.06 132.35 51.8 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.226 1.951 . . . . 0.0 112.393 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.438 ' N ' HD22 ' A' ' 117' ' ' ASN . 22.1 m -151.5 156.12 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.276 -0.89 . . . . 0.0 109.863 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.29 -40.63 96.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.824 . . . . 0.0 109.379 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.7 t -161.51 156.0 22.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.258 -0.901 . . . . 0.0 109.347 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.43 156.47 38.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.6 t -88.6 130.19 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.342 -0.849 . . . . 0.0 109.247 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.52 149.2 34.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.838 . . . . 0.0 110.218 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.526 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.41 163.81 37.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.416 -0.802 . . . . 0.0 109.267 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.497 ' ND2' ' OG1' ' A' ' 148' ' ' THR . 18.1 m120 -56.53 138.49 51.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.285 -0.884 . . . . 0.0 110.43 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.36 13.55 81.6 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 27.5 m-20 -83.03 145.15 29.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.25 . . . . 0.0 109.623 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -112.87 126.53 55.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.42 132.47 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.6 -0.688 . . . . 0.0 109.333 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 140' ' ' GLY . 13.3 tm0? -119.42 127.8 53.44 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.57 127.46 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.531 0.681 . . . . 0.0 110.052 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.506 ' O ' ' NE2' ' A' ' 138' ' ' GLN . . . 54.51 -104.65 0.27 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -116.78 -24.85 7.52 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.616 -0.932 . . . . 0.0 109.465 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.468 ' CE1' ' CG ' ' A' ' 91' ' ' ASP . 25.2 m-85 -76.33 142.77 41.14 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.347 -0.846 . . . . 0.0 110.077 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -107.85 137.08 46.5 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -136.54 155.49 49.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.389 -0.819 . . . . 0.0 109.415 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.3 p -119.82 131.14 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -94.8 120.54 35.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.397 -0.814 . . . . 0.0 109.985 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 16.3 mt -134.18 150.43 51.08 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.497 ' OG1' ' ND2' ' A' ' 133' ' ' ASN . 4.5 p -128.37 159.93 33.8 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.87 86.95 1.47 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.638 ' CG ' ' H ' ' A' ' 151' ' ' LYS . 86.3 t60 -85.95 177.2 7.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.445 -1.032 . . . . 0.0 109.482 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.638 ' H ' ' CG ' ' A' ' 150' ' ' HIS . 99.0 mttt -68.85 157.91 35.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 110.396 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 55.83 164.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.679 . . . . 0.0 110.741 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.37 -147.43 4.83 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 155' ' ' ASP . 79.1 mm-40 48.51 -124.42 1.83 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.275 -1.132 . . . . 0.0 109.772 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 154' ' ' GLU . 99.7 m-20 54.49 167.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 110.012 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 156' ' ' LEU . 3.8 mm? -90.8 129.27 36.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.41 -0.806 . . . . 0.0 109.913 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -145.09 -49.58 0.25 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.402 -0.812 . . . . 0.0 108.899 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -152.48 165.65 34.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.27 -0.894 . . . . 0.0 109.815 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -60.89 111.11 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.375 -0.828 . . . . 0.0 109.363 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -86.03 134.04 33.87 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.301 -0.875 . . . . 0.0 109.649 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -78.65 119.47 21.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.455 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 163' ' ' HIS . 58.2 t-80 -85.58 164.82 17.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 162' ' ' HIS . 84.7 t60 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.037 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.691 0.758 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CG ' ' N ' ' A' ' 26' ' ' ARG . 14.0 t80 -153.11 -163.76 1.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.68 0.752 . . . . 0.0 110.024 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.434 ' N ' ' CG ' ' A' ' 25' ' ' PHE . 96.4 mtt180 55.79 179.04 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.548 0.689 . . . . 0.0 110.292 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 29' ' ' PHE . . . -67.95 151.26 47.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.654 0.74 . . . . 0.0 109.991 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -58.04 -0.67 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.546 ' H ' ' C ' ' A' ' 27' ' ' ALA . 32.8 p90 -145.04 -160.13 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.498 -0.751 . . . . 0.0 109.711 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' A' ' 29' ' ' PHE . 51.8 mt -61.46 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.763 0.792 . . . . 0.0 110.277 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -66.93 -15.87 63.96 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 58.54 84.48 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.606 0.717 . . . . 0.0 110.175 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.1 tp -63.95 -42.53 97.28 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -85.71 110.18 19.13 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.733 0.777 . . . . 0.0 109.711 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.95 152.35 50.87 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.832 -0.542 . . . . 0.0 110.565 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 37' ' ' ALA . 26.4 Cg_endo -63.49 146.67 93.2 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.463 2.108 . . . . 0.0 112.847 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . 50.32 103.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.544 0.687 . . . . 0.0 109.993 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.85 175.22 2.04 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.809 0.814 . . . . 0.0 110.385 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.07 139.88 54.84 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.804 0.812 . . . . 0.0 110.063 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.99 174.99 31.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.6 p -98.02 -13.32 21.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.743 -0.857 . . . . 0.0 108.897 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' A' ' 42' ' ' GLU . 1.1 pm0 -111.08 -109.57 0.34 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.575 -0.703 . . . . 0.0 109.639 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.529 ' C ' ' H ' ' A' ' 45' ' ' VAL . 96.2 p -164.82 -32.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.446 ' O ' ' O ' ' A' ' 45' ' ' VAL . . . 70.14 -39.34 0.44 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.729 -0.607 . . . . 0.0 109.64 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.529 ' H ' ' C ' ' A' ' 43' ' ' SER . 10.5 t 51.68 106.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.686 0.755 . . . . 0.0 110.28 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.7 p -73.91 162.57 28.93 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.732 0.777 . . . . 0.0 110.209 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . -170.43 -156.94 11.77 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' CG1' HH22 ' A' ' 69' ' ' ARG . 24.9 m -74.32 30.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.913 -0.757 . . . . 0.0 109.608 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' A' ' 47' ' ' GLY . 80.1 mm-40 -69.71 -4.2 18.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.25 141.13 3.06 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -141.51 76.26 21.14 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.75 -0.853 . . . . 0.0 109.293 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 51' ' ' LEU . 50.4 Cg_exo -47.64 -176.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.373 2.049 . . . . 0.0 111.396 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 52' ' ' PRO . 33.7 Cg_exo -60.15 146.33 96.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.381 2.054 . . . . 0.0 113.07 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.6 -0.01 82.41 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.9 mt -124.6 145.96 49.32 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.654 -0.91 . . . . 0.0 110.36 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.37 166.51 31.64 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.588 0.708 . . . . 0.0 109.85 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -125.83 146.19 49.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.843 0.83 . . . . 0.0 110.236 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.6 mt -125.43 140.9 52.39 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.672 0.749 . . . . 0.0 109.575 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -140.99 143.37 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.745 0.784 . . . . 0.0 110.341 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.6 t -73.76 131.09 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.792 0.806 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -95.22 -32.0 13.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -151.71 140.55 20.95 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.781 0.8 . . . . 0.0 109.966 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.37 167.48 11.66 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.05 -17.71 40.67 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.823 2.349 . . . . 0.0 111.384 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.38 19.52 13.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.43 143.05 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.865 0.84 . . . . 0.0 110.369 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.96 -14.28 61.6 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.4 t -68.16 138.61 55.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.644 -0.915 . . . . 0.0 110.892 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.45 HH22 ' CG1' ' A' ' 48' ' ' VAL . 85.8 mtp180 -134.52 143.48 47.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.74 0.781 . . . . 0.0 110.231 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -128.91 136.58 50.6 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.633 0.73 . . . . 0.0 109.652 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt -110.25 123.52 49.93 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.885 0.85 . . . . 0.0 109.74 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 57.5 mt -90.3 113.38 25.22 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.552 0.691 . . . . 0.0 109.59 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -147.21 70.88 1.2 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.674 0.75 . . . . 0.0 109.197 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -171.07 -121.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.651 -0.656 . . . . 0.0 109.763 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -167.14 127.6 1.51 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.751 0.786 . . . . 0.0 109.805 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.407 HD11 HG23 ' A' ' 76' ' ' ILE . 14.2 mm 63.57 82.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.632 0.729 . . . . 0.0 109.385 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.4 m -99.41 123.38 43.64 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.781 0.801 . . . . 0.0 110.136 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.1 t -91.44 166.43 12.87 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.538 0.685 . . . . 0.0 109.411 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.54 154.95 26.27 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.774 0.797 . . . . 0.0 110.019 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 101.83 -118.97 6.31 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.551 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 84.9 mtp180 -124.08 130.62 52.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.78 -0.835 . . . . 0.0 110.352 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 3.1 m-70 176.3 149.37 0.31 Allowed Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.05 -30.99 20.09 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.88 2.386 . . . . 0.0 112.158 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -93.0 -0.25 57.25 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.0 t -94.74 118.93 32.53 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.717 0.77 . . . . 0.0 109.803 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.01 -39.94 94.17 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.335 0.588 . . . . 0.0 109.44 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.526 ' CD1' ' N ' ' A' ' 87' ' ' ILE . 1.9 mp -82.56 125.57 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.718 . . . . 0.0 109.987 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CE2' ' OD1' ' A' ' 90' ' ' ASP . 34.0 t80 -124.82 102.3 7.5 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.811 0.815 . . . . 0.0 108.922 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.8 mt -107.34 112.67 25.61 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.821 0.819 . . . . 0.0 110.038 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD1' ' CE2' ' A' ' 88' ' ' PHE . 99.9 m-20 -91.52 81.31 5.37 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.496 0.665 . . . . 0.0 109.435 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 92' ' ' VAL . 66.9 t0 -156.16 140.76 16.91 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.71 0.767 . . . . 0.0 110.071 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.542 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 33.4 m -67.62 -22.64 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.9 p -65.72 -29.08 69.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.575 -0.703 . . . . 0.0 109.165 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -103.34 128.84 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 121.887 0.851 . . . . 0.0 110.033 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 p -72.66 172.41 10.7 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.881 0.848 . . . . 0.0 111.03 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -59.19 -43.75 92.22 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.911 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.557 ' O ' ' N ' ' A' ' 99' ' ' ALA . 95.1 mtt-85 -108.29 -51.81 2.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 59.5 -72.56 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.423 0.63 . . . . 0.0 109.951 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -142.32 163.51 32.65 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.712 0.768 . . . . 0.0 109.919 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -132.03 146.11 51.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.803 0.811 . . . . 0.0 110.062 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.35 140.51 48.59 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.432 0.634 . . . . 0.0 109.392 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -128.1 142.91 51.07 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.805 0.812 . . . . 0.0 110.212 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.6 tp -103.56 123.1 46.31 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.548 0.69 . . . . 0.0 109.361 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -92.25 -127.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.444 0.64 . . . . 0.0 110.141 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.64 -40.8 92.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.805 -0.559 . . . . 0.0 109.641 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -174.82 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -140.91 136.59 32.42 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.653 0.74 . . . . 0.0 109.478 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -79.41 146.88 32.57 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.694 0.759 . . . . 0.0 110.228 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.26 160.87 31.63 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.426 0.631 . . . . 0.0 109.488 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -123.82 127.06 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.885 0.85 . . . . 0.0 109.595 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.74 133.95 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.685 0.755 . . . . 0.0 109.404 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -80.61 151.84 28.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.635 0.731 . . . . 0.0 110.451 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.8 m -102.83 11.7 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.12 15.3 69.91 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.9 t -59.04 172.7 0.53 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.784 0.802 . . . . 0.0 110.767 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 116' ' ' LEU . 4.0 mm? -62.53 -41.14 98.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -86.41 114.98 23.63 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.612 0.72 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.85 104.84 2.59 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.0 m -63.51 137.74 58.25 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.914 0.864 . . . . 0.0 110.748 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.427 ' OH ' ' OE1' ' A' ' 138' ' ' GLN . 51.0 p90 -138.97 160.71 39.11 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.379 0.609 . . . . 0.0 109.584 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 123' ' ' ARG . 10.4 p -105.92 128.24 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 121.858 0.837 . . . . 0.0 109.99 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 53.42 -83.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.321 0.581 . . . . 0.0 109.707 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 121' ' ' VAL . 64.3 ttt180 -156.91 42.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -147.64 85.15 6.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.94 133.95 61.36 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.44 2.093 . . . . 0.0 112.177 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -145.92 162.98 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.905 0.86 . . . . 0.0 110.574 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -65.44 -34.08 77.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.2 p -153.2 159.9 42.73 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.571 0.7 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.62 155.91 30.92 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.709 0.766 . . . . 0.0 110.388 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.3 t -105.78 130.12 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.852 0.834 . . . . 0.0 109.641 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -75.79 146.35 40.04 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.625 0.726 . . . . 0.0 109.835 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.546 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.58 155.35 40.15 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.019 0.914 . . . . 0.0 110.289 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.422 ' OD1' ' OG1' ' A' ' 148' ' ' THR . 33.1 m-20 -48.41 122.93 5.88 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.937 0.875 . . . . 0.0 110.755 -178.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.62 18.79 54.11 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 16.1 m-20 -87.66 151.93 22.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.694 -0.886 . . . . 0.0 110.301 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -114.86 129.92 56.79 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.734 0.778 . . . . 0.0 109.721 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.64 131.03 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.709 0.766 . . . . 0.0 109.133 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.427 ' OE1' ' OH ' ' A' ' 120' ' ' TYR . 57.0 tt0 -117.26 126.69 53.15 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.795 0.807 . . . . 0.0 109.883 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.18 129.1 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.573 0.701 . . . . 0.0 109.619 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 48.0 -107.28 0.23 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -111.31 -21.05 12.05 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.51 148.14 33.56 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.684 0.754 . . . . 0.0 110.76 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -115.33 126.98 55.11 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.718 0.77 . . . . 0.0 109.453 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.11 155.92 44.7 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.625 0.726 . . . . 0.0 110.173 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.9 p -126.75 135.37 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.715 0.769 . . . . 0.0 109.763 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -92.73 118.77 31.42 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.861 0.838 . . . . 0.0 109.673 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 93.0 mt -134.58 148.83 50.53 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.627 0.727 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 150' ' ' HIS . 5.1 p -130.93 110.6 11.39 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.624 0.726 . . . . 0.0 109.759 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 59.79 -74.31 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 148' ' ' THR . 86.5 t60 54.97 88.26 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.946 -0.738 . . . . 0.0 109.735 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -61.7 135.5 57.64 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.729 0.776 . . . . 0.0 110.406 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -73.12 146.23 45.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.931 0.872 . . . . 0.0 110.448 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -71.43 168.21 51.23 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 56.32 14.37 1.56 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 122.092 -0.652 . . . . 0.0 109.395 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 157' ' ' GLU . 65.5 t0 -81.3 -80.67 0.15 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.669 -0.644 . . . . 0.0 110.077 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.6 mt 58.94 -71.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.459 0.647 . . . . 0.0 110.007 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 155' ' ' ASP . 80.3 mm-40 -43.31 149.4 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.779 0.8 . . . . 0.0 110.499 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 159' ' ' HIS . 80.7 m80 -111.34 162.43 15.04 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.916 0.865 . . . . 0.0 110.065 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 158' ' ' HIS . 97.8 m-70 57.97 153.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.685 0.755 . . . . 0.0 110.598 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -82.8 149.08 27.41 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.861 0.839 . . . . 0.0 110.264 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -60.01 -43.85 94.98 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.498 ' ND1' ' O ' ' A' ' 162' ' ' HIS . 32.0 p80 -92.74 123.74 36.24 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.874 0.845 . . . . 0.0 110.036 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.876 -1.059 . . . . 0.0 109.997 179.832 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.342 0.591 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -150.23 -21.52 0.25 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.874 . . . . 0.0 108.869 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.444 ' O ' ' CE2' ' A' ' 29' ' ' PHE . 36.1 ttm180 -95.24 -11.04 28.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -0.845 . . . . 0.0 108.842 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 46.43 -140.18 0.48 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 110.102 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -156.66 76.42 0.88 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.408 -0.807 . . . . 0.0 109.605 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.444 ' CE2' ' O ' ' A' ' 26' ' ' ARG . 0.7 OUTLIER -105.0 -55.07 2.38 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.462 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 4.1 pp -103.35 -13.3 16.73 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.483 -0.761 . . . . 0.0 109.199 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.6 p -72.4 160.42 32.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.375 -0.828 . . . . 0.0 109.736 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 33' ' ' LEU . 81.4 tt0 -126.64 -27.57 3.1 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 32' ' ' GLU . 83.9 mt 40.47 87.28 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.553 0.692 . . . . 0.0 110.093 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 48.5 p-10 -70.19 138.62 51.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.445 -0.784 . . . . 0.0 109.93 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -173.2 80.74 0.4 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.414 -0.804 . . . . 0.0 109.054 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.83 147.07 83.14 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.6 2.2 . . . . 0.0 112.269 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.11 145.4 55.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.769 . . . . 0.0 110.599 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -103.9 -66.8 0.93 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.517 0.675 . . . . 0.0 109.551 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.98 58.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.822 . . . . 0.0 110.271 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.87 -5.85 73.26 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.0 149.4 34.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.255 -1.144 . . . . 0.0 109.391 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.465 ' C ' ' H ' ' A' ' 44' ' ' ALA . 46.9 tp10 -163.12 124.59 2.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 109.478 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.4 p -76.69 20.42 0.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.388 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 42' ' ' GLU . . . -78.52 2.66 18.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.306 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.81 135.69 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 110.191 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 t 61.1 143.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.645 0.736 . . . . 0.0 110.573 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.16 30.43 0.02 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.45 -43.06 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.355 -1.085 . . . . 0.0 109.61 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -48.64 140.13 8.63 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.638 0.732 . . . . 0.0 110.679 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.88 -88.47 0.11 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 70.26 83.24 0.16 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.717 -0.873 . . . . 0.0 109.675 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.85 170.81 19.13 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.922 1.748 . . . . 0.0 111.731 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.08 147.23 76.53 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.316 2.011 . . . . 0.0 113.524 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.58 -16.77 43.92 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.25 146.1 46.39 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.396 -1.061 . . . . 0.0 109.942 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.58 157.15 40.63 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 pp -141.49 157.67 44.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.225 -0.922 . . . . 0.0 109.673 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mp -116.18 151.75 35.07 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.17 133.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.37 134.59 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.409 -0.807 . . . . 0.0 110.398 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -112.23 50.72 0.84 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 141' ' ' LYS . 3.6 tpt180 -120.42 173.43 7.15 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.72 -57.63 3.04 Favored Glycine 0 N--CA 1.49 2.241 0 O-C-N 120.92 -1.112 . . . . 0.0 111.443 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -85.07 12.67 3.0 Favored 'Trans proline' 0 N--CA 1.515 2.761 0 C-N-CA 123.917 3.078 . . . . 0.0 114.366 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -148.62 17.08 1.02 Allowed 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.335 -1.478 . . . . 0.0 108.663 -176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.78 153.39 32.92 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.382 0.611 . . . . 0.0 109.896 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.47 -21.63 43.34 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.7 m -66.17 141.24 58.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.29 -1.123 . . . . 0.0 109.263 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -133.81 146.95 51.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.679 -0.638 . . . . 0.0 109.359 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.18 102.24 4.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.41 -0.806 . . . . 0.0 108.878 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -85.63 137.72 32.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 109.4 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.3 mt -95.91 97.45 9.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.526 -0.734 . . . . 0.0 109.82 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 51.5 t0 -109.92 17.54 21.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -127.35 152.92 46.85 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.505 -0.747 . . . . 0.0 109.997 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.41 -47.89 83.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.636 -0.665 . . . . 0.0 110.452 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.24 126.12 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.299 -0.876 . . . . 0.0 109.618 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 92.6 m -121.96 120.95 35.92 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 p -85.29 163.13 18.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.387 -0.82 . . . . 0.0 109.853 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.58 177.83 4.5 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.478 -0.764 . . . . 0.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.88 -129.64 10.4 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.367 -0.92 . . . . 0.0 110.887 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.558 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 85.1 mtt85 -96.63 114.75 26.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.447 -1.031 . . . . 0.0 110.231 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 32.3 m-70 -170.58 80.33 0.57 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.81 -38.39 67.43 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.282 1.988 . . . . 0.0 111.266 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.56 -39.85 95.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.441 -0.787 . . . . 0.0 109.28 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 t -72.09 158.27 36.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.352 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -62.45 -40.55 96.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.514 -0.741 . . . . 0.0 109.883 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 93.2 mt -94.49 117.09 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.07 -1.019 . . . . 0.0 109.671 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 16.5 p90 -130.33 88.26 2.62 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.19 92.33 9.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.029 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -95.71 92.65 6.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.419 -0.801 . . . . 0.0 109.488 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -159.99 176.93 11.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.82 -44.38 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.312 -0.867 . . . . 0.0 109.994 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.6 p -71.61 173.6 7.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.63 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t 61.81 108.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.679 0.752 . . . . 0.0 109.707 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -61.1 -150.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.551 0.691 . . . . 0.0 110.752 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -60.31 -45.69 92.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.483 -0.76 . . . . 0.0 109.364 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 99' ' ' ALA . 36.4 ptt85 179.99 -54.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' A' ' 97' ' ' ARG . 46.8 p-80 43.09 15.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.675 -0.641 . . . . 0.0 110.141 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -154.7 143.13 20.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.861 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -149.42 147.67 28.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.34 143.31 39.02 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.51 -0.744 . . . . 0.0 109.547 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -128.71 137.59 51.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.655 -0.653 . . . . 0.0 109.509 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.2 tp -91.64 126.89 36.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.382 -0.824 . . . . 0.0 108.78 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 106' ' ' ASN . 83.7 tt0 -119.83 129.87 54.63 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.467 -0.771 . . . . 0.0 109.763 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 m120 50.79 -86.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.518 -0.739 . . . . 0.0 109.957 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 104' ' ' GLU . 9.0 m120 -148.35 23.6 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.171 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -134.97 139.05 44.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.698 . . . . 0.0 109.561 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -75.5 149.0 38.54 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.646 -0.659 . . . . 0.0 109.716 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -135.92 165.33 25.9 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 109.092 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.69 132.28 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -129.78 132.73 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 119' ' ' THR . 88.8 m-20 -103.71 139.28 39.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.432 -0.792 . . . . 0.0 109.391 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.0 m -89.4 131.7 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 77.33 -176.54 53.37 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.6 m -126.27 64.78 1.24 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.718 -0.872 . . . . 0.0 109.176 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.25 111.81 2.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.027 -1.045 . . . . 0.0 109.0 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 6.7 m120 55.79 35.19 24.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.734 -0.604 . . . . 0.0 109.847 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.6 168.36 39.45 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.52 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 21.3 m -62.93 138.66 58.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.396 -1.061 . . . . 0.0 109.952 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -119.62 150.25 40.62 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.623 -0.673 . . . . 0.0 109.326 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.423 ' O ' ' O ' ' A' ' 122' ' ' ASN . 11.7 p -120.37 130.84 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.595 -0.69 . . . . 0.0 110.01 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 124' ' ' GLU . 91.0 m-20 45.58 -172.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.637 0.732 . . . . 0.0 110.781 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -59.67 -2.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.59 -0.694 . . . . 0.0 110.051 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.497 ' H ' ' C ' ' A' ' 122' ' ' ASN . 27.1 mt-10 -109.6 95.16 18.49 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.421 -0.799 . . . . 0.0 109.436 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.28 127.82 8.54 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.834 1.69 . . . . 0.0 111.795 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.04 162.25 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.309 -0.869 . . . . 0.0 110.363 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -74.66 -22.44 58.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.531 -0.731 . . . . 0.0 109.553 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.4 p -162.54 160.34 25.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.632 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -173.06 166.14 4.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.166 -0.959 . . . . 0.0 109.677 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.79 130.66 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.453 -0.779 . . . . 0.0 109.516 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.73 148.7 34.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 109.91 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.537 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -151.02 152.74 33.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 108.945 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.461 HD22 ' CE1' ' A' ' 150' ' ' HIS . 64.4 t30 -51.87 134.13 31.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.371 -0.831 . . . . 0.0 110.441 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.19 11.4 64.82 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 79.4 m-20 -89.09 148.64 23.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.269 -1.136 . . . . 0.0 109.724 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -112.22 128.06 56.14 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.93 130.6 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.645 -0.659 . . . . 0.0 109.301 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -126.01 122.45 35.9 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.595 -0.691 . . . . 0.0 109.214 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 95.4 mt -123.82 129.73 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.638 -0.664 . . . . 0.0 109.914 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.36 -108.02 2.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.527 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 88.7 tttt -126.16 -26.1 3.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.913 . . . . 0.0 109.255 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -74.34 146.58 42.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -103.84 139.7 38.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.493 -0.754 . . . . 0.0 109.269 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.53 137.43 40.26 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.814 . . . . 0.0 109.589 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.8 p -109.49 130.18 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -89.72 111.45 22.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.923 . . . . 0.0 109.971 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.8 mt -140.12 159.85 41.26 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.612 0.72 . . . . 0.0 109.813 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.451 ' OG1' ' CE1' ' A' ' 150' ' ' HIS . 60.0 p -96.33 168.58 10.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.543 -0.723 . . . . 0.0 110.356 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -77.49 96.91 1.29 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.461 ' CE1' HD22 ' A' ' 133' ' ' ASN . 76.5 m80 -87.79 147.26 25.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.43 -1.041 . . . . 0.0 110.131 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -90.42 -8.1 51.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.412 -0.805 . . . . 0.0 109.505 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -88.69 144.25 26.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.291 -0.881 . . . . 0.0 110.136 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 157.93 -35.7 0.53 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -140.97 71.08 1.36 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.4 -1.059 . . . . 0.0 109.434 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.575 ' C ' ' H ' ' A' ' 157' ' ' GLU . 96.7 m-20 -89.49 -1.7 58.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 108.97 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 61.8 mt 59.74 -2.86 0.12 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.575 ' H ' ' C ' ' A' ' 155' ' ' ASP . 97.7 mt-10 -98.31 -3.88 36.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.326 -0.859 . . . . 0.0 108.909 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -60.32 -41.65 93.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 109.527 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -72.27 130.26 40.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.383 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -111.39 142.03 44.16 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.551 -0.718 . . . . 0.0 109.784 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -65.34 -38.36 89.89 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.537 -0.727 . . . . 0.0 109.807 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.509 ' ND1' ' OXT' ' A' ' 163' ' ' HIS . 64.6 t-80 -145.5 138.89 26.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.11 -0.994 . . . . 0.0 109.775 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.509 ' OXT' ' ND1' ' A' ' 162' ' ' HIS . 75.5 m80 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.745 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 121.4 0.619 . . . . 0.0 109.334 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.47 -43.76 96.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.218 -0.926 . . . . 0.0 109.636 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -73.68 144.9 45.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.89 . . . . 0.0 110.726 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.76 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.037 0.922 . . . . 0.0 110.649 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -71.14 -2.32 15.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.506 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 28.3 p90 -149.31 -160.67 1.2 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.011 -1.056 . . . . 0.0 109.93 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 29' ' ' PHE . 56.4 mt -62.89 91.69 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.899 0.857 . . . . 0.0 109.651 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 83.1 p -81.71 -6.57 59.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -92.02 97.99 11.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.062 -1.024 . . . . 0.0 109.571 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.6 mt 50.43 -171.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.034 0.921 . . . . 0.0 110.956 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 20.3 p-10 -98.67 -61.15 1.41 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.48 -0.763 . . . . 0.0 109.317 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.515 ' H ' ' CG ' ' A' ' 34' ' ' ASP . . . -178.15 80.2 0.23 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.782 . . . . 0.0 108.922 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.72 145.05 97.34 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.798 2.332 . . . . 0.0 112.382 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.63 125.68 2.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.736 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -77.08 140.71 40.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.814 . . . . 0.0 109.901 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.94 165.29 21.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 0.0 110.809 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.87 -176.77 49.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.8 m 42.75 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.697 -0.884 . . . . 0.0 110.359 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -164.9 126.11 2.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.223 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -73.47 150.91 41.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 110.309 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.74 -35.43 0.08 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.025 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 m -94.88 37.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.218 -0.926 . . . . 0.0 109.134 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 91.2 p -81.88 -3.51 54.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.36 43.68 4.24 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.6 m -83.2 -8.28 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -1.112 . . . . 0.0 109.072 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -95.85 -76.54 0.5 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.31 -0.869 . . . . 0.0 109.747 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.73 94.46 1.89 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -100.95 153.08 37.94 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.538 -0.978 . . . . 0.0 109.142 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 51' ' ' LEU . 84.8 Cg_exo -39.56 166.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.302 2.002 . . . . 0.0 112.283 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -54.75 139.51 77.42 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.066 1.844 . . . . 0.0 112.801 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 43.89 84.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 tp -149.95 141.65 23.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.92 -1.341 . . . . 0.0 109.237 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.17 165.93 23.64 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.55 0.69 . . . . 0.0 109.739 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.03 154.75 47.88 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.623 0.725 . . . . 0.0 109.744 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.3 mt -114.37 136.81 52.58 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.35 131.56 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.609 0.719 . . . . 0.0 109.782 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.0 t -73.21 133.63 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.593 0.711 . . . . 0.0 109.72 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -86.29 -74.02 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.906 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -121.61 149.24 43.45 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.757 0.789 . . . . 0.0 110.09 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.54 175.09 25.3 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.42 -18.43 43.87 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.864 2.376 . . . . 0.0 111.727 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' ALA . 92.5 m-20 -88.93 -74.93 0.45 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.186 -0.947 . . . . 0.0 109.38 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 60.59 132.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.473 -0.767 . . . . 0.0 110.521 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.99 -20.24 50.85 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 m -71.54 144.79 49.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -1.143 . . . . 0.0 110.777 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -146.69 151.66 37.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 109.64 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -130.32 145.66 51.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -109.66 146.25 35.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.563 -0.71 . . . . 0.0 109.22 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.6 mt -97.65 115.82 28.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.882 . . . . 0.0 110.17 -178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -89.45 53.33 2.58 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.963 0.887 . . . . 0.0 108.693 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 43.31 -165.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.174 0.988 . . . . 0.0 111.199 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 59.95 -144.5 0.52 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.663 0.745 . . . . 0.0 110.479 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.407 HD11 HG23 ' A' ' 76' ' ' ILE . 96.7 mt -111.12 127.21 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.734 -0.604 . . . . 0.0 109.5 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.6 m -120.24 120.58 36.51 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.531 ' HG ' ' CG ' ' A' ' 82' ' ' HIS . 17.2 p -83.03 162.29 21.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.429 -0.795 . . . . 0.0 109.885 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.73 -179.46 3.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.34 -0.85 . . . . 0.0 110.137 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.45 -124.17 28.91 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -105.62 127.26 52.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.43 -1.041 . . . . 0.0 109.963 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.531 ' CG ' ' HG ' ' A' ' 78' ' ' SER . 36.6 t-80 -173.94 135.09 0.62 Allowed Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.509 ' C ' ' H ' ' A' ' 85' ' ' SER . 49.3 Cg_endo -68.92 150.32 73.1 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.391 2.061 . . . . 0.0 113.394 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t0 65.24 -8.3 0.26 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.821 -0.549 . . . . 0.0 110.087 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 83' ' ' PRO . 46.7 t -73.84 133.98 43.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.991 -1.068 . . . . 0.0 110.191 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.26 -41.1 97.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.544 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.84 126.02 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.722 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -129.66 85.87 2.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.511 -0.743 . . . . 0.0 109.148 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.2 mt -104.83 93.66 4.85 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.455 -0.778 . . . . 0.0 109.331 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -99.96 83.34 2.7 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.526 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 24.3 p30 -155.4 172.57 17.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.127 -0.983 . . . . 0.0 109.958 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.541 ' C ' ' H ' ' A' ' 94' ' ' VAL . 5.3 t -62.81 169.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.534 -0.729 . . . . 0.0 110.703 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 92' ' ' VAL . 4.4 p 65.74 -7.38 0.36 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 92' ' ' VAL . 82.2 t -125.87 122.19 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.475 -0.766 . . . . 0.0 109.254 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.3 p -86.65 -162.09 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.824 0.821 . . . . 0.0 110.498 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -62.57 -38.65 90.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.837 . . . . 0.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -152.81 81.69 1.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.077 -1.015 . . . . 0.0 108.947 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -65.95 -39.76 90.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.737 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.62 160.97 36.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.841 . . . . 0.0 109.621 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -137.88 144.96 41.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.506 -0.746 . . . . 0.0 109.196 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.52 140.35 48.21 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -136.95 142.15 42.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.815 . . . . 0.0 109.625 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 53.8 tp -95.53 126.9 41.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.514 -0.742 . . . . 0.0 109.385 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.413 ' HG2' ' H ' ' A' ' 105' ' ' ASN . 53.5 tt0 -94.12 -128.46 0.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.236 -0.915 . . . . 0.0 110.012 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.413 ' H ' ' HG2' ' A' ' 104' ' ' GLU . 9.0 m120 -64.48 -41.57 96.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.825 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -174.05 25.83 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.02 -1.05 . . . . 0.0 109.092 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -137.41 142.4 41.67 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.234 -0.917 . . . . 0.0 110.059 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -76.64 145.63 38.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.499 -0.75 . . . . 0.0 110.05 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -139.27 162.16 35.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.279 -0.888 . . . . 0.0 109.221 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.57 132.57 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.6 t -127.37 132.84 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.669 0.747 . . . . 0.0 109.475 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 1.5 m-20 -78.01 138.06 38.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.561 -0.712 . . . . 0.0 109.584 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 m -114.27 12.33 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.05 123.93 1.23 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.125 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 p 61.4 116.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.535 -0.98 . . . . 0.0 110.542 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 10.5 mp -64.17 -40.02 95.23 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.582 -0.699 . . . . 0.0 109.821 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -80.02 5.46 14.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.06 -1.025 . . . . 0.0 108.583 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.94 -101.78 0.01 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.5 m -64.85 138.38 58.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -1.141 . . . . 0.0 110.267 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -140.46 157.67 45.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.181 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 122' ' ' ASN . 7.6 p -107.29 156.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.69 -0.631 . . . . 0.0 109.638 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 121' ' ' VAL . 6.5 m120 -41.23 -39.35 1.32 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.517 0.675 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -65.63 -90.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.984 . . . . 0.0 109.967 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -142.62 146.39 38.22 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.297 -0.877 . . . . 0.0 109.8 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.96 133.88 34.9 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.257 1.971 . . . . 0.0 112.636 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.6 m -144.24 157.31 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.082 -1.011 . . . . 0.0 110.64 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -72.96 -16.85 61.52 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.679 0.752 . . . . 0.0 109.049 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.6 p -158.61 161.23 37.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.968 . . . . 0.0 109.434 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.63 153.96 25.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.942 -1.099 . . . . 0.0 109.84 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.2 t -98.78 126.81 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.386 -0.821 . . . . 0.0 109.57 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 76.8 mt -79.53 146.44 32.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 110.303 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.526 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -151.96 151.17 30.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.175 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.471 ' ND2' ' HG1' ' A' ' 148' ' ' THR . 22.1 t-20 -46.93 124.99 6.87 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.461 -0.774 . . . . 0.0 110.998 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.53 13.6 59.57 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 32.9 m-20 -87.57 154.68 20.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.043 -1.269 . . . . 0.0 109.693 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -115.35 135.86 53.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.446 -0.784 . . . . 0.0 109.553 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.07 132.1 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.0 109.144 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -120.27 122.19 40.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 0.0 109.445 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.62 126.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.52 0.676 . . . . 0.0 109.232 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.2 -134.3 48.46 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -91.86 -7.95 47.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -1.032 . . . . 0.0 109.38 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.526 ' CE1' ' OD2' ' A' ' 91' ' ' ASP . 82.5 m-85 -95.28 143.86 26.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 0.0 110.516 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -108.16 136.9 47.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.622 -0.674 . . . . 0.0 109.202 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.29 154.27 51.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.59 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.89 136.53 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.436 0.636 . . . . 0.0 109.289 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -92.46 113.48 25.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.677 -0.639 . . . . 0.0 109.297 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.4 mt -137.06 147.77 46.34 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.756 . . . . 0.0 109.784 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 150' ' ' HIS . 68.3 p -90.53 168.05 12.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 110.016 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 150' ' ' HIS . . . -59.67 79.94 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 148' ' ' THR . 98.4 m-70 49.24 178.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.401 -1.058 . . . . 0.0 110.928 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.516 ' C ' ' H ' ' A' ' 153' ' ' GLY . 51.5 mtmt -96.66 -0.17 48.84 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.511 ' C ' ' H ' ' A' ' 154' ' ' GLU . 98.3 mm-40 -65.14 3.12 0.65 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.12 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . -74.31 36.16 0.96 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.511 ' H ' ' C ' ' A' ' 152' ' ' GLN . 79.9 mm-40 -64.48 139.72 58.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.173 -1.193 . . . . 0.0 110.44 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -70.04 152.38 44.45 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.832 0.825 . . . . 0.0 110.826 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.67 143.24 56.45 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.819 0.819 . . . . 0.0 110.791 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -71.32 102.51 2.61 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.812 0.815 . . . . 0.0 109.997 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -83.51 -17.3 42.4 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.476 -0.765 . . . . 0.0 108.965 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.566 ' CG ' ' N ' ' A' ' 160' ' ' HIS . 53.3 t-80 -151.33 170.95 18.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 110.01 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.566 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 60.7 m170 -68.74 139.62 55.35 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.929 0.871 . . . . 0.0 111.131 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -79.41 154.77 28.73 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.856 0.836 . . . . 0.0 110.935 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 47.27 91.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.953 0.882 . . . . 0.0 110.093 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 78.4 m80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.703 179.774 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 26' ' ' ARG . 47.1 p90 -106.9 -159.6 0.7 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.41 -0.806 . . . . 0.0 110.309 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.486 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 56.4 ttp180 -62.76 139.52 58.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 110.13 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.6 -111.5 0.09 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.487 -0.758 . . . . 0.0 109.432 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -101.42 -21.12 14.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.493 -0.754 . . . . 0.0 109.769 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 30' ' ' LEU . 1.3 p90 -82.17 -21.02 36.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.179 -0.951 . . . . 0.0 109.364 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 31' ' ' SER . 7.4 mp 38.45 60.13 1.37 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.607 0.718 . . . . 0.0 110.254 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.554 ' C ' ' H ' ' A' ' 33' ' ' LEU . 20.7 t 38.84 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.77 0.795 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 33' ' ' LEU . 24.4 tp10 62.5 -4.36 0.23 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.554 ' H ' ' C ' ' A' ' 31' ' ' SER . 76.5 mt 48.4 -179.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.418 -0.801 . . . . 0.0 110.55 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 67.9 t0 45.67 -88.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.651 -0.656 . . . . 0.0 110.223 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . 64.43 68.76 0.77 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.426 -0.796 . . . . 0.0 109.585 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -77.58 145.87 23.69 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.762 2.308 . . . . 0.0 112.316 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.09 -12.8 22.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.45 -0.782 . . . . 0.0 109.565 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 38' ' ' GLN . 5.1 pp0? -84.1 139.44 32.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.316 -0.865 . . . . 0.0 110.367 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.42 -19.48 1.66 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.05 -133.05 49.13 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.2 m 48.09 73.83 0.19 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.568 -0.96 . . . . 0.0 109.89 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -100.13 0.16 40.09 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.868 . . . . 0.0 109.157 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 m -65.35 147.35 53.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.554 -0.716 . . . . 0.0 110.156 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -167.95 79.89 0.17 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.4 m -82.88 142.27 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.343 -0.848 . . . . 0.0 110.606 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.4 p 40.93 -162.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.482 0.658 . . . . 0.0 110.651 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.69 -98.67 0.15 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.8 m -89.31 127.89 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.025 -1.279 . . . . 0.0 110.343 -178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' CG ' ' N ' ' A' ' 50' ' ' GLY . 18.1 pt-20 -163.47 -42.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 0.0 109.38 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' C ' ' A' ' 51' ' ' LEU . . . -104.73 0.83 42.11 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER -27.83 92.34 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.434 0 CA-C-N 117.412 0.606 . . . . 0.0 110.6 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.461 ' N ' ' O ' ' A' ' 50' ' ' GLY . 42.8 Cg_exo -53.81 156.61 11.78 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.326 2.017 . . . . 0.0 112.436 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.28 149.48 75.74 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.801 2.334 . . . . 0.0 112.236 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.27 -2.19 88.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.34 151.79 33.98 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.497 -1.001 . . . . 0.0 109.846 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -146.4 156.25 43.17 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.425 ' CB ' ' O ' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -137.99 171.75 13.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.805 . . . . 0.0 109.326 -179.502 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 mt -118.76 134.3 55.24 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.77 130.05 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.3 t -70.07 134.91 29.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.537 -0.727 . . . . 0.0 109.986 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -104.55 36.3 2.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.626 -0.672 . . . . 0.0 109.338 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.42 ' O ' ' N ' ' A' ' 66' ' ' ALA . 77.8 mtp85 -126.85 144.27 51.02 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.429 -0.794 . . . . 0.0 109.93 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.76 -57.21 15.09 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -46.43 -36.93 18.8 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.314 2.009 . . . . 0.0 111.781 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.401 ' ND2' ' CE1' ' A' ' 142' ' ' PHE . 41.0 m-20 -119.66 25.31 10.09 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.581 -0.699 . . . . 0.0 109.18 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . -66.46 140.52 58.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.313 -0.867 . . . . 0.0 109.801 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.413 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 101.21 -18.87 53.48 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 m -64.12 136.55 57.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.38 -1.071 . . . . 0.0 109.739 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' NH1' ' O ' ' A' ' 67' ' ' GLY . 90.6 mtm-85 -140.58 146.82 38.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.728 . . . . 0.0 109.098 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 57' ' ' LEU . 88.0 m-85 -129.01 136.58 50.5 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.511 -0.743 . . . . 0.0 109.324 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 tp -103.84 129.73 51.34 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.494 -0.754 . . . . 0.0 109.163 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.55 70.46 3.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.357 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 67.1 t0 -95.18 34.67 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -141.52 150.81 42.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.341 -0.85 . . . . 0.0 109.96 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.76 81.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.684 -0.635 . . . . 0.0 110.299 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.39 125.27 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.407 -0.808 . . . . 0.0 109.32 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.0 m -122.65 122.14 38.09 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.42 ' OG ' ' OE2' ' A' ' 100' ' ' GLU . 7.1 m -87.15 153.12 21.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 109.727 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -118.34 122.38 42.73 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.637 -0.665 . . . . 0.0 109.341 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.22 -124.38 2.52 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.476 ' C ' ' CG ' ' A' ' 82' ' ' HIS . 62.8 ttm-85 -119.72 121.92 40.28 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.532 -0.981 . . . . 0.0 109.222 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -170.05 161.54 6.67 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.12 -78.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.45 2.1 . . . . 0.0 112.077 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -81.37 97.41 7.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.325 -0.86 . . . . 0.0 109.743 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 p -166.51 126.96 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.767 . . . . 0.0 109.019 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.35 -37.72 84.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.48 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.3 mm -87.86 120.31 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.0 109.649 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CE2' ' OD2' ' A' ' 90' ' ' ASP . 69.3 t80 -130.28 85.72 2.32 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.19 107.86 18.96 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.444 -0.785 . . . . 0.0 109.507 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD2' ' CE2' ' A' ' 88' ' ' PHE . 97.9 m-20 -90.38 87.32 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 109.276 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -151.71 150.1 29.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.379 -0.826 . . . . 0.0 109.641 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.37 -25.05 26.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.041 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.412 ' HG1' ' N ' ' A' ' 94' ' ' VAL . 72.0 p -65.27 -33.94 77.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.479 -0.763 . . . . 0.0 109.647 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.412 ' N ' ' HG1' ' A' ' 93' ' ' THR . 25.1 t -101.68 118.02 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.3 -0.875 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.7 m -70.81 174.7 5.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.342 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -60.67 -43.72 97.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.564 -0.71 . . . . 0.0 109.356 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -127.04 55.23 1.58 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.564 -0.71 . . . . 0.0 109.114 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -60.7 -41.87 96.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.5 -0.75 . . . . 0.0 109.761 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.45 158.58 44.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.357 -0.839 . . . . 0.0 109.08 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.42 ' OE2' ' OG ' ' A' ' 78' ' ' SER . 28.0 tp10 -133.13 148.63 52.12 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.518 -0.739 . . . . 0.0 109.227 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -113.84 135.48 53.92 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -128.59 141.26 51.42 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.465 -0.772 . . . . 0.0 109.655 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.1 tp -98.93 127.23 44.81 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 106' ' ' ASN . 49.2 tp10 -123.39 132.76 54.07 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.578 -0.701 . . . . 0.0 109.701 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 51.97 -84.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 109.859 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' GLU . 63.8 t30 -153.51 25.74 0.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -134.73 138.58 44.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.489 -0.757 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -77.04 146.98 37.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -0.779 . . . . 0.0 109.74 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -132.92 157.62 44.66 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.29 136.54 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.35 133.5 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 44.5 p-10 -95.87 115.69 27.8 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.247 -0.908 . . . . 0.0 109.769 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.37 7.51 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.466 -0.772 . . . . 0.0 108.935 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.1 101.61 1.73 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.5 t -64.14 -40.19 95.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.493 -1.004 . . . . 0.0 109.895 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.3 tp -61.55 -43.29 99.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.896 . . . . 0.0 109.481 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -138.71 -73.73 0.39 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.94 153.5 30.3 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 93.8 m -75.63 158.46 32.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.513 -0.993 . . . . 0.0 109.777 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -147.49 162.7 38.54 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 p -120.74 128.13 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.435 -0.791 . . . . 0.0 109.844 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.1 m120 55.38 38.5 30.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.509 -0.745 . . . . 0.0 110.01 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 59.26 40.16 21.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.459 -0.776 . . . . 0.0 109.492 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -144.59 87.36 7.58 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.0 108.494 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.1 135.09 67.3 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.498 2.132 . . . . 0.0 112.202 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.3 m -141.79 162.96 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.307 -0.871 . . . . 0.0 110.014 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.64 -40.54 97.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.503 -0.748 . . . . 0.0 109.366 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.2 p -157.58 161.35 38.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.098 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.37 150.58 23.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.006 -1.058 . . . . 0.0 109.908 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.6 t -95.0 132.26 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.494 -0.754 . . . . 0.0 109.239 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.64 151.44 37.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.389 -0.819 . . . . 0.0 109.943 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.544 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -147.4 159.34 43.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.345 -0.847 . . . . 0.0 109.636 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -57.25 132.36 52.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 110.637 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.34 14.93 72.9 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 29.4 m-20 -83.18 148.84 27.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.242 -1.152 . . . . 0.0 109.581 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -113.29 128.12 56.37 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.42 131.73 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -120.06 118.45 30.65 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.539 -0.725 . . . . 0.0 109.229 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.31 129.36 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.611 -0.68 . . . . 0.0 109.744 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 59.98 -131.41 50.32 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -102.43 -16.32 16.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.587 -0.949 . . . . 0.0 109.18 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.401 ' CE1' ' ND2' ' A' ' 65' ' ' ASN . 79.0 m-85 -80.47 147.81 30.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.455 -0.778 . . . . 0.0 109.895 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.16 137.24 43.24 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.476 -0.765 . . . . 0.0 109.2 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.5 150.67 46.64 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.336 -0.853 . . . . 0.0 109.24 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.02 132.78 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.463 -0.773 . . . . 0.0 108.943 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.449 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 74.1 t80 -93.29 117.48 30.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 109.513 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.0 mt -129.06 139.76 51.89 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 150' ' ' HIS . 69.7 p -100.03 167.03 10.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.446 -0.784 . . . . 0.0 109.993 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.76 83.32 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 148' ' ' THR . 98.0 m-70 47.02 -161.52 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -1.033 . . . . 0.0 110.866 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.12 135.22 54.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.566 -0.708 . . . . 0.0 110.213 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -85.51 141.33 29.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.472 -0.767 . . . . 0.0 110.106 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.07 51.75 0.4 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.5 131.1 45.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -1.085 . . . . 0.0 110.258 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -151.18 106.27 3.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 108.995 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.37 127.57 36.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -76.91 131.17 38.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.464 -0.772 . . . . 0.0 110.237 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.529 ' O ' ' CG ' ' A' ' 159' ' ' HIS . 84.6 t60 -165.59 133.89 3.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.489 -0.757 . . . . 0.0 109.247 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 158' ' ' HIS . 99.1 m-70 -158.48 -63.25 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 108.955 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.493 ' ND1' ' N ' ' A' ' 161' ' ' HIS . 53.0 t-80 41.11 -96.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.809 -0.557 . . . . 0.0 110.218 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.493 ' N ' ' ND1' ' A' ' 160' ' ' HIS . 85.0 t60 42.73 85.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.642 -0.661 . . . . 0.0 109.666 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -71.64 142.55 49.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.472 -0.768 . . . . 0.0 110.058 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.367 179.583 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.364 0.602 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.631 ' O ' ' N ' ' A' ' 27' ' ' ALA . 8.4 p90 -149.18 -14.35 0.3 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 45.9 mtp180 53.58 -74.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 120.93 0.395 . . . . 0.0 110.278 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 25' ' ' PHE . . . 86.09 146.9 0.06 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.465 0.65 . . . . 0.0 109.947 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.3 t0 62.06 36.14 15.52 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.208 0.527 . . . . 0.0 109.672 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.61 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 2.6 p90 -142.31 -142.12 0.14 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.216 -0.928 . . . . 0.0 109.337 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.61 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 6.2 mp -62.12 -42.29 99.09 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.443 -0.786 . . . . 0.0 108.928 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.7 p 45.34 41.06 5.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.406 -0.809 . . . . 0.0 109.343 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -64.63 -24.48 67.6 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.0 -41.67 99.64 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.559 -0.713 . . . . 0.0 109.378 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -83.17 114.87 21.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.372 -0.83 . . . . 0.0 110.099 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.18 78.6 4.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.2 147.58 83.17 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.735 2.29 . . . . 0.0 112.552 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.43 150.27 27.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.474 -0.766 . . . . 0.0 110.248 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -60.43 147.8 39.72 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.711 0.767 . . . . 0.0 110.379 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.36 176.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.524 0.678 . . . . 0.0 110.696 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 41' ' ' THR . . . -175.67 -172.8 40.83 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 40' ' ' GLY . 6.7 p 60.7 139.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.606 -0.938 . . . . 0.0 110.535 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -66.4 138.29 57.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.584 -0.698 . . . . 0.0 110.134 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -72.95 147.82 44.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.776 . . . . 0.0 110.364 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.65 34.79 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -109.57 130.89 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.491 -0.755 . . . . 0.0 109.004 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 96.3 p -75.29 167.04 22.68 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.395 -0.816 . . . . 0.0 110.514 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.65 -165.29 35.04 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.614 ' H ' HH22 ' A' ' 69' ' ' ARG . 95.9 t -83.28 132.08 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.493 -1.004 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -112.25 -92.6 0.47 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.515 -0.741 . . . . 0.0 110.361 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.39 151.99 37.15 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.332 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.64 74.4 5.23 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 24.7 Cg_exo -53.04 -41.93 68.18 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.07 1.846 . . . . 0.0 112.112 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 32.4 Cg_exo -56.23 -4.17 0.68 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.553 1.502 . . . . 0.0 111.31 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 52' ' ' PRO . . . 75.39 62.59 2.69 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.3 mt -96.54 172.31 8.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.155 -1.203 . . . . 0.0 110.243 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.71 157.66 43.65 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.598 ' CD2' HH21 ' A' ' 69' ' ' ARG . 5.1 mp -131.87 150.3 52.19 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.341 -0.849 . . . . 0.0 110.022 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.5 mt -117.39 134.89 54.3 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.61 132.53 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.654 0.74 . . . . 0.0 109.259 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.1 132.53 33.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.491 -0.755 . . . . 0.0 109.779 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -93.31 -15.12 26.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.373 -0.829 . . . . 0.0 109.284 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -165.87 141.77 5.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.034 . . . . 0.0 109.925 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.91 176.82 24.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.23 -40.23 83.13 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.423 2.082 . . . . 0.0 111.764 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -108.43 53.58 0.68 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.96 143.47 42.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.463 -0.773 . . . . 0.0 110.13 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.13 1.56 75.64 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.2 m -71.84 152.33 42.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.466 -1.02 . . . . 0.0 109.941 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.614 HH22 ' H ' ' A' ' 48' ' ' VAL . 17.8 ptm180 -133.81 144.37 48.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.516 -0.74 . . . . 0.0 109.279 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -121.16 138.31 54.27 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.487 -0.758 . . . . 0.0 109.385 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 tp -99.48 125.71 45.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.388 -0.82 . . . . 0.0 109.13 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -99.34 75.05 1.96 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.282 -0.886 . . . . 0.0 109.13 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 64.3 t0 -99.07 17.3 20.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.392 -0.817 . . . . 0.0 109.053 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -119.26 144.45 46.77 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.562 -0.711 . . . . 0.0 109.658 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.82 99.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 110.076 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.4 mt -124.81 126.78 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.431 -0.793 . . . . 0.0 109.012 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 m -124.52 124.05 41.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.564 -0.71 . . . . 0.0 109.364 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -96.67 156.57 16.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 109.334 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.91 147.81 35.04 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.69 -48.44 1.01 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -88.01 141.11 28.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.151 -1.205 . . . . 0.0 109.989 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.615 ' CD2' ' N ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -88.72 -44.49 0.45 Allowed Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.419 -0.801 . . . . 0.0 109.817 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 32.5 Cg_exo -57.25 137.19 80.59 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.374 2.049 . . . . 0.0 112.701 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 44.76 46.43 8.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.603 -0.686 . . . . 0.0 109.709 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.9 m -156.07 116.89 3.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.325 -0.859 . . . . 0.0 109.74 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.24 -38.29 90.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.3 mm -78.2 128.09 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.427 -0.796 . . . . 0.0 109.819 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -129.99 85.92 2.35 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.4 98.05 7.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 46.7 p-10 -91.46 94.62 9.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.701 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -154.3 158.14 39.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.18 -0.95 . . . . 0.0 109.926 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.7 m -69.13 -32.47 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.534 -0.729 . . . . 0.0 109.761 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p -65.83 -29.96 70.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.901 . . . . 0.0 110.341 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -99.84 125.9 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -0.994 . . . . 0.0 109.562 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.0 m -79.39 -170.15 2.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.643 -0.661 . . . . 0.0 110.19 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -60.28 -45.45 93.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.758 . . . . 0.0 109.614 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 99' ' ' ALA . 79.7 mtp85 -108.17 -47.83 3.47 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.8 t60 52.81 -80.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.619 -0.675 . . . . 0.0 110.074 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -127.71 155.8 43.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.541 -0.724 . . . . 0.0 109.131 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -136.02 154.23 51.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 109.094 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -118.73 143.66 46.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -130.19 144.29 51.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.4 -0.813 . . . . 0.0 109.511 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.6 tp -104.46 123.96 48.4 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.511 -0.743 . . . . 0.0 109.437 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -95.19 -117.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 92.5 m-20 -65.07 -50.3 66.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 110.13 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 68.6 m-20 -169.03 23.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.572 -0.705 . . . . 0.0 109.282 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.54 136.68 43.22 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -77.0 146.62 37.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.49 -0.756 . . . . 0.0 110.126 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -123.37 156.62 35.06 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.7 p -117.75 131.15 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.76 143.13 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.485 -0.759 . . . . 0.0 109.731 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -99.58 112.82 24.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 0.0 108.938 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.6 m -77.73 150.21 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.172 -0.955 . . . . 0.0 110.742 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.97 17.79 64.55 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.592 ' HG ' ' H ' ' A' ' 116' ' ' LEU . 44.4 t 45.39 -147.8 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.55 -0.971 . . . . 0.0 110.135 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.592 ' H ' ' HG ' ' A' ' 115' ' ' SER . 49.0 tp 59.29 150.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.426 0.631 . . . . 0.0 110.283 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -66.45 141.91 57.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.945 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -172.13 -93.94 0.09 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.5 m -63.87 136.49 57.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 110.211 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -138.78 153.19 48.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.429 -0.794 . . . . 0.0 109.387 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.1 p -120.25 129.36 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.664 0.745 . . . . 0.0 109.52 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.512 ' CG ' ' H ' ' A' ' 123' ' ' ARG . 6.8 t-20 55.37 -167.09 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.585 0.707 . . . . 0.0 110.229 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.512 ' H ' ' CG ' ' A' ' 122' ' ' ASN . 11.0 mmp_? -72.6 -4.63 31.99 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.691 -0.631 . . . . 0.0 109.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -107.81 99.53 30.46 Favored Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -76.19 128.46 10.58 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.021 1.814 . . . . 0.0 112.056 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.59 160.79 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.299 -0.876 . . . . 0.0 110.478 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.89 -42.21 97.51 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.556 -0.715 . . . . 0.0 109.266 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 m -157.94 158.43 34.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 109.467 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -168.05 159.09 10.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.035 -1.041 . . . . 0.0 109.859 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.19 131.53 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.763 . . . . 0.0 109.954 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.6 150.31 36.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.866 . . . . 0.0 109.864 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.96 156.76 46.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.418 -0.801 . . . . 0.0 109.567 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -55.83 135.03 52.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.52 -0.737 . . . . 0.0 110.667 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.99 19.16 65.77 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 136' ' ' GLU . 64.4 t0 -96.76 133.73 40.96 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.308 -1.113 . . . . 0.0 109.986 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.488 ' N ' ' OD1' ' A' ' 135' ' ' ASP . 98.4 mt-10 -94.35 130.45 40.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.319 -0.863 . . . . 0.0 109.224 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.5 t -124.51 132.53 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.565 -0.71 . . . . 0.0 109.126 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -126.22 127.53 45.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.42 127.47 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.496 -0.753 . . . . 0.0 109.698 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.48 -95.35 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -128.43 -18.37 4.01 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.643 -0.916 . . . . 0.0 109.123 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -74.76 141.44 44.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -0.859 . . . . 0.0 109.63 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -105.28 131.83 52.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.432 -0.792 . . . . 0.0 109.814 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.75 152.62 51.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.506 -0.746 . . . . 0.0 109.161 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.43 131.39 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -92.5 111.39 22.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.44 -0.788 . . . . 0.0 109.271 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.77 143.17 50.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.467 0.651 . . . . 0.0 109.715 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.2 p -86.46 170.9 11.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 0.0 109.775 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -43.94 -79.4 0.06 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.667 ' HD1' ' H ' ' A' ' 151' ' ' LYS . 52.4 t-80 -162.62 -123.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -1.151 . . . . 0.0 109.556 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.667 ' H ' ' HD1' ' A' ' 150' ' ' HIS . 68.9 mttm 51.05 -93.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 110.186 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 150' ' ' HIS . 14.5 pt20 -74.03 148.35 42.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 110.682 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 145.31 -10.05 1.73 Allowed Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 155' ' ' ASP . 57.2 mp0 -63.86 140.99 58.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.498 -1.001 . . . . 0.0 110.234 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 154' ' ' GLU . 98.0 m-20 56.69 123.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.964 0.887 . . . . 0.0 109.997 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.536 ' CD2' ' N ' ' A' ' 156' ' ' LEU . 3.6 mm? -74.63 139.48 43.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.146 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -71.01 84.18 0.69 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.569 -0.707 . . . . 0.0 109.801 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 160' ' ' HIS . 86.2 t60 -67.33 -40.34 85.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.574 -0.704 . . . . 0.0 109.888 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -43.38 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.517 -0.74 . . . . 0.0 110.42 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 158' ' ' HIS . 81.1 m-70 -95.44 -10.39 30.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.245 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -78.51 148.51 33.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.88 . . . . 0.0 109.763 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -62.04 -39.63 92.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.393 -0.817 . . . . 0.0 109.779 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.294 -179.731 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.453 ' CE2' ' O ' ' A' ' 26' ' ' ARG . 89.1 t80 -65.87 133.4 50.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.411 -0.806 . . . . 0.0 109.85 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 95.9 mtt-85 -72.25 146.67 47.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.35 -0.844 . . . . 0.0 110.424 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.39 168.44 20.02 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.666 0.746 . . . . 0.0 110.54 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -64.0 -37.14 86.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.617 -0.677 . . . . 0.0 110.2 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -80.83 -164.15 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.063 -1.023 . . . . 0.0 110.581 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.421 ' CD2' ' H ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -76.29 92.63 3.33 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.0 t -69.32 144.97 53.38 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.517 0.675 . . . . 0.0 109.978 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -163.1 25.64 0.09 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.399 -0.813 . . . . 0.0 108.842 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.22 140.65 50.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.955 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.78 114.5 26.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.8 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.89 154.43 91.0 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.7 -10.73 27.02 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.522 2.148 . . . . 0.0 111.377 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.06 140.68 54.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.432 -0.793 . . . . 0.0 109.894 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 39' ' ' ALA . 27.2 mt-30 -108.44 -100.56 0.37 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.497 -0.752 . . . . 0.0 109.473 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 38' ' ' GLN . . . 59.3 151.36 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -0.781 . . . . 0.0 110.17 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.1 -122.27 0.94 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.7 p -89.47 117.1 28.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.218 -1.166 . . . . 0.0 110.038 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 43' ' ' SER . 49.1 tp10 -87.91 141.01 28.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.374 -0.829 . . . . 0.0 110.262 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 42' ' ' GLU . 26.1 t 46.37 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.697 0.76 . . . . 0.0 110.343 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.28 -5.62 59.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.577 -0.702 . . . . 0.0 109.116 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 46' ' ' SER . 27.7 m -79.61 158.54 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 110.097 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 2.4 p 80.17 136.98 0.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.524 0.678 . . . . 0.0 109.993 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.41 -80.51 0.1 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 m -83.65 129.03 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -1.217 . . . . 0.0 110.025 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -96.97 -47.92 5.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.35 -0.844 . . . . 0.0 109.315 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.7 95.14 0.1 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -93.44 153.85 41.35 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.253 -1.145 . . . . 0.0 108.881 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.9 160.88 48.0 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.187 1.925 . . . . 0.0 111.408 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.33 144.54 80.74 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.57 2.18 . . . . 0.0 112.635 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 98.15 -23.06 37.72 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.92 148.21 26.93 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.187 -1.184 . . . . 0.0 109.931 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.26 176.87 8.02 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.614 0.721 . . . . 0.0 109.315 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 57' ' ' LEU . 0.0 OUTLIER -157.33 172.58 18.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.886 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.6 mp -130.47 149.3 52.21 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 68.2 t -124.61 131.56 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.571 -0.705 . . . . 0.0 109.804 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.6 t -73.05 119.88 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.487 -0.758 . . . . 0.0 109.333 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -92.92 -16.64 24.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 109.122 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -155.5 132.68 10.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.599 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.15 172.14 22.52 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.97 -42.44 66.76 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.518 2.146 . . . . 0.0 112.003 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -100.66 49.71 0.89 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.471 -0.768 . . . . 0.0 109.09 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.09 141.98 26.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.539 -0.726 . . . . 0.0 110.234 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.65 -18.48 56.86 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -68.64 149.88 48.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.284 -1.127 . . . . 0.0 110.695 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -139.06 135.81 34.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -111.58 115.46 29.2 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.416 -0.802 . . . . 0.0 109.07 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 tt -94.5 133.23 38.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 110.244 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.3 mt -89.75 131.17 35.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.578 -0.701 . . . . 0.0 109.608 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -136.33 26.74 3.17 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.61 155.46 47.43 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.299 -0.876 . . . . 0.0 109.783 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.69 84.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.932 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.419 HG22 HD12 ' A' ' 76' ' ' ILE . 96.8 mt -123.14 126.31 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.419 -0.801 . . . . 0.0 109.156 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.4 m -119.69 124.03 45.24 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.712 . . . . 0.0 109.549 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 m -86.87 155.43 20.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.476 -0.765 . . . . 0.0 109.193 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.41 131.7 53.73 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.448 -0.783 . . . . 0.0 109.364 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.3 -138.91 6.31 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 72.7 ttp85 -113.37 125.58 54.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.509 -0.995 . . . . 0.0 110.042 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 11.8 m-70 -168.94 152.17 5.17 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.14 -19.5 50.91 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.201 1.934 . . . . 0.0 111.589 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 85' ' ' SER . 84.5 m-20 -117.95 -129.95 0.3 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.543 -0.723 . . . . 0.0 109.744 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 84' ' ' ASP . 6.1 m 57.87 138.18 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.74 0.781 . . . . 0.0 110.602 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.34 -43.53 97.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.492 -0.755 . . . . 0.0 109.355 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.418 HG23 HD13 ' A' ' 87' ' ' ILE . 93.5 mt -100.81 115.25 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.332 -0.855 . . . . 0.0 109.228 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.516 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 26.3 p90 -130.23 98.1 4.62 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.9 mt -97.0 123.8 40.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.581 ' CG ' ' H ' ' A' ' 91' ' ' ASP . 31.0 t0 -95.25 -151.62 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.538 -0.726 . . . . 0.0 109.8 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.581 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 34.5 t70 58.82 171.53 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.686 0.755 . . . . 0.0 110.351 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.447 ' N ' ' CG ' ' A' ' 91' ' ' ASP . 71.9 t -91.25 114.21 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.599 -0.688 . . . . 0.0 110.151 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER 172.29 -31.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.099 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.9 t -115.52 131.99 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 121.704 0.764 . . . . 0.0 109.689 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -77.06 -175.78 3.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.589 -0.695 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -62.11 -39.16 91.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.756 . . . . 0.0 109.65 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -139.77 57.81 1.62 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.155 -0.966 . . . . 0.0 109.16 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.664 ' CE1' ' H ' ' A' ' 118' ' ' GLY . 57.0 t-80 -61.66 -40.11 93.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.452 -0.78 . . . . 0.0 109.639 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.39 156.33 43.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.106 -0.996 . . . . 0.0 110.097 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -137.25 145.9 44.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.57 145.65 38.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.542 -0.724 . . . . 0.0 109.181 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.2 mtp85 -130.78 144.65 51.6 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.6 -0.687 . . . . 0.0 109.283 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.0 tp -105.17 126.44 52.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.589 -0.694 . . . . 0.0 109.686 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -158.05 149.89 21.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.014 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 55.51 35.2 24.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.446 -0.784 . . . . 0.0 109.415 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 54.9 31.62 16.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.677 -0.639 . . . . 0.0 109.716 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -143.53 138.97 29.54 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -77.08 145.69 37.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.528 -0.733 . . . . 0.0 109.618 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -130.94 159.0 38.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.708 . . . . 0.0 109.195 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.6 p -122.28 128.05 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.1 t -125.96 132.81 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 53.3 p-10 -95.9 144.94 25.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.435 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.5 m -77.71 75.92 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 109.969 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.07 167.0 22.24 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 71.2 m -60.93 -41.28 95.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.867 . . . . 0.0 109.677 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.4 125.84 30.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 0.0 109.966 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 119' ' ' THR . 65.1 t30 -174.1 164.31 4.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.545 -0.722 . . . . 0.0 109.571 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.664 ' H ' ' CE1' ' A' ' 98' ' ' HIS . . . -95.57 -5.97 59.91 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 117' ' ' ASN . 45.2 m -67.55 130.58 43.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -1.152 . . . . 0.0 109.945 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 119' ' ' THR . 38.4 m-85 -144.28 152.11 40.34 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.214 -0.929 . . . . 0.0 109.585 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.4 p -129.08 138.91 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.48 -0.763 . . . . 0.0 109.454 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 58.98 38.34 24.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.596 -0.69 . . . . 0.0 109.839 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 48.58 35.9 6.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.0 109.945 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -145.49 148.22 36.33 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 108.642 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.427 ' O ' ' OE2' ' A' ' 124' ' ' GLU . 25.7 Cg_endo -61.43 139.9 84.8 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.367 2.044 . . . . 0.0 112.095 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.45 ' CG2' ' N ' ' A' ' 127' ' ' ASP . 2.0 p -147.76 161.19 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.33 -0.856 . . . . 0.0 108.996 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 128' ' ' SER . 67.3 t0 -124.73 66.83 1.09 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 127' ' ' ASP . 3.5 p 84.82 116.87 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.15 0.5 . . . . 0.0 109.809 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.84 43.32 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.25 -0.906 . . . . 0.0 109.931 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.1 t -79.21 133.23 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -0.779 . . . . 0.0 110.519 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.52 147.88 37.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.384 -0.823 . . . . 0.0 109.617 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.537 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -142.15 148.42 38.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.254 -0.903 . . . . 0.0 109.186 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 49.9 p-10 -48.48 132.23 17.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.772 . . . . 0.0 111.021 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.23 13.1 66.56 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 79.8 m-20 -89.48 150.28 22.55 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.097 -1.237 . . . . 0.0 110.042 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -111.74 136.99 50.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.599 -0.688 . . . . 0.0 109.515 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -128.27 134.74 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.515 -0.741 . . . . 0.0 109.221 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -124.15 117.4 24.56 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.84 128.35 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.479 -0.763 . . . . 0.0 109.524 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 142' ' ' PHE . . . 61.62 45.29 96.61 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.541 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? 70.2 -29.33 0.18 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.571 -0.958 . . . . 0.0 110.119 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 140' ' ' GLY . 72.8 m-85 -66.64 137.12 56.49 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.65 -0.656 . . . . 0.0 110.273 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -106.85 124.61 49.87 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.287 -0.883 . . . . 0.0 109.191 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.7 mp -126.37 147.64 49.72 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.533 -0.729 . . . . 0.0 109.327 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 10.4 p -108.59 126.61 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -89.76 120.49 31.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.557 -0.714 . . . . 0.0 109.879 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.8 mt -131.89 150.46 52.15 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.463 0.649 . . . . 0.0 109.762 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.1 p -118.65 124.53 47.62 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.695 -0.628 . . . . 0.0 109.377 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -91.96 102.37 2.91 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 151' ' ' LYS . 53.5 p-80 -154.38 14.3 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.275 -1.132 . . . . 0.0 108.854 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 150' ' ' HIS . 55.7 mtpt 40.95 -166.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.677 0.751 . . . . 0.0 111.326 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -66.78 129.94 41.53 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.479 0.657 . . . . 0.0 110.324 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 154.87 93.89 0.1 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -69.41 140.67 54.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -1.189 . . . . 0.0 109.988 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -92.9 8.66 38.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.9 mt -76.71 122.83 25.27 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 110.034 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -174.51 -63.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -67.11 -39.67 86.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 109.519 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -69.62 141.56 53.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.828 . . . . 0.0 110.112 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -130.03 86.29 2.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.524 -0.735 . . . . 0.0 109.04 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -89.49 -10.65 45.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.436 -0.79 . . . . 0.0 108.916 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -83.39 -12.72 56.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 109.071 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.71 179.65 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.823 0.821 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -64.3 169.25 4.77 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.824 0.821 . . . . 0.0 110.622 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -141.57 116.88 10.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.799 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 43.87 -129.12 0.86 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.413 0.625 . . . . 0.0 110.552 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -124.87 -41.29 2.12 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -100.08 -164.02 1.08 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.329 -0.857 . . . . 0.0 111.002 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.426 ' H ' ' CD2' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -82.67 99.24 9.48 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.983 0.896 . . . . 0.0 109.819 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.9 p -65.63 160.76 21.9 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.032 0.92 . . . . 0.0 110.68 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 55.58 71.55 0.54 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.788 0.804 . . . . 0.0 109.704 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.11 -41.32 99.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.663 -0.648 . . . . 0.0 109.309 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 35' ' ' ALA . 91.8 m-20 57.71 50.87 10.09 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 34' ' ' ASP . . . -37.58 154.64 0.11 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.893 -0.504 . . . . 0.0 110.397 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.23 152.99 75.53 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.78 2.32 . . . . 0.0 112.779 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -167.63 -18.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' CD ' ' H ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -92.53 0.08 57.39 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.155 -0.966 . . . . 0.0 109.289 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' A' ' 41' ' ' THR . . . -69.77 2.73 3.06 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.148 -0.97 . . . . 0.0 109.274 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 38' ' ' GLN . . . -72.39 5.46 15.16 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 39' ' ' ALA . 16.0 m -61.85 137.02 58.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 110.081 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -68.19 -0.18 4.38 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.6 0.714 . . . . 0.0 109.296 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.416 ' H ' ' C ' ' A' ' 41' ' ' THR . 62.2 p -85.74 -8.69 58.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.314 -0.866 . . . . 0.0 109.77 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.21 -12.32 24.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.096 -1.003 . . . . 0.0 108.922 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.5 -17.41 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.219 -0.925 . . . . 0.0 108.887 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.2 t -66.75 143.86 56.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.367 -0.833 . . . . 0.0 110.358 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.33 -173.91 52.57 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.1 t 42.98 86.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.939 0.876 . . . . 0.0 110.373 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -152.67 101.37 2.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.434 -0.791 . . . . 0.0 109.824 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.32 146.97 21.53 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD1' ' ND1' ' A' ' 150' ' ' HIS . 20.0 tp -173.65 74.55 0.38 Allowed Pre-proline 0 N--CA 1.486 1.356 0 O-C-N 121.891 -0.77 . . . . 0.0 109.441 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.445 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 44.1 Cg_exo -54.13 -43.28 59.81 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.894 2.396 . . . . 0.0 112.619 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 58.7 Cg_endo -78.72 156.98 27.94 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.1 1.867 . . . . 0.0 112.98 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.34 84.67 0.95 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -138.55 163.61 31.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.456 -1.026 . . . . 0.0 109.636 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.73 156.83 42.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.508 -0.745 . . . . 0.0 109.949 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.423 ' CD1' ' C ' ' A' ' 57' ' ' LEU . 3.9 pp -142.7 169.9 16.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.355 -0.841 . . . . 0.0 110.626 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.9 mt -124.49 144.01 50.34 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -130.42 132.49 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.743 0.782 . . . . 0.0 109.61 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.3 t -75.71 132.62 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.69 0.757 . . . . 0.0 109.993 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.527 ' NZ ' ' OE2' ' A' ' 136' ' ' GLU . 51.9 mtmt -86.78 -73.78 0.45 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.724 -0.61 . . . . 0.0 110.017 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.583 HH21 ' NH1' ' A' ' 143' ' ' ARG . 61.7 ttp180 -117.33 134.69 54.52 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.433 -0.792 . . . . 0.0 110.356 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.26 173.9 21.6 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.47 -19.74 48.63 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.882 2.388 . . . . 0.0 111.726 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -97.37 19.77 12.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 109.047 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.22 139.32 29.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.389 -0.819 . . . . 0.0 110.373 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.78 -22.27 40.18 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.3 m -71.9 149.39 45.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.367 -1.078 . . . . 0.0 110.831 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -145.78 152.31 39.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.327 -0.858 . . . . 0.0 110.232 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -121.55 131.76 54.31 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.463 0.649 . . . . 0.0 109.444 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 46.8 tp -100.42 128.87 46.37 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 0.0 109.263 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.08 128.27 42.83 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.836 0.826 . . . . 0.0 110.428 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 67.6 t0 -155.24 41.03 0.42 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -141.39 152.61 44.47 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.353 -0.842 . . . . 0.0 109.553 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.46 -48.02 83.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.687 -0.633 . . . . 0.0 109.987 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.42 121.33 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.45 -0.781 . . . . 0.0 109.372 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -116.92 118.9 33.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.583 0.706 . . . . 0.0 109.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 m -86.16 155.28 20.82 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.554 0.692 . . . . 0.0 109.895 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -103.69 169.75 8.34 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.905 0.859 . . . . 0.0 110.339 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.31 -119.9 5.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.532 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 74.1 ttp85 -118.63 121.6 40.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.888 . . . . 0.0 109.884 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 41.7 m-70 -167.9 151.28 5.79 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.82 145.02 79.48 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.787 2.324 . . . . 0.0 112.783 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 54.82 31.1 14.93 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.511 0.672 . . . . 0.0 109.584 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 t -99.14 123.45 43.44 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.209 -0.932 . . . . 0.0 110.555 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 71' ' ' LEU . 54.3 m-20 -65.85 -39.57 90.88 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -85.01 125.51 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 109.841 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -127.19 86.11 2.46 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.2 mt -115.26 94.29 4.66 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -92.79 109.68 21.12 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.525 0.679 . . . . 0.0 109.622 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -158.58 163.1 37.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.958 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.3 -44.21 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.63 0.729 . . . . 0.0 110.285 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.5 p -68.22 -29.4 68.23 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.344 -0.848 . . . . 0.0 109.996 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.4 t -92.46 112.1 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.131 -0.981 . . . . 0.0 109.97 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.9 m -77.58 176.73 8.67 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.686 0.755 . . . . 0.0 110.444 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.53 -41.84 99.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.646 -0.658 . . . . 0.0 110.017 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -124.18 49.2 1.81 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.377 -0.827 . . . . 0.0 109.005 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.08 -39.93 94.1 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.511 0.672 . . . . 0.0 109.45 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.99 154.89 40.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.957 -1.089 . . . . 0.0 110.272 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -136.58 151.6 49.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.497 0.665 . . . . 0.0 109.848 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -121.09 138.83 54.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -130.71 141.21 50.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.635 0.731 . . . . 0.0 109.718 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.06 123.87 38.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 106' ' ' ASN . 80.7 tt0 -115.13 120.38 39.58 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.862 0.839 . . . . 0.0 109.867 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.464 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 21.3 t-20 52.09 -84.52 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.426 0.631 . . . . 0.0 110.372 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -144.03 20.36 1.77 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 108.503 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -130.16 137.47 50.13 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.714 0.769 . . . . 0.0 109.721 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -82.08 147.47 29.09 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.433 0.635 . . . . 0.0 109.76 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -136.06 157.87 45.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.518 -0.739 . . . . 0.0 109.769 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.84 127.35 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.1 t -131.03 131.26 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 119' ' ' THR . 42.9 t0 -100.38 126.48 46.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.697 0.76 . . . . 0.0 109.447 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.5 m -85.43 3.29 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.644 0.735 . . . . 0.0 109.228 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -79.35 -1.29 85.8 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.8 m 48.62 -88.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.976 . . . . 0.0 109.966 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 114' ' ' GLY . 46.5 tp -73.09 133.62 44.23 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.877 0.846 . . . . 0.0 111.368 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 57.2 38.42 28.82 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.746 0.784 . . . . 0.0 109.725 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.6 -163.59 20.56 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.324 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.549 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 28.4 m -60.84 137.16 58.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.904 . . . . 0.0 110.582 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.434 ' OH ' ' NE2' ' A' ' 138' ' ' GLN . 22.7 p90 -119.57 150.51 40.17 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.579 0.704 . . . . 0.0 109.905 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 122' ' ' ASN . 9.6 p -121.28 130.07 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.974 0.892 . . . . 0.0 109.29 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 124' ' ' GLU . 14.0 m120 41.9 -168.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.098 0.951 . . . . 0.0 111.324 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.05 -0.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.757 -0.59 . . . . 0.0 110.163 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 122' ' ' ASN . 17.2 tt0 -113.25 93.09 24.6 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.384 -0.822 . . . . 0.0 109.42 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.04 122.36 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.74 2.293 . . . . 0.0 112.361 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.0 m -136.72 165.07 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.447 -0.783 . . . . 0.0 109.891 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.83 -37.81 88.78 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.591 0.71 . . . . 0.0 109.3 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.4 p -155.54 161.34 40.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.903 . . . . 0.0 110.065 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.06 156.26 24.34 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.597 0.713 . . . . 0.0 110.166 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.36 129.75 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.624 0.726 . . . . 0.0 110.098 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.88 143.04 38.08 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.906 0.86 . . . . 0.0 110.592 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.544 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.86 147.18 27.65 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.596 0.712 . . . . 0.0 109.279 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 20.5 p30 -43.17 130.19 4.65 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.057 0.932 . . . . 0.0 111.667 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.06 13.47 68.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 81.2 m-20 -89.95 150.03 22.33 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.986 -1.302 . . . . 0.0 109.673 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 61' ' ' LYS . 84.0 tt0 -108.5 129.25 55.29 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.696 0.76 . . . . 0.0 110.05 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.9 t -126.11 131.25 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.434 ' NE2' ' OH ' ' A' ' 120' ' ' TYR . 56.6 tt0 -121.5 120.92 36.31 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.465 0.65 . . . . 0.0 109.772 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.442 HG21 HD13 ' A' ' 139' ' ' ILE . 39.7 mm -110.71 122.2 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.75 0.786 . . . . 0.0 109.284 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 56.3 -129.74 48.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -95.06 -6.59 41.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.544 -0.974 . . . . 0.0 109.059 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -89.88 139.92 30.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 0.0 109.519 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.583 ' NH1' HH21 ' A' ' 62' ' ' ARG . 85.0 mtt85 -102.95 136.52 42.61 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.674 0.75 . . . . 0.0 110.027 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.53 157.37 46.69 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.55 133.52 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.671 0.748 . . . . 0.0 109.431 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -87.27 111.51 21.11 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.595 0.712 . . . . 0.0 109.978 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.7 mt -136.19 157.7 46.19 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.426 0.631 . . . . 0.0 109.335 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.4 p -112.79 130.23 56.15 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.496 0.665 . . . . 0.0 109.718 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.26 77.16 0.02 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.503 ' ND1' ' CD1' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -88.53 140.2 29.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.345 -1.091 . . . . 0.0 109.998 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' A' ' 153' ' ' GLY . 17.8 mmmt -69.76 -85.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.609 -0.682 . . . . 0.0 110.568 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 62.21 -13.1 0.06 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.443 0.64 . . . . 0.0 110.028 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 77.29 149.78 3.63 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -143.01 -26.41 0.59 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.687 -0.89 . . . . 0.0 109.033 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -82.35 115.21 21.29 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.884 . . . . 0.0 109.846 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.423 ' CD1' ' N ' ' A' ' 156' ' ' LEU . 9.5 mp -80.89 -78.37 0.18 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.889 0.852 . . . . 0.0 109.847 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 158' ' ' HIS . 97.3 mt-10 47.21 23.0 0.27 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.81 0.814 . . . . 0.0 109.341 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 157' ' ' GLU . 77.5 m80 51.27 168.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.776 0.798 . . . . 0.0 111.234 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.536 ' C ' ' H ' ' A' ' 161' ' ' HIS . 84.3 t60 -153.53 143.04 21.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 56.11 4.93 0.14 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.653 0.74 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.602 ' CD2' ' NE2' ' A' ' 162' ' ' HIS . 9.4 t60 -66.52 -40.83 89.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.501 -0.75 . . . . 0.0 109.666 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.602 ' NE2' ' CD2' ' A' ' 161' ' ' HIS . 97.7 m-70 -130.64 143.17 50.57 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.304 -0.873 . . . . 0.0 109.999 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.258 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.432 ' CG1' ' N ' ' A' ' 25' ' ' PHE . 10.5 p . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.47 0.653 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.432 ' N ' ' CG1' ' A' ' 24' ' ' VAL . 84.0 t80 -156.95 114.69 3.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.0 109.342 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -76.8 144.53 39.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.6 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.05 -179.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.827 0.822 . . . . 0.0 110.631 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -80.65 -0.27 37.36 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.631 0.729 . . . . 0.0 109.093 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 31' ' ' SER . 48.8 p90 -140.96 -160.02 1.03 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.495 -0.753 . . . . 0.0 109.551 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 31' ' ' SER . 18.6 mt -37.26 96.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.929 0.871 . . . . 0.0 110.31 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 29' ' ' PHE . 33.5 t -38.9 162.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.538 0.685 . . . . 0.0 110.918 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 31' ' ' SER . 97.5 mt-10 59.3 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.924 0.868 . . . . 0.0 110.308 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.532 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 3.7 mm? -74.1 152.75 39.84 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.873 0.844 . . . . 0.0 110.196 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 54.5 p-10 -58.77 146.42 36.98 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.911 0.862 . . . . 0.0 110.755 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.67 71.72 20.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -75.72 -9.27 19.72 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.657 2.238 . . . . 0.0 110.985 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.49 -139.24 1.02 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.606 0.717 . . . . 0.0 110.39 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 2.7 pm0 -146.81 12.43 1.12 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 47.55 -97.73 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.698 0.761 . . . . 0.0 110.508 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.81 139.91 35.62 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.8 m -68.3 134.62 50.63 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.778 -0.836 . . . . 0.0 110.729 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -82.21 -80.74 0.16 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.666 0.746 . . . . 0.0 109.772 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 59.0 p -151.24 -31.53 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 109.274 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 42.62 89.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.669 0.747 . . . . 0.0 110.411 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.99 -40.79 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.626 0.727 . . . . 0.0 109.262 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 t 45.0 -164.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.836 0.827 . . . . 0.0 111.158 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.82 -91.13 0.22 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.87 131.27 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.987 . . . . 0.0 110.494 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -112.35 -25.95 8.98 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.46 96.03 1.49 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 52' ' ' PRO . 0.6 OUTLIER -177.47 79.48 0.24 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.805 -0.821 . . . . 0.0 109.545 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 47.3 Cg_exo -50.17 -175.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.451 2.101 . . . . 0.0 111.612 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 52' ' ' PRO . 31.5 Cg_exo -59.77 140.25 92.44 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.428 2.085 . . . . 0.0 112.429 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.32 -87.68 0.16 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.543 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 2.6 mm? -102.09 167.54 9.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.563 -0.963 . . . . 0.0 110.272 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.19 176.96 7.5 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -130.55 146.6 52.1 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.023 0.916 . . . . 0.0 110.712 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mt -116.4 134.33 55.0 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.2 t -122.43 135.08 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.586 0.708 . . . . 0.0 109.187 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.3 t -69.18 133.39 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.58 0.705 . . . . 0.0 110.184 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -95.17 -28.61 14.96 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.548 0.689 . . . . 0.0 109.196 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -147.73 138.19 23.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.194 -0.941 . . . . 0.0 110.072 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.65 174.4 15.9 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.17 -13.1 25.84 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.958 2.439 . . . . 0.0 111.132 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ALA . 97.9 m-20 -97.88 16.69 20.1 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . -39.78 133.04 1.62 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.884 0.849 . . . . 0.0 110.924 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.34 -14.24 65.42 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -66.39 146.71 54.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.437 -1.037 . . . . 0.0 110.971 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -134.96 142.11 46.42 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.269 0.557 . . . . 0.0 109.604 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.98 125.42 49.36 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.621 0.724 . . . . 0.0 109.95 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 tt -102.16 132.97 47.74 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.281 0.563 . . . . 0.0 110.044 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -87.72 157.74 18.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.512 -0.743 . . . . 0.0 110.344 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 66.7 t0 -173.51 33.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -156.58 147.17 21.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.452 -0.78 . . . . 0.0 109.88 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.23 136.81 46.46 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.802 0.811 . . . . 0.0 110.83 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 85.3 mt 55.11 100.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.542 0.687 . . . . 0.0 109.873 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -103.7 126.06 50.59 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.607 0.717 . . . . 0.0 109.571 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -92.94 143.64 26.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.491 0.662 . . . . 0.0 109.923 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -101.97 170.06 8.37 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.75 0.786 . . . . 0.0 110.282 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . 92.02 -129.47 9.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.52 ' O ' ' CD2' ' A' ' 82' ' ' HIS . 8.7 ptp180 -103.8 110.83 23.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.932 . . . . 0.0 109.612 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 81' ' ' ARG . 80.3 m-70 -161.87 90.56 1.43 Allowed Pre-proline 0 N--CA 1.486 1.341 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 58.6 Cg_exo -52.12 145.72 33.13 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.679 2.253 . . . . 0.0 112.507 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 7.0 t0 81.5 -22.32 0.27 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -71.97 146.98 47.39 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.79 0.805 . . . . 0.0 110.891 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -62.62 -42.86 99.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.64 -0.663 . . . . 0.0 109.845 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.03 114.05 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 109.563 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.501 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 22.0 p90 -129.85 97.87 4.62 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.577 0.703 . . . . 0.0 109.414 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 80' ' ' GLY . 96.1 mt -102.03 96.75 7.22 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.763 0.792 . . . . 0.0 108.871 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 30.0 p30 -85.34 90.61 7.97 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.515 0.674 . . . . 0.0 109.764 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -146.06 150.05 35.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.485 -0.759 . . . . 0.0 109.477 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.08 -32.32 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.551 0.691 . . . . 0.0 109.912 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.6 p -66.43 -32.51 73.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.459 -0.776 . . . . 0.0 109.786 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.32 128.47 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.306 -0.871 . . . . 0.0 109.917 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.643 ' HG ' ' H ' ' A' ' 96' ' ' ARG . 25.2 t -78.29 -170.96 2.2 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.666 0.745 . . . . 0.0 110.594 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.643 ' H ' ' HG ' ' A' ' 95' ' ' SER . 95.3 mtt180 -61.66 -41.62 97.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.516 -0.74 . . . . 0.0 109.036 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -142.21 62.41 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -62.3 -40.81 97.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.507 -0.745 . . . . 0.0 109.084 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.32 151.07 44.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 0.0 109.777 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -140.83 136.57 32.52 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.656 0.741 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -99.43 146.69 26.05 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.396 0.617 . . . . 0.0 109.356 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -130.81 131.74 44.82 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.483 0.659 . . . . 0.0 109.342 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.1 tp -102.93 123.51 46.7 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.437 ' HG2' ' H ' ' A' ' 105' ' ' ASN . 44.6 tt0 -93.18 -132.04 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.625 -0.672 . . . . 0.0 109.827 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.437 ' H ' ' HG2' ' A' ' 104' ' ' GLU . 90.9 m-20 -64.35 -44.34 91.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.321 -0.862 . . . . 0.0 109.616 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 3.9 m120 -169.79 24.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.78 131.53 51.27 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.654 0.74 . . . . 0.0 109.514 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.409 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 63.9 m-85 -78.94 146.43 33.48 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.486 0.66 . . . . 0.0 109.836 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 93.4 m-20 -144.61 159.38 42.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 p -126.93 131.98 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.483 0.658 . . . . 0.0 109.343 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.04 133.46 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.633 0.73 . . . . 0.0 109.414 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -96.53 114.09 25.72 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.569 0.699 . . . . 0.0 109.215 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.72 130.32 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.649 0.738 . . . . 0.0 110.385 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.44 161.32 37.38 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.8 p -88.56 -148.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.617 -0.931 . . . . 0.0 110.538 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.8 mt 57.03 -168.84 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.813 0.816 . . . . 0.0 110.753 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 118' ' ' GLY . 63.1 t-20 -66.8 145.8 55.11 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.703 0.763 . . . . 0.0 110.336 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 117' ' ' ASN . . . -170.6 -146.92 5.37 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.1 m -60.38 137.64 58.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.764 -0.845 . . . . 0.0 110.428 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -137.57 157.73 45.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.622 -0.674 . . . . 0.0 109.411 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 11.2 p -117.86 129.57 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.752 0.787 . . . . 0.0 109.965 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.9 m120 52.65 49.56 20.08 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.701 0.762 . . . . 0.0 109.719 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 52.29 26.17 3.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.968 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -123.95 101.22 35.95 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.82 127.01 13.71 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.323 2.015 . . . . 0.0 112.274 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.4 p -144.36 138.69 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.474 -0.766 . . . . 0.0 109.946 -179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -66.49 -40.17 89.14 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.474 0.654 . . . . 0.0 109.449 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 87.7 p -156.87 154.26 29.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.13 157.14 27.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.854 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 82.3 t -91.61 128.13 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.729 0.776 . . . . 0.0 109.796 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.67 152.29 35.84 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.754 0.788 . . . . 0.0 110.411 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.534 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.4 155.73 40.92 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.51 0.671 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 43.0 p-10 -51.77 132.57 31.44 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.883 0.849 . . . . 0.0 111.084 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 82.45 18.19 66.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 23.5 m-20 -83.57 149.38 26.61 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.223 -1.163 . . . . 0.0 110.073 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 57.6 mp0 -108.84 123.97 49.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.624 -0.672 . . . . 0.0 109.435 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.4 t -125.17 132.32 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.38 125.18 44.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 141' ' ' LYS . 36.3 mm -111.34 127.51 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.737 0.779 . . . . 0.0 109.308 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 54.91 -92.19 0.01 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 139' ' ' ILE . 60.8 pttt -129.9 -18.46 3.4 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -76.99 142.61 39.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 110.036 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -105.65 132.49 51.73 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.684 0.754 . . . . 0.0 110.13 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.54 155.35 50.56 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.446 0.641 . . . . 0.0 109.578 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.39 134.39 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.559 0.695 . . . . 0.0 109.802 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -94.12 120.73 34.79 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.0 mt -132.74 152.85 51.65 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.799 0.809 . . . . 0.0 109.613 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 t -142.61 164.41 30.2 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.587 0.708 . . . . 0.0 109.693 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.491 ' O ' ' CG ' ' A' ' 150' ' ' HIS . . . -61.88 -68.65 1.57 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 149' ' ' GLY . 23.2 m80 -159.38 151.64 21.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.447 -1.031 . . . . 0.0 109.766 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -100.18 142.29 31.87 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.508 0.671 . . . . 0.0 109.781 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -107.59 -40.63 5.27 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.695 0.759 . . . . 0.0 109.189 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 79.45 -69.59 2.97 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 57.9 mp0 -71.62 144.77 49.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.718 -0.872 . . . . 0.0 110.758 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -68.69 150.01 48.42 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.704 0.764 . . . . 0.0 110.375 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.456 ' CD2' ' H ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -71.04 129.09 38.08 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.865 0.84 . . . . 0.0 110.123 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 157' ' ' GLU . 1.2 pm0 -75.34 137.9 41.41 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.693 0.759 . . . . 0.0 110.313 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -67.19 -38.08 84.75 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.633 0.73 . . . . 0.0 109.723 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -66.06 174.04 2.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.445 -0.784 . . . . 0.0 110.632 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -146.53 163.52 35.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.44 -0.788 . . . . 0.0 110.047 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -107.14 131.03 54.58 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.68 0.752 . . . . 0.0 110.44 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -85.32 149.84 25.18 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.523 0.678 . . . . 0.0 109.945 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 117.829 -1.082 . . . . 0.0 109.857 179.856 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -70.44 130.6 42.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 0.0 110.13 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -73.28 145.67 45.92 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.693 0.758 . . . . 0.0 110.79 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -167.14 -39.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.567 -0.708 . . . . 0.0 109.181 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -144.62 -64.43 0.35 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.513 0.673 . . . . 0.0 109.837 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.572 ' O ' ' N ' ' A' ' 31' ' ' SER . 1.6 p90 -60.83 165.0 4.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.359 -0.838 . . . . 0.0 110.124 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.9 mt 58.32 -70.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.459 0.647 . . . . 0.0 109.926 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 29' ' ' PHE . 7.9 m -67.32 147.29 53.15 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.377 -0.827 . . . . 0.0 110.5 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -148.57 -69.18 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 tp -133.33 -35.16 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -84.59 108.11 17.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 110.031 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.593 ' H ' ' CD ' ' A' ' 36' ' ' PRO . . . -110.4 -43.34 0.1 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.82 -0.55 . . . . 0.0 109.689 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.593 ' CD ' ' H ' ' A' ' 35' ' ' ALA . 25.1 Cg_exo -60.93 143.39 99.34 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.253 1.969 . . . . 0.0 112.411 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.13 -13.11 21.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.447 -0.783 . . . . 0.0 109.277 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.424 ' C ' ' H ' ' A' ' 40' ' ' GLY . 13.0 pt20 -160.22 -33.11 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 109.089 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 57.9 6.4 0.47 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.341 0.591 . . . . 0.0 110.332 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 38' ' ' GLN . . . 86.39 158.78 31.95 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.44 125.31 50.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.669 -0.9 . . . . 0.0 109.576 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -168.49 130.0 1.32 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.868 . . . . 0.0 109.608 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 m -71.63 146.5 48.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.483 -0.76 . . . . 0.0 110.097 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -166.36 22.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.06 -14.03 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.426 -0.796 . . . . 0.0 108.99 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.4 t -64.87 145.0 56.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.48 -0.762 . . . . 0.0 110.503 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.49 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . 164.64 -84.48 0.1 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 t 66.13 -41.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 122.201 -0.587 . . . . 0.0 109.666 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.49 ' H ' ' C ' ' A' ' 47' ' ' GLY . 98.5 mt-10 -54.82 138.84 41.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 0.0 110.857 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 52.38 90.94 0.01 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.99 78.15 48.08 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.677 -0.896 . . . . 0.0 109.033 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.437 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 22.6 Cg_exo -64.38 -175.9 0.36 Allowed 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.181 1.921 . . . . 0.0 111.84 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 52' ' ' PRO . 23.2 Cg_exo -65.48 156.05 65.58 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 123.108 2.539 . . . . 0.0 113.285 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.36 -25.43 28.32 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.4 mt -125.56 149.58 48.22 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.433 -1.039 . . . . 0.0 110.636 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -151.43 156.31 40.39 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.39 151.47 41.18 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.097 0.951 . . . . 0.0 110.188 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.0 mt -117.88 142.51 47.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.2 t -127.32 130.7 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.56 -0.713 . . . . 0.0 109.816 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.41 130.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 121.649 0.738 . . . . 0.0 110.061 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.21 -76.47 0.12 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.559 -0.713 . . . . 0.0 109.756 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -123.62 148.53 46.34 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.625 0.726 . . . . 0.0 110.16 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.53 175.28 30.31 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.89 -21.23 50.64 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.887 2.391 . . . . 0.0 111.346 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -110.31 23.8 13.82 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -39.96 145.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.643 0.735 . . . . 0.0 110.923 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.6 -1.3 88.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.6 m -72.38 146.23 47.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -1.073 . . . . 0.0 110.742 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -134.38 147.6 50.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.682 . . . . 0.0 109.571 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -128.77 146.92 50.77 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.492 -0.755 . . . . 0.0 109.55 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.1 tp -105.25 127.64 53.04 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.559 0.695 . . . . 0.0 109.756 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.9 mt -92.88 77.81 4.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 54.8 t0 -108.59 16.81 22.63 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -124.51 140.02 53.34 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.571 0.7 . . . . 0.0 109.622 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.54 85.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.618 -0.676 . . . . 0.0 109.869 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.407 HD11 HG23 ' A' ' 76' ' ' ILE . 97.1 mt -112.91 121.09 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.531 -0.731 . . . . 0.0 109.354 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.6 m -126.83 124.0 38.62 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -97.67 155.25 17.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.448 -0.782 . . . . 0.0 109.625 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.6 158.37 20.9 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.672 0.748 . . . . 0.0 110.219 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.68 -120.95 5.29 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -93.87 111.32 23.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.342 -1.093 . . . . 0.0 109.944 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -175.05 88.71 0.31 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 46.1 Cg_exo -54.91 148.27 47.75 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.574 2.183 . . . . 0.0 112.526 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 10.3 t0 82.14 -7.75 1.32 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.492 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 66.7 m -78.48 147.12 34.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.345 -0.847 . . . . 0.0 110.618 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.17 -38.71 92.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.511 -0.743 . . . . 0.0 109.153 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.08 126.75 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.341 -0.849 . . . . 0.0 109.907 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 50.3 m-85 -125.2 98.78 5.79 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.413 0.625 . . . . 0.0 109.316 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.561 ' C ' ' H ' ' A' ' 91' ' ' ASP . 49.0 mt -107.87 146.81 31.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.61 -0.681 . . . . 0.0 109.608 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 41.4 t0 -60.48 -1.16 0.32 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 89' ' ' LEU . 2.6 p30 47.22 31.92 1.9 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.643 0.735 . . . . 0.0 110.444 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.9 m -68.88 -24.79 28.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 109.885 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 140' ' ' GLY . 60.6 p -138.22 13.27 2.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.392 -0.817 . . . . 0.0 109.234 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.73 131.35 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.584 0.706 . . . . 0.0 109.582 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.3 p -66.67 -162.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.636 0.731 . . . . 0.0 110.887 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.38 -40.85 92.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 109.77 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.542 ' O ' ' N ' ' A' ' 99' ' ' ALA . 93.3 mtm-85 -133.24 -41.7 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 t60 60.6 -67.27 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.954 -0.466 . . . . 0.0 109.939 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -140.99 154.3 45.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.079 -1.013 . . . . 0.0 109.412 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -138.7 142.34 38.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.555 -0.715 . . . . 0.0 109.551 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -99.88 140.31 34.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.421 -0.799 . . . . 0.0 109.446 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.406 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 50.5 mmm-85 -130.48 141.53 50.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.636 -0.665 . . . . 0.0 109.547 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.8 tp -115.24 119.54 36.69 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.571 0.7 . . . . 0.0 109.183 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -160.16 -34.04 0.06 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.562 -0.712 . . . . 0.0 109.124 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 107' ' ' GLU . 13.7 m120 -88.58 41.85 1.04 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 0.0 109.232 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 57.48 1.64 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 109.973 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.519 ' H ' ' C ' ' A' ' 105' ' ' ASN . 96.1 mt-10 -142.99 157.22 44.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.167 -0.958 . . . . 0.0 109.906 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -74.25 141.65 45.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.515 -0.741 . . . . 0.0 110.14 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 102' ' ' ARG . 39.6 p30 -139.66 173.76 11.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.458 -0.776 . . . . 0.0 109.548 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.3 134.64 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.687 -0.633 . . . . 0.0 109.847 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -127.02 130.81 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.72 155.19 24.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.414 -0.804 . . . . 0.0 110.127 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -94.95 -7.94 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.34 3.88 10.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 78.2 p -61.84 -42.29 98.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.128 -1.219 . . . . 0.0 109.045 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.2 pp -173.06 135.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.799 0.809 . . . . 0.0 110.532 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 57.27 90.47 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.646 0.736 . . . . 0.0 110.71 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.08 140.1 45.13 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.451 -1.059 . . . . 0.0 110.451 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.456 ' CG2' ' N ' ' A' ' 120' ' ' TYR . 44.2 m -76.69 161.99 28.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.509 -0.995 . . . . 0.0 110.327 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.456 ' N ' ' CG2' ' A' ' 119' ' ' THR . 44.2 p90 -142.48 162.28 35.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.545 -0.722 . . . . 0.0 109.956 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 123' ' ' ARG . 8.4 p -114.68 131.42 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.654 0.74 . . . . 0.0 109.722 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 43.59 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.582 -0.699 . . . . 0.0 110.385 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 121' ' ' VAL . 15.0 ptp180 -143.68 41.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 109.059 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -146.71 82.43 8.68 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.369 -0.832 . . . . 0.0 109.185 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.58 128.9 32.31 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.806 2.338 . . . . 0.0 112.811 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.3 m -150.81 161.87 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 109.945 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.62 -38.01 89.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 109.557 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -153.22 152.65 31.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 109.511 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.5 152.13 32.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.212 -0.93 . . . . 0.0 110.072 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.27 130.16 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.461 -0.775 . . . . 0.0 109.913 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.96 148.93 34.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.793 0.806 . . . . 0.0 110.272 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.437 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -148.98 156.36 42.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.494 -0.754 . . . . 0.0 109.317 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.711 ' ND2' ' H ' ' A' ' 148' ' ' THR . 31.8 t-20 -57.72 136.14 56.85 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.776 0.798 . . . . 0.0 111.301 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.3 10.46 77.55 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.437 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 89.5 m-20 -89.62 156.42 18.6 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.228 -1.16 . . . . 0.0 110.275 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -108.78 136.57 48.12 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.704 -0.623 . . . . 0.0 109.376 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.72 133.25 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.647 -0.658 . . . . 0.0 109.458 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -123.14 114.77 20.76 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 140' ' ' GLY . 96.7 mt -132.78 122.43 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.448 -0.782 . . . . 0.0 109.74 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . 35.14 72.8 0.11 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 142' ' ' PHE . 6.2 tmtt? 64.16 -63.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.911 -0.758 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 140' ' ' GLY . 33.1 m-85 -36.31 123.19 0.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.504 0.669 . . . . 0.0 110.595 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -101.56 132.46 47.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.725 -0.609 . . . . 0.0 109.46 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -138.06 156.43 47.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.56 -0.712 . . . . 0.0 109.423 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.09 137.9 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.619 -0.676 . . . . 0.0 109.424 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -90.82 114.48 26.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.589 -0.694 . . . . 0.0 109.262 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.6 mt -134.01 149.4 51.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.774 0.797 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.711 ' H ' ' ND2' ' A' ' 133' ' ' ASN . 82.4 p -141.27 98.72 3.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.568 -0.707 . . . . 0.0 109.52 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 148' ' ' THR . . . 36.36 -110.5 0.09 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 45.07 92.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.779 -0.836 . . . . 0.0 109.946 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -92.05 112.95 25.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.363 -0.836 . . . . 0.0 109.761 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -168.4 100.76 0.42 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.415 ' O ' ' CD2' ' A' ' 156' ' ' LEU . . . -87.49 -2.94 81.88 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -77.49 152.48 34.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.55 -0.97 . . . . 0.0 111.008 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.03 58.14 4.59 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.622 0.725 . . . . 0.0 109.421 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.415 ' CD2' ' O ' ' A' ' 153' ' ' GLY . 86.2 mt -70.97 144.88 50.37 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.712 0.768 . . . . 0.0 110.333 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 50.43 25.48 1.94 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.677 0.751 . . . . 0.0 109.108 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -148.2 137.4 22.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.421 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -144.1 121.53 11.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.293 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -67.46 -40.21 85.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.409 -0.807 . . . . 0.0 109.708 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -80.52 144.2 32.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 110.803 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -76.94 141.43 40.48 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.742 0.782 . . . . 0.0 110.402 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.986 179.793 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -83.58 161.87 21.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.341 -0.849 . . . . 0.0 110.431 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 27' ' ' ALA . 69.8 ttt180 -150.87 115.76 5.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.604 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.518 ' CB ' ' HG ' ' A' ' 31' ' ' SER . . . 57.33 154.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.78 0.8 . . . . 0.0 110.776 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -81.43 -4.56 56.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.037 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.493 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 31.3 p90 -156.17 -160.03 0.96 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.872 . . . . 0.0 110.168 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' N ' ' CD2' ' A' ' 29' ' ' PHE . 59.6 mt -60.95 97.77 0.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.93 0.871 . . . . 0.0 109.917 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.518 ' HG ' ' CB ' ' A' ' 27' ' ' ALA . 69.5 m -48.03 -95.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.674 -0.641 . . . . 0.0 109.904 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 33' ' ' LEU . 47.9 tp10 -173.72 -48.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 32' ' ' GLU . 50.4 tp 57.1 116.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.839 0.828 . . . . 0.0 110.297 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.498 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 44.4 t0 -63.37 -49.73 72.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 0.0 109.549 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 34' ' ' ASP . . . 163.08 154.2 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.708 -0.62 . . . . 0.0 109.354 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.13 146.75 91.13 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 123.011 2.474 . . . . 0.0 112.966 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.76 143.3 55.93 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.707 0.765 . . . . 0.0 110.152 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 39' ' ' ALA . 5.0 pp0? -173.13 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' GLN . . . 39.82 -105.9 0.05 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.526 0.679 . . . . 0.0 110.429 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.16 2.58 87.94 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.8 m -103.96 119.58 39.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.375 -1.074 . . . . 0.0 109.693 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -106.59 -15.57 14.74 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -65.64 138.64 58.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.508 -0.745 . . . . 0.0 110.252 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -172.74 24.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.17 -19.98 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.6 t -166.4 130.1 2.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 109.809 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . -164.45 -148.41 5.43 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.8 t -67.56 3.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.47 -1.018 . . . . 0.0 109.458 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 47' ' ' GLY . 98.1 mt-10 -58.96 -39.19 80.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 109.62 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 172.17 94.89 0.1 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.26 150.55 37.3 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.195 -1.18 . . . . 0.0 109.772 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.77 166.08 28.8 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.56 2.174 . . . . 0.0 111.905 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -53.22 140.1 62.13 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.891 1.727 . . . . 0.0 112.277 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.81 -76.19 0.29 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.13 151.77 19.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.399 -1.06 . . . . 0.0 110.289 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -127.02 162.63 25.56 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.23 153.8 45.66 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.917 0.865 . . . . 0.0 110.509 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.7 mt -114.3 141.21 47.89 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.8 132.72 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.585 0.707 . . . . 0.0 109.794 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.8 t -72.06 132.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.606 0.717 . . . . 0.0 109.686 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -81.9 -77.16 0.23 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.543 -0.723 . . . . 0.0 109.188 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -133.94 139.16 45.95 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.806 0.813 . . . . 0.0 109.836 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.62 -177.74 37.77 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.51 -38.63 90.07 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.758 2.305 . . . . 0.0 111.919 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 66' ' ' ALA . 98.7 m-20 -75.53 -78.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.662 -0.648 . . . . 0.0 110.102 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 59.63 122.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.442 -0.787 . . . . 0.0 110.391 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.14 -19.58 53.55 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.6 t -67.63 144.78 55.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.295 -1.121 . . . . 0.0 110.554 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -134.54 145.07 48.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.627 -0.671 . . . . 0.0 109.732 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.22 139.3 48.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.54 -0.725 . . . . 0.0 109.6 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pp -106.41 145.41 31.77 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.5 0.667 . . . . 0.0 109.833 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.34 123.92 44.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.373 -0.83 . . . . 0.0 109.635 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -93.94 37.93 1.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 109.157 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 55.93 -168.09 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.718 0.77 . . . . 0.0 111.034 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 62.76 -141.37 0.39 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.526 0.679 . . . . 0.0 110.667 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.436 HG23 HD12 ' A' ' 76' ' ' ILE . 93.4 mt -113.57 127.82 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.741 -0.599 . . . . 0.0 109.705 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.1 m -120.84 124.95 46.29 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.502 0.668 . . . . 0.0 109.27 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.5 m -94.42 161.63 14.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.518 -0.739 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.57 151.68 31.31 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.606 0.717 . . . . 0.0 109.848 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.85 -58.02 1.53 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -77.62 145.83 36.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -1.091 . . . . 0.0 110.691 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.495 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -86.02 -47.35 0.57 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.505 -0.747 . . . . 0.0 109.742 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 72.9 Cg_exo -51.97 133.71 46.89 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.325 2.017 . . . . 0.0 113.172 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' PRO . 45.7 t0 41.8 49.88 3.96 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.726 0.774 . . . . 0.0 109.718 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 t -157.01 114.25 3.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.62 -37.66 88.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.533 -0.73 . . . . 0.0 109.9 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.432 HG21 HD13 ' A' ' 87' ' ' ILE . 23.5 mm -73.22 131.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.416 -0.802 . . . . 0.0 110.12 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -129.78 86.54 2.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.705 -0.622 . . . . 0.0 109.541 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -123.12 93.52 3.98 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 97.2 m-20 -94.68 104.18 16.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.431 -0.793 . . . . 0.0 109.468 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 62.3 m-20 -159.52 168.58 25.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.243 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.4 m -67.34 -35.99 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.507 0.67 . . . . 0.0 109.827 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.2 p -65.77 -26.78 67.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.41 128.83 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.487 -0.758 . . . . 0.0 109.499 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.4 m -88.95 -164.07 1.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.605 0.717 . . . . 0.0 110.03 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -62.92 -43.64 98.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.497 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' A' ' 99' ' ' ALA . 84.7 mtp180 -108.39 -57.83 2.07 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 57.69 -73.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.864 -0.522 . . . . 0.0 109.655 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -132.12 155.24 48.5 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.651 0.738 . . . . 0.0 109.439 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -139.37 146.25 39.98 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -113.05 139.18 48.9 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -128.85 139.26 52.24 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.02 121.53 36.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.493 -0.754 . . . . 0.0 109.541 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -99.44 -124.99 0.16 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -84.59 88.18 7.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.829 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 52.71 27.0 4.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.64 -0.663 . . . . 0.0 110.051 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -142.19 131.12 23.02 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.019 -1.051 . . . . 0.0 110.02 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -76.73 147.75 37.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.636 -0.665 . . . . 0.0 110.206 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -139.67 159.78 41.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.104 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.0 p -126.44 132.73 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.702 -0.624 . . . . 0.0 109.435 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.9 135.82 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.509 0.671 . . . . 0.0 109.244 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.425 ' OD2' ' OD1' ' A' ' 117' ' ' ASN . 68.0 m-20 -85.3 115.29 22.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.496 -0.753 . . . . 0.0 109.378 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.65 -2.12 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.66 137.99 14.93 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.5 t -63.27 -42.59 99.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.432 -1.04 . . . . 0.0 109.838 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.2 pp -65.1 -36.8 85.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 109.861 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.425 ' OD1' ' OD2' ' A' ' 112' ' ' ASP . 55.2 t30 68.35 81.4 0.19 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.674 0.75 . . . . 0.0 109.945 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -94.24 -10.28 58.51 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.2 m -76.1 132.45 40.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.328 -1.101 . . . . 0.0 110.196 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.37 149.95 49.81 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 122' ' ' ASN . 9.9 p -130.52 156.69 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.604 -0.685 . . . . 0.0 110.009 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 121' ' ' VAL . 97.5 m-20 -40.61 173.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.995 0.902 . . . . 0.0 111.063 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 60.46 -105.12 0.2 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.856 -0.528 . . . . 0.0 109.992 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -125.62 145.5 51.6 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.779 -0.576 . . . . 0.0 109.602 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -49.24 139.12 28.35 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.355 2.037 . . . . 0.0 113.053 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -137.85 160.08 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.489 -0.757 . . . . 0.0 109.977 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -69.13 -37.68 78.45 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.661 -0.649 . . . . 0.0 109.525 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p -156.28 161.83 40.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.048 -1.032 . . . . 0.0 110.456 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.33 165.55 31.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.45 -0.781 . . . . 0.0 109.579 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.0 t -93.46 130.24 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.441 -0.787 . . . . 0.0 109.719 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.6 mt -77.33 147.2 36.31 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.645 0.736 . . . . 0.0 110.467 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.88 164.17 34.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.614 0.721 . . . . 0.0 109.698 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 18.5 p30 -64.0 127.34 30.97 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.66 0.743 . . . . 0.0 110.714 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.41 16.33 69.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -85.69 160.23 19.61 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.154 -1.204 . . . . 0.0 109.928 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -112.15 124.37 52.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.522 -0.736 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.1 t -127.35 132.67 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -121.7 113.96 20.46 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.5 130.05 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.462 0.648 . . . . 0.0 109.795 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.54 ' C ' ' H ' ' A' ' 142' ' ' PHE . . . 67.29 36.01 88.84 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 140' ' ' GLY . 15.0 tptp 71.37 -19.18 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.677 -0.896 . . . . 0.0 109.475 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.54 ' H ' ' C ' ' A' ' 140' ' ' GLY . 95.6 m-85 -73.96 143.34 45.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.882 . . . . 0.0 109.961 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -99.71 120.68 40.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 109.17 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.33 153.39 47.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.6 -0.687 . . . . 0.0 109.944 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.09 138.72 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.581 0.705 . . . . 0.0 109.554 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -89.9 120.34 31.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.675 . . . . 0.0 109.397 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 66.3 mt -134.72 152.87 52.1 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.396 0.617 . . . . 0.0 109.878 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.7 p -128.1 158.81 36.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.569 0.699 . . . . 0.0 109.567 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 150' ' ' HIS . . . -45.75 -78.61 0.08 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 149' ' ' GLY . 56.4 t-80 48.29 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.474 -1.015 . . . . 0.0 110.058 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -76.7 156.19 32.72 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.721 0.772 . . . . 0.0 110.581 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -62.02 138.6 58.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.577 -0.702 . . . . 0.0 110.433 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 172.01 178.37 42.22 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -98.24 88.76 4.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.429 -1.042 . . . . 0.0 109.388 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 156' ' ' LEU . 65.8 t0 -79.29 151.41 31.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.817 . . . . 0.0 109.793 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.563 ' N ' ' OD1' ' A' ' 155' ' ' ASP . 86.1 mt -69.58 -79.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 109.636 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 156' ' ' LEU . 97.0 mt-10 46.9 97.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.862 0.839 . . . . 0.0 110.01 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -60.13 -39.99 88.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.533 -0.729 . . . . 0.0 109.7 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -101.64 138.44 38.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.552 -0.718 . . . . 0.0 109.573 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -148.86 79.71 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 80.2 m80 44.82 88.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.753 0.787 . . . . 0.0 110.064 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -90.78 125.62 35.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.471 -0.768 . . . . 0.0 110.217 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.517 ' H ' ' CD2' ' A' ' 163' ' ' HIS . 7.9 p80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.882 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.526 0.679 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -70.21 135.65 49.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 110.201 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -73.43 143.87 46.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.351 -0.843 . . . . 0.0 110.252 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 29' ' ' PHE . . . -92.9 81.37 4.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.229 -0.919 . . . . 0.0 109.755 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.2 t0 66.93 -16.33 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.581 -0.699 . . . . 0.0 109.923 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.573 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 16.5 p90 -171.8 -161.83 0.2 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.944 -1.098 . . . . 0.0 110.16 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 29' ' ' PHE . 71.3 mt -69.99 85.35 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.546 0.689 . . . . 0.0 109.614 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.7 p -63.21 150.34 43.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.404 -0.81 . . . . 0.0 110.612 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -174.35 137.49 0.51 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.182 -0.949 . . . . 0.0 110.02 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.06 -40.6 96.63 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.45 -0.781 . . . . 0.0 109.961 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.4 144.26 57.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 111.095 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -169.54 57.8 0.31 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 109.402 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.5 155.93 62.47 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.754 2.303 . . . . 0.0 112.26 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.57 -107.33 0.14 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.195 -0.941 . . . . 0.0 109.161 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -105.87 -25.71 12.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.78 135.85 38.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.586 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 40.97 87.67 0.01 OUTLIER Glycine 0 N--CA 1.498 2.784 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -68.77 136.09 52.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.025 -1.279 . . . . 0.0 110.343 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -85.46 142.56 29.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 110.033 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 44' ' ' ALA . 41.9 t -59.08 -82.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 110.205 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 43' ' ' SER . . . 42.02 49.36 4.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.523 -0.736 . . . . 0.0 109.941 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.9 m -93.29 -4.62 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.306 -0.871 . . . . 0.0 108.71 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 p -73.52 155.53 39.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.369 -0.832 . . . . 0.0 110.63 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.15 144.65 0.12 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.4 t -91.32 -5.65 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.239 -1.154 . . . . 0.0 108.611 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 59.75 106.79 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.518 0.675 . . . . 0.0 110.717 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 51' ' ' LEU . . . 102.55 -49.91 0.96 Allowed Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER 40.99 80.63 0.27 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.635 -0.921 . . . . 0.0 109.72 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -56.38 127.43 25.95 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.94 1.76 . . . . 0.0 111.139 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -47.75 138.67 19.88 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.968 1.779 . . . . 0.0 112.695 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.5 -18.64 54.95 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mp -100.72 149.76 23.46 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.158 -1.201 . . . . 0.0 110.178 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -149.05 165.85 30.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.444 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.04 155.16 47.35 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.67 0.748 . . . . 0.0 109.818 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -116.14 136.69 52.79 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -120.48 135.28 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.672 0.749 . . . . 0.0 109.744 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.3 116.52 20.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.527 -0.733 . . . . 0.0 110.007 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -66.76 -45.15 79.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.43 -0.794 . . . . 0.0 109.918 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -154.29 151.55 29.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.017 . . . . 0.0 110.396 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.42 -176.53 28.11 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.53 -38.37 74.94 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.894 2.396 . . . . 0.0 112.274 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -82.17 -76.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.572 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 70.27 118.07 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.563 0.697 . . . . 0.0 110.249 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.27 -15.65 62.87 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.8 t -67.21 145.46 55.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -1.144 . . . . 0.0 110.546 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -133.4 151.81 51.86 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.667 -0.645 . . . . 0.0 109.676 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -128.17 142.05 51.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.505 -0.747 . . . . 0.0 109.052 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.4 tp -102.27 128.29 48.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.608 -0.683 . . . . 0.0 109.969 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -92.5 75.02 5.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 109.161 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.417 ' N ' ' OD1' ' A' ' 73' ' ' ASP . 35.6 p-10 -95.07 5.52 51.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 109.134 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -115.09 139.43 49.89 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.512 -0.742 . . . . 0.0 109.81 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.61 -50.72 72.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.589 -0.695 . . . . 0.0 110.004 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.9 mm -110.14 120.87 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.346 -0.847 . . . . 0.0 108.828 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.4 m -125.69 115.04 19.48 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.369 0.604 . . . . 0.0 109.688 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.1 m -84.31 151.52 24.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.37 -0.831 . . . . 0.0 109.022 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.61 162.23 13.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.216 -0.928 . . . . 0.0 110.348 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.8 -132.18 11.0 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.545 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 94.9 mtt180 -102.97 131.32 50.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.477 -1.013 . . . . 0.0 110.226 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 23.9 m-70 -172.92 153.93 2.67 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.17 -54.38 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.33 2.02 . . . . 0.0 111.305 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 50.3 p-10 -96.79 88.7 4.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.453 -0.78 . . . . 0.0 109.806 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.6 p -166.33 126.79 1.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.991 . . . . 0.0 109.381 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.11 -39.95 95.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.847 . . . . 0.0 109.649 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.6 mt -87.76 127.45 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.104 -0.997 . . . . 0.0 109.594 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -129.28 85.75 2.35 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.2 mt -101.51 94.53 5.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 108.808 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -88.47 85.52 6.87 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.498 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 12.2 p-10 -155.29 170.11 22.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.36 -0.838 . . . . 0.0 109.655 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.505 ' C ' ' H ' ' A' ' 94' ' ' VAL . 4.1 t -71.9 171.9 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.597 -0.689 . . . . 0.0 110.504 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 92' ' ' VAL . 2.7 p 66.24 -5.93 0.53 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.668 -0.645 . . . . 0.0 109.627 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.505 ' H ' ' C ' ' A' ' 92' ' ' VAL . 94.4 t -109.44 -19.2 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 94' ' ' VAL . 1.4 m 44.5 -173.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.826 0.822 . . . . 0.0 110.827 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -70.11 -43.79 70.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.932 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.424 ' CG ' ' NE2' ' A' ' 82' ' ' HIS . 79.3 mtp85 -140.91 88.98 2.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.836 . . . . 0.0 109.421 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -99.53 -30.57 12.08 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.92 151.44 33.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -140.85 150.32 43.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.478 -0.763 . . . . 0.0 109.503 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.34 145.66 37.09 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -132.99 136.28 45.97 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 57.4 tp -96.78 124.75 40.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 109.743 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -107.18 -109.93 0.3 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.518 -0.739 . . . . 0.0 109.571 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -91.84 79.35 5.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.065 . . . . 0.0 109.38 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.0 m120 55.89 34.68 24.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.558 -0.713 . . . . 0.0 109.538 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.24 131.51 13.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.912 . . . . 0.0 109.044 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -83.73 150.35 25.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.172 -0.955 . . . . 0.0 110.357 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -122.31 157.77 31.03 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.9 p -120.87 127.73 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.593 -0.692 . . . . 0.0 109.222 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -130.72 137.55 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.755 -0.59 . . . . 0.0 109.543 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.468 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 49.4 p-10 -84.55 95.68 8.92 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.275 -0.891 . . . . 0.0 109.277 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.41 -42.99 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.429 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.52 -151.17 1.31 Allowed Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.275 -0.965 . . . . 0.0 110.966 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 t -62.0 149.52 40.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.449 -1.03 . . . . 0.0 110.717 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.1 mt -62.8 -40.09 96.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.601 -0.687 . . . . 0.0 109.531 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -79.95 131.4 35.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.867 -1.146 . . . . 0.0 110.307 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 133.41 -72.24 0.48 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 48.7 m -82.02 129.58 34.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.973 -1.31 . . . . 0.0 109.749 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.422 ' OH ' ' OE1' ' A' ' 138' ' ' GLN . 44.2 p90 -146.22 158.81 43.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.98 . . . . 0.0 109.245 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.55 133.85 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.717 -0.615 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 124' ' ' GLU . 97.7 m-20 57.69 38.43 27.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.779 -0.575 . . . . 0.0 110.006 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 56.79 0.06 0.07 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.525 -0.734 . . . . 0.0 110.634 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 122' ' ' ASN . 72.3 mt-10 -107.28 147.65 35.61 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.266 -0.896 . . . . 0.0 109.44 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.92 148.08 0.23 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.265 1.977 . . . . 0.0 112.227 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 12.9 p -124.69 135.15 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.769 0.795 . . . . 0.0 109.663 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 128' ' ' SER . 65.7 t0 -148.58 59.85 1.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 128' ' ' SER . 2.8 p 80.97 95.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.526 0.679 . . . . 0.0 109.506 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.09 151.22 49.45 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.397 -0.814 . . . . 0.0 109.501 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.6 t -81.5 131.49 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.47 -0.769 . . . . 0.0 109.957 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.03 151.7 35.45 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.478 -0.764 . . . . 0.0 110.267 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.543 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -152.63 153.8 34.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -0.899 . . . . 0.0 109.934 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -49.23 129.84 18.61 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.66 0.743 . . . . 0.0 111.383 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.16 15.13 61.23 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 92.2 m-20 -91.08 150.86 21.24 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.744 -1.445 . . . . 0.0 109.86 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -108.84 130.86 55.42 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.473 -0.767 . . . . 0.0 109.122 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -124.45 133.1 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.604 -0.685 . . . . 0.0 109.248 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.456 ' OE1' ' CZ ' ' A' ' 143' ' ' ARG . 57.3 tt0 -121.07 124.66 45.35 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.49 129.84 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.49 0.662 . . . . 0.0 110.027 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 50.46 -98.38 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -127.4 -19.3 4.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.623 -0.928 . . . . 0.0 108.888 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.498 ' CE1' ' OD2' ' A' ' 91' ' ' ASP . 13.6 m-85 -74.82 143.31 43.99 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.406 -0.809 . . . . 0.0 109.874 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.456 ' CZ ' ' OE1' ' A' ' 138' ' ' GLN . 28.1 mmt180 -103.32 137.17 41.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.496 -0.753 . . . . 0.0 109.653 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.86 151.96 44.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.809 -0.557 . . . . 0.0 109.794 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.0 p -124.28 134.28 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 67.2 t80 -93.04 108.63 20.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.5 mt -140.22 150.75 44.53 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.622 0.725 . . . . 0.0 109.414 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.557 ' C ' ' H ' ' A' ' 150' ' ' HIS . 13.5 p -87.58 172.39 9.78 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.519 -0.738 . . . . 0.0 110.062 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.34 3.46 0.82 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.557 ' H ' ' C ' ' A' ' 148' ' ' THR . 80.8 t60 41.77 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.485 -1.009 . . . . 0.0 110.353 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -82.67 157.51 23.33 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.738 0.78 . . . . 0.0 110.233 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -59.88 142.9 52.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.857 . . . . 0.0 110.41 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.75 143.95 47.51 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.97 166.49 22.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.569 -0.959 . . . . 0.0 110.659 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -57.3 -162.08 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.79 0.805 . . . . 0.0 110.748 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.3 mt -70.25 146.17 50.84 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.686 0.755 . . . . 0.0 110.686 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.25 52.5 1.83 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.43 -0.793 . . . . 0.0 109.137 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' HIS . 61.7 t-80 45.69 86.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.663 0.744 . . . . 0.0 110.378 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 160' ' ' HIS . 80.3 m80 54.01 165.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.511 0.672 . . . . 0.0 111.097 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 159' ' ' HIS . 79.4 m80 58.02 140.3 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.448 0.642 . . . . 0.0 110.706 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' A' ' 163' ' ' HIS . 58.5 t-80 -120.17 123.6 43.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.0 109.709 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 53.3 t-80 49.72 -93.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.788 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.427 ' N ' ' ND1' ' A' ' 162' ' ' HIS . 46.7 t-80 . . . . . 0 N--CA 1.488 1.436 0 O-C-N 120.878 -1.138 . . . . 0.0 109.097 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.463 0.649 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -70.77 128.99 37.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.443 -0.786 . . . . 0.0 110.199 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -143.93 -6.16 0.77 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 52.55 -138.27 1.13 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.706 0.765 . . . . 0.0 110.479 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -152.29 65.76 0.83 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -172.74 -29.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.1 pp -92.68 -28.94 16.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.133 -0.979 . . . . 0.0 109.359 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.5 t -91.11 99.74 12.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.935 . . . . 0.0 109.481 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -87.77 97.77 11.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.475 -0.766 . . . . 0.0 109.66 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' A' ' 33' ' ' LEU . 9.9 mp -72.18 -171.81 0.8 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.645 0.735 . . . . 0.0 110.646 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.81 140.45 58.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.288 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.68 60.62 2.0 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.47 -0.769 . . . . 0.0 109.273 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.7 155.83 65.12 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.801 2.334 . . . . 0.0 112.629 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.28 141.37 58.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.235 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -99.22 154.39 18.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.459 -0.775 . . . . 0.0 110.264 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.55 18.2 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.44 -179.57 53.42 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.35 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.8 m -87.52 127.61 35.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.599 -0.942 . . . . 0.0 109.994 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -175.34 -87.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.6 p 45.5 -131.93 0.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.537 -0.727 . . . . 0.0 110.12 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -169.66 50.08 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.0 m -90.68 -7.19 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -69.52 140.42 53.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.433 -0.792 . . . . 0.0 110.567 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.22 174.92 11.27 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLU . 10.3 p -89.34 2.89 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.577 -0.954 . . . . 0.0 109.02 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 50' ' ' GLY . 80.5 mm-40 -39.6 155.02 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.448 0.642 . . . . 0.0 110.809 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 49' ' ' GLU . . . -35.16 109.29 0.06 OUTLIER Glycine 0 N--CA 1.497 2.754 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.401 ' CD1' ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -102.22 158.27 32.09 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.47 167.59 26.89 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.019 1.813 . . . . 0.0 111.992 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.85 148.14 85.37 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.435 2.09 . . . . 0.0 112.866 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.81 60.29 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -114.24 131.69 56.39 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.621 -0.929 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.15 155.03 44.48 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.4 153.27 48.07 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.827 0.823 . . . . 0.0 110.399 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -114.35 127.08 55.68 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.54 134.05 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.661 0.743 . . . . 0.0 109.809 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.77 128.95 34.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.581 -0.699 . . . . 0.0 109.789 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -88.45 -35.56 16.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.166 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -150.18 132.49 15.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.636 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 141.43 169.48 11.92 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 66' ' ' ALA . 54.4 Cg_exo -52.12 -39.42 70.82 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.755 2.303 . . . . 0.0 111.816 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -81.81 30.63 0.37 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 64' ' ' PRO . . . -63.17 134.26 55.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.524 -0.735 . . . . 0.0 110.278 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.73 -15.61 58.61 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -65.57 144.53 56.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.525 -0.985 . . . . 0.0 110.076 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -136.87 148.9 47.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.642 -0.661 . . . . 0.0 109.698 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -128.79 153.5 47.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.603 -0.686 . . . . 0.0 109.181 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.8 tp -110.16 143.57 40.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.835 -0.541 . . . . 0.0 109.903 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.9 mt -116.59 78.96 1.25 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.513 -0.742 . . . . 0.0 109.686 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 67.1 t0 -110.31 41.01 1.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -135.93 150.33 49.26 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.704 . . . . 0.0 109.428 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.85 79.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.409 -0.807 . . . . 0.0 109.67 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.62 127.51 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.8 m -122.8 124.98 44.54 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.0 t -97.63 168.16 10.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.335 -0.853 . . . . 0.0 110.443 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -116.16 -178.93 3.52 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.652 0.739 . . . . 0.0 109.753 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.34 -134.74 39.25 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.588 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 38.1 mmt180 -74.58 133.9 42.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.436 -1.037 . . . . 0.0 109.818 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 1.2 m80 166.96 85.92 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.15 -36.47 66.65 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.992 1.795 . . . . 0.0 110.964 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -94.82 72.34 3.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.351 -0.843 . . . . 0.0 109.591 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.4 t -169.13 148.3 3.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.072 -1.018 . . . . 0.0 109.41 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.29 -41.5 98.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.354 -0.842 . . . . 0.0 109.681 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.85 123.64 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 109.912 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CZ ' ' OD2' ' A' ' 90' ' ' ASP . 89.3 t80 -130.4 85.73 2.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.12 128.61 53.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.376 -0.828 . . . . 0.0 109.694 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD2' ' CZ ' ' A' ' 88' ' ' PHE . 94.6 m-20 -135.1 86.06 2.22 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 63.3 m-20 -158.92 178.99 9.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.88 . . . . 0.0 110.032 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.528 ' C ' ' H ' ' A' ' 94' ' ' VAL . 2.8 t -63.42 166.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.611 -0.681 . . . . 0.0 110.847 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 92' ' ' VAL . 3.0 p 66.06 -4.76 0.62 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.528 ' H ' ' C ' ' A' ' 92' ' ' VAL . 55.3 t -123.99 129.5 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.3 m -107.59 -139.24 0.37 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 109.958 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -63.42 -42.53 98.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.546 -0.721 . . . . 0.0 110.662 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -156.89 94.02 1.4 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 109.005 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -61.29 -39.04 88.95 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.438 -0.789 . . . . 0.0 109.438 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -152.55 162.08 41.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 110.573 -179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -133.39 145.56 50.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -113.87 141.89 46.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.333 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.71 135.81 50.68 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.748 0.785 . . . . 0.0 109.834 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 107' ' ' GLU . 47.2 tp -98.42 128.49 44.82 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.39 -126.62 0.15 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.152 -0.967 . . . . 0.0 110.94 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 8.0 m120 -64.53 -48.91 73.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 110.529 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 5.5 m120 -168.82 21.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.33 -0.856 . . . . 0.0 109.665 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.466 ' O ' ' CD1' ' A' ' 103' ' ' LEU . 96.8 mt-10 -116.37 -126.92 0.29 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.35 -0.844 . . . . 0.0 109.057 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.439 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 13.7 m-85 -164.23 155.35 15.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.017 -1.052 . . . . 0.0 108.933 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 58.6 m-20 -143.45 149.51 37.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.149 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.32 130.51 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.44 131.54 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.355 0.597 . . . . 0.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -100.25 118.16 35.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.53 -0.731 . . . . 0.0 109.356 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 115' ' ' SER . 25.3 m -75.66 -157.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.355 -0.841 . . . . 0.0 110.215 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.93 28.43 0.94 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 113' ' ' VAL . 17.0 m -71.87 150.99 43.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -1.171 . . . . 0.0 110.671 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 10.5 mp -60.03 176.0 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.825 0.822 . . . . 0.0 111.02 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.431 ' CG ' ' H ' ' A' ' 118' ' ' GLY . 50.0 t30 58.17 -116.27 0.88 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.291 0.567 . . . . 0.0 110.367 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.476 ' O ' ' CZ ' ' A' ' 120' ' ' TYR . . . 162.16 125.31 0.76 Allowed Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.7 m -72.09 138.79 48.03 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.422 -1.046 . . . . 0.0 109.856 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.476 ' CZ ' ' O ' ' A' ' 118' ' ' GLY . 11.2 m-85 -124.12 142.15 51.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.61 -0.681 . . . . 0.0 109.188 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.9 p -124.13 132.08 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.606 0.717 . . . . 0.0 109.622 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 124' ' ' GLU . 98.1 m-20 52.6 -171.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.819 0.819 . . . . 0.0 110.894 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -71.37 6.84 1.56 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.394 -0.817 . . . . 0.0 108.871 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.467 ' H ' ' C ' ' A' ' 122' ' ' ASN . 3.9 pt-20 -120.44 84.74 36.22 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.45 134.38 60.84 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.373 2.049 . . . . 0.0 112.009 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 27.3 m -151.04 156.15 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.132 -0.98 . . . . 0.0 109.809 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.45 -41.88 96.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.1 p -158.11 143.5 16.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.399 -0.813 . . . . 0.0 109.546 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -172.93 167.52 5.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.289 -0.882 . . . . 0.0 110.056 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.8 t -78.05 144.31 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.981 0.896 . . . . 0.0 109.96 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -136.8 158.06 45.31 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.544 0.688 . . . . 0.0 110.444 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.06 -172.02 4.06 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.629 0.728 . . . . 0.0 109.201 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 47.2 p-10 -50.78 141.52 12.96 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.834 0.826 . . . . 0.0 111.538 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.17 21.36 57.2 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -110.08 151.88 26.67 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.446 -1.032 . . . . 0.0 109.267 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -113.46 138.09 50.6 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.8 t -125.61 132.27 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -118.71 125.45 49.7 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.46 128.95 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.65 0.738 . . . . 0.0 109.518 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.67 -120.98 4.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -98.45 -16.31 19.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.421 -1.046 . . . . 0.0 108.808 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -80.37 145.47 32.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 0.0 110.214 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -115.85 126.68 54.29 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.03 158.43 36.98 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.65 -0.656 . . . . 0.0 109.762 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.83 135.47 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -90.24 109.87 20.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.924 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.44 143.59 39.74 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.401 0.62 . . . . 0.0 109.374 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 79.8 p -86.47 167.27 14.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 110.396 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.87 -3.28 90.56 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -88.1 117.25 26.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.236 . . . . 0.0 109.752 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -172.03 -26.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.87 158.12 36.12 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.814 0.816 . . . . 0.0 110.518 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 91.71 128.69 4.37 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 54.8 20.02 2.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.636 -0.92 . . . . 0.0 109.353 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -86.81 56.63 4.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.346 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 79.1 mt -80.43 133.05 35.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.381 -0.825 . . . . 0.0 110.025 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -87.23 122.96 31.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.889 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -110.15 118.25 35.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.537 -0.727 . . . . 0.0 109.661 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.496 ' CE1' ' OXT' ' A' ' 163' ' ' HIS . 59.3 t-80 -86.17 -7.52 58.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.481 -0.762 . . . . 0.0 108.965 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 159' ' ' HIS . 70.2 m80 58.42 133.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.085 0.945 . . . . 0.0 110.909 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 162' ' ' HIS . 60.1 t-80 48.55 86.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.784 0.802 . . . . 0.0 110.291 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 161' ' ' HIS . 74.0 m80 46.93 -176.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.726 0.774 . . . . 0.0 110.762 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.496 ' OXT' ' CE1' ' A' ' 159' ' ' HIS . 86.7 t60 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.857 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.666 0.746 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -75.97 148.23 38.29 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.925 0.869 . . . . 0.0 110.457 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -78.53 144.54 35.55 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.648 0.737 . . . . 0.0 110.512 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 28' ' ' ASP . . . -177.28 153.19 0.92 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.179 0.514 . . . . 0.0 109.675 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 27' ' ' ALA . 8.1 t70 75.3 16.15 2.74 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.325 0.583 . . . . 0.0 109.448 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 30' ' ' LEU . 41.7 p90 -174.05 -38.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.575 ' N ' ' CD1' ' A' ' 29' ' ' PHE . 71.9 mt 54.19 110.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.895 0.855 . . . . 0.0 110.041 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.6 t 57.23 82.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.577 0.703 . . . . 0.0 109.999 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -69.3 -35.2 75.75 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.402 ' C ' ' CD2' ' A' ' 33' ' ' LEU . 4.0 tt -91.36 116.74 29.09 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.845 0.831 . . . . 0.0 109.364 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -66.96 142.82 57.13 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.938 0.875 . . . . 0.0 111.015 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.439 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . -171.73 54.11 0.2 Allowed Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.528 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 38' ' ' GLN . 37.7 Cg_endo -66.32 146.24 80.19 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.881 2.387 . . . . 0.0 112.574 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 36' ' ' PRO . . . 40.5 -91.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.106 0.479 . . . . 0.0 110.128 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 36' ' ' PRO . 1.8 mm100 -74.91 148.74 39.82 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.882 0.848 . . . . 0.0 110.333 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.12 -8.15 58.75 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.03 -167.05 34.92 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 87.3 m -61.5 131.8 51.31 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.691 0.758 . . . . 0.0 110.431 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -90.82 -15.72 29.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 m -73.98 147.15 43.26 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.923 0.868 . . . . 0.0 110.49 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.98 -39.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.2 t -78.9 -78.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.478 -0.764 . . . . 0.0 109.62 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 95.5 p -76.9 161.46 28.38 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.766 0.793 . . . . 0.0 110.36 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -171.43 -170.02 35.02 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.1 m -84.19 -8.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.842 -0.799 . . . . 0.0 109.179 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -83.59 107.14 15.86 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.907 0.86 . . . . 0.0 109.827 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 60.77 132.64 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.62 68.4 4.54 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.557 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 45.5 Cg_exo -47.59 -41.89 29.82 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.408 2.072 . . . . 0.0 112.101 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 35.0 Cg_exo -60.86 146.79 97.0 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.867 2.378 . . . . 0.0 112.837 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -51.27 83.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 53' ' ' PRO . 95.4 mt -131.57 154.01 49.28 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.118 0.961 . . . . 0.0 110.535 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.77 158.89 42.94 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.16 151.0 51.16 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.309 1.052 . . . . 0.0 110.929 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -115.25 136.4 53.14 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.221 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.8 t -121.75 132.97 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.855 0.836 . . . . 0.0 109.859 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.7 t -69.8 102.82 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.927 0.87 . . . . 0.0 109.538 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HZ3' ' NH2' ' A' ' 143' ' ' ARG . 88.6 tttt -66.07 -43.87 86.11 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.632 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -130.97 136.82 48.89 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.945 0.879 . . . . 0.0 109.797 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.9 168.62 16.45 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.11 -34.66 68.63 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.88 2.387 . . . . 0.0 111.471 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 66' ' ' ALA . 87.3 m-20 -66.89 -45.52 77.77 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . 31.52 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.455 0.645 . . . . 0.0 110.838 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.01 -24.62 4.5 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.4 p -70.02 160.68 31.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.779 -0.836 . . . . 0.0 110.849 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.566 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -152.46 164.04 38.35 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.937 0.875 . . . . 0.0 110.556 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -128.24 142.35 51.19 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.887 0.851 . . . . 0.0 109.723 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -104.48 127.52 52.2 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.822 0.82 . . . . 0.0 110.406 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.3 mt -91.37 116.49 28.88 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.898 0.856 . . . . 0.0 109.966 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -157.69 19.7 0.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -129.65 138.89 51.46 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.895 0.855 . . . . 0.0 109.821 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.79 134.62 51.28 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.78 0.8 . . . . 0.0 110.458 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 mm 53.09 93.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.6 m -106.08 118.13 35.81 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.029 0.918 . . . . 0.0 110.169 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.406 ' O ' ' OG ' ' A' ' 85' ' ' SER . 12.2 m -85.67 159.33 19.84 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.639 0.733 . . . . 0.0 109.909 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 96' ' ' ARG . . . -106.89 170.09 8.15 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.865 0.841 . . . . 0.0 110.388 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.5 -70.67 2.62 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.621 ' NH1' ' NH2' ' A' ' 96' ' ' ARG . 79.7 mtp85 -71.74 142.59 49.77 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.714 0.769 . . . . 0.0 110.118 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.525 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -86.43 -46.07 0.56 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.837 -0.539 . . . . 0.0 109.91 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 54.3 Cg_exo -54.24 135.0 63.43 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.257 1.971 . . . . 0.0 112.725 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 54.48 33.21 18.31 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 78' ' ' SER . 1.6 t -159.65 117.63 2.72 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.932 0.872 . . . . 0.0 109.876 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.23 -37.85 88.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.404 HD13 HG23 ' A' ' 87' ' ' ILE . 96.7 mt -80.57 125.36 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.58 0.705 . . . . 0.0 109.702 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.4 ' CD1' ' CB ' ' A' ' 82' ' ' HIS . 57.4 t80 -130.01 86.19 2.38 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.965 0.888 . . . . 0.0 109.566 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 90' ' ' ASP . 96.8 mt -79.7 146.71 32.28 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.763 0.792 . . . . 0.0 109.787 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 89' ' ' LEU . 64.7 t0 -55.88 -109.12 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.454 0.645 . . . . 0.0 110.267 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 93' ' ' THR . 58.6 m-20 -162.23 -103.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.461 0.648 . . . . 0.0 109.486 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 t 53.01 -77.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.151 0.501 . . . . 0.0 109.904 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 91' ' ' ASP . 11.8 p -115.17 9.23 15.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.656 -0.653 . . . . 0.0 109.375 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.1 131.09 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 121.918 0.866 . . . . 0.0 109.862 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.47 ' HG ' ' H ' ' A' ' 96' ' ' ARG . 7.5 t -89.33 -155.74 0.37 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.813 0.816 . . . . 0.0 110.94 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.621 ' NH2' ' NH1' ' A' ' 81' ' ' ARG . 79.3 mtp85 -63.7 -41.22 98.14 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.312 0.577 . . . . 0.0 109.894 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.416 ' C ' ' H ' ' A' ' 99' ' ' ALA . 33.5 ptt180 -166.41 56.36 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.433 0.635 . . . . 0.0 109.593 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -62.85 -6.42 3.74 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 97' ' ' ARG . . . -143.56 147.49 34.51 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.939 0.876 . . . . 0.0 109.673 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -143.93 138.94 28.87 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.057 0.932 . . . . 0.0 109.925 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -106.38 145.81 31.25 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.717 0.77 . . . . 0.0 109.302 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -132.93 143.98 49.84 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.985 0.897 . . . . 0.0 110.177 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.0 tp -106.83 121.77 45.05 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.839 0.828 . . . . 0.0 109.569 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 104' ' ' GLU . 9.8 pm0 -107.12 -116.51 0.26 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.444 0.64 . . . . 0.0 109.876 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.469 ' H ' ' CG ' ' A' ' 104' ' ' GLU . 47.7 p-10 -87.38 80.82 8.04 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.604 0.716 . . . . 0.0 110.437 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 54.22 31.42 14.07 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.421 0.629 . . . . 0.0 109.508 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -141.4 130.41 23.24 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.66 0.743 . . . . 0.0 109.562 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -93.31 148.72 21.79 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.465 0.65 . . . . 0.0 109.647 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -147.25 172.34 13.99 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.637 0.732 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.3 p -124.66 131.65 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-O 121.966 0.888 . . . . 0.0 109.576 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.97 133.29 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.712 0.768 . . . . 0.0 109.5 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -89.05 113.82 24.98 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.553 0.692 . . . . 0.0 109.515 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m -71.48 81.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.718 0.771 . . . . 0.0 109.578 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 115' ' ' SER . . . 90.98 177.84 43.55 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 114' ' ' GLY . 5.2 m 56.09 114.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.684 0.754 . . . . 0.0 110.187 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.19 -40.21 96.85 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -88.66 109.69 20.33 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.825 0.821 . . . . 0.0 110.266 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.506 ' O ' ' CE1' ' A' ' 120' ' ' TYR . . . -156.92 -116.42 0.51 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.6 m -65.77 133.86 51.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.55 -0.971 . . . . 0.0 110.021 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.506 ' CE1' ' O ' ' A' ' 118' ' ' GLY . 8.9 m-85 -121.7 144.15 48.94 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.825 0.821 . . . . 0.0 109.611 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 122' ' ' ASN . 3.2 p -101.99 154.4 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.42 0.628 . . . . 0.0 109.954 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' A' ' 123' ' ' ARG . 37.9 p-10 -34.04 -45.3 0.2 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.106 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.499 ' N ' ' OD1' ' A' ' 122' ' ' ASN . 99.8 mtt180 -74.5 -114.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.64 -0.662 . . . . 0.0 110.919 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -102.36 147.29 33.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.679 -0.638 . . . . 0.0 109.989 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.77 137.7 78.39 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.793 2.329 . . . . 0.0 113.022 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.07 161.23 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.789 0.804 . . . . 0.0 110.558 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.46 -18.35 61.13 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.8 p -158.16 159.24 35.94 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.721 0.772 . . . . 0.0 109.901 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.69 155.28 31.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.88 0.847 . . . . 0.0 110.219 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.5 t -99.64 128.91 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.708 0.765 . . . . 0.0 109.622 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.24 143.21 35.52 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.789 0.804 . . . . 0.0 110.552 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.53 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -153.25 150.36 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.611 0.72 . . . . 0.0 109.635 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -39.95 122.87 1.54 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.773 0.797 . . . . 0.0 111.145 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.44 13.11 68.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 28.0 m-20 -85.9 149.15 25.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.516 -0.991 . . . . 0.0 109.861 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -112.47 141.96 45.59 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.867 0.842 . . . . 0.0 110.219 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.2 t -121.74 133.66 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.804 0.812 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -128.45 112.66 14.61 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.829 0.823 . . . . 0.0 109.472 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 139' ' ' ILE . 96.8 mt -131.13 128.59 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.871 0.843 . . . . 0.0 109.654 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 56.07 -134.46 50.27 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -95.45 -13.59 24.46 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.56 130.53 35.86 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.832 0.825 . . . . 0.0 110.073 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.467 ' NH2' ' HZ3' ' A' ' 61' ' ' LYS . 85.7 mtp180 -105.99 135.56 47.22 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.714 0.768 . . . . 0.0 109.752 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.69 149.33 51.49 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.658 0.742 . . . . 0.0 109.714 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.32 132.18 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.721 0.772 . . . . 0.0 109.239 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -94.49 111.94 23.7 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.941 0.877 . . . . 0.0 110.008 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.7 mt -138.14 150.52 46.89 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.805 0.812 . . . . 0.0 109.989 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 150' ' ' HIS . 7.8 p -88.18 -170.1 2.83 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.702 0.763 . . . . 0.0 110.354 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 151' ' ' LYS . . . -39.9 90.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.546 ' N ' ' O ' ' A' ' 148' ' ' THR . 80.6 m80 -49.84 -11.54 0.06 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 149' ' ' GLY . 4.5 tppt? -79.01 101.48 7.83 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.739 0.78 . . . . 0.0 110.226 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -105.2 139.9 39.16 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.809 0.814 . . . . 0.0 110.088 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 169.6 43.29 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -131.77 39.55 3.46 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.43 -1.041 . . . . 0.0 109.504 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -173.9 173.81 3.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.502 -0.749 . . . . 0.0 109.747 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 65.2 mt -70.0 148.25 49.12 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.698 0.761 . . . . 0.0 110.298 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.21 145.14 52.23 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.636 0.732 . . . . 0.0 110.93 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.651 ' H ' ' HD1' ' A' ' 158' ' ' HIS . 8.7 p-80 -88.89 169.38 11.62 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.8 0.81 . . . . 0.0 110.978 -179.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 -68.04 142.95 55.73 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.641 0.734 . . . . 0.0 110.641 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -75.77 146.18 40.21 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.674 0.75 . . . . 0.0 110.301 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -144.62 140.1 28.48 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.803 0.811 . . . . 0.0 110.126 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.472 ' ND1' ' OXT' ' A' ' 163' ' ' HIS . 61.3 t-80 -82.47 129.58 34.94 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.84 0.829 . . . . 0.0 110.222 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.472 ' OXT' ' ND1' ' A' ' 162' ' ' HIS . 97.8 m-70 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.805 -1.093 . . . . 0.0 109.935 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 25' ' ' PHE . 11.4 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.335 0.588 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.593 ' CG ' ' N ' ' A' ' 26' ' ' ARG . 74.5 t80 48.08 -179.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.571 0.701 . . . . 0.0 110.272 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.593 ' N ' ' CG ' ' A' ' 25' ' ' PHE . 85.0 mtt85 -67.91 146.47 53.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 0.0 111.105 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 26' ' ' ARG . . . 41.3 -166.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.66 0.743 . . . . 0.0 110.799 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.66 -62.92 1.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.785 -0.572 . . . . 0.0 110.193 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -88.19 -163.54 0.97 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.383 -0.823 . . . . 0.0 110.638 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.42 ' H ' ' CD2' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -83.96 97.35 9.21 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.443 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -76.79 159.18 30.32 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.626 0.727 . . . . 0.0 111.3 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 34' ' ' ASP . 23.8 tp10 68.38 128.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.611 0.72 . . . . 0.0 110.45 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.9 mt -85.8 -3.07 58.81 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.41 ' H ' ' HG3' ' A' ' 32' ' ' GLU . 95.8 m-20 -89.58 2.62 54.42 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.429 ' N ' ' HD2' ' A' ' 36' ' ' PRO . . . -41.84 -61.5 1.47 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.77 -0.582 . . . . 0.0 110.1 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 35' ' ' ALA . 30.5 Cg_endo -61.05 144.91 99.55 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.256 1.97 . . . . 0.0 111.865 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.8 130.64 1.03 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.407 -0.808 . . . . 0.0 109.822 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 40' ' ' GLY . 13.6 pt20 -154.59 -26.42 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 45.01 -89.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.872 -0.517 . . . . 0.0 110.177 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 38' ' ' GLN . . . 79.1 25.33 59.86 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 43' ' ' SER . 70.0 p -87.49 -5.02 58.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.391 -1.064 . . . . 0.0 109.243 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -51.36 89.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.56 -0.712 . . . . 0.0 109.863 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 41' ' ' THR . 70.0 p -86.71 -4.71 59.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.537 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.39 79.2 0.25 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.404 0.621 . . . . 0.0 109.343 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.4 m -98.89 159.51 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.563 -0.71 . . . . 0.0 110.577 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.8 m -53.0 -96.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.646 -0.659 . . . . 0.0 109.3 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.83 -165.48 53.63 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 50' ' ' GLY . 2.8 t -83.19 118.88 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.932 . . . . 0.0 110.007 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 50' ' ' GLY . 13.6 pt-20 36.35 25.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.84 -0.538 . . . . 0.0 111.11 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . 52.62 175.75 0.05 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -139.44 45.41 0.89 Allowed Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.429 -1.042 . . . . 0.0 109.184 179.578 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 51' ' ' LEU . 2.7 Cg_endo -42.62 -54.44 3.21 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.346 2.031 . . . . 0.0 112.236 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 52' ' ' PRO . 36.0 Cg_endo -60.84 -81.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.858 1.705 . . . . 0.0 111.944 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -174.75 57.01 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.52 136.81 42.55 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.512 -0.993 . . . . 0.0 109.46 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.64 160.64 26.7 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.38 150.22 50.2 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.486 -0.759 . . . . 0.0 109.858 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.34 136.08 53.47 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.5 133.79 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.11 112.46 3.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.425 -0.797 . . . . 0.0 109.464 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.52 ' O ' ' NE ' ' A' ' 62' ' ' ARG . 24.2 tptp -64.71 -47.07 79.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.453 -0.78 . . . . 0.0 109.505 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 61' ' ' LYS . 4.7 mmp_? -143.61 155.26 44.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 109.847 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.43 167.18 11.55 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.56 -19.51 54.39 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.544 2.163 . . . . 0.0 111.873 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -106.25 33.44 3.84 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.452 -0.78 . . . . 0.0 109.192 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.79 145.88 11.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 109.922 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.21 53.68 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.3 m -69.96 145.89 51.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -1.053 . . . . 0.0 109.907 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -141.81 156.1 45.57 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -129.51 146.97 51.27 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.449 -0.782 . . . . 0.0 109.511 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.519 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 53.9 tp -106.44 124.93 50.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.541 -0.724 . . . . 0.0 109.114 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.7 68.73 5.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.152 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.3 p30 -98.75 5.84 47.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.438 -0.789 . . . . 0.0 109.727 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -119.45 135.55 54.7 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.457 -0.777 . . . . 0.0 109.335 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.68 136.06 54.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.514 -0.741 . . . . 0.0 110.659 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.1 mm 60.23 85.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.439 0.637 . . . . 0.0 109.992 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.4 m -102.93 121.84 43.34 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.418 ' O ' ' OG ' ' A' ' 85' ' ' SER . 11.5 m -85.52 162.17 19.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.711 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.37 127.08 44.94 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.86 -141.9 9.64 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -104.48 132.47 50.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.437 -1.037 . . . . 0.0 110.401 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.653 ' N ' ' ND1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 174.15 151.1 0.25 Allowed Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.63 -23.29 49.51 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.14 1.893 . . . . 0.0 112.104 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 85' ' ' SER . 73.0 m-20 -103.3 -146.84 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 109.732 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 84' ' ' ASP . 8.7 t 59.6 128.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.612 0.72 . . . . 0.0 110.389 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 71' ' ' LEU . 48.0 t0 -64.7 -39.69 94.09 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.03 124.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.422 -0.799 . . . . 0.0 109.223 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -130.2 86.25 2.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.723 -0.61 . . . . 0.0 109.482 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.65 99.68 11.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -84.39 92.57 8.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.658 -0.651 . . . . 0.0 109.766 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.413 ' OD2' ' OG1' ' A' ' 93' ' ' THR . 43.3 t0 -154.38 151.76 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 109.593 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 m -71.21 -26.91 27.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.314 -0.867 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.413 ' OG1' ' OD2' ' A' ' 91' ' ' ASP . 66.1 p -65.7 -33.85 76.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.499 -0.751 . . . . 0.0 109.737 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.97 121.53 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.293 -0.879 . . . . 0.0 109.374 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.8 m -77.3 179.77 6.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 0.0 110.34 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -58.03 -44.27 87.23 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -135.68 78.63 1.73 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.49 -0.757 . . . . 0.0 109.03 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -94.68 -18.93 20.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.518 -0.739 . . . . 0.0 109.219 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -153.13 152.32 31.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.483 -0.76 . . . . 0.0 109.184 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -139.6 139.6 36.81 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -106.43 119.79 40.19 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.578 -0.702 . . . . 0.0 109.165 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -107.61 134.93 49.89 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 109.398 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.9 tp -103.4 126.68 50.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.386 -0.821 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.428 ' CG ' ' H ' ' A' ' 105' ' ' ASN . 27.0 tp10 -99.57 -131.2 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.512 -0.743 . . . . 0.0 109.08 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.428 ' H ' ' CG ' ' A' ' 104' ' ' GLU . 42.6 t-20 -65.54 -49.43 68.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.402 -0.811 . . . . 0.0 109.902 -179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.421 ' CG ' ' O ' ' A' ' 106' ' ' ASN . 2.5 t-20 177.51 46.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 108' ' ' PHE . 80.5 mm-40 -134.32 -6.25 2.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.981 -1.074 . . . . 0.0 109.251 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 107' ' ' GLU . 62.3 m-85 56.71 151.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.724 0.773 . . . . 0.0 110.209 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 88.8 m-20 -143.49 159.89 41.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.379 -0.826 . . . . 0.0 109.487 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.85 137.42 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 30.8 t -133.8 157.27 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.405 -0.809 . . . . 0.0 109.763 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 114' ' ' GLY . 36.5 p-10 -84.7 13.63 5.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.674 -0.641 . . . . 0.0 109.582 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 112' ' ' ASP . 9.4 p 37.12 26.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.419 0.628 . . . . 0.0 110.394 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . 102.96 -155.69 18.17 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 114' ' ' GLY . 46.4 m 58.99 141.94 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.748 -0.854 . . . . 0.0 110.164 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.2 tp -78.54 134.74 37.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.643 -0.66 . . . . 0.0 110.489 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 62.7 t30 58.04 40.07 25.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.587 -0.695 . . . . 0.0 109.714 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -76.17 -130.04 0.33 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 17.5 m -62.87 138.98 58.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.419 -1.048 . . . . 0.0 110.599 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -141.91 160.36 40.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.1 p -112.17 129.2 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.293 -0.88 . . . . 0.0 110.486 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.536 ' CG ' ' H ' ' A' ' 123' ' ' ARG . 5.9 t-20 59.47 -167.44 0.16 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.682 0.753 . . . . 0.0 110.824 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.536 ' H ' ' CG ' ' A' ' 122' ' ' ASN . 96.0 mtt-85 -72.71 -12.75 61.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.884 -0.51 . . . . 0.0 109.9 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -86.41 116.53 66.22 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.27 -0.894 . . . . 0.0 109.2 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.22 121.63 5.8 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.507 1.472 . . . . 0.0 111.768 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.53 156.74 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 128' ' ' SER . 38.4 p-10 -72.96 -36.76 67.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.416 -0.803 . . . . 0.0 109.606 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.53 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 99.5 p -160.55 161.83 32.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.413 -0.805 . . . . 0.0 108.852 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -165.53 157.68 15.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.918 -1.114 . . . . 0.0 110.386 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 87.3 t -81.31 134.0 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.462 -0.774 . . . . 0.0 109.638 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.9 mt -80.8 148.07 30.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 109.696 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.548 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -146.28 160.72 41.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.345 -0.847 . . . . 0.0 109.611 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.423 ' OD1' ' OG1' ' A' ' 148' ' ' THR . 51.3 m-20 -57.54 136.79 56.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.737 . . . . 0.0 110.628 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 80.53 18.62 70.49 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 84.8 m-20 -93.5 155.25 17.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.162 -1.199 . . . . 0.0 109.642 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 56.4 mp0 -113.33 137.43 51.52 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.4 t -122.94 133.6 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -124.12 116.71 23.2 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.592 -0.692 . . . . 0.0 109.304 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.422 HG21 HD12 ' A' ' 139' ' ' ILE . 96.6 mt -126.31 128.07 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.612 -0.68 . . . . 0.0 109.811 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 52.82 -134.23 39.85 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -95.49 -4.59 44.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.6 -0.941 . . . . 0.0 109.076 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -95.84 132.34 41.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.553 -0.717 . . . . 0.0 109.506 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -103.36 133.8 47.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.34 154.88 47.2 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.9 134.18 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.687 -0.633 . . . . 0.0 109.368 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -92.0 112.44 24.38 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.2 mt -134.2 148.65 50.92 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.457 0.646 . . . . 0.0 110.101 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 133' ' ' ASN . 35.8 p -117.82 122.23 42.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.796 -0.565 . . . . 0.0 109.984 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 50.23 -94.73 0.01 OUTLIER Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.523 ' CG ' ' N ' ' A' ' 151' ' ' LYS . 49.0 t-80 47.72 -110.57 0.34 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.383 -1.069 . . . . 0.0 110.48 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.523 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 10.9 ttmm -60.9 135.84 57.9 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.613 0.721 . . . . 0.0 110.629 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.55 128.17 35.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.607 -0.683 . . . . 0.0 109.558 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.86 165.53 52.45 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -157.81 -79.41 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -1.044 . . . . 0.0 108.996 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 45.38 81.36 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.432 -0.793 . . . . 0.0 109.483 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 86.0 mt -68.5 143.31 55.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.543 -0.723 . . . . 0.0 109.742 -179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -173.34 -128.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.638 ' ND1' ' N ' ' A' ' 159' ' ' HIS . 56.4 t-80 44.16 -110.46 0.18 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.42 -0.8 . . . . 0.0 110.418 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.66 ' CG ' ' H ' ' A' ' 160' ' ' HIS . 23.0 t60 44.8 -170.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.597 -0.689 . . . . 0.0 110.473 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.66 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 49.4 m170 55.06 174.91 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.497 0.665 . . . . 0.0 110.269 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -106.04 138.16 42.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.595 -0.691 . . . . 0.0 109.574 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -73.27 139.16 45.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.533 -0.73 . . . . 0.0 110.05 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.69 -179.873 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.531 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 mt -128.16 151.12 49.62 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.513 -0.992 . . . . 0.0 109.702 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.629 ' C ' HD12 ' A' ' 57' ' ' LEU . . . -137.65 143.48 41.39 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.629 HD12 ' C ' ' A' ' 56' ' ' ALA . 11.1 mp -120.23 150.72 40.22 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.335 -0.853 . . . . 0.0 109.868 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.3 mt -117.11 132.58 56.64 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 t -119.08 132.11 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.406 -0.809 . . . . 0.0 109.887 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.78 102.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.542 -0.724 . . . . 0.0 109.134 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.71 -42.91 97.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.679 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -150.21 136.93 19.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.165 -0.96 . . . . 0.0 109.888 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.87 173.27 29.27 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.07 -43.17 60.75 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.224 1.949 . . . . 0.0 112.39 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -102.81 66.15 0.92 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.36 144.75 49.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.278 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.49 -9.7 66.87 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.8 m -66.13 145.64 55.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.404 -1.057 . . . . 0.0 109.665 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.61 146.96 51.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.58 -0.7 . . . . 0.0 109.475 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -125.33 134.49 52.2 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tt -101.98 124.23 47.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.504 -0.748 . . . . 0.0 109.471 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.56 111.74 24.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.32 -0.862 . . . . 0.0 109.271 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -86.22 55.42 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.612 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 88.0 mt-30 51.26 -169.09 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.655 0.74 . . . . 0.0 110.855 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 74' ' ' GLN . . . 68.57 -142.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.491 0.663 . . . . 0.0 110.32 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.45 127.85 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.2 m -121.61 116.64 24.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.559 -0.713 . . . . 0.0 109.123 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 p -83.09 165.33 19.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.359 -0.838 . . . . 0.0 109.553 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.51 140.86 51.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.55 -27.25 16.35 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -67.85 143.71 55.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -1.108 . . . . 0.0 109.864 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.59 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -92.14 -40.43 0.36 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.651 -0.655 . . . . 0.0 109.857 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 65.8 Cg_exo -53.32 -133.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.785 2.323 . . . . 0.0 113.356 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -73.83 101.37 3.73 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.283 -0.885 . . . . 0.0 109.751 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.9 m -166.54 129.25 1.88 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 109.25 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.75 -41.17 97.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 109.992 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.68 126.01 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.732 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -129.5 86.94 2.48 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.0 mt -102.18 96.16 6.8 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.354 -0.841 . . . . 0.0 109.514 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 65.9 t0 -87.92 97.3 10.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.317 -0.865 . . . . 0.0 109.62 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 62.9 m-20 -159.97 173.22 16.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.127 -0.983 . . . . 0.0 109.661 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 93' ' ' THR . 31.5 m -63.61 -41.42 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.464 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -79.32 -178.11 6.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.831 . . . . 0.0 110.211 -179.326 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.518 ' N ' ' OG1' ' A' ' 93' ' ' THR . 4.8 t 61.64 93.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 121.63 0.728 . . . . 0.0 109.597 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.4 m -62.87 -167.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 0.0 109.897 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -63.48 -40.5 97.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.0 109.836 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -132.28 40.93 3.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.474 -0.766 . . . . 0.0 109.265 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -44.06 -35.75 2.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.749 . . . . 0.0 110.03 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.16 152.58 38.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -139.88 149.29 43.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.488 -0.758 . . . . 0.0 109.039 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.24 140.63 49.11 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.471 -0.768 . . . . 0.0 109.057 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -131.28 137.12 48.7 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.377 -0.827 . . . . 0.0 109.061 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.6 tp -95.66 127.65 41.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.244 -0.91 . . . . 0.0 109.789 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 105' ' ' ASN . 40.6 tt0 -142.11 145.11 33.91 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.202 -0.936 . . . . 0.0 109.142 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.443 ' OD1' ' CG ' ' A' ' 107' ' ' GLU . 11.2 p30 45.39 41.39 6.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.754 . . . . 0.0 109.571 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m120 56.8 33.98 23.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.536 -0.727 . . . . 0.0 109.994 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.443 ' CG ' ' OD1' ' A' ' 105' ' ' ASN . 73.9 mm-40 -138.47 129.87 27.45 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.273 -0.892 . . . . 0.0 109.264 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -71.27 148.16 47.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 109.953 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.91 166.66 24.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.349 -0.845 . . . . 0.0 109.511 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 110' ' ' VAL . 10.3 p -123.77 131.12 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.5 t -123.68 136.8 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 122.238 1.018 . . . . 0.0 109.065 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -101.93 112.92 25.72 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.124 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.503 2.221 0 O-C-N 120.829 -1.169 . . . . 0.0 108.246 177.691 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.392 0.615 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -141.11 161.41 37.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.363 -0.836 . . . . 0.0 108.86 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.39 134.99 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.353 -0.842 . . . . 0.0 109.334 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 56.97 36.54 27.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.59 -0.694 . . . . 0.0 109.539 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 58.33 45.83 16.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.522 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -144.71 119.86 5.92 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.999 -1.063 . . . . 0.0 108.679 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.58 115.99 4.19 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.537 1.492 . . . . 0.0 111.771 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.55 158.68 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.322 -0.861 . . . . 0.0 109.975 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.18 -42.09 99.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.7 t -162.85 157.64 21.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 109.1 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.2 156.04 40.86 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.999 -1.063 . . . . 0.0 109.712 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -90.82 129.71 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.228 -0.92 . . . . 0.0 109.53 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.1 mt -80.76 153.32 27.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 0.0 110.105 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.54 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.22 156.01 40.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.411 -0.805 . . . . 0.0 109.131 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -54.86 134.03 48.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.34 -0.85 . . . . 0.0 110.742 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.571 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 85.72 14.68 67.23 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 83.5 m-20 -91.66 152.4 20.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.135 -1.215 . . . . 0.0 109.711 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -114.02 131.15 56.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.602 -0.686 . . . . 0.0 109.24 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 144' ' ' LEU . 55.2 t -122.29 132.59 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -120.64 120.65 36.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.465 -0.772 . . . . 0.0 109.299 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.14 128.63 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.58 -0.7 . . . . 0.0 109.842 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 53.61 -128.9 40.35 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.1 -1.43 39.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.577 -0.955 . . . . 0.0 109.291 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -97.09 145.16 26.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.457 -0.777 . . . . 0.0 109.262 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -116.22 126.12 53.18 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' VAL . 5.2 mp -128.62 154.55 46.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.573 -0.705 . . . . 0.0 109.437 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.72 130.97 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 109.156 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -87.22 119.41 27.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 134' ' ' GLY . 95.9 mt -132.98 150.92 52.12 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.791 -0.568 . . . . 0.0 109.468 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 74.0 p . . . . . 0 N--CA 1.498 1.955 0 O-C-N 121.568 -0.707 . . . . 0.0 109.269 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 55' ' ' LEU . 10.9 mp -95.08 157.08 16.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.277 -1.131 . . . . 0.0 109.304 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.422 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -127.18 166.91 16.8 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -137.39 159.68 41.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.466 -0.771 . . . . 0.0 109.758 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.0 mt -112.35 135.47 53.0 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.36 137.48 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.57 0.7 . . . . 0.0 109.509 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.45 131.32 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.485 -0.759 . . . . 0.0 109.896 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -96.35 -32.53 12.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 109.172 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -132.21 155.35 48.41 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.762 0.791 . . . . 0.0 110.221 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.35 164.82 14.44 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.76 -15.6 40.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.686 2.257 . . . . 0.0 111.001 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -92.05 13.94 17.37 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.17 135.15 13.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.814 . . . . 0.0 110.369 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.73 -18.5 47.01 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -65.7 144.26 57.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -1.153 . . . . 0.0 109.824 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -138.79 148.72 44.15 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.358 -0.839 . . . . 0.0 109.904 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.99 137.29 50.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.544 -0.722 . . . . 0.0 109.175 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.429 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 40.8 tp -98.76 128.89 45.14 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.339 -0.85 . . . . 0.0 109.794 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.5 mt -85.97 78.91 9.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 108.986 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -98.21 10.89 39.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.469 -0.769 . . . . 0.0 109.074 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -125.11 148.43 48.55 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.5 -0.75 . . . . 0.0 109.817 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.98 95.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.542 -0.724 . . . . 0.0 109.91 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.53 126.15 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.465 -0.772 . . . . 0.0 109.058 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.5 m -123.85 119.45 29.72 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.626 -0.671 . . . . 0.0 109.249 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 m -82.86 153.87 24.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 109.482 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.22 177.2 4.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.578 -0.701 . . . . 0.0 109.984 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.94 -129.1 20.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -98.99 122.03 41.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.347 -1.09 . . . . 0.0 110.241 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.533 ' ND1' ' OG ' ' A' ' 85' ' ' SER . 4.8 t-80 -174.15 94.63 0.32 Allowed Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 38.4 Cg_exo -53.87 150.78 28.79 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.504 2.136 . . . . 0.0 112.995 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 1.2 m-20 77.24 -19.12 0.45 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.533 ' OG ' ' ND1' ' A' ' 82' ' ' HIS . 11.2 m -74.69 148.01 40.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.825 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 71' ' ' LEU . 34.2 t70 -62.92 -46.35 88.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.445 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -100.99 112.0 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.84 . . . . 0.0 109.348 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 22.9 p90 -130.91 90.13 2.85 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.3 94.94 7.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.419 -0.801 . . . . 0.0 109.063 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 43.7 t0 -87.02 98.94 11.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.459 -0.776 . . . . 0.0 109.413 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 64.5 m-20 -158.32 172.88 17.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 109.586 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.77 -44.67 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.506 -0.746 . . . . 0.0 109.818 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.6 p -78.28 -171.0 2.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.992 -1.068 . . . . 0.0 110.509 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 t 62.5 115.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.618 0.723 . . . . 0.0 109.9 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 p -69.84 170.71 10.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.6 -0.687 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -58.19 -32.99 68.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.291 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.51 59.8 1.55 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -63.55 -40.16 96.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.513 -0.742 . . . . 0.0 109.262 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.4 156.0 39.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.075 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -137.03 140.6 42.21 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.6 146.87 27.91 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -136.18 147.24 47.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.285 -0.884 . . . . 0.0 109.817 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.406 HD13 ' CZ ' ' A' ' 108' ' ' PHE . 55.5 tp -101.97 127.25 48.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.611 -0.681 . . . . 0.0 109.407 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -157.29 144.41 18.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.488 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 56.36 35.12 25.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.736 -0.603 . . . . 0.0 109.704 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 58.14 31.99 21.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.492 -0.755 . . . . 0.0 109.748 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -142.63 143.13 32.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.363 -0.835 . . . . 0.0 109.455 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.406 ' CZ ' HD13 ' A' ' 103' ' ' LEU . 64.8 m-85 -92.45 149.16 21.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 109.64 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -144.11 170.75 15.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.351 -0.843 . . . . 0.0 109.554 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 110' ' ' VAL . 14.6 p -125.79 131.04 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.6 t -126.95 130.52 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -103.38 128.55 50.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.568 -0.708 . . . . 0.0 109.509 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.907 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -124.76 157.29 36.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.67 -0.644 . . . . 0.0 109.542 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.82 134.55 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.509 0.671 . . . . 0.0 109.939 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 47.47 -108.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.759 -0.588 . . . . 0.0 109.934 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -128.32 17.13 6.56 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.611 -0.681 . . . . 0.0 109.329 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -124.32 83.31 57.09 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.524 -0.735 . . . . 0.0 109.449 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.81 136.4 75.13 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.609 2.206 . . . . 0.0 112.466 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.9 m -151.37 159.28 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.188 -0.945 . . . . 0.0 110.071 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -62.87 -43.66 98.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.503 -0.748 . . . . 0.0 109.584 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.6 m -135.85 151.25 49.84 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.324 -0.86 . . . . 0.0 109.223 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.73 152.45 35.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.095 -1.003 . . . . 0.0 110.128 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.6 t -95.95 132.14 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.744 . . . . 0.0 109.317 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.52 146.56 40.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 109.769 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.493 ' H ' ' HB2' ' A' ' 135' ' ' ASP . . . -135.43 153.49 51.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.702 . . . . 0.0 109.517 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -45.41 104.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.74 . . . . 0.0 110.591 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.32 44.52 4.03 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.493 ' HB2' ' H ' ' A' ' 132' ' ' ALA . 15.1 t0 -87.87 163.51 16.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.213 -1.169 . . . . 0.0 109.656 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -113.35 116.99 30.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -124.62 133.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -132.51 118.96 19.92 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.0 128.22 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.589 -0.694 . . . . 0.0 109.961 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 53.52 -128.99 40.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -95.72 -9.76 31.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.485 -1.009 . . . . 0.0 109.019 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -94.45 142.68 27.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -118.16 130.53 56.16 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.19 149.26 46.55 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.622 -0.674 . . . . 0.0 109.785 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.4 p -124.94 136.88 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 77.0 t80 -83.01 117.66 22.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 70.7 mt -135.34 146.53 48.5 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.419 0.628 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.829 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.586 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 55' ' ' LEU . 7.5 mp -105.27 143.23 33.73 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.417 -1.049 . . . . 0.0 110.054 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.22 159.36 42.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -137.64 163.35 31.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.461 -0.774 . . . . 0.0 109.786 -179.207 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -120.14 136.49 54.59 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.8 t -123.11 133.47 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.571 0.701 . . . . 0.0 109.989 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.96 113.43 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.533 -0.729 . . . . 0.0 109.57 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -65.81 -45.6 81.75 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.589 -0.694 . . . . 0.0 109.555 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -156.95 144.43 18.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . 157.2 -176.62 34.36 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -54.4 -38.79 89.4 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.993 2.462 . . . . 0.0 112.004 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -106.17 22.32 15.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . -39.69 107.62 0.07 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.789 -0.569 . . . . 0.0 110.427 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.6 -20.59 3.1 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.2 p -69.06 158.09 35.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.042 -1.269 . . . . 0.0 110.977 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -143.44 158.14 43.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.472 -0.767 . . . . 0.0 109.713 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.62 143.75 50.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.713 . . . . 0.0 109.648 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.4 tp -108.42 126.54 53.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.9 mt -98.68 112.16 24.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.342 -0.849 . . . . 0.0 109.355 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 66.7 t0 -132.34 36.47 3.6 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -140.0 155.06 47.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.273 -0.892 . . . . 0.0 109.885 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.04 91.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.551 -0.718 . . . . 0.0 110.203 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -128.31 129.09 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.342 -0.849 . . . . 0.0 109.852 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.9 m -124.66 125.96 44.95 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.5 m -87.31 161.61 17.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 109.527 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 99' ' ' ALA . . . -120.41 152.54 37.78 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.621 -0.674 . . . . 0.0 109.962 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.5 -130.37 10.2 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.522 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 96.7 mtt180 -100.43 134.39 43.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -1.06 . . . . 0.0 110.043 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 50.6 m-70 -165.4 152.23 9.22 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.07 -15.88 47.78 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.126 1.884 . . . . 0.0 110.893 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 85' ' ' SER . 34.5 t70 -142.13 -124.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.564 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.445 ' H ' ' CG ' ' A' ' 84' ' ' ASP . 3.5 m 59.02 138.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.765 0.793 . . . . 0.0 110.179 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.18 -41.13 99.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.459 -0.776 . . . . 0.0 109.87 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -88.11 120.47 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -129.97 86.75 2.44 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.593 -0.692 . . . . 0.0 109.208 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.9 mt -96.52 99.63 11.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.287 -0.883 . . . . 0.0 109.163 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -90.76 94.92 9.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -153.75 152.52 30.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.282 -0.886 . . . . 0.0 109.805 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 93' ' ' THR . 13.6 p -66.42 -34.72 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.401 ' N ' HG13 ' A' ' 92' ' ' VAL . 42.0 p -64.97 -31.42 72.64 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.858 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.4 t -98.16 126.26 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.111 -0.993 . . . . 0.0 110.196 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.9 t -76.58 168.52 19.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 110.242 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -60.84 -42.87 98.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.452 -0.78 . . . . 0.0 109.819 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -124.06 54.31 1.35 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.42 -0.8 . . . . 0.0 109.08 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.01 -41.72 97.37 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.557 -0.714 . . . . 0.0 109.551 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -151.73 157.44 42.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.05 -1.031 . . . . 0.0 109.971 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -136.11 149.18 48.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -112.14 144.03 42.2 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -132.86 138.18 46.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.537 -0.727 . . . . 0.0 109.247 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD1' ' O ' ' A' ' 107' ' ' GLU . 39.3 tp -88.99 129.79 35.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.44 -0.787 . . . . 0.0 109.997 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -169.54 158.66 7.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.402 -0.811 . . . . 0.0 108.928 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 59.24 31.81 21.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.591 -0.693 . . . . 0.0 109.652 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 52.47 32.53 11.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.444 -0.785 . . . . 0.0 109.607 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.555 ' O ' ' CG ' ' A' ' 108' ' ' PHE . 77.3 mm-40 -143.75 -119.71 0.09 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.322 -0.861 . . . . 0.0 108.852 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 107' ' ' GLU . 56.5 m-85 -162.92 150.98 13.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 109.222 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -137.26 151.2 48.43 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 110' ' ' VAL . 13.7 p -123.08 131.62 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.17 131.08 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.478 0.656 . . . . 0.0 109.31 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.484 ' OD2' ' N ' ' A' ' 119' ' ' THR . 89.2 m-20 -90.78 147.08 23.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.794 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.373 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 120' ' ' TYR . 33.4 m . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.101 0.476 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.583 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 1.6 m-85 -127.22 138.84 53.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.598 -0.688 . . . . 0.0 109.452 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.9 134.24 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 47.76 -171.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.433 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -65.4 -18.82 65.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.2 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -104.99 104.47 46.88 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.568 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.84 142.13 28.01 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.043 1.828 . . . . 0.0 112.447 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 129' ' ' ALA . 3.8 m -139.6 163.09 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.252 -0.905 . . . . 0.0 110.454 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -66.76 -38.58 86.88 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.1 p -158.45 160.17 36.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.981 -1.074 . . . . 0.0 109.8 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -169.05 164.3 11.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.061 -1.025 . . . . 0.0 110.315 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.65 130.46 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.583 -0.698 . . . . 0.0 109.447 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.97 150.06 34.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 110.731 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.54 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -147.05 152.18 38.12 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.735 . . . . 0.0 109.358 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -55.52 134.36 50.72 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.669 0.747 . . . . 0.0 111.183 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.479 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 87.5 13.69 64.96 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 84.4 m-20 -89.99 163.88 14.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.253 -1.145 . . . . 0.0 110.17 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -121.12 132.95 55.16 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.58 131.67 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -114.53 119.02 35.41 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.1 mm -111.66 124.16 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.654 0.74 . . . . 0.0 109.638 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.72 -124.6 7.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -96.56 -1.9 46.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.515 -0.991 . . . . 0.0 108.59 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -95.51 142.48 27.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.575 -0.703 . . . . 0.0 109.847 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -107.44 133.74 51.5 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.637 -0.664 . . . . 0.0 109.882 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -138.34 161.14 37.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.422 -0.799 . . . . 0.0 109.132 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.95 132.39 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -90.03 117.56 28.92 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.479 HD23 ' H ' ' A' ' 134' ' ' GLY . 97.1 mt -134.86 163.64 29.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.716 -0.615 . . . . 0.0 110.125 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.633 -0.667 . . . . 0.0 109.897 -179.576 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.67 151.6 42.93 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.446 -1.032 . . . . 0.0 109.847 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.84 156.19 42.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.42 153.55 49.58 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.98 0.895 . . . . 0.0 110.13 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.63 134.9 54.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -122.97 135.36 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.875 0.845 . . . . 0.0 109.902 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.37 135.6 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.676 0.75 . . . . 0.0 110.101 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -84.65 -74.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.399 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.685 HH21 ' NH1' ' A' ' 143' ' ' ARG . 88.2 mtm180 -129.11 147.65 50.99 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.433 -0.792 . . . . 0.0 110.0 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.97 177.66 26.78 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -65.83 -19.04 58.93 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.664 2.243 . . . . 0.0 110.922 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 66' ' ' ALA . 35.5 m120 -84.47 -80.77 0.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.875 . . . . 0.0 109.508 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 58.8 131.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.974 0.892 . . . . 0.0 110.901 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.62 41.43 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.8 m -69.87 146.3 51.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -1.145 . . . . 0.0 111.011 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -145.5 156.53 43.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 109.786 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -129.54 144.35 51.23 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.5 tp -104.06 127.94 51.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.685 -0.634 . . . . 0.0 109.301 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -100.07 74.04 1.76 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.025 -1.047 . . . . 0.0 109.177 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -94.67 3.87 54.54 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -106.6 153.07 22.89 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.281 -0.887 . . . . 0.0 110.059 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.06 94.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.454 -0.779 . . . . 0.0 109.808 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.2 mt -125.55 126.86 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 86' ' ' ASP . 96.6 m -126.46 120.66 30.31 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 p -84.76 166.49 16.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.962 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.38 170.89 7.64 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.932 0.872 . . . . 0.0 110.215 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.29 -131.3 29.91 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -110.77 130.65 55.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -1.06 . . . . 0.0 110.104 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -170.08 136.14 1.27 Allowed Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -42.57 -58.47 1.26 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.485 2.123 . . . . 0.0 112.653 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -96.1 92.72 6.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.935 . . . . 0.0 109.88 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.48 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 82.9 p -171.13 121.09 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 108.972 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.466 ' H ' HG23 ' A' ' 77' ' ' THR . 59.3 m-20 -68.1 -34.32 76.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.421 -0.799 . . . . 0.0 109.298 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.94 130.19 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.861 -1.149 . . . . 0.0 109.761 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 62.4 m-85 -129.07 89.33 2.85 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.427 -0.796 . . . . 0.0 109.401 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.7 mt -101.18 103.35 14.39 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -92.52 87.66 6.05 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.626 0.727 . . . . 0.0 109.881 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.46 ' OD2' ' CZ ' ' A' ' 142' ' ' PHE . 65.2 m-20 -150.22 149.53 30.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.963 . . . . 0.0 109.757 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.2 m -72.79 -26.27 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.733 0.778 . . . . 0.0 109.568 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.2 p -71.66 -17.21 62.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 109.382 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.0 t -110.94 126.78 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.325 -0.859 . . . . 0.0 109.415 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 p -77.08 168.63 19.76 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.797 0.808 . . . . 0.0 110.667 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -63.67 -38.08 89.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.477 -0.764 . . . . 0.0 109.878 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -129.97 50.56 2.17 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.117 -0.989 . . . . 0.0 109.115 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -62.63 -40.8 98.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.078 -1.014 . . . . 0.0 108.969 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.99 159.89 43.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.898 -1.126 . . . . 0.0 110.107 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -134.55 150.53 50.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.498 -0.751 . . . . 0.0 109.436 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.27 140.05 48.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.575 -0.703 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -134.56 136.86 43.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.433 -0.792 . . . . 0.0 109.189 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 38.5 tp -102.63 127.68 49.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -155.66 143.74 19.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.19 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 56.24 39.73 30.15 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.547 0.689 . . . . 0.0 110.135 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 55.22 31.79 17.2 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.597 0.713 . . . . 0.0 109.382 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -139.79 130.96 26.5 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.237 -0.914 . . . . 0.0 109.753 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -83.62 146.27 28.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -147.58 167.15 25.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.152 -0.967 . . . . 0.0 109.379 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.21 135.59 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.9 t -125.63 130.84 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 119' ' ' THR . 15.0 m-20 -95.23 134.35 38.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.497 1.908 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.281 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.508 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 29.0 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.602 0.715 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -127.89 145.34 50.98 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.786 . . . . 0.0 109.379 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.452 HG22 ' N ' ' A' ' 122' ' ' ASN . 9.4 p -109.59 157.05 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.847 0.832 . . . . 0.0 109.752 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.452 ' N ' HG22 ' A' ' 121' ' ' VAL . 6.8 m120 -53.21 -39.6 63.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.828 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -57.41 -83.41 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.941 -1.099 . . . . 0.0 109.631 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -143.35 147.39 39.94 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.076 -1.015 . . . . 0.0 109.553 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.18 120.73 8.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.603 2.202 . . . . 0.0 111.894 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.69 163.18 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.186 -0.946 . . . . 0.0 110.203 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 128' ' ' SER . 47.8 p-10 -66.94 -33.03 74.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.55 -0.719 . . . . 0.0 109.487 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.548 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 86.4 p -152.23 160.19 43.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.047 . . . . 0.0 109.278 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.39 156.51 30.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.029 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.1 130.15 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.491 -0.755 . . . . 0.0 109.941 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.6 mt -76.49 151.38 36.45 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.849 0.833 . . . . 0.0 110.209 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.553 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.77 155.71 39.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.507 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -51.33 124.02 10.91 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.921 0.867 . . . . 0.0 110.972 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.07 16.22 59.71 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.553 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 28.9 m-20 -87.75 155.48 19.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.925 -1.338 . . . . 0.0 110.565 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 56.6 mp0 -113.61 128.2 56.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.661 -0.649 . . . . 0.0 109.499 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 144' ' ' LEU . 54.8 t -125.45 131.48 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.403 ' O ' ' NE2' ' A' ' 138' ' ' GLN . 4.9 pp0? -123.2 132.83 54.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.706 -0.621 . . . . 0.0 109.776 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.18 117.08 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.668 0.747 . . . . 0.0 109.052 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 61.26 -127.84 43.07 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -93.27 -5.33 50.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -1.161 . . . . 0.0 109.02 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.46 ' CZ ' ' OD2' ' A' ' 91' ' ' ASP . 57.8 m-85 -96.13 133.7 40.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.184 -0.947 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.685 ' NH1' HH21 ' A' ' 62' ' ' ARG . 83.3 mtp180 -103.27 139.4 38.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.592 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 137' ' ' VAL . 4.7 mp -135.51 166.47 23.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 109.47 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.0 p -128.69 133.67 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.652 0.739 . . . . 0.0 109.567 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -96.1 115.52 27.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -0.828 . . . . 0.0 109.249 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.57 147.88 51.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.626 0.727 . . . . 0.0 109.668 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.541 0.686 . . . . 0.0 109.632 -179.755 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.582 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -122.37 142.97 49.95 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.558 -0.966 . . . . 0.0 109.223 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.13 155.18 41.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -127.38 157.12 40.82 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.186 0.517 . . . . 0.0 109.733 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.4 mt -117.04 128.7 55.42 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.01 134.08 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.642 0.734 . . . . 0.0 109.538 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.6 t -78.36 111.69 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.677 -0.64 . . . . 0.0 109.898 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -64.88 -43.62 92.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.577 -0.702 . . . . 0.0 110.219 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -137.21 151.77 49.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.534 -0.729 . . . . 0.0 110.287 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.06 172.29 22.61 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.21 -20.83 55.81 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.956 2.437 . . . . 0.0 112.006 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' O ' ' C ' ' A' ' 66' ' ' ALA . 93.1 m-20 -98.65 -35.74 10.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.446 -0.784 . . . . 0.0 109.357 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . 35.42 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.313 0.578 . . . . 0.0 110.789 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.48 -15.13 3.66 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.9 m -62.86 144.49 56.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -1.008 . . . . 0.0 110.766 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -137.57 156.04 48.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.603 -0.686 . . . . 0.0 109.354 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -126.32 146.75 49.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.626 -0.671 . . . . 0.0 109.315 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.665 HD13 ' N ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -104.78 126.56 51.97 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 71' ' ' LEU . 79.3 mt -100.53 124.47 46.12 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.452 0.644 . . . . 0.0 109.669 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -154.39 56.63 0.7 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.429 ' CD ' ' N ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -161.08 175.57 12.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.491 -0.756 . . . . 0.0 109.547 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.13 -65.53 1.0 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.495 -0.753 . . . . 0.0 110.297 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mm -108.56 124.56 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.765 . . . . 0.0 110.212 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.411 ' OG1' ' CD ' ' A' ' 74' ' ' GLN . 31.5 m -127.97 127.08 42.62 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 p -84.65 165.02 18.27 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.562 -0.711 . . . . 0.0 109.936 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 98' ' ' HIS . . . -109.79 164.93 12.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.631 -0.668 . . . . 0.0 110.026 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.445 ' N ' ' NE2' ' A' ' 98' ' ' HIS . . . 70.99 -127.73 15.51 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.535 ' O ' ' ND1' ' A' ' 82' ' ' HIS . 96.9 mtt180 -101.87 137.01 40.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.399 -1.059 . . . . 0.0 110.491 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 173.13 153.79 0.25 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.3 144.41 51.07 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.733 2.289 . . . . 0.0 113.059 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 55.5 t0 57.09 28.6 15.17 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.451 -0.781 . . . . 0.0 109.348 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 18.3 t -98.19 119.81 37.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.34 -0.85 . . . . 0.0 109.572 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -65.03 -36.45 84.41 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.42 -0.8 . . . . 0.0 109.318 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -78.24 128.45 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.892 . . . . 0.0 110.212 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 91.6 m-85 -126.85 86.98 2.58 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.8 mt -108.21 106.45 16.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.619 0.723 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 55.6 t0 -86.51 90.82 8.35 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.501 ' OD2' ' CE2' ' A' ' 142' ' ' PHE . 71.1 m-20 -151.33 130.66 12.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.876 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.14 -24.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.4 p -75.18 -13.81 60.49 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.554 -0.717 . . . . 0.0 109.182 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 95' ' ' SER . 89.5 t -101.75 -15.1 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 94' ' ' VAL . 79.4 p 50.23 174.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.592 0.71 . . . . 0.0 110.792 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -59.88 -65.66 0.64 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 109.935 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -102.17 134.53 45.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.648 -0.658 . . . . 0.0 109.779 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.484 ' CE1' ' HB1' ' A' ' 79' ' ' ALA . 4.8 p80 -154.3 -35.42 0.1 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -151.67 158.52 43.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.823 . . . . 0.0 109.928 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -137.16 151.2 48.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.653 -0.654 . . . . 0.0 109.67 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.5 142.63 43.53 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -134.65 141.03 46.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.796 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.9 tp -102.44 127.13 49.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.683 -0.635 . . . . 0.0 109.32 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 106' ' ' ASN . 80.5 tt0 -155.99 -70.69 0.11 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.557 -0.714 . . . . 0.0 109.355 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -72.05 32.71 0.06 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.497 -0.752 . . . . 0.0 109.529 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 104' ' ' GLU . 16.2 p30 44.02 30.19 0.4 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.658 0.742 . . . . 0.0 109.53 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 108' ' ' PHE . 96.1 mt-10 -144.47 10.24 1.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 107' ' ' GLU . 94.1 m-85 58.17 144.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.255 0.55 . . . . 0.0 110.494 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -133.76 163.7 28.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.3 132.18 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.737 -0.602 . . . . 0.0 109.487 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.7 t -128.65 133.6 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.98 114.67 21.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.317 -0.864 . . . . 0.0 109.487 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 111.006 -179.049 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 121.334 0.588 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.423 ' OH ' ' NH1' ' A' ' 123' ' ' ARG . 31.4 p90 -141.54 157.98 44.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.513 -0.742 . . . . 0.0 109.12 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 121' ' ' VAL . 9.1 p -121.02 128.86 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.451 0.643 . . . . 0.0 109.888 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 54.35 38.54 29.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.65 -0.656 . . . . 0.0 109.614 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.423 ' NH1' ' OH ' ' A' ' 120' ' ' TYR . 31.0 mmt180 60.47 44.01 12.45 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.436 0.636 . . . . 0.0 110.21 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -147.63 87.21 6.01 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.522 -0.736 . . . . 0.0 109.127 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.4 130.45 38.61 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.378 2.052 . . . . 0.0 112.076 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.5 m -147.34 154.4 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.326 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.89 -39.81 94.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.6 p -157.26 157.35 34.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.229 -0.919 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.37 149.99 14.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.288 -0.883 . . . . 0.0 109.806 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.65 135.98 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.501 -0.749 . . . . 0.0 110.434 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.28 148.89 37.25 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.358 -0.839 . . . . 0.0 109.856 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.03 154.72 44.28 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.571 0.701 . . . . 0.0 109.773 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -55.97 115.07 2.19 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.581 0.705 . . . . 0.0 110.751 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 146' ' ' PHE . . . 84.13 15.34 69.78 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 136' ' ' GLU . 67.7 t0 -64.23 145.74 55.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -1.211 . . . . 0.0 109.996 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 135' ' ' ASP . 98.4 mt-10 -93.49 122.12 35.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 52.8 t -122.05 132.89 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -122.67 124.92 44.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 141' ' ' LYS . 96.6 mt -124.42 129.95 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.307 0.575 . . . . 0.0 109.947 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.69 -88.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 139' ' ' ILE . 63.3 mttp -141.88 -4.33 1.07 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.461 -1.023 . . . . 0.0 108.624 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.501 ' CE2' ' OD2' ' A' ' 91' ' ' ASP . 62.2 m-85 -96.94 140.49 31.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.767 . . . . 0.0 109.924 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -105.0 129.48 53.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.658 -0.651 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.07 149.68 50.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.22 129.06 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.6 0.714 . . . . 0.0 109.119 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 134' ' ' GLY . 76.0 t80 -90.08 127.67 36.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.764 -0.585 . . . . 0.0 109.582 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.911 HD23 ' N ' ' A' ' 147' ' ' LEU . 0.6 OUTLIER -143.41 174.95 10.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.823 0.821 . . . . 0.0 110.06 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.525 0.678 . . . . 0.0 109.482 179.841 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.479 ' O ' HD12 ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.421 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 54' ' ' GLY . 7.2 mp -116.52 160.75 20.17 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.509 -0.995 . . . . 0.0 109.526 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.81 154.93 51.04 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.35 152.66 48.67 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.454 -0.779 . . . . 0.0 109.616 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.0 mt -113.7 134.41 54.76 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.8 134.98 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.62 110.84 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.576 -0.703 . . . . 0.0 109.632 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -64.55 -44.98 89.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.861 . . . . 0.0 109.68 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -141.88 148.34 38.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.363 -0.835 . . . . 0.0 109.898 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.52 178.69 27.43 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.68 -40.48 84.22 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.326 2.017 . . . . 0.0 111.497 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -114.02 48.24 1.11 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.09 95.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.512 -0.743 . . . . 0.0 109.387 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.53 -17.04 0.58 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.2 t -62.56 150.23 41.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.492 -1.005 . . . . 0.0 109.513 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -130.3 156.2 45.05 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.633 -0.667 . . . . 0.0 109.292 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.17 146.07 50.83 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.533 -0.73 . . . . 0.0 109.286 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 tp -105.66 125.36 50.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.642 -0.661 . . . . 0.0 109.557 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.54 77.85 2.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.406 -0.809 . . . . 0.0 109.0 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.01 12.85 18.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 0.0 109.405 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -126.51 140.63 52.31 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.93 88.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.521 -0.737 . . . . 0.0 110.446 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 mm -106.18 118.47 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.303 -0.873 . . . . 0.0 109.764 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.9 m -123.22 122.85 39.41 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.5 t -87.65 167.3 14.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.175 -0.953 . . . . 0.0 109.543 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 99' ' ' ALA . . . -122.51 146.88 46.99 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.556 -0.715 . . . . 0.0 109.097 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.71 -125.22 8.01 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 99.8 mtt180 -103.32 133.33 48.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.436 -1.037 . . . . 0.0 110.556 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 0.7 OUTLIER 175.11 120.12 0.12 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.08 -14.76 23.44 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.59 1.526 . . . . 0.0 111.287 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 66.5 t0 -96.74 -24.13 16.09 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.727 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.5 t -74.55 139.92 44.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.446 -0.784 . . . . 0.0 110.659 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.59 -41.29 96.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 109.687 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.74 129.51 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.344 -0.848 . . . . 0.0 110.303 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CZ ' ' OD2' ' A' ' 90' ' ' ASP . 84.4 t80 -129.25 84.84 2.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.7 mt -108.54 109.34 20.55 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.559 -0.713 . . . . 0.0 109.916 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.517 ' OD2' ' CZ ' ' A' ' 88' ' ' PHE . 97.9 m-20 -99.95 -93.38 0.27 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.511 -0.743 . . . . 0.0 109.352 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.468 ' CG ' ' CE1' ' A' ' 142' ' ' PHE . 1.5 p30 39.75 -165.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.645 0.736 . . . . 0.0 110.783 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.9 m -71.84 161.55 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 110.057 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.5 p 54.56 -139.77 0.98 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.279 0.562 . . . . 0.0 110.676 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.2 t 42.72 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.493 -0.754 . . . . 0.0 109.649 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -69.36 173.33 5.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.47 -0.769 . . . . 0.0 110.816 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -60.39 -43.91 96.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.48 -0.762 . . . . 0.0 109.358 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -123.23 64.14 1.0 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.36 -35.08 25.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.536 -0.728 . . . . 0.0 109.69 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -150.45 149.62 30.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 109.803 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -141.49 134.23 28.68 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -100.98 145.8 28.23 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.507 -0.746 . . . . 0.0 109.786 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -131.63 132.18 43.81 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.9 tp -90.75 130.57 36.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.307 -0.871 . . . . 0.0 109.622 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 106' ' ' ASN . 49.1 tp10 -131.97 140.81 49.1 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.582 -0.699 . . . . 0.0 109.319 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 51.63 -85.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.469 -0.769 . . . . 0.0 110.085 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 104' ' ' GLU . 16.9 t-20 -155.75 20.57 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.456 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -134.02 139.95 46.37 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.548 -0.72 . . . . 0.0 109.373 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -77.34 147.13 36.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.513 -0.742 . . . . 0.0 109.981 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -124.85 160.89 27.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.33 134.15 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.8 t -127.33 135.48 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 119' ' ' THR . 50.2 t0 -84.0 111.73 19.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.188 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.425 -0.797 . . . . 0.0 109.304 -179.874 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.444 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 23.8 m . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.107 0.479 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -132.9 157.62 44.63 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.462 -0.774 . . . . 0.0 109.223 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 121' ' ' VAL . 8.8 p -118.94 128.42 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.561 -0.712 . . . . 0.0 109.375 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 54.55 38.24 29.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.918 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 63.1 46.69 4.53 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.506 0.67 . . . . 0.0 109.833 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -148.6 88.98 5.15 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.091 -1.005 . . . . 0.0 109.24 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -55.06 132.35 51.8 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.226 1.951 . . . . 0.0 112.393 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.1 m -151.5 156.12 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.276 -0.89 . . . . 0.0 109.863 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.29 -40.63 96.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.824 . . . . 0.0 109.379 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.7 t -161.51 156.0 22.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.258 -0.901 . . . . 0.0 109.347 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.43 156.47 38.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.6 t -88.6 130.19 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.342 -0.849 . . . . 0.0 109.247 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.52 149.2 34.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.838 . . . . 0.0 110.218 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.526 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.41 163.81 37.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.416 -0.802 . . . . 0.0 109.267 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.421 ' ND2' ' OG1' ' A' ' 148' ' ' THR . 46.2 m-80 -56.53 138.49 51.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.285 -0.884 . . . . 0.0 110.43 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.549 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 80.36 13.55 81.6 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 27.5 m-20 -83.03 145.15 29.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.25 . . . . 0.0 109.623 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -112.87 126.53 55.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.42 132.47 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.6 -0.688 . . . . 0.0 109.333 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -119.42 127.8 53.44 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.57 127.46 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.531 0.681 . . . . 0.0 110.052 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 54.51 -104.65 0.27 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -116.78 -24.85 7.52 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.616 -0.932 . . . . 0.0 109.465 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.468 ' CE1' ' CG ' ' A' ' 91' ' ' ASP . 25.2 m-85 -76.33 142.77 41.14 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.347 -0.846 . . . . 0.0 110.077 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -107.85 137.08 46.5 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -136.54 155.49 49.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.389 -0.819 . . . . 0.0 109.415 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 145' ' ' VAL . 12.3 p -119.82 131.14 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -94.8 120.54 35.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.397 -0.814 . . . . 0.0 109.985 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.549 HD23 ' H ' ' A' ' 134' ' ' GLY . 16.3 mt -134.18 150.43 51.08 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.421 ' OG1' ' ND2' ' A' ' 133' ' ' ASN . 4.5 p . . . . . 0 N--CA 1.498 1.929 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.9 mt -124.6 145.96 49.32 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.654 -0.91 . . . . 0.0 110.36 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.37 166.51 31.64 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.588 0.708 . . . . 0.0 109.85 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -125.83 146.19 49.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.843 0.83 . . . . 0.0 110.236 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.6 mt -125.43 140.9 52.39 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.672 0.749 . . . . 0.0 109.575 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -140.99 143.37 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.745 0.784 . . . . 0.0 110.341 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.6 t -73.76 131.09 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.792 0.806 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -95.22 -32.0 13.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -151.71 140.55 20.95 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.781 0.8 . . . . 0.0 109.966 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.37 167.48 11.66 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.05 -17.71 40.67 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.823 2.349 . . . . 0.0 111.384 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.38 19.52 13.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.43 143.05 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.865 0.84 . . . . 0.0 110.369 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.96 -14.28 61.6 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.4 t -68.16 138.61 55.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.644 -0.915 . . . . 0.0 110.892 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -134.52 143.48 47.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.74 0.781 . . . . 0.0 110.231 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -128.91 136.58 50.6 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.633 0.73 . . . . 0.0 109.652 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.513 HD23 ' C ' ' A' ' 71' ' ' LEU . 6.6 tt -110.25 123.52 49.93 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.885 0.85 . . . . 0.0 109.74 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 71' ' ' LEU . 57.5 mt -90.3 113.38 25.22 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.552 0.691 . . . . 0.0 109.59 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -147.21 70.88 1.2 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.674 0.75 . . . . 0.0 109.197 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 75' ' ' ALA . 54.3 tp60 -171.07 -121.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.651 -0.656 . . . . 0.0 109.763 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 74' ' ' GLN . . . -167.14 127.6 1.51 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.751 0.786 . . . . 0.0 109.805 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mm 63.57 82.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.632 0.729 . . . . 0.0 109.385 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.4 m -99.41 123.38 43.64 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.781 0.801 . . . . 0.0 110.136 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.1 t -91.44 166.43 12.87 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.538 0.685 . . . . 0.0 109.411 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.54 154.95 26.27 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.774 0.797 . . . . 0.0 110.019 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 101.83 -118.97 6.31 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.551 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 84.9 mtp180 -124.08 130.62 52.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.78 -0.835 . . . . 0.0 110.352 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 3.1 m-70 176.3 149.37 0.31 Allowed Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.05 -30.99 20.09 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.88 2.386 . . . . 0.0 112.158 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -93.0 -0.25 57.25 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.0 t -94.74 118.93 32.53 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.717 0.77 . . . . 0.0 109.803 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.01 -39.94 94.17 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.335 0.588 . . . . 0.0 109.44 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.714 HD12 ' N ' ' A' ' 87' ' ' ILE . 1.9 mp -82.56 125.57 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.718 . . . . 0.0 109.987 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CE2' ' OD1' ' A' ' 90' ' ' ASP . 34.0 t80 -124.82 102.3 7.5 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.811 0.815 . . . . 0.0 108.922 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.8 mt -107.34 112.67 25.61 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.821 0.819 . . . . 0.0 110.038 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD1' ' CE2' ' A' ' 88' ' ' PHE . 99.9 m-20 -91.52 81.31 5.37 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.496 0.665 . . . . 0.0 109.435 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 92' ' ' VAL . 66.9 t0 -156.16 140.76 16.91 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.71 0.767 . . . . 0.0 110.071 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.542 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 33.4 m -67.62 -22.64 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.9 p -65.72 -29.08 69.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.575 -0.703 . . . . 0.0 109.165 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -103.34 128.84 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 121.887 0.851 . . . . 0.0 110.033 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 p -72.66 172.41 10.7 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.881 0.848 . . . . 0.0 111.03 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -59.19 -43.75 92.22 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.911 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.565 ' O ' ' N ' ' A' ' 99' ' ' ALA . 95.1 mtt-85 -108.29 -51.81 2.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 59.5 -72.56 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.423 0.63 . . . . 0.0 109.951 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -142.32 163.51 32.65 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.712 0.768 . . . . 0.0 109.919 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -132.03 146.11 51.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.803 0.811 . . . . 0.0 110.062 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.35 140.51 48.59 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.432 0.634 . . . . 0.0 109.392 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -128.1 142.91 51.07 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.805 0.812 . . . . 0.0 110.212 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.6 tp -103.56 123.1 46.31 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.548 0.69 . . . . 0.0 109.361 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -92.25 -127.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.444 0.64 . . . . 0.0 110.141 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.64 -40.8 92.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.805 -0.559 . . . . 0.0 109.641 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -174.82 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -140.91 136.59 32.42 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.653 0.74 . . . . 0.0 109.478 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -79.41 146.88 32.57 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.694 0.759 . . . . 0.0 110.228 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.26 160.87 31.63 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.426 0.631 . . . . 0.0 109.488 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -123.82 127.06 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.885 0.85 . . . . 0.0 109.595 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.74 133.95 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.685 0.755 . . . . 0.0 109.404 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -80.61 151.84 28.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.635 0.731 . . . . 0.0 110.451 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.812 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.914 0.864 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -138.97 160.71 39.11 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.379 0.609 . . . . 0.0 109.584 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 123' ' ' ARG . 10.4 p -105.92 128.24 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 121.858 0.837 . . . . 0.0 109.99 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 53.42 -83.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.321 0.581 . . . . 0.0 109.707 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 121' ' ' VAL . 64.3 ttt180 -156.91 42.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -147.64 85.15 6.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.94 133.95 61.36 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.44 2.093 . . . . 0.0 112.177 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -145.92 162.98 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.905 0.86 . . . . 0.0 110.574 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -65.44 -34.08 77.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.2 p -153.2 159.9 42.73 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.571 0.7 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.62 155.91 30.92 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.709 0.766 . . . . 0.0 110.388 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.3 t -105.78 130.12 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.852 0.834 . . . . 0.0 109.641 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -75.79 146.35 40.04 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.625 0.726 . . . . 0.0 109.835 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.546 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.58 155.35 40.15 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.019 0.914 . . . . 0.0 110.289 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -48.41 122.93 5.88 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.937 0.875 . . . . 0.0 110.755 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.527 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 88.62 18.79 54.11 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 16.1 m-20 -87.66 151.93 22.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.694 -0.886 . . . . 0.0 110.301 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -114.86 129.92 56.79 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.734 0.778 . . . . 0.0 109.721 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.64 131.03 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.709 0.766 . . . . 0.0 109.133 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -117.26 126.69 53.15 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.795 0.807 . . . . 0.0 109.883 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.18 129.1 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.573 0.701 . . . . 0.0 109.619 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 48.0 -107.28 0.23 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -111.31 -21.05 12.05 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.51 148.14 33.56 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.684 0.754 . . . . 0.0 110.76 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -115.33 126.98 55.11 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.718 0.77 . . . . 0.0 109.453 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.11 155.92 44.7 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.625 0.726 . . . . 0.0 110.173 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.9 p -126.75 135.37 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.715 0.769 . . . . 0.0 109.763 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -92.73 118.77 31.42 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.861 0.838 . . . . 0.0 109.673 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 134' ' ' GLY . 93.0 mt -134.58 148.83 50.53 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.627 0.727 . . . . 0.0 109.498 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.624 0.726 . . . . 0.0 109.759 179.805 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.905 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.25 146.1 46.39 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.396 -1.061 . . . . 0.0 109.942 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.58 157.15 40.63 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 pp -141.49 157.67 44.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.225 -0.922 . . . . 0.0 109.673 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mp -116.18 151.75 35.07 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.17 133.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 62' ' ' ARG . 53.7 t -67.37 134.59 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.409 -0.807 . . . . 0.0 110.398 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -112.23 50.72 0.84 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.654 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 3.6 tpt180 -120.42 173.43 7.15 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.72 -57.63 3.04 Favored Glycine 0 N--CA 1.49 2.241 0 O-C-N 120.92 -1.112 . . . . 0.0 111.443 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -85.07 12.67 3.0 Favored 'Trans proline' 0 N--CA 1.515 2.761 0 C-N-CA 123.917 3.078 . . . . 0.0 114.366 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.414 ' O ' HG11 ' A' ' 60' ' ' VAL . 57.4 t30 -148.62 17.08 1.02 Allowed 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.335 -1.478 . . . . 0.0 108.663 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . -77.78 153.39 32.92 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.382 0.611 . . . . 0.0 109.896 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.47 -21.63 43.34 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.7 m -66.17 141.24 58.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.29 -1.123 . . . . 0.0 109.263 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -133.81 146.95 51.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.679 -0.638 . . . . 0.0 109.359 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.18 102.24 4.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.41 -0.806 . . . . 0.0 108.878 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -85.63 137.72 32.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 109.4 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.3 mt -95.91 97.45 9.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.526 -0.734 . . . . 0.0 109.82 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 51.5 t0 -109.92 17.54 21.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -127.35 152.92 46.85 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.505 -0.747 . . . . 0.0 109.997 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.41 -47.89 83.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.636 -0.665 . . . . 0.0 110.452 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.24 126.12 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.299 -0.876 . . . . 0.0 109.618 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 92.6 m -121.96 120.95 35.92 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 p -85.29 163.13 18.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.387 -0.82 . . . . 0.0 109.853 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.58 177.83 4.5 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.478 -0.764 . . . . 0.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.88 -129.64 10.4 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.367 -0.92 . . . . 0.0 110.887 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.558 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 85.1 mtt85 -96.63 114.75 26.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.447 -1.031 . . . . 0.0 110.231 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 32.3 m-70 -170.58 80.33 0.57 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.81 -38.39 67.43 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.282 1.988 . . . . 0.0 111.266 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.56 -39.85 95.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.441 -0.787 . . . . 0.0 109.28 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 t -72.09 158.27 36.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.352 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -62.45 -40.55 96.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.514 -0.741 . . . . 0.0 109.883 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 93.2 mt -94.49 117.09 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.07 -1.019 . . . . 0.0 109.671 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 16.5 p90 -130.33 88.26 2.62 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.19 92.33 9.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.029 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -95.71 92.65 6.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.419 -0.801 . . . . 0.0 109.488 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -159.99 176.93 11.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.82 -44.38 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.312 -0.867 . . . . 0.0 109.994 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.6 p -71.61 173.6 7.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.63 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t 61.81 108.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.679 0.752 . . . . 0.0 109.707 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -61.1 -150.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.551 0.691 . . . . 0.0 110.752 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -60.31 -45.69 92.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.483 -0.76 . . . . 0.0 109.364 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 99' ' ' ALA . 36.4 ptt85 179.99 -54.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' A' ' 97' ' ' ARG . 46.8 p-80 43.09 15.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.675 -0.641 . . . . 0.0 110.141 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -154.7 143.13 20.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.861 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -149.42 147.67 28.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.34 143.31 39.02 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.51 -0.744 . . . . 0.0 109.547 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -128.71 137.59 51.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.655 -0.653 . . . . 0.0 109.509 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.2 tp -91.64 126.89 36.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.382 -0.824 . . . . 0.0 108.78 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 106' ' ' ASN . 83.7 tt0 -119.83 129.87 54.63 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.467 -0.771 . . . . 0.0 109.763 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 50.79 -86.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.518 -0.739 . . . . 0.0 109.957 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 104' ' ' GLU . 76.9 m-20 -148.35 23.6 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.171 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -134.97 139.05 44.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.698 . . . . 0.0 109.561 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -75.5 149.0 38.54 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.646 -0.659 . . . . 0.0 109.716 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -135.92 165.33 25.9 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 109.092 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.69 132.28 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -129.78 132.73 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 119' ' ' THR . 88.8 m-20 -103.71 139.28 39.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.432 -0.792 . . . . 0.0 109.391 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 113' ' ' VAL . 3.0 m . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.52 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 21.3 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.157 0.503 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -119.62 150.25 40.62 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.623 -0.673 . . . . 0.0 109.326 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.7 p -120.37 130.84 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.595 -0.69 . . . . 0.0 110.01 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 124' ' ' GLU . 91.0 m-20 45.58 -172.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.637 0.732 . . . . 0.0 110.781 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -59.67 -2.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.59 -0.694 . . . . 0.0 110.051 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 122' ' ' ASN . 27.1 mt-10 -109.6 95.16 18.49 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.421 -0.799 . . . . 0.0 109.436 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.28 127.82 8.54 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.834 1.69 . . . . 0.0 111.795 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 129' ' ' ALA . 35.5 m -139.04 162.25 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.309 -0.869 . . . . 0.0 110.363 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -74.66 -22.44 58.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.531 -0.731 . . . . 0.0 109.553 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.4 p -162.54 160.34 25.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.632 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -173.06 166.14 4.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.166 -0.959 . . . . 0.0 109.677 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.79 130.66 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.453 -0.779 . . . . 0.0 109.516 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.73 148.7 34.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 109.91 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.537 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -151.02 152.74 33.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 108.945 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -51.87 134.13 31.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.371 -0.831 . . . . 0.0 110.441 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.19 11.4 64.82 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 79.4 m-20 -89.09 148.64 23.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.269 -1.136 . . . . 0.0 109.724 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -112.22 128.06 56.14 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.93 130.6 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.645 -0.659 . . . . 0.0 109.301 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -126.01 122.45 35.9 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.595 -0.691 . . . . 0.0 109.214 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 95.4 mt -123.82 129.73 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.638 -0.664 . . . . 0.0 109.914 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.36 -108.02 2.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.527 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 88.7 tttt -126.16 -26.1 3.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.913 . . . . 0.0 109.255 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -74.34 146.58 42.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -103.84 139.7 38.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.493 -0.754 . . . . 0.0 109.269 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.53 137.43 40.26 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.814 . . . . 0.0 109.589 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 145' ' ' VAL . 12.8 p -109.49 130.18 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -89.72 111.45 22.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.923 . . . . 0.0 109.971 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.8 mt -140.12 159.85 41.26 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.612 0.72 . . . . 0.0 109.813 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.543 -0.723 . . . . 0.0 110.356 -179.345 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 72' ' ' LEU . 1.9 tp -149.95 141.65 23.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.92 -1.341 . . . . 0.0 109.237 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.17 165.93 23.64 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.55 0.69 . . . . 0.0 109.739 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.03 154.75 47.88 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.623 0.725 . . . . 0.0 109.744 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.3 mt -114.37 136.81 52.58 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.35 131.56 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.609 0.719 . . . . 0.0 109.782 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.0 t -73.21 133.63 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.593 0.711 . . . . 0.0 109.72 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -86.29 -74.02 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.906 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -121.61 149.24 43.45 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.757 0.789 . . . . 0.0 110.09 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.54 175.09 25.3 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.42 -18.43 43.87 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.864 2.376 . . . . 0.0 111.727 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' ALA . 92.5 m-20 -88.93 -74.93 0.45 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.186 -0.947 . . . . 0.0 109.38 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 60.59 132.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.473 -0.767 . . . . 0.0 110.521 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.99 -20.24 50.85 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 m -71.54 144.79 49.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -1.143 . . . . 0.0 110.777 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -146.69 151.66 37.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 109.64 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -130.32 145.66 51.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -109.66 146.25 35.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.563 -0.71 . . . . 0.0 109.22 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.453 ' O ' HD11 ' A' ' 55' ' ' LEU . 66.6 mt -97.65 115.82 28.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.882 . . . . 0.0 110.17 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -89.45 53.33 2.58 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.963 0.887 . . . . 0.0 108.693 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 43.31 -165.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.174 0.988 . . . . 0.0 111.199 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 59.95 -144.5 0.52 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.663 0.745 . . . . 0.0 110.479 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.12 127.21 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.734 -0.604 . . . . 0.0 109.5 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.6 m -120.24 120.58 36.51 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.2 p -83.03 162.29 21.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.429 -0.795 . . . . 0.0 109.885 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.73 -179.46 3.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.34 -0.85 . . . . 0.0 110.137 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.45 -124.17 28.91 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -105.62 127.26 52.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.43 -1.041 . . . . 0.0 109.963 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 83' ' ' PRO . 36.6 t-80 -173.94 135.09 0.62 Allowed Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.478 ' O ' ' ND1' ' A' ' 82' ' ' HIS . 49.3 Cg_endo -68.92 150.32 73.1 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.391 2.061 . . . . 0.0 113.394 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t0 65.24 -8.3 0.26 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.821 -0.549 . . . . 0.0 110.087 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 83' ' ' PRO . 46.7 t -73.84 133.98 43.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.991 -1.068 . . . . 0.0 110.191 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.26 -41.1 97.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.544 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.84 126.02 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.722 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -129.66 85.87 2.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.511 -0.743 . . . . 0.0 109.148 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.2 mt -104.83 93.66 4.85 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.455 -0.778 . . . . 0.0 109.331 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -99.96 83.34 2.7 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.526 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 24.3 p30 -155.4 172.57 17.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.127 -0.983 . . . . 0.0 109.958 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 93' ' ' THR . 5.3 t -62.81 169.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.534 -0.729 . . . . 0.0 110.703 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.499 ' N ' HG12 ' A' ' 92' ' ' VAL . 4.4 p 65.74 -7.38 0.36 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 92' ' ' VAL . 82.2 t -125.87 122.19 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.475 -0.766 . . . . 0.0 109.254 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.3 p -86.65 -162.09 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.824 0.821 . . . . 0.0 110.498 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -62.57 -38.65 90.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.837 . . . . 0.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -152.81 81.69 1.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.077 -1.015 . . . . 0.0 108.947 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -65.95 -39.76 90.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.737 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.62 160.97 36.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.841 . . . . 0.0 109.621 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -137.88 144.96 41.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.506 -0.746 . . . . 0.0 109.196 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.52 140.35 48.21 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -136.95 142.15 42.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.815 . . . . 0.0 109.625 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 53.8 tp -95.53 126.9 41.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.514 -0.742 . . . . 0.0 109.385 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -94.12 -128.46 0.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.236 -0.915 . . . . 0.0 110.012 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -64.48 -41.57 96.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.825 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -174.05 25.83 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.02 -1.05 . . . . 0.0 109.092 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -137.41 142.4 41.67 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.234 -0.917 . . . . 0.0 110.059 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -76.64 145.63 38.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.499 -0.75 . . . . 0.0 110.05 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -139.27 162.16 35.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.279 -0.888 . . . . 0.0 109.221 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.57 132.57 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.6 t -127.37 132.84 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.669 0.747 . . . . 0.0 109.475 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 1.5 m-20 -78.01 138.06 38.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.561 -0.712 . . . . 0.0 109.584 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.341 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.621 0.724 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -140.46 157.67 45.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.181 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 122' ' ' ASN . 7.6 p -107.29 156.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.69 -0.631 . . . . 0.0 109.638 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.446 ' N ' HG22 ' A' ' 121' ' ' VAL . 84.2 m-20 -41.23 -39.35 1.32 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.517 0.675 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -65.63 -90.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.984 . . . . 0.0 109.967 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -142.62 146.39 38.22 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.297 -0.877 . . . . 0.0 109.8 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.96 133.88 34.9 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.257 1.971 . . . . 0.0 112.636 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.6 m -144.24 157.31 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.082 -1.011 . . . . 0.0 110.64 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -72.96 -16.85 61.52 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.679 0.752 . . . . 0.0 109.049 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.6 p -158.61 161.23 37.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.968 . . . . 0.0 109.434 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.63 153.96 25.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.942 -1.099 . . . . 0.0 109.84 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.2 t -98.78 126.81 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.386 -0.821 . . . . 0.0 109.57 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 76.8 mt -79.53 146.44 32.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 110.303 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.526 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -151.96 151.17 30.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.175 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -46.93 124.99 6.87 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.461 -0.774 . . . . 0.0 110.998 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.473 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 90.53 13.6 59.57 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 32.9 m-20 -87.57 154.68 20.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.043 -1.269 . . . . 0.0 109.693 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.442 ' OE1' ' ND2' ' A' ' 122' ' ' ASN . 82.1 tt0 -115.35 135.86 53.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.446 -0.784 . . . . 0.0 109.553 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.07 132.1 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.0 109.144 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -120.27 122.19 40.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 0.0 109.445 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.62 126.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.52 0.676 . . . . 0.0 109.232 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.2 -134.3 48.46 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -91.86 -7.95 47.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -1.032 . . . . 0.0 109.38 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.526 ' CE1' ' OD2' ' A' ' 91' ' ' ASP . 82.5 m-85 -95.28 143.86 26.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 0.0 110.516 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -108.16 136.9 47.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.622 -0.674 . . . . 0.0 109.202 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.29 154.27 51.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.59 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.89 136.53 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.436 0.636 . . . . 0.0 109.289 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -92.46 113.48 25.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.677 -0.639 . . . . 0.0 109.297 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 134' ' ' GLY . 94.4 mt -137.06 147.77 46.34 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.756 . . . . 0.0 109.784 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.3 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 110.016 -179.961 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.394 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.34 151.79 33.98 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.497 -1.001 . . . . 0.0 109.846 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -146.4 156.25 43.17 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -137.99 171.75 13.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.805 . . . . 0.0 109.326 -179.502 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 mt -118.76 134.3 55.24 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.77 130.05 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' ' 62' ' ' ARG . 42.3 t -70.07 134.91 29.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.537 -0.727 . . . . 0.0 109.986 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -104.55 36.3 2.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.626 -0.672 . . . . 0.0 109.338 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.75 ' H ' HG12 ' A' ' 60' ' ' VAL . 77.8 mtp85 -126.85 144.27 51.02 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.429 -0.794 . . . . 0.0 109.93 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.76 -57.21 15.09 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -46.43 -36.93 18.8 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.314 2.009 . . . . 0.0 111.781 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.401 ' ND2' ' CE1' ' A' ' 142' ' ' PHE . 41.0 m-20 -119.66 25.31 10.09 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.581 -0.699 . . . . 0.0 109.18 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . -66.46 140.52 58.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.313 -0.867 . . . . 0.0 109.801 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.413 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 101.21 -18.87 53.48 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 m -64.12 136.55 57.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.38 -1.071 . . . . 0.0 109.739 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' NH1' ' O ' ' A' ' 67' ' ' GLY . 90.6 mtm-85 -140.58 146.82 38.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.728 . . . . 0.0 109.098 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 57' ' ' LEU . 88.0 m-85 -129.01 136.58 50.5 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.511 -0.743 . . . . 0.0 109.324 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 tp -103.84 129.73 51.34 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.494 -0.754 . . . . 0.0 109.163 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.55 70.46 3.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.357 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 67.1 t0 -95.18 34.67 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -141.52 150.81 42.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.341 -0.85 . . . . 0.0 109.96 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.76 81.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.684 -0.635 . . . . 0.0 110.299 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.39 125.27 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.407 -0.808 . . . . 0.0 109.32 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.0 m -122.65 122.14 38.09 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 m -87.15 153.12 21.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 109.727 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -118.34 122.38 42.73 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.637 -0.665 . . . . 0.0 109.341 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.22 -124.38 2.52 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.476 ' C ' ' CG ' ' A' ' 82' ' ' HIS . 62.8 ttm-85 -119.72 121.92 40.28 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.532 -0.981 . . . . 0.0 109.222 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -170.05 161.54 6.67 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.12 -78.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.45 2.1 . . . . 0.0 112.077 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -81.37 97.41 7.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.325 -0.86 . . . . 0.0 109.743 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 p -166.51 126.96 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.767 . . . . 0.0 109.019 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.35 -37.72 84.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.48 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.3 mm -87.86 120.31 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.0 109.649 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CE2' ' OD2' ' A' ' 90' ' ' ASP . 69.3 t80 -130.28 85.72 2.32 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.19 107.86 18.96 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.444 -0.785 . . . . 0.0 109.507 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD2' ' CE2' ' A' ' 88' ' ' PHE . 97.9 m-20 -90.38 87.32 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 109.276 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -151.71 150.1 29.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.379 -0.826 . . . . 0.0 109.641 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.37 -25.05 26.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.041 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -65.27 -33.94 77.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.479 -0.763 . . . . 0.0 109.647 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.1 t -101.68 118.02 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.3 -0.875 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.7 m -70.81 174.7 5.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.342 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -60.67 -43.72 97.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.564 -0.71 . . . . 0.0 109.356 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -127.04 55.23 1.58 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.564 -0.71 . . . . 0.0 109.114 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -60.7 -41.87 96.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.5 -0.75 . . . . 0.0 109.761 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.45 158.58 44.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.357 -0.839 . . . . 0.0 109.08 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -133.13 148.63 52.12 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.518 -0.739 . . . . 0.0 109.227 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -113.84 135.48 53.92 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -128.59 141.26 51.42 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.465 -0.772 . . . . 0.0 109.655 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.1 tp -98.93 127.23 44.81 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 106' ' ' ASN . 49.2 tp10 -123.39 132.76 54.07 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.578 -0.701 . . . . 0.0 109.701 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 51.97 -84.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 109.859 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' GLU . 63.8 t30 -153.51 25.74 0.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -134.73 138.58 44.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.489 -0.757 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -77.04 146.98 37.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -0.779 . . . . 0.0 109.74 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -132.92 157.62 44.66 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.29 136.54 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.35 133.5 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 44.5 p-10 -95.87 115.69 27.8 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.247 -0.908 . . . . 0.0 109.769 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.466 -0.772 . . . . 0.0 108.935 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 120' ' ' TYR . 93.8 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.356 0.598 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.453 ' N ' HG22 ' A' ' 119' ' ' THR . 40.4 p90 -147.49 162.7 38.54 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 p -120.74 128.13 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.435 -0.791 . . . . 0.0 109.844 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.1 m120 55.38 38.5 30.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.509 -0.745 . . . . 0.0 110.01 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 59.26 40.16 21.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.459 -0.776 . . . . 0.0 109.492 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -144.59 87.36 7.58 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.0 108.494 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.1 135.09 67.3 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.498 2.132 . . . . 0.0 112.202 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.3 m -141.79 162.96 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.307 -0.871 . . . . 0.0 110.014 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.64 -40.54 97.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.503 -0.748 . . . . 0.0 109.366 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.2 p -157.58 161.35 38.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.098 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.37 150.58 23.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.006 -1.058 . . . . 0.0 109.908 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.6 t -95.0 132.26 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.494 -0.754 . . . . 0.0 109.239 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.64 151.44 37.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.389 -0.819 . . . . 0.0 109.943 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.544 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -147.4 159.34 43.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.345 -0.847 . . . . 0.0 109.636 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -57.25 132.36 52.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 110.637 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.496 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 83.34 14.93 72.9 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 29.4 m-20 -83.18 148.84 27.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.242 -1.152 . . . . 0.0 109.581 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -113.29 128.12 56.37 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.42 131.73 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -120.06 118.45 30.65 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.539 -0.725 . . . . 0.0 109.229 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.31 129.36 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.611 -0.68 . . . . 0.0 109.744 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 59.98 -131.41 50.32 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -102.43 -16.32 16.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.587 -0.949 . . . . 0.0 109.18 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.401 ' CE1' ' ND2' ' A' ' 65' ' ' ASN . 79.0 m-85 -80.47 147.81 30.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.455 -0.778 . . . . 0.0 109.895 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.16 137.24 43.24 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.476 -0.765 . . . . 0.0 109.2 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.5 150.67 46.64 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.336 -0.853 . . . . 0.0 109.24 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.02 132.78 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.463 -0.773 . . . . 0.0 108.943 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.449 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 74.1 t80 -93.29 117.48 30.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 109.513 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 134' ' ' GLY . 94.0 mt -129.06 139.76 51.89 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 69.7 p . . . . . 0 N--CA 1.496 1.849 0 O-C-N 121.446 -0.784 . . . . 0.0 109.993 -179.524 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.444 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.3 mt -96.54 172.31 8.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.155 -1.203 . . . . 0.0 110.243 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.71 157.66 43.65 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.618 ' CD2' HH21 ' A' ' 69' ' ' ARG . 5.1 mp -131.87 150.3 52.19 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.341 -0.849 . . . . 0.0 110.022 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.5 mt -117.39 134.89 54.3 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.61 132.53 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.654 0.74 . . . . 0.0 109.259 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.1 132.53 33.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.491 -0.755 . . . . 0.0 109.779 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -93.31 -15.12 26.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.373 -0.829 . . . . 0.0 109.284 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -165.87 141.77 5.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.034 . . . . 0.0 109.925 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.91 176.82 24.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.23 -40.23 83.13 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.423 2.082 . . . . 0.0 111.764 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -108.43 53.58 0.68 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.96 143.47 42.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.463 -0.773 . . . . 0.0 110.13 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.13 1.56 75.64 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.2 m -71.84 152.33 42.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.466 -1.02 . . . . 0.0 109.941 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.618 HH21 ' CD2' ' A' ' 57' ' ' LEU . 17.8 ptm180 -133.81 144.37 48.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.516 -0.74 . . . . 0.0 109.279 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -121.16 138.31 54.27 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.487 -0.758 . . . . 0.0 109.385 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 tp -99.48 125.71 45.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.388 -0.82 . . . . 0.0 109.13 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -99.34 75.05 1.96 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.282 -0.886 . . . . 0.0 109.13 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 64.3 t0 -99.07 17.3 20.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.392 -0.817 . . . . 0.0 109.053 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -119.26 144.45 46.77 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.562 -0.711 . . . . 0.0 109.658 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.82 99.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 110.076 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.4 mt -124.81 126.78 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.431 -0.793 . . . . 0.0 109.012 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 m -124.52 124.05 41.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.564 -0.71 . . . . 0.0 109.364 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -96.67 156.57 16.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 109.334 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.91 147.81 35.04 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.69 -48.44 1.01 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -88.01 141.11 28.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.151 -1.205 . . . . 0.0 109.989 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.575 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -88.72 -44.49 0.45 Allowed Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.419 -0.801 . . . . 0.0 109.817 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 32.5 Cg_exo -57.25 137.19 80.59 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.374 2.049 . . . . 0.0 112.701 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 44.76 46.43 8.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.603 -0.686 . . . . 0.0 109.709 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.9 m -156.07 116.89 3.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.325 -0.859 . . . . 0.0 109.74 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.24 -38.29 90.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.3 mm -78.2 128.09 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.427 -0.796 . . . . 0.0 109.819 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -129.99 85.92 2.35 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.4 98.05 7.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 46.7 p-10 -91.46 94.62 9.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.701 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -154.3 158.14 39.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.18 -0.95 . . . . 0.0 109.926 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.7 m -69.13 -32.47 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.534 -0.729 . . . . 0.0 109.761 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p -65.83 -29.96 70.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.901 . . . . 0.0 110.341 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -99.84 125.9 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -0.994 . . . . 0.0 109.562 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.0 m -79.39 -170.15 2.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.643 -0.661 . . . . 0.0 110.19 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -60.28 -45.45 93.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.758 . . . . 0.0 109.614 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 99' ' ' ALA . 79.7 mtp85 -108.17 -47.83 3.47 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 113' ' ' VAL . 85.8 t60 52.81 -80.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.619 -0.675 . . . . 0.0 110.074 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -127.71 155.8 43.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.541 -0.724 . . . . 0.0 109.131 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -136.02 154.23 51.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 109.094 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -118.73 143.66 46.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -130.19 144.29 51.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.4 -0.813 . . . . 0.0 109.511 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.6 tp -104.46 123.96 48.4 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.511 -0.743 . . . . 0.0 109.437 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -95.19 -117.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 92.5 m-20 -65.07 -50.3 66.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 110.13 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 68.6 m-20 -169.03 23.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.572 -0.705 . . . . 0.0 109.282 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.54 136.68 43.22 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -77.0 146.62 37.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.49 -0.756 . . . . 0.0 110.126 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -123.37 156.62 35.06 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 110' ' ' VAL . 11.7 p -117.75 131.15 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.76 143.13 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.485 -0.759 . . . . 0.0 109.731 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -99.58 112.82 24.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 0.0 108.938 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 98' ' ' HIS . 16.6 m . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.172 -0.955 . . . . 0.0 110.742 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.199 0.523 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -138.78 153.19 48.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.429 -0.794 . . . . 0.0 109.387 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.1 p -120.25 129.36 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.664 0.745 . . . . 0.0 109.52 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.489 ' CG ' ' H ' ' A' ' 123' ' ' ARG . 6.8 t-20 55.37 -167.09 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.585 0.707 . . . . 0.0 110.229 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.489 ' H ' ' CG ' ' A' ' 122' ' ' ASN . 11.0 mmp_? -72.6 -4.63 31.99 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.691 -0.631 . . . . 0.0 109.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -107.81 99.53 30.46 Favored Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -76.19 128.46 10.58 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.021 1.814 . . . . 0.0 112.056 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 129' ' ' ALA . 4.8 m -136.59 160.79 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.299 -0.876 . . . . 0.0 110.478 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.89 -42.21 97.51 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.556 -0.715 . . . . 0.0 109.266 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 m -157.94 158.43 34.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 109.467 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -168.05 159.09 10.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.035 -1.041 . . . . 0.0 109.859 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.19 131.53 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.763 . . . . 0.0 109.954 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.6 150.31 36.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.866 . . . . 0.0 109.864 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.96 156.76 46.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.418 -0.801 . . . . 0.0 109.567 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -55.83 135.03 52.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.52 -0.737 . . . . 0.0 110.667 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.99 19.16 65.77 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 136' ' ' GLU . 64.4 t0 -96.76 133.73 40.96 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.308 -1.113 . . . . 0.0 109.986 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.488 ' N ' ' OD1' ' A' ' 135' ' ' ASP . 98.4 mt-10 -94.35 130.45 40.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.319 -0.863 . . . . 0.0 109.224 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.5 t -124.51 132.53 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.565 -0.71 . . . . 0.0 109.126 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -126.22 127.53 45.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.42 127.47 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.496 -0.753 . . . . 0.0 109.698 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.48 -95.35 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -128.43 -18.37 4.01 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.643 -0.916 . . . . 0.0 109.123 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -74.76 141.44 44.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -0.859 . . . . 0.0 109.63 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -105.28 131.83 52.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.432 -0.792 . . . . 0.0 109.814 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.75 152.62 51.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.506 -0.746 . . . . 0.0 109.161 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.43 131.39 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -92.5 111.39 22.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.44 -0.788 . . . . 0.0 109.271 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.77 143.17 50.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.467 0.651 . . . . 0.0 109.715 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 0.0 109.775 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.425 ' C ' HD12 ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.495 2.633 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 54' ' ' GLY . 11.1 mp -104.92 148.21 26.93 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.187 -1.184 . . . . 0.0 109.931 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.26 176.87 8.02 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.614 0.721 . . . . 0.0 109.315 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.714 ' C ' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -157.33 172.58 18.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.886 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 57' ' ' LEU . 4.6 mp -130.47 149.3 52.21 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 68.2 t -124.61 131.56 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.571 -0.705 . . . . 0.0 109.804 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.6 t -73.05 119.88 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.487 -0.758 . . . . 0.0 109.333 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -92.92 -16.64 24.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 109.122 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -155.5 132.68 10.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.599 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.15 172.14 22.52 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.97 -42.44 66.76 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.518 2.146 . . . . 0.0 112.003 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -100.66 49.71 0.89 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.471 -0.768 . . . . 0.0 109.09 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.09 141.98 26.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.539 -0.726 . . . . 0.0 110.234 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.65 -18.48 56.86 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -68.64 149.88 48.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.284 -1.127 . . . . 0.0 110.695 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -139.06 135.81 34.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -111.58 115.46 29.2 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.416 -0.802 . . . . 0.0 109.07 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 tt -94.5 133.23 38.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 110.244 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.402 HD21 HD11 ' A' ' 87' ' ' ILE . 81.3 mt -89.75 131.17 35.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.578 -0.701 . . . . 0.0 109.608 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -136.33 26.74 3.17 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.61 155.46 47.43 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.299 -0.876 . . . . 0.0 109.783 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.69 84.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.932 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.14 126.31 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.419 -0.801 . . . . 0.0 109.156 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.4 m -119.69 124.03 45.24 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.712 . . . . 0.0 109.549 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 m -86.87 155.43 20.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.476 -0.765 . . . . 0.0 109.193 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.41 131.7 53.73 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.448 -0.783 . . . . 0.0 109.364 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.3 -138.91 6.31 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 72.7 ttp85 -113.37 125.58 54.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.509 -0.995 . . . . 0.0 110.042 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 11.8 m-70 -168.94 152.17 5.17 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.14 -19.5 50.91 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.201 1.934 . . . . 0.0 111.589 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 85' ' ' SER . 84.5 m-20 -117.95 -129.95 0.3 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.543 -0.723 . . . . 0.0 109.744 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 84' ' ' ASP . 6.1 m 57.87 138.18 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.74 0.781 . . . . 0.0 110.602 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.34 -43.53 97.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.492 -0.755 . . . . 0.0 109.355 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.402 HD11 HD21 ' A' ' 72' ' ' LEU . 93.5 mt -100.81 115.25 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.332 -0.855 . . . . 0.0 109.228 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 26.3 p90 -130.23 98.1 4.62 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.9 mt -97.0 123.8 40.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 91' ' ' ASP . 31.0 t0 -95.25 -151.62 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.538 -0.726 . . . . 0.0 109.8 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.545 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 34.5 t70 58.82 171.53 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.686 0.755 . . . . 0.0 110.351 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.447 ' N ' ' CG ' ' A' ' 91' ' ' ASP . 71.9 t -91.25 114.21 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.599 -0.688 . . . . 0.0 110.151 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER 172.29 -31.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.099 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.9 t -115.52 131.99 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 121.704 0.764 . . . . 0.0 109.689 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -77.06 -175.78 3.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.589 -0.695 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -62.11 -39.16 91.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.756 . . . . 0.0 109.65 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -139.77 57.81 1.62 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.155 -0.966 . . . . 0.0 109.16 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -61.66 -40.11 93.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.452 -0.78 . . . . 0.0 109.639 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.39 156.33 43.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.106 -0.996 . . . . 0.0 110.097 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -137.25 145.9 44.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.57 145.65 38.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.542 -0.724 . . . . 0.0 109.181 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.2 mtp85 -130.78 144.65 51.6 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.6 -0.687 . . . . 0.0 109.283 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.0 tp -105.17 126.44 52.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.589 -0.694 . . . . 0.0 109.686 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -158.05 149.89 21.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.014 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 55.51 35.2 24.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.446 -0.784 . . . . 0.0 109.415 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 54.9 31.62 16.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.677 -0.639 . . . . 0.0 109.716 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -143.53 138.97 29.54 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -77.08 145.69 37.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.528 -0.733 . . . . 0.0 109.618 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -130.94 159.0 38.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.708 . . . . 0.0 109.195 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 110' ' ' VAL . 8.6 p -122.28 128.05 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.1 t -125.96 132.81 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 53.3 p-10 -95.9 144.94 25.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.435 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 113' ' ' VAL . 3.5 m . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 109.969 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.522 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 45.2 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.236 0.541 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 119' ' ' THR . 38.4 m-85 -144.28 152.11 40.34 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.214 -0.929 . . . . 0.0 109.585 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.511 HG12 HG11 ' A' ' 126' ' ' VAL . 9.4 p -129.08 138.91 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.48 -0.763 . . . . 0.0 109.454 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 27.1 m120 58.98 38.34 24.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.596 -0.69 . . . . 0.0 109.839 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 48.58 35.9 6.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.0 109.945 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -145.49 148.22 36.33 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 108.642 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.427 ' O ' ' OE2' ' A' ' 124' ' ' GLU . 25.7 Cg_endo -61.43 139.9 84.8 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.367 2.044 . . . . 0.0 112.095 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.511 HG11 HG12 ' A' ' 121' ' ' VAL . 2.0 p -147.76 161.19 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.33 -0.856 . . . . 0.0 108.996 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 128' ' ' SER . 67.3 t0 -124.73 66.83 1.09 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 127' ' ' ASP . 3.5 p 84.82 116.87 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.15 0.5 . . . . 0.0 109.809 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.84 43.32 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.25 -0.906 . . . . 0.0 109.931 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.1 t -79.21 133.23 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -0.779 . . . . 0.0 110.519 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.52 147.88 37.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.384 -0.823 . . . . 0.0 109.617 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.537 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -142.15 148.42 38.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.254 -0.903 . . . . 0.0 109.186 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 49.9 p-10 -48.48 132.23 17.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.772 . . . . 0.0 111.021 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.518 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 87.23 13.1 66.56 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 79.8 m-20 -89.48 150.28 22.55 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.097 -1.237 . . . . 0.0 110.042 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -111.74 136.99 50.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.599 -0.688 . . . . 0.0 109.515 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -128.27 134.74 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.515 -0.741 . . . . 0.0 109.221 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -124.15 117.4 24.56 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.84 128.35 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.479 -0.763 . . . . 0.0 109.524 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 142' ' ' PHE . . . 61.62 45.29 96.61 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.541 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? 70.2 -29.33 0.18 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.571 -0.958 . . . . 0.0 110.119 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 140' ' ' GLY . 72.8 m-85 -66.64 137.12 56.49 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.65 -0.656 . . . . 0.0 110.273 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -106.85 124.61 49.87 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.287 -0.883 . . . . 0.0 109.191 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.7 mp -126.37 147.64 49.72 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.533 -0.729 . . . . 0.0 109.327 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 145' ' ' VAL . 10.4 p -108.59 126.61 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -89.76 120.49 31.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.557 -0.714 . . . . 0.0 109.879 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 134' ' ' GLY . 96.8 mt -131.89 150.46 52.15 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.463 0.649 . . . . 0.0 109.762 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.499 1.993 0 O-C-N 121.695 -0.628 . . . . 0.0 109.377 -179.734 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.549 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -138.55 163.61 31.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.456 -1.026 . . . . 0.0 109.636 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.73 156.83 42.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.508 -0.745 . . . . 0.0 109.949 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.671 HD12 ' C ' ' A' ' 57' ' ' LEU . 3.9 pp -142.7 169.9 16.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.355 -0.841 . . . . 0.0 110.626 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.9 mt -124.49 144.01 50.34 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -130.42 132.49 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.743 0.782 . . . . 0.0 109.61 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.3 t -75.71 132.62 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.69 0.757 . . . . 0.0 109.993 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.527 ' NZ ' ' OE2' ' A' ' 136' ' ' GLU . 51.9 mtmt -86.78 -73.78 0.45 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.724 -0.61 . . . . 0.0 110.017 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.603 HH21 ' NH1' ' A' ' 143' ' ' ARG . 61.7 ttp180 -117.33 134.69 54.52 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.433 -0.792 . . . . 0.0 110.356 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.26 173.9 21.6 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.47 -19.74 48.63 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.882 2.388 . . . . 0.0 111.726 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -97.37 19.77 12.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 109.047 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.22 139.32 29.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.389 -0.819 . . . . 0.0 110.373 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.78 -22.27 40.18 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.3 m -71.9 149.39 45.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.367 -1.078 . . . . 0.0 110.831 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -145.78 152.31 39.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.327 -0.858 . . . . 0.0 110.232 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -121.55 131.76 54.31 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.463 0.649 . . . . 0.0 109.444 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 46.8 tp -100.42 128.87 46.37 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 0.0 109.263 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.08 128.27 42.83 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.836 0.826 . . . . 0.0 110.428 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 67.6 t0 -155.24 41.03 0.42 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -141.39 152.61 44.47 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.353 -0.842 . . . . 0.0 109.553 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.46 -48.02 83.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.687 -0.633 . . . . 0.0 109.987 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.42 121.33 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.45 -0.781 . . . . 0.0 109.372 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -116.92 118.9 33.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.583 0.706 . . . . 0.0 109.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 m -86.16 155.28 20.82 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.554 0.692 . . . . 0.0 109.895 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 99' ' ' ALA . . . -103.69 169.75 8.34 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.905 0.859 . . . . 0.0 110.339 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.31 -119.9 5.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.532 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 74.1 ttp85 -118.63 121.6 40.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.888 . . . . 0.0 109.884 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 41.7 m-70 -167.9 151.28 5.79 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.82 145.02 79.48 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.787 2.324 . . . . 0.0 112.783 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 54.82 31.1 14.93 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.511 0.672 . . . . 0.0 109.584 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 t -99.14 123.45 43.44 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.209 -0.932 . . . . 0.0 110.555 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 71' ' ' LEU . 54.3 m-20 -65.85 -39.57 90.88 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -85.01 125.51 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 109.841 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -127.19 86.11 2.46 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.2 mt -115.26 94.29 4.66 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -92.79 109.68 21.12 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.525 0.679 . . . . 0.0 109.622 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -158.58 163.1 37.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.958 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.3 -44.21 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.63 0.729 . . . . 0.0 110.285 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.5 p -68.22 -29.4 68.23 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.344 -0.848 . . . . 0.0 109.996 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.4 t -92.46 112.1 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.131 -0.981 . . . . 0.0 109.97 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.9 m -77.58 176.73 8.67 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.686 0.755 . . . . 0.0 110.444 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.53 -41.84 99.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.646 -0.658 . . . . 0.0 110.017 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -124.18 49.2 1.81 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.377 -0.827 . . . . 0.0 109.005 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.08 -39.93 94.1 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.511 0.672 . . . . 0.0 109.45 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -147.99 154.89 40.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.957 -1.089 . . . . 0.0 110.272 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -136.58 151.6 49.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.497 0.665 . . . . 0.0 109.848 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.435 ' CE1' HG23 ' A' ' 110' ' ' VAL . 97.0 m-85 -121.09 138.83 54.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -130.71 141.21 50.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.635 0.731 . . . . 0.0 109.718 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.06 123.87 38.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 106' ' ' ASN . 80.7 tt0 -115.13 120.38 39.58 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.862 0.839 . . . . 0.0 109.867 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.464 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 21.3 t-20 52.09 -84.52 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.426 0.631 . . . . 0.0 110.372 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -144.03 20.36 1.77 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 108.503 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -130.16 137.47 50.13 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.714 0.769 . . . . 0.0 109.721 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -82.08 147.47 29.09 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.433 0.635 . . . . 0.0 109.76 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -136.06 157.87 45.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.518 -0.739 . . . . 0.0 109.769 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.6 p -125.84 127.35 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.1 t -131.03 131.26 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 119' ' ' THR . 42.9 t0 -100.38 126.48 46.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.697 0.76 . . . . 0.0 109.447 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.644 0.735 . . . . 0.0 109.228 -179.88 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.549 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 28.4 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.62 0.724 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.434 ' OH ' ' NE2' ' A' ' 138' ' ' GLN . 22.7 p90 -119.57 150.51 40.17 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.579 0.704 . . . . 0.0 109.905 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 122' ' ' ASN . 9.6 p -121.28 130.07 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.974 0.892 . . . . 0.0 109.29 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 124' ' ' GLU . 90.1 m-20 41.9 -168.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.098 0.951 . . . . 0.0 111.324 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.05 -0.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.757 -0.59 . . . . 0.0 110.163 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 122' ' ' ASN . 17.2 tt0 -113.25 93.09 24.6 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.384 -0.822 . . . . 0.0 109.42 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.04 122.36 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.74 2.293 . . . . 0.0 112.361 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.0 m -136.72 165.07 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.447 -0.783 . . . . 0.0 109.891 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.83 -37.81 88.78 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.591 0.71 . . . . 0.0 109.3 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.4 p -155.54 161.34 40.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.903 . . . . 0.0 110.065 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.06 156.26 24.34 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.597 0.713 . . . . 0.0 110.166 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.36 129.75 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.624 0.726 . . . . 0.0 110.098 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.88 143.04 38.08 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.906 0.86 . . . . 0.0 110.592 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.544 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.86 147.18 27.65 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.596 0.712 . . . . 0.0 109.279 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 20.5 p30 -43.17 130.19 4.65 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.057 0.932 . . . . 0.0 111.667 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.06 13.47 68.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 81.2 m-20 -89.95 150.03 22.33 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.986 -1.302 . . . . 0.0 109.673 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 61' ' ' LYS . 84.0 tt0 -108.5 129.25 55.29 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.696 0.76 . . . . 0.0 110.05 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.9 t -126.11 131.25 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.434 ' NE2' ' OH ' ' A' ' 120' ' ' TYR . 56.6 tt0 -121.5 120.92 36.31 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.465 0.65 . . . . 0.0 109.772 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 39.7 mm -110.71 122.2 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.75 0.786 . . . . 0.0 109.284 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 56.3 -129.74 48.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -95.06 -6.59 41.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.544 -0.974 . . . . 0.0 109.059 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -89.88 139.92 30.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 0.0 109.519 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.603 ' NH1' HH21 ' A' ' 62' ' ' ARG . 85.0 mtt85 -102.95 136.52 42.61 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.674 0.75 . . . . 0.0 110.027 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.53 157.37 46.69 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.55 133.52 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.671 0.748 . . . . 0.0 109.431 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -87.27 111.51 21.11 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.595 0.712 . . . . 0.0 109.978 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.7 mt -136.19 157.7 46.19 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.426 0.631 . . . . 0.0 109.335 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.4 p . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.496 0.665 . . . . 0.0 109.718 -179.423 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' C ' HD22 ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 55' ' ' LEU . 2.6 mm? -102.09 167.54 9.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.563 -0.963 . . . . 0.0 110.272 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.19 176.96 7.5 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -130.55 146.6 52.1 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.023 0.916 . . . . 0.0 110.712 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mt -116.4 134.33 55.0 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.2 t -122.43 135.08 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.586 0.708 . . . . 0.0 109.187 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.3 t -69.18 133.39 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.58 0.705 . . . . 0.0 110.184 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -95.17 -28.61 14.96 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.548 0.689 . . . . 0.0 109.196 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -147.73 138.19 23.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.194 -0.941 . . . . 0.0 110.072 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.65 174.4 15.9 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.17 -13.1 25.84 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.958 2.439 . . . . 0.0 111.132 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ALA . 97.9 m-20 -97.88 16.69 20.1 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . -39.78 133.04 1.62 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.884 0.849 . . . . 0.0 110.924 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.34 -14.24 65.42 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -66.39 146.71 54.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.437 -1.037 . . . . 0.0 110.971 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -134.96 142.11 46.42 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.269 0.557 . . . . 0.0 109.604 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.98 125.42 49.36 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.621 0.724 . . . . 0.0 109.95 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 tt -102.16 132.97 47.74 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.281 0.563 . . . . 0.0 110.044 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -87.72 157.74 18.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.512 -0.743 . . . . 0.0 110.344 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 66.7 t0 -173.51 33.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -156.58 147.17 21.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.452 -0.78 . . . . 0.0 109.88 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.23 136.81 46.46 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.802 0.811 . . . . 0.0 110.83 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 85.3 mt 55.11 100.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.542 0.687 . . . . 0.0 109.873 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -103.7 126.06 50.59 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.607 0.717 . . . . 0.0 109.571 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -92.94 143.64 26.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.491 0.662 . . . . 0.0 109.923 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -101.97 170.06 8.37 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.75 0.786 . . . . 0.0 110.282 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . 92.02 -129.47 9.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.52 ' O ' ' CD2' ' A' ' 82' ' ' HIS . 8.7 ptp180 -103.8 110.83 23.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.932 . . . . 0.0 109.612 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 81' ' ' ARG . 80.3 m-70 -161.87 90.56 1.43 Allowed Pre-proline 0 N--CA 1.486 1.341 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 58.6 Cg_exo -52.12 145.72 33.13 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.679 2.253 . . . . 0.0 112.507 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 7.0 t0 81.5 -22.32 0.27 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -71.97 146.98 47.39 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.79 0.805 . . . . 0.0 110.891 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -62.62 -42.86 99.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.64 -0.663 . . . . 0.0 109.845 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.03 114.05 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 109.563 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 22.0 p90 -129.85 97.87 4.62 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.577 0.703 . . . . 0.0 109.414 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 80' ' ' GLY . 96.1 mt -102.03 96.75 7.22 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.763 0.792 . . . . 0.0 108.871 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 30.0 p30 -85.34 90.61 7.97 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.515 0.674 . . . . 0.0 109.764 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -146.06 150.05 35.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.485 -0.759 . . . . 0.0 109.477 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.08 -32.32 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.551 0.691 . . . . 0.0 109.912 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.6 p -66.43 -32.51 73.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.459 -0.776 . . . . 0.0 109.786 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.32 128.47 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.306 -0.871 . . . . 0.0 109.917 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 96' ' ' ARG . 25.2 t -78.29 -170.96 2.2 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.666 0.745 . . . . 0.0 110.594 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.503 ' N ' ' OG ' ' A' ' 95' ' ' SER . 95.3 mtt180 -61.66 -41.62 97.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.516 -0.74 . . . . 0.0 109.036 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -142.21 62.41 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -62.3 -40.81 97.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.507 -0.745 . . . . 0.0 109.084 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.32 151.07 44.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 0.0 109.777 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -140.83 136.57 32.52 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.656 0.741 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -99.43 146.69 26.05 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.396 0.617 . . . . 0.0 109.356 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -130.81 131.74 44.82 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.483 0.659 . . . . 0.0 109.342 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.1 tp -102.93 123.51 46.7 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 105' ' ' ASN . 44.6 tt0 -93.18 -132.04 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.625 -0.672 . . . . 0.0 109.827 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 90.9 m-20 -64.35 -44.34 91.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.321 -0.862 . . . . 0.0 109.616 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 48.3 m-20 -169.79 24.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.78 131.53 51.27 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.654 0.74 . . . . 0.0 109.514 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.409 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 63.9 m-85 -78.94 146.43 33.48 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.486 0.66 . . . . 0.0 109.836 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 93.4 m-20 -144.61 159.38 42.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 p -126.93 131.98 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.483 0.658 . . . . 0.0 109.343 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.04 133.46 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.633 0.73 . . . . 0.0 109.414 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -96.53 114.09 25.72 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.569 0.699 . . . . 0.0 109.215 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.649 0.738 . . . . 0.0 110.385 -179.263 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.657 0.741 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -137.57 157.73 45.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.622 -0.674 . . . . 0.0 109.411 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.2 p -117.86 129.57 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.752 0.787 . . . . 0.0 109.965 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 52.65 49.56 20.08 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.701 0.762 . . . . 0.0 109.719 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 52.29 26.17 3.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.968 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -123.95 101.22 35.95 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.82 127.01 13.71 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.323 2.015 . . . . 0.0 112.274 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 128' ' ' SER . 2.4 p -144.36 138.69 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.474 -0.766 . . . . 0.0 109.946 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -66.49 -40.17 89.14 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.474 0.654 . . . . 0.0 109.449 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.425 ' N ' HG22 ' A' ' 126' ' ' VAL . 87.7 p -156.87 154.26 29.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.13 157.14 27.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.854 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 82.3 t -91.61 128.13 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.729 0.776 . . . . 0.0 109.796 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.67 152.29 35.84 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.754 0.788 . . . . 0.0 110.411 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.534 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.4 155.73 40.92 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.51 0.671 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.405 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 43.0 p-10 -51.77 132.57 31.44 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.883 0.849 . . . . 0.0 111.084 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.515 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 82.45 18.19 66.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 23.5 m-20 -83.57 149.38 26.61 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.223 -1.163 . . . . 0.0 110.073 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 57.6 mp0 -108.84 123.97 49.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.624 -0.672 . . . . 0.0 109.435 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.4 t -125.17 132.32 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.38 125.18 44.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 141' ' ' LYS . 36.3 mm -111.34 127.51 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.737 0.779 . . . . 0.0 109.308 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 54.91 -92.19 0.01 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 139' ' ' ILE . 60.8 pttt -129.9 -18.46 3.4 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -76.99 142.61 39.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 110.036 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -105.65 132.49 51.73 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.684 0.754 . . . . 0.0 110.13 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.54 155.35 50.56 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.446 0.641 . . . . 0.0 109.578 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.39 134.39 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.559 0.695 . . . . 0.0 109.802 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -94.12 120.73 34.79 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 134' ' ' GLY . 84.0 mt -132.74 152.85 51.65 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.799 0.809 . . . . 0.0 109.613 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.587 0.708 . . . . 0.0 109.693 -179.734 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.4 mt -125.56 149.58 48.22 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.433 -1.039 . . . . 0.0 110.636 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.459 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -151.43 156.31 40.39 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.39 151.47 41.18 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.097 0.951 . . . . 0.0 110.188 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.0 mt -117.88 142.51 47.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.2 t -127.32 130.7 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.56 -0.713 . . . . 0.0 109.816 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.41 130.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 121.649 0.738 . . . . 0.0 110.061 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.21 -76.47 0.12 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.559 -0.713 . . . . 0.0 109.756 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -123.62 148.53 46.34 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.625 0.726 . . . . 0.0 110.16 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.53 175.28 30.31 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.89 -21.23 50.64 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.887 2.391 . . . . 0.0 111.346 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -110.31 23.8 13.82 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -39.96 145.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.643 0.735 . . . . 0.0 110.923 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.6 -1.3 88.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.6 m -72.38 146.23 47.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -1.073 . . . . 0.0 110.742 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -134.38 147.6 50.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.682 . . . . 0.0 109.571 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -128.77 146.92 50.77 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.492 -0.755 . . . . 0.0 109.55 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.1 tp -105.25 127.64 53.04 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.559 0.695 . . . . 0.0 109.756 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 56' ' ' ALA . 84.9 mt -92.88 77.81 4.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 54.8 t0 -108.59 16.81 22.63 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -124.51 140.02 53.34 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.571 0.7 . . . . 0.0 109.622 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.54 85.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.618 -0.676 . . . . 0.0 109.869 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.91 121.09 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.531 -0.731 . . . . 0.0 109.354 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.6 m -126.83 124.0 38.62 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -97.67 155.25 17.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.448 -0.782 . . . . 0.0 109.625 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.6 158.37 20.9 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.672 0.748 . . . . 0.0 110.219 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.68 -120.95 5.29 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -93.87 111.32 23.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.342 -1.093 . . . . 0.0 109.944 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -175.05 88.71 0.31 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 46.1 Cg_exo -54.91 148.27 47.75 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.574 2.183 . . . . 0.0 112.526 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 10.3 t0 82.14 -7.75 1.32 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.492 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 66.7 m -78.48 147.12 34.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.345 -0.847 . . . . 0.0 110.618 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.17 -38.71 92.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.511 -0.743 . . . . 0.0 109.153 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.08 126.75 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.341 -0.849 . . . . 0.0 109.907 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 50.3 m-85 -125.2 98.78 5.79 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.413 0.625 . . . . 0.0 109.316 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 91' ' ' ASP . 49.0 mt -107.87 146.81 31.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.61 -0.681 . . . . 0.0 109.608 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 41.4 t0 -60.48 -1.16 0.32 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 89' ' ' LEU . 2.6 p30 47.22 31.92 1.9 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.643 0.735 . . . . 0.0 110.444 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.9 m -68.88 -24.79 28.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 109.885 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 140' ' ' GLY . 60.6 p -138.22 13.27 2.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.392 -0.817 . . . . 0.0 109.234 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.73 131.35 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.584 0.706 . . . . 0.0 109.582 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.3 p -66.67 -162.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.636 0.731 . . . . 0.0 110.887 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.38 -40.85 92.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 109.77 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' A' ' 99' ' ' ALA . 93.3 mtm-85 -133.24 -41.7 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 60.6 -67.27 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.954 -0.466 . . . . 0.0 109.939 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -140.99 154.3 45.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.079 -1.013 . . . . 0.0 109.412 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -138.7 142.34 38.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.555 -0.715 . . . . 0.0 109.551 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -99.88 140.31 34.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.421 -0.799 . . . . 0.0 109.446 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.406 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 50.5 mmm-85 -130.48 141.53 50.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.636 -0.665 . . . . 0.0 109.547 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.8 tp -115.24 119.54 36.69 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.571 0.7 . . . . 0.0 109.183 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -160.16 -34.04 0.06 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.562 -0.712 . . . . 0.0 109.124 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 107' ' ' GLU . 90.5 m-20 -88.58 41.85 1.04 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 0.0 109.232 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 57.48 1.64 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 109.973 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 105' ' ' ASN . 96.1 mt-10 -142.99 157.22 44.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.167 -0.958 . . . . 0.0 109.906 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -74.25 141.65 45.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.515 -0.741 . . . . 0.0 110.14 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 102' ' ' ARG . 39.6 p30 -139.66 173.76 11.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.458 -0.776 . . . . 0.0 109.548 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.3 134.64 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.687 -0.633 . . . . 0.0 109.847 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -127.02 130.81 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.72 155.19 24.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.414 -0.804 . . . . 0.0 110.127 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.399 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 120' ' ' TYR . 44.2 m . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.637 0.732 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.528 ' N ' HG22 ' A' ' 119' ' ' THR . 44.2 p90 -142.48 162.28 35.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.545 -0.722 . . . . 0.0 109.956 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 123' ' ' ARG . 8.4 p -114.68 131.42 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.654 0.74 . . . . 0.0 109.722 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 43.59 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.582 -0.699 . . . . 0.0 110.385 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 121' ' ' VAL . 15.0 ptp180 -143.68 41.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 109.059 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -146.71 82.43 8.68 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.369 -0.832 . . . . 0.0 109.185 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.58 128.9 32.31 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.806 2.338 . . . . 0.0 112.811 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.3 m -150.81 161.87 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 109.945 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.62 -38.01 89.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 109.557 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -153.22 152.65 31.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 109.511 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.5 152.13 32.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.212 -0.93 . . . . 0.0 110.072 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.27 130.16 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.461 -0.775 . . . . 0.0 109.913 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.96 148.93 34.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.793 0.806 . . . . 0.0 110.272 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.431 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -148.98 156.36 42.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.494 -0.754 . . . . 0.0 109.317 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.766 ' ND2' ' H ' ' A' ' 148' ' ' THR . 31.8 t-20 -57.72 136.14 56.85 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.776 0.798 . . . . 0.0 111.301 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.3 10.46 77.55 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 89.5 m-20 -89.62 156.42 18.6 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.228 -1.16 . . . . 0.0 110.275 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -108.78 136.57 48.12 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.704 -0.623 . . . . 0.0 109.376 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.72 133.25 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.647 -0.658 . . . . 0.0 109.458 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.544 HE22 ' HG2' ' A' ' 143' ' ' ARG . 17.4 tp60 -123.14 114.77 20.76 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 140' ' ' GLY . 96.7 mt -132.78 122.43 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.448 -0.782 . . . . 0.0 109.74 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . 35.14 72.8 0.11 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 142' ' ' PHE . 6.2 tmtt? 64.16 -63.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.911 -0.758 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 140' ' ' GLY . 33.1 m-85 -36.31 123.19 0.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.504 0.669 . . . . 0.0 110.595 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.544 ' HG2' HE22 ' A' ' 138' ' ' GLN . 95.6 mtt180 -101.56 132.46 47.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.725 -0.609 . . . . 0.0 109.46 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -138.06 156.43 47.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.56 -0.712 . . . . 0.0 109.423 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.09 137.9 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.619 -0.676 . . . . 0.0 109.424 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -90.82 114.48 26.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.589 -0.694 . . . . 0.0 109.262 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.6 mt -134.01 149.4 51.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.774 0.797 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.766 ' H ' ' ND2' ' A' ' 133' ' ' ASN . 82.4 p . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.568 -0.707 . . . . 0.0 109.52 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 55' ' ' LEU . 10.7 mp -96.13 151.77 19.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.399 -1.06 . . . . 0.0 110.289 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -127.02 162.63 25.56 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.23 153.8 45.66 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.917 0.865 . . . . 0.0 110.509 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.7 mt -114.3 141.21 47.89 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.8 132.72 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.585 0.707 . . . . 0.0 109.794 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.8 t -72.06 132.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.606 0.717 . . . . 0.0 109.686 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -81.9 -77.16 0.23 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.543 -0.723 . . . . 0.0 109.188 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -133.94 139.16 45.95 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.806 0.813 . . . . 0.0 109.836 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.62 -177.74 37.77 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.51 -38.63 90.07 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.758 2.305 . . . . 0.0 111.919 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 66' ' ' ALA . 98.7 m-20 -75.53 -78.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.662 -0.648 . . . . 0.0 110.102 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 59.63 122.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.442 -0.787 . . . . 0.0 110.391 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.14 -19.58 53.55 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.6 t -67.63 144.78 55.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.295 -1.121 . . . . 0.0 110.554 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -134.54 145.07 48.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.627 -0.671 . . . . 0.0 109.732 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.22 139.3 48.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.54 -0.725 . . . . 0.0 109.6 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pp -106.41 145.41 31.77 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.5 0.667 . . . . 0.0 109.833 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.34 123.92 44.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.373 -0.83 . . . . 0.0 109.635 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -93.94 37.93 1.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 109.157 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 55.93 -168.09 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.718 0.77 . . . . 0.0 111.034 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 62.76 -141.37 0.39 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.526 0.679 . . . . 0.0 110.667 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 93.4 mt -113.57 127.82 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.741 -0.599 . . . . 0.0 109.705 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.1 m -120.84 124.95 46.29 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.502 0.668 . . . . 0.0 109.27 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.5 m -94.42 161.63 14.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.518 -0.739 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.57 151.68 31.31 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.606 0.717 . . . . 0.0 109.848 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.85 -58.02 1.53 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -77.62 145.83 36.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -1.091 . . . . 0.0 110.691 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.495 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -86.02 -47.35 0.57 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.505 -0.747 . . . . 0.0 109.742 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 72.9 Cg_exo -51.97 133.71 46.89 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.325 2.017 . . . . 0.0 113.172 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' PRO . 45.7 t0 41.8 49.88 3.96 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.726 0.774 . . . . 0.0 109.718 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 t -157.01 114.25 3.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.62 -37.66 88.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.533 -0.73 . . . . 0.0 109.9 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 mm -73.22 131.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.416 -0.802 . . . . 0.0 110.12 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -129.78 86.54 2.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.705 -0.622 . . . . 0.0 109.541 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -123.12 93.52 3.98 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 97.2 m-20 -94.68 104.18 16.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.431 -0.793 . . . . 0.0 109.468 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 62.3 m-20 -159.52 168.58 25.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.243 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 93' ' ' THR . 17.4 m -67.34 -35.99 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.507 0.67 . . . . 0.0 109.827 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.421 ' N ' HG23 ' A' ' 92' ' ' VAL . 59.2 p -65.77 -26.78 67.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.41 128.83 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.487 -0.758 . . . . 0.0 109.499 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.4 m -88.95 -164.07 1.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.605 0.717 . . . . 0.0 110.03 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -62.92 -43.64 98.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.497 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' A' ' 99' ' ' ALA . 84.7 mtp180 -108.39 -57.83 2.07 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 57.69 -73.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.864 -0.522 . . . . 0.0 109.655 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -132.12 155.24 48.5 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.651 0.738 . . . . 0.0 109.439 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -139.37 146.25 39.98 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' A' ' 110' ' ' VAL . 99.0 m-85 -113.05 139.18 48.9 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -128.85 139.26 52.24 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.02 121.53 36.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.493 -0.754 . . . . 0.0 109.541 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -99.44 -124.99 0.16 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -84.59 88.18 7.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.829 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 52.71 27.0 4.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.64 -0.663 . . . . 0.0 110.051 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -142.19 131.12 23.02 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.019 -1.051 . . . . 0.0 110.02 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -76.73 147.75 37.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.636 -0.665 . . . . 0.0 110.206 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -139.67 159.78 41.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.104 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.446 HG23 ' CE1' ' A' ' 101' ' ' PHE . 9.0 p -126.44 132.73 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.702 -0.624 . . . . 0.0 109.435 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.9 135.82 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.509 0.671 . . . . 0.0 109.244 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -85.3 115.29 22.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.496 -0.753 . . . . 0.0 109.378 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.617 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.2 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.489 0.661 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.37 149.95 49.81 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 122' ' ' ASN . 9.9 p -130.52 156.69 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.604 -0.685 . . . . 0.0 110.009 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 121' ' ' VAL . 97.5 m-20 -40.61 173.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.995 0.902 . . . . 0.0 111.063 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 60.46 -105.12 0.2 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.856 -0.528 . . . . 0.0 109.992 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -125.62 145.5 51.6 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.779 -0.576 . . . . 0.0 109.602 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -49.24 139.12 28.35 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.355 2.037 . . . . 0.0 113.053 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -137.85 160.08 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.489 -0.757 . . . . 0.0 109.977 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -69.13 -37.68 78.45 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.661 -0.649 . . . . 0.0 109.525 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p -156.28 161.83 40.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.048 -1.032 . . . . 0.0 110.456 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.33 165.55 31.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.45 -0.781 . . . . 0.0 109.579 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.0 t -93.46 130.24 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.441 -0.787 . . . . 0.0 109.719 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.6 mt -77.33 147.2 36.31 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.645 0.736 . . . . 0.0 110.467 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.88 164.17 34.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.614 0.721 . . . . 0.0 109.698 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 18.5 p30 -64.0 127.34 30.97 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.66 0.743 . . . . 0.0 110.714 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.41 16.33 69.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 145' ' ' VAL . 44.8 t0 -85.69 160.23 19.61 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.154 -1.204 . . . . 0.0 109.928 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -112.15 124.37 52.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.522 -0.736 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.1 t -127.35 132.67 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -121.7 113.96 20.46 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.5 130.05 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.462 0.648 . . . . 0.0 109.795 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 142' ' ' PHE . . . 67.29 36.01 88.84 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 140' ' ' GLY . 15.0 tptp 71.37 -19.18 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.677 -0.896 . . . . 0.0 109.475 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 140' ' ' GLY . 95.6 m-85 -73.96 143.34 45.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.882 . . . . 0.0 109.961 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -99.71 120.68 40.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 109.17 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.33 153.39 47.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.6 -0.687 . . . . 0.0 109.944 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 135' ' ' ASP . 9.9 p -127.09 138.72 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.581 0.705 . . . . 0.0 109.554 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -89.9 120.34 31.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.675 . . . . 0.0 109.397 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 66.3 mt -134.72 152.87 52.1 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.396 0.617 . . . . 0.0 109.878 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.569 0.699 . . . . 0.0 109.567 179.988 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 55' ' ' LEU . 11.0 mp -100.72 149.76 23.46 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.158 -1.201 . . . . 0.0 110.178 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -149.05 165.85 30.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.444 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.04 155.16 47.35 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.67 0.748 . . . . 0.0 109.818 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -116.14 136.69 52.79 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -120.48 135.28 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.672 0.749 . . . . 0.0 109.744 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.3 116.52 20.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.527 -0.733 . . . . 0.0 110.007 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -66.76 -45.15 79.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.43 -0.794 . . . . 0.0 109.918 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -154.29 151.55 29.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.017 . . . . 0.0 110.396 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.42 -176.53 28.11 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.53 -38.37 74.94 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.894 2.396 . . . . 0.0 112.274 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 58.3 m-20 -82.17 -76.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.572 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . 70.27 118.07 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.563 0.697 . . . . 0.0 110.249 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.27 -15.65 62.87 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.8 t -67.21 145.46 55.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -1.144 . . . . 0.0 110.546 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -133.4 151.81 51.86 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.667 -0.645 . . . . 0.0 109.676 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -128.17 142.05 51.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.505 -0.747 . . . . 0.0 109.052 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.4 tp -102.27 128.29 48.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.608 -0.683 . . . . 0.0 109.969 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -92.5 75.02 5.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 109.161 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -95.07 5.52 51.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 109.134 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -115.09 139.43 49.89 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.512 -0.742 . . . . 0.0 109.81 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.61 -50.72 72.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.589 -0.695 . . . . 0.0 110.004 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.9 mm -110.14 120.87 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.346 -0.847 . . . . 0.0 108.828 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.4 m -125.69 115.04 19.48 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.369 0.604 . . . . 0.0 109.688 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.1 m -84.31 151.52 24.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.37 -0.831 . . . . 0.0 109.022 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.61 162.23 13.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.216 -0.928 . . . . 0.0 110.348 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.8 -132.18 11.0 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.545 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 94.9 mtt180 -102.97 131.32 50.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.477 -1.013 . . . . 0.0 110.226 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 23.9 m-70 -172.92 153.93 2.67 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.17 -54.38 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.33 2.02 . . . . 0.0 111.305 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 50.3 p-10 -96.79 88.7 4.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.453 -0.78 . . . . 0.0 109.806 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.6 p -166.33 126.79 1.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.991 . . . . 0.0 109.381 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.11 -39.95 95.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.847 . . . . 0.0 109.649 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.6 mt -87.76 127.45 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.104 -0.997 . . . . 0.0 109.594 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -129.28 85.75 2.35 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.2 mt -101.51 94.53 5.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 108.808 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -88.47 85.52 6.87 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.498 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 12.2 p-10 -155.29 170.11 22.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.36 -0.838 . . . . 0.0 109.655 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 93' ' ' THR . 4.1 t -71.9 171.9 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.597 -0.689 . . . . 0.0 110.504 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.55 ' H ' HG12 ' A' ' 92' ' ' VAL . 2.7 p 66.24 -5.93 0.53 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.668 -0.645 . . . . 0.0 109.627 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 92' ' ' VAL . 94.4 t -109.44 -19.2 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 94' ' ' VAL . 1.4 m 44.5 -173.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.826 0.822 . . . . 0.0 110.827 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -70.11 -43.79 70.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.932 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.424 ' CG ' ' NE2' ' A' ' 82' ' ' HIS . 79.3 mtp85 -140.91 88.98 2.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.836 . . . . 0.0 109.421 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -99.53 -30.57 12.08 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.92 151.44 33.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -140.85 150.32 43.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.478 -0.763 . . . . 0.0 109.503 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.34 145.66 37.09 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -132.99 136.28 45.97 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 57.4 tp -96.78 124.75 40.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 109.743 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 105' ' ' ASN . 80.6 tt0 -107.18 -109.93 0.3 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.518 -0.739 . . . . 0.0 109.571 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.402 ' N ' ' HG2' ' A' ' 104' ' ' GLU . 82.1 m-20 -91.84 79.35 5.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.065 . . . . 0.0 109.38 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 55.89 34.68 24.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.558 -0.713 . . . . 0.0 109.538 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.24 131.51 13.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.912 . . . . 0.0 109.044 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -83.73 150.35 25.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.172 -0.955 . . . . 0.0 110.357 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -122.31 157.77 31.03 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.9 p -120.87 127.73 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.593 -0.692 . . . . 0.0 109.222 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -130.72 137.55 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.755 -0.59 . . . . 0.0 109.543 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 49.4 p-10 -84.55 95.68 8.92 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.275 -0.891 . . . . 0.0 109.277 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.429 -179.823 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.316 0.579 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -146.22 158.81 43.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.98 . . . . 0.0 109.245 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.55 133.85 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.717 -0.615 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 124' ' ' GLU . 97.7 m-20 57.69 38.43 27.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.779 -0.575 . . . . 0.0 110.006 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 56.79 0.06 0.07 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.525 -0.734 . . . . 0.0 110.634 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 122' ' ' ASN . 72.3 mt-10 -107.28 147.65 35.61 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.266 -0.896 . . . . 0.0 109.44 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.92 148.08 0.23 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.265 1.977 . . . . 0.0 112.227 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 12.9 p -124.69 135.15 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.769 0.795 . . . . 0.0 109.663 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 128' ' ' SER . 65.7 t0 -148.58 59.85 1.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 128' ' ' SER . 2.8 p 80.97 95.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.526 0.679 . . . . 0.0 109.506 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.09 151.22 49.45 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.397 -0.814 . . . . 0.0 109.501 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.6 t -81.5 131.49 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.47 -0.769 . . . . 0.0 109.957 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.03 151.7 35.45 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.478 -0.764 . . . . 0.0 110.267 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.543 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -152.63 153.8 34.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -0.899 . . . . 0.0 109.934 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -49.23 129.84 18.61 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.66 0.743 . . . . 0.0 111.383 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.16 15.13 61.23 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 92.2 m-20 -91.08 150.86 21.24 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.744 -1.445 . . . . 0.0 109.86 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -108.84 130.86 55.42 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.473 -0.767 . . . . 0.0 109.122 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -124.45 133.1 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.604 -0.685 . . . . 0.0 109.248 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.456 ' OE1' ' CZ ' ' A' ' 143' ' ' ARG . 57.3 tt0 -121.07 124.66 45.35 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.49 129.84 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.49 0.662 . . . . 0.0 110.027 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 50.46 -98.38 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -127.4 -19.3 4.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.623 -0.928 . . . . 0.0 108.888 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.498 ' CE1' ' OD2' ' A' ' 91' ' ' ASP . 13.6 m-85 -74.82 143.31 43.99 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.406 -0.809 . . . . 0.0 109.874 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.456 ' CZ ' ' OE1' ' A' ' 138' ' ' GLN . 28.1 mmt180 -103.32 137.17 41.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.496 -0.753 . . . . 0.0 109.653 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.86 151.96 44.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.809 -0.557 . . . . 0.0 109.794 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.0 p -124.28 134.28 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 67.2 t80 -93.04 108.63 20.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.5 mt -140.22 150.75 44.53 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.622 0.725 . . . . 0.0 109.414 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.519 -0.738 . . . . 0.0 110.062 -179.398 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.478 ' O ' HD22 ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.666 HD12 HD11 ' A' ' 71' ' ' LEU . 3.9 mm? -114.24 131.69 56.39 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.621 -0.929 . . . . 0.0 110.098 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.15 155.03 44.48 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.4 153.27 48.07 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.827 0.823 . . . . 0.0 110.399 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -114.35 127.08 55.68 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.54 134.05 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.661 0.743 . . . . 0.0 109.809 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.77 128.95 34.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.581 -0.699 . . . . 0.0 109.789 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -88.45 -35.56 16.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.166 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -150.18 132.49 15.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.636 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 66' ' ' ALA . . . 141.43 169.48 11.92 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.12 -39.42 70.82 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.755 2.303 . . . . 0.0 111.816 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -81.81 30.63 0.37 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 63' ' ' GLY . . . -63.17 134.26 55.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.524 -0.735 . . . . 0.0 110.278 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.73 -15.61 58.61 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -65.57 144.53 56.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.525 -0.985 . . . . 0.0 110.076 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -136.87 148.9 47.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.642 -0.661 . . . . 0.0 109.698 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -128.79 153.5 47.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.603 -0.686 . . . . 0.0 109.181 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.666 HD11 HD12 ' A' ' 55' ' ' LEU . 53.8 tp -110.16 143.57 40.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.835 -0.541 . . . . 0.0 109.903 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.9 mt -116.59 78.96 1.25 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.513 -0.742 . . . . 0.0 109.686 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 67.1 t0 -110.31 41.01 1.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -135.93 150.33 49.26 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.704 . . . . 0.0 109.428 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.85 79.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.409 -0.807 . . . . 0.0 109.67 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.62 127.51 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.8 m -122.8 124.98 44.54 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.0 t -97.63 168.16 10.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.335 -0.853 . . . . 0.0 110.443 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB3' ' H ' ' A' ' 99' ' ' ALA . . . -116.16 -178.93 3.52 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.652 0.739 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.34 -134.74 39.25 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.588 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 38.1 mmt180 -74.58 133.9 42.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.436 -1.037 . . . . 0.0 109.818 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 1.2 m80 166.96 85.92 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.15 -36.47 66.65 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.992 1.795 . . . . 0.0 110.964 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -94.82 72.34 3.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.351 -0.843 . . . . 0.0 109.591 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.4 t -169.13 148.3 3.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.072 -1.018 . . . . 0.0 109.41 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.29 -41.5 98.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.354 -0.842 . . . . 0.0 109.681 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.85 123.64 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 109.912 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CZ ' ' OD2' ' A' ' 90' ' ' ASP . 89.3 t80 -130.4 85.73 2.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.12 128.61 53.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.376 -0.828 . . . . 0.0 109.694 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD2' ' CZ ' ' A' ' 88' ' ' PHE . 94.6 m-20 -135.1 86.06 2.22 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 63.3 m-20 -158.92 178.99 9.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.88 . . . . 0.0 110.032 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 94' ' ' VAL . 2.8 t -63.42 166.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.611 -0.681 . . . . 0.0 110.847 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.417 ' H ' HG12 ' A' ' 92' ' ' VAL . 3.0 p 66.06 -4.76 0.62 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 92' ' ' VAL . 55.3 t -123.99 129.5 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.3 m -107.59 -139.24 0.37 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 109.958 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -63.42 -42.53 98.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.546 -0.721 . . . . 0.0 110.662 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -156.89 94.02 1.4 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 109.005 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -61.29 -39.04 88.95 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.438 -0.789 . . . . 0.0 109.438 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 79' ' ' ALA . . . -152.55 162.08 41.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 110.573 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -133.39 145.56 50.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -113.87 141.89 46.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.333 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.71 135.81 50.68 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.748 0.785 . . . . 0.0 109.834 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 107' ' ' GLU . 47.2 tp -98.42 128.49 44.82 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.39 -126.62 0.15 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.152 -0.967 . . . . 0.0 110.94 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 93.5 m-20 -64.53 -48.91 73.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 110.529 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 53.6 m-20 -168.82 21.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.33 -0.856 . . . . 0.0 109.665 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.466 ' O ' ' CD1' ' A' ' 103' ' ' LEU . 96.8 mt-10 -116.37 -126.92 0.29 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.35 -0.844 . . . . 0.0 109.057 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.439 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 13.7 m-85 -164.23 155.35 15.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.017 -1.052 . . . . 0.0 108.933 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 58.6 m-20 -143.45 149.51 37.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.149 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.32 130.51 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.44 131.54 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.355 0.597 . . . . 0.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -100.25 118.16 35.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.53 -0.731 . . . . 0.0 109.356 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.355 -0.841 . . . . 0.0 110.215 -179.091 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.227 0.537 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -124.12 142.15 51.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.61 -0.681 . . . . 0.0 109.188 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 126' ' ' VAL . 5.9 p -124.13 132.08 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.606 0.717 . . . . 0.0 109.622 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.433 ' C ' ' H ' ' A' ' 124' ' ' GLU . 98.1 m-20 52.6 -171.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.819 0.819 . . . . 0.0 110.894 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -71.37 6.84 1.56 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.394 -0.817 . . . . 0.0 108.871 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 122' ' ' ASN . 3.9 pt-20 -120.44 84.74 36.22 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.45 134.38 60.84 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.373 2.049 . . . . 0.0 112.009 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.513 HG22 HG12 ' A' ' 121' ' ' VAL . 27.3 m -151.04 156.15 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.132 -0.98 . . . . 0.0 109.809 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.45 -41.88 96.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.1 p -158.11 143.5 16.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.399 -0.813 . . . . 0.0 109.546 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -172.93 167.52 5.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.289 -0.882 . . . . 0.0 110.056 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.8 t -78.05 144.31 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.981 0.896 . . . . 0.0 109.96 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.83 ' H ' HD13 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -136.8 158.06 45.31 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.544 0.688 . . . . 0.0 110.444 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.06 -172.02 4.06 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.629 0.728 . . . . 0.0 109.201 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 47.2 p-10 -50.78 141.52 12.96 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.834 0.826 . . . . 0.0 111.538 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.17 21.36 57.2 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -110.08 151.88 26.67 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.446 -1.032 . . . . 0.0 109.267 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -113.46 138.09 50.6 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.8 t -125.61 132.27 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -118.71 125.45 49.7 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.46 128.95 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.65 0.738 . . . . 0.0 109.518 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.67 -120.98 4.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -98.45 -16.31 19.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.421 -1.046 . . . . 0.0 108.808 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -80.37 145.47 32.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 0.0 110.214 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -115.85 126.68 54.29 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.03 158.43 36.98 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.65 -0.656 . . . . 0.0 109.762 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.83 135.47 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -90.24 109.87 20.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.924 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.44 143.59 39.74 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.401 0.62 . . . . 0.0 109.374 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 110.396 -179.54 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.4 mt -131.57 154.01 49.28 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.118 0.961 . . . . 0.0 110.535 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.77 158.89 42.94 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.16 151.0 51.16 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.309 1.052 . . . . 0.0 110.929 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -115.25 136.4 53.14 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.221 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.8 t -121.75 132.97 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.855 0.836 . . . . 0.0 109.859 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.7 t -69.8 102.82 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.927 0.87 . . . . 0.0 109.538 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.07 -43.87 86.11 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.632 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -130.97 136.82 48.89 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.945 0.879 . . . . 0.0 109.797 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.9 168.62 16.45 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.11 -34.66 68.63 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.88 2.387 . . . . 0.0 111.471 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 66' ' ' ALA . 87.3 m-20 -66.89 -45.52 77.77 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . 31.52 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.455 0.645 . . . . 0.0 110.838 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.01 -24.62 4.5 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.4 p -70.02 160.68 31.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.779 -0.836 . . . . 0.0 110.849 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.566 ' CD ' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -152.46 164.04 38.35 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.937 0.875 . . . . 0.0 110.556 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -128.24 142.35 51.19 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.887 0.851 . . . . 0.0 109.723 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -104.48 127.52 52.2 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.822 0.82 . . . . 0.0 110.406 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.3 mt -91.37 116.49 28.88 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.898 0.856 . . . . 0.0 109.966 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -157.69 19.7 0.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -129.65 138.89 51.46 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.895 0.855 . . . . 0.0 109.821 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.79 134.62 51.28 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.78 0.8 . . . . 0.0 110.458 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 mm 53.09 93.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.6 m -106.08 118.13 35.81 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.029 0.918 . . . . 0.0 110.169 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.2 m -85.67 159.33 19.84 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.639 0.733 . . . . 0.0 109.909 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 96' ' ' ARG . . . -106.89 170.09 8.15 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.865 0.841 . . . . 0.0 110.388 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.5 -70.67 2.62 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.621 ' NH1' ' NH2' ' A' ' 96' ' ' ARG . 79.7 mtp85 -71.74 142.59 49.77 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.714 0.769 . . . . 0.0 110.118 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.525 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -86.43 -46.07 0.56 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.837 -0.539 . . . . 0.0 109.91 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 54.3 Cg_exo -54.24 135.0 63.43 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.257 1.971 . . . . 0.0 112.725 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 54.48 33.21 18.31 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t -159.65 117.63 2.72 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.932 0.872 . . . . 0.0 109.876 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.23 -37.85 88.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.57 125.36 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.58 0.705 . . . . 0.0 109.702 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.4 ' CD1' ' CB ' ' A' ' 82' ' ' HIS . 57.4 t80 -130.01 86.19 2.38 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.965 0.888 . . . . 0.0 109.566 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 90' ' ' ASP . 96.8 mt -79.7 146.71 32.28 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.763 0.792 . . . . 0.0 109.787 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 89' ' ' LEU . 64.7 t0 -55.88 -109.12 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.454 0.645 . . . . 0.0 110.267 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 93' ' ' THR . 58.6 m-20 -162.23 -103.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.461 0.648 . . . . 0.0 109.486 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 t 53.01 -77.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.151 0.501 . . . . 0.0 109.904 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 91' ' ' ASP . 11.8 p -115.17 9.23 15.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.656 -0.653 . . . . 0.0 109.375 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.1 131.09 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 121.918 0.866 . . . . 0.0 109.862 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.5 t -89.33 -155.74 0.37 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.813 0.816 . . . . 0.0 110.94 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.621 ' NH2' ' NH1' ' A' ' 81' ' ' ARG . 79.3 mtp85 -63.7 -41.22 98.14 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.312 0.577 . . . . 0.0 109.894 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -166.41 56.36 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.433 0.635 . . . . 0.0 109.593 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -62.85 -6.42 3.74 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.56 147.49 34.51 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.939 0.876 . . . . 0.0 109.673 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -143.93 138.94 28.87 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.057 0.932 . . . . 0.0 109.925 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -106.38 145.81 31.25 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.717 0.77 . . . . 0.0 109.302 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -132.93 143.98 49.84 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.985 0.897 . . . . 0.0 110.177 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.0 tp -106.83 121.77 45.05 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.839 0.828 . . . . 0.0 109.569 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 104' ' ' GLU . 9.8 pm0 -107.12 -116.51 0.26 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.444 0.64 . . . . 0.0 109.876 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.43 ' H ' ' CG ' ' A' ' 104' ' ' GLU . 47.7 p-10 -87.38 80.82 8.04 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.604 0.716 . . . . 0.0 110.437 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 54.22 31.42 14.07 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.421 0.629 . . . . 0.0 109.508 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -141.4 130.41 23.24 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.66 0.743 . . . . 0.0 109.562 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -93.31 148.72 21.79 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.465 0.65 . . . . 0.0 109.647 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -147.25 172.34 13.99 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.637 0.732 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.3 p -124.66 131.65 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-O 121.966 0.888 . . . . 0.0 109.576 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.97 133.29 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.712 0.768 . . . . 0.0 109.5 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -89.05 113.82 24.98 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.553 0.692 . . . . 0.0 109.515 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 121.718 0.771 . . . . 0.0 109.578 -179.731 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.455 0.645 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -121.7 144.15 48.94 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.825 0.821 . . . . 0.0 109.611 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 122' ' ' ASN . 3.2 p -101.99 154.4 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.42 0.628 . . . . 0.0 109.954 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 123' ' ' ARG . 37.9 p-10 -34.04 -45.3 0.2 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.106 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 122' ' ' ASN . 99.8 mtt180 -74.5 -114.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.64 -0.662 . . . . 0.0 110.919 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -102.36 147.29 33.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.679 -0.638 . . . . 0.0 109.989 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.77 137.7 78.39 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.793 2.329 . . . . 0.0 113.022 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.07 161.23 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.789 0.804 . . . . 0.0 110.558 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.46 -18.35 61.13 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.8 p -158.16 159.24 35.94 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.721 0.772 . . . . 0.0 109.901 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.69 155.28 31.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.88 0.847 . . . . 0.0 110.219 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.5 t -99.64 128.91 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.708 0.765 . . . . 0.0 109.622 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.24 143.21 35.52 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.789 0.804 . . . . 0.0 110.552 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.53 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -153.25 150.36 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.611 0.72 . . . . 0.0 109.635 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -39.95 122.87 1.54 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.773 0.797 . . . . 0.0 111.145 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.44 13.11 68.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 28.0 m-20 -85.9 149.15 25.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.516 -0.991 . . . . 0.0 109.861 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -112.47 141.96 45.59 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.867 0.842 . . . . 0.0 110.219 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.2 t -121.74 133.66 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.804 0.812 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -128.45 112.66 14.61 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.829 0.823 . . . . 0.0 109.472 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.13 128.59 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.871 0.843 . . . . 0.0 109.654 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 56.07 -134.46 50.27 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -95.45 -13.59 24.46 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.56 130.53 35.86 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.832 0.825 . . . . 0.0 110.073 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -105.99 135.56 47.22 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.714 0.768 . . . . 0.0 109.752 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.69 149.33 51.49 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.658 0.742 . . . . 0.0 109.714 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.32 132.18 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.721 0.772 . . . . 0.0 109.239 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -94.49 111.94 23.7 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.941 0.877 . . . . 0.0 110.008 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.7 mt -138.14 150.52 46.89 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.805 0.812 . . . . 0.0 109.989 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.702 0.763 . . . . 0.0 110.354 -179.723 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.52 136.81 42.55 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.512 -0.993 . . . . 0.0 109.46 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.64 160.64 26.7 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.38 150.22 50.2 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.486 -0.759 . . . . 0.0 109.858 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.34 136.08 53.47 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.5 133.79 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.11 112.46 3.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.425 -0.797 . . . . 0.0 109.464 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.52 ' O ' ' NE ' ' A' ' 62' ' ' ARG . 24.2 tptp -64.71 -47.07 79.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.453 -0.78 . . . . 0.0 109.505 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 61' ' ' LYS . 4.7 mmp_? -143.61 155.26 44.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 109.847 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.43 167.18 11.55 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.56 -19.51 54.39 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.544 2.163 . . . . 0.0 111.873 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -106.25 33.44 3.84 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.452 -0.78 . . . . 0.0 109.192 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.79 145.88 11.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 109.922 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.21 53.68 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.3 m -69.96 145.89 51.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -1.053 . . . . 0.0 109.907 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -141.81 156.1 45.57 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -129.51 146.97 51.27 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.449 -0.782 . . . . 0.0 109.511 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.519 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 53.9 tp -106.44 124.93 50.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.541 -0.724 . . . . 0.0 109.114 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.7 68.73 5.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.152 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.3 p30 -98.75 5.84 47.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.438 -0.789 . . . . 0.0 109.727 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -119.45 135.55 54.7 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.457 -0.777 . . . . 0.0 109.335 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.68 136.06 54.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.514 -0.741 . . . . 0.0 110.659 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.1 mm 60.23 85.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.439 0.637 . . . . 0.0 109.992 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.4 m -102.93 121.84 43.34 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.418 ' O ' ' OG ' ' A' ' 85' ' ' SER . 11.5 m -85.52 162.17 19.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.711 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.37 127.08 44.94 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.86 -141.9 9.64 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -104.48 132.47 50.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.437 -1.037 . . . . 0.0 110.401 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.653 ' N ' ' ND1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 174.15 151.1 0.25 Allowed Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.63 -23.29 49.51 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.14 1.893 . . . . 0.0 112.104 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 85' ' ' SER . 73.0 m-20 -103.3 -146.84 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 109.732 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 84' ' ' ASP . 8.7 t 59.6 128.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.612 0.72 . . . . 0.0 110.389 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 71' ' ' LEU . 48.0 t0 -64.7 -39.69 94.09 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.03 124.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.422 -0.799 . . . . 0.0 109.223 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -130.2 86.25 2.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.723 -0.61 . . . . 0.0 109.482 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.65 99.68 11.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -84.39 92.57 8.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.658 -0.651 . . . . 0.0 109.766 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -154.38 151.76 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 109.593 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 m -71.21 -26.91 27.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.314 -0.867 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.1 p -65.7 -33.85 76.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.499 -0.751 . . . . 0.0 109.737 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.97 121.53 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.293 -0.879 . . . . 0.0 109.374 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.8 m -77.3 179.77 6.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 0.0 110.34 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -58.03 -44.27 87.23 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -135.68 78.63 1.73 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.49 -0.757 . . . . 0.0 109.03 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -94.68 -18.93 20.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.518 -0.739 . . . . 0.0 109.219 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.488 ' HB2' ' OG1' ' A' ' 119' ' ' THR . . . -153.13 152.32 31.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.483 -0.76 . . . . 0.0 109.184 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -139.6 139.6 36.81 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -106.43 119.79 40.19 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.578 -0.702 . . . . 0.0 109.165 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -107.61 134.93 49.89 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 109.398 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.9 tp -103.4 126.68 50.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.386 -0.821 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -99.57 -131.2 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.512 -0.743 . . . . 0.0 109.08 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -65.54 -49.43 68.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.402 -0.811 . . . . 0.0 109.902 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.421 ' CG ' ' O ' ' A' ' 106' ' ' ASN . 28.3 t30 177.51 46.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 108' ' ' PHE . 80.5 mm-40 -134.32 -6.25 2.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.981 -1.074 . . . . 0.0 109.251 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 107' ' ' GLU . 62.3 m-85 56.71 151.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.724 0.773 . . . . 0.0 110.209 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 88.8 m-20 -143.49 159.89 41.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.379 -0.826 . . . . 0.0 109.487 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.85 137.42 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 112' ' ' ASP . 30.8 t -133.8 157.27 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.405 -0.809 . . . . 0.0 109.763 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.422 ' N ' HG12 ' A' ' 111' ' ' VAL . 36.5 p-10 -84.7 13.63 5.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.674 -0.641 . . . . 0.0 109.582 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.504 ' O ' HG22 ' A' ' 113' ' ' VAL . 9.4 p . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 121.419 0.628 . . . . 0.0 110.394 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 99' ' ' ALA . 17.5 m . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.442 0.639 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -141.91 160.36 40.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 121' ' ' VAL . 14.1 p -112.17 129.2 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.293 -0.88 . . . . 0.0 110.486 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.502 ' CG ' ' H ' ' A' ' 123' ' ' ARG . 5.9 t-20 59.47 -167.44 0.16 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.682 0.753 . . . . 0.0 110.824 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.502 ' H ' ' CG ' ' A' ' 122' ' ' ASN . 96.0 mtt-85 -72.71 -12.75 61.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.884 -0.51 . . . . 0.0 109.9 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -86.41 116.53 66.22 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.27 -0.894 . . . . 0.0 109.2 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.22 121.63 5.8 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.507 1.472 . . . . 0.0 111.768 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.53 156.74 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 128' ' ' SER . 38.4 p-10 -72.96 -36.76 67.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.416 -0.803 . . . . 0.0 109.606 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.53 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 99.5 p -160.55 161.83 32.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.413 -0.805 . . . . 0.0 108.852 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -165.53 157.68 15.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.918 -1.114 . . . . 0.0 110.386 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 87.3 t -81.31 134.0 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.462 -0.774 . . . . 0.0 109.638 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.9 mt -80.8 148.07 30.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 109.696 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.548 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -146.28 160.72 41.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.345 -0.847 . . . . 0.0 109.611 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.423 ' OD1' ' OG1' ' A' ' 148' ' ' THR . 51.3 m-20 -57.54 136.79 56.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.737 . . . . 0.0 110.628 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.561 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 80.53 18.62 70.49 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 84.8 m-20 -93.5 155.25 17.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.162 -1.199 . . . . 0.0 109.642 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 56.4 mp0 -113.33 137.43 51.52 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.4 t -122.94 133.6 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -124.12 116.71 23.2 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.592 -0.692 . . . . 0.0 109.304 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.31 128.07 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.612 -0.68 . . . . 0.0 109.811 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 52.82 -134.23 39.85 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -95.49 -4.59 44.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.6 -0.941 . . . . 0.0 109.076 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -95.84 132.34 41.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.553 -0.717 . . . . 0.0 109.506 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -103.36 133.8 47.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.34 154.88 47.2 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.9 134.18 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.687 -0.633 . . . . 0.0 109.368 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -92.0 112.44 24.38 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 134' ' ' GLY . 94.2 mt -134.2 148.65 50.92 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.457 0.646 . . . . 0.0 110.101 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 133' ' ' ASN . 35.8 p . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.796 -0.565 . . . . 0.0 109.984 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.492 0.663 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -84.37 2.24 41.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 109.288 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 63.6 ttm-85 -159.71 119.76 2.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 0.0 109.108 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.54 154.06 39.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.805 . . . . 0.0 109.756 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.42 61.45 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 109.359 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 31' ' ' SER . 7.2 p90 -112.99 125.31 54.27 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.305 -0.872 . . . . 0.0 109.12 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.8 mt 45.86 13.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -0.976 . . . . 0.0 110.047 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 29' ' ' PHE . 13.5 m -73.1 146.15 45.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.172 -0.955 . . . . 0.0 110.03 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 33' ' ' LEU . 97.2 mt-10 53.48 25.93 5.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.302 -0.874 . . . . 0.0 109.762 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.618 ' H ' HD22 ' A' ' 33' ' ' LEU . 3.4 mm? 40.48 -111.35 0.12 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.721 -0.612 . . . . 0.0 110.42 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -125.39 -59.18 1.4 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.545 -0.722 . . . . 0.0 109.342 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.461 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . -179.31 53.02 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.529 -0.732 . . . . 0.0 109.393 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 35.4 Cg_endo -64.33 146.86 90.61 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.671 2.247 . . . . 0.0 112.379 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.41 -75.68 0.36 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.825 . . . . 0.0 109.959 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -82.74 152.83 25.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 0.0 110.186 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.95 -33.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.71 58.35 8.53 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 66.0 p -82.0 166.79 19.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.153 . . . . 0.0 109.974 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -133.59 -86.44 0.43 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.494 -0.754 . . . . 0.0 109.788 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 p -76.25 154.97 34.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 110.263 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -175.91 -73.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.3 m -106.24 -4.9 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.575 -0.703 . . . . 0.0 109.31 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.4 m -149.2 86.04 1.48 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.185 -0.947 . . . . 0.0 109.436 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.51 4.93 84.1 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 48' ' ' VAL . 37.3 t -71.56 -0.46 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -1.084 . . . . 0.0 108.945 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -51.34 -80.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.759 . . . . 0.0 110.031 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' A' ' 51' ' ' LEU . . . -130.66 -2.66 4.8 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 50' ' ' GLY . 0.4 OUTLIER 23.79 66.58 0.38 Allowed Pre-proline 0 N--CA 1.506 2.344 0 CA-C-O 121.07 0.462 . . . . 0.0 111.015 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 19.3 Cg_exo -48.91 -41.81 38.83 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.934 1.756 . . . . 0.0 112.72 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 55' ' ' LEU . 27.7 Cg_exo -61.64 150.79 84.07 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.152 1.901 . . . . 0.0 112.354 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.17 80.23 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 53' ' ' PRO . 67.0 mt -128.16 151.12 49.62 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.513 -0.992 . . . . 0.0 109.702 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.629 ' C ' HD12 ' A' ' 57' ' ' LEU . . . -137.65 143.48 41.39 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.629 HD12 ' C ' ' A' ' 56' ' ' ALA . 11.1 mp -120.23 150.72 40.22 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.335 -0.853 . . . . 0.0 109.868 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.3 mt -117.11 132.58 56.64 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 t -119.08 132.11 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.406 -0.809 . . . . 0.0 109.887 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.78 102.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.542 -0.724 . . . . 0.0 109.134 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.71 -42.91 97.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.679 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -150.21 136.93 19.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.165 -0.96 . . . . 0.0 109.888 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.87 173.27 29.27 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.07 -43.17 60.75 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.224 1.949 . . . . 0.0 112.39 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -102.81 66.15 0.92 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.36 144.75 49.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.278 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.49 -9.7 66.87 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.8 m -66.13 145.64 55.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.404 -1.057 . . . . 0.0 109.665 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.61 146.96 51.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.58 -0.7 . . . . 0.0 109.475 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -125.33 134.49 52.2 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tt -101.98 124.23 47.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.504 -0.748 . . . . 0.0 109.471 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.56 111.74 24.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.32 -0.862 . . . . 0.0 109.271 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -86.22 55.42 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.612 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 88.0 mt-30 51.26 -169.09 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.655 0.74 . . . . 0.0 110.855 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 74' ' ' GLN . . . 68.57 -142.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.491 0.663 . . . . 0.0 110.32 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.45 127.85 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.2 m -121.61 116.64 24.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.559 -0.713 . . . . 0.0 109.123 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 p -83.09 165.33 19.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.359 -0.838 . . . . 0.0 109.553 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.51 140.86 51.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.55 -27.25 16.35 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -67.85 143.71 55.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -1.108 . . . . 0.0 109.864 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.59 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -92.14 -40.43 0.36 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.651 -0.655 . . . . 0.0 109.857 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 65.8 Cg_exo -53.32 -133.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.785 2.323 . . . . 0.0 113.356 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -73.83 101.37 3.73 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.283 -0.885 . . . . 0.0 109.751 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.9 m -166.54 129.25 1.88 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 109.25 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.75 -41.17 97.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 109.992 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.68 126.01 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.732 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -129.5 86.94 2.48 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.0 mt -102.18 96.16 6.8 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.354 -0.841 . . . . 0.0 109.514 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 65.9 t0 -87.92 97.3 10.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.317 -0.865 . . . . 0.0 109.62 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 62.9 m-20 -159.97 173.22 16.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.127 -0.983 . . . . 0.0 109.661 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 93' ' ' THR . 31.5 m -63.61 -41.42 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.464 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -79.32 -178.11 6.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.831 . . . . 0.0 110.211 -179.326 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.518 ' N ' ' OG1' ' A' ' 93' ' ' THR . 4.8 t 61.64 93.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 121.63 0.728 . . . . 0.0 109.597 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.4 m -62.87 -167.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 0.0 109.897 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -63.48 -40.5 97.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.0 109.836 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -132.28 40.93 3.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.474 -0.766 . . . . 0.0 109.265 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -44.06 -35.75 2.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.749 . . . . 0.0 110.03 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.16 152.58 38.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -139.88 149.29 43.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.488 -0.758 . . . . 0.0 109.039 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.24 140.63 49.11 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.471 -0.768 . . . . 0.0 109.057 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -131.28 137.12 48.7 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.377 -0.827 . . . . 0.0 109.061 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.6 tp -95.66 127.65 41.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.244 -0.91 . . . . 0.0 109.789 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 105' ' ' ASN . 40.6 tt0 -142.11 145.11 33.91 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.202 -0.936 . . . . 0.0 109.142 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' OD1' ' CG ' ' A' ' 107' ' ' GLU . 11.2 p30 45.39 41.39 6.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.754 . . . . 0.0 109.571 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m120 56.8 33.98 23.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.536 -0.727 . . . . 0.0 109.994 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.443 ' CG ' ' OD1' ' A' ' 105' ' ' ASN . 73.9 mm-40 -138.47 129.87 27.45 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.273 -0.892 . . . . 0.0 109.264 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -71.27 148.16 47.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 109.953 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.91 166.66 24.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.349 -0.845 . . . . 0.0 109.511 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 110' ' ' VAL . 10.3 p -123.77 131.12 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.5 t -123.68 136.8 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 122.238 1.018 . . . . 0.0 109.065 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -101.93 112.92 25.72 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.124 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.1 m -96.09 0.55 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 120.829 -1.169 . . . . 0.0 108.246 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.63 142.73 34.18 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' LEU . 9.7 m -69.73 144.44 52.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.332 -1.099 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 116' ' ' LEU . 9.1 mp 38.2 -98.85 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.744 -0.598 . . . . 0.0 110.92 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 117' ' ' ASN . 32.4 p30 -78.31 152.71 32.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.13 -140.54 6.09 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -61.97 138.15 58.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -1.137 . . . . 0.0 110.255 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -141.11 161.41 37.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.363 -0.836 . . . . 0.0 108.86 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.39 134.99 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.353 -0.842 . . . . 0.0 109.334 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 56.97 36.54 27.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.59 -0.694 . . . . 0.0 109.539 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 58.33 45.83 16.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.522 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -144.71 119.86 5.92 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.999 -1.063 . . . . 0.0 108.679 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.58 115.99 4.19 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.537 1.492 . . . . 0.0 111.771 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.55 158.68 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.322 -0.861 . . . . 0.0 109.975 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.18 -42.09 99.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.7 t -162.85 157.64 21.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 109.1 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.2 156.04 40.86 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.999 -1.063 . . . . 0.0 109.712 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -90.82 129.71 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.228 -0.92 . . . . 0.0 109.53 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.1 mt -80.76 153.32 27.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 0.0 110.105 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.54 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.22 156.01 40.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.411 -0.805 . . . . 0.0 109.131 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -54.86 134.03 48.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.34 -0.85 . . . . 0.0 110.742 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.571 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 85.72 14.68 67.23 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 83.5 m-20 -91.66 152.4 20.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.135 -1.215 . . . . 0.0 109.711 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -114.02 131.15 56.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.602 -0.686 . . . . 0.0 109.24 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 144' ' ' LEU . 55.2 t -122.29 132.59 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -120.64 120.65 36.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.465 -0.772 . . . . 0.0 109.299 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.14 128.63 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.58 -0.7 . . . . 0.0 109.842 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 53.61 -128.9 40.35 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.1 -1.43 39.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.577 -0.955 . . . . 0.0 109.291 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -97.09 145.16 26.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.457 -0.777 . . . . 0.0 109.262 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -116.22 126.12 53.18 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' VAL . 5.2 mp -128.62 154.55 46.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.573 -0.705 . . . . 0.0 109.437 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.72 130.97 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 109.156 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -87.22 119.41 27.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 134' ' ' GLY . 95.9 mt -132.98 150.92 52.12 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.791 -0.568 . . . . 0.0 109.468 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 74.0 p -127.99 160.0 33.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.568 -0.707 . . . . 0.0 109.269 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -74.06 100.53 1.14 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.546 ' N ' ' ND1' ' A' ' 150' ' ' HIS . 0.0 OUTLIER -80.9 157.18 25.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 0.0 109.929 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -87.46 -3.42 59.01 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 50.49 18.37 0.45 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.73 . . . . 0.0 109.358 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -73.4 -125.45 0.1 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.67 135.36 57.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -1.117 . . . . 0.0 110.552 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.9 p30 -94.62 10.94 32.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.416 -0.802 . . . . 0.0 109.424 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.84 133.4 47.34 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.537 -0.727 . . . . 0.0 109.861 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -148.26 -88.91 0.08 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.385 -0.822 . . . . 0.0 108.88 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' A' ' 158' ' ' HIS . 1.3 p-80 -152.7 117.58 5.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.132 -0.98 . . . . 0.0 109.571 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -163.61 138.16 6.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 108.833 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.448 ' NE2' ' O ' ' A' ' 162' ' ' HIS . 76.9 t60 -113.14 107.42 15.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.433 -0.792 . . . . 0.0 109.285 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 37.3 p-80 -107.5 45.85 0.97 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.479 -0.763 . . . . 0.0 108.954 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.448 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 62.8 t-80 -146.3 140.19 26.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.362 -0.836 . . . . 0.0 110.098 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.644 179.843 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 26' ' ' ARG . 14.3 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.5 t80 57.57 -77.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.716 -0.615 . . . . 0.0 109.846 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 24' ' ' VAL . 60.0 ttt85 -148.89 105.79 3.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.145 -0.972 . . . . 0.0 109.414 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 46.02 -147.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 110.076 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -135.12 -30.19 1.06 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -97.47 -8.97 28.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.286 -0.884 . . . . 0.0 109.576 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.01 -4.07 53.27 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.217 -0.927 . . . . 0.0 108.796 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.6 t -66.3 146.18 54.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 110.172 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -147.94 98.47 2.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.306 -0.871 . . . . 0.0 108.754 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.17 149.9 40.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.506 -0.746 . . . . 0.0 110.211 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.0 t0 64.41 79.2 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.659 0.742 . . . . 0.0 109.587 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -51.49 165.79 0.4 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.698 -0.626 . . . . 0.0 109.535 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 73.2 Cg_endo -76.1 -6.11 16.98 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.704 2.269 . . . . 0.0 111.352 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.34 128.34 1.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.819 . . . . 0.0 110.0 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' C ' ' H ' ' A' ' 40' ' ' GLY . 56.1 tt0 -74.35 -79.03 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.569 -0.707 . . . . 0.0 109.588 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.9 1.17 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.385 -0.822 . . . . 0.0 108.999 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 38' ' ' GLN . . . 70.68 59.12 5.39 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 p -95.26 -2.36 49.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -1.157 . . . . 0.0 108.73 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -52.67 140.03 24.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.416 -0.802 . . . . 0.0 110.038 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.7 t -66.22 144.18 56.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 110.716 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.89 14.53 0.73 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.52 -43.39 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.316 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 m -62.08 141.76 57.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.32 -0.863 . . . . 0.0 109.924 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.55 174.69 20.46 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.74 130.52 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.473 -1.016 . . . . 0.0 109.269 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -78.43 146.52 34.45 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.454 -0.779 . . . . 0.0 110.492 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 51' ' ' LEU . . . 78.27 -119.65 5.22 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.586 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 0.2 OUTLIER 77.04 46.59 0.12 Allowed Pre-proline 0 C--N 1.299 -1.627 0 O-C-N 121.971 -0.723 . . . . 0.0 109.733 -178.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 51' ' ' LEU . 27.3 Cg_exo -51.36 -42.84 52.88 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 121.512 1.474 . . . . 0.0 111.687 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 55' ' ' LEU . 43.1 Cg_exo -56.76 145.71 81.45 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.65 1.567 . . . . 0.0 112.802 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.97 28.68 0.94 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 55' ' ' LEU . 10.9 mp -95.08 157.08 16.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.277 -1.131 . . . . 0.0 109.304 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -127.18 166.91 16.8 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -137.39 159.68 41.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.466 -0.771 . . . . 0.0 109.758 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.0 mt -112.35 135.47 53.0 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.36 137.48 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.57 0.7 . . . . 0.0 109.509 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.45 131.32 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.485 -0.759 . . . . 0.0 109.896 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -96.35 -32.53 12.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 109.172 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -132.21 155.35 48.41 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.762 0.791 . . . . 0.0 110.221 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.35 164.82 14.44 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.76 -15.6 40.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.686 2.257 . . . . 0.0 111.001 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -92.05 13.94 17.37 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.17 135.15 13.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.814 . . . . 0.0 110.369 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.73 -18.5 47.01 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -65.7 144.26 57.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -1.153 . . . . 0.0 109.824 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -138.79 148.72 44.15 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.358 -0.839 . . . . 0.0 109.904 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.99 137.29 50.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.544 -0.722 . . . . 0.0 109.175 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.429 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 40.8 tp -98.76 128.89 45.14 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.339 -0.85 . . . . 0.0 109.794 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.5 mt -85.97 78.91 9.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 108.986 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -98.21 10.89 39.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.469 -0.769 . . . . 0.0 109.074 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -125.11 148.43 48.55 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.5 -0.75 . . . . 0.0 109.817 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.98 95.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.542 -0.724 . . . . 0.0 109.91 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.53 126.15 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.465 -0.772 . . . . 0.0 109.058 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.5 m -123.85 119.45 29.72 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.626 -0.671 . . . . 0.0 109.249 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 m -82.86 153.87 24.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 109.482 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.22 177.2 4.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.578 -0.701 . . . . 0.0 109.984 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.94 -129.1 20.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -98.99 122.03 41.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.347 -1.09 . . . . 0.0 110.241 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.533 ' ND1' ' OG ' ' A' ' 85' ' ' SER . 4.8 t-80 -174.15 94.63 0.32 Allowed Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 38.4 Cg_exo -53.87 150.78 28.79 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.504 2.136 . . . . 0.0 112.995 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 1.2 m-20 77.24 -19.12 0.45 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.533 ' OG ' ' ND1' ' A' ' 82' ' ' HIS . 11.2 m -74.69 148.01 40.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.825 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 71' ' ' LEU . 34.2 t70 -62.92 -46.35 88.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.445 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -100.99 112.0 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.84 . . . . 0.0 109.348 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 22.9 p90 -130.91 90.13 2.85 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.3 94.94 7.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.419 -0.801 . . . . 0.0 109.063 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 43.7 t0 -87.02 98.94 11.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.459 -0.776 . . . . 0.0 109.413 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 64.5 m-20 -158.32 172.88 17.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 109.586 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.77 -44.67 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.506 -0.746 . . . . 0.0 109.818 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.6 p -78.28 -171.0 2.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.992 -1.068 . . . . 0.0 110.509 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 t 62.5 115.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.618 0.723 . . . . 0.0 109.9 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 p -69.84 170.71 10.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.6 -0.687 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -58.19 -32.99 68.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.291 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.51 59.8 1.55 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -63.55 -40.16 96.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.513 -0.742 . . . . 0.0 109.262 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.4 156.0 39.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.075 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -137.03 140.6 42.21 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.6 146.87 27.91 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -136.18 147.24 47.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.285 -0.884 . . . . 0.0 109.817 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.406 HD13 ' CZ ' ' A' ' 108' ' ' PHE . 55.5 tp -101.97 127.25 48.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.611 -0.681 . . . . 0.0 109.407 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -157.29 144.41 18.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.488 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 56.36 35.12 25.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.736 -0.603 . . . . 0.0 109.704 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 58.14 31.99 21.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.492 -0.755 . . . . 0.0 109.748 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -142.63 143.13 32.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.363 -0.835 . . . . 0.0 109.455 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.406 ' CZ ' HD13 ' A' ' 103' ' ' LEU . 64.8 m-85 -92.45 149.16 21.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 109.64 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -144.11 170.75 15.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.351 -0.843 . . . . 0.0 109.554 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 110' ' ' VAL . 14.6 p -125.79 131.04 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.6 t -126.95 130.52 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.53 ' CB ' ' H ' ' A' ' 119' ' ' THR . 26.9 t0 -103.38 128.55 50.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.568 -0.708 . . . . 0.0 109.509 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.9 m -91.68 10.28 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.12 148.58 50.94 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.7 m -82.62 -88.05 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.513 -0.992 . . . . 0.0 110.117 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 116' ' ' LEU . 3.5 tt -62.96 -48.12 80.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.796 . . . . 0.0 109.729 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -92.86 175.41 6.81 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.184 -0.947 . . . . 0.0 110.102 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.68 160.22 27.47 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.53 ' H ' ' CB ' ' A' ' 112' ' ' ASP . 26.0 m -63.59 142.48 58.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -1.084 . . . . 0.0 109.871 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -124.76 157.29 36.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.67 -0.644 . . . . 0.0 109.542 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.82 134.55 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.509 0.671 . . . . 0.0 109.939 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 47.47 -108.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.759 -0.588 . . . . 0.0 109.934 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -128.32 17.13 6.56 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.611 -0.681 . . . . 0.0 109.329 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -124.32 83.31 57.09 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.524 -0.735 . . . . 0.0 109.449 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.81 136.4 75.13 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.609 2.206 . . . . 0.0 112.466 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.9 m -151.37 159.28 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.188 -0.945 . . . . 0.0 110.071 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -62.87 -43.66 98.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.503 -0.748 . . . . 0.0 109.584 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.6 m -135.85 151.25 49.84 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.324 -0.86 . . . . 0.0 109.223 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.73 152.45 35.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.095 -1.003 . . . . 0.0 110.128 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.6 t -95.95 132.14 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.744 . . . . 0.0 109.317 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.52 146.56 40.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 109.769 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.493 ' H ' ' HB2' ' A' ' 135' ' ' ASP . . . -135.43 153.49 51.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.702 . . . . 0.0 109.517 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 38.8 p-10 -45.41 104.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.74 . . . . 0.0 110.591 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.32 44.52 4.03 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.493 ' HB2' ' H ' ' A' ' 132' ' ' ALA . 15.1 t0 -87.87 163.51 16.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.213 -1.169 . . . . 0.0 109.656 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -113.35 116.99 30.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -124.62 133.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -132.51 118.96 19.92 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.0 128.22 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.589 -0.694 . . . . 0.0 109.961 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 53.52 -128.99 40.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -95.72 -9.76 31.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.485 -1.009 . . . . 0.0 109.019 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -94.45 142.68 27.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -118.16 130.53 56.16 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.19 149.26 46.55 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.622 -0.674 . . . . 0.0 109.785 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.4 p -124.94 136.88 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 77.0 t80 -83.01 117.66 22.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 70.7 mt -135.34 146.53 48.5 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.419 0.628 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.9 p -111.21 131.79 54.84 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -72.71 2.85 29.67 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -123.9 108.96 13.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.551 -0.97 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -83.61 143.18 30.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 109.756 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -173.49 166.38 4.67 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.393 -0.817 . . . . 0.0 109.67 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.69 -17.83 55.94 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -135.02 -11.86 2.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.472 -1.017 . . . . 0.0 109.036 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 155' ' ' ASP . 53.4 p-10 -70.43 145.33 51.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.085 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 156' ' ' LEU . 10.1 mp -77.72 142.83 38.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.271 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -87.37 -9.48 54.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.59 -0.694 . . . . 0.0 109.467 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -82.58 137.41 34.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 0.0 109.962 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -145.32 137.61 25.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.093 -1.005 . . . . 0.0 109.269 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -85.29 165.21 17.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.207 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -64.2 -12.35 39.7 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.527 -0.733 . . . . 0.0 109.566 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.617 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 60.8 t-80 -70.55 173.41 7.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.334 -0.854 . . . . 0.0 110.658 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.617 ' N ' ' ND1' ' A' ' 162' ' ' HIS . 66.0 m80 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.908 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.449 0.643 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -73.87 150.14 41.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.704 0.764 . . . . 0.0 110.809 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -67.34 144.78 55.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.597 0.713 . . . . 0.0 110.257 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.87 138.74 53.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 0.0 110.235 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -87.77 109.84 20.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 110.025 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.44 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 38.9 p90 -171.47 -26.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.44 HD23 ' CZ ' ' A' ' 29' ' ' PHE . 2.2 pp -105.8 -25.81 12.03 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 t -101.66 72.17 1.36 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.423 -0.798 . . . . 0.0 109.42 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 19.1 pt-20 -96.47 124.09 40.35 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.795 0.807 . . . . 0.0 109.524 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 35' ' ' ALA . 83.1 mt -87.45 -3.45 59.01 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.1 t0 56.63 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.547 -0.721 . . . . 0.0 110.552 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -92.25 151.74 41.86 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.659 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.93 144.76 77.88 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.501 2.134 . . . . 0.0 112.373 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 42.5 -141.31 0.13 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.611 0.719 . . . . 0.0 110.504 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 39' ' ' ALA . 1.5 pp0? -100.57 -4.56 28.32 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 38' ' ' GLN . . . 43.73 97.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.65 0.738 . . . . 0.0 110.253 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.16 149.5 50.15 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 43' ' ' SER . 73.6 m -83.51 -76.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.431 -1.04 . . . . 0.0 109.87 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 60.47 -1.05 0.23 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.0 109.144 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.67 ' H ' HG22 ' A' ' 41' ' ' THR . 12.4 p -71.63 158.02 36.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.038 -1.038 . . . . 0.0 110.412 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -175.02 27.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.13 137.69 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.409 -0.807 . . . . 0.0 109.952 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 m -71.34 150.97 44.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.226 -0.921 . . . . 0.0 110.499 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.58 -87.0 0.07 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 49' ' ' GLU . 3.5 m -60.63 -108.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.366 -1.079 . . . . 0.0 110.835 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.503 ' H ' HG23 ' A' ' 48' ' ' VAL . 64.7 tt0 58.99 37.4 24.54 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.38 97.05 0.11 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.9 tp -172.1 71.14 0.45 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.243 -1.151 . . . . 0.0 108.95 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.43 179.26 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.656 2.237 . . . . 0.0 112.105 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.07 147.16 91.64 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.397 2.065 . . . . 0.0 112.81 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.35 -20.86 43.8 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 55' ' ' LEU . 7.5 mp -105.27 143.23 33.73 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.417 -1.049 . . . . 0.0 110.054 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.22 159.36 42.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -137.64 163.35 31.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.461 -0.774 . . . . 0.0 109.786 -179.207 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -120.14 136.49 54.59 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.8 t -123.11 133.47 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.571 0.701 . . . . 0.0 109.989 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.96 113.43 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.533 -0.729 . . . . 0.0 109.57 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -65.81 -45.6 81.75 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.589 -0.694 . . . . 0.0 109.555 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -156.95 144.43 18.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . 157.2 -176.62 34.36 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -54.4 -38.79 89.4 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.993 2.462 . . . . 0.0 112.004 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -106.17 22.32 15.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . -39.69 107.62 0.07 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.789 -0.569 . . . . 0.0 110.427 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.6 -20.59 3.1 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.2 p -69.06 158.09 35.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.042 -1.269 . . . . 0.0 110.977 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -143.44 158.14 43.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.472 -0.767 . . . . 0.0 109.713 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.62 143.75 50.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.713 . . . . 0.0 109.648 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.4 tp -108.42 126.54 53.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.9 mt -98.68 112.16 24.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.342 -0.849 . . . . 0.0 109.355 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 66.7 t0 -132.34 36.47 3.6 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -140.0 155.06 47.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.273 -0.892 . . . . 0.0 109.885 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.04 91.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.551 -0.718 . . . . 0.0 110.203 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -128.31 129.09 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.342 -0.849 . . . . 0.0 109.852 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.9 m -124.66 125.96 44.95 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.5 m -87.31 161.61 17.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 109.527 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 99' ' ' ALA . . . -120.41 152.54 37.78 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.621 -0.674 . . . . 0.0 109.962 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.5 -130.37 10.2 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.522 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 96.7 mtt180 -100.43 134.39 43.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -1.06 . . . . 0.0 110.043 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 50.6 m-70 -165.4 152.23 9.22 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.07 -15.88 47.78 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.126 1.884 . . . . 0.0 110.893 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 85' ' ' SER . 34.5 t70 -142.13 -124.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.564 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.445 ' H ' ' CG ' ' A' ' 84' ' ' ASP . 3.5 m 59.02 138.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.765 0.793 . . . . 0.0 110.179 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.18 -41.13 99.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.459 -0.776 . . . . 0.0 109.87 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -88.11 120.47 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -129.97 86.75 2.44 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.593 -0.692 . . . . 0.0 109.208 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.9 mt -96.52 99.63 11.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.287 -0.883 . . . . 0.0 109.163 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -90.76 94.92 9.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -153.75 152.52 30.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.282 -0.886 . . . . 0.0 109.805 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 93' ' ' THR . 13.6 p -66.42 -34.72 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.401 ' N ' HG13 ' A' ' 92' ' ' VAL . 42.0 p -64.97 -31.42 72.64 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.858 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.4 t -98.16 126.26 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.111 -0.993 . . . . 0.0 110.196 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.9 t -76.58 168.52 19.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 110.242 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -60.84 -42.87 98.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.452 -0.78 . . . . 0.0 109.819 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -124.06 54.31 1.35 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.42 -0.8 . . . . 0.0 109.08 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.01 -41.72 97.37 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.557 -0.714 . . . . 0.0 109.551 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -151.73 157.44 42.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.05 -1.031 . . . . 0.0 109.971 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -136.11 149.18 48.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -112.14 144.03 42.2 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -132.86 138.18 46.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.537 -0.727 . . . . 0.0 109.247 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD1' ' O ' ' A' ' 107' ' ' GLU . 39.3 tp -88.99 129.79 35.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.44 -0.787 . . . . 0.0 109.997 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -169.54 158.66 7.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.402 -0.811 . . . . 0.0 108.928 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 59.24 31.81 21.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.591 -0.693 . . . . 0.0 109.652 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 52.47 32.53 11.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.444 -0.785 . . . . 0.0 109.607 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.555 ' O ' ' CG ' ' A' ' 108' ' ' PHE . 77.3 mm-40 -143.75 -119.71 0.09 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.322 -0.861 . . . . 0.0 108.852 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 107' ' ' GLU . 56.5 m-85 -162.92 150.98 13.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 109.222 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -137.26 151.2 48.43 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 110' ' ' VAL . 13.7 p -123.08 131.62 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.17 131.08 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.478 0.656 . . . . 0.0 109.31 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.611 ' CG ' ' H ' ' A' ' 119' ' ' THR . 89.2 m-20 -90.78 147.08 23.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.794 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 m -133.17 3.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.41 -136.72 6.61 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 116' ' ' LEU . 28.6 t -55.84 179.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.537 -0.978 . . . . 0.0 110.724 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.459 ' O ' HD13 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -62.38 -50.47 71.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.504 -0.747 . . . . 0.0 109.493 -179.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -65.18 -40.97 94.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 109.511 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.06 -140.51 22.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.611 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 33.4 m -64.3 163.69 12.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.068 . . . . 0.0 109.789 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.583 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 1.6 m-85 -127.22 138.84 53.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.598 -0.688 . . . . 0.0 109.452 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.9 134.24 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 47.76 -171.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.433 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -65.4 -18.82 65.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.2 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -104.99 104.47 46.88 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.568 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.84 142.13 28.01 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.043 1.828 . . . . 0.0 112.447 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 129' ' ' ALA . 3.8 m -139.6 163.09 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.252 -0.905 . . . . 0.0 110.454 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -66.76 -38.58 86.88 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.1 p -158.45 160.17 36.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.981 -1.074 . . . . 0.0 109.8 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -169.05 164.3 11.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.061 -1.025 . . . . 0.0 110.315 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.65 130.46 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.583 -0.698 . . . . 0.0 109.447 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.97 150.06 34.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 110.731 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.54 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -147.05 152.18 38.12 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.735 . . . . 0.0 109.358 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -55.52 134.36 50.72 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.669 0.747 . . . . 0.0 111.183 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.479 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 87.5 13.69 64.96 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 84.4 m-20 -89.99 163.88 14.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.253 -1.145 . . . . 0.0 110.17 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -121.12 132.95 55.16 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.58 131.67 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -114.53 119.02 35.41 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.1 mm -111.66 124.16 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.654 0.74 . . . . 0.0 109.638 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.72 -124.6 7.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -96.56 -1.9 46.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.515 -0.991 . . . . 0.0 108.59 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -95.51 142.48 27.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.575 -0.703 . . . . 0.0 109.847 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -107.44 133.74 51.5 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.637 -0.664 . . . . 0.0 109.882 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -138.34 161.14 37.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.422 -0.799 . . . . 0.0 109.132 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.95 132.39 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -90.03 117.56 28.92 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.479 HD23 ' H ' ' A' ' 134' ' ' GLY . 97.1 mt -134.86 163.64 29.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.716 -0.615 . . . . 0.0 110.125 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 150' ' ' HIS . 25.6 p -137.43 -162.01 1.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.633 -0.667 . . . . 0.0 109.897 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.43 74.54 0.02 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 148' ' ' THR . 12.7 p80 -76.19 129.47 36.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.171 -1.193 . . . . 0.0 110.24 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -78.28 139.27 38.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -0.835 . . . . 0.0 110.209 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -115.96 -71.44 0.74 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 57.34 63.2 5.52 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -64.28 144.59 57.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.093 -1.24 . . . . 0.0 109.846 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 157' ' ' GLU . 46.6 t0 57.34 22.21 7.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.485 -0.759 . . . . 0.0 109.442 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.487 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 74.4 mt 38.98 27.61 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.441 0.639 . . . . 0.0 109.82 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 155' ' ' ASP . 10.5 tm-20 -72.72 127.48 32.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.845 . . . . 0.0 110.205 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 156' ' ' LEU . 35.5 p-80 -174.23 44.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -60.08 -44.29 94.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.504 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -155.06 151.7 28.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.071 -1.018 . . . . 0.0 109.953 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -154.04 148.92 26.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.591 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.455 ' O ' ' OXT' ' A' ' 163' ' ' HIS . 33.9 t-80 -151.41 140.24 20.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.219 -0.926 . . . . 0.0 109.682 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.455 ' OXT' ' O ' ' A' ' 162' ' ' HIS . 58.0 t-80 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 117.753 -1.118 . . . . 0.0 110.205 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.715 0.769 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -82.64 -76.38 0.27 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.765 0.793 . . . . 0.0 109.666 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -72.67 136.31 45.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.359 -0.838 . . . . 0.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.34 147.79 52.82 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.926 0.87 . . . . 0.0 110.439 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -75.77 -4.42 40.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.523 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.505 ' CE1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -88.74 162.57 16.17 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.954 -1.091 . . . . 0.0 109.701 -179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.505 ' O ' ' CE1' ' A' ' 29' ' ' PHE . 33.9 mt -58.78 81.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.474 -0.767 . . . . 0.0 109.8 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 29' ' ' PHE . 7.0 t -103.45 -134.98 0.33 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.802 0.811 . . . . 0.0 109.832 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' OE1' ' OG ' ' A' ' 31' ' ' SER . 39.9 mp0 -80.04 106.88 12.38 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.019 0.914 . . . . 0.0 109.996 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.1 mp -70.65 143.36 51.45 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.817 0.818 . . . . 0.0 109.585 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -48.88 113.54 0.81 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.875 . . . . 0.0 110.86 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.412 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . -171.72 56.32 0.23 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.443 -0.785 . . . . 0.0 109.063 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 49.7 Cg_endo -68.96 156.15 66.26 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.851 2.367 . . . . 0.0 112.184 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.86 144.75 56.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 110.629 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -158.6 -68.44 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.765 0.793 . . . . 0.0 109.287 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -44.3 112.69 0.44 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.099 0.952 . . . . 0.0 110.559 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 41' ' ' THR . . . -85.61 -0.73 87.88 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 40' ' ' GLY . 3.1 p 38.33 55.36 1.79 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.907 0.86 . . . . 0.0 110.167 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.85 134.96 55.18 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.838 0.828 . . . . 0.0 110.336 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.4 m 49.32 -111.15 0.45 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.634 -0.666 . . . . 0.0 110.052 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -175.31 -27.77 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.15 139.18 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 0.0 110.483 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.3 m 56.07 87.53 0.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.966 0.889 . . . . 0.0 110.078 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.09 -60.77 0.83 Allowed Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.4 HG11 HD22 ' A' ' 51' ' ' LEU . 98.8 t -64.83 -45.67 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.214 -1.168 . . . . 0.0 110.296 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 43.99 79.21 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.139 -0.976 . . . . 0.0 110.397 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.14 117.24 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.576 HD11 ' H ' ' A' ' 149' ' ' GLY . 0.3 OUTLIER -110.66 139.59 21.77 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.616 -0.931 . . . . 0.0 109.819 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -50.36 160.29 1.62 Allowed 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.532 2.155 . . . . 0.0 112.09 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.45 144.2 49.68 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.666 2.244 . . . . 0.0 112.976 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.61 14.05 68.84 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.67 151.6 42.93 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.446 -1.032 . . . . 0.0 109.847 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.84 156.19 42.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.42 153.55 49.58 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.98 0.895 . . . . 0.0 110.13 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.63 134.9 54.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -122.97 135.36 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.875 0.845 . . . . 0.0 109.902 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.37 135.6 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.676 0.75 . . . . 0.0 110.101 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -84.65 -74.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.399 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.685 HH21 ' NH1' ' A' ' 143' ' ' ARG . 88.2 mtm180 -129.11 147.65 50.99 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.433 -0.792 . . . . 0.0 110.0 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.97 177.66 26.78 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -65.83 -19.04 58.93 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.664 2.243 . . . . 0.0 110.922 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 66' ' ' ALA . 35.5 m120 -84.47 -80.77 0.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.875 . . . . 0.0 109.508 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 58.8 131.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.974 0.892 . . . . 0.0 110.901 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.62 41.43 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.8 m -69.87 146.3 51.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -1.145 . . . . 0.0 111.011 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -145.5 156.53 43.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 109.786 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -129.54 144.35 51.23 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.5 tp -104.06 127.94 51.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.685 -0.634 . . . . 0.0 109.301 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -100.07 74.04 1.76 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.025 -1.047 . . . . 0.0 109.177 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -94.67 3.87 54.54 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -106.6 153.07 22.89 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.281 -0.887 . . . . 0.0 110.059 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.06 94.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.454 -0.779 . . . . 0.0 109.808 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.2 mt -125.55 126.86 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 86' ' ' ASP . 96.6 m -126.46 120.66 30.31 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 p -84.76 166.49 16.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.962 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.38 170.89 7.64 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.932 0.872 . . . . 0.0 110.215 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.29 -131.3 29.91 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -110.77 130.65 55.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -1.06 . . . . 0.0 110.104 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -170.08 136.14 1.27 Allowed Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -42.57 -58.47 1.26 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.485 2.123 . . . . 0.0 112.653 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -96.1 92.72 6.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.935 . . . . 0.0 109.88 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.48 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 82.9 p -171.13 121.09 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 108.972 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.466 ' H ' HG23 ' A' ' 77' ' ' THR . 59.3 m-20 -68.1 -34.32 76.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.421 -0.799 . . . . 0.0 109.298 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.94 130.19 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.861 -1.149 . . . . 0.0 109.761 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 62.4 m-85 -129.07 89.33 2.85 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.427 -0.796 . . . . 0.0 109.401 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.7 mt -101.18 103.35 14.39 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -92.52 87.66 6.05 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.626 0.727 . . . . 0.0 109.881 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.46 ' OD2' ' CZ ' ' A' ' 142' ' ' PHE . 65.2 m-20 -150.22 149.53 30.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.963 . . . . 0.0 109.757 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.2 m -72.79 -26.27 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.733 0.778 . . . . 0.0 109.568 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.2 p -71.66 -17.21 62.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 109.382 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.0 t -110.94 126.78 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.325 -0.859 . . . . 0.0 109.415 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 p -77.08 168.63 19.76 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.797 0.808 . . . . 0.0 110.667 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -63.67 -38.08 89.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.477 -0.764 . . . . 0.0 109.878 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -129.97 50.56 2.17 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.117 -0.989 . . . . 0.0 109.115 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -62.63 -40.8 98.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.078 -1.014 . . . . 0.0 108.969 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.99 159.89 43.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.898 -1.126 . . . . 0.0 110.107 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -134.55 150.53 50.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.498 -0.751 . . . . 0.0 109.436 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.27 140.05 48.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.575 -0.703 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -134.56 136.86 43.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.433 -0.792 . . . . 0.0 109.189 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 38.5 tp -102.63 127.68 49.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -155.66 143.74 19.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.19 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 56.24 39.73 30.15 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.547 0.689 . . . . 0.0 110.135 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 55.22 31.79 17.2 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.597 0.713 . . . . 0.0 109.382 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -139.79 130.96 26.5 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.237 -0.914 . . . . 0.0 109.753 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -83.62 146.27 28.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -147.58 167.15 25.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.152 -0.967 . . . . 0.0 109.379 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.21 135.59 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.9 t -125.63 130.84 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 119' ' ' THR . 15.0 m-20 -95.23 134.35 38.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.37 -3.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -88.44 129.86 9.82 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.442 ' C ' ' N ' ' A' ' 117' ' ' ASN . 2.9 t 39.87 24.53 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.075 0.94 . . . . 0.0 109.791 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 114' ' ' GLY . 4.6 tp 55.81 9.56 0.45 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.927 0.87 . . . . 0.0 108.78 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' N ' ' C ' ' A' ' 115' ' ' SER . 66.1 t30 -155.98 114.77 3.46 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.341 -0.85 . . . . 0.0 109.188 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.501 ' O ' ' CZ ' ' A' ' 120' ' ' TYR . . . -149.11 -67.18 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.572 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 29.0 m -67.44 137.03 55.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.331 -1.099 . . . . 0.0 110.489 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.501 ' CZ ' ' O ' ' A' ' 118' ' ' GLY . 22.5 m-85 -127.89 145.34 50.98 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.786 . . . . 0.0 109.379 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.452 HG22 ' N ' ' A' ' 122' ' ' ASN . 9.4 p -109.59 157.05 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.847 0.832 . . . . 0.0 109.752 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.452 ' N ' HG22 ' A' ' 121' ' ' VAL . 6.8 m120 -53.21 -39.6 63.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.828 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -57.41 -83.41 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.941 -1.099 . . . . 0.0 109.631 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -143.35 147.39 39.94 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.076 -1.015 . . . . 0.0 109.553 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.18 120.73 8.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.603 2.202 . . . . 0.0 111.894 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.69 163.18 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.186 -0.946 . . . . 0.0 110.203 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 128' ' ' SER . 47.8 p-10 -66.94 -33.03 74.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.55 -0.719 . . . . 0.0 109.487 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.548 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 86.4 p -152.23 160.19 43.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.047 . . . . 0.0 109.278 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.39 156.51 30.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.029 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.1 130.15 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.491 -0.755 . . . . 0.0 109.941 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.6 mt -76.49 151.38 36.45 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.849 0.833 . . . . 0.0 110.209 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.553 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.77 155.71 39.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.507 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -51.33 124.02 10.91 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.921 0.867 . . . . 0.0 110.972 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.07 16.22 59.71 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.553 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 28.9 m-20 -87.75 155.48 19.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.925 -1.338 . . . . 0.0 110.565 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 56.6 mp0 -113.61 128.2 56.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.661 -0.649 . . . . 0.0 109.499 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 144' ' ' LEU . 54.8 t -125.45 131.48 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.403 ' O ' ' NE2' ' A' ' 138' ' ' GLN . 4.9 pp0? -123.2 132.83 54.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.706 -0.621 . . . . 0.0 109.776 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.18 117.08 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.668 0.747 . . . . 0.0 109.052 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 61.26 -127.84 43.07 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -93.27 -5.33 50.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -1.161 . . . . 0.0 109.02 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.46 ' CZ ' ' OD2' ' A' ' 91' ' ' ASP . 57.8 m-85 -96.13 133.7 40.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.184 -0.947 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.685 ' NH1' HH21 ' A' ' 62' ' ' ARG . 83.3 mtp180 -103.27 139.4 38.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.592 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 137' ' ' VAL . 4.7 mp -135.51 166.47 23.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 109.47 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.0 p -128.69 133.67 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.652 0.739 . . . . 0.0 109.567 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -96.1 115.52 27.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -0.828 . . . . 0.0 109.249 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.57 147.88 51.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.626 0.727 . . . . 0.0 109.668 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 150' ' ' HIS . 6.3 p -134.41 167.46 20.71 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.541 0.686 . . . . 0.0 109.632 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.576 ' H ' HD11 ' A' ' 51' ' ' LEU . . . -69.84 34.26 0.38 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.522 ' H ' ' C ' ' A' ' 148' ' ' THR . 51.0 t-80 58.02 146.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.598 -0.943 . . . . 0.0 111.039 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -77.1 147.94 36.34 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.875 0.845 . . . . 0.0 110.616 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -70.24 165.05 23.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.922 0.868 . . . . 0.0 111.045 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.14 111.22 0.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -150.83 -35.07 0.15 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.281 -1.129 . . . . 0.0 108.292 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.5 p-10 -68.15 148.08 51.41 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.247 -0.908 . . . . 0.0 110.53 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 74.5 mt -69.27 141.9 54.25 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.92 0.867 . . . . 0.0 110.524 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -76.79 143.66 39.68 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.986 0.898 . . . . 0.0 110.107 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -74.51 141.31 44.89 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.695 0.759 . . . . 0.0 110.514 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -152.78 -158.81 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.319 -0.863 . . . . 0.0 109.979 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 55.4 79.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.977 0.894 . . . . 0.0 109.862 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -154.64 146.55 23.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.549 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -144.6 124.6 13.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.265 -0.897 . . . . 0.0 108.994 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 163' ' ' HIS . 61.3 t-80 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.457 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' ' O ' ' A' ' 26' ' ' ARG . 43.5 p90 -87.33 -11.68 48.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 109.241 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 25' ' ' PHE . 91.1 mtm-85 55.62 116.26 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.632 0.729 . . . . 0.0 110.892 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.409 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -66.14 -136.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.582 -0.699 . . . . 0.0 110.41 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -78.94 -3.46 44.99 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.267 -0.896 . . . . 0.0 109.663 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 3.0 p90 -148.64 -125.4 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.559 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 32' ' ' GLU . 89.6 mt 60.42 130.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.663 0.744 . . . . 0.0 110.384 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.5 t 47.86 -86.94 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.18 0.514 . . . . 0.0 110.079 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' LEU . 45.7 tp10 56.46 72.18 0.52 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.326 -0.859 . . . . 0.0 110.086 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 mt 58.08 -178.3 0.07 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.715 0.769 . . . . 0.0 111.494 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -86.86 111.6 20.94 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.427 0.632 . . . . 0.0 109.643 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.673 ' HB1' ' CD ' ' A' ' 36' ' ' PRO . . . -78.29 -178.23 1.01 Allowed Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.434 -0.791 . . . . 0.0 109.587 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.673 ' CD ' ' HB1' ' A' ' 35' ' ' ALA . 35.8 Cg_exo -59.84 144.83 99.39 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.918 2.412 . . . . 0.0 112.944 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 39' ' ' ALA . . . -86.53 -11.12 52.53 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 51.8 -83.24 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.583 -0.698 . . . . 0.0 110.127 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . -62.74 -21.28 65.69 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.284 -0.885 . . . . 0.0 109.472 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.91 25.36 41.51 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 98.7 m -63.23 -43.37 98.26 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.407 -1.055 . . . . 0.0 109.711 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -50.35 139.83 14.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 110.992 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 p 45.63 70.25 0.38 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.684 -0.635 . . . . 0.0 110.188 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.76 -64.46 1.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.703 -0.623 . . . . 0.0 109.379 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.48 128.23 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.931 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.1 p -78.63 162.85 25.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.444 -0.785 . . . . 0.0 110.545 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.61 -174.49 48.19 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 50' ' ' GLY . 15.1 t -85.17 118.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.549 -0.971 . . . . 0.0 109.827 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' VAL . 46.0 tt0 39.7 -93.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.779 -0.576 . . . . 0.0 110.668 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . -107.64 -44.38 1.23 Allowed Glycine 0 N--CA 1.497 2.754 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 50' ' ' GLY . 0.4 OUTLIER 42.72 78.5 0.38 Allowed Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.327 -1.102 . . . . 0.0 109.566 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.38 169.94 20.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.108 1.872 . . . . 0.0 112.485 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -56.82 147.42 72.72 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.395 2.063 . . . . 0.0 112.872 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.24 -15.02 54.85 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -122.37 142.97 49.95 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.558 -0.966 . . . . 0.0 109.223 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.13 155.18 41.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -127.38 157.12 40.82 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.186 0.517 . . . . 0.0 109.733 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.4 mt -117.04 128.7 55.42 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.01 134.08 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.642 0.734 . . . . 0.0 109.538 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.6 t -78.36 111.69 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.677 -0.64 . . . . 0.0 109.898 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -64.88 -43.62 92.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.577 -0.702 . . . . 0.0 110.219 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -137.21 151.77 49.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.534 -0.729 . . . . 0.0 110.287 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.06 172.29 22.61 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.21 -20.83 55.81 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.956 2.437 . . . . 0.0 112.006 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' O ' ' C ' ' A' ' 66' ' ' ALA . 93.1 m-20 -98.65 -35.74 10.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.446 -0.784 . . . . 0.0 109.357 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . 35.42 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.313 0.578 . . . . 0.0 110.789 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.48 -15.13 3.66 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.9 m -62.86 144.49 56.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -1.008 . . . . 0.0 110.766 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -137.57 156.04 48.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.603 -0.686 . . . . 0.0 109.354 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -126.32 146.75 49.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.626 -0.671 . . . . 0.0 109.315 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.665 HD13 ' N ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -104.78 126.56 51.97 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 71' ' ' LEU . 79.3 mt -100.53 124.47 46.12 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.452 0.644 . . . . 0.0 109.669 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -154.39 56.63 0.7 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.429 ' CD ' ' N ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -161.08 175.57 12.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.491 -0.756 . . . . 0.0 109.547 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.13 -65.53 1.0 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.495 -0.753 . . . . 0.0 110.297 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mm -108.56 124.56 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.765 . . . . 0.0 110.212 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.411 ' OG1' ' CD ' ' A' ' 74' ' ' GLN . 31.5 m -127.97 127.08 42.62 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 p -84.65 165.02 18.27 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.562 -0.711 . . . . 0.0 109.936 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 98' ' ' HIS . . . -109.79 164.93 12.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.631 -0.668 . . . . 0.0 110.026 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.445 ' N ' ' NE2' ' A' ' 98' ' ' HIS . . . 70.99 -127.73 15.51 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.535 ' O ' ' ND1' ' A' ' 82' ' ' HIS . 96.9 mtt180 -101.87 137.01 40.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.399 -1.059 . . . . 0.0 110.491 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 173.13 153.79 0.25 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.3 144.41 51.07 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.733 2.289 . . . . 0.0 113.059 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 55.5 t0 57.09 28.6 15.17 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.451 -0.781 . . . . 0.0 109.348 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 18.3 t -98.19 119.81 37.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.34 -0.85 . . . . 0.0 109.572 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -65.03 -36.45 84.41 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.42 -0.8 . . . . 0.0 109.318 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -78.24 128.45 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.892 . . . . 0.0 110.212 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 91.6 m-85 -126.85 86.98 2.58 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.8 mt -108.21 106.45 16.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.619 0.723 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 55.6 t0 -86.51 90.82 8.35 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.501 ' OD2' ' CE2' ' A' ' 142' ' ' PHE . 71.1 m-20 -151.33 130.66 12.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.876 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.14 -24.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.4 p -75.18 -13.81 60.49 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.554 -0.717 . . . . 0.0 109.182 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 95' ' ' SER . 89.5 t -101.75 -15.1 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 94' ' ' VAL . 79.4 p 50.23 174.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.592 0.71 . . . . 0.0 110.792 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -59.88 -65.66 0.64 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 109.935 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -102.17 134.53 45.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.648 -0.658 . . . . 0.0 109.779 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.484 ' CE1' ' HB1' ' A' ' 79' ' ' ALA . 4.8 p80 -154.3 -35.42 0.1 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -151.67 158.52 43.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.823 . . . . 0.0 109.928 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -137.16 151.2 48.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.653 -0.654 . . . . 0.0 109.67 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.5 142.63 43.53 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -134.65 141.03 46.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.796 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.9 tp -102.44 127.13 49.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.683 -0.635 . . . . 0.0 109.32 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 106' ' ' ASN . 80.5 tt0 -155.99 -70.69 0.11 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.557 -0.714 . . . . 0.0 109.355 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -72.05 32.71 0.06 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.497 -0.752 . . . . 0.0 109.529 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 104' ' ' GLU . 16.2 p30 44.02 30.19 0.4 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.658 0.742 . . . . 0.0 109.53 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 108' ' ' PHE . 96.1 mt-10 -144.47 10.24 1.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 107' ' ' GLU . 94.1 m-85 58.17 144.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.255 0.55 . . . . 0.0 110.494 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -133.76 163.7 28.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.3 132.18 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.737 -0.602 . . . . 0.0 109.487 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.7 t -128.65 133.6 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.98 114.67 21.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.317 -0.864 . . . . 0.0 109.487 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.04 -177.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 111.006 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.2 -3.64 65.92 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.7 p -74.09 158.89 33.42 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 110.429 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.522 HD23 ' C ' ' A' ' 116' ' ' LEU . 3.5 tt -69.86 106.58 3.2 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.404 -0.81 . . . . 0.0 109.854 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.406 ' N ' HD23 ' A' ' 116' ' ' LEU . 63.2 t-20 -155.24 110.17 3.0 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.346 -0.846 . . . . 0.0 108.902 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.38 48.52 4.06 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -63.81 136.06 57.11 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.358 -1.084 . . . . 0.0 110.402 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.423 ' OH ' ' NH1' ' A' ' 123' ' ' ARG . 31.4 p90 -141.54 157.98 44.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.513 -0.742 . . . . 0.0 109.12 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 121' ' ' VAL . 9.1 p -121.02 128.86 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.451 0.643 . . . . 0.0 109.888 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 54.35 38.54 29.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.65 -0.656 . . . . 0.0 109.614 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.423 ' NH1' ' OH ' ' A' ' 120' ' ' TYR . 31.0 mmt180 60.47 44.01 12.45 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.436 0.636 . . . . 0.0 110.21 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -147.63 87.21 6.01 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.522 -0.736 . . . . 0.0 109.127 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.4 130.45 38.61 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.378 2.052 . . . . 0.0 112.076 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.5 m -147.34 154.4 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.326 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.89 -39.81 94.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.6 p -157.26 157.35 34.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.229 -0.919 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.37 149.99 14.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.288 -0.883 . . . . 0.0 109.806 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.65 135.98 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.501 -0.749 . . . . 0.0 110.434 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.28 148.89 37.25 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.358 -0.839 . . . . 0.0 109.856 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.03 154.72 44.28 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.571 0.701 . . . . 0.0 109.773 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -55.97 115.07 2.19 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.581 0.705 . . . . 0.0 110.751 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 146' ' ' PHE . . . 84.13 15.34 69.78 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 136' ' ' GLU . 67.7 t0 -64.23 145.74 55.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -1.211 . . . . 0.0 109.996 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 135' ' ' ASP . 98.4 mt-10 -93.49 122.12 35.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 52.8 t -122.05 132.89 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -122.67 124.92 44.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 141' ' ' LYS . 96.6 mt -124.42 129.95 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.307 0.575 . . . . 0.0 109.947 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.69 -88.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 139' ' ' ILE . 63.3 mttp -141.88 -4.33 1.07 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.461 -1.023 . . . . 0.0 108.624 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.501 ' CE2' ' OD2' ' A' ' 91' ' ' ASP . 62.2 m-85 -96.94 140.49 31.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.767 . . . . 0.0 109.924 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -105.0 129.48 53.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.658 -0.651 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.07 149.68 50.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.22 129.06 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.6 0.714 . . . . 0.0 109.119 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 134' ' ' GLY . 76.0 t80 -90.08 127.67 36.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.764 -0.585 . . . . 0.0 109.582 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.911 HD23 ' N ' ' A' ' 147' ' ' LEU . 0.6 OUTLIER -143.41 174.95 10.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.823 0.821 . . . . 0.0 110.06 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 18.9 p -145.34 -151.58 0.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.525 0.678 . . . . 0.0 109.482 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -73.69 8.35 11.0 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 86.1 t60 54.03 77.12 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.216 -1.167 . . . . 0.0 109.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -85.69 143.09 28.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.28 -0.888 . . . . 0.0 110.591 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.36 143.06 53.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.563 -0.711 . . . . 0.0 110.238 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -74.88 -124.65 0.14 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 54.91 -165.77 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.625 -0.927 . . . . 0.0 110.84 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -61.55 149.11 40.03 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.803 0.811 . . . . 0.0 110.92 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.03 144.97 55.85 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.604 0.716 . . . . 0.0 110.669 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -61.81 148.73 42.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.515 -0.741 . . . . 0.0 110.299 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -76.34 155.28 34.3 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.723 -0.611 . . . . 0.0 110.307 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -133.88 138.14 45.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.513 -0.742 . . . . 0.0 109.416 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -90.46 129.76 36.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.441 -0.787 . . . . 0.0 110.221 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -66.53 -35.56 80.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.6 -0.687 . . . . 0.0 109.617 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 82.8 t60 58.11 86.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.49 -0.757 . . . . 0.0 109.716 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 82.4 t60 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.63 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 25' ' ' PHE . 7.5 p . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 26' ' ' ARG . 72.1 t80 54.13 108.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.371 -0.831 . . . . 0.0 110.225 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 25' ' ' PHE . 62.8 ttm-85 56.89 149.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.71 0.767 . . . . 0.0 110.251 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.02 137.75 58.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.877 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 9.7 p-10 -95.35 -0.74 52.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 0.0 109.602 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -105.16 -17.66 14.4 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -94.44 -10.39 32.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -89.9 -12.97 37.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -111.38 117.06 32.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.449 -0.782 . . . . 0.0 109.335 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.69 -41.96 98.07 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.762 -0.586 . . . . 0.0 110.617 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.92 114.12 25.2 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.117 -0.99 . . . . 0.0 109.973 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.651 ' HB3' ' CD ' ' A' ' 36' ' ' PRO . . . -166.09 -62.95 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.447 -0.783 . . . . 0.0 109.399 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.651 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 22.4 Cg_endo -59.51 -28.7 88.14 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.073 1.849 . . . . 0.0 111.45 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.411 ' C ' ' O ' ' A' ' 36' ' ' PRO . . . 39.27 -153.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.6 0.714 . . . . 0.0 110.926 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.661 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -95.51 10.96 34.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.433 -0.792 . . . . 0.0 109.136 179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 38' ' ' GLN . . . 63.29 18.92 11.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.0 109.938 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.427 ' H ' ' HG2' ' A' ' 38' ' ' GLN . . . -87.16 -135.4 4.45 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.5 p 48.09 -162.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.997 . . . . 0.0 110.817 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.38 -168.74 0.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.689 0.757 . . . . 0.0 111.163 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.418 ' O ' ' OG ' ' A' ' 43' ' ' SER . 7.8 t 51.38 22.12 1.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.714 . . . . 0.0 109.252 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.94 -5.42 59.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.404 -0.81 . . . . 0.0 109.368 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.88 138.49 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.322 -0.861 . . . . 0.0 109.877 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 p -75.95 162.16 28.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 95.77 0.98 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 50' ' ' GLY . 33.6 m -77.61 138.35 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -1.112 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -50.69 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.411 -0.805 . . . . 0.0 110.661 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . 58.63 165.06 0.1 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.444 HD22 ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -154.75 85.61 3.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.454 -1.027 . . . . 0.0 108.54 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -55.58 -42.43 67.83 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.44 2.094 . . . . 0.0 113.783 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -73.6 23.7 0.33 Allowed 'Trans proline' 0 N--CA 1.489 1.242 0 CA-C-N 120.058 1.056 . . . . 0.0 112.048 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.479 ' O ' HD12 ' A' ' 55' ' ' LEU . . . 49.76 81.68 0.05 OUTLIER Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 54' ' ' GLY . 7.2 mp -116.52 160.75 20.17 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.509 -0.995 . . . . 0.0 109.526 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.81 154.93 51.04 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.35 152.66 48.67 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.454 -0.779 . . . . 0.0 109.616 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.0 mt -113.7 134.41 54.76 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.8 134.98 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.62 110.84 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.576 -0.703 . . . . 0.0 109.632 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -64.55 -44.98 89.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.861 . . . . 0.0 109.68 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -141.88 148.34 38.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.363 -0.835 . . . . 0.0 109.898 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.52 178.69 27.43 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.68 -40.48 84.22 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.326 2.017 . . . . 0.0 111.497 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -114.02 48.24 1.11 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.09 95.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.512 -0.743 . . . . 0.0 109.387 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.53 -17.04 0.58 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.2 t -62.56 150.23 41.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.492 -1.005 . . . . 0.0 109.513 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -130.3 156.2 45.05 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.633 -0.667 . . . . 0.0 109.292 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.17 146.07 50.83 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.533 -0.73 . . . . 0.0 109.286 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 tp -105.66 125.36 50.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.642 -0.661 . . . . 0.0 109.557 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.54 77.85 2.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.406 -0.809 . . . . 0.0 109.0 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.01 12.85 18.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 0.0 109.405 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -126.51 140.63 52.31 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.93 88.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.521 -0.737 . . . . 0.0 110.446 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 mm -106.18 118.47 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.303 -0.873 . . . . 0.0 109.764 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.9 m -123.22 122.85 39.41 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.5 t -87.65 167.3 14.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.175 -0.953 . . . . 0.0 109.543 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 99' ' ' ALA . . . -122.51 146.88 46.99 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.556 -0.715 . . . . 0.0 109.097 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.71 -125.22 8.01 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 99.8 mtt180 -103.32 133.33 48.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.436 -1.037 . . . . 0.0 110.556 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 0.7 OUTLIER 175.11 120.12 0.12 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.08 -14.76 23.44 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.59 1.526 . . . . 0.0 111.287 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 66.5 t0 -96.74 -24.13 16.09 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.727 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.5 t -74.55 139.92 44.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.446 -0.784 . . . . 0.0 110.659 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.59 -41.29 96.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 109.687 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.74 129.51 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.344 -0.848 . . . . 0.0 110.303 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CZ ' ' OD2' ' A' ' 90' ' ' ASP . 84.4 t80 -129.25 84.84 2.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.7 mt -108.54 109.34 20.55 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.559 -0.713 . . . . 0.0 109.916 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.517 ' OD2' ' CZ ' ' A' ' 88' ' ' PHE . 97.9 m-20 -99.95 -93.38 0.27 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.511 -0.743 . . . . 0.0 109.352 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.468 ' CG ' ' CE1' ' A' ' 142' ' ' PHE . 1.5 p30 39.75 -165.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.645 0.736 . . . . 0.0 110.783 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.9 m -71.84 161.55 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 110.057 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.5 p 54.56 -139.77 0.98 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.279 0.562 . . . . 0.0 110.676 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.2 t 42.72 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.493 -0.754 . . . . 0.0 109.649 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -69.36 173.33 5.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.47 -0.769 . . . . 0.0 110.816 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -60.39 -43.91 96.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.48 -0.762 . . . . 0.0 109.358 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -123.23 64.14 1.0 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.36 -35.08 25.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.536 -0.728 . . . . 0.0 109.69 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -150.45 149.62 30.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 109.803 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -141.49 134.23 28.68 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -100.98 145.8 28.23 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.507 -0.746 . . . . 0.0 109.786 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -131.63 132.18 43.81 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.9 tp -90.75 130.57 36.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.307 -0.871 . . . . 0.0 109.622 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 106' ' ' ASN . 49.1 tp10 -131.97 140.81 49.1 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.582 -0.699 . . . . 0.0 109.319 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 51.63 -85.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.469 -0.769 . . . . 0.0 110.085 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 104' ' ' GLU . 16.9 t-20 -155.75 20.57 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.456 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -134.02 139.95 46.37 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.548 -0.72 . . . . 0.0 109.373 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -77.34 147.13 36.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.513 -0.742 . . . . 0.0 109.981 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -124.85 160.89 27.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.33 134.15 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.8 t -127.33 135.48 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 119' ' ' THR . 50.2 t0 -84.0 111.73 19.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.188 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.0 t -94.23 109.48 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.425 -0.797 . . . . 0.0 109.304 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.12 -177.9 39.68 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 116' ' ' LEU . 39.6 t -69.7 135.49 49.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -1.095 . . . . 0.0 109.907 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.525 ' N ' HD22 ' A' ' 116' ' ' LEU . 3.8 mm? 43.93 -170.85 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.327 -0.858 . . . . 0.0 110.684 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 118' ' ' GLY . 58.6 t-20 -71.95 147.75 46.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.769 . . . . 0.0 110.341 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 117' ' ' ASN . . . -148.98 -72.59 0.01 OUTLIER Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.553 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 23.8 m -62.28 139.59 58.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.174 -1.192 . . . . 0.0 109.874 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -132.9 157.62 44.63 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.462 -0.774 . . . . 0.0 109.223 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 121' ' ' VAL . 8.8 p -118.94 128.42 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.561 -0.712 . . . . 0.0 109.375 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 54.55 38.24 29.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.918 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 63.1 46.69 4.53 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.506 0.67 . . . . 0.0 109.833 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -148.6 88.98 5.15 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.091 -1.005 . . . . 0.0 109.24 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.446 ' C ' HD21 ' A' ' 117' ' ' ASN . 37.1 Cg_exo -55.06 132.35 51.8 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.226 1.951 . . . . 0.0 112.393 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.471 ' N ' HD21 ' A' ' 117' ' ' ASN . 22.1 m -151.5 156.12 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.276 -0.89 . . . . 0.0 109.863 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.29 -40.63 96.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.824 . . . . 0.0 109.379 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.7 t -161.51 156.0 22.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.258 -0.901 . . . . 0.0 109.347 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.43 156.47 38.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.6 t -88.6 130.19 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.342 -0.849 . . . . 0.0 109.247 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.52 149.2 34.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.838 . . . . 0.0 110.218 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.526 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.41 163.81 37.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.416 -0.802 . . . . 0.0 109.267 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.421 ' ND2' ' OG1' ' A' ' 148' ' ' THR . 46.2 m-80 -56.53 138.49 51.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.285 -0.884 . . . . 0.0 110.43 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.549 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 80.36 13.55 81.6 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 27.5 m-20 -83.03 145.15 29.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.25 . . . . 0.0 109.623 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -112.87 126.53 55.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.42 132.47 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.6 -0.688 . . . . 0.0 109.333 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -119.42 127.8 53.44 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.57 127.46 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.531 0.681 . . . . 0.0 110.052 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 54.51 -104.65 0.27 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -116.78 -24.85 7.52 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.616 -0.932 . . . . 0.0 109.465 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.468 ' CE1' ' CG ' ' A' ' 91' ' ' ASP . 25.2 m-85 -76.33 142.77 41.14 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.347 -0.846 . . . . 0.0 110.077 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -107.85 137.08 46.5 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -136.54 155.49 49.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.389 -0.819 . . . . 0.0 109.415 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 145' ' ' VAL . 12.3 p -119.82 131.14 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -94.8 120.54 35.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.397 -0.814 . . . . 0.0 109.985 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.549 HD23 ' H ' ' A' ' 134' ' ' GLY . 16.3 mt -134.18 150.43 51.08 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.421 ' OG1' ' ND2' ' A' ' 133' ' ' ASN . 4.5 p -128.37 159.93 33.8 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.434 ' H ' HD21 ' A' ' 51' ' ' LEU . . . -82.87 86.95 1.47 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.611 ' CG ' ' H ' ' A' ' 151' ' ' LYS . 86.3 t60 -85.95 177.2 7.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.445 -1.032 . . . . 0.0 109.482 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.611 ' H ' ' CG ' ' A' ' 150' ' ' HIS . 99.0 mttt -68.85 157.91 35.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 110.396 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 55.83 164.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.679 . . . . 0.0 110.741 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.37 -147.43 4.83 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 155' ' ' ASP . 79.1 mm-40 48.51 -124.42 1.83 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.275 -1.132 . . . . 0.0 109.772 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 154' ' ' GLU . 99.7 m-20 54.49 167.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 110.012 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.558 ' N ' HD22 ' A' ' 156' ' ' LEU . 3.8 mm? -90.8 129.27 36.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.41 -0.806 . . . . 0.0 109.913 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -145.09 -49.58 0.25 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.402 -0.812 . . . . 0.0 108.899 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -152.48 165.65 34.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.27 -0.894 . . . . 0.0 109.815 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -60.89 111.11 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.375 -0.828 . . . . 0.0 109.363 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -86.03 134.04 33.87 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.301 -0.875 . . . . 0.0 109.649 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -78.65 119.47 21.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.455 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 163' ' ' HIS . 58.2 t-80 -85.58 164.82 17.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 162' ' ' HIS . 84.7 t60 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.037 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.691 0.758 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CG ' ' N ' ' A' ' 26' ' ' ARG . 14.0 t80 -153.11 -163.76 1.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.68 0.752 . . . . 0.0 110.024 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.434 ' N ' ' CG ' ' A' ' 25' ' ' PHE . 96.4 mtt180 55.79 179.04 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.548 0.689 . . . . 0.0 110.292 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 29' ' ' PHE . . . -67.95 151.26 47.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.654 0.74 . . . . 0.0 109.991 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -58.04 -0.67 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 27' ' ' ALA . 32.8 p90 -145.04 -160.13 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.498 -0.751 . . . . 0.0 109.711 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' A' ' 29' ' ' PHE . 51.8 mt -61.46 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.763 0.792 . . . . 0.0 110.277 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -66.93 -15.87 63.96 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 58.54 84.48 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.606 0.717 . . . . 0.0 110.175 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.1 tp -63.95 -42.53 97.28 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -85.71 110.18 19.13 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.733 0.777 . . . . 0.0 109.711 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.95 152.35 50.87 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.832 -0.542 . . . . 0.0 110.565 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 37' ' ' ALA . 26.4 Cg_endo -63.49 146.67 93.2 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.463 2.108 . . . . 0.0 112.847 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . 50.32 103.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.544 0.687 . . . . 0.0 109.993 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -65.85 175.22 2.04 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.809 0.814 . . . . 0.0 110.385 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.07 139.88 54.84 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.804 0.812 . . . . 0.0 110.063 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.99 174.99 31.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.6 p -98.02 -13.32 21.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.743 -0.857 . . . . 0.0 108.897 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.1 pm0 -111.08 -109.57 0.34 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.575 -0.703 . . . . 0.0 109.639 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.533 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 96.2 p -164.82 -32.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . 70.14 -39.34 0.44 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.729 -0.607 . . . . 0.0 109.64 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.505 ' H ' ' C ' ' A' ' 43' ' ' SER . 10.5 t 51.68 106.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.686 0.755 . . . . 0.0 110.28 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.7 p -73.91 162.57 28.93 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.732 0.777 . . . . 0.0 110.209 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . -170.43 -156.94 11.77 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.565 HG11 HH22 ' A' ' 69' ' ' ARG . 24.9 m -74.32 30.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.913 -0.757 . . . . 0.0 109.608 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 47' ' ' GLY . 80.1 mm-40 -69.71 -4.2 18.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.25 141.13 3.06 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -141.51 76.26 21.14 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.75 -0.853 . . . . 0.0 109.293 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 51' ' ' LEU . 50.4 Cg_exo -47.64 -176.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.373 2.049 . . . . 0.0 111.396 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 52' ' ' PRO . 33.7 Cg_exo -60.15 146.33 96.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.381 2.054 . . . . 0.0 113.07 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.6 -0.01 82.41 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.9 mt -124.6 145.96 49.32 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.654 -0.91 . . . . 0.0 110.36 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.37 166.51 31.64 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.588 0.708 . . . . 0.0 109.85 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -125.83 146.19 49.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.843 0.83 . . . . 0.0 110.236 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.6 mt -125.43 140.9 52.39 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.672 0.749 . . . . 0.0 109.575 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -140.99 143.37 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.745 0.784 . . . . 0.0 110.341 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.6 t -73.76 131.09 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.792 0.806 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -95.22 -32.0 13.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -151.71 140.55 20.95 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.781 0.8 . . . . 0.0 109.966 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.37 167.48 11.66 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.05 -17.71 40.67 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.823 2.349 . . . . 0.0 111.384 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.38 19.52 13.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.43 143.05 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.865 0.84 . . . . 0.0 110.369 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.96 -14.28 61.6 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.4 t -68.16 138.61 55.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.644 -0.915 . . . . 0.0 110.892 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.565 HH22 HG11 ' A' ' 48' ' ' VAL . 85.8 mtp180 -134.52 143.48 47.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.74 0.781 . . . . 0.0 110.231 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -128.91 136.58 50.6 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.633 0.73 . . . . 0.0 109.652 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.513 HD23 ' C ' ' A' ' 71' ' ' LEU . 6.6 tt -110.25 123.52 49.93 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.885 0.85 . . . . 0.0 109.74 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 71' ' ' LEU . 57.5 mt -90.3 113.38 25.22 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.552 0.691 . . . . 0.0 109.59 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -147.21 70.88 1.2 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.674 0.75 . . . . 0.0 109.197 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 75' ' ' ALA . 54.3 tp60 -171.07 -121.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.651 -0.656 . . . . 0.0 109.763 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 74' ' ' GLN . . . -167.14 127.6 1.51 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.751 0.786 . . . . 0.0 109.805 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mm 63.57 82.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.632 0.729 . . . . 0.0 109.385 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.4 m -99.41 123.38 43.64 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.781 0.801 . . . . 0.0 110.136 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.1 t -91.44 166.43 12.87 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.538 0.685 . . . . 0.0 109.411 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.54 154.95 26.27 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.774 0.797 . . . . 0.0 110.019 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 101.83 -118.97 6.31 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.551 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 84.9 mtp180 -124.08 130.62 52.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.78 -0.835 . . . . 0.0 110.352 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 3.1 m-70 176.3 149.37 0.31 Allowed Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.05 -30.99 20.09 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.88 2.386 . . . . 0.0 112.158 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -93.0 -0.25 57.25 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.0 t -94.74 118.93 32.53 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.717 0.77 . . . . 0.0 109.803 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.01 -39.94 94.17 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.335 0.588 . . . . 0.0 109.44 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.714 ' N ' HD12 ' A' ' 87' ' ' ILE . 1.9 mp -82.56 125.57 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.718 . . . . 0.0 109.987 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CE2' ' OD1' ' A' ' 90' ' ' ASP . 34.0 t80 -124.82 102.3 7.5 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.811 0.815 . . . . 0.0 108.922 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.8 mt -107.34 112.67 25.61 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.821 0.819 . . . . 0.0 110.038 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD1' ' CE2' ' A' ' 88' ' ' PHE . 99.9 m-20 -91.52 81.31 5.37 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.496 0.665 . . . . 0.0 109.435 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 92' ' ' VAL . 66.9 t0 -156.16 140.76 16.91 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.71 0.767 . . . . 0.0 110.071 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.542 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 33.4 m -67.62 -22.64 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.9 p -65.72 -29.08 69.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.575 -0.703 . . . . 0.0 109.165 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -103.34 128.84 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 121.887 0.851 . . . . 0.0 110.033 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 p -72.66 172.41 10.7 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.881 0.848 . . . . 0.0 111.03 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -59.19 -43.75 92.22 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.911 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.565 ' O ' ' N ' ' A' ' 99' ' ' ALA . 95.1 mtt-85 -108.29 -51.81 2.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 59.5 -72.56 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.423 0.63 . . . . 0.0 109.951 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -142.32 163.51 32.65 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.712 0.768 . . . . 0.0 109.919 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -132.03 146.11 51.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.803 0.811 . . . . 0.0 110.062 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.35 140.51 48.59 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.432 0.634 . . . . 0.0 109.392 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -128.1 142.91 51.07 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.805 0.812 . . . . 0.0 110.212 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.6 tp -103.56 123.1 46.31 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.548 0.69 . . . . 0.0 109.361 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -92.25 -127.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.444 0.64 . . . . 0.0 110.141 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.64 -40.8 92.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.805 -0.559 . . . . 0.0 109.641 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -174.82 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -140.91 136.59 32.42 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.653 0.74 . . . . 0.0 109.478 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -79.41 146.88 32.57 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.694 0.759 . . . . 0.0 110.228 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.26 160.87 31.63 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.426 0.631 . . . . 0.0 109.488 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -123.82 127.06 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.885 0.85 . . . . 0.0 109.595 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.74 133.95 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.685 0.755 . . . . 0.0 109.404 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -80.61 151.84 28.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.635 0.731 . . . . 0.0 110.451 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.8 m -102.83 11.7 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.12 15.3 69.91 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.9 t -59.04 172.7 0.53 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.784 0.802 . . . . 0.0 110.767 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 116' ' ' LEU . 4.0 mm? -62.53 -41.14 98.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -86.41 114.98 23.63 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.612 0.72 . . . . 0.0 109.513 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.85 104.84 2.59 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.0 m -63.51 137.74 58.25 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.914 0.864 . . . . 0.0 110.748 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -138.97 160.71 39.11 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.379 0.609 . . . . 0.0 109.584 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 123' ' ' ARG . 10.4 p -105.92 128.24 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 121.858 0.837 . . . . 0.0 109.99 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 53.42 -83.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.321 0.581 . . . . 0.0 109.707 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 121' ' ' VAL . 64.3 ttt180 -156.91 42.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -147.64 85.15 6.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.94 133.95 61.36 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.44 2.093 . . . . 0.0 112.177 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -145.92 162.98 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.905 0.86 . . . . 0.0 110.574 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -65.44 -34.08 77.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.2 p -153.2 159.9 42.73 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.571 0.7 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.62 155.91 30.92 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.709 0.766 . . . . 0.0 110.388 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.3 t -105.78 130.12 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.852 0.834 . . . . 0.0 109.641 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -75.79 146.35 40.04 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.625 0.726 . . . . 0.0 109.835 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.546 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.58 155.35 40.15 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.019 0.914 . . . . 0.0 110.289 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -48.41 122.93 5.88 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.937 0.875 . . . . 0.0 110.755 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.527 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 88.62 18.79 54.11 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 16.1 m-20 -87.66 151.93 22.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.694 -0.886 . . . . 0.0 110.301 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -114.86 129.92 56.79 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.734 0.778 . . . . 0.0 109.721 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.64 131.03 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.709 0.766 . . . . 0.0 109.133 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -117.26 126.69 53.15 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.795 0.807 . . . . 0.0 109.883 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.18 129.1 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.573 0.701 . . . . 0.0 109.619 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 48.0 -107.28 0.23 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -111.31 -21.05 12.05 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.51 148.14 33.56 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.684 0.754 . . . . 0.0 110.76 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -115.33 126.98 55.11 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.718 0.77 . . . . 0.0 109.453 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.11 155.92 44.7 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.625 0.726 . . . . 0.0 110.173 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.9 p -126.75 135.37 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.715 0.769 . . . . 0.0 109.763 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -92.73 118.77 31.42 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.861 0.838 . . . . 0.0 109.673 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 134' ' ' GLY . 93.0 mt -134.58 148.83 50.53 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.627 0.727 . . . . 0.0 109.498 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 150' ' ' HIS . 5.1 p -130.93 110.6 11.39 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.624 0.726 . . . . 0.0 109.759 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 59.79 -74.31 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 148' ' ' THR . 86.5 t60 54.97 88.26 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.946 -0.738 . . . . 0.0 109.735 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -61.7 135.5 57.64 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.729 0.776 . . . . 0.0 110.406 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -73.12 146.23 45.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.931 0.872 . . . . 0.0 110.448 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -71.43 168.21 51.23 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 56.32 14.37 1.56 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 122.092 -0.652 . . . . 0.0 109.395 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 157' ' ' GLU . 65.5 t0 -81.3 -80.67 0.15 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.669 -0.644 . . . . 0.0 110.077 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.6 mt 58.94 -71.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.459 0.647 . . . . 0.0 110.007 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 155' ' ' ASP . 80.3 mm-40 -43.31 149.4 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.779 0.8 . . . . 0.0 110.499 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 159' ' ' HIS . 80.7 m80 -111.34 162.43 15.04 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.916 0.865 . . . . 0.0 110.065 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 158' ' ' HIS . 97.8 m-70 57.97 153.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.685 0.755 . . . . 0.0 110.598 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -82.8 149.08 27.41 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.861 0.839 . . . . 0.0 110.264 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -60.01 -43.85 94.98 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.498 ' O ' ' ND1' ' A' ' 162' ' ' HIS . 32.0 p80 -92.74 123.74 36.24 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.874 0.845 . . . . 0.0 110.036 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.876 -1.059 . . . . 0.0 109.997 179.832 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.342 0.591 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -150.23 -21.52 0.25 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.874 . . . . 0.0 108.869 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.444 ' O ' ' CE2' ' A' ' 29' ' ' PHE . 36.1 ttm180 -95.24 -11.04 28.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -0.845 . . . . 0.0 108.842 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 46.43 -140.18 0.48 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 110.102 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -156.66 76.42 0.88 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.408 -0.807 . . . . 0.0 109.605 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.444 ' CE2' ' O ' ' A' ' 26' ' ' ARG . 0.7 OUTLIER -105.0 -55.07 2.38 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.713 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.1 pp -103.35 -13.3 16.73 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.483 -0.761 . . . . 0.0 109.199 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.465 ' N ' HD12 ' A' ' 30' ' ' LEU . 82.6 p -72.4 160.42 32.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.375 -0.828 . . . . 0.0 109.736 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 33' ' ' LEU . 81.4 tt0 -126.64 -27.57 3.1 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 32' ' ' GLU . 83.9 mt 40.47 87.28 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.553 0.692 . . . . 0.0 110.093 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 48.5 p-10 -70.19 138.62 51.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.445 -0.784 . . . . 0.0 109.93 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -173.2 80.74 0.4 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.414 -0.804 . . . . 0.0 109.054 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.83 147.07 83.14 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.6 2.2 . . . . 0.0 112.269 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.11 145.4 55.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.769 . . . . 0.0 110.599 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -103.9 -66.8 0.93 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.517 0.675 . . . . 0.0 109.551 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.98 58.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.822 . . . . 0.0 110.271 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.87 -5.85 73.26 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 41' ' ' THR . 0.1 OUTLIER -78.0 149.4 34.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.255 -1.144 . . . . 0.0 109.391 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 44' ' ' ALA . 46.9 tp10 -163.12 124.59 2.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 109.478 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.4 p -76.69 20.42 0.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.388 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' H ' ' HG3' ' A' ' 42' ' ' GLU . . . -78.52 2.66 18.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.306 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.81 135.69 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 110.191 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 t 61.1 143.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.645 0.736 . . . . 0.0 110.573 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.16 30.43 0.02 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.45 -43.06 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.355 -1.085 . . . . 0.0 109.61 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -48.64 140.13 8.63 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.638 0.732 . . . . 0.0 110.679 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.88 -88.47 0.11 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.453 ' HG ' ' H ' ' A' ' 149' ' ' GLY . 0.2 OUTLIER 70.26 83.24 0.16 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.717 -0.873 . . . . 0.0 109.675 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.85 170.81 19.13 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.922 1.748 . . . . 0.0 111.731 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.08 147.23 76.53 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.316 2.011 . . . . 0.0 113.524 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.58 -16.77 43.92 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.25 146.1 46.39 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.396 -1.061 . . . . 0.0 109.942 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.58 157.15 40.63 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 pp -141.49 157.67 44.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.225 -0.922 . . . . 0.0 109.673 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mp -116.18 151.75 35.07 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.17 133.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 62' ' ' ARG . 53.7 t -67.37 134.59 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.409 -0.807 . . . . 0.0 110.398 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -112.23 50.72 0.84 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.654 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 3.6 tpt180 -120.42 173.43 7.15 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.72 -57.63 3.04 Favored Glycine 0 N--CA 1.49 2.241 0 O-C-N 120.92 -1.112 . . . . 0.0 111.443 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -85.07 12.67 3.0 Favored 'Trans proline' 0 N--CA 1.515 2.761 0 C-N-CA 123.917 3.078 . . . . 0.0 114.366 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.414 ' O ' HG11 ' A' ' 60' ' ' VAL . 57.4 t30 -148.62 17.08 1.02 Allowed 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.335 -1.478 . . . . 0.0 108.663 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . -77.78 153.39 32.92 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.382 0.611 . . . . 0.0 109.896 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.47 -21.63 43.34 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.7 m -66.17 141.24 58.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.29 -1.123 . . . . 0.0 109.263 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -133.81 146.95 51.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.679 -0.638 . . . . 0.0 109.359 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.18 102.24 4.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.41 -0.806 . . . . 0.0 108.878 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -85.63 137.72 32.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 109.4 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.3 mt -95.91 97.45 9.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.526 -0.734 . . . . 0.0 109.82 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 51.5 t0 -109.92 17.54 21.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -127.35 152.92 46.85 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.505 -0.747 . . . . 0.0 109.997 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.41 -47.89 83.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.636 -0.665 . . . . 0.0 110.452 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.24 126.12 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.299 -0.876 . . . . 0.0 109.618 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 92.6 m -121.96 120.95 35.92 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 p -85.29 163.13 18.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.387 -0.82 . . . . 0.0 109.853 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.58 177.83 4.5 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.478 -0.764 . . . . 0.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.88 -129.64 10.4 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.367 -0.92 . . . . 0.0 110.887 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.558 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 85.1 mtt85 -96.63 114.75 26.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.447 -1.031 . . . . 0.0 110.231 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 32.3 m-70 -170.58 80.33 0.57 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.81 -38.39 67.43 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.282 1.988 . . . . 0.0 111.266 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.56 -39.85 95.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.441 -0.787 . . . . 0.0 109.28 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 t -72.09 158.27 36.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.352 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -62.45 -40.55 96.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.514 -0.741 . . . . 0.0 109.883 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 93.2 mt -94.49 117.09 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.07 -1.019 . . . . 0.0 109.671 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 16.5 p90 -130.33 88.26 2.62 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.19 92.33 9.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.029 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -95.71 92.65 6.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.419 -0.801 . . . . 0.0 109.488 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -159.99 176.93 11.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.82 -44.38 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.312 -0.867 . . . . 0.0 109.994 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.6 p -71.61 173.6 7.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.63 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t 61.81 108.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.679 0.752 . . . . 0.0 109.707 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -61.1 -150.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.551 0.691 . . . . 0.0 110.752 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -60.31 -45.69 92.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.483 -0.76 . . . . 0.0 109.364 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 99' ' ' ALA . 36.4 ptt85 179.99 -54.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' A' ' 97' ' ' ARG . 46.8 p-80 43.09 15.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.675 -0.641 . . . . 0.0 110.141 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -154.7 143.13 20.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.861 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -149.42 147.67 28.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.34 143.31 39.02 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.51 -0.744 . . . . 0.0 109.547 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -128.71 137.59 51.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.655 -0.653 . . . . 0.0 109.509 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.2 tp -91.64 126.89 36.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.382 -0.824 . . . . 0.0 108.78 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 106' ' ' ASN . 83.7 tt0 -119.83 129.87 54.63 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.467 -0.771 . . . . 0.0 109.763 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 50.79 -86.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.518 -0.739 . . . . 0.0 109.957 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 104' ' ' GLU . 76.9 m-20 -148.35 23.6 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.171 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -134.97 139.05 44.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.698 . . . . 0.0 109.561 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -75.5 149.0 38.54 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.646 -0.659 . . . . 0.0 109.716 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -135.92 165.33 25.9 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 109.092 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.69 132.28 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -129.78 132.73 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 119' ' ' THR . 88.8 m-20 -103.71 139.28 39.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.432 -0.792 . . . . 0.0 109.391 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 113' ' ' VAL . 3.0 m -89.4 131.7 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 77.33 -176.54 53.37 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.6 m -126.27 64.78 1.24 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.718 -0.872 . . . . 0.0 109.176 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.488 HD13 ' N ' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -156.25 111.81 2.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.027 -1.045 . . . . 0.0 109.0 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.488 ' N ' HD13 ' A' ' 116' ' ' LEU . 83.8 m-20 55.79 35.19 24.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.734 -0.604 . . . . 0.0 109.847 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.6 168.36 39.45 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.563 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 21.3 m -62.93 138.66 58.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.396 -1.061 . . . . 0.0 109.952 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -119.62 150.25 40.62 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.623 -0.673 . . . . 0.0 109.326 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.7 p -120.37 130.84 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.595 -0.69 . . . . 0.0 110.01 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 124' ' ' GLU . 91.0 m-20 45.58 -172.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.637 0.732 . . . . 0.0 110.781 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -59.67 -2.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.59 -0.694 . . . . 0.0 110.051 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 122' ' ' ASN . 27.1 mt-10 -109.6 95.16 18.49 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.421 -0.799 . . . . 0.0 109.436 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.28 127.82 8.54 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.834 1.69 . . . . 0.0 111.795 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 129' ' ' ALA . 35.5 m -139.04 162.25 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.309 -0.869 . . . . 0.0 110.363 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -74.66 -22.44 58.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.531 -0.731 . . . . 0.0 109.553 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.4 p -162.54 160.34 25.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.632 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -173.06 166.14 4.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.166 -0.959 . . . . 0.0 109.677 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.79 130.66 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.453 -0.779 . . . . 0.0 109.516 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.73 148.7 34.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 109.91 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.537 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -151.02 152.74 33.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 108.945 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.493 HD21 ' CE1' ' A' ' 150' ' ' HIS . 64.4 t30 -51.87 134.13 31.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.371 -0.831 . . . . 0.0 110.441 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.19 11.4 64.82 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 79.4 m-20 -89.09 148.64 23.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.269 -1.136 . . . . 0.0 109.724 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -112.22 128.06 56.14 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.93 130.6 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.645 -0.659 . . . . 0.0 109.301 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -126.01 122.45 35.9 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.595 -0.691 . . . . 0.0 109.214 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 95.4 mt -123.82 129.73 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.638 -0.664 . . . . 0.0 109.914 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.36 -108.02 2.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.527 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 88.7 tttt -126.16 -26.1 3.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.913 . . . . 0.0 109.255 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -74.34 146.58 42.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -103.84 139.7 38.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.493 -0.754 . . . . 0.0 109.269 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.53 137.43 40.26 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.814 . . . . 0.0 109.589 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 145' ' ' VAL . 12.8 p -109.49 130.18 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -89.72 111.45 22.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.923 . . . . 0.0 109.971 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.8 mt -140.12 159.85 41.26 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.612 0.72 . . . . 0.0 109.813 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.451 ' OG1' ' CE1' ' A' ' 150' ' ' HIS . 60.0 p -96.33 168.58 10.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.543 -0.723 . . . . 0.0 110.356 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.453 ' H ' ' HG ' ' A' ' 51' ' ' LEU . . . -77.49 96.91 1.29 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.493 ' CE1' HD21 ' A' ' 133' ' ' ASN . 76.5 m80 -87.79 147.26 25.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.43 -1.041 . . . . 0.0 110.131 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -90.42 -8.1 51.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.412 -0.805 . . . . 0.0 109.505 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -88.69 144.25 26.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.291 -0.881 . . . . 0.0 110.136 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 157.93 -35.7 0.53 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -140.97 71.08 1.36 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.4 -1.059 . . . . 0.0 109.434 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.545 ' C ' ' H ' ' A' ' 157' ' ' GLU . 96.7 m-20 -89.49 -1.7 58.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 108.97 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 61.8 mt 59.74 -2.86 0.12 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 155' ' ' ASP . 97.7 mt-10 -98.31 -3.88 36.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.326 -0.859 . . . . 0.0 108.909 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -60.32 -41.65 93.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 109.527 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -72.27 130.26 40.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.383 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -111.39 142.03 44.16 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.551 -0.718 . . . . 0.0 109.784 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -65.34 -38.36 89.89 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.537 -0.727 . . . . 0.0 109.807 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.509 ' ND1' ' OXT' ' A' ' 163' ' ' HIS . 64.6 t-80 -145.5 138.89 26.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.11 -0.994 . . . . 0.0 109.775 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.509 ' OXT' ' ND1' ' A' ' 162' ' ' HIS . 75.5 m80 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.745 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 25' ' ' PHE . 16.2 m . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 121.4 0.619 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.401 ' N ' HG23 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -63.47 -43.76 96.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.218 -0.926 . . . . 0.0 109.636 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -73.68 144.9 45.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.89 . . . . 0.0 110.726 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.428 ' H ' ' HB3' ' A' ' 31' ' ' SER . . . -52.76 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.037 0.922 . . . . 0.0 110.649 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -71.14 -2.32 15.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.506 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 28.3 p90 -149.31 -160.67 1.2 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.011 -1.056 . . . . 0.0 109.93 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 29' ' ' PHE . 56.4 mt -62.89 91.69 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.899 0.857 . . . . 0.0 109.651 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.428 ' HB3' ' H ' ' A' ' 27' ' ' ALA . 83.1 p -81.71 -6.57 59.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -92.02 97.99 11.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.062 -1.024 . . . . 0.0 109.571 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.6 mt 50.43 -171.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.034 0.921 . . . . 0.0 110.956 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 20.3 p-10 -98.67 -61.15 1.41 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.48 -0.763 . . . . 0.0 109.317 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.476 ' H ' ' CG ' ' A' ' 34' ' ' ASP . . . -178.15 80.2 0.23 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.782 . . . . 0.0 108.922 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.72 145.05 97.34 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.798 2.332 . . . . 0.0 112.382 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.63 125.68 2.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.736 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -77.08 140.71 40.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.814 . . . . 0.0 109.901 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.94 165.29 21.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 0.0 110.809 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.87 -176.77 49.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.8 m 42.75 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.697 -0.884 . . . . 0.0 110.359 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -164.9 126.11 2.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.223 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -73.47 150.91 41.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 110.309 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.74 -35.43 0.08 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.025 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 m -94.88 37.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.218 -0.926 . . . . 0.0 109.134 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 91.2 p -81.88 -3.51 54.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.36 43.68 4.24 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.6 m -83.2 -8.28 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -1.112 . . . . 0.0 109.072 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -95.85 -76.54 0.5 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.31 -0.869 . . . . 0.0 109.747 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.73 94.46 1.89 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -100.95 153.08 37.94 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.538 -0.978 . . . . 0.0 109.142 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 51' ' ' LEU . 84.8 Cg_exo -39.56 166.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.302 2.002 . . . . 0.0 112.283 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -54.75 139.51 77.42 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.066 1.844 . . . . 0.0 112.801 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 43.89 84.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 72' ' ' LEU . 1.9 tp -149.95 141.65 23.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.92 -1.341 . . . . 0.0 109.237 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.17 165.93 23.64 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.55 0.69 . . . . 0.0 109.739 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.03 154.75 47.88 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.623 0.725 . . . . 0.0 109.744 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.3 mt -114.37 136.81 52.58 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.35 131.56 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.609 0.719 . . . . 0.0 109.782 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.0 t -73.21 133.63 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.593 0.711 . . . . 0.0 109.72 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -86.29 -74.02 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.906 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -121.61 149.24 43.45 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.757 0.789 . . . . 0.0 110.09 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.54 175.09 25.3 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.42 -18.43 43.87 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.864 2.376 . . . . 0.0 111.727 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' ALA . 92.5 m-20 -88.93 -74.93 0.45 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.186 -0.947 . . . . 0.0 109.38 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 60.59 132.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.473 -0.767 . . . . 0.0 110.521 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.99 -20.24 50.85 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 m -71.54 144.79 49.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -1.143 . . . . 0.0 110.777 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -146.69 151.66 37.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 109.64 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -130.32 145.66 51.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -109.66 146.25 35.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.563 -0.71 . . . . 0.0 109.22 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.453 ' O ' HD11 ' A' ' 55' ' ' LEU . 66.6 mt -97.65 115.82 28.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.882 . . . . 0.0 110.17 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -89.45 53.33 2.58 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.963 0.887 . . . . 0.0 108.693 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 43.31 -165.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.174 0.988 . . . . 0.0 111.199 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 59.95 -144.5 0.52 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.663 0.745 . . . . 0.0 110.479 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.12 127.21 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.734 -0.604 . . . . 0.0 109.5 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.6 m -120.24 120.58 36.51 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.2 p -83.03 162.29 21.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.429 -0.795 . . . . 0.0 109.885 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.73 -179.46 3.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.34 -0.85 . . . . 0.0 110.137 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.45 -124.17 28.91 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -105.62 127.26 52.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.43 -1.041 . . . . 0.0 109.963 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 83' ' ' PRO . 36.6 t-80 -173.94 135.09 0.62 Allowed Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.478 ' O ' ' ND1' ' A' ' 82' ' ' HIS . 49.3 Cg_endo -68.92 150.32 73.1 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.391 2.061 . . . . 0.0 113.394 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t0 65.24 -8.3 0.26 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.821 -0.549 . . . . 0.0 110.087 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 83' ' ' PRO . 46.7 t -73.84 133.98 43.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.991 -1.068 . . . . 0.0 110.191 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.26 -41.1 97.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.544 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.84 126.02 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.722 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -129.66 85.87 2.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.511 -0.743 . . . . 0.0 109.148 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.2 mt -104.83 93.66 4.85 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.455 -0.778 . . . . 0.0 109.331 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -99.96 83.34 2.7 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.526 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 24.3 p30 -155.4 172.57 17.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.127 -0.983 . . . . 0.0 109.958 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 93' ' ' THR . 5.3 t -62.81 169.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.534 -0.729 . . . . 0.0 110.703 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.499 ' N ' HG12 ' A' ' 92' ' ' VAL . 4.4 p 65.74 -7.38 0.36 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 92' ' ' VAL . 82.2 t -125.87 122.19 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.475 -0.766 . . . . 0.0 109.254 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.3 p -86.65 -162.09 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.824 0.821 . . . . 0.0 110.498 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -62.57 -38.65 90.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.837 . . . . 0.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -152.81 81.69 1.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.077 -1.015 . . . . 0.0 108.947 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -65.95 -39.76 90.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.737 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.62 160.97 36.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.841 . . . . 0.0 109.621 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -137.88 144.96 41.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.506 -0.746 . . . . 0.0 109.196 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.52 140.35 48.21 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -136.95 142.15 42.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.815 . . . . 0.0 109.625 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 53.8 tp -95.53 126.9 41.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.514 -0.742 . . . . 0.0 109.385 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -94.12 -128.46 0.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.236 -0.915 . . . . 0.0 110.012 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -64.48 -41.57 96.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.825 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -174.05 25.83 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.02 -1.05 . . . . 0.0 109.092 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -137.41 142.4 41.67 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.234 -0.917 . . . . 0.0 110.059 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -76.64 145.63 38.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.499 -0.75 . . . . 0.0 110.05 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -139.27 162.16 35.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.279 -0.888 . . . . 0.0 109.221 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.57 132.57 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.6 t -127.37 132.84 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.669 0.747 . . . . 0.0 109.475 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 1.5 m-20 -78.01 138.06 38.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.561 -0.712 . . . . 0.0 109.584 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 m -114.27 12.33 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.05 123.93 1.23 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.125 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 p 61.4 116.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.535 -0.98 . . . . 0.0 110.542 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 116' ' ' LEU . 10.5 mp -64.17 -40.02 95.23 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.582 -0.699 . . . . 0.0 109.821 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -80.02 5.46 14.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.06 -1.025 . . . . 0.0 108.583 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.94 -101.78 0.01 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.5 m -64.85 138.38 58.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -1.141 . . . . 0.0 110.267 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -140.46 157.67 45.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.181 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 122' ' ' ASN . 7.6 p -107.29 156.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.69 -0.631 . . . . 0.0 109.638 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.446 ' N ' HG22 ' A' ' 121' ' ' VAL . 84.2 m-20 -41.23 -39.35 1.32 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.517 0.675 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -65.63 -90.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.984 . . . . 0.0 109.967 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -142.62 146.39 38.22 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.297 -0.877 . . . . 0.0 109.8 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.96 133.88 34.9 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.257 1.971 . . . . 0.0 112.636 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.6 m -144.24 157.31 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.082 -1.011 . . . . 0.0 110.64 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -72.96 -16.85 61.52 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.679 0.752 . . . . 0.0 109.049 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.6 p -158.61 161.23 37.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.968 . . . . 0.0 109.434 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.63 153.96 25.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.942 -1.099 . . . . 0.0 109.84 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.2 t -98.78 126.81 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.386 -0.821 . . . . 0.0 109.57 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 76.8 mt -79.53 146.44 32.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 110.303 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.526 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -151.96 151.17 30.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.175 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -46.93 124.99 6.87 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.461 -0.774 . . . . 0.0 110.998 -179.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.473 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 90.53 13.6 59.57 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 32.9 m-20 -87.57 154.68 20.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.043 -1.269 . . . . 0.0 109.693 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.442 ' OE1' ' ND2' ' A' ' 122' ' ' ASN . 82.1 tt0 -115.35 135.86 53.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.446 -0.784 . . . . 0.0 109.553 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.07 132.1 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.0 109.144 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -120.27 122.19 40.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 0.0 109.445 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.62 126.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.52 0.676 . . . . 0.0 109.232 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.2 -134.3 48.46 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -91.86 -7.95 47.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -1.032 . . . . 0.0 109.38 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.526 ' CE1' ' OD2' ' A' ' 91' ' ' ASP . 82.5 m-85 -95.28 143.86 26.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 0.0 110.516 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -108.16 136.9 47.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.622 -0.674 . . . . 0.0 109.202 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.29 154.27 51.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.59 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.89 136.53 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.436 0.636 . . . . 0.0 109.289 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -92.46 113.48 25.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.677 -0.639 . . . . 0.0 109.297 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 134' ' ' GLY . 94.4 mt -137.06 147.77 46.34 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.756 . . . . 0.0 109.784 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 150' ' ' HIS . 68.3 p -90.53 168.05 12.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 110.016 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 150' ' ' HIS . . . -59.67 79.94 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 148' ' ' THR . 98.4 m-70 49.24 178.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.401 -1.058 . . . . 0.0 110.928 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 153' ' ' GLY . 51.5 mtmt -96.66 -0.17 48.84 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 154' ' ' GLU . 98.3 mm-40 -65.14 3.12 0.65 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.12 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . -74.31 36.16 0.96 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' A' ' 152' ' ' GLN . 79.9 mm-40 -64.48 139.72 58.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.173 -1.193 . . . . 0.0 110.44 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -70.04 152.38 44.45 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.832 0.825 . . . . 0.0 110.826 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.67 143.24 56.45 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.819 0.819 . . . . 0.0 110.791 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -71.32 102.51 2.61 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.812 0.815 . . . . 0.0 109.997 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -83.51 -17.3 42.4 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.476 -0.765 . . . . 0.0 108.965 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.566 ' CG ' ' N ' ' A' ' 160' ' ' HIS . 53.3 t-80 -151.33 170.95 18.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 110.01 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.566 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 60.7 m170 -68.74 139.62 55.35 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.929 0.871 . . . . 0.0 111.131 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -79.41 154.77 28.73 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.856 0.836 . . . . 0.0 110.935 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 47.27 91.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.953 0.882 . . . . 0.0 110.093 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 78.4 m80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.703 179.774 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 26' ' ' ARG . 47.1 p90 -106.9 -159.6 0.7 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.41 -0.806 . . . . 0.0 110.309 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.486 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 56.4 ttp180 -62.76 139.52 58.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 110.13 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.6 -111.5 0.09 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.487 -0.758 . . . . 0.0 109.432 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -101.42 -21.12 14.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.493 -0.754 . . . . 0.0 109.769 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 30' ' ' LEU . 1.3 p90 -82.17 -21.02 36.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.179 -0.951 . . . . 0.0 109.364 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 30' ' ' LEU . 7.4 mp 38.45 60.13 1.37 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.607 0.718 . . . . 0.0 110.254 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.53 ' C ' ' H ' ' A' ' 33' ' ' LEU . 20.7 t 38.84 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.77 0.795 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 33' ' ' LEU . 24.4 tp10 62.5 -4.36 0.23 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 35' ' ' ALA . 76.5 mt 48.4 -179.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.418 -0.801 . . . . 0.0 110.55 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 67.9 t0 45.67 -88.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.651 -0.656 . . . . 0.0 110.223 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . 64.43 68.76 0.77 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.426 -0.796 . . . . 0.0 109.585 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -77.58 145.87 23.69 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.762 2.308 . . . . 0.0 112.316 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.09 -12.8 22.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.45 -0.782 . . . . 0.0 109.565 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 38' ' ' GLN . 5.1 pp0? -84.1 139.44 32.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.316 -0.865 . . . . 0.0 110.367 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.42 -19.48 1.66 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.05 -133.05 49.13 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.2 m 48.09 73.83 0.19 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.568 -0.96 . . . . 0.0 109.89 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -100.13 0.16 40.09 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.868 . . . . 0.0 109.157 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 m -65.35 147.35 53.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.554 -0.716 . . . . 0.0 110.156 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -167.95 79.89 0.17 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.453 HG22 ' H ' ' A' ' 45' ' ' VAL . 5.4 m -82.88 142.27 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.343 -0.848 . . . . 0.0 110.606 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.4 p 40.93 -162.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.482 0.658 . . . . 0.0 110.651 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.69 -98.67 0.15 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 48' ' ' VAL . 17.8 m -89.31 127.89 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.025 -1.279 . . . . 0.0 110.343 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' CG ' ' N ' ' A' ' 50' ' ' GLY . 18.1 pt-20 -163.47 -42.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 0.0 109.38 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' C ' ' A' ' 51' ' ' LEU . . . -104.73 0.83 42.11 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER -27.83 92.34 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.434 0 CA-C-N 117.412 0.606 . . . . 0.0 110.6 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.461 ' N ' ' O ' ' A' ' 50' ' ' GLY . 42.8 Cg_exo -53.81 156.61 11.78 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.326 2.017 . . . . 0.0 112.436 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.28 149.48 75.74 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.801 2.334 . . . . 0.0 112.236 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.27 -2.19 88.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.34 151.79 33.98 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.497 -1.001 . . . . 0.0 109.846 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -146.4 156.25 43.17 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -137.99 171.75 13.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.805 . . . . 0.0 109.326 -179.502 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 mt -118.76 134.3 55.24 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.77 130.05 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' ' 62' ' ' ARG . 42.3 t -70.07 134.91 29.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.537 -0.727 . . . . 0.0 109.986 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -104.55 36.3 2.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.626 -0.672 . . . . 0.0 109.338 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.75 ' H ' HG12 ' A' ' 60' ' ' VAL . 77.8 mtp85 -126.85 144.27 51.02 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.429 -0.794 . . . . 0.0 109.93 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.76 -57.21 15.09 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -46.43 -36.93 18.8 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.314 2.009 . . . . 0.0 111.781 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.401 ' ND2' ' CE1' ' A' ' 142' ' ' PHE . 41.0 m-20 -119.66 25.31 10.09 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.581 -0.699 . . . . 0.0 109.18 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . -66.46 140.52 58.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.313 -0.867 . . . . 0.0 109.801 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.413 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 101.21 -18.87 53.48 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 m -64.12 136.55 57.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.38 -1.071 . . . . 0.0 109.739 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' NH1' ' O ' ' A' ' 67' ' ' GLY . 90.6 mtm-85 -140.58 146.82 38.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.728 . . . . 0.0 109.098 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 57' ' ' LEU . 88.0 m-85 -129.01 136.58 50.5 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.511 -0.743 . . . . 0.0 109.324 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 tp -103.84 129.73 51.34 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.494 -0.754 . . . . 0.0 109.163 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.55 70.46 3.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.357 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 67.1 t0 -95.18 34.67 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -141.52 150.81 42.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.341 -0.85 . . . . 0.0 109.96 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.76 81.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.684 -0.635 . . . . 0.0 110.299 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.39 125.27 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.407 -0.808 . . . . 0.0 109.32 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.0 m -122.65 122.14 38.09 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 m -87.15 153.12 21.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 109.727 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -118.34 122.38 42.73 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.637 -0.665 . . . . 0.0 109.341 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.22 -124.38 2.52 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.476 ' C ' ' CG ' ' A' ' 82' ' ' HIS . 62.8 ttm-85 -119.72 121.92 40.28 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.532 -0.981 . . . . 0.0 109.222 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -170.05 161.54 6.67 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.12 -78.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.45 2.1 . . . . 0.0 112.077 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -81.37 97.41 7.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.325 -0.86 . . . . 0.0 109.743 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 p -166.51 126.96 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.767 . . . . 0.0 109.019 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.35 -37.72 84.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.48 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.3 mm -87.86 120.31 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.0 109.649 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CE2' ' OD2' ' A' ' 90' ' ' ASP . 69.3 t80 -130.28 85.72 2.32 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.19 107.86 18.96 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.444 -0.785 . . . . 0.0 109.507 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD2' ' CE2' ' A' ' 88' ' ' PHE . 97.9 m-20 -90.38 87.32 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 109.276 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -151.71 150.1 29.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.379 -0.826 . . . . 0.0 109.641 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.37 -25.05 26.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.041 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -65.27 -33.94 77.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.479 -0.763 . . . . 0.0 109.647 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.1 t -101.68 118.02 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.3 -0.875 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.7 m -70.81 174.7 5.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.342 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -60.67 -43.72 97.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.564 -0.71 . . . . 0.0 109.356 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -127.04 55.23 1.58 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.564 -0.71 . . . . 0.0 109.114 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -60.7 -41.87 96.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.5 -0.75 . . . . 0.0 109.761 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.45 158.58 44.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.357 -0.839 . . . . 0.0 109.08 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -133.13 148.63 52.12 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.518 -0.739 . . . . 0.0 109.227 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -113.84 135.48 53.92 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -128.59 141.26 51.42 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.465 -0.772 . . . . 0.0 109.655 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.1 tp -98.93 127.23 44.81 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 106' ' ' ASN . 49.2 tp10 -123.39 132.76 54.07 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.578 -0.701 . . . . 0.0 109.701 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 51.97 -84.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 109.859 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' GLU . 63.8 t30 -153.51 25.74 0.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -134.73 138.58 44.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.489 -0.757 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -77.04 146.98 37.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -0.779 . . . . 0.0 109.74 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -132.92 157.62 44.66 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.29 136.54 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.35 133.5 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 44.5 p-10 -95.87 115.69 27.8 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.247 -0.908 . . . . 0.0 109.769 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.37 7.51 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.466 -0.772 . . . . 0.0 108.935 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.1 101.61 1.73 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.5 t -64.14 -40.19 95.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.493 -1.004 . . . . 0.0 109.895 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.3 tp -61.55 -43.29 99.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.896 . . . . 0.0 109.481 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -138.71 -73.73 0.39 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.94 153.5 30.3 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 120' ' ' TYR . 93.8 m -75.63 158.46 32.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.513 -0.993 . . . . 0.0 109.777 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.453 ' N ' HG22 ' A' ' 119' ' ' THR . 40.4 p90 -147.49 162.7 38.54 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 p -120.74 128.13 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.435 -0.791 . . . . 0.0 109.844 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.1 m120 55.38 38.5 30.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.509 -0.745 . . . . 0.0 110.01 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 59.26 40.16 21.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.459 -0.776 . . . . 0.0 109.492 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -144.59 87.36 7.58 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.0 108.494 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.1 135.09 67.3 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.498 2.132 . . . . 0.0 112.202 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.3 m -141.79 162.96 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.307 -0.871 . . . . 0.0 110.014 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.64 -40.54 97.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.503 -0.748 . . . . 0.0 109.366 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.2 p -157.58 161.35 38.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.098 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.37 150.58 23.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.006 -1.058 . . . . 0.0 109.908 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.6 t -95.0 132.26 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.494 -0.754 . . . . 0.0 109.239 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.64 151.44 37.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.389 -0.819 . . . . 0.0 109.943 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.544 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -147.4 159.34 43.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.345 -0.847 . . . . 0.0 109.636 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -57.25 132.36 52.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 110.637 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.496 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 83.34 14.93 72.9 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 29.4 m-20 -83.18 148.84 27.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.242 -1.152 . . . . 0.0 109.581 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -113.29 128.12 56.37 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.42 131.73 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -120.06 118.45 30.65 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.539 -0.725 . . . . 0.0 109.229 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.31 129.36 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.611 -0.68 . . . . 0.0 109.744 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 59.98 -131.41 50.32 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -102.43 -16.32 16.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.587 -0.949 . . . . 0.0 109.18 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.401 ' CE1' ' ND2' ' A' ' 65' ' ' ASN . 79.0 m-85 -80.47 147.81 30.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.455 -0.778 . . . . 0.0 109.895 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.16 137.24 43.24 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.476 -0.765 . . . . 0.0 109.2 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.5 150.67 46.64 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.336 -0.853 . . . . 0.0 109.24 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.02 132.78 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.463 -0.773 . . . . 0.0 108.943 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.449 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 74.1 t80 -93.29 117.48 30.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 109.513 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 134' ' ' GLY . 94.0 mt -129.06 139.76 51.89 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 150' ' ' HIS . 69.7 p -100.03 167.03 10.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.446 -0.784 . . . . 0.0 109.993 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.76 83.32 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 148' ' ' THR . 98.0 m-70 47.02 -161.52 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -1.033 . . . . 0.0 110.866 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.12 135.22 54.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.566 -0.708 . . . . 0.0 110.213 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -85.51 141.33 29.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.472 -0.767 . . . . 0.0 110.106 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.07 51.75 0.4 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.5 131.1 45.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -1.085 . . . . 0.0 110.258 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -151.18 106.27 3.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 108.995 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.37 127.57 36.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -76.91 131.17 38.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.464 -0.772 . . . . 0.0 110.237 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.529 ' O ' ' CG ' ' A' ' 159' ' ' HIS . 84.6 t60 -165.59 133.89 3.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.489 -0.757 . . . . 0.0 109.247 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 158' ' ' HIS . 99.1 m-70 -158.48 -63.25 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 108.955 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.493 ' ND1' ' N ' ' A' ' 161' ' ' HIS . 53.0 t-80 41.11 -96.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.809 -0.557 . . . . 0.0 110.218 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.493 ' N ' ' ND1' ' A' ' 160' ' ' HIS . 85.0 t60 42.73 85.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.642 -0.661 . . . . 0.0 109.666 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -71.64 142.55 49.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.472 -0.768 . . . . 0.0 110.058 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.367 179.583 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.364 0.602 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.631 ' O ' ' N ' ' A' ' 27' ' ' ALA . 8.4 p90 -149.18 -14.35 0.3 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.674 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 45.9 mtp180 53.58 -74.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 120.93 0.395 . . . . 0.0 110.278 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 26' ' ' ARG . . . 86.09 146.9 0.06 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.465 0.65 . . . . 0.0 109.947 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.3 t0 62.06 36.14 15.52 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.208 0.527 . . . . 0.0 109.672 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.61 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 2.6 p90 -142.31 -142.12 0.14 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.216 -0.928 . . . . 0.0 109.337 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.61 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 6.2 mp -62.12 -42.29 99.09 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.443 -0.786 . . . . 0.0 108.928 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.7 p 45.34 41.06 5.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.406 -0.809 . . . . 0.0 109.343 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -64.63 -24.48 67.6 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.0 -41.67 99.64 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.559 -0.713 . . . . 0.0 109.378 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -83.17 114.87 21.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.372 -0.83 . . . . 0.0 110.099 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.18 78.6 4.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.2 147.58 83.17 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.735 2.29 . . . . 0.0 112.552 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.43 150.27 27.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.474 -0.766 . . . . 0.0 110.248 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -60.43 147.8 39.72 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.711 0.767 . . . . 0.0 110.379 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.36 176.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.524 0.678 . . . . 0.0 110.696 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 41' ' ' THR . . . -175.67 -172.8 40.83 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 40' ' ' GLY . 6.7 p 60.7 139.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.606 -0.938 . . . . 0.0 110.535 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -66.4 138.29 57.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.584 -0.698 . . . . 0.0 110.134 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -72.95 147.82 44.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.776 . . . . 0.0 110.364 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.65 34.79 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -109.57 130.89 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.491 -0.755 . . . . 0.0 109.004 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 96.3 p -75.29 167.04 22.68 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.395 -0.816 . . . . 0.0 110.514 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.65 -165.29 35.04 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.704 ' H ' HH22 ' A' ' 69' ' ' ARG . 95.9 t -83.28 132.08 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.493 -1.004 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -112.25 -92.6 0.47 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.515 -0.741 . . . . 0.0 110.361 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.39 151.99 37.15 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.332 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.64 74.4 5.23 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 24.7 Cg_exo -53.04 -41.93 68.18 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.07 1.846 . . . . 0.0 112.112 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 32.4 Cg_exo -56.23 -4.17 0.68 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.553 1.502 . . . . 0.0 111.31 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 52' ' ' PRO . . . 75.39 62.59 2.69 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.3 mt -96.54 172.31 8.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.155 -1.203 . . . . 0.0 110.243 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.71 157.66 43.65 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.618 ' CD2' HH21 ' A' ' 69' ' ' ARG . 5.1 mp -131.87 150.3 52.19 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.341 -0.849 . . . . 0.0 110.022 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.5 mt -117.39 134.89 54.3 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.61 132.53 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.654 0.74 . . . . 0.0 109.259 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.1 132.53 33.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.491 -0.755 . . . . 0.0 109.779 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -93.31 -15.12 26.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.373 -0.829 . . . . 0.0 109.284 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -165.87 141.77 5.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.034 . . . . 0.0 109.925 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.91 176.82 24.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.23 -40.23 83.13 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.423 2.082 . . . . 0.0 111.764 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -108.43 53.58 0.68 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.96 143.47 42.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.463 -0.773 . . . . 0.0 110.13 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.13 1.56 75.64 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.2 m -71.84 152.33 42.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.466 -1.02 . . . . 0.0 109.941 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.704 HH22 ' H ' ' A' ' 48' ' ' VAL . 17.8 ptm180 -133.81 144.37 48.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.516 -0.74 . . . . 0.0 109.279 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -121.16 138.31 54.27 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.487 -0.758 . . . . 0.0 109.385 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 tp -99.48 125.71 45.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.388 -0.82 . . . . 0.0 109.13 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -99.34 75.05 1.96 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.282 -0.886 . . . . 0.0 109.13 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 64.3 t0 -99.07 17.3 20.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.392 -0.817 . . . . 0.0 109.053 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -119.26 144.45 46.77 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.562 -0.711 . . . . 0.0 109.658 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.82 99.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 110.076 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.4 mt -124.81 126.78 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.431 -0.793 . . . . 0.0 109.012 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 m -124.52 124.05 41.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.564 -0.71 . . . . 0.0 109.364 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -96.67 156.57 16.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 109.334 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.91 147.81 35.04 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.69 -48.44 1.01 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -88.01 141.11 28.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.151 -1.205 . . . . 0.0 109.989 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.575 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -88.72 -44.49 0.45 Allowed Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.419 -0.801 . . . . 0.0 109.817 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 32.5 Cg_exo -57.25 137.19 80.59 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.374 2.049 . . . . 0.0 112.701 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 44.76 46.43 8.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.603 -0.686 . . . . 0.0 109.709 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.9 m -156.07 116.89 3.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.325 -0.859 . . . . 0.0 109.74 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.24 -38.29 90.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.3 mm -78.2 128.09 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.427 -0.796 . . . . 0.0 109.819 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -129.99 85.92 2.35 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.4 98.05 7.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 46.7 p-10 -91.46 94.62 9.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.701 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -154.3 158.14 39.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.18 -0.95 . . . . 0.0 109.926 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.7 m -69.13 -32.47 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.534 -0.729 . . . . 0.0 109.761 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p -65.83 -29.96 70.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.901 . . . . 0.0 110.341 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -99.84 125.9 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -0.994 . . . . 0.0 109.562 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.0 m -79.39 -170.15 2.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.643 -0.661 . . . . 0.0 110.19 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -60.28 -45.45 93.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.758 . . . . 0.0 109.614 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 99' ' ' ALA . 79.7 mtp85 -108.17 -47.83 3.47 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 113' ' ' VAL . 85.8 t60 52.81 -80.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.619 -0.675 . . . . 0.0 110.074 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -127.71 155.8 43.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.541 -0.724 . . . . 0.0 109.131 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -136.02 154.23 51.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 109.094 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -118.73 143.66 46.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -130.19 144.29 51.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.4 -0.813 . . . . 0.0 109.511 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.6 tp -104.46 123.96 48.4 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.511 -0.743 . . . . 0.0 109.437 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -95.19 -117.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 92.5 m-20 -65.07 -50.3 66.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 110.13 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 68.6 m-20 -169.03 23.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.572 -0.705 . . . . 0.0 109.282 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.54 136.68 43.22 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -77.0 146.62 37.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.49 -0.756 . . . . 0.0 110.126 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -123.37 156.62 35.06 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 110' ' ' VAL . 11.7 p -117.75 131.15 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.76 143.13 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.485 -0.759 . . . . 0.0 109.731 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -99.58 112.82 24.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 0.0 108.938 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 98' ' ' HIS . 16.6 m -77.73 150.21 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.172 -0.955 . . . . 0.0 110.742 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.97 17.79 64.55 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' A' ' 116' ' ' LEU . 44.4 t 45.39 -147.8 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.55 -0.971 . . . . 0.0 110.135 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.435 ' N ' ' OG ' ' A' ' 115' ' ' SER . 49.0 tp 59.29 150.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.426 0.631 . . . . 0.0 110.283 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -66.45 141.91 57.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.945 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -172.13 -93.94 0.09 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.5 m -63.87 136.49 57.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 110.211 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -138.78 153.19 48.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.429 -0.794 . . . . 0.0 109.387 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.1 p -120.25 129.36 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.664 0.745 . . . . 0.0 109.52 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.489 ' CG ' ' H ' ' A' ' 123' ' ' ARG . 6.8 t-20 55.37 -167.09 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.585 0.707 . . . . 0.0 110.229 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.489 ' H ' ' CG ' ' A' ' 122' ' ' ASN . 11.0 mmp_? -72.6 -4.63 31.99 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.691 -0.631 . . . . 0.0 109.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -107.81 99.53 30.46 Favored Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -76.19 128.46 10.58 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.021 1.814 . . . . 0.0 112.056 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 129' ' ' ALA . 4.8 m -136.59 160.79 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.299 -0.876 . . . . 0.0 110.478 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.89 -42.21 97.51 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.556 -0.715 . . . . 0.0 109.266 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 m -157.94 158.43 34.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 109.467 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -168.05 159.09 10.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.035 -1.041 . . . . 0.0 109.859 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.19 131.53 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.763 . . . . 0.0 109.954 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.6 150.31 36.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.866 . . . . 0.0 109.864 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.96 156.76 46.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.418 -0.801 . . . . 0.0 109.567 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -55.83 135.03 52.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.52 -0.737 . . . . 0.0 110.667 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.99 19.16 65.77 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 136' ' ' GLU . 64.4 t0 -96.76 133.73 40.96 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.308 -1.113 . . . . 0.0 109.986 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.488 ' N ' ' OD1' ' A' ' 135' ' ' ASP . 98.4 mt-10 -94.35 130.45 40.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.319 -0.863 . . . . 0.0 109.224 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.5 t -124.51 132.53 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.565 -0.71 . . . . 0.0 109.126 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -126.22 127.53 45.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.42 127.47 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.496 -0.753 . . . . 0.0 109.698 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.48 -95.35 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -128.43 -18.37 4.01 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.643 -0.916 . . . . 0.0 109.123 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -74.76 141.44 44.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -0.859 . . . . 0.0 109.63 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -105.28 131.83 52.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.432 -0.792 . . . . 0.0 109.814 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.75 152.62 51.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.506 -0.746 . . . . 0.0 109.161 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.43 131.39 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -92.5 111.39 22.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.44 -0.788 . . . . 0.0 109.271 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.77 143.17 50.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.467 0.651 . . . . 0.0 109.715 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.2 p -86.46 170.9 11.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 0.0 109.775 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -43.94 -79.4 0.06 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.538 ' ND1' ' N ' ' A' ' 151' ' ' LYS . 52.4 t-80 -162.62 -123.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -1.151 . . . . 0.0 109.556 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.538 ' N ' ' ND1' ' A' ' 150' ' ' HIS . 68.9 mttm 51.05 -93.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 110.186 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 150' ' ' HIS . 14.5 pt20 -74.03 148.35 42.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 110.682 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 145.31 -10.05 1.73 Allowed Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 155' ' ' ASP . 57.2 mp0 -63.86 140.99 58.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.498 -1.001 . . . . 0.0 110.234 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 154' ' ' GLU . 98.0 m-20 56.69 123.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.964 0.887 . . . . 0.0 109.997 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 156' ' ' LEU . 3.6 mm? -74.63 139.48 43.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.146 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -71.01 84.18 0.69 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.569 -0.707 . . . . 0.0 109.801 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 160' ' ' HIS . 86.2 t60 -67.33 -40.34 85.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.574 -0.704 . . . . 0.0 109.888 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -43.38 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.517 -0.74 . . . . 0.0 110.42 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 158' ' ' HIS . 32.6 m80 -95.44 -10.39 30.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.245 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -78.51 148.51 33.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.88 . . . . 0.0 109.763 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -62.04 -39.63 92.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.393 -0.817 . . . . 0.0 109.779 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.294 -179.731 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.453 ' CE2' ' O ' ' A' ' 26' ' ' ARG . 89.1 t80 -65.87 133.4 50.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.411 -0.806 . . . . 0.0 109.85 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 95.9 mtt-85 -72.25 146.67 47.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.35 -0.844 . . . . 0.0 110.424 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.39 168.44 20.02 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.666 0.746 . . . . 0.0 110.54 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -64.0 -37.14 86.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.617 -0.677 . . . . 0.0 110.2 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -80.83 -164.15 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.063 -1.023 . . . . 0.0 110.581 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' CD2' ' H ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -76.29 92.63 3.33 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.0 t -69.32 144.97 53.38 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.517 0.675 . . . . 0.0 109.978 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -163.1 25.64 0.09 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.399 -0.813 . . . . 0.0 108.842 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.22 140.65 50.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.955 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.78 114.5 26.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.8 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.89 154.43 91.0 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.7 -10.73 27.02 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.522 2.148 . . . . 0.0 111.377 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.06 140.68 54.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.432 -0.793 . . . . 0.0 109.894 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 39' ' ' ALA . 95.3 mt-30 -108.44 -100.56 0.37 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.497 -0.752 . . . . 0.0 109.473 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 38' ' ' GLN . . . 59.3 151.36 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -0.781 . . . . 0.0 110.17 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.1 -122.27 0.94 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.7 p -89.47 117.1 28.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.218 -1.166 . . . . 0.0 110.038 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 43' ' ' SER . 49.1 tp10 -87.91 141.01 28.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.374 -0.829 . . . . 0.0 110.262 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 42' ' ' GLU . 26.1 t 46.37 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.697 0.76 . . . . 0.0 110.343 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.28 -5.62 59.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.577 -0.702 . . . . 0.0 109.116 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 46' ' ' SER . 27.7 m -79.61 158.54 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 110.097 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 2.4 p 80.17 136.98 0.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.524 0.678 . . . . 0.0 109.993 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.41 -80.51 0.1 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 48' ' ' VAL . 22.0 m -83.65 129.03 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -1.217 . . . . 0.0 110.025 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -96.97 -47.92 5.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.35 -0.844 . . . . 0.0 109.315 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.7 95.14 0.1 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -93.44 153.85 41.35 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.253 -1.145 . . . . 0.0 108.881 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.9 160.88 48.0 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.187 1.925 . . . . 0.0 111.408 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.33 144.54 80.74 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.57 2.18 . . . . 0.0 112.635 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.425 ' C ' HD12 ' A' ' 55' ' ' LEU . . . 98.15 -23.06 37.72 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 54' ' ' GLY . 11.1 mp -104.92 148.21 26.93 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.187 -1.184 . . . . 0.0 109.931 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.26 176.87 8.02 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.614 0.721 . . . . 0.0 109.315 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.714 ' C ' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -157.33 172.58 18.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.886 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 57' ' ' LEU . 4.6 mp -130.47 149.3 52.21 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 68.2 t -124.61 131.56 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.571 -0.705 . . . . 0.0 109.804 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.6 t -73.05 119.88 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.487 -0.758 . . . . 0.0 109.333 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -92.92 -16.64 24.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 109.122 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -155.5 132.68 10.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.599 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.15 172.14 22.52 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.97 -42.44 66.76 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.518 2.146 . . . . 0.0 112.003 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -100.66 49.71 0.89 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.471 -0.768 . . . . 0.0 109.09 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.09 141.98 26.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.539 -0.726 . . . . 0.0 110.234 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.65 -18.48 56.86 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -68.64 149.88 48.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.284 -1.127 . . . . 0.0 110.695 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -139.06 135.81 34.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -111.58 115.46 29.2 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.416 -0.802 . . . . 0.0 109.07 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 tt -94.5 133.23 38.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 110.244 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.402 HD21 HD11 ' A' ' 87' ' ' ILE . 81.3 mt -89.75 131.17 35.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.578 -0.701 . . . . 0.0 109.608 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -136.33 26.74 3.17 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.61 155.46 47.43 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.299 -0.876 . . . . 0.0 109.783 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.69 84.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.932 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.14 126.31 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.419 -0.801 . . . . 0.0 109.156 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.4 m -119.69 124.03 45.24 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.712 . . . . 0.0 109.549 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 m -86.87 155.43 20.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.476 -0.765 . . . . 0.0 109.193 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.41 131.7 53.73 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.448 -0.783 . . . . 0.0 109.364 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.3 -138.91 6.31 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 72.7 ttp85 -113.37 125.58 54.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.509 -0.995 . . . . 0.0 110.042 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 11.8 m-70 -168.94 152.17 5.17 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.14 -19.5 50.91 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.201 1.934 . . . . 0.0 111.589 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 85' ' ' SER . 84.5 m-20 -117.95 -129.95 0.3 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.543 -0.723 . . . . 0.0 109.744 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 84' ' ' ASP . 6.1 m 57.87 138.18 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.74 0.781 . . . . 0.0 110.602 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.34 -43.53 97.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.492 -0.755 . . . . 0.0 109.355 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.402 HD11 HD21 ' A' ' 72' ' ' LEU . 93.5 mt -100.81 115.25 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.332 -0.855 . . . . 0.0 109.228 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 26.3 p90 -130.23 98.1 4.62 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.9 mt -97.0 123.8 40.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 91' ' ' ASP . 31.0 t0 -95.25 -151.62 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.538 -0.726 . . . . 0.0 109.8 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.545 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 34.5 t70 58.82 171.53 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.686 0.755 . . . . 0.0 110.351 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.447 ' N ' ' CG ' ' A' ' 91' ' ' ASP . 71.9 t -91.25 114.21 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.599 -0.688 . . . . 0.0 110.151 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER 172.29 -31.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.099 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.9 t -115.52 131.99 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 121.704 0.764 . . . . 0.0 109.689 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -77.06 -175.78 3.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.589 -0.695 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -62.11 -39.16 91.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.756 . . . . 0.0 109.65 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -139.77 57.81 1.62 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.155 -0.966 . . . . 0.0 109.16 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.746 ' CE1' ' H ' ' A' ' 118' ' ' GLY . 57.0 t-80 -61.66 -40.11 93.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.452 -0.78 . . . . 0.0 109.639 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.39 156.33 43.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.106 -0.996 . . . . 0.0 110.097 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -137.25 145.9 44.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.57 145.65 38.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.542 -0.724 . . . . 0.0 109.181 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.2 mtp85 -130.78 144.65 51.6 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.6 -0.687 . . . . 0.0 109.283 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.0 tp -105.17 126.44 52.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.589 -0.694 . . . . 0.0 109.686 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -158.05 149.89 21.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.014 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 55.51 35.2 24.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.446 -0.784 . . . . 0.0 109.415 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 54.9 31.62 16.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.677 -0.639 . . . . 0.0 109.716 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -143.53 138.97 29.54 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -77.08 145.69 37.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.528 -0.733 . . . . 0.0 109.618 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -130.94 159.0 38.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.708 . . . . 0.0 109.195 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 110' ' ' VAL . 8.6 p -122.28 128.05 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.1 t -125.96 132.81 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 53.3 p-10 -95.9 144.94 25.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.435 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 113' ' ' VAL . 3.5 m -77.71 75.92 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 109.969 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.07 167.0 22.24 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 71.2 m -60.93 -41.28 95.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.867 . . . . 0.0 109.677 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.4 125.84 30.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 0.0 109.966 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 119' ' ' THR . 65.1 t30 -174.1 164.31 4.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.545 -0.722 . . . . 0.0 109.571 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.746 ' H ' ' CE1' ' A' ' 98' ' ' HIS . . . -95.57 -5.97 59.91 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 117' ' ' ASN . 45.2 m -67.55 130.58 43.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -1.152 . . . . 0.0 109.945 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 119' ' ' THR . 38.4 m-85 -144.28 152.11 40.34 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.214 -0.929 . . . . 0.0 109.585 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.511 HG12 HG11 ' A' ' 126' ' ' VAL . 9.4 p -129.08 138.91 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.48 -0.763 . . . . 0.0 109.454 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 27.1 m120 58.98 38.34 24.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.596 -0.69 . . . . 0.0 109.839 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 48.58 35.9 6.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.0 109.945 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -145.49 148.22 36.33 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 108.642 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.427 ' O ' ' OE2' ' A' ' 124' ' ' GLU . 25.7 Cg_endo -61.43 139.9 84.8 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.367 2.044 . . . . 0.0 112.095 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.511 HG11 HG12 ' A' ' 121' ' ' VAL . 2.0 p -147.76 161.19 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.33 -0.856 . . . . 0.0 108.996 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 128' ' ' SER . 67.3 t0 -124.73 66.83 1.09 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 127' ' ' ASP . 3.5 p 84.82 116.87 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.15 0.5 . . . . 0.0 109.809 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.84 43.32 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.25 -0.906 . . . . 0.0 109.931 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.1 t -79.21 133.23 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -0.779 . . . . 0.0 110.519 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.52 147.88 37.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.384 -0.823 . . . . 0.0 109.617 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.537 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -142.15 148.42 38.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.254 -0.903 . . . . 0.0 109.186 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 49.9 p-10 -48.48 132.23 17.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.772 . . . . 0.0 111.021 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.518 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 87.23 13.1 66.56 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 79.8 m-20 -89.48 150.28 22.55 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.097 -1.237 . . . . 0.0 110.042 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -111.74 136.99 50.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.599 -0.688 . . . . 0.0 109.515 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -128.27 134.74 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.515 -0.741 . . . . 0.0 109.221 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -124.15 117.4 24.56 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.84 128.35 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.479 -0.763 . . . . 0.0 109.524 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 142' ' ' PHE . . . 61.62 45.29 96.61 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.541 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? 70.2 -29.33 0.18 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.571 -0.958 . . . . 0.0 110.119 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 140' ' ' GLY . 72.8 m-85 -66.64 137.12 56.49 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.65 -0.656 . . . . 0.0 110.273 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -106.85 124.61 49.87 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.287 -0.883 . . . . 0.0 109.191 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.7 mp -126.37 147.64 49.72 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.533 -0.729 . . . . 0.0 109.327 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 145' ' ' VAL . 10.4 p -108.59 126.61 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -89.76 120.49 31.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.557 -0.714 . . . . 0.0 109.879 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 134' ' ' GLY . 96.8 mt -131.89 150.46 52.15 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.463 0.649 . . . . 0.0 109.762 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.1 p -118.65 124.53 47.62 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.695 -0.628 . . . . 0.0 109.377 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -91.96 102.37 2.91 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 151' ' ' LYS . 53.5 p-80 -154.38 14.3 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.275 -1.132 . . . . 0.0 108.854 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 150' ' ' HIS . 55.7 mtpt 40.95 -166.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.677 0.751 . . . . 0.0 111.326 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -66.78 129.94 41.53 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.479 0.657 . . . . 0.0 110.324 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 154.87 93.89 0.1 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -69.41 140.67 54.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -1.189 . . . . 0.0 109.988 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -92.9 8.66 38.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.9 mt -76.71 122.83 25.27 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 110.034 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -174.51 -63.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -67.11 -39.67 86.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 109.519 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -69.62 141.56 53.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.828 . . . . 0.0 110.112 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 59.0 m80 -130.03 86.29 2.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.524 -0.735 . . . . 0.0 109.04 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -89.49 -10.65 45.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.436 -0.79 . . . . 0.0 108.916 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -83.39 -12.72 56.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 109.071 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.71 179.65 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.823 0.821 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -64.3 169.25 4.77 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.824 0.821 . . . . 0.0 110.622 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -141.57 116.88 10.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.799 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 43.87 -129.12 0.86 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.413 0.625 . . . . 0.0 110.552 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -124.87 -41.29 2.12 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -100.08 -164.02 1.08 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.329 -0.857 . . . . 0.0 111.002 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -82.67 99.24 9.48 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.983 0.896 . . . . 0.0 109.819 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.9 p -65.63 160.76 21.9 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.032 0.92 . . . . 0.0 110.68 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 55.58 71.55 0.54 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.788 0.804 . . . . 0.0 109.704 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.11 -41.32 99.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.663 -0.648 . . . . 0.0 109.309 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 35' ' ' ALA . 91.8 m-20 57.71 50.87 10.09 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 34' ' ' ASP . . . -37.58 154.64 0.11 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.893 -0.504 . . . . 0.0 110.397 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.23 152.99 75.53 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.78 2.32 . . . . 0.0 112.779 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.423 ' H ' ' H ' ' A' ' 38' ' ' GLN . . . -167.63 -18.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 7.7 mp0 -92.53 0.08 57.39 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.155 -0.966 . . . . 0.0 109.289 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.77 2.73 3.06 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.148 -0.97 . . . . 0.0 109.274 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.39 5.46 15.16 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.534 HG22 ' H ' ' A' ' 43' ' ' SER . 16.0 m -61.85 137.02 58.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 110.081 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -68.19 -0.18 4.38 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.6 0.714 . . . . 0.0 109.296 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.534 ' H ' HG22 ' A' ' 41' ' ' THR . 62.2 p -85.74 -8.69 58.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.314 -0.866 . . . . 0.0 109.77 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.21 -12.32 24.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.096 -1.003 . . . . 0.0 108.922 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.5 -17.41 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.219 -0.925 . . . . 0.0 108.887 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.2 t -66.75 143.86 56.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.367 -0.833 . . . . 0.0 110.358 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.33 -173.91 52.57 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.1 t 42.98 86.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.939 0.876 . . . . 0.0 110.373 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -152.67 101.37 2.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.434 -0.791 . . . . 0.0 109.824 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.32 146.97 21.53 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD1' ' ND1' ' A' ' 150' ' ' HIS . 20.0 tp -173.65 74.55 0.38 Allowed Pre-proline 0 N--CA 1.486 1.356 0 O-C-N 121.891 -0.77 . . . . 0.0 109.441 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.445 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 44.1 Cg_exo -54.13 -43.28 59.81 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.894 2.396 . . . . 0.0 112.619 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 58.7 Cg_endo -78.72 156.98 27.94 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.1 1.867 . . . . 0.0 112.98 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.34 84.67 0.95 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -138.55 163.61 31.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.456 -1.026 . . . . 0.0 109.636 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.73 156.83 42.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.508 -0.745 . . . . 0.0 109.949 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 57' ' ' LEU . 3.9 pp -142.7 169.9 16.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.355 -0.841 . . . . 0.0 110.626 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.9 mt -124.49 144.01 50.34 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -130.42 132.49 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.743 0.782 . . . . 0.0 109.61 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.3 t -75.71 132.62 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.69 0.757 . . . . 0.0 109.993 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.527 ' NZ ' ' OE2' ' A' ' 136' ' ' GLU . 51.9 mtmt -86.78 -73.78 0.45 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.724 -0.61 . . . . 0.0 110.017 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.603 HH21 ' NH1' ' A' ' 143' ' ' ARG . 61.7 ttp180 -117.33 134.69 54.52 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.433 -0.792 . . . . 0.0 110.356 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.26 173.9 21.6 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.47 -19.74 48.63 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.882 2.388 . . . . 0.0 111.726 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -97.37 19.77 12.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 109.047 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.22 139.32 29.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.389 -0.819 . . . . 0.0 110.373 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.78 -22.27 40.18 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.3 m -71.9 149.39 45.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.367 -1.078 . . . . 0.0 110.831 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -145.78 152.31 39.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.327 -0.858 . . . . 0.0 110.232 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -121.55 131.76 54.31 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.463 0.649 . . . . 0.0 109.444 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 46.8 tp -100.42 128.87 46.37 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 0.0 109.263 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.08 128.27 42.83 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.836 0.826 . . . . 0.0 110.428 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 67.6 t0 -155.24 41.03 0.42 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -141.39 152.61 44.47 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.353 -0.842 . . . . 0.0 109.553 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.46 -48.02 83.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.687 -0.633 . . . . 0.0 109.987 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.42 121.33 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.45 -0.781 . . . . 0.0 109.372 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -116.92 118.9 33.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.583 0.706 . . . . 0.0 109.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 m -86.16 155.28 20.82 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.554 0.692 . . . . 0.0 109.895 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 99' ' ' ALA . . . -103.69 169.75 8.34 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.905 0.859 . . . . 0.0 110.339 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.31 -119.9 5.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.532 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 74.1 ttp85 -118.63 121.6 40.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.888 . . . . 0.0 109.884 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 41.7 m-70 -167.9 151.28 5.79 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.82 145.02 79.48 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.787 2.324 . . . . 0.0 112.783 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 54.82 31.1 14.93 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.511 0.672 . . . . 0.0 109.584 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 t -99.14 123.45 43.44 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.209 -0.932 . . . . 0.0 110.555 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 71' ' ' LEU . 54.3 m-20 -65.85 -39.57 90.88 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -85.01 125.51 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 109.841 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -127.19 86.11 2.46 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.2 mt -115.26 94.29 4.66 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -92.79 109.68 21.12 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.525 0.679 . . . . 0.0 109.622 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -158.58 163.1 37.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.958 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.3 -44.21 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.63 0.729 . . . . 0.0 110.285 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.5 p -68.22 -29.4 68.23 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.344 -0.848 . . . . 0.0 109.996 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.4 t -92.46 112.1 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.131 -0.981 . . . . 0.0 109.97 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.9 m -77.58 176.73 8.67 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.686 0.755 . . . . 0.0 110.444 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.53 -41.84 99.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.646 -0.658 . . . . 0.0 110.017 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -124.18 49.2 1.81 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.377 -0.827 . . . . 0.0 109.005 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.08 -39.93 94.1 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.511 0.672 . . . . 0.0 109.45 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -147.99 154.89 40.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.957 -1.089 . . . . 0.0 110.272 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -136.58 151.6 49.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.497 0.665 . . . . 0.0 109.848 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.435 ' CE1' HG23 ' A' ' 110' ' ' VAL . 97.0 m-85 -121.09 138.83 54.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -130.71 141.21 50.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.635 0.731 . . . . 0.0 109.718 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.06 123.87 38.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 106' ' ' ASN . 80.7 tt0 -115.13 120.38 39.58 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.862 0.839 . . . . 0.0 109.867 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.464 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 21.3 t-20 52.09 -84.52 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.426 0.631 . . . . 0.0 110.372 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -144.03 20.36 1.77 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 108.503 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -130.16 137.47 50.13 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.714 0.769 . . . . 0.0 109.721 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -82.08 147.47 29.09 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.433 0.635 . . . . 0.0 109.76 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -136.06 157.87 45.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.518 -0.739 . . . . 0.0 109.769 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.6 p -125.84 127.35 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.1 t -131.03 131.26 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 119' ' ' THR . 42.9 t0 -100.38 126.48 46.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.697 0.76 . . . . 0.0 109.447 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.5 m -85.43 3.29 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.644 0.735 . . . . 0.0 109.228 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -79.35 -1.29 85.8 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.8 m 48.62 -88.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.976 . . . . 0.0 109.966 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 114' ' ' GLY . 46.5 tp -73.09 133.62 44.23 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.877 0.846 . . . . 0.0 111.368 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 57.2 38.42 28.82 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.746 0.784 . . . . 0.0 109.725 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.6 -163.59 20.56 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.324 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.549 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 28.4 m -60.84 137.16 58.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.904 . . . . 0.0 110.582 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.434 ' OH ' ' NE2' ' A' ' 138' ' ' GLN . 22.7 p90 -119.57 150.51 40.17 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.579 0.704 . . . . 0.0 109.905 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 122' ' ' ASN . 9.6 p -121.28 130.07 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.974 0.892 . . . . 0.0 109.29 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 124' ' ' GLU . 90.1 m-20 41.9 -168.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.098 0.951 . . . . 0.0 111.324 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.05 -0.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.757 -0.59 . . . . 0.0 110.163 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 122' ' ' ASN . 17.2 tt0 -113.25 93.09 24.6 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.384 -0.822 . . . . 0.0 109.42 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.04 122.36 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.74 2.293 . . . . 0.0 112.361 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.0 m -136.72 165.07 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.447 -0.783 . . . . 0.0 109.891 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.83 -37.81 88.78 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.591 0.71 . . . . 0.0 109.3 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.4 p -155.54 161.34 40.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.903 . . . . 0.0 110.065 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.06 156.26 24.34 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.597 0.713 . . . . 0.0 110.166 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.36 129.75 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.624 0.726 . . . . 0.0 110.098 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.88 143.04 38.08 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.906 0.86 . . . . 0.0 110.592 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.544 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.86 147.18 27.65 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.596 0.712 . . . . 0.0 109.279 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 20.5 p30 -43.17 130.19 4.65 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.057 0.932 . . . . 0.0 111.667 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.06 13.47 68.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 81.2 m-20 -89.95 150.03 22.33 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.986 -1.302 . . . . 0.0 109.673 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 61' ' ' LYS . 84.0 tt0 -108.5 129.25 55.29 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.696 0.76 . . . . 0.0 110.05 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.9 t -126.11 131.25 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.434 ' NE2' ' OH ' ' A' ' 120' ' ' TYR . 56.6 tt0 -121.5 120.92 36.31 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.465 0.65 . . . . 0.0 109.772 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 39.7 mm -110.71 122.2 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.75 0.786 . . . . 0.0 109.284 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 56.3 -129.74 48.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -95.06 -6.59 41.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.544 -0.974 . . . . 0.0 109.059 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -89.88 139.92 30.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 0.0 109.519 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.603 ' NH1' HH21 ' A' ' 62' ' ' ARG . 85.0 mtt85 -102.95 136.52 42.61 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.674 0.75 . . . . 0.0 110.027 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.53 157.37 46.69 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.55 133.52 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.671 0.748 . . . . 0.0 109.431 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -87.27 111.51 21.11 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.595 0.712 . . . . 0.0 109.978 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.7 mt -136.19 157.7 46.19 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.426 0.631 . . . . 0.0 109.335 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.4 p -112.79 130.23 56.15 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.496 0.665 . . . . 0.0 109.718 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.26 77.16 0.02 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.503 ' ND1' ' CD1' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -88.53 140.2 29.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.345 -1.091 . . . . 0.0 109.998 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.594 ' C ' ' H ' ' A' ' 153' ' ' GLY . 17.8 mmmt -69.76 -85.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.609 -0.682 . . . . 0.0 110.568 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 62.21 -13.1 0.06 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.443 0.64 . . . . 0.0 110.028 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 77.29 149.78 3.63 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -143.01 -26.41 0.59 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.687 -0.89 . . . . 0.0 109.033 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -82.35 115.21 21.29 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.884 . . . . 0.0 109.846 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 156' ' ' LEU . 9.5 mp -80.89 -78.37 0.18 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.889 0.852 . . . . 0.0 109.847 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 158' ' ' HIS . 97.3 mt-10 47.21 23.0 0.27 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.81 0.814 . . . . 0.0 109.341 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 157' ' ' GLU . 77.5 m80 51.27 168.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.776 0.798 . . . . 0.0 111.234 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.506 ' C ' ' H ' ' A' ' 161' ' ' HIS . 84.3 t60 -153.53 143.04 21.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 56.11 4.93 0.14 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.653 0.74 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' A' ' 159' ' ' HIS . 13.1 t-160 -66.52 -40.83 89.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.501 -0.75 . . . . 0.0 109.666 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.435 ' NE2' ' CE1' ' A' ' 161' ' ' HIS . 97.7 m-70 -130.64 143.17 50.57 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.304 -0.873 . . . . 0.0 109.999 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.258 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.522 HG13 ' N ' ' A' ' 25' ' ' PHE . 10.5 p . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.47 0.653 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.522 ' N ' HG13 ' A' ' 24' ' ' VAL . 84.0 t80 -156.95 114.69 3.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.0 109.342 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -76.8 144.53 39.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.6 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.05 -179.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.827 0.822 . . . . 0.0 110.631 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -80.65 -0.27 37.36 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.631 0.729 . . . . 0.0 109.093 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 31' ' ' SER . 48.8 p90 -140.96 -160.02 1.03 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.495 -0.753 . . . . 0.0 109.551 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 31' ' ' SER . 18.6 mt -37.26 96.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.929 0.871 . . . . 0.0 110.31 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 29' ' ' PHE . 33.5 t -38.9 162.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.538 0.685 . . . . 0.0 110.918 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 31' ' ' SER . 97.5 mt-10 59.3 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.924 0.868 . . . . 0.0 110.308 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.7 mm? -74.1 152.75 39.84 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.873 0.844 . . . . 0.0 110.196 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 54.5 p-10 -58.77 146.42 36.98 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.911 0.862 . . . . 0.0 110.755 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.67 71.72 20.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -75.72 -9.27 19.72 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.657 2.238 . . . . 0.0 110.985 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.49 -139.24 1.02 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.606 0.717 . . . . 0.0 110.39 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 2.7 pm0 -146.81 12.43 1.12 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 47.55 -97.73 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.698 0.761 . . . . 0.0 110.508 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.81 139.91 35.62 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.8 m -68.3 134.62 50.63 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.778 -0.836 . . . . 0.0 110.729 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -82.21 -80.74 0.16 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.666 0.746 . . . . 0.0 109.772 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 59.0 p -151.24 -31.53 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 109.274 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 42.62 89.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.669 0.747 . . . . 0.0 110.411 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.99 -40.79 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.626 0.727 . . . . 0.0 109.262 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 t 45.0 -164.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.836 0.827 . . . . 0.0 111.158 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.82 -91.13 0.22 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.87 131.27 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.987 . . . . 0.0 110.494 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -112.35 -25.95 8.98 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.46 96.03 1.49 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.527 HD11 ' N ' ' A' ' 149' ' ' GLY . 0.6 OUTLIER -177.47 79.48 0.24 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.805 -0.821 . . . . 0.0 109.545 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 47.3 Cg_exo -50.17 -175.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.451 2.101 . . . . 0.0 111.612 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 52' ' ' PRO . 31.5 Cg_exo -59.77 140.25 92.44 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.428 2.085 . . . . 0.0 112.429 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' C ' HD22 ' A' ' 55' ' ' LEU . . . 146.32 -87.68 0.16 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 55' ' ' LEU . 2.6 mm? -102.09 167.54 9.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.563 -0.963 . . . . 0.0 110.272 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.19 176.96 7.5 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -130.55 146.6 52.1 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.023 0.916 . . . . 0.0 110.712 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mt -116.4 134.33 55.0 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.2 t -122.43 135.08 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.586 0.708 . . . . 0.0 109.187 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.3 t -69.18 133.39 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.58 0.705 . . . . 0.0 110.184 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -95.17 -28.61 14.96 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.548 0.689 . . . . 0.0 109.196 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -147.73 138.19 23.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.194 -0.941 . . . . 0.0 110.072 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.65 174.4 15.9 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.17 -13.1 25.84 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.958 2.439 . . . . 0.0 111.132 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ALA . 97.9 m-20 -97.88 16.69 20.1 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . -39.78 133.04 1.62 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.884 0.849 . . . . 0.0 110.924 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.34 -14.24 65.42 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -66.39 146.71 54.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.437 -1.037 . . . . 0.0 110.971 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -134.96 142.11 46.42 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.269 0.557 . . . . 0.0 109.604 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.98 125.42 49.36 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.621 0.724 . . . . 0.0 109.95 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 tt -102.16 132.97 47.74 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.281 0.563 . . . . 0.0 110.044 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -87.72 157.74 18.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.512 -0.743 . . . . 0.0 110.344 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 66.7 t0 -173.51 33.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -156.58 147.17 21.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.452 -0.78 . . . . 0.0 109.88 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.23 136.81 46.46 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.802 0.811 . . . . 0.0 110.83 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 85.3 mt 55.11 100.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.542 0.687 . . . . 0.0 109.873 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -103.7 126.06 50.59 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.607 0.717 . . . . 0.0 109.571 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -92.94 143.64 26.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.491 0.662 . . . . 0.0 109.923 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -101.97 170.06 8.37 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.75 0.786 . . . . 0.0 110.282 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . 92.02 -129.47 9.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.52 ' O ' ' CD2' ' A' ' 82' ' ' HIS . 8.7 ptp180 -103.8 110.83 23.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.932 . . . . 0.0 109.612 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 81' ' ' ARG . 80.3 m-70 -161.87 90.56 1.43 Allowed Pre-proline 0 N--CA 1.486 1.341 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 58.6 Cg_exo -52.12 145.72 33.13 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.679 2.253 . . . . 0.0 112.507 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 7.0 t0 81.5 -22.32 0.27 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -71.97 146.98 47.39 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.79 0.805 . . . . 0.0 110.891 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -62.62 -42.86 99.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.64 -0.663 . . . . 0.0 109.845 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.03 114.05 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 109.563 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 22.0 p90 -129.85 97.87 4.62 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.577 0.703 . . . . 0.0 109.414 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 80' ' ' GLY . 96.1 mt -102.03 96.75 7.22 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.763 0.792 . . . . 0.0 108.871 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 30.0 p30 -85.34 90.61 7.97 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.515 0.674 . . . . 0.0 109.764 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -146.06 150.05 35.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.485 -0.759 . . . . 0.0 109.477 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.08 -32.32 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.551 0.691 . . . . 0.0 109.912 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.6 p -66.43 -32.51 73.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.459 -0.776 . . . . 0.0 109.786 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.32 128.47 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.306 -0.871 . . . . 0.0 109.917 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 96' ' ' ARG . 25.2 t -78.29 -170.96 2.2 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.666 0.745 . . . . 0.0 110.594 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.503 ' N ' ' OG ' ' A' ' 95' ' ' SER . 95.3 mtt180 -61.66 -41.62 97.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.516 -0.74 . . . . 0.0 109.036 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -142.21 62.41 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -62.3 -40.81 97.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.507 -0.745 . . . . 0.0 109.084 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.32 151.07 44.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 0.0 109.777 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -140.83 136.57 32.52 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.656 0.741 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -99.43 146.69 26.05 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.396 0.617 . . . . 0.0 109.356 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -130.81 131.74 44.82 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.483 0.659 . . . . 0.0 109.342 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.1 tp -102.93 123.51 46.7 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 105' ' ' ASN . 44.6 tt0 -93.18 -132.04 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.625 -0.672 . . . . 0.0 109.827 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 90.9 m-20 -64.35 -44.34 91.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.321 -0.862 . . . . 0.0 109.616 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 48.3 m-20 -169.79 24.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.78 131.53 51.27 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.654 0.74 . . . . 0.0 109.514 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.409 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 63.9 m-85 -78.94 146.43 33.48 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.486 0.66 . . . . 0.0 109.836 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 93.4 m-20 -144.61 159.38 42.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 p -126.93 131.98 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.483 0.658 . . . . 0.0 109.343 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.04 133.46 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.633 0.73 . . . . 0.0 109.414 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -96.53 114.09 25.72 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.569 0.699 . . . . 0.0 109.215 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.72 130.32 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.649 0.738 . . . . 0.0 110.385 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.44 161.32 37.38 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.8 p -88.56 -148.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.617 -0.931 . . . . 0.0 110.538 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.8 mt 57.03 -168.84 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.813 0.816 . . . . 0.0 110.753 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 118' ' ' GLY . 63.1 t-20 -66.8 145.8 55.11 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.703 0.763 . . . . 0.0 110.336 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 117' ' ' ASN . . . -170.6 -146.92 5.37 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.1 m -60.38 137.64 58.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.764 -0.845 . . . . 0.0 110.428 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -137.57 157.73 45.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.622 -0.674 . . . . 0.0 109.411 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.2 p -117.86 129.57 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.752 0.787 . . . . 0.0 109.965 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 52.65 49.56 20.08 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.701 0.762 . . . . 0.0 109.719 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 52.29 26.17 3.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.968 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -123.95 101.22 35.95 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.82 127.01 13.71 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.323 2.015 . . . . 0.0 112.274 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 128' ' ' SER . 2.4 p -144.36 138.69 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.474 -0.766 . . . . 0.0 109.946 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -66.49 -40.17 89.14 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.474 0.654 . . . . 0.0 109.449 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.425 ' N ' HG22 ' A' ' 126' ' ' VAL . 87.7 p -156.87 154.26 29.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.13 157.14 27.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.854 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 82.3 t -91.61 128.13 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.729 0.776 . . . . 0.0 109.796 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.67 152.29 35.84 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.754 0.788 . . . . 0.0 110.411 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.534 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.4 155.73 40.92 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.51 0.671 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.405 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 43.0 p-10 -51.77 132.57 31.44 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.883 0.849 . . . . 0.0 111.084 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.515 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 82.45 18.19 66.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 23.5 m-20 -83.57 149.38 26.61 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.223 -1.163 . . . . 0.0 110.073 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 57.6 mp0 -108.84 123.97 49.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.624 -0.672 . . . . 0.0 109.435 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.4 t -125.17 132.32 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.38 125.18 44.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 141' ' ' LYS . 36.3 mm -111.34 127.51 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.737 0.779 . . . . 0.0 109.308 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 54.91 -92.19 0.01 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 139' ' ' ILE . 60.8 pttt -129.9 -18.46 3.4 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -76.99 142.61 39.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 110.036 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -105.65 132.49 51.73 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.684 0.754 . . . . 0.0 110.13 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.54 155.35 50.56 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.446 0.641 . . . . 0.0 109.578 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.39 134.39 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.559 0.695 . . . . 0.0 109.802 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -94.12 120.73 34.79 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 134' ' ' GLY . 84.0 mt -132.74 152.85 51.65 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.799 0.809 . . . . 0.0 109.613 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 t -142.61 164.41 30.2 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.587 0.708 . . . . 0.0 109.693 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.527 ' N ' HD11 ' A' ' 51' ' ' LEU . . . -61.88 -68.65 1.57 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 149' ' ' GLY . 59.3 m-70 -159.38 151.64 21.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.447 -1.031 . . . . 0.0 109.766 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -100.18 142.29 31.87 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.508 0.671 . . . . 0.0 109.781 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -107.59 -40.63 5.27 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.695 0.759 . . . . 0.0 109.189 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 79.45 -69.59 2.97 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 57.9 mp0 -71.62 144.77 49.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.718 -0.872 . . . . 0.0 110.758 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -68.69 150.01 48.42 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.704 0.764 . . . . 0.0 110.375 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.534 ' CD2' ' H ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -71.04 129.09 38.08 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.865 0.84 . . . . 0.0 110.123 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.655 ' H ' ' CD ' ' A' ' 157' ' ' GLU . 1.2 pm0 -75.34 137.9 41.41 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.693 0.759 . . . . 0.0 110.313 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -67.19 -38.08 84.75 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.633 0.73 . . . . 0.0 109.723 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -66.06 174.04 2.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.445 -0.784 . . . . 0.0 110.632 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -146.53 163.52 35.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.44 -0.788 . . . . 0.0 110.047 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -107.14 131.03 54.58 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.68 0.752 . . . . 0.0 110.44 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -85.32 149.84 25.18 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.523 0.678 . . . . 0.0 109.945 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 117.829 -1.082 . . . . 0.0 109.857 179.856 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -70.44 130.6 42.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 0.0 110.13 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -73.28 145.67 45.92 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.693 0.758 . . . . 0.0 110.79 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -167.14 -39.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.567 -0.708 . . . . 0.0 109.181 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -144.62 -64.43 0.35 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.513 0.673 . . . . 0.0 109.837 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.572 ' O ' ' N ' ' A' ' 31' ' ' SER . 1.6 p90 -60.83 165.0 4.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.359 -0.838 . . . . 0.0 110.124 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.474 HD12 ' CE2' ' A' ' 29' ' ' PHE . 78.9 mt 58.32 -70.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.459 0.647 . . . . 0.0 109.926 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 29' ' ' PHE . 7.9 m -67.32 147.29 53.15 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.377 -0.827 . . . . 0.0 110.5 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -148.57 -69.18 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 tp -133.33 -35.16 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -84.59 108.11 17.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 110.031 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.661 ' H ' ' CD ' ' A' ' 36' ' ' PRO . . . -110.4 -43.34 0.1 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.82 -0.55 . . . . 0.0 109.689 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.661 ' CD ' ' H ' ' A' ' 35' ' ' ALA . 25.1 Cg_exo -60.93 143.39 99.34 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.253 1.969 . . . . 0.0 112.411 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.13 -13.11 21.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.447 -0.783 . . . . 0.0 109.277 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -160.22 -33.11 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 109.089 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 57.9 6.4 0.47 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.341 0.591 . . . . 0.0 110.332 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.39 158.78 31.95 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.44 125.31 50.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.669 -0.9 . . . . 0.0 109.576 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -168.49 130.0 1.32 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.868 . . . . 0.0 109.608 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 m -71.63 146.5 48.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.483 -0.76 . . . . 0.0 110.097 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -166.36 22.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.06 -14.03 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.426 -0.796 . . . . 0.0 108.99 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.4 t -64.87 145.0 56.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.48 -0.762 . . . . 0.0 110.503 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . 164.64 -84.48 0.1 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 t 66.13 -41.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 122.201 -0.587 . . . . 0.0 109.666 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.474 ' H ' ' C ' ' A' ' 47' ' ' GLY . 98.5 mt-10 -54.82 138.84 41.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 0.0 110.857 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 52.38 90.94 0.01 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -135.99 78.15 48.08 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.677 -0.896 . . . . 0.0 109.033 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.437 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 22.6 Cg_exo -64.38 -175.9 0.36 Allowed 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.181 1.921 . . . . 0.0 111.84 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 52' ' ' PRO . 23.2 Cg_exo -65.48 156.05 65.58 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 123.108 2.539 . . . . 0.0 113.285 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.36 -25.43 28.32 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.4 mt -125.56 149.58 48.22 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.433 -1.039 . . . . 0.0 110.636 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.459 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -151.43 156.31 40.39 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.39 151.47 41.18 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.097 0.951 . . . . 0.0 110.188 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.0 mt -117.88 142.51 47.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.2 t -127.32 130.7 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.56 -0.713 . . . . 0.0 109.816 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.41 130.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 121.649 0.738 . . . . 0.0 110.061 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.21 -76.47 0.12 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.559 -0.713 . . . . 0.0 109.756 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -123.62 148.53 46.34 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.625 0.726 . . . . 0.0 110.16 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.53 175.28 30.31 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.89 -21.23 50.64 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.887 2.391 . . . . 0.0 111.346 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -110.31 23.8 13.82 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -39.96 145.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.643 0.735 . . . . 0.0 110.923 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.6 -1.3 88.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.6 m -72.38 146.23 47.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -1.073 . . . . 0.0 110.742 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -134.38 147.6 50.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.682 . . . . 0.0 109.571 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -128.77 146.92 50.77 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.492 -0.755 . . . . 0.0 109.55 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.1 tp -105.25 127.64 53.04 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.559 0.695 . . . . 0.0 109.756 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 56' ' ' ALA . 84.9 mt -92.88 77.81 4.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 54.8 t0 -108.59 16.81 22.63 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -124.51 140.02 53.34 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.571 0.7 . . . . 0.0 109.622 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.54 85.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.618 -0.676 . . . . 0.0 109.869 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.91 121.09 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.531 -0.731 . . . . 0.0 109.354 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.6 m -126.83 124.0 38.62 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -97.67 155.25 17.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.448 -0.782 . . . . 0.0 109.625 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.6 158.37 20.9 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.672 0.748 . . . . 0.0 110.219 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.68 -120.95 5.29 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -93.87 111.32 23.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.342 -1.093 . . . . 0.0 109.944 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -175.05 88.71 0.31 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 46.1 Cg_exo -54.91 148.27 47.75 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.574 2.183 . . . . 0.0 112.526 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 10.3 t0 82.14 -7.75 1.32 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.492 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 66.7 m -78.48 147.12 34.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.345 -0.847 . . . . 0.0 110.618 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.17 -38.71 92.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.511 -0.743 . . . . 0.0 109.153 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.08 126.75 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.341 -0.849 . . . . 0.0 109.907 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 50.3 m-85 -125.2 98.78 5.79 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.413 0.625 . . . . 0.0 109.316 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 91' ' ' ASP . 49.0 mt -107.87 146.81 31.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.61 -0.681 . . . . 0.0 109.608 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 41.4 t0 -60.48 -1.16 0.32 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 89' ' ' LEU . 2.6 p30 47.22 31.92 1.9 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.643 0.735 . . . . 0.0 110.444 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.9 m -68.88 -24.79 28.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 109.885 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 140' ' ' GLY . 60.6 p -138.22 13.27 2.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.392 -0.817 . . . . 0.0 109.234 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.73 131.35 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.584 0.706 . . . . 0.0 109.582 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.3 p -66.67 -162.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.636 0.731 . . . . 0.0 110.887 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.38 -40.85 92.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 109.77 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' A' ' 99' ' ' ALA . 93.3 mtm-85 -133.24 -41.7 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 60.6 -67.27 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.954 -0.466 . . . . 0.0 109.939 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -140.99 154.3 45.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.079 -1.013 . . . . 0.0 109.412 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -138.7 142.34 38.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.555 -0.715 . . . . 0.0 109.551 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -99.88 140.31 34.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.421 -0.799 . . . . 0.0 109.446 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.406 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 50.5 mmm-85 -130.48 141.53 50.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.636 -0.665 . . . . 0.0 109.547 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.8 tp -115.24 119.54 36.69 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.571 0.7 . . . . 0.0 109.183 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -160.16 -34.04 0.06 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.562 -0.712 . . . . 0.0 109.124 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 107' ' ' GLU . 90.5 m-20 -88.58 41.85 1.04 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 0.0 109.232 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 57.48 1.64 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 109.973 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 105' ' ' ASN . 96.1 mt-10 -142.99 157.22 44.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.167 -0.958 . . . . 0.0 109.906 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -74.25 141.65 45.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.515 -0.741 . . . . 0.0 110.14 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 102' ' ' ARG . 39.6 p30 -139.66 173.76 11.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.458 -0.776 . . . . 0.0 109.548 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.3 134.64 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.687 -0.633 . . . . 0.0 109.847 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -127.02 130.81 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.72 155.19 24.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.414 -0.804 . . . . 0.0 110.127 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.541 HG23 ' H ' ' A' ' 115' ' ' SER . 13.0 m -94.95 -7.94 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.34 3.88 10.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.541 ' H ' HG23 ' A' ' 113' ' ' VAL . 78.2 p -61.84 -42.29 98.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.128 -1.219 . . . . 0.0 109.045 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.2 pp -173.06 135.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.799 0.809 . . . . 0.0 110.532 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 57.27 90.47 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.646 0.736 . . . . 0.0 110.71 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.08 140.1 45.13 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.451 -1.059 . . . . 0.0 110.451 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 120' ' ' TYR . 44.2 m -76.69 161.99 28.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.509 -0.995 . . . . 0.0 110.327 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.528 ' N ' HG22 ' A' ' 119' ' ' THR . 44.2 p90 -142.48 162.28 35.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.545 -0.722 . . . . 0.0 109.956 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 123' ' ' ARG . 8.4 p -114.68 131.42 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.654 0.74 . . . . 0.0 109.722 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 43.59 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.582 -0.699 . . . . 0.0 110.385 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 121' ' ' VAL . 15.0 ptp180 -143.68 41.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 109.059 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -146.71 82.43 8.68 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.369 -0.832 . . . . 0.0 109.185 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.58 128.9 32.31 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.806 2.338 . . . . 0.0 112.811 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.3 m -150.81 161.87 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 109.945 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.62 -38.01 89.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 109.557 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -153.22 152.65 31.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 109.511 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.5 152.13 32.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.212 -0.93 . . . . 0.0 110.072 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.27 130.16 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.461 -0.775 . . . . 0.0 109.913 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.96 148.93 34.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.793 0.806 . . . . 0.0 110.272 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.431 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -148.98 156.36 42.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.494 -0.754 . . . . 0.0 109.317 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.766 ' ND2' ' H ' ' A' ' 148' ' ' THR . 31.8 t-20 -57.72 136.14 56.85 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.776 0.798 . . . . 0.0 111.301 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.3 10.46 77.55 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 89.5 m-20 -89.62 156.42 18.6 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.228 -1.16 . . . . 0.0 110.275 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -108.78 136.57 48.12 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.704 -0.623 . . . . 0.0 109.376 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.72 133.25 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.647 -0.658 . . . . 0.0 109.458 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.544 HE22 ' HG2' ' A' ' 143' ' ' ARG . 17.4 tp60 -123.14 114.77 20.76 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 140' ' ' GLY . 96.7 mt -132.78 122.43 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.448 -0.782 . . . . 0.0 109.74 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . 35.14 72.8 0.11 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 142' ' ' PHE . 6.2 tmtt? 64.16 -63.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.911 -0.758 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 140' ' ' GLY . 33.1 m-85 -36.31 123.19 0.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.504 0.669 . . . . 0.0 110.595 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.544 ' HG2' HE22 ' A' ' 138' ' ' GLN . 95.6 mtt180 -101.56 132.46 47.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.725 -0.609 . . . . 0.0 109.46 -179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -138.06 156.43 47.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.56 -0.712 . . . . 0.0 109.423 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.09 137.9 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.619 -0.676 . . . . 0.0 109.424 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -90.82 114.48 26.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.589 -0.694 . . . . 0.0 109.262 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.6 mt -134.01 149.4 51.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.774 0.797 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.766 ' H ' ' ND2' ' A' ' 133' ' ' ASN . 82.4 p -141.27 98.72 3.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.568 -0.707 . . . . 0.0 109.52 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 148' ' ' THR . . . 36.36 -110.5 0.09 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 32.6 m170 45.07 92.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.779 -0.836 . . . . 0.0 109.946 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -92.05 112.95 25.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.363 -0.836 . . . . 0.0 109.761 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -168.4 100.76 0.42 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.545 ' O ' HD21 ' A' ' 156' ' ' LEU . . . -87.49 -2.94 81.88 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -77.49 152.48 34.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.55 -0.97 . . . . 0.0 111.008 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.03 58.14 4.59 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.622 0.725 . . . . 0.0 109.421 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.545 HD21 ' O ' ' A' ' 153' ' ' GLY . 86.2 mt -70.97 144.88 50.37 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.712 0.768 . . . . 0.0 110.333 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 50.43 25.48 1.94 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.677 0.751 . . . . 0.0 109.108 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -148.2 137.4 22.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.421 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -144.1 121.53 11.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.293 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -67.46 -40.21 85.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.409 -0.807 . . . . 0.0 109.708 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -80.52 144.2 32.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 110.803 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -76.94 141.43 40.48 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.742 0.782 . . . . 0.0 110.402 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.986 179.793 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -83.58 161.87 21.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.341 -0.849 . . . . 0.0 110.431 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 27' ' ' ALA . 69.8 ttt180 -150.87 115.76 5.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.604 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 26' ' ' ARG . . . 57.33 154.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.78 0.8 . . . . 0.0 110.776 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -81.43 -4.56 56.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.037 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.493 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 31.3 p90 -156.17 -160.03 0.96 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.872 . . . . 0.0 110.168 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' N ' ' CD2' ' A' ' 29' ' ' PHE . 59.6 mt -60.95 97.77 0.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.93 0.871 . . . . 0.0 109.917 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 30' ' ' LEU . 69.5 m -48.03 -95.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.674 -0.641 . . . . 0.0 109.904 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 33' ' ' LEU . 47.9 tp10 -173.72 -48.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 32' ' ' GLU . 50.4 tp 57.1 116.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.839 0.828 . . . . 0.0 110.297 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.678 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 44.4 t0 -63.37 -49.73 72.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 0.0 109.549 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 34' ' ' ASP . . . 163.08 154.2 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.708 -0.62 . . . . 0.0 109.354 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.13 146.75 91.13 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 123.011 2.474 . . . . 0.0 112.966 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.76 143.3 55.93 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.707 0.765 . . . . 0.0 110.152 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 39' ' ' ALA . 5.0 pp0? -173.13 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' GLN . . . 39.82 -105.9 0.05 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.526 0.679 . . . . 0.0 110.429 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.16 2.58 87.94 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.8 m -103.96 119.58 39.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.375 -1.074 . . . . 0.0 109.693 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -106.59 -15.57 14.74 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -65.64 138.64 58.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.508 -0.745 . . . . 0.0 110.252 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -172.74 24.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.17 -19.98 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.6 t -166.4 130.1 2.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 109.809 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . -164.45 -148.41 5.43 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 48' ' ' VAL . 17.8 t -67.56 3.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.47 -1.018 . . . . 0.0 109.458 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 47' ' ' GLY . 98.1 mt-10 -58.96 -39.19 80.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 109.62 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 172.17 94.89 0.1 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -96.26 150.55 37.3 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.195 -1.18 . . . . 0.0 109.772 -179.328 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.77 166.08 28.8 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.56 2.174 . . . . 0.0 111.905 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -53.22 140.1 62.13 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.891 1.727 . . . . 0.0 112.277 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.81 -76.19 0.29 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 55' ' ' LEU . 10.7 mp -96.13 151.77 19.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.399 -1.06 . . . . 0.0 110.289 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -127.02 162.63 25.56 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.23 153.8 45.66 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.917 0.865 . . . . 0.0 110.509 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.7 mt -114.3 141.21 47.89 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.8 132.72 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.585 0.707 . . . . 0.0 109.794 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.8 t -72.06 132.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.606 0.717 . . . . 0.0 109.686 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -81.9 -77.16 0.23 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.543 -0.723 . . . . 0.0 109.188 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -133.94 139.16 45.95 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.806 0.813 . . . . 0.0 109.836 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.62 -177.74 37.77 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.51 -38.63 90.07 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.758 2.305 . . . . 0.0 111.919 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 66' ' ' ALA . 98.7 m-20 -75.53 -78.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.662 -0.648 . . . . 0.0 110.102 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 59.63 122.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.442 -0.787 . . . . 0.0 110.391 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.14 -19.58 53.55 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.6 t -67.63 144.78 55.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.295 -1.121 . . . . 0.0 110.554 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -134.54 145.07 48.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.627 -0.671 . . . . 0.0 109.732 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.22 139.3 48.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.54 -0.725 . . . . 0.0 109.6 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pp -106.41 145.41 31.77 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.5 0.667 . . . . 0.0 109.833 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.34 123.92 44.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.373 -0.83 . . . . 0.0 109.635 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -93.94 37.93 1.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 109.157 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 55.93 -168.09 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.718 0.77 . . . . 0.0 111.034 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 62.76 -141.37 0.39 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.526 0.679 . . . . 0.0 110.667 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 93.4 mt -113.57 127.82 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.741 -0.599 . . . . 0.0 109.705 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.1 m -120.84 124.95 46.29 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.502 0.668 . . . . 0.0 109.27 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.5 m -94.42 161.63 14.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.518 -0.739 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.57 151.68 31.31 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.606 0.717 . . . . 0.0 109.848 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.85 -58.02 1.53 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -77.62 145.83 36.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -1.091 . . . . 0.0 110.691 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.495 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -86.02 -47.35 0.57 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.505 -0.747 . . . . 0.0 109.742 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 72.9 Cg_exo -51.97 133.71 46.89 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.325 2.017 . . . . 0.0 113.172 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' PRO . 45.7 t0 41.8 49.88 3.96 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.726 0.774 . . . . 0.0 109.718 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 t -157.01 114.25 3.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.62 -37.66 88.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.533 -0.73 . . . . 0.0 109.9 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 mm -73.22 131.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.416 -0.802 . . . . 0.0 110.12 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -129.78 86.54 2.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.705 -0.622 . . . . 0.0 109.541 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -123.12 93.52 3.98 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 97.2 m-20 -94.68 104.18 16.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.431 -0.793 . . . . 0.0 109.468 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 62.3 m-20 -159.52 168.58 25.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.243 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 93' ' ' THR . 17.4 m -67.34 -35.99 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.507 0.67 . . . . 0.0 109.827 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.421 ' N ' HG23 ' A' ' 92' ' ' VAL . 59.2 p -65.77 -26.78 67.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.41 128.83 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.487 -0.758 . . . . 0.0 109.499 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.4 m -88.95 -164.07 1.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.605 0.717 . . . . 0.0 110.03 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -62.92 -43.64 98.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.497 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' A' ' 99' ' ' ALA . 84.7 mtp180 -108.39 -57.83 2.07 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 57.69 -73.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.864 -0.522 . . . . 0.0 109.655 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -132.12 155.24 48.5 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.651 0.738 . . . . 0.0 109.439 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -139.37 146.25 39.98 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' A' ' 110' ' ' VAL . 99.0 m-85 -113.05 139.18 48.9 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -128.85 139.26 52.24 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.02 121.53 36.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.493 -0.754 . . . . 0.0 109.541 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -99.44 -124.99 0.16 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -84.59 88.18 7.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.829 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 52.71 27.0 4.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.64 -0.663 . . . . 0.0 110.051 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -142.19 131.12 23.02 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.019 -1.051 . . . . 0.0 110.02 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -76.73 147.75 37.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.636 -0.665 . . . . 0.0 110.206 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -139.67 159.78 41.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.104 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.446 HG23 ' CE1' ' A' ' 101' ' ' PHE . 9.0 p -126.44 132.73 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.702 -0.624 . . . . 0.0 109.435 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.9 135.82 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.509 0.671 . . . . 0.0 109.244 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.425 ' OD2' ' OD1' ' A' ' 117' ' ' ASN . 68.0 m-20 -85.3 115.29 22.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.496 -0.753 . . . . 0.0 109.378 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.65 -2.12 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.66 137.99 14.93 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.5 t -63.27 -42.59 99.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.432 -1.04 . . . . 0.0 109.838 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 118' ' ' GLY . 2.2 pp -65.1 -36.8 85.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 109.861 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.425 ' OD1' ' OD2' ' A' ' 112' ' ' ASP . 55.2 t30 68.35 81.4 0.19 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.674 0.75 . . . . 0.0 109.945 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.438 ' N ' HD12 ' A' ' 116' ' ' LEU . . . -94.24 -10.28 58.51 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.2 m -76.1 132.45 40.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.328 -1.101 . . . . 0.0 110.196 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.37 149.95 49.81 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 122' ' ' ASN . 9.9 p -130.52 156.69 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.604 -0.685 . . . . 0.0 110.009 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 121' ' ' VAL . 97.5 m-20 -40.61 173.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.995 0.902 . . . . 0.0 111.063 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 60.46 -105.12 0.2 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.856 -0.528 . . . . 0.0 109.992 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -125.62 145.5 51.6 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.779 -0.576 . . . . 0.0 109.602 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -49.24 139.12 28.35 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.355 2.037 . . . . 0.0 113.053 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -137.85 160.08 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.489 -0.757 . . . . 0.0 109.977 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -69.13 -37.68 78.45 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.661 -0.649 . . . . 0.0 109.525 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p -156.28 161.83 40.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.048 -1.032 . . . . 0.0 110.456 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.33 165.55 31.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.45 -0.781 . . . . 0.0 109.579 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.0 t -93.46 130.24 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.441 -0.787 . . . . 0.0 109.719 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.6 mt -77.33 147.2 36.31 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.645 0.736 . . . . 0.0 110.467 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.88 164.17 34.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.614 0.721 . . . . 0.0 109.698 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 18.5 p30 -64.0 127.34 30.97 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.66 0.743 . . . . 0.0 110.714 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.41 16.33 69.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 145' ' ' VAL . 44.8 t0 -85.69 160.23 19.61 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.154 -1.204 . . . . 0.0 109.928 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -112.15 124.37 52.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.522 -0.736 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.1 t -127.35 132.67 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -121.7 113.96 20.46 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.5 130.05 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.462 0.648 . . . . 0.0 109.795 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 142' ' ' PHE . . . 67.29 36.01 88.84 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 140' ' ' GLY . 15.0 tptp 71.37 -19.18 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.677 -0.896 . . . . 0.0 109.475 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 140' ' ' GLY . 95.6 m-85 -73.96 143.34 45.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.882 . . . . 0.0 109.961 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -99.71 120.68 40.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 109.17 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.33 153.39 47.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.6 -0.687 . . . . 0.0 109.944 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 135' ' ' ASP . 9.9 p -127.09 138.72 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.581 0.705 . . . . 0.0 109.554 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -89.9 120.34 31.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.675 . . . . 0.0 109.397 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 66.3 mt -134.72 152.87 52.1 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.396 0.617 . . . . 0.0 109.878 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.7 p -128.1 158.81 36.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.569 0.699 . . . . 0.0 109.567 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 150' ' ' HIS . . . -45.75 -78.61 0.08 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 149' ' ' GLY . 56.4 t-80 48.29 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.474 -1.015 . . . . 0.0 110.058 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -76.7 156.19 32.72 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.721 0.772 . . . . 0.0 110.581 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -62.02 138.6 58.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.577 -0.702 . . . . 0.0 110.433 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 172.01 178.37 42.22 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -98.24 88.76 4.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.429 -1.042 . . . . 0.0 109.388 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 156' ' ' LEU . 65.8 t0 -79.29 151.41 31.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.817 . . . . 0.0 109.793 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.563 ' N ' ' OD1' ' A' ' 155' ' ' ASP . 86.1 mt -69.58 -79.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 109.636 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 156' ' ' LEU . 97.0 mt-10 46.9 97.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.862 0.839 . . . . 0.0 110.01 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -60.13 -39.99 88.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.533 -0.729 . . . . 0.0 109.7 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -101.64 138.44 38.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.552 -0.718 . . . . 0.0 109.573 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -148.86 79.71 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 80.2 m80 44.82 88.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.753 0.787 . . . . 0.0 110.064 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -90.78 125.62 35.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.471 -0.768 . . . . 0.0 110.217 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.882 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.526 0.679 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -70.21 135.65 49.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 110.201 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -73.43 143.87 46.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.351 -0.843 . . . . 0.0 110.252 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 29' ' ' PHE . . . -92.9 81.37 4.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.229 -0.919 . . . . 0.0 109.755 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.2 t0 66.93 -16.33 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.581 -0.699 . . . . 0.0 109.923 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.573 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 16.5 p90 -171.8 -161.83 0.2 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.944 -1.098 . . . . 0.0 110.16 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 29' ' ' PHE . 71.3 mt -69.99 85.35 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.546 0.689 . . . . 0.0 109.614 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.7 p -63.21 150.34 43.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.404 -0.81 . . . . 0.0 110.612 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -174.35 137.49 0.51 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.182 -0.949 . . . . 0.0 110.02 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.06 -40.6 96.63 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.45 -0.781 . . . . 0.0 109.961 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.4 144.26 57.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 111.095 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -169.54 57.8 0.31 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 109.402 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.5 155.93 62.47 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.754 2.303 . . . . 0.0 112.26 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.57 -107.33 0.14 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.195 -0.941 . . . . 0.0 109.161 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -105.87 -25.71 12.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.78 135.85 38.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.586 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 40.97 87.67 0.01 OUTLIER Glycine 0 N--CA 1.498 2.784 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -68.77 136.09 52.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.025 -1.279 . . . . 0.0 110.343 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -85.46 142.56 29.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 110.033 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 44' ' ' ALA . 41.9 t -59.08 -82.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 110.205 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 43' ' ' SER . . . 42.02 49.36 4.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.523 -0.736 . . . . 0.0 109.941 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.9 m -93.29 -4.62 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.306 -0.871 . . . . 0.0 108.71 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 p -73.52 155.53 39.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.369 -0.832 . . . . 0.0 110.63 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.15 144.65 0.12 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.4 t -91.32 -5.65 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.239 -1.154 . . . . 0.0 108.611 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 59.75 106.79 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.518 0.675 . . . . 0.0 110.717 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 51' ' ' LEU . . . 102.55 -49.91 0.96 Allowed Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.444 HD23 ' HA3' ' A' ' 149' ' ' GLY . 0.3 OUTLIER 40.99 80.63 0.27 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.635 -0.921 . . . . 0.0 109.72 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -56.38 127.43 25.95 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.94 1.76 . . . . 0.0 111.139 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -47.75 138.67 19.88 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.968 1.779 . . . . 0.0 112.695 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.5 -18.64 54.95 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 55' ' ' LEU . 11.0 mp -100.72 149.76 23.46 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.158 -1.201 . . . . 0.0 110.178 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -149.05 165.85 30.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.444 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.04 155.16 47.35 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.67 0.748 . . . . 0.0 109.818 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -116.14 136.69 52.79 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -120.48 135.28 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.672 0.749 . . . . 0.0 109.744 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.3 116.52 20.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.527 -0.733 . . . . 0.0 110.007 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -66.76 -45.15 79.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.43 -0.794 . . . . 0.0 109.918 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -154.29 151.55 29.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.017 . . . . 0.0 110.396 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.42 -176.53 28.11 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.53 -38.37 74.94 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.894 2.396 . . . . 0.0 112.274 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 58.3 m-20 -82.17 -76.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.572 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . 70.27 118.07 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.563 0.697 . . . . 0.0 110.249 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.27 -15.65 62.87 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.8 t -67.21 145.46 55.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -1.144 . . . . 0.0 110.546 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -133.4 151.81 51.86 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.667 -0.645 . . . . 0.0 109.676 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -128.17 142.05 51.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.505 -0.747 . . . . 0.0 109.052 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.4 tp -102.27 128.29 48.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.608 -0.683 . . . . 0.0 109.969 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -92.5 75.02 5.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 109.161 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -95.07 5.52 51.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 109.134 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -115.09 139.43 49.89 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.512 -0.742 . . . . 0.0 109.81 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.61 -50.72 72.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.589 -0.695 . . . . 0.0 110.004 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.9 mm -110.14 120.87 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.346 -0.847 . . . . 0.0 108.828 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.4 m -125.69 115.04 19.48 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.369 0.604 . . . . 0.0 109.688 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.1 m -84.31 151.52 24.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.37 -0.831 . . . . 0.0 109.022 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.61 162.23 13.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.216 -0.928 . . . . 0.0 110.348 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.8 -132.18 11.0 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.545 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 94.9 mtt180 -102.97 131.32 50.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.477 -1.013 . . . . 0.0 110.226 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 23.9 m-70 -172.92 153.93 2.67 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.17 -54.38 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.33 2.02 . . . . 0.0 111.305 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 50.3 p-10 -96.79 88.7 4.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.453 -0.78 . . . . 0.0 109.806 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.6 p -166.33 126.79 1.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.991 . . . . 0.0 109.381 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.11 -39.95 95.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.847 . . . . 0.0 109.649 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.6 mt -87.76 127.45 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.104 -0.997 . . . . 0.0 109.594 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -129.28 85.75 2.35 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.2 mt -101.51 94.53 5.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 108.808 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -88.47 85.52 6.87 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.498 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 12.2 p-10 -155.29 170.11 22.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.36 -0.838 . . . . 0.0 109.655 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 93' ' ' THR . 4.1 t -71.9 171.9 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.597 -0.689 . . . . 0.0 110.504 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.55 ' H ' HG12 ' A' ' 92' ' ' VAL . 2.7 p 66.24 -5.93 0.53 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.668 -0.645 . . . . 0.0 109.627 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 92' ' ' VAL . 94.4 t -109.44 -19.2 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 94' ' ' VAL . 1.4 m 44.5 -173.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.826 0.822 . . . . 0.0 110.827 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -70.11 -43.79 70.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.932 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.424 ' CG ' ' NE2' ' A' ' 82' ' ' HIS . 79.3 mtp85 -140.91 88.98 2.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.836 . . . . 0.0 109.421 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -99.53 -30.57 12.08 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.92 151.44 33.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -140.85 150.32 43.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.478 -0.763 . . . . 0.0 109.503 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.34 145.66 37.09 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -132.99 136.28 45.97 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 57.4 tp -96.78 124.75 40.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 109.743 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 105' ' ' ASN . 80.6 tt0 -107.18 -109.93 0.3 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.518 -0.739 . . . . 0.0 109.571 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.402 ' N ' ' HG2' ' A' ' 104' ' ' GLU . 82.1 m-20 -91.84 79.35 5.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.065 . . . . 0.0 109.38 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 55.89 34.68 24.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.558 -0.713 . . . . 0.0 109.538 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.24 131.51 13.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.912 . . . . 0.0 109.044 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -83.73 150.35 25.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.172 -0.955 . . . . 0.0 110.357 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -122.31 157.77 31.03 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.9 p -120.87 127.73 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.593 -0.692 . . . . 0.0 109.222 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -130.72 137.55 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.755 -0.59 . . . . 0.0 109.543 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.479 ' OD2' HD23 ' A' ' 116' ' ' LEU . 49.4 p-10 -84.55 95.68 8.92 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.275 -0.891 . . . . 0.0 109.277 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.41 -42.99 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.429 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.52 -151.17 1.31 Allowed Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.275 -0.965 . . . . 0.0 110.966 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 t -62.0 149.52 40.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.449 -1.03 . . . . 0.0 110.717 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.479 HD23 ' OD2' ' A' ' 112' ' ' ASP . 84.1 mt -62.8 -40.09 96.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.601 -0.687 . . . . 0.0 109.531 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -79.95 131.4 35.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.867 -1.146 . . . . 0.0 110.307 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 133.41 -72.24 0.48 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 48.7 m -82.02 129.58 34.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.973 -1.31 . . . . 0.0 109.749 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -146.22 158.81 43.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.98 . . . . 0.0 109.245 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.55 133.85 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.717 -0.615 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 124' ' ' GLU . 97.7 m-20 57.69 38.43 27.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.779 -0.575 . . . . 0.0 110.006 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 56.79 0.06 0.07 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.525 -0.734 . . . . 0.0 110.634 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 122' ' ' ASN . 72.3 mt-10 -107.28 147.65 35.61 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.266 -0.896 . . . . 0.0 109.44 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.92 148.08 0.23 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.265 1.977 . . . . 0.0 112.227 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 12.9 p -124.69 135.15 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.769 0.795 . . . . 0.0 109.663 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 128' ' ' SER . 65.7 t0 -148.58 59.85 1.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 128' ' ' SER . 2.8 p 80.97 95.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.526 0.679 . . . . 0.0 109.506 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.09 151.22 49.45 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.397 -0.814 . . . . 0.0 109.501 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.6 t -81.5 131.49 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.47 -0.769 . . . . 0.0 109.957 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.03 151.7 35.45 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.478 -0.764 . . . . 0.0 110.267 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.543 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -152.63 153.8 34.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -0.899 . . . . 0.0 109.934 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -49.23 129.84 18.61 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.66 0.743 . . . . 0.0 111.383 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.16 15.13 61.23 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 92.2 m-20 -91.08 150.86 21.24 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.744 -1.445 . . . . 0.0 109.86 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -108.84 130.86 55.42 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.473 -0.767 . . . . 0.0 109.122 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -124.45 133.1 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.604 -0.685 . . . . 0.0 109.248 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.456 ' OE1' ' CZ ' ' A' ' 143' ' ' ARG . 57.3 tt0 -121.07 124.66 45.35 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.49 129.84 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.49 0.662 . . . . 0.0 110.027 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 50.46 -98.38 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -127.4 -19.3 4.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.623 -0.928 . . . . 0.0 108.888 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.498 ' CE1' ' OD2' ' A' ' 91' ' ' ASP . 13.6 m-85 -74.82 143.31 43.99 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.406 -0.809 . . . . 0.0 109.874 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.456 ' CZ ' ' OE1' ' A' ' 138' ' ' GLN . 28.1 mmt180 -103.32 137.17 41.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.496 -0.753 . . . . 0.0 109.653 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.86 151.96 44.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.809 -0.557 . . . . 0.0 109.794 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.0 p -124.28 134.28 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 67.2 t80 -93.04 108.63 20.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.5 mt -140.22 150.75 44.53 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.622 0.725 . . . . 0.0 109.414 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 150' ' ' HIS . 13.5 p -87.58 172.39 9.78 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.519 -0.738 . . . . 0.0 110.062 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.444 ' HA3' HD23 ' A' ' 51' ' ' LEU . . . -62.34 3.46 0.82 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' A' ' 148' ' ' THR . 80.8 t60 41.77 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.485 -1.009 . . . . 0.0 110.353 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -82.67 157.51 23.33 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.738 0.78 . . . . 0.0 110.233 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -59.88 142.9 52.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.857 . . . . 0.0 110.41 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.75 143.95 47.51 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.97 166.49 22.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.569 -0.959 . . . . 0.0 110.659 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -57.3 -162.08 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.79 0.805 . . . . 0.0 110.748 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.3 mt -70.25 146.17 50.84 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.686 0.755 . . . . 0.0 110.686 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.25 52.5 1.83 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.43 -0.793 . . . . 0.0 109.137 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' HIS . 61.7 t-80 45.69 86.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.663 0.744 . . . . 0.0 110.378 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 160' ' ' HIS . 80.3 m80 54.01 165.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.511 0.672 . . . . 0.0 111.097 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 159' ' ' HIS . 79.4 m80 58.02 140.3 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.448 0.642 . . . . 0.0 110.706 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' A' ' 163' ' ' HIS . 58.5 t-80 -120.17 123.6 43.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.0 109.709 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 53.3 t-80 49.72 -93.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.788 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.427 ' N ' ' ND1' ' A' ' 162' ' ' HIS . 46.7 t-80 . . . . . 0 N--CA 1.488 1.436 0 O-C-N 120.878 -1.138 . . . . 0.0 109.097 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.463 0.649 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -70.77 128.99 37.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.443 -0.786 . . . . 0.0 110.199 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -143.93 -6.16 0.77 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 52.55 -138.27 1.13 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.706 0.765 . . . . 0.0 110.479 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -152.29 65.76 0.83 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.417 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 49.7 p90 -172.74 -29.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.417 HD23 ' CZ ' ' A' ' 29' ' ' PHE . 2.1 pp -92.68 -28.94 16.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.133 -0.979 . . . . 0.0 109.359 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.5 t -91.11 99.74 12.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.935 . . . . 0.0 109.481 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -87.77 97.77 11.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.475 -0.766 . . . . 0.0 109.66 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 33' ' ' LEU . 9.9 mp -72.18 -171.81 0.8 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.645 0.735 . . . . 0.0 110.646 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.81 140.45 58.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.288 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.68 60.62 2.0 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.47 -0.769 . . . . 0.0 109.273 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.7 155.83 65.12 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.801 2.334 . . . . 0.0 112.629 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.28 141.37 58.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.235 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -99.22 154.39 18.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.459 -0.775 . . . . 0.0 110.264 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.55 18.2 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.44 -179.57 53.42 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.35 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.8 m -87.52 127.61 35.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.599 -0.942 . . . . 0.0 109.994 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -175.34 -87.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.6 p 45.5 -131.93 0.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.537 -0.727 . . . . 0.0 110.12 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -169.66 50.08 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.0 m -90.68 -7.19 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -69.52 140.42 53.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.433 -0.792 . . . . 0.0 110.567 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.22 174.92 11.27 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 48' ' ' VAL . 10.3 p -89.34 2.89 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.577 -0.954 . . . . 0.0 109.02 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 50' ' ' GLY . 80.5 mm-40 -39.6 155.02 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.448 0.642 . . . . 0.0 110.809 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 49' ' ' GLU . . . -35.16 109.29 0.06 OUTLIER Glycine 0 N--CA 1.497 2.754 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.625 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -102.22 158.27 32.09 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.47 167.59 26.89 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.019 1.813 . . . . 0.0 111.992 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.85 148.14 85.37 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.435 2.09 . . . . 0.0 112.866 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.478 ' O ' HD22 ' A' ' 55' ' ' LEU . . . 88.1 15.81 60.29 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.666 HD12 HD11 ' A' ' 71' ' ' LEU . 3.9 mm? -114.24 131.69 56.39 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.621 -0.929 . . . . 0.0 110.098 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.15 155.03 44.48 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.4 153.27 48.07 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.827 0.823 . . . . 0.0 110.399 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -114.35 127.08 55.68 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.54 134.05 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.661 0.743 . . . . 0.0 109.809 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.77 128.95 34.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.581 -0.699 . . . . 0.0 109.789 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -88.45 -35.56 16.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.166 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -150.18 132.49 15.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.636 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 66' ' ' ALA . . . 141.43 169.48 11.92 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.12 -39.42 70.82 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.755 2.303 . . . . 0.0 111.816 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -81.81 30.63 0.37 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 63' ' ' GLY . . . -63.17 134.26 55.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.524 -0.735 . . . . 0.0 110.278 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.73 -15.61 58.61 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -65.57 144.53 56.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.525 -0.985 . . . . 0.0 110.076 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -136.87 148.9 47.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.642 -0.661 . . . . 0.0 109.698 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -128.79 153.5 47.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.603 -0.686 . . . . 0.0 109.181 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.666 HD11 HD12 ' A' ' 55' ' ' LEU . 53.8 tp -110.16 143.57 40.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.835 -0.541 . . . . 0.0 109.903 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.9 mt -116.59 78.96 1.25 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.513 -0.742 . . . . 0.0 109.686 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 67.1 t0 -110.31 41.01 1.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -135.93 150.33 49.26 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.704 . . . . 0.0 109.428 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.85 79.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.409 -0.807 . . . . 0.0 109.67 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.62 127.51 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.8 m -122.8 124.98 44.54 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.0 t -97.63 168.16 10.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.335 -0.853 . . . . 0.0 110.443 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB3' ' H ' ' A' ' 99' ' ' ALA . . . -116.16 -178.93 3.52 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.652 0.739 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.34 -134.74 39.25 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.588 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 38.1 mmt180 -74.58 133.9 42.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.436 -1.037 . . . . 0.0 109.818 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 1.2 m80 166.96 85.92 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.15 -36.47 66.65 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.992 1.795 . . . . 0.0 110.964 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -94.82 72.34 3.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.351 -0.843 . . . . 0.0 109.591 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.4 t -169.13 148.3 3.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.072 -1.018 . . . . 0.0 109.41 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.29 -41.5 98.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.354 -0.842 . . . . 0.0 109.681 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.85 123.64 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 109.912 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CZ ' ' OD2' ' A' ' 90' ' ' ASP . 89.3 t80 -130.4 85.73 2.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.12 128.61 53.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.376 -0.828 . . . . 0.0 109.694 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD2' ' CZ ' ' A' ' 88' ' ' PHE . 94.6 m-20 -135.1 86.06 2.22 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 63.3 m-20 -158.92 178.99 9.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.88 . . . . 0.0 110.032 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 94' ' ' VAL . 2.8 t -63.42 166.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.611 -0.681 . . . . 0.0 110.847 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.417 ' H ' HG12 ' A' ' 92' ' ' VAL . 3.0 p 66.06 -4.76 0.62 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 92' ' ' VAL . 55.3 t -123.99 129.5 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.3 m -107.59 -139.24 0.37 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 109.958 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -63.42 -42.53 98.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.546 -0.721 . . . . 0.0 110.662 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -156.89 94.02 1.4 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 109.005 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -61.29 -39.04 88.95 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.438 -0.789 . . . . 0.0 109.438 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 79' ' ' ALA . . . -152.55 162.08 41.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 110.573 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -133.39 145.56 50.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -113.87 141.89 46.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.333 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.71 135.81 50.68 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.748 0.785 . . . . 0.0 109.834 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 107' ' ' GLU . 47.2 tp -98.42 128.49 44.82 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.39 -126.62 0.15 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.152 -0.967 . . . . 0.0 110.94 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 93.5 m-20 -64.53 -48.91 73.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 110.529 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 53.6 m-20 -168.82 21.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.33 -0.856 . . . . 0.0 109.665 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.466 ' O ' ' CD1' ' A' ' 103' ' ' LEU . 96.8 mt-10 -116.37 -126.92 0.29 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.35 -0.844 . . . . 0.0 109.057 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.439 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 13.7 m-85 -164.23 155.35 15.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.017 -1.052 . . . . 0.0 108.933 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 58.6 m-20 -143.45 149.51 37.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.149 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.32 130.51 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.44 131.54 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.355 0.597 . . . . 0.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -100.25 118.16 35.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.53 -0.731 . . . . 0.0 109.356 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 115' ' ' SER . 25.3 m -75.66 -157.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.355 -0.841 . . . . 0.0 110.215 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.93 28.43 0.94 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 113' ' ' VAL . 17.0 m -71.87 150.99 43.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -1.171 . . . . 0.0 110.671 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 116' ' ' LEU . 10.5 mp -60.03 176.0 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.825 0.822 . . . . 0.0 111.02 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 118' ' ' GLY . 50.0 t30 58.17 -116.27 0.88 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.291 0.567 . . . . 0.0 110.367 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.476 ' O ' ' CZ ' ' A' ' 120' ' ' TYR . . . 162.16 125.31 0.76 Allowed Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.7 m -72.09 138.79 48.03 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.422 -1.046 . . . . 0.0 109.856 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.476 ' CZ ' ' O ' ' A' ' 118' ' ' GLY . 11.2 m-85 -124.12 142.15 51.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.61 -0.681 . . . . 0.0 109.188 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 126' ' ' VAL . 5.9 p -124.13 132.08 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.606 0.717 . . . . 0.0 109.622 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.433 ' C ' ' H ' ' A' ' 124' ' ' GLU . 98.1 m-20 52.6 -171.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.819 0.819 . . . . 0.0 110.894 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -71.37 6.84 1.56 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.394 -0.817 . . . . 0.0 108.871 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 122' ' ' ASN . 3.9 pt-20 -120.44 84.74 36.22 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.45 134.38 60.84 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.373 2.049 . . . . 0.0 112.009 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.513 HG22 HG12 ' A' ' 121' ' ' VAL . 27.3 m -151.04 156.15 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.132 -0.98 . . . . 0.0 109.809 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.45 -41.88 96.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.1 p -158.11 143.5 16.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.399 -0.813 . . . . 0.0 109.546 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -172.93 167.52 5.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.289 -0.882 . . . . 0.0 110.056 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.8 t -78.05 144.31 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.981 0.896 . . . . 0.0 109.96 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.83 ' H ' HD13 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -136.8 158.06 45.31 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.544 0.688 . . . . 0.0 110.444 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.06 -172.02 4.06 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.629 0.728 . . . . 0.0 109.201 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 47.2 p-10 -50.78 141.52 12.96 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.834 0.826 . . . . 0.0 111.538 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.17 21.36 57.2 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -110.08 151.88 26.67 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.446 -1.032 . . . . 0.0 109.267 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -113.46 138.09 50.6 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.8 t -125.61 132.27 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -118.71 125.45 49.7 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.46 128.95 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.65 0.738 . . . . 0.0 109.518 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.67 -120.98 4.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -98.45 -16.31 19.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.421 -1.046 . . . . 0.0 108.808 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -80.37 145.47 32.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 0.0 110.214 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -115.85 126.68 54.29 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.03 158.43 36.98 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.65 -0.656 . . . . 0.0 109.762 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.83 135.47 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -90.24 109.87 20.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.924 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.44 143.59 39.74 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.401 0.62 . . . . 0.0 109.374 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 79.8 p -86.47 167.27 14.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 110.396 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.87 -3.28 90.56 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -88.1 117.25 26.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.236 . . . . 0.0 109.752 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -172.03 -26.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' A' ' 152' ' ' GLN . 0.0 OUTLIER -69.87 158.12 36.12 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.814 0.816 . . . . 0.0 110.518 -179.336 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 91.71 128.69 4.37 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 54.8 20.02 2.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.636 -0.92 . . . . 0.0 109.353 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -86.81 56.63 4.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.346 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 79.1 mt -80.43 133.05 35.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.381 -0.825 . . . . 0.0 110.025 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -87.23 122.96 31.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.889 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -110.15 118.25 35.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.537 -0.727 . . . . 0.0 109.661 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.496 ' CE1' ' OXT' ' A' ' 163' ' ' HIS . 59.3 t-80 -86.17 -7.52 58.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.481 -0.762 . . . . 0.0 108.965 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 159' ' ' HIS . 70.2 m80 58.42 133.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.085 0.945 . . . . 0.0 110.909 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 162' ' ' HIS . 60.1 t-80 48.55 86.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.784 0.802 . . . . 0.0 110.291 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 161' ' ' HIS . 74.0 m80 46.93 -176.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.726 0.774 . . . . 0.0 110.762 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.496 ' OXT' ' CE1' ' A' ' 159' ' ' HIS . 86.7 t60 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.857 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.666 0.746 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -75.97 148.23 38.29 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.925 0.869 . . . . 0.0 110.457 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -78.53 144.54 35.55 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.648 0.737 . . . . 0.0 110.512 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 28' ' ' ASP . . . -177.28 153.19 0.92 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.179 0.514 . . . . 0.0 109.675 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 27' ' ' ALA . 8.1 t70 75.3 16.15 2.74 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.325 0.583 . . . . 0.0 109.448 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 30' ' ' LEU . 41.7 p90 -174.05 -38.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.575 ' N ' ' CD1' ' A' ' 29' ' ' PHE . 71.9 mt 54.19 110.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.895 0.855 . . . . 0.0 110.041 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.6 t 57.23 82.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.577 0.703 . . . . 0.0 109.999 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -69.3 -35.2 75.75 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 34' ' ' ASP . 4.0 tt -91.36 116.74 29.09 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.845 0.831 . . . . 0.0 109.364 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.605 ' N ' HD23 ' A' ' 33' ' ' LEU . 97.3 m-20 -66.96 142.82 57.13 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.938 0.875 . . . . 0.0 111.015 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.439 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . -171.73 54.11 0.2 Allowed Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.528 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 38' ' ' GLN . 37.7 Cg_endo -66.32 146.24 80.19 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.881 2.387 . . . . 0.0 112.574 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 36' ' ' PRO . . . 40.5 -91.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.106 0.479 . . . . 0.0 110.128 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 36' ' ' PRO . 36.3 mm-40 -74.91 148.74 39.82 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.882 0.848 . . . . 0.0 110.333 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.12 -8.15 58.75 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.03 -167.05 34.92 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 43' ' ' SER . 87.3 m -61.5 131.8 51.31 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.691 0.758 . . . . 0.0 110.431 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -90.82 -15.72 29.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.476 ' H ' HG22 ' A' ' 41' ' ' THR . 16.4 m -73.98 147.15 43.26 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.923 0.868 . . . . 0.0 110.49 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.98 -39.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.2 t -78.9 -78.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.478 -0.764 . . . . 0.0 109.62 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 95.5 p -76.9 161.46 28.38 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.766 0.793 . . . . 0.0 110.36 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -171.43 -170.02 35.02 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.1 m -84.19 -8.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.842 -0.799 . . . . 0.0 109.179 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -83.59 107.14 15.86 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.907 0.86 . . . . 0.0 109.827 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 60.77 132.64 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.415 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -156.62 68.4 4.54 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.557 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 45.5 Cg_exo -47.59 -41.89 29.82 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.408 2.072 . . . . 0.0 112.101 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 35.0 Cg_exo -60.86 146.79 97.0 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.867 2.378 . . . . 0.0 112.837 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -51.27 83.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 53' ' ' PRO . 95.4 mt -131.57 154.01 49.28 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.118 0.961 . . . . 0.0 110.535 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.77 158.89 42.94 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.16 151.0 51.16 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.309 1.052 . . . . 0.0 110.929 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -115.25 136.4 53.14 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.221 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.8 t -121.75 132.97 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.855 0.836 . . . . 0.0 109.859 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.7 t -69.8 102.82 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.927 0.87 . . . . 0.0 109.538 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.07 -43.87 86.11 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.632 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -130.97 136.82 48.89 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.945 0.879 . . . . 0.0 109.797 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.9 168.62 16.45 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.11 -34.66 68.63 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.88 2.387 . . . . 0.0 111.471 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 66' ' ' ALA . 87.3 m-20 -66.89 -45.52 77.77 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . 31.52 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.455 0.645 . . . . 0.0 110.838 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.01 -24.62 4.5 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.4 p -70.02 160.68 31.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.779 -0.836 . . . . 0.0 110.849 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.566 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -152.46 164.04 38.35 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.937 0.875 . . . . 0.0 110.556 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -128.24 142.35 51.19 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.887 0.851 . . . . 0.0 109.723 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -104.48 127.52 52.2 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.822 0.82 . . . . 0.0 110.406 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.3 mt -91.37 116.49 28.88 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.898 0.856 . . . . 0.0 109.966 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -157.69 19.7 0.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -129.65 138.89 51.46 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.895 0.855 . . . . 0.0 109.821 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.79 134.62 51.28 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.78 0.8 . . . . 0.0 110.458 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 mm 53.09 93.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.6 m -106.08 118.13 35.81 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.029 0.918 . . . . 0.0 110.169 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.2 m -85.67 159.33 19.84 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.639 0.733 . . . . 0.0 109.909 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 96' ' ' ARG . . . -106.89 170.09 8.15 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.865 0.841 . . . . 0.0 110.388 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.5 -70.67 2.62 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.621 ' NH1' ' NH2' ' A' ' 96' ' ' ARG . 79.7 mtp85 -71.74 142.59 49.77 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.714 0.769 . . . . 0.0 110.118 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.525 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -86.43 -46.07 0.56 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.837 -0.539 . . . . 0.0 109.91 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 54.3 Cg_exo -54.24 135.0 63.43 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.257 1.971 . . . . 0.0 112.725 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 54.48 33.21 18.31 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t -159.65 117.63 2.72 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.932 0.872 . . . . 0.0 109.876 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.23 -37.85 88.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.57 125.36 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.58 0.705 . . . . 0.0 109.702 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.4 ' CD1' ' CB ' ' A' ' 82' ' ' HIS . 57.4 t80 -130.01 86.19 2.38 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.965 0.888 . . . . 0.0 109.566 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 90' ' ' ASP . 96.8 mt -79.7 146.71 32.28 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.763 0.792 . . . . 0.0 109.787 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 89' ' ' LEU . 64.7 t0 -55.88 -109.12 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.454 0.645 . . . . 0.0 110.267 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 93' ' ' THR . 58.6 m-20 -162.23 -103.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.461 0.648 . . . . 0.0 109.486 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 t 53.01 -77.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.151 0.501 . . . . 0.0 109.904 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 91' ' ' ASP . 11.8 p -115.17 9.23 15.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.656 -0.653 . . . . 0.0 109.375 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.1 131.09 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 121.918 0.866 . . . . 0.0 109.862 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.5 t -89.33 -155.74 0.37 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.813 0.816 . . . . 0.0 110.94 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.621 ' NH2' ' NH1' ' A' ' 81' ' ' ARG . 79.3 mtp85 -63.7 -41.22 98.14 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.312 0.577 . . . . 0.0 109.894 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -166.41 56.36 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.433 0.635 . . . . 0.0 109.593 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -62.85 -6.42 3.74 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.56 147.49 34.51 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.939 0.876 . . . . 0.0 109.673 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -143.93 138.94 28.87 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.057 0.932 . . . . 0.0 109.925 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -106.38 145.81 31.25 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.717 0.77 . . . . 0.0 109.302 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -132.93 143.98 49.84 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.985 0.897 . . . . 0.0 110.177 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.0 tp -106.83 121.77 45.05 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.839 0.828 . . . . 0.0 109.569 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 104' ' ' GLU . 9.8 pm0 -107.12 -116.51 0.26 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.444 0.64 . . . . 0.0 109.876 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.43 ' H ' ' CG ' ' A' ' 104' ' ' GLU . 47.7 p-10 -87.38 80.82 8.04 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.604 0.716 . . . . 0.0 110.437 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 54.22 31.42 14.07 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.421 0.629 . . . . 0.0 109.508 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -141.4 130.41 23.24 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.66 0.743 . . . . 0.0 109.562 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -93.31 148.72 21.79 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.465 0.65 . . . . 0.0 109.647 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -147.25 172.34 13.99 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.637 0.732 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.3 p -124.66 131.65 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-O 121.966 0.888 . . . . 0.0 109.576 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.97 133.29 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.712 0.768 . . . . 0.0 109.5 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -89.05 113.82 24.98 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.553 0.692 . . . . 0.0 109.515 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m -71.48 81.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.718 0.771 . . . . 0.0 109.578 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 115' ' ' SER . . . 90.98 177.84 43.55 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 114' ' ' GLY . 5.2 m 56.09 114.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.684 0.754 . . . . 0.0 110.187 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 116' ' ' LEU . 11.0 mp -63.19 -40.21 96.85 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -88.66 109.69 20.33 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.825 0.821 . . . . 0.0 110.266 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.506 ' O ' ' CE1' ' A' ' 120' ' ' TYR . . . -156.92 -116.42 0.51 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.6 m -65.77 133.86 51.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.55 -0.971 . . . . 0.0 110.021 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.506 ' CE1' ' O ' ' A' ' 118' ' ' GLY . 8.9 m-85 -121.7 144.15 48.94 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.825 0.821 . . . . 0.0 109.611 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 122' ' ' ASN . 3.2 p -101.99 154.4 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.42 0.628 . . . . 0.0 109.954 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 123' ' ' ARG . 37.9 p-10 -34.04 -45.3 0.2 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.106 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 122' ' ' ASN . 99.8 mtt180 -74.5 -114.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.64 -0.662 . . . . 0.0 110.919 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -102.36 147.29 33.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.679 -0.638 . . . . 0.0 109.989 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.77 137.7 78.39 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.793 2.329 . . . . 0.0 113.022 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.07 161.23 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.789 0.804 . . . . 0.0 110.558 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.46 -18.35 61.13 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.8 p -158.16 159.24 35.94 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.721 0.772 . . . . 0.0 109.901 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.69 155.28 31.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.88 0.847 . . . . 0.0 110.219 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.5 t -99.64 128.91 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.708 0.765 . . . . 0.0 109.622 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.24 143.21 35.52 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.789 0.804 . . . . 0.0 110.552 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.53 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -153.25 150.36 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.611 0.72 . . . . 0.0 109.635 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -39.95 122.87 1.54 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.773 0.797 . . . . 0.0 111.145 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.44 13.11 68.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 28.0 m-20 -85.9 149.15 25.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.516 -0.991 . . . . 0.0 109.861 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -112.47 141.96 45.59 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.867 0.842 . . . . 0.0 110.219 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.2 t -121.74 133.66 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.804 0.812 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -128.45 112.66 14.61 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.829 0.823 . . . . 0.0 109.472 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.13 128.59 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.871 0.843 . . . . 0.0 109.654 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 56.07 -134.46 50.27 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -95.45 -13.59 24.46 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.56 130.53 35.86 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.832 0.825 . . . . 0.0 110.073 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -105.99 135.56 47.22 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.714 0.768 . . . . 0.0 109.752 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.69 149.33 51.49 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.658 0.742 . . . . 0.0 109.714 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.32 132.18 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.721 0.772 . . . . 0.0 109.239 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -94.49 111.94 23.7 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.941 0.877 . . . . 0.0 110.008 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.7 mt -138.14 150.52 46.89 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.805 0.812 . . . . 0.0 109.989 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 150' ' ' HIS . 7.8 p -88.18 -170.1 2.83 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.702 0.763 . . . . 0.0 110.354 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 151' ' ' LYS . . . -39.9 90.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.546 ' N ' ' O ' ' A' ' 148' ' ' THR . 80.6 m80 -49.84 -11.54 0.06 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 149' ' ' GLY . 4.5 tppt? -79.01 101.48 7.83 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.739 0.78 . . . . 0.0 110.226 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -105.2 139.9 39.16 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.809 0.814 . . . . 0.0 110.088 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 169.6 43.29 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -131.77 39.55 3.46 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.43 -1.041 . . . . 0.0 109.504 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -173.9 173.81 3.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.502 -0.749 . . . . 0.0 109.747 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 65.2 mt -70.0 148.25 49.12 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.698 0.761 . . . . 0.0 110.298 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.21 145.14 52.23 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.636 0.732 . . . . 0.0 110.93 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -88.89 169.38 11.62 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.8 0.81 . . . . 0.0 110.978 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 -68.04 142.95 55.73 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.641 0.734 . . . . 0.0 110.641 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -75.77 146.18 40.21 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.674 0.75 . . . . 0.0 110.301 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -144.62 140.1 28.48 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.803 0.811 . . . . 0.0 110.126 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.472 ' ND1' ' OXT' ' A' ' 163' ' ' HIS . 61.3 t-80 -82.47 129.58 34.94 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.84 0.829 . . . . 0.0 110.222 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.472 ' OXT' ' ND1' ' A' ' 162' ' ' HIS . 97.8 m-70 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.805 -1.093 . . . . 0.0 109.935 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 25' ' ' PHE . 11.4 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.335 0.588 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.593 ' CG ' ' N ' ' A' ' 26' ' ' ARG . 74.5 t80 48.08 -179.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.571 0.701 . . . . 0.0 110.272 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.593 ' N ' ' CG ' ' A' ' 25' ' ' PHE . 85.0 mtt85 -67.91 146.47 53.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 0.0 111.105 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 26' ' ' ARG . . . 41.3 -166.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.66 0.743 . . . . 0.0 110.799 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.66 -62.92 1.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.785 -0.572 . . . . 0.0 110.193 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -88.19 -163.54 0.97 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.383 -0.823 . . . . 0.0 110.638 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.487 ' CD2' ' H ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -83.96 97.35 9.21 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.443 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -76.79 159.18 30.32 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.626 0.727 . . . . 0.0 111.3 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.494 ' HG3' ' H ' ' A' ' 34' ' ' ASP . 23.8 tp10 68.38 128.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.611 0.72 . . . . 0.0 110.45 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.9 mt -85.8 -3.07 58.81 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' H ' ' HG3' ' A' ' 32' ' ' GLU . 95.8 m-20 -89.58 2.62 54.42 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.624 ' HB3' ' CD ' ' A' ' 36' ' ' PRO . . . -41.84 -61.5 1.47 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.77 -0.582 . . . . 0.0 110.1 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.624 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 30.5 Cg_endo -61.05 144.91 99.55 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.256 1.97 . . . . 0.0 111.865 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.8 130.64 1.03 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.407 -0.808 . . . . 0.0 109.822 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 40' ' ' GLY . 13.6 pt20 -154.59 -26.42 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 45.01 -89.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.872 -0.517 . . . . 0.0 110.177 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 38' ' ' GLN . . . 79.1 25.33 59.86 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 43' ' ' SER . 70.0 p -87.49 -5.02 58.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.391 -1.064 . . . . 0.0 109.243 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -51.36 89.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.56 -0.712 . . . . 0.0 109.863 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 41' ' ' THR . 70.0 p -86.71 -4.71 59.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.537 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.39 79.2 0.25 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.404 0.621 . . . . 0.0 109.343 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.4 m -98.89 159.51 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.563 -0.71 . . . . 0.0 110.577 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.8 m -53.0 -96.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.646 -0.659 . . . . 0.0 109.3 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' HA2' ' H ' ' A' ' 153' ' ' GLY . . . 76.83 -165.48 53.63 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 50' ' ' GLY . 2.8 t -83.19 118.88 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.932 . . . . 0.0 110.007 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 50' ' ' GLY . 13.6 pt-20 36.35 25.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.84 -0.538 . . . . 0.0 111.11 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . 52.62 175.75 0.05 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -139.44 45.41 0.89 Allowed Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.429 -1.042 . . . . 0.0 109.184 179.578 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 51' ' ' LEU . 2.7 Cg_endo -42.62 -54.44 3.21 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.346 2.031 . . . . 0.0 112.236 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 52' ' ' PRO . 36.0 Cg_endo -60.84 -81.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.858 1.705 . . . . 0.0 111.944 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -174.75 57.01 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.52 136.81 42.55 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.512 -0.993 . . . . 0.0 109.46 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.64 160.64 26.7 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.38 150.22 50.2 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.486 -0.759 . . . . 0.0 109.858 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.34 136.08 53.47 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.5 133.79 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.11 112.46 3.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.425 -0.797 . . . . 0.0 109.464 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.52 ' O ' ' NE ' ' A' ' 62' ' ' ARG . 24.2 tptp -64.71 -47.07 79.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.453 -0.78 . . . . 0.0 109.505 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 61' ' ' LYS . 4.7 mmp_? -143.61 155.26 44.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 109.847 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.43 167.18 11.55 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.56 -19.51 54.39 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.544 2.163 . . . . 0.0 111.873 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -106.25 33.44 3.84 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.452 -0.78 . . . . 0.0 109.192 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.79 145.88 11.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 109.922 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.21 53.68 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.3 m -69.96 145.89 51.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -1.053 . . . . 0.0 109.907 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -141.81 156.1 45.57 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -129.51 146.97 51.27 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.449 -0.782 . . . . 0.0 109.511 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.519 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 53.9 tp -106.44 124.93 50.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.541 -0.724 . . . . 0.0 109.114 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.7 68.73 5.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.152 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.3 p30 -98.75 5.84 47.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.438 -0.789 . . . . 0.0 109.727 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -119.45 135.55 54.7 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.457 -0.777 . . . . 0.0 109.335 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.68 136.06 54.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.514 -0.741 . . . . 0.0 110.659 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.1 mm 60.23 85.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.439 0.637 . . . . 0.0 109.992 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.4 m -102.93 121.84 43.34 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.418 ' O ' ' OG ' ' A' ' 85' ' ' SER . 11.5 m -85.52 162.17 19.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.711 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.37 127.08 44.94 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.86 -141.9 9.64 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -104.48 132.47 50.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.437 -1.037 . . . . 0.0 110.401 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.653 ' N ' ' ND1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 174.15 151.1 0.25 Allowed Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.63 -23.29 49.51 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.14 1.893 . . . . 0.0 112.104 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 85' ' ' SER . 73.0 m-20 -103.3 -146.84 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 109.732 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 84' ' ' ASP . 8.7 t 59.6 128.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.612 0.72 . . . . 0.0 110.389 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 71' ' ' LEU . 48.0 t0 -64.7 -39.69 94.09 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.03 124.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.422 -0.799 . . . . 0.0 109.223 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -130.2 86.25 2.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.723 -0.61 . . . . 0.0 109.482 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.65 99.68 11.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -84.39 92.57 8.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.658 -0.651 . . . . 0.0 109.766 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -154.38 151.76 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 109.593 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 m -71.21 -26.91 27.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.314 -0.867 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.1 p -65.7 -33.85 76.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.499 -0.751 . . . . 0.0 109.737 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.97 121.53 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.293 -0.879 . . . . 0.0 109.374 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.8 m -77.3 179.77 6.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 0.0 110.34 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -58.03 -44.27 87.23 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -135.68 78.63 1.73 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.49 -0.757 . . . . 0.0 109.03 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -94.68 -18.93 20.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.518 -0.739 . . . . 0.0 109.219 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.488 ' HB2' ' OG1' ' A' ' 119' ' ' THR . . . -153.13 152.32 31.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.483 -0.76 . . . . 0.0 109.184 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -139.6 139.6 36.81 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -106.43 119.79 40.19 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.578 -0.702 . . . . 0.0 109.165 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -107.61 134.93 49.89 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 109.398 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.9 tp -103.4 126.68 50.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.386 -0.821 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -99.57 -131.2 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.512 -0.743 . . . . 0.0 109.08 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -65.54 -49.43 68.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.402 -0.811 . . . . 0.0 109.902 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.421 ' CG ' ' O ' ' A' ' 106' ' ' ASN . 28.3 t30 177.51 46.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 108' ' ' PHE . 80.5 mm-40 -134.32 -6.25 2.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.981 -1.074 . . . . 0.0 109.251 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 107' ' ' GLU . 62.3 m-85 56.71 151.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.724 0.773 . . . . 0.0 110.209 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 88.8 m-20 -143.49 159.89 41.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.379 -0.826 . . . . 0.0 109.487 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.85 137.42 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 112' ' ' ASP . 30.8 t -133.8 157.27 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.405 -0.809 . . . . 0.0 109.763 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 114' ' ' GLY . 36.5 p-10 -84.7 13.63 5.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.674 -0.641 . . . . 0.0 109.582 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.504 ' O ' HG22 ' A' ' 113' ' ' VAL . 9.4 p 37.12 26.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.419 0.628 . . . . 0.0 110.394 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . 102.96 -155.69 18.17 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 114' ' ' GLY . 46.4 m 58.99 141.94 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.748 -0.854 . . . . 0.0 110.164 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.2 tp -78.54 134.74 37.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.643 -0.66 . . . . 0.0 110.489 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 62.7 t30 58.04 40.07 25.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.587 -0.695 . . . . 0.0 109.714 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -76.17 -130.04 0.33 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 99' ' ' ALA . 17.5 m -62.87 138.98 58.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.419 -1.048 . . . . 0.0 110.599 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -141.91 160.36 40.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 121' ' ' VAL . 14.1 p -112.17 129.2 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.293 -0.88 . . . . 0.0 110.486 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.502 ' CG ' ' H ' ' A' ' 123' ' ' ARG . 5.9 t-20 59.47 -167.44 0.16 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.682 0.753 . . . . 0.0 110.824 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.502 ' H ' ' CG ' ' A' ' 122' ' ' ASN . 96.0 mtt-85 -72.71 -12.75 61.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.884 -0.51 . . . . 0.0 109.9 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -86.41 116.53 66.22 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.27 -0.894 . . . . 0.0 109.2 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.22 121.63 5.8 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.507 1.472 . . . . 0.0 111.768 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.53 156.74 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 128' ' ' SER . 38.4 p-10 -72.96 -36.76 67.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.416 -0.803 . . . . 0.0 109.606 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.53 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 99.5 p -160.55 161.83 32.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.413 -0.805 . . . . 0.0 108.852 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -165.53 157.68 15.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.918 -1.114 . . . . 0.0 110.386 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 87.3 t -81.31 134.0 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.462 -0.774 . . . . 0.0 109.638 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.9 mt -80.8 148.07 30.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 109.696 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.548 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -146.28 160.72 41.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.345 -0.847 . . . . 0.0 109.611 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.423 ' OD1' ' OG1' ' A' ' 148' ' ' THR . 51.3 m-20 -57.54 136.79 56.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.737 . . . . 0.0 110.628 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.561 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 80.53 18.62 70.49 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 84.8 m-20 -93.5 155.25 17.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.162 -1.199 . . . . 0.0 109.642 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 56.4 mp0 -113.33 137.43 51.52 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.4 t -122.94 133.6 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -124.12 116.71 23.2 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.592 -0.692 . . . . 0.0 109.304 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.31 128.07 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.612 -0.68 . . . . 0.0 109.811 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 52.82 -134.23 39.85 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -95.49 -4.59 44.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.6 -0.941 . . . . 0.0 109.076 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -95.84 132.34 41.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.553 -0.717 . . . . 0.0 109.506 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -103.36 133.8 47.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.34 154.88 47.2 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.9 134.18 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.687 -0.633 . . . . 0.0 109.368 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -92.0 112.44 24.38 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 134' ' ' GLY . 94.2 mt -134.2 148.65 50.92 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.457 0.646 . . . . 0.0 110.101 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 133' ' ' ASN . 35.8 p -117.82 122.23 42.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.796 -0.565 . . . . 0.0 109.984 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 50.23 -94.73 0.01 OUTLIER Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.523 ' CG ' ' N ' ' A' ' 151' ' ' LYS . 49.0 t-80 47.72 -110.57 0.34 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.383 -1.069 . . . . 0.0 110.48 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.523 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 10.9 ttmm -60.9 135.84 57.9 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.613 0.721 . . . . 0.0 110.629 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.55 128.17 35.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.607 -0.683 . . . . 0.0 109.558 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.431 ' H ' ' HA2' ' A' ' 47' ' ' GLY . . . -77.86 165.53 52.45 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.499 ' OE2' HD21 ' A' ' 156' ' ' LEU . 47.2 tp10 -157.81 -79.41 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -1.044 . . . . 0.0 108.996 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 45.38 81.36 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.432 -0.793 . . . . 0.0 109.483 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.499 HD21 ' OE2' ' A' ' 154' ' ' GLU . 86.0 mt -68.5 143.31 55.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.543 -0.723 . . . . 0.0 109.742 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -173.34 -128.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.638 ' ND1' ' N ' ' A' ' 159' ' ' HIS . 56.4 t-80 44.16 -110.46 0.18 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.42 -0.8 . . . . 0.0 110.418 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.638 ' N ' ' ND1' ' A' ' 158' ' ' HIS . 6.1 t-80 44.8 -170.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.597 -0.689 . . . . 0.0 110.473 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 6.3 m-70 55.06 174.91 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.497 0.665 . . . . 0.0 110.269 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -106.04 138.16 42.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.595 -0.691 . . . . 0.0 109.574 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -73.27 139.16 45.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.533 -0.73 . . . . 0.0 110.05 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.69 -179.873 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.531 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 67.0 mt -128.16 151.12 49.62 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.513 -0.992 . . . . 0.0 109.702 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.629 ' C ' HD12 ' A' ' 57' ' ' LEU . . . -137.65 143.48 41.39 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.629 HD12 ' C ' ' A' ' 56' ' ' ALA . 11.1 mp -120.23 150.72 40.22 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.335 -0.853 . . . . 0.0 109.868 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.3 mt -117.11 132.58 56.64 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 t -119.08 132.11 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.406 -0.809 . . . . 0.0 109.887 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.78 102.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.542 -0.724 . . . . 0.0 109.134 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.71 -42.91 97.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.679 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -150.21 136.93 19.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.165 -0.96 . . . . 0.0 109.888 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.87 173.27 29.27 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.07 -43.17 60.75 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.224 1.949 . . . . 0.0 112.39 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -102.81 66.15 0.92 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.36 144.75 49.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.278 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.49 -9.7 66.87 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.8 m -66.13 145.64 55.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.404 -1.057 . . . . 0.0 109.665 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.61 146.96 51.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.58 -0.7 . . . . 0.0 109.475 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -125.33 134.49 52.2 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tt -101.98 124.23 47.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.504 -0.748 . . . . 0.0 109.471 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.56 111.74 24.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.32 -0.862 . . . . 0.0 109.271 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -86.22 55.42 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.612 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 88.0 mt-30 51.26 -169.09 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.655 0.74 . . . . 0.0 110.855 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 74' ' ' GLN . . . 68.57 -142.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.491 0.663 . . . . 0.0 110.32 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.45 127.85 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.2 m -121.61 116.64 24.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.559 -0.713 . . . . 0.0 109.123 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 p -83.09 165.33 19.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.359 -0.838 . . . . 0.0 109.553 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.51 140.86 51.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.55 -27.25 16.35 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -67.85 143.71 55.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -1.108 . . . . 0.0 109.864 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.59 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -92.14 -40.43 0.36 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.651 -0.655 . . . . 0.0 109.857 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 65.8 Cg_exo -53.32 -133.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.785 2.323 . . . . 0.0 113.356 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -73.83 101.37 3.73 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.283 -0.885 . . . . 0.0 109.751 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.9 m -166.54 129.25 1.88 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 109.25 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.75 -41.17 97.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 109.992 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.68 126.01 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.732 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -129.5 86.94 2.48 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.0 mt -102.18 96.16 6.8 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.354 -0.841 . . . . 0.0 109.514 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 65.9 t0 -87.92 97.3 10.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.317 -0.865 . . . . 0.0 109.62 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 62.9 m-20 -159.97 173.22 16.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.127 -0.983 . . . . 0.0 109.661 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 93' ' ' THR . 31.5 m -63.61 -41.42 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.464 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -79.32 -178.11 6.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.831 . . . . 0.0 110.211 -179.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.518 ' N ' ' OG1' ' A' ' 93' ' ' THR . 4.8 t 61.64 93.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 121.63 0.728 . . . . 0.0 109.597 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.4 m -62.87 -167.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 0.0 109.897 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -63.48 -40.5 97.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.0 109.836 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -132.28 40.93 3.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.474 -0.766 . . . . 0.0 109.265 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -44.06 -35.75 2.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.749 . . . . 0.0 110.03 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.16 152.58 38.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -139.88 149.29 43.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.488 -0.758 . . . . 0.0 109.039 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.24 140.63 49.11 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.471 -0.768 . . . . 0.0 109.057 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -131.28 137.12 48.7 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.377 -0.827 . . . . 0.0 109.061 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.6 tp -95.66 127.65 41.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.244 -0.91 . . . . 0.0 109.789 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 105' ' ' ASN . 40.6 tt0 -142.11 145.11 33.91 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.202 -0.936 . . . . 0.0 109.142 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.443 ' OD1' ' CG ' ' A' ' 107' ' ' GLU . 11.2 p30 45.39 41.39 6.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.754 . . . . 0.0 109.571 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m120 56.8 33.98 23.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.536 -0.727 . . . . 0.0 109.994 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.443 ' CG ' ' OD1' ' A' ' 105' ' ' ASN . 73.9 mm-40 -138.47 129.87 27.45 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.273 -0.892 . . . . 0.0 109.264 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -71.27 148.16 47.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 109.953 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.91 166.66 24.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.349 -0.845 . . . . 0.0 109.511 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 110' ' ' VAL . 10.3 p -123.77 131.12 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.5 t -123.68 136.8 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 122.238 1.018 . . . . 0.0 109.065 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -101.93 112.92 25.72 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.124 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.503 2.221 0 O-C-N 120.829 -1.169 . . . . 0.0 108.246 177.691 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.392 0.615 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -141.11 161.41 37.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.363 -0.836 . . . . 0.0 108.86 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.39 134.99 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.353 -0.842 . . . . 0.0 109.334 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 56.97 36.54 27.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.59 -0.694 . . . . 0.0 109.539 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 58.33 45.83 16.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.522 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -144.71 119.86 5.92 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.999 -1.063 . . . . 0.0 108.679 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.58 115.99 4.19 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.537 1.492 . . . . 0.0 111.771 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.55 158.68 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.322 -0.861 . . . . 0.0 109.975 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.18 -42.09 99.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.7 t -162.85 157.64 21.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 109.1 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.2 156.04 40.86 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.999 -1.063 . . . . 0.0 109.712 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -90.82 129.71 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.228 -0.92 . . . . 0.0 109.53 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.1 mt -80.76 153.32 27.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 0.0 110.105 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.54 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.22 156.01 40.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.411 -0.805 . . . . 0.0 109.131 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -54.86 134.03 48.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.34 -0.85 . . . . 0.0 110.742 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.571 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 85.72 14.68 67.23 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 83.5 m-20 -91.66 152.4 20.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.135 -1.215 . . . . 0.0 109.711 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -114.02 131.15 56.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.602 -0.686 . . . . 0.0 109.24 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 144' ' ' LEU . 55.2 t -122.29 132.59 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -120.64 120.65 36.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.465 -0.772 . . . . 0.0 109.299 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.14 128.63 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.58 -0.7 . . . . 0.0 109.842 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 53.61 -128.9 40.35 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.1 -1.43 39.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.577 -0.955 . . . . 0.0 109.291 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -97.09 145.16 26.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.457 -0.777 . . . . 0.0 109.262 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -116.22 126.12 53.18 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' VAL . 5.2 mp -128.62 154.55 46.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.573 -0.705 . . . . 0.0 109.437 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.72 130.97 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 109.156 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -87.22 119.41 27.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 134' ' ' GLY . 95.9 mt -132.98 150.92 52.12 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.791 -0.568 . . . . 0.0 109.468 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 74.0 p . . . . . 0 N--CA 1.498 1.955 0 O-C-N 121.568 -0.707 . . . . 0.0 109.269 179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 55' ' ' LEU . 10.9 mp -95.08 157.08 16.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.277 -1.131 . . . . 0.0 109.304 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.422 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -127.18 166.91 16.8 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -137.39 159.68 41.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.466 -0.771 . . . . 0.0 109.758 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.0 mt -112.35 135.47 53.0 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.36 137.48 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.57 0.7 . . . . 0.0 109.509 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.45 131.32 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.485 -0.759 . . . . 0.0 109.896 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -96.35 -32.53 12.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 109.172 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -132.21 155.35 48.41 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.762 0.791 . . . . 0.0 110.221 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.35 164.82 14.44 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.76 -15.6 40.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.686 2.257 . . . . 0.0 111.001 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -92.05 13.94 17.37 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.17 135.15 13.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.814 . . . . 0.0 110.369 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.73 -18.5 47.01 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -65.7 144.26 57.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -1.153 . . . . 0.0 109.824 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -138.79 148.72 44.15 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.358 -0.839 . . . . 0.0 109.904 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.99 137.29 50.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.544 -0.722 . . . . 0.0 109.175 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.429 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 40.8 tp -98.76 128.89 45.14 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.339 -0.85 . . . . 0.0 109.794 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.5 mt -85.97 78.91 9.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 108.986 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -98.21 10.89 39.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.469 -0.769 . . . . 0.0 109.074 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -125.11 148.43 48.55 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.5 -0.75 . . . . 0.0 109.817 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.98 95.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.542 -0.724 . . . . 0.0 109.91 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.53 126.15 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.465 -0.772 . . . . 0.0 109.058 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.5 m -123.85 119.45 29.72 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.626 -0.671 . . . . 0.0 109.249 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 m -82.86 153.87 24.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 109.482 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.22 177.2 4.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.578 -0.701 . . . . 0.0 109.984 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.94 -129.1 20.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -98.99 122.03 41.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.347 -1.09 . . . . 0.0 110.241 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.533 ' ND1' ' OG ' ' A' ' 85' ' ' SER . 4.8 t-80 -174.15 94.63 0.32 Allowed Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 38.4 Cg_exo -53.87 150.78 28.79 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.504 2.136 . . . . 0.0 112.995 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 1.2 m-20 77.24 -19.12 0.45 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.533 ' OG ' ' ND1' ' A' ' 82' ' ' HIS . 11.2 m -74.69 148.01 40.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.825 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 71' ' ' LEU . 34.2 t70 -62.92 -46.35 88.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.445 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -100.99 112.0 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.84 . . . . 0.0 109.348 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 22.9 p90 -130.91 90.13 2.85 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.3 94.94 7.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.419 -0.801 . . . . 0.0 109.063 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 43.7 t0 -87.02 98.94 11.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.459 -0.776 . . . . 0.0 109.413 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 64.5 m-20 -158.32 172.88 17.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 109.586 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.77 -44.67 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.506 -0.746 . . . . 0.0 109.818 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.6 p -78.28 -171.0 2.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.992 -1.068 . . . . 0.0 110.509 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 t 62.5 115.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.618 0.723 . . . . 0.0 109.9 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 p -69.84 170.71 10.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.6 -0.687 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -58.19 -32.99 68.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.291 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.51 59.8 1.55 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -63.55 -40.16 96.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.513 -0.742 . . . . 0.0 109.262 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.4 156.0 39.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.075 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -137.03 140.6 42.21 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.6 146.87 27.91 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -136.18 147.24 47.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.285 -0.884 . . . . 0.0 109.817 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.406 HD13 ' CZ ' ' A' ' 108' ' ' PHE . 55.5 tp -101.97 127.25 48.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.611 -0.681 . . . . 0.0 109.407 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -157.29 144.41 18.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.488 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 56.36 35.12 25.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.736 -0.603 . . . . 0.0 109.704 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 58.14 31.99 21.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.492 -0.755 . . . . 0.0 109.748 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -142.63 143.13 32.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.363 -0.835 . . . . 0.0 109.455 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.406 ' CZ ' HD13 ' A' ' 103' ' ' LEU . 64.8 m-85 -92.45 149.16 21.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 109.64 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -144.11 170.75 15.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.351 -0.843 . . . . 0.0 109.554 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 110' ' ' VAL . 14.6 p -125.79 131.04 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.6 t -126.95 130.52 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -103.38 128.55 50.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.568 -0.708 . . . . 0.0 109.509 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.907 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -124.76 157.29 36.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.67 -0.644 . . . . 0.0 109.542 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.82 134.55 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.509 0.671 . . . . 0.0 109.939 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.0 m120 47.47 -108.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.759 -0.588 . . . . 0.0 109.934 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -128.32 17.13 6.56 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.611 -0.681 . . . . 0.0 109.329 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -124.32 83.31 57.09 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.524 -0.735 . . . . 0.0 109.449 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.81 136.4 75.13 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.609 2.206 . . . . 0.0 112.466 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.9 m -151.37 159.28 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.188 -0.945 . . . . 0.0 110.071 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -62.87 -43.66 98.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.503 -0.748 . . . . 0.0 109.584 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.6 m -135.85 151.25 49.84 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.324 -0.86 . . . . 0.0 109.223 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.73 152.45 35.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.095 -1.003 . . . . 0.0 110.128 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.6 t -95.95 132.14 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.744 . . . . 0.0 109.317 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.52 146.56 40.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 109.769 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.493 ' H ' ' HB2' ' A' ' 135' ' ' ASP . . . -135.43 153.49 51.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.702 . . . . 0.0 109.517 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.665 HD22 ' N ' ' A' ' 133' ' ' ASN . 0.0 OUTLIER -45.41 104.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.74 . . . . 0.0 110.591 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.32 44.52 4.03 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.493 ' HB2' ' H ' ' A' ' 132' ' ' ALA . 15.1 t0 -87.87 163.51 16.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.213 -1.169 . . . . 0.0 109.656 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -113.35 116.99 30.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -124.62 133.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -132.51 118.96 19.92 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.0 128.22 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.589 -0.694 . . . . 0.0 109.961 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 53.52 -128.99 40.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -95.72 -9.76 31.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.485 -1.009 . . . . 0.0 109.019 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -94.45 142.68 27.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -118.16 130.53 56.16 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.19 149.26 46.55 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.622 -0.674 . . . . 0.0 109.785 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.4 p -124.94 136.88 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 77.0 t80 -83.01 117.66 22.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 70.7 mt -135.34 146.53 48.5 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.419 0.628 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.9 p . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.829 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.586 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 55' ' ' LEU . 7.5 mp -105.27 143.23 33.73 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.417 -1.049 . . . . 0.0 110.054 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.22 159.36 42.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.5 HD12 ' O ' ' A' ' 57' ' ' LEU . 0.3 OUTLIER -137.64 163.35 31.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.461 -0.774 . . . . 0.0 109.786 -179.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -120.14 136.49 54.59 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.8 t -123.11 133.47 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.571 0.701 . . . . 0.0 109.989 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.96 113.43 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.533 -0.729 . . . . 0.0 109.57 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -65.81 -45.6 81.75 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.589 -0.694 . . . . 0.0 109.555 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -156.95 144.43 18.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . 157.2 -176.62 34.36 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -54.4 -38.79 89.4 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.993 2.462 . . . . 0.0 112.004 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -106.17 22.32 15.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . -39.69 107.62 0.07 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.789 -0.569 . . . . 0.0 110.427 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.6 -20.59 3.1 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.2 p -69.06 158.09 35.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.042 -1.269 . . . . 0.0 110.977 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -143.44 158.14 43.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.472 -0.767 . . . . 0.0 109.713 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.62 143.75 50.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.713 . . . . 0.0 109.648 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.4 tp -108.42 126.54 53.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.9 mt -98.68 112.16 24.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.342 -0.849 . . . . 0.0 109.355 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 66.7 t0 -132.34 36.47 3.6 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -140.0 155.06 47.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.273 -0.892 . . . . 0.0 109.885 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.04 91.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.551 -0.718 . . . . 0.0 110.203 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -128.31 129.09 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.342 -0.849 . . . . 0.0 109.852 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.9 m -124.66 125.96 44.95 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.5 m -87.31 161.61 17.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 109.527 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 99' ' ' ALA . . . -120.41 152.54 37.78 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.621 -0.674 . . . . 0.0 109.962 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.5 -130.37 10.2 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.522 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 96.7 mtt180 -100.43 134.39 43.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -1.06 . . . . 0.0 110.043 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 50.6 m-70 -165.4 152.23 9.22 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.07 -15.88 47.78 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.126 1.884 . . . . 0.0 110.893 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 85' ' ' SER . 34.5 t70 -142.13 -124.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.564 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.445 ' H ' ' CG ' ' A' ' 84' ' ' ASP . 3.5 m 59.02 138.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.765 0.793 . . . . 0.0 110.179 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.18 -41.13 99.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.459 -0.776 . . . . 0.0 109.87 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -88.11 120.47 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -129.97 86.75 2.44 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.593 -0.692 . . . . 0.0 109.208 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.9 mt -96.52 99.63 11.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.287 -0.883 . . . . 0.0 109.163 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -90.76 94.92 9.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -153.75 152.52 30.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.282 -0.886 . . . . 0.0 109.805 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 93' ' ' THR . 13.6 p -66.42 -34.72 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.401 ' N ' HG13 ' A' ' 92' ' ' VAL . 42.0 p -64.97 -31.42 72.64 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.858 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.4 t -98.16 126.26 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.111 -0.993 . . . . 0.0 110.196 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.9 t -76.58 168.52 19.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 110.242 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -60.84 -42.87 98.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.452 -0.78 . . . . 0.0 109.819 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -124.06 54.31 1.35 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.42 -0.8 . . . . 0.0 109.08 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.01 -41.72 97.37 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.557 -0.714 . . . . 0.0 109.551 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -151.73 157.44 42.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.05 -1.031 . . . . 0.0 109.971 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -136.11 149.18 48.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -112.14 144.03 42.2 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -132.86 138.18 46.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.537 -0.727 . . . . 0.0 109.247 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD1' ' O ' ' A' ' 107' ' ' GLU . 39.3 tp -88.99 129.79 35.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.44 -0.787 . . . . 0.0 109.997 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -169.54 158.66 7.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.402 -0.811 . . . . 0.0 108.928 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 59.24 31.81 21.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.591 -0.693 . . . . 0.0 109.652 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 52.47 32.53 11.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.444 -0.785 . . . . 0.0 109.607 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.555 ' O ' ' CG ' ' A' ' 108' ' ' PHE . 77.3 mm-40 -143.75 -119.71 0.09 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.322 -0.861 . . . . 0.0 108.852 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 107' ' ' GLU . 56.5 m-85 -162.92 150.98 13.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 109.222 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -137.26 151.2 48.43 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 110' ' ' VAL . 13.7 p -123.08 131.62 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.17 131.08 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.478 0.656 . . . . 0.0 109.31 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.484 ' OD2' ' N ' ' A' ' 119' ' ' THR . 89.2 m-20 -90.78 147.08 23.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.794 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.373 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.507 HG22 ' N ' ' A' ' 120' ' ' TYR . 33.4 m . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.101 0.476 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.583 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 1.6 m-85 -127.22 138.84 53.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.598 -0.688 . . . . 0.0 109.452 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.9 134.24 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 m120 47.76 -171.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.433 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -65.4 -18.82 65.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.2 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -104.99 104.47 46.88 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.568 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.84 142.13 28.01 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.043 1.828 . . . . 0.0 112.447 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 129' ' ' ALA . 3.8 m -139.6 163.09 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.252 -0.905 . . . . 0.0 110.454 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -66.76 -38.58 86.88 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.1 p -158.45 160.17 36.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.981 -1.074 . . . . 0.0 109.8 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -169.05 164.3 11.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.061 -1.025 . . . . 0.0 110.315 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.65 130.46 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.583 -0.698 . . . . 0.0 109.447 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.97 150.06 34.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 110.731 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.54 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -147.05 152.18 38.12 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.735 . . . . 0.0 109.358 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -55.52 134.36 50.72 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.669 0.747 . . . . 0.0 111.183 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.479 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 87.5 13.69 64.96 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 84.4 m-20 -89.99 163.88 14.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.253 -1.145 . . . . 0.0 110.17 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -121.12 132.95 55.16 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.58 131.67 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -114.53 119.02 35.41 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.1 mm -111.66 124.16 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.654 0.74 . . . . 0.0 109.638 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.72 -124.6 7.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -96.56 -1.9 46.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.515 -0.991 . . . . 0.0 108.59 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -95.51 142.48 27.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.575 -0.703 . . . . 0.0 109.847 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -107.44 133.74 51.5 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.637 -0.664 . . . . 0.0 109.882 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -138.34 161.14 37.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.422 -0.799 . . . . 0.0 109.132 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.95 132.39 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -90.03 117.56 28.92 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.479 HD23 ' H ' ' A' ' 134' ' ' GLY . 97.1 mt -134.86 163.64 29.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.716 -0.615 . . . . 0.0 110.125 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 25.6 p . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.633 -0.667 . . . . 0.0 109.897 -179.576 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.431 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.67 151.6 42.93 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.446 -1.032 . . . . 0.0 109.847 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.84 156.19 42.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.42 153.55 49.58 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.98 0.895 . . . . 0.0 110.13 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.63 134.9 54.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -122.97 135.36 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.875 0.845 . . . . 0.0 109.902 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.37 135.6 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.676 0.75 . . . . 0.0 110.101 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -84.65 -74.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.399 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.685 HH21 ' NH1' ' A' ' 143' ' ' ARG . 88.2 mtm180 -129.11 147.65 50.99 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.433 -0.792 . . . . 0.0 110.0 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.97 177.66 26.78 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -65.83 -19.04 58.93 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.664 2.243 . . . . 0.0 110.922 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 66' ' ' ALA . 35.5 m120 -84.47 -80.77 0.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.875 . . . . 0.0 109.508 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 58.8 131.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.974 0.892 . . . . 0.0 110.901 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.62 41.43 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.8 m -69.87 146.3 51.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -1.145 . . . . 0.0 111.011 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -145.5 156.53 43.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 109.786 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -129.54 144.35 51.23 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.5 tp -104.06 127.94 51.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.685 -0.634 . . . . 0.0 109.301 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -100.07 74.04 1.76 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.025 -1.047 . . . . 0.0 109.177 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -94.67 3.87 54.54 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -106.6 153.07 22.89 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.281 -0.887 . . . . 0.0 110.059 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.06 94.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.454 -0.779 . . . . 0.0 109.808 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.2 mt -125.55 126.86 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 86' ' ' ASP . 96.6 m -126.46 120.66 30.31 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 p -84.76 166.49 16.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.962 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.38 170.89 7.64 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.932 0.872 . . . . 0.0 110.215 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.29 -131.3 29.91 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -110.77 130.65 55.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -1.06 . . . . 0.0 110.104 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -170.08 136.14 1.27 Allowed Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -42.57 -58.47 1.26 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.485 2.123 . . . . 0.0 112.653 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -96.1 92.72 6.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.935 . . . . 0.0 109.88 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.48 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 82.9 p -171.13 121.09 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 108.972 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.466 ' H ' HG23 ' A' ' 77' ' ' THR . 59.3 m-20 -68.1 -34.32 76.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.421 -0.799 . . . . 0.0 109.298 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.94 130.19 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.861 -1.149 . . . . 0.0 109.761 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 62.4 m-85 -129.07 89.33 2.85 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.427 -0.796 . . . . 0.0 109.401 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.7 mt -101.18 103.35 14.39 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -92.52 87.66 6.05 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.626 0.727 . . . . 0.0 109.881 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.46 ' OD2' ' CZ ' ' A' ' 142' ' ' PHE . 65.2 m-20 -150.22 149.53 30.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.963 . . . . 0.0 109.757 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.2 m -72.79 -26.27 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.733 0.778 . . . . 0.0 109.568 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.2 p -71.66 -17.21 62.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 109.382 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.0 t -110.94 126.78 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.325 -0.859 . . . . 0.0 109.415 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 p -77.08 168.63 19.76 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.797 0.808 . . . . 0.0 110.667 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -63.67 -38.08 89.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.477 -0.764 . . . . 0.0 109.878 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -129.97 50.56 2.17 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.117 -0.989 . . . . 0.0 109.115 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -62.63 -40.8 98.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.078 -1.014 . . . . 0.0 108.969 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.99 159.89 43.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.898 -1.126 . . . . 0.0 110.107 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -134.55 150.53 50.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.498 -0.751 . . . . 0.0 109.436 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.27 140.05 48.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.575 -0.703 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -134.56 136.86 43.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.433 -0.792 . . . . 0.0 109.189 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 38.5 tp -102.63 127.68 49.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -155.66 143.74 19.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.19 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 56.24 39.73 30.15 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.547 0.689 . . . . 0.0 110.135 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.2 m120 55.22 31.79 17.2 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.597 0.713 . . . . 0.0 109.382 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -139.79 130.96 26.5 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.237 -0.914 . . . . 0.0 109.753 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -83.62 146.27 28.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -147.58 167.15 25.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.152 -0.967 . . . . 0.0 109.379 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.21 135.59 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.9 t -125.63 130.84 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.508 ' OD2' ' N ' ' A' ' 119' ' ' THR . 15.0 m-20 -95.23 134.35 38.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.6 m . . . . . 0 N--CA 1.497 1.908 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.281 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.508 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 29.0 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.602 0.715 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -127.89 145.34 50.98 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.786 . . . . 0.0 109.379 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.452 HG22 ' N ' ' A' ' 122' ' ' ASN . 9.4 p -109.59 157.05 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.847 0.832 . . . . 0.0 109.752 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.464 ' ND2' ' CD ' ' A' ' 136' ' ' GLU . 90.8 m-20 -53.21 -39.6 63.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.828 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -57.41 -83.41 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.941 -1.099 . . . . 0.0 109.631 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -143.35 147.39 39.94 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.076 -1.015 . . . . 0.0 109.553 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.18 120.73 8.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.603 2.202 . . . . 0.0 111.894 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.69 163.18 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.186 -0.946 . . . . 0.0 110.203 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 128' ' ' SER . 47.8 p-10 -66.94 -33.03 74.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.55 -0.719 . . . . 0.0 109.487 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.548 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 86.4 p -152.23 160.19 43.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.047 . . . . 0.0 109.278 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.39 156.51 30.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.029 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.1 130.15 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.491 -0.755 . . . . 0.0 109.941 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.6 mt -76.49 151.38 36.45 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.849 0.833 . . . . 0.0 110.209 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.553 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.77 155.71 39.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.507 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -51.33 124.02 10.91 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.921 0.867 . . . . 0.0 110.972 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.07 16.22 59.71 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.553 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 28.9 m-20 -87.75 155.48 19.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.925 -1.338 . . . . 0.0 110.565 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 56.6 mp0 -113.61 128.2 56.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.661 -0.649 . . . . 0.0 109.499 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 144' ' ' LEU . 54.8 t -125.45 131.48 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.403 ' O ' ' NE2' ' A' ' 138' ' ' GLN . 4.9 pp0? -123.2 132.83 54.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.706 -0.621 . . . . 0.0 109.776 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.18 117.08 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.668 0.747 . . . . 0.0 109.052 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 61.26 -127.84 43.07 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -93.27 -5.33 50.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -1.161 . . . . 0.0 109.02 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.46 ' CZ ' ' OD2' ' A' ' 91' ' ' ASP . 57.8 m-85 -96.13 133.7 40.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.184 -0.947 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.685 ' NH1' HH21 ' A' ' 62' ' ' ARG . 83.3 mtp180 -103.27 139.4 38.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.592 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 137' ' ' VAL . 4.7 mp -135.51 166.47 23.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 109.47 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.0 p -128.69 133.67 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.652 0.739 . . . . 0.0 109.567 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -96.1 115.52 27.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -0.828 . . . . 0.0 109.249 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.57 147.88 51.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.626 0.727 . . . . 0.0 109.668 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 121.541 0.686 . . . . 0.0 109.632 -179.755 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.582 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -122.37 142.97 49.95 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.558 -0.966 . . . . 0.0 109.223 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.13 155.18 41.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -127.38 157.12 40.82 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.186 0.517 . . . . 0.0 109.733 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.4 mt -117.04 128.7 55.42 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.01 134.08 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.642 0.734 . . . . 0.0 109.538 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.6 t -78.36 111.69 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.677 -0.64 . . . . 0.0 109.898 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -64.88 -43.62 92.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.577 -0.702 . . . . 0.0 110.219 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -137.21 151.77 49.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.534 -0.729 . . . . 0.0 110.287 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.06 172.29 22.61 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.21 -20.83 55.81 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.956 2.437 . . . . 0.0 112.006 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.427 ' O ' ' C ' ' A' ' 66' ' ' ALA . 93.1 m-20 -98.65 -35.74 10.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.446 -0.784 . . . . 0.0 109.357 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . 35.42 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.313 0.578 . . . . 0.0 110.789 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.48 -15.13 3.66 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.9 m -62.86 144.49 56.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -1.008 . . . . 0.0 110.766 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -137.57 156.04 48.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.603 -0.686 . . . . 0.0 109.354 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -126.32 146.75 49.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.626 -0.671 . . . . 0.0 109.315 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.665 HD13 ' N ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -104.78 126.56 51.97 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 71' ' ' LEU . 79.3 mt -100.53 124.47 46.12 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.452 0.644 . . . . 0.0 109.669 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -154.39 56.63 0.7 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.429 ' CD ' ' N ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -161.08 175.57 12.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.491 -0.756 . . . . 0.0 109.547 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.13 -65.53 1.0 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.495 -0.753 . . . . 0.0 110.297 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mm -108.56 124.56 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.765 . . . . 0.0 110.212 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.411 ' OG1' ' CD ' ' A' ' 74' ' ' GLN . 31.5 m -127.97 127.08 42.62 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 p -84.65 165.02 18.27 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.562 -0.711 . . . . 0.0 109.936 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 98' ' ' HIS . . . -109.79 164.93 12.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.631 -0.668 . . . . 0.0 110.026 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.445 ' N ' ' NE2' ' A' ' 98' ' ' HIS . . . 70.99 -127.73 15.51 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.535 ' O ' ' ND1' ' A' ' 82' ' ' HIS . 96.9 mtt180 -101.87 137.01 40.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.399 -1.059 . . . . 0.0 110.491 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 173.13 153.79 0.25 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.3 144.41 51.07 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.733 2.289 . . . . 0.0 113.059 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 55.5 t0 57.09 28.6 15.17 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.451 -0.781 . . . . 0.0 109.348 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 18.3 t -98.19 119.81 37.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.34 -0.85 . . . . 0.0 109.572 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -65.03 -36.45 84.41 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.42 -0.8 . . . . 0.0 109.318 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -78.24 128.45 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.892 . . . . 0.0 110.212 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 91.6 m-85 -126.85 86.98 2.58 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.8 mt -108.21 106.45 16.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.619 0.723 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 55.6 t0 -86.51 90.82 8.35 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.501 ' OD2' ' CE2' ' A' ' 142' ' ' PHE . 71.1 m-20 -151.33 130.66 12.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.876 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.14 -24.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.4 p -75.18 -13.81 60.49 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.554 -0.717 . . . . 0.0 109.182 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 95' ' ' SER . 89.5 t -101.75 -15.1 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 94' ' ' VAL . 79.4 p 50.23 174.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.592 0.71 . . . . 0.0 110.792 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -59.88 -65.66 0.64 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 109.935 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -102.17 134.53 45.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.648 -0.658 . . . . 0.0 109.779 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.484 ' CE1' ' HB1' ' A' ' 79' ' ' ALA . 4.8 p80 -154.3 -35.42 0.1 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -151.67 158.52 43.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.823 . . . . 0.0 109.928 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -137.16 151.2 48.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.653 -0.654 . . . . 0.0 109.67 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.5 142.63 43.53 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -134.65 141.03 46.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.796 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.9 tp -102.44 127.13 49.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.683 -0.635 . . . . 0.0 109.32 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 106' ' ' ASN . 80.5 tt0 -155.99 -70.69 0.11 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.557 -0.714 . . . . 0.0 109.355 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -72.05 32.71 0.06 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.497 -0.752 . . . . 0.0 109.529 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 104' ' ' GLU . 16.2 p30 44.02 30.19 0.4 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.658 0.742 . . . . 0.0 109.53 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 108' ' ' PHE . 96.1 mt-10 -144.47 10.24 1.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 107' ' ' GLU . 94.1 m-85 58.17 144.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.255 0.55 . . . . 0.0 110.494 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -133.76 163.7 28.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.3 132.18 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.737 -0.602 . . . . 0.0 109.487 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.7 t -128.65 133.6 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.98 114.67 21.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.317 -0.864 . . . . 0.0 109.487 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 111.006 -179.049 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.484 1.268 0 CA-C-O 121.334 0.588 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.423 ' OH ' ' NH1' ' A' ' 123' ' ' ARG . 31.4 p90 -141.54 157.98 44.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.513 -0.742 . . . . 0.0 109.12 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 121' ' ' VAL . 9.1 p -121.02 128.86 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.451 0.643 . . . . 0.0 109.888 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 54.35 38.54 29.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.65 -0.656 . . . . 0.0 109.614 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.423 ' NH1' ' OH ' ' A' ' 120' ' ' TYR . 31.0 mmt180 60.47 44.01 12.45 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.436 0.636 . . . . 0.0 110.21 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -147.63 87.21 6.01 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.522 -0.736 . . . . 0.0 109.127 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.4 130.45 38.61 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.378 2.052 . . . . 0.0 112.076 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.5 m -147.34 154.4 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.326 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.89 -39.81 94.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.6 p -157.26 157.35 34.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.229 -0.919 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.37 149.99 14.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.288 -0.883 . . . . 0.0 109.806 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.65 135.98 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.501 -0.749 . . . . 0.0 110.434 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.28 148.89 37.25 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.358 -0.839 . . . . 0.0 109.856 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.03 154.72 44.28 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.571 0.701 . . . . 0.0 109.773 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.608 ' ND2' ' H ' ' A' ' 148' ' ' THR . 24.4 t-20 -55.97 115.07 2.19 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.581 0.705 . . . . 0.0 110.751 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 146' ' ' PHE . . . 84.13 15.34 69.78 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 136' ' ' GLU . 67.7 t0 -64.23 145.74 55.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -1.211 . . . . 0.0 109.996 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 135' ' ' ASP . 98.4 mt-10 -93.49 122.12 35.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 52.8 t -122.05 132.89 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -122.67 124.92 44.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 141' ' ' LYS . 96.6 mt -124.42 129.95 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.307 0.575 . . . . 0.0 109.947 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.69 -88.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 139' ' ' ILE . 63.3 mttp -141.88 -4.33 1.07 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.461 -1.023 . . . . 0.0 108.624 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.501 ' CE2' ' OD2' ' A' ' 91' ' ' ASP . 62.2 m-85 -96.94 140.49 31.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.767 . . . . 0.0 109.924 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -105.0 129.48 53.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.658 -0.651 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.07 149.68 50.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.22 129.06 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.6 0.714 . . . . 0.0 109.119 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 134' ' ' GLY . 76.0 t80 -90.08 127.67 36.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.764 -0.585 . . . . 0.0 109.582 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.911 HD23 ' N ' ' A' ' 147' ' ' LEU . 0.6 OUTLIER -143.41 174.95 10.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.823 0.821 . . . . 0.0 110.06 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.608 ' H ' ' ND2' ' A' ' 133' ' ' ASN . 18.9 p . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 121.525 0.678 . . . . 0.0 109.482 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.479 ' O ' HD12 ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.492 2.421 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 54' ' ' GLY . 7.2 mp -116.52 160.75 20.17 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.509 -0.995 . . . . 0.0 109.526 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.81 154.93 51.04 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.35 152.66 48.67 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.454 -0.779 . . . . 0.0 109.616 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.0 mt -113.7 134.41 54.76 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.8 134.98 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.62 110.84 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.576 -0.703 . . . . 0.0 109.632 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -64.55 -44.98 89.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.861 . . . . 0.0 109.68 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -141.88 148.34 38.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.363 -0.835 . . . . 0.0 109.898 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.52 178.69 27.43 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.68 -40.48 84.22 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.326 2.017 . . . . 0.0 111.497 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -114.02 48.24 1.11 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.09 95.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.512 -0.743 . . . . 0.0 109.387 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.53 -17.04 0.58 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.2 t -62.56 150.23 41.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.492 -1.005 . . . . 0.0 109.513 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -130.3 156.2 45.05 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.633 -0.667 . . . . 0.0 109.292 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.17 146.07 50.83 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.533 -0.73 . . . . 0.0 109.286 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 tp -105.66 125.36 50.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.642 -0.661 . . . . 0.0 109.557 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.54 77.85 2.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.406 -0.809 . . . . 0.0 109.0 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.01 12.85 18.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 0.0 109.405 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -126.51 140.63 52.31 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.93 88.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.521 -0.737 . . . . 0.0 110.446 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 mm -106.18 118.47 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.303 -0.873 . . . . 0.0 109.764 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.9 m -123.22 122.85 39.41 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.5 t -87.65 167.3 14.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.175 -0.953 . . . . 0.0 109.543 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 99' ' ' ALA . . . -122.51 146.88 46.99 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.556 -0.715 . . . . 0.0 109.097 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.71 -125.22 8.01 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 99.8 mtt180 -103.32 133.33 48.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.436 -1.037 . . . . 0.0 110.556 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 0.7 OUTLIER 175.11 120.12 0.12 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.08 -14.76 23.44 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.59 1.526 . . . . 0.0 111.287 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 66.5 t0 -96.74 -24.13 16.09 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.727 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.5 t -74.55 139.92 44.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.446 -0.784 . . . . 0.0 110.659 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.59 -41.29 96.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 109.687 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.74 129.51 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.344 -0.848 . . . . 0.0 110.303 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CZ ' ' OD2' ' A' ' 90' ' ' ASP . 84.4 t80 -129.25 84.84 2.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.7 mt -108.54 109.34 20.55 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.559 -0.713 . . . . 0.0 109.916 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.517 ' OD2' ' CZ ' ' A' ' 88' ' ' PHE . 97.9 m-20 -99.95 -93.38 0.27 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.511 -0.743 . . . . 0.0 109.352 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.468 ' CG ' ' CE1' ' A' ' 142' ' ' PHE . 1.5 p30 39.75 -165.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.645 0.736 . . . . 0.0 110.783 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.9 m -71.84 161.55 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 110.057 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.5 p 54.56 -139.77 0.98 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.279 0.562 . . . . 0.0 110.676 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.2 t 42.72 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.493 -0.754 . . . . 0.0 109.649 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -69.36 173.33 5.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.47 -0.769 . . . . 0.0 110.816 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -60.39 -43.91 96.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.48 -0.762 . . . . 0.0 109.358 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -123.23 64.14 1.0 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.36 -35.08 25.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.536 -0.728 . . . . 0.0 109.69 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -150.45 149.62 30.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 109.803 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -141.49 134.23 28.68 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -100.98 145.8 28.23 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.507 -0.746 . . . . 0.0 109.786 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -131.63 132.18 43.81 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.9 tp -90.75 130.57 36.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.307 -0.871 . . . . 0.0 109.622 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 106' ' ' ASN . 49.1 tp10 -131.97 140.81 49.1 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.582 -0.699 . . . . 0.0 109.319 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 51.63 -85.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.469 -0.769 . . . . 0.0 110.085 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 104' ' ' GLU . 16.9 t-20 -155.75 20.57 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.456 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -134.02 139.95 46.37 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.548 -0.72 . . . . 0.0 109.373 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -77.34 147.13 36.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.513 -0.742 . . . . 0.0 109.981 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -124.85 160.89 27.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.33 134.15 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.8 t -127.33 135.48 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 119' ' ' THR . 50.2 t0 -84.0 111.73 19.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.188 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.425 -0.797 . . . . 0.0 109.304 -179.874 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.444 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 23.8 m . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.107 0.479 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -132.9 157.62 44.63 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.462 -0.774 . . . . 0.0 109.223 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 121' ' ' VAL . 8.8 p -118.94 128.42 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.561 -0.712 . . . . 0.0 109.375 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 54.55 38.24 29.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.918 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 63.1 46.69 4.53 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.506 0.67 . . . . 0.0 109.833 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -148.6 88.98 5.15 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.091 -1.005 . . . . 0.0 109.24 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -55.06 132.35 51.8 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.226 1.951 . . . . 0.0 112.393 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.1 m -151.5 156.12 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.276 -0.89 . . . . 0.0 109.863 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.29 -40.63 96.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.824 . . . . 0.0 109.379 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.7 t -161.51 156.0 22.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.258 -0.901 . . . . 0.0 109.347 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.43 156.47 38.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.6 t -88.6 130.19 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.342 -0.849 . . . . 0.0 109.247 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.52 149.2 34.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.838 . . . . 0.0 110.218 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.526 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.41 163.81 37.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.416 -0.802 . . . . 0.0 109.267 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.572 ' ND2' ' H ' ' A' ' 148' ' ' THR . 18.1 m120 -56.53 138.49 51.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.285 -0.884 . . . . 0.0 110.43 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.549 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 80.36 13.55 81.6 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 27.5 m-20 -83.03 145.15 29.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.25 . . . . 0.0 109.623 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -112.87 126.53 55.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.42 132.47 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.6 -0.688 . . . . 0.0 109.333 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 140' ' ' GLY . 13.3 tm0? -119.42 127.8 53.44 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.57 127.46 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.531 0.681 . . . . 0.0 110.052 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.506 ' O ' ' NE2' ' A' ' 138' ' ' GLN . . . 54.51 -104.65 0.27 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -116.78 -24.85 7.52 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.616 -0.932 . . . . 0.0 109.465 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.468 ' CE1' ' CG ' ' A' ' 91' ' ' ASP . 25.2 m-85 -76.33 142.77 41.14 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.347 -0.846 . . . . 0.0 110.077 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -107.85 137.08 46.5 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -136.54 155.49 49.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.389 -0.819 . . . . 0.0 109.415 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 145' ' ' VAL . 12.3 p -119.82 131.14 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -94.8 120.54 35.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.397 -0.814 . . . . 0.0 109.985 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.549 HD23 ' H ' ' A' ' 134' ' ' GLY . 16.3 mt -134.18 150.43 51.08 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.572 ' H ' ' ND2' ' A' ' 133' ' ' ASN . 4.5 p . . . . . 0 N--CA 1.498 1.929 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.9 mt -124.6 145.96 49.32 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.654 -0.91 . . . . 0.0 110.36 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.37 166.51 31.64 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.588 0.708 . . . . 0.0 109.85 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -125.83 146.19 49.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.843 0.83 . . . . 0.0 110.236 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.6 mt -125.43 140.9 52.39 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.672 0.749 . . . . 0.0 109.575 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -140.99 143.37 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.745 0.784 . . . . 0.0 110.341 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.6 t -73.76 131.09 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.792 0.806 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -95.22 -32.0 13.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -151.71 140.55 20.95 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.781 0.8 . . . . 0.0 109.966 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.37 167.48 11.66 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.05 -17.71 40.67 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.823 2.349 . . . . 0.0 111.384 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.38 19.52 13.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.43 143.05 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.865 0.84 . . . . 0.0 110.369 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.96 -14.28 61.6 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.4 t -68.16 138.61 55.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.644 -0.915 . . . . 0.0 110.892 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -134.52 143.48 47.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.74 0.781 . . . . 0.0 110.231 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -128.91 136.58 50.6 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.633 0.73 . . . . 0.0 109.652 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.513 HD23 ' C ' ' A' ' 71' ' ' LEU . 6.6 tt -110.25 123.52 49.93 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.885 0.85 . . . . 0.0 109.74 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 71' ' ' LEU . 57.5 mt -90.3 113.38 25.22 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.552 0.691 . . . . 0.0 109.59 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -147.21 70.88 1.2 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.674 0.75 . . . . 0.0 109.197 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 75' ' ' ALA . 54.3 tp60 -171.07 -121.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.651 -0.656 . . . . 0.0 109.763 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 74' ' ' GLN . . . -167.14 127.6 1.51 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.751 0.786 . . . . 0.0 109.805 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mm 63.57 82.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.632 0.729 . . . . 0.0 109.385 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.4 m -99.41 123.38 43.64 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.781 0.801 . . . . 0.0 110.136 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.1 t -91.44 166.43 12.87 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.538 0.685 . . . . 0.0 109.411 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.54 154.95 26.27 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.774 0.797 . . . . 0.0 110.019 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 101.83 -118.97 6.31 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.551 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 84.9 mtp180 -124.08 130.62 52.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.78 -0.835 . . . . 0.0 110.352 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 3.1 m-70 176.3 149.37 0.31 Allowed Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.05 -30.99 20.09 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.88 2.386 . . . . 0.0 112.158 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -93.0 -0.25 57.25 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.0 t -94.74 118.93 32.53 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.717 0.77 . . . . 0.0 109.803 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.01 -39.94 94.17 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.335 0.588 . . . . 0.0 109.44 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.714 HD12 ' N ' ' A' ' 87' ' ' ILE . 1.9 mp -82.56 125.57 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.718 . . . . 0.0 109.987 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CE2' ' OD1' ' A' ' 90' ' ' ASP . 34.0 t80 -124.82 102.3 7.5 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.811 0.815 . . . . 0.0 108.922 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.8 mt -107.34 112.67 25.61 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.821 0.819 . . . . 0.0 110.038 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD1' ' CE2' ' A' ' 88' ' ' PHE . 99.9 m-20 -91.52 81.31 5.37 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.496 0.665 . . . . 0.0 109.435 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 92' ' ' VAL . 66.9 t0 -156.16 140.76 16.91 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.71 0.767 . . . . 0.0 110.071 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.542 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 33.4 m -67.62 -22.64 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.9 p -65.72 -29.08 69.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.575 -0.703 . . . . 0.0 109.165 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -103.34 128.84 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 121.887 0.851 . . . . 0.0 110.033 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 p -72.66 172.41 10.7 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.881 0.848 . . . . 0.0 111.03 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -59.19 -43.75 92.22 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.911 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.565 ' O ' ' N ' ' A' ' 99' ' ' ALA . 95.1 mtt-85 -108.29 -51.81 2.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 59.5 -72.56 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.423 0.63 . . . . 0.0 109.951 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -142.32 163.51 32.65 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.712 0.768 . . . . 0.0 109.919 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -132.03 146.11 51.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.803 0.811 . . . . 0.0 110.062 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.35 140.51 48.59 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.432 0.634 . . . . 0.0 109.392 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -128.1 142.91 51.07 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.805 0.812 . . . . 0.0 110.212 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.6 tp -103.56 123.1 46.31 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.548 0.69 . . . . 0.0 109.361 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -92.25 -127.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.444 0.64 . . . . 0.0 110.141 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.64 -40.8 92.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.805 -0.559 . . . . 0.0 109.641 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -174.82 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -140.91 136.59 32.42 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.653 0.74 . . . . 0.0 109.478 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -79.41 146.88 32.57 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.694 0.759 . . . . 0.0 110.228 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.26 160.87 31.63 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.426 0.631 . . . . 0.0 109.488 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -123.82 127.06 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.885 0.85 . . . . 0.0 109.595 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.74 133.95 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.685 0.755 . . . . 0.0 109.404 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -80.61 151.84 28.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.635 0.731 . . . . 0.0 110.451 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.812 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.914 0.864 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -138.97 160.71 39.11 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.379 0.609 . . . . 0.0 109.584 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 123' ' ' ARG . 10.4 p -105.92 128.24 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 121.858 0.837 . . . . 0.0 109.99 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 53.42 -83.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.321 0.581 . . . . 0.0 109.707 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 121' ' ' VAL . 64.3 ttt180 -156.91 42.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -147.64 85.15 6.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.94 133.95 61.36 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.44 2.093 . . . . 0.0 112.177 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -145.92 162.98 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.905 0.86 . . . . 0.0 110.574 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -65.44 -34.08 77.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.2 p -153.2 159.9 42.73 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.571 0.7 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.62 155.91 30.92 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.709 0.766 . . . . 0.0 110.388 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.3 t -105.78 130.12 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.852 0.834 . . . . 0.0 109.641 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -75.79 146.35 40.04 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.625 0.726 . . . . 0.0 109.835 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.546 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.58 155.35 40.15 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.019 0.914 . . . . 0.0 110.289 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -48.41 122.93 5.88 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.937 0.875 . . . . 0.0 110.755 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.527 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 88.62 18.79 54.11 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 16.1 m-20 -87.66 151.93 22.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.694 -0.886 . . . . 0.0 110.301 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -114.86 129.92 56.79 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.734 0.778 . . . . 0.0 109.721 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.64 131.03 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.709 0.766 . . . . 0.0 109.133 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -117.26 126.69 53.15 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.795 0.807 . . . . 0.0 109.883 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.18 129.1 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.573 0.701 . . . . 0.0 109.619 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 48.0 -107.28 0.23 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -111.31 -21.05 12.05 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.51 148.14 33.56 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.684 0.754 . . . . 0.0 110.76 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -115.33 126.98 55.11 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.718 0.77 . . . . 0.0 109.453 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.11 155.92 44.7 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.625 0.726 . . . . 0.0 110.173 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.9 p -126.75 135.37 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.715 0.769 . . . . 0.0 109.763 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -92.73 118.77 31.42 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.861 0.838 . . . . 0.0 109.673 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 134' ' ' GLY . 93.0 mt -134.58 148.83 50.53 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.627 0.727 . . . . 0.0 109.498 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.624 0.726 . . . . 0.0 109.759 179.805 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.905 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.25 146.1 46.39 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.396 -1.061 . . . . 0.0 109.942 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.58 157.15 40.63 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 pp -141.49 157.67 44.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.225 -0.922 . . . . 0.0 109.673 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mp -116.18 151.75 35.07 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.17 133.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 62' ' ' ARG . 53.7 t -67.37 134.59 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.409 -0.807 . . . . 0.0 110.398 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -112.23 50.72 0.84 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.654 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 3.6 tpt180 -120.42 173.43 7.15 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.72 -57.63 3.04 Favored Glycine 0 N--CA 1.49 2.241 0 O-C-N 120.92 -1.112 . . . . 0.0 111.443 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -85.07 12.67 3.0 Favored 'Trans proline' 0 N--CA 1.515 2.761 0 C-N-CA 123.917 3.078 . . . . 0.0 114.366 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.414 ' O ' HG11 ' A' ' 60' ' ' VAL . 57.4 t30 -148.62 17.08 1.02 Allowed 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.335 -1.478 . . . . 0.0 108.663 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . -77.78 153.39 32.92 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.382 0.611 . . . . 0.0 109.896 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.47 -21.63 43.34 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.7 m -66.17 141.24 58.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.29 -1.123 . . . . 0.0 109.263 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -133.81 146.95 51.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.679 -0.638 . . . . 0.0 109.359 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.18 102.24 4.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.41 -0.806 . . . . 0.0 108.878 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -85.63 137.72 32.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 109.4 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.3 mt -95.91 97.45 9.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.526 -0.734 . . . . 0.0 109.82 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 51.5 t0 -109.92 17.54 21.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -127.35 152.92 46.85 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.505 -0.747 . . . . 0.0 109.997 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.41 -47.89 83.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.636 -0.665 . . . . 0.0 110.452 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.24 126.12 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.299 -0.876 . . . . 0.0 109.618 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 92.6 m -121.96 120.95 35.92 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 p -85.29 163.13 18.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.387 -0.82 . . . . 0.0 109.853 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.58 177.83 4.5 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.478 -0.764 . . . . 0.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.88 -129.64 10.4 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.367 -0.92 . . . . 0.0 110.887 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.558 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 85.1 mtt85 -96.63 114.75 26.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.447 -1.031 . . . . 0.0 110.231 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 32.3 m-70 -170.58 80.33 0.57 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.81 -38.39 67.43 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.282 1.988 . . . . 0.0 111.266 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.56 -39.85 95.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.441 -0.787 . . . . 0.0 109.28 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 t -72.09 158.27 36.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.352 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -62.45 -40.55 96.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.514 -0.741 . . . . 0.0 109.883 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 93.2 mt -94.49 117.09 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.07 -1.019 . . . . 0.0 109.671 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 16.5 p90 -130.33 88.26 2.62 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.19 92.33 9.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.029 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -95.71 92.65 6.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.419 -0.801 . . . . 0.0 109.488 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -159.99 176.93 11.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.82 -44.38 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.312 -0.867 . . . . 0.0 109.994 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.6 p -71.61 173.6 7.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.63 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t 61.81 108.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.679 0.752 . . . . 0.0 109.707 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -61.1 -150.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.551 0.691 . . . . 0.0 110.752 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -60.31 -45.69 92.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.483 -0.76 . . . . 0.0 109.364 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 99' ' ' ALA . 36.4 ptt85 179.99 -54.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' A' ' 97' ' ' ARG . 46.8 p-80 43.09 15.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.675 -0.641 . . . . 0.0 110.141 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -154.7 143.13 20.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.861 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -149.42 147.67 28.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.34 143.31 39.02 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.51 -0.744 . . . . 0.0 109.547 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -128.71 137.59 51.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.655 -0.653 . . . . 0.0 109.509 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.2 tp -91.64 126.89 36.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.382 -0.824 . . . . 0.0 108.78 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 106' ' ' ASN . 83.7 tt0 -119.83 129.87 54.63 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.467 -0.771 . . . . 0.0 109.763 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 m120 50.79 -86.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.518 -0.739 . . . . 0.0 109.957 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 104' ' ' GLU . 9.0 m120 -148.35 23.6 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.171 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -134.97 139.05 44.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.698 . . . . 0.0 109.561 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -75.5 149.0 38.54 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.646 -0.659 . . . . 0.0 109.716 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -135.92 165.33 25.9 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 109.092 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.69 132.28 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -129.78 132.73 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 119' ' ' THR . 88.8 m-20 -103.71 139.28 39.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.432 -0.792 . . . . 0.0 109.391 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 113' ' ' VAL . 3.0 m . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.52 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 21.3 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.157 0.503 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -119.62 150.25 40.62 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.623 -0.673 . . . . 0.0 109.326 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.7 p -120.37 130.84 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.595 -0.69 . . . . 0.0 110.01 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 124' ' ' GLU . 91.0 m-20 45.58 -172.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.637 0.732 . . . . 0.0 110.781 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -59.67 -2.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.59 -0.694 . . . . 0.0 110.051 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 122' ' ' ASN . 27.1 mt-10 -109.6 95.16 18.49 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.421 -0.799 . . . . 0.0 109.436 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.28 127.82 8.54 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.834 1.69 . . . . 0.0 111.795 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 129' ' ' ALA . 35.5 m -139.04 162.25 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.309 -0.869 . . . . 0.0 110.363 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -74.66 -22.44 58.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.531 -0.731 . . . . 0.0 109.553 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.4 p -162.54 160.34 25.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.632 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -173.06 166.14 4.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.166 -0.959 . . . . 0.0 109.677 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.79 130.66 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.453 -0.779 . . . . 0.0 109.516 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.73 148.7 34.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 109.91 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.537 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -151.02 152.74 33.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 108.945 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -51.87 134.13 31.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.371 -0.831 . . . . 0.0 110.441 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.19 11.4 64.82 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 79.4 m-20 -89.09 148.64 23.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.269 -1.136 . . . . 0.0 109.724 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -112.22 128.06 56.14 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.93 130.6 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.645 -0.659 . . . . 0.0 109.301 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -126.01 122.45 35.9 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.595 -0.691 . . . . 0.0 109.214 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 95.4 mt -123.82 129.73 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.638 -0.664 . . . . 0.0 109.914 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.36 -108.02 2.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.527 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 88.7 tttt -126.16 -26.1 3.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.913 . . . . 0.0 109.255 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -74.34 146.58 42.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -103.84 139.7 38.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.493 -0.754 . . . . 0.0 109.269 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.53 137.43 40.26 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.814 . . . . 0.0 109.589 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 145' ' ' VAL . 12.8 p -109.49 130.18 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -89.72 111.45 22.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.923 . . . . 0.0 109.971 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.8 mt -140.12 159.85 41.26 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.612 0.72 . . . . 0.0 109.813 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.496 1.831 0 O-C-N 121.543 -0.723 . . . . 0.0 110.356 -179.345 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 72' ' ' LEU . 1.9 tp -149.95 141.65 23.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.92 -1.341 . . . . 0.0 109.237 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.17 165.93 23.64 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.55 0.69 . . . . 0.0 109.739 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.03 154.75 47.88 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.623 0.725 . . . . 0.0 109.744 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.3 mt -114.37 136.81 52.58 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.35 131.56 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.609 0.719 . . . . 0.0 109.782 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.0 t -73.21 133.63 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.593 0.711 . . . . 0.0 109.72 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -86.29 -74.02 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.906 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -121.61 149.24 43.45 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.757 0.789 . . . . 0.0 110.09 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.54 175.09 25.3 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.42 -18.43 43.87 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.864 2.376 . . . . 0.0 111.727 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' ALA . 92.5 m-20 -88.93 -74.93 0.45 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.186 -0.947 . . . . 0.0 109.38 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 60.59 132.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.473 -0.767 . . . . 0.0 110.521 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.99 -20.24 50.85 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 m -71.54 144.79 49.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -1.143 . . . . 0.0 110.777 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -146.69 151.66 37.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 109.64 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -130.32 145.66 51.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -109.66 146.25 35.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.563 -0.71 . . . . 0.0 109.22 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.453 ' O ' HD11 ' A' ' 55' ' ' LEU . 66.6 mt -97.65 115.82 28.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.882 . . . . 0.0 110.17 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -89.45 53.33 2.58 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.963 0.887 . . . . 0.0 108.693 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 43.31 -165.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.174 0.988 . . . . 0.0 111.199 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 59.95 -144.5 0.52 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.663 0.745 . . . . 0.0 110.479 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.12 127.21 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.734 -0.604 . . . . 0.0 109.5 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.6 m -120.24 120.58 36.51 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.2 p -83.03 162.29 21.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.429 -0.795 . . . . 0.0 109.885 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.73 -179.46 3.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.34 -0.85 . . . . 0.0 110.137 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.45 -124.17 28.91 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -105.62 127.26 52.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.43 -1.041 . . . . 0.0 109.963 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 83' ' ' PRO . 36.6 t-80 -173.94 135.09 0.62 Allowed Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.478 ' O ' ' ND1' ' A' ' 82' ' ' HIS . 49.3 Cg_endo -68.92 150.32 73.1 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.391 2.061 . . . . 0.0 113.394 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t0 65.24 -8.3 0.26 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.821 -0.549 . . . . 0.0 110.087 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 83' ' ' PRO . 46.7 t -73.84 133.98 43.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.991 -1.068 . . . . 0.0 110.191 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.26 -41.1 97.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.544 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.84 126.02 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.722 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -129.66 85.87 2.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.511 -0.743 . . . . 0.0 109.148 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.2 mt -104.83 93.66 4.85 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.455 -0.778 . . . . 0.0 109.331 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -99.96 83.34 2.7 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.526 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 24.3 p30 -155.4 172.57 17.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.127 -0.983 . . . . 0.0 109.958 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 93' ' ' THR . 5.3 t -62.81 169.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.534 -0.729 . . . . 0.0 110.703 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.499 ' N ' HG12 ' A' ' 92' ' ' VAL . 4.4 p 65.74 -7.38 0.36 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 92' ' ' VAL . 82.2 t -125.87 122.19 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.475 -0.766 . . . . 0.0 109.254 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.3 p -86.65 -162.09 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.824 0.821 . . . . 0.0 110.498 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -62.57 -38.65 90.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.837 . . . . 0.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -152.81 81.69 1.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.077 -1.015 . . . . 0.0 108.947 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -65.95 -39.76 90.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.737 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.62 160.97 36.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.841 . . . . 0.0 109.621 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -137.88 144.96 41.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.506 -0.746 . . . . 0.0 109.196 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.52 140.35 48.21 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -136.95 142.15 42.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.815 . . . . 0.0 109.625 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 53.8 tp -95.53 126.9 41.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.514 -0.742 . . . . 0.0 109.385 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -94.12 -128.46 0.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.236 -0.915 . . . . 0.0 110.012 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -64.48 -41.57 96.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.825 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -174.05 25.83 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.02 -1.05 . . . . 0.0 109.092 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -137.41 142.4 41.67 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.234 -0.917 . . . . 0.0 110.059 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -76.64 145.63 38.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.499 -0.75 . . . . 0.0 110.05 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -139.27 162.16 35.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.279 -0.888 . . . . 0.0 109.221 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.57 132.57 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.6 t -127.37 132.84 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.669 0.747 . . . . 0.0 109.475 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 1.5 m-20 -78.01 138.06 38.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.561 -0.712 . . . . 0.0 109.584 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.341 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.621 0.724 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -140.46 157.67 45.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.181 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 122' ' ' ASN . 7.6 p -107.29 156.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.69 -0.631 . . . . 0.0 109.638 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.446 ' N ' HG22 ' A' ' 121' ' ' VAL . 6.5 m120 -41.23 -39.35 1.32 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.517 0.675 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -65.63 -90.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.984 . . . . 0.0 109.967 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -142.62 146.39 38.22 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.297 -0.877 . . . . 0.0 109.8 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.96 133.88 34.9 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.257 1.971 . . . . 0.0 112.636 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.6 m -144.24 157.31 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.082 -1.011 . . . . 0.0 110.64 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -72.96 -16.85 61.52 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.679 0.752 . . . . 0.0 109.049 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.6 p -158.61 161.23 37.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.968 . . . . 0.0 109.434 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.63 153.96 25.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.942 -1.099 . . . . 0.0 109.84 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.2 t -98.78 126.81 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.386 -0.821 . . . . 0.0 109.57 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 76.8 mt -79.53 146.44 32.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 110.303 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.526 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -151.96 151.17 30.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.175 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.468 HD22 ' H ' ' A' ' 148' ' ' THR . 22.1 t-20 -46.93 124.99 6.87 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.461 -0.774 . . . . 0.0 110.998 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.473 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 90.53 13.6 59.57 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 32.9 m-20 -87.57 154.68 20.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.043 -1.269 . . . . 0.0 109.693 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -115.35 135.86 53.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.446 -0.784 . . . . 0.0 109.553 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.07 132.1 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.0 109.144 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -120.27 122.19 40.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 0.0 109.445 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.62 126.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.52 0.676 . . . . 0.0 109.232 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.2 -134.3 48.46 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -91.86 -7.95 47.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -1.032 . . . . 0.0 109.38 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.526 ' CE1' ' OD2' ' A' ' 91' ' ' ASP . 82.5 m-85 -95.28 143.86 26.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 0.0 110.516 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -108.16 136.9 47.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.622 -0.674 . . . . 0.0 109.202 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.29 154.27 51.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.59 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.89 136.53 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.436 0.636 . . . . 0.0 109.289 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -92.46 113.48 25.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.677 -0.639 . . . . 0.0 109.297 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 134' ' ' GLY . 94.4 mt -137.06 147.77 46.34 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.756 . . . . 0.0 109.784 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.468 ' H ' HD22 ' A' ' 133' ' ' ASN . 68.3 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 110.016 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.394 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.34 151.79 33.98 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.497 -1.001 . . . . 0.0 109.846 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -146.4 156.25 43.17 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 57' ' ' LEU . 0.4 OUTLIER -137.99 171.75 13.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.805 . . . . 0.0 109.326 -179.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 mt -118.76 134.3 55.24 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.77 130.05 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' ' 62' ' ' ARG . 42.3 t -70.07 134.91 29.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.537 -0.727 . . . . 0.0 109.986 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -104.55 36.3 2.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.626 -0.672 . . . . 0.0 109.338 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.75 ' H ' HG12 ' A' ' 60' ' ' VAL . 77.8 mtp85 -126.85 144.27 51.02 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.429 -0.794 . . . . 0.0 109.93 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.76 -57.21 15.09 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -46.43 -36.93 18.8 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.314 2.009 . . . . 0.0 111.781 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.401 ' ND2' ' CE1' ' A' ' 142' ' ' PHE . 41.0 m-20 -119.66 25.31 10.09 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.581 -0.699 . . . . 0.0 109.18 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . -66.46 140.52 58.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.313 -0.867 . . . . 0.0 109.801 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.413 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 101.21 -18.87 53.48 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 m -64.12 136.55 57.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.38 -1.071 . . . . 0.0 109.739 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.413 ' NH1' ' O ' ' A' ' 67' ' ' GLY . 90.6 mtm-85 -140.58 146.82 38.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.728 . . . . 0.0 109.098 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 57' ' ' LEU . 88.0 m-85 -129.01 136.58 50.5 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.511 -0.743 . . . . 0.0 109.324 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 tp -103.84 129.73 51.34 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.494 -0.754 . . . . 0.0 109.163 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.55 70.46 3.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.357 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 67.1 t0 -95.18 34.67 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -141.52 150.81 42.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.341 -0.85 . . . . 0.0 109.96 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.76 81.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.684 -0.635 . . . . 0.0 110.299 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.39 125.27 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.407 -0.808 . . . . 0.0 109.32 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.0 m -122.65 122.14 38.09 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 m -87.15 153.12 21.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 109.727 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -118.34 122.38 42.73 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.637 -0.665 . . . . 0.0 109.341 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.22 -124.38 2.52 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.476 ' C ' ' CG ' ' A' ' 82' ' ' HIS . 62.8 ttm-85 -119.72 121.92 40.28 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.532 -0.981 . . . . 0.0 109.222 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -170.05 161.54 6.67 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.12 -78.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.45 2.1 . . . . 0.0 112.077 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -81.37 97.41 7.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.325 -0.86 . . . . 0.0 109.743 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 p -166.51 126.96 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.767 . . . . 0.0 109.019 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.35 -37.72 84.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.48 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.3 mm -87.86 120.31 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.0 109.649 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CE2' ' OD2' ' A' ' 90' ' ' ASP . 69.3 t80 -130.28 85.72 2.32 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.19 107.86 18.96 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.444 -0.785 . . . . 0.0 109.507 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD2' ' CE2' ' A' ' 88' ' ' PHE . 97.9 m-20 -90.38 87.32 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 109.276 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -151.71 150.1 29.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.379 -0.826 . . . . 0.0 109.641 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.37 -25.05 26.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.041 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -65.27 -33.94 77.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.479 -0.763 . . . . 0.0 109.647 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.1 t -101.68 118.02 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.3 -0.875 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.7 m -70.81 174.7 5.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.342 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -60.67 -43.72 97.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.564 -0.71 . . . . 0.0 109.356 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -127.04 55.23 1.58 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.564 -0.71 . . . . 0.0 109.114 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -60.7 -41.87 96.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.5 -0.75 . . . . 0.0 109.761 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.45 158.58 44.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.357 -0.839 . . . . 0.0 109.08 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -133.13 148.63 52.12 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.518 -0.739 . . . . 0.0 109.227 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -113.84 135.48 53.92 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -128.59 141.26 51.42 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.465 -0.772 . . . . 0.0 109.655 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.1 tp -98.93 127.23 44.81 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 106' ' ' ASN . 49.2 tp10 -123.39 132.76 54.07 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.578 -0.701 . . . . 0.0 109.701 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 51.97 -84.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 109.859 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' GLU . 63.8 t30 -153.51 25.74 0.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -134.73 138.58 44.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.489 -0.757 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -77.04 146.98 37.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -0.779 . . . . 0.0 109.74 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -132.92 157.62 44.66 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.29 136.54 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.35 133.5 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 44.5 p-10 -95.87 115.69 27.8 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.247 -0.908 . . . . 0.0 109.769 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.466 -0.772 . . . . 0.0 108.935 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 120' ' ' TYR . 93.8 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.356 0.598 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.453 ' N ' HG22 ' A' ' 119' ' ' THR . 40.4 p90 -147.49 162.7 38.54 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 p -120.74 128.13 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.435 -0.791 . . . . 0.0 109.844 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.1 m120 55.38 38.5 30.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.509 -0.745 . . . . 0.0 110.01 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 59.26 40.16 21.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.459 -0.776 . . . . 0.0 109.492 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -144.59 87.36 7.58 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.0 108.494 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.1 135.09 67.3 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.498 2.132 . . . . 0.0 112.202 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.3 m -141.79 162.96 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.307 -0.871 . . . . 0.0 110.014 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.64 -40.54 97.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.503 -0.748 . . . . 0.0 109.366 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.2 p -157.58 161.35 38.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.098 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.37 150.58 23.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.006 -1.058 . . . . 0.0 109.908 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.6 t -95.0 132.26 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.494 -0.754 . . . . 0.0 109.239 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.64 151.44 37.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.389 -0.819 . . . . 0.0 109.943 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.544 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -147.4 159.34 43.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.345 -0.847 . . . . 0.0 109.636 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -57.25 132.36 52.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 110.637 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.496 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 83.34 14.93 72.9 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 29.4 m-20 -83.18 148.84 27.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.242 -1.152 . . . . 0.0 109.581 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -113.29 128.12 56.37 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.42 131.73 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -120.06 118.45 30.65 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.539 -0.725 . . . . 0.0 109.229 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.31 129.36 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.611 -0.68 . . . . 0.0 109.744 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 59.98 -131.41 50.32 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -102.43 -16.32 16.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.587 -0.949 . . . . 0.0 109.18 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.401 ' CE1' ' ND2' ' A' ' 65' ' ' ASN . 79.0 m-85 -80.47 147.81 30.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.455 -0.778 . . . . 0.0 109.895 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.16 137.24 43.24 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.476 -0.765 . . . . 0.0 109.2 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.5 150.67 46.64 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.336 -0.853 . . . . 0.0 109.24 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.02 132.78 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.463 -0.773 . . . . 0.0 108.943 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.449 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 74.1 t80 -93.29 117.48 30.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 109.513 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 134' ' ' GLY . 94.0 mt -129.06 139.76 51.89 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 69.7 p . . . . . 0 N--CA 1.496 1.849 0 O-C-N 121.446 -0.784 . . . . 0.0 109.993 -179.524 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.444 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.3 mt -96.54 172.31 8.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.155 -1.203 . . . . 0.0 110.243 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.71 157.66 43.65 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.618 ' CD2' HH21 ' A' ' 69' ' ' ARG . 5.1 mp -131.87 150.3 52.19 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.341 -0.849 . . . . 0.0 110.022 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.5 mt -117.39 134.89 54.3 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.61 132.53 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.654 0.74 . . . . 0.0 109.259 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.1 132.53 33.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.491 -0.755 . . . . 0.0 109.779 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -93.31 -15.12 26.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.373 -0.829 . . . . 0.0 109.284 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -165.87 141.77 5.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.034 . . . . 0.0 109.925 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.91 176.82 24.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.23 -40.23 83.13 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.423 2.082 . . . . 0.0 111.764 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -108.43 53.58 0.68 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.96 143.47 42.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.463 -0.773 . . . . 0.0 110.13 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.13 1.56 75.64 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.2 m -71.84 152.33 42.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.466 -1.02 . . . . 0.0 109.941 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.618 HH21 ' CD2' ' A' ' 57' ' ' LEU . 17.8 ptm180 -133.81 144.37 48.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.516 -0.74 . . . . 0.0 109.279 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -121.16 138.31 54.27 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.487 -0.758 . . . . 0.0 109.385 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 tp -99.48 125.71 45.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.388 -0.82 . . . . 0.0 109.13 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -99.34 75.05 1.96 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.282 -0.886 . . . . 0.0 109.13 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 64.3 t0 -99.07 17.3 20.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.392 -0.817 . . . . 0.0 109.053 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -119.26 144.45 46.77 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.562 -0.711 . . . . 0.0 109.658 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.82 99.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 110.076 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.4 mt -124.81 126.78 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.431 -0.793 . . . . 0.0 109.012 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 m -124.52 124.05 41.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.564 -0.71 . . . . 0.0 109.364 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -96.67 156.57 16.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 109.334 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.91 147.81 35.04 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.69 -48.44 1.01 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -88.01 141.11 28.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.151 -1.205 . . . . 0.0 109.989 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.615 ' CD2' ' N ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -88.72 -44.49 0.45 Allowed Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.419 -0.801 . . . . 0.0 109.817 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 32.5 Cg_exo -57.25 137.19 80.59 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.374 2.049 . . . . 0.0 112.701 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 44.76 46.43 8.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.603 -0.686 . . . . 0.0 109.709 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.9 m -156.07 116.89 3.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.325 -0.859 . . . . 0.0 109.74 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.24 -38.29 90.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.3 mm -78.2 128.09 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.427 -0.796 . . . . 0.0 109.819 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -129.99 85.92 2.35 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.4 98.05 7.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 46.7 p-10 -91.46 94.62 9.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.701 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -154.3 158.14 39.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.18 -0.95 . . . . 0.0 109.926 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.7 m -69.13 -32.47 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.534 -0.729 . . . . 0.0 109.761 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p -65.83 -29.96 70.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.901 . . . . 0.0 110.341 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -99.84 125.9 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -0.994 . . . . 0.0 109.562 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.0 m -79.39 -170.15 2.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.643 -0.661 . . . . 0.0 110.19 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -60.28 -45.45 93.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.758 . . . . 0.0 109.614 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 99' ' ' ALA . 79.7 mtp85 -108.17 -47.83 3.47 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 113' ' ' VAL . 85.8 t60 52.81 -80.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.619 -0.675 . . . . 0.0 110.074 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -127.71 155.8 43.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.541 -0.724 . . . . 0.0 109.131 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -136.02 154.23 51.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 109.094 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -118.73 143.66 46.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -130.19 144.29 51.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.4 -0.813 . . . . 0.0 109.511 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.6 tp -104.46 123.96 48.4 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.511 -0.743 . . . . 0.0 109.437 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -95.19 -117.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 92.5 m-20 -65.07 -50.3 66.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 110.13 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 68.6 m-20 -169.03 23.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.572 -0.705 . . . . 0.0 109.282 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.54 136.68 43.22 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -77.0 146.62 37.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.49 -0.756 . . . . 0.0 110.126 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -123.37 156.62 35.06 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 110' ' ' VAL . 11.7 p -117.75 131.15 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.76 143.13 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.485 -0.759 . . . . 0.0 109.731 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -99.58 112.82 24.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 0.0 108.938 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 98' ' ' HIS . 16.6 m . . . . . 0 N--CA 1.494 1.752 0 O-C-N 121.172 -0.955 . . . . 0.0 110.742 -178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.5 m . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.199 0.523 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -138.78 153.19 48.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.429 -0.794 . . . . 0.0 109.387 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.1 p -120.25 129.36 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.664 0.745 . . . . 0.0 109.52 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.489 ' CG ' ' H ' ' A' ' 123' ' ' ARG . 6.8 t-20 55.37 -167.09 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.585 0.707 . . . . 0.0 110.229 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.489 ' H ' ' CG ' ' A' ' 122' ' ' ASN . 11.0 mmp_? -72.6 -4.63 31.99 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.691 -0.631 . . . . 0.0 109.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -107.81 99.53 30.46 Favored Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -76.19 128.46 10.58 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.021 1.814 . . . . 0.0 112.056 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 129' ' ' ALA . 4.8 m -136.59 160.79 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.299 -0.876 . . . . 0.0 110.478 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.89 -42.21 97.51 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.556 -0.715 . . . . 0.0 109.266 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 m -157.94 158.43 34.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 109.467 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -168.05 159.09 10.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.035 -1.041 . . . . 0.0 109.859 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.19 131.53 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.763 . . . . 0.0 109.954 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.6 150.31 36.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.866 . . . . 0.0 109.864 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.96 156.76 46.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.418 -0.801 . . . . 0.0 109.567 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -55.83 135.03 52.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.52 -0.737 . . . . 0.0 110.667 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.99 19.16 65.77 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 136' ' ' GLU . 64.4 t0 -96.76 133.73 40.96 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.308 -1.113 . . . . 0.0 109.986 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.488 ' N ' ' OD1' ' A' ' 135' ' ' ASP . 98.4 mt-10 -94.35 130.45 40.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.319 -0.863 . . . . 0.0 109.224 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.5 t -124.51 132.53 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.565 -0.71 . . . . 0.0 109.126 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -126.22 127.53 45.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.42 127.47 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.496 -0.753 . . . . 0.0 109.698 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.48 -95.35 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -128.43 -18.37 4.01 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.643 -0.916 . . . . 0.0 109.123 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -74.76 141.44 44.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -0.859 . . . . 0.0 109.63 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -105.28 131.83 52.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.432 -0.792 . . . . 0.0 109.814 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.75 152.62 51.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.506 -0.746 . . . . 0.0 109.161 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.43 131.39 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -92.5 111.39 22.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.44 -0.788 . . . . 0.0 109.271 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.77 143.17 50.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.467 0.651 . . . . 0.0 109.715 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.2 p . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 0.0 109.775 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.425 ' C ' HD12 ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.495 2.633 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 54' ' ' GLY . 11.1 mp -104.92 148.21 26.93 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.187 -1.184 . . . . 0.0 109.931 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.26 176.87 8.02 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.614 0.721 . . . . 0.0 109.315 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.714 ' C ' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -157.33 172.58 18.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.886 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 57' ' ' LEU . 4.6 mp -130.47 149.3 52.21 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 68.2 t -124.61 131.56 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.571 -0.705 . . . . 0.0 109.804 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.6 t -73.05 119.88 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.487 -0.758 . . . . 0.0 109.333 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -92.92 -16.64 24.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 109.122 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -155.5 132.68 10.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.599 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.15 172.14 22.52 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.97 -42.44 66.76 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.518 2.146 . . . . 0.0 112.003 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -100.66 49.71 0.89 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.471 -0.768 . . . . 0.0 109.09 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.09 141.98 26.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.539 -0.726 . . . . 0.0 110.234 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.65 -18.48 56.86 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -68.64 149.88 48.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.284 -1.127 . . . . 0.0 110.695 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -139.06 135.81 34.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -111.58 115.46 29.2 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.416 -0.802 . . . . 0.0 109.07 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 tt -94.5 133.23 38.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 110.244 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.402 HD21 HD11 ' A' ' 87' ' ' ILE . 81.3 mt -89.75 131.17 35.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.578 -0.701 . . . . 0.0 109.608 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -136.33 26.74 3.17 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.61 155.46 47.43 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.299 -0.876 . . . . 0.0 109.783 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.69 84.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.932 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.14 126.31 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.419 -0.801 . . . . 0.0 109.156 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.4 m -119.69 124.03 45.24 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.712 . . . . 0.0 109.549 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 m -86.87 155.43 20.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.476 -0.765 . . . . 0.0 109.193 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.41 131.7 53.73 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.448 -0.783 . . . . 0.0 109.364 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.3 -138.91 6.31 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 72.7 ttp85 -113.37 125.58 54.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.509 -0.995 . . . . 0.0 110.042 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 11.8 m-70 -168.94 152.17 5.17 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.14 -19.5 50.91 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.201 1.934 . . . . 0.0 111.589 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 85' ' ' SER . 84.5 m-20 -117.95 -129.95 0.3 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.543 -0.723 . . . . 0.0 109.744 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 84' ' ' ASP . 6.1 m 57.87 138.18 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.74 0.781 . . . . 0.0 110.602 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.34 -43.53 97.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.492 -0.755 . . . . 0.0 109.355 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.402 HD11 HD21 ' A' ' 72' ' ' LEU . 93.5 mt -100.81 115.25 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.332 -0.855 . . . . 0.0 109.228 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 26.3 p90 -130.23 98.1 4.62 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.9 mt -97.0 123.8 40.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 91' ' ' ASP . 31.0 t0 -95.25 -151.62 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.538 -0.726 . . . . 0.0 109.8 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.545 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 34.5 t70 58.82 171.53 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.686 0.755 . . . . 0.0 110.351 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.447 ' N ' ' CG ' ' A' ' 91' ' ' ASP . 71.9 t -91.25 114.21 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.599 -0.688 . . . . 0.0 110.151 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER 172.29 -31.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.099 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.9 t -115.52 131.99 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 121.704 0.764 . . . . 0.0 109.689 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -77.06 -175.78 3.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.589 -0.695 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -62.11 -39.16 91.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.756 . . . . 0.0 109.65 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -139.77 57.81 1.62 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.155 -0.966 . . . . 0.0 109.16 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.0 t-80 -61.66 -40.11 93.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.452 -0.78 . . . . 0.0 109.639 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.39 156.33 43.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.106 -0.996 . . . . 0.0 110.097 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -137.25 145.9 44.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.57 145.65 38.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.542 -0.724 . . . . 0.0 109.181 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.2 mtp85 -130.78 144.65 51.6 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.6 -0.687 . . . . 0.0 109.283 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.0 tp -105.17 126.44 52.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.589 -0.694 . . . . 0.0 109.686 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -158.05 149.89 21.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.014 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 55.51 35.2 24.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.446 -0.784 . . . . 0.0 109.415 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 54.9 31.62 16.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.677 -0.639 . . . . 0.0 109.716 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -143.53 138.97 29.54 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -77.08 145.69 37.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.528 -0.733 . . . . 0.0 109.618 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -130.94 159.0 38.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.708 . . . . 0.0 109.195 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 110' ' ' VAL . 8.6 p -122.28 128.05 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.1 t -125.96 132.81 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 53.3 p-10 -95.9 144.94 25.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.435 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 113' ' ' VAL . 3.5 m . . . . . 0 C--N 1.301 -1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 109.969 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.522 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 45.2 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.236 0.541 . . . . 0.0 109.945 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 119' ' ' THR . 38.4 m-85 -144.28 152.11 40.34 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.214 -0.929 . . . . 0.0 109.585 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.511 HG12 HG11 ' A' ' 126' ' ' VAL . 9.4 p -129.08 138.91 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.48 -0.763 . . . . 0.0 109.454 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 58.98 38.34 24.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.596 -0.69 . . . . 0.0 109.839 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 48.58 35.9 6.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.0 109.945 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -145.49 148.22 36.33 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 108.642 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.427 ' O ' ' OE2' ' A' ' 124' ' ' GLU . 25.7 Cg_endo -61.43 139.9 84.8 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.367 2.044 . . . . 0.0 112.095 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.511 HG11 HG12 ' A' ' 121' ' ' VAL . 2.0 p -147.76 161.19 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.33 -0.856 . . . . 0.0 108.996 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 128' ' ' SER . 67.3 t0 -124.73 66.83 1.09 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 127' ' ' ASP . 3.5 p 84.82 116.87 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.15 0.5 . . . . 0.0 109.809 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.84 43.32 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.25 -0.906 . . . . 0.0 109.931 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.1 t -79.21 133.23 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -0.779 . . . . 0.0 110.519 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.52 147.88 37.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.384 -0.823 . . . . 0.0 109.617 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.537 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -142.15 148.42 38.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.254 -0.903 . . . . 0.0 109.186 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 49.9 p-10 -48.48 132.23 17.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.772 . . . . 0.0 111.021 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.518 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 87.23 13.1 66.56 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 79.8 m-20 -89.48 150.28 22.55 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.097 -1.237 . . . . 0.0 110.042 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -111.74 136.99 50.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.599 -0.688 . . . . 0.0 109.515 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -128.27 134.74 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.515 -0.741 . . . . 0.0 109.221 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -124.15 117.4 24.56 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.84 128.35 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.479 -0.763 . . . . 0.0 109.524 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 142' ' ' PHE . . . 61.62 45.29 96.61 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.541 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? 70.2 -29.33 0.18 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.571 -0.958 . . . . 0.0 110.119 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 140' ' ' GLY . 72.8 m-85 -66.64 137.12 56.49 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.65 -0.656 . . . . 0.0 110.273 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -106.85 124.61 49.87 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.287 -0.883 . . . . 0.0 109.191 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.7 mp -126.37 147.64 49.72 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.533 -0.729 . . . . 0.0 109.327 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 145' ' ' VAL . 10.4 p -108.59 126.61 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -89.76 120.49 31.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.557 -0.714 . . . . 0.0 109.879 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 134' ' ' GLY . 96.8 mt -131.89 150.46 52.15 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.463 0.649 . . . . 0.0 109.762 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.499 1.993 0 O-C-N 121.695 -0.628 . . . . 0.0 109.377 -179.734 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.549 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -138.55 163.61 31.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.456 -1.026 . . . . 0.0 109.636 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.73 156.83 42.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.508 -0.745 . . . . 0.0 109.949 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.671 HD12 ' C ' ' A' ' 57' ' ' LEU . 3.9 pp -142.7 169.9 16.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.355 -0.841 . . . . 0.0 110.626 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.9 mt -124.49 144.01 50.34 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -130.42 132.49 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.743 0.782 . . . . 0.0 109.61 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.3 t -75.71 132.62 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.69 0.757 . . . . 0.0 109.993 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.527 ' NZ ' ' OE2' ' A' ' 136' ' ' GLU . 51.9 mtmt -86.78 -73.78 0.45 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.724 -0.61 . . . . 0.0 110.017 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.603 HH21 ' NH1' ' A' ' 143' ' ' ARG . 61.7 ttp180 -117.33 134.69 54.52 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.433 -0.792 . . . . 0.0 110.356 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.26 173.9 21.6 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.47 -19.74 48.63 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.882 2.388 . . . . 0.0 111.726 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -97.37 19.77 12.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 109.047 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.22 139.32 29.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.389 -0.819 . . . . 0.0 110.373 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.78 -22.27 40.18 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.3 m -71.9 149.39 45.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.367 -1.078 . . . . 0.0 110.831 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -145.78 152.31 39.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.327 -0.858 . . . . 0.0 110.232 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -121.55 131.76 54.31 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.463 0.649 . . . . 0.0 109.444 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 46.8 tp -100.42 128.87 46.37 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 0.0 109.263 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.08 128.27 42.83 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.836 0.826 . . . . 0.0 110.428 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 67.6 t0 -155.24 41.03 0.42 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -141.39 152.61 44.47 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.353 -0.842 . . . . 0.0 109.553 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.46 -48.02 83.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.687 -0.633 . . . . 0.0 109.987 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.42 121.33 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.45 -0.781 . . . . 0.0 109.372 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -116.92 118.9 33.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.583 0.706 . . . . 0.0 109.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 m -86.16 155.28 20.82 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.554 0.692 . . . . 0.0 109.895 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 99' ' ' ALA . . . -103.69 169.75 8.34 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.905 0.859 . . . . 0.0 110.339 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.31 -119.9 5.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.532 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 74.1 ttp85 -118.63 121.6 40.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.888 . . . . 0.0 109.884 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 41.7 m-70 -167.9 151.28 5.79 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.82 145.02 79.48 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.787 2.324 . . . . 0.0 112.783 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 54.82 31.1 14.93 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.511 0.672 . . . . 0.0 109.584 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 t -99.14 123.45 43.44 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.209 -0.932 . . . . 0.0 110.555 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 71' ' ' LEU . 54.3 m-20 -65.85 -39.57 90.88 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -85.01 125.51 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 109.841 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -127.19 86.11 2.46 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.2 mt -115.26 94.29 4.66 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -92.79 109.68 21.12 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.525 0.679 . . . . 0.0 109.622 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -158.58 163.1 37.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.958 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.3 -44.21 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.63 0.729 . . . . 0.0 110.285 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.5 p -68.22 -29.4 68.23 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.344 -0.848 . . . . 0.0 109.996 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.4 t -92.46 112.1 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.131 -0.981 . . . . 0.0 109.97 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.9 m -77.58 176.73 8.67 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.686 0.755 . . . . 0.0 110.444 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.53 -41.84 99.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.646 -0.658 . . . . 0.0 110.017 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -124.18 49.2 1.81 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.377 -0.827 . . . . 0.0 109.005 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.08 -39.93 94.1 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.511 0.672 . . . . 0.0 109.45 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -147.99 154.89 40.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.957 -1.089 . . . . 0.0 110.272 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -136.58 151.6 49.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.497 0.665 . . . . 0.0 109.848 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.435 ' CE1' HG23 ' A' ' 110' ' ' VAL . 97.0 m-85 -121.09 138.83 54.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -130.71 141.21 50.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.635 0.731 . . . . 0.0 109.718 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.06 123.87 38.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 106' ' ' ASN . 80.7 tt0 -115.13 120.38 39.58 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.862 0.839 . . . . 0.0 109.867 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.464 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 21.3 t-20 52.09 -84.52 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.426 0.631 . . . . 0.0 110.372 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -144.03 20.36 1.77 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 108.503 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -130.16 137.47 50.13 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.714 0.769 . . . . 0.0 109.721 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -82.08 147.47 29.09 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.433 0.635 . . . . 0.0 109.76 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -136.06 157.87 45.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.518 -0.739 . . . . 0.0 109.769 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.6 p -125.84 127.35 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.1 t -131.03 131.26 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 119' ' ' THR . 42.9 t0 -100.38 126.48 46.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.697 0.76 . . . . 0.0 109.447 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.644 0.735 . . . . 0.0 109.228 -179.88 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.549 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 28.4 m . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.62 0.724 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.434 ' OH ' ' NE2' ' A' ' 138' ' ' GLN . 22.7 p90 -119.57 150.51 40.17 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.579 0.704 . . . . 0.0 109.905 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 122' ' ' ASN . 9.6 p -121.28 130.07 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.974 0.892 . . . . 0.0 109.29 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 124' ' ' GLU . 14.0 m120 41.9 -168.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.098 0.951 . . . . 0.0 111.324 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.05 -0.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.757 -0.59 . . . . 0.0 110.163 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 122' ' ' ASN . 17.2 tt0 -113.25 93.09 24.6 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.384 -0.822 . . . . 0.0 109.42 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.04 122.36 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.74 2.293 . . . . 0.0 112.361 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.0 m -136.72 165.07 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.447 -0.783 . . . . 0.0 109.891 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.83 -37.81 88.78 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.591 0.71 . . . . 0.0 109.3 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.4 p -155.54 161.34 40.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.903 . . . . 0.0 110.065 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.06 156.26 24.34 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.597 0.713 . . . . 0.0 110.166 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.36 129.75 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.624 0.726 . . . . 0.0 110.098 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.88 143.04 38.08 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.906 0.86 . . . . 0.0 110.592 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.544 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.86 147.18 27.65 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.596 0.712 . . . . 0.0 109.279 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 20.5 p30 -43.17 130.19 4.65 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.057 0.932 . . . . 0.0 111.667 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.06 13.47 68.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 81.2 m-20 -89.95 150.03 22.33 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.986 -1.302 . . . . 0.0 109.673 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 61' ' ' LYS . 84.0 tt0 -108.5 129.25 55.29 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.696 0.76 . . . . 0.0 110.05 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.9 t -126.11 131.25 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.434 ' NE2' ' OH ' ' A' ' 120' ' ' TYR . 56.6 tt0 -121.5 120.92 36.31 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.465 0.65 . . . . 0.0 109.772 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 39.7 mm -110.71 122.2 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.75 0.786 . . . . 0.0 109.284 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 56.3 -129.74 48.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -95.06 -6.59 41.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.544 -0.974 . . . . 0.0 109.059 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -89.88 139.92 30.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 0.0 109.519 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.603 ' NH1' HH21 ' A' ' 62' ' ' ARG . 85.0 mtt85 -102.95 136.52 42.61 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.674 0.75 . . . . 0.0 110.027 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.53 157.37 46.69 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.55 133.52 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.671 0.748 . . . . 0.0 109.431 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -87.27 111.51 21.11 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.595 0.712 . . . . 0.0 109.978 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.7 mt -136.19 157.7 46.19 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.426 0.631 . . . . 0.0 109.335 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.4 p . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.496 0.665 . . . . 0.0 109.718 -179.423 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.475 ' C ' HD22 ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 55' ' ' LEU . 2.6 mm? -102.09 167.54 9.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.563 -0.963 . . . . 0.0 110.272 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.19 176.96 7.5 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -130.55 146.6 52.1 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.023 0.916 . . . . 0.0 110.712 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mt -116.4 134.33 55.0 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.2 t -122.43 135.08 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.586 0.708 . . . . 0.0 109.187 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.3 t -69.18 133.39 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.58 0.705 . . . . 0.0 110.184 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -95.17 -28.61 14.96 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.548 0.689 . . . . 0.0 109.196 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -147.73 138.19 23.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.194 -0.941 . . . . 0.0 110.072 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.65 174.4 15.9 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.17 -13.1 25.84 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.958 2.439 . . . . 0.0 111.132 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ALA . 97.9 m-20 -97.88 16.69 20.1 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . -39.78 133.04 1.62 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.884 0.849 . . . . 0.0 110.924 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.34 -14.24 65.42 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -66.39 146.71 54.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.437 -1.037 . . . . 0.0 110.971 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -134.96 142.11 46.42 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.269 0.557 . . . . 0.0 109.604 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.98 125.42 49.36 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.621 0.724 . . . . 0.0 109.95 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 tt -102.16 132.97 47.74 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.281 0.563 . . . . 0.0 110.044 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -87.72 157.74 18.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.512 -0.743 . . . . 0.0 110.344 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 66.7 t0 -173.51 33.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -156.58 147.17 21.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.452 -0.78 . . . . 0.0 109.88 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.23 136.81 46.46 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.802 0.811 . . . . 0.0 110.83 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 85.3 mt 55.11 100.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.542 0.687 . . . . 0.0 109.873 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -103.7 126.06 50.59 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.607 0.717 . . . . 0.0 109.571 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -92.94 143.64 26.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.491 0.662 . . . . 0.0 109.923 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -101.97 170.06 8.37 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.75 0.786 . . . . 0.0 110.282 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . 92.02 -129.47 9.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.52 ' O ' ' CD2' ' A' ' 82' ' ' HIS . 8.7 ptp180 -103.8 110.83 23.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.932 . . . . 0.0 109.612 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 81' ' ' ARG . 80.3 m-70 -161.87 90.56 1.43 Allowed Pre-proline 0 N--CA 1.486 1.341 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 58.6 Cg_exo -52.12 145.72 33.13 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.679 2.253 . . . . 0.0 112.507 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 7.0 t0 81.5 -22.32 0.27 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -71.97 146.98 47.39 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.79 0.805 . . . . 0.0 110.891 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -62.62 -42.86 99.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.64 -0.663 . . . . 0.0 109.845 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.03 114.05 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 109.563 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 22.0 p90 -129.85 97.87 4.62 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.577 0.703 . . . . 0.0 109.414 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 80' ' ' GLY . 96.1 mt -102.03 96.75 7.22 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.763 0.792 . . . . 0.0 108.871 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 30.0 p30 -85.34 90.61 7.97 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.515 0.674 . . . . 0.0 109.764 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -146.06 150.05 35.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.485 -0.759 . . . . 0.0 109.477 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.08 -32.32 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.551 0.691 . . . . 0.0 109.912 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.6 p -66.43 -32.51 73.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.459 -0.776 . . . . 0.0 109.786 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.32 128.47 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.306 -0.871 . . . . 0.0 109.917 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 96' ' ' ARG . 25.2 t -78.29 -170.96 2.2 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.666 0.745 . . . . 0.0 110.594 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.503 ' N ' ' OG ' ' A' ' 95' ' ' SER . 95.3 mtt180 -61.66 -41.62 97.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.516 -0.74 . . . . 0.0 109.036 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -142.21 62.41 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -62.3 -40.81 97.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.507 -0.745 . . . . 0.0 109.084 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.32 151.07 44.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 0.0 109.777 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -140.83 136.57 32.52 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.656 0.741 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -99.43 146.69 26.05 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.396 0.617 . . . . 0.0 109.356 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -130.81 131.74 44.82 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.483 0.659 . . . . 0.0 109.342 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.1 tp -102.93 123.51 46.7 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 105' ' ' ASN . 44.6 tt0 -93.18 -132.04 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.625 -0.672 . . . . 0.0 109.827 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 90.9 m-20 -64.35 -44.34 91.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.321 -0.862 . . . . 0.0 109.616 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 3.9 m120 -169.79 24.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.78 131.53 51.27 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.654 0.74 . . . . 0.0 109.514 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.409 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 63.9 m-85 -78.94 146.43 33.48 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.486 0.66 . . . . 0.0 109.836 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 93.4 m-20 -144.61 159.38 42.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 p -126.93 131.98 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.483 0.658 . . . . 0.0 109.343 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.04 133.46 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.633 0.73 . . . . 0.0 109.414 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -96.53 114.09 25.72 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.569 0.699 . . . . 0.0 109.215 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.649 0.738 . . . . 0.0 110.385 -179.263 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.657 0.741 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -137.57 157.73 45.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.622 -0.674 . . . . 0.0 109.411 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.2 p -117.86 129.57 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.752 0.787 . . . . 0.0 109.965 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.9 m120 52.65 49.56 20.08 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.701 0.762 . . . . 0.0 109.719 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 52.29 26.17 3.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.968 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -123.95 101.22 35.95 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.82 127.01 13.71 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.323 2.015 . . . . 0.0 112.274 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 128' ' ' SER . 2.4 p -144.36 138.69 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.474 -0.766 . . . . 0.0 109.946 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -66.49 -40.17 89.14 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.474 0.654 . . . . 0.0 109.449 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.425 ' N ' HG22 ' A' ' 126' ' ' VAL . 87.7 p -156.87 154.26 29.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.13 157.14 27.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.854 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 82.3 t -91.61 128.13 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.729 0.776 . . . . 0.0 109.796 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.67 152.29 35.84 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.754 0.788 . . . . 0.0 110.411 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.534 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.4 155.73 40.92 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.51 0.671 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.405 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 43.0 p-10 -51.77 132.57 31.44 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.883 0.849 . . . . 0.0 111.084 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.515 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 82.45 18.19 66.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 23.5 m-20 -83.57 149.38 26.61 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.223 -1.163 . . . . 0.0 110.073 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 57.6 mp0 -108.84 123.97 49.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.624 -0.672 . . . . 0.0 109.435 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.4 t -125.17 132.32 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.38 125.18 44.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 141' ' ' LYS . 36.3 mm -111.34 127.51 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.737 0.779 . . . . 0.0 109.308 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 54.91 -92.19 0.01 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 139' ' ' ILE . 60.8 pttt -129.9 -18.46 3.4 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -76.99 142.61 39.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 110.036 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -105.65 132.49 51.73 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.684 0.754 . . . . 0.0 110.13 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.54 155.35 50.56 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.446 0.641 . . . . 0.0 109.578 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.39 134.39 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.559 0.695 . . . . 0.0 109.802 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -94.12 120.73 34.79 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 134' ' ' GLY . 84.0 mt -132.74 152.85 51.65 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.799 0.809 . . . . 0.0 109.613 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.587 0.708 . . . . 0.0 109.693 -179.734 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.4 mt -125.56 149.58 48.22 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.433 -1.039 . . . . 0.0 110.636 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.459 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -151.43 156.31 40.39 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.39 151.47 41.18 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.097 0.951 . . . . 0.0 110.188 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.0 mt -117.88 142.51 47.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.2 t -127.32 130.7 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.56 -0.713 . . . . 0.0 109.816 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.41 130.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 121.649 0.738 . . . . 0.0 110.061 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.21 -76.47 0.12 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.559 -0.713 . . . . 0.0 109.756 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -123.62 148.53 46.34 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.625 0.726 . . . . 0.0 110.16 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.53 175.28 30.31 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.89 -21.23 50.64 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.887 2.391 . . . . 0.0 111.346 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -110.31 23.8 13.82 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -39.96 145.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.643 0.735 . . . . 0.0 110.923 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.6 -1.3 88.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.6 m -72.38 146.23 47.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -1.073 . . . . 0.0 110.742 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -134.38 147.6 50.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.682 . . . . 0.0 109.571 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -128.77 146.92 50.77 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.492 -0.755 . . . . 0.0 109.55 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.1 tp -105.25 127.64 53.04 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.559 0.695 . . . . 0.0 109.756 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 56' ' ' ALA . 84.9 mt -92.88 77.81 4.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 73' ' ' ASP . 54.8 t0 -108.59 16.81 22.63 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -124.51 140.02 53.34 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.571 0.7 . . . . 0.0 109.622 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.54 85.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.618 -0.676 . . . . 0.0 109.869 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.91 121.09 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.531 -0.731 . . . . 0.0 109.354 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.6 m -126.83 124.0 38.62 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -97.67 155.25 17.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.448 -0.782 . . . . 0.0 109.625 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.6 158.37 20.9 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.672 0.748 . . . . 0.0 110.219 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.68 -120.95 5.29 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -93.87 111.32 23.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.342 -1.093 . . . . 0.0 109.944 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -175.05 88.71 0.31 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 46.1 Cg_exo -54.91 148.27 47.75 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.574 2.183 . . . . 0.0 112.526 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 10.3 t0 82.14 -7.75 1.32 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.492 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 66.7 m -78.48 147.12 34.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.345 -0.847 . . . . 0.0 110.618 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.17 -38.71 92.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.511 -0.743 . . . . 0.0 109.153 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.08 126.75 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.341 -0.849 . . . . 0.0 109.907 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 50.3 m-85 -125.2 98.78 5.79 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.413 0.625 . . . . 0.0 109.316 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 91' ' ' ASP . 49.0 mt -107.87 146.81 31.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.61 -0.681 . . . . 0.0 109.608 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 41.4 t0 -60.48 -1.16 0.32 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 89' ' ' LEU . 2.6 p30 47.22 31.92 1.9 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.643 0.735 . . . . 0.0 110.444 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.9 m -68.88 -24.79 28.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 109.885 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 140' ' ' GLY . 60.6 p -138.22 13.27 2.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.392 -0.817 . . . . 0.0 109.234 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.73 131.35 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.584 0.706 . . . . 0.0 109.582 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.3 p -66.67 -162.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.636 0.731 . . . . 0.0 110.887 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.38 -40.85 92.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 109.77 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' A' ' 99' ' ' ALA . 93.3 mtm-85 -133.24 -41.7 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 t60 60.6 -67.27 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.954 -0.466 . . . . 0.0 109.939 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -140.99 154.3 45.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.079 -1.013 . . . . 0.0 109.412 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -138.7 142.34 38.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.555 -0.715 . . . . 0.0 109.551 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -99.88 140.31 34.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.421 -0.799 . . . . 0.0 109.446 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.406 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 50.5 mmm-85 -130.48 141.53 50.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.636 -0.665 . . . . 0.0 109.547 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.8 tp -115.24 119.54 36.69 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.571 0.7 . . . . 0.0 109.183 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -160.16 -34.04 0.06 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.562 -0.712 . . . . 0.0 109.124 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 107' ' ' GLU . 13.7 m120 -88.58 41.85 1.04 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 0.0 109.232 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 57.48 1.64 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 109.973 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 105' ' ' ASN . 96.1 mt-10 -142.99 157.22 44.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.167 -0.958 . . . . 0.0 109.906 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -74.25 141.65 45.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.515 -0.741 . . . . 0.0 110.14 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 102' ' ' ARG . 39.6 p30 -139.66 173.76 11.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.458 -0.776 . . . . 0.0 109.548 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.3 134.64 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.687 -0.633 . . . . 0.0 109.847 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -127.02 130.81 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.72 155.19 24.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.414 -0.804 . . . . 0.0 110.127 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.399 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 120' ' ' TYR . 44.2 m . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 121.637 0.732 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.528 ' N ' HG22 ' A' ' 119' ' ' THR . 44.2 p90 -142.48 162.28 35.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.545 -0.722 . . . . 0.0 109.956 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 123' ' ' ARG . 8.4 p -114.68 131.42 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.654 0.74 . . . . 0.0 109.722 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 43.59 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.582 -0.699 . . . . 0.0 110.385 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 121' ' ' VAL . 15.0 ptp180 -143.68 41.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 109.059 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -146.71 82.43 8.68 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.369 -0.832 . . . . 0.0 109.185 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.58 128.9 32.31 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.806 2.338 . . . . 0.0 112.811 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.3 m -150.81 161.87 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 109.945 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.62 -38.01 89.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 109.557 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -153.22 152.65 31.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 109.511 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.5 152.13 32.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.212 -0.93 . . . . 0.0 110.072 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.27 130.16 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.461 -0.775 . . . . 0.0 109.913 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.96 148.93 34.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.793 0.806 . . . . 0.0 110.272 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.431 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -148.98 156.36 42.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.494 -0.754 . . . . 0.0 109.317 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.766 ' ND2' ' H ' ' A' ' 148' ' ' THR . 31.8 t-20 -57.72 136.14 56.85 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.776 0.798 . . . . 0.0 111.301 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.3 10.46 77.55 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 89.5 m-20 -89.62 156.42 18.6 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.228 -1.16 . . . . 0.0 110.275 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -108.78 136.57 48.12 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.704 -0.623 . . . . 0.0 109.376 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.72 133.25 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.647 -0.658 . . . . 0.0 109.458 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -123.14 114.77 20.76 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 140' ' ' GLY . 96.7 mt -132.78 122.43 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.448 -0.782 . . . . 0.0 109.74 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . 35.14 72.8 0.11 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 142' ' ' PHE . 6.2 tmtt? 64.16 -63.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.911 -0.758 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 140' ' ' GLY . 33.1 m-85 -36.31 123.19 0.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.504 0.669 . . . . 0.0 110.595 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -101.56 132.46 47.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.725 -0.609 . . . . 0.0 109.46 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -138.06 156.43 47.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.56 -0.712 . . . . 0.0 109.423 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.09 137.9 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.619 -0.676 . . . . 0.0 109.424 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -90.82 114.48 26.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.589 -0.694 . . . . 0.0 109.262 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.6 mt -134.01 149.4 51.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.774 0.797 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.766 ' H ' ' ND2' ' A' ' 133' ' ' ASN . 82.4 p . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.568 -0.707 . . . . 0.0 109.52 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.492 HD12 ' N ' ' A' ' 55' ' ' LEU . 10.7 mp -96.13 151.77 19.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.399 -1.06 . . . . 0.0 110.289 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -127.02 162.63 25.56 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.23 153.8 45.66 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.917 0.865 . . . . 0.0 110.509 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.7 mt -114.3 141.21 47.89 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.8 132.72 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.585 0.707 . . . . 0.0 109.794 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.8 t -72.06 132.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.606 0.717 . . . . 0.0 109.686 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -81.9 -77.16 0.23 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.543 -0.723 . . . . 0.0 109.188 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -133.94 139.16 45.95 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.806 0.813 . . . . 0.0 109.836 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.62 -177.74 37.77 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.51 -38.63 90.07 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.758 2.305 . . . . 0.0 111.919 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 66' ' ' ALA . 98.7 m-20 -75.53 -78.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.662 -0.648 . . . . 0.0 110.102 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 59.63 122.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.442 -0.787 . . . . 0.0 110.391 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.14 -19.58 53.55 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.6 t -67.63 144.78 55.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.295 -1.121 . . . . 0.0 110.554 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -134.54 145.07 48.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.627 -0.671 . . . . 0.0 109.732 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.22 139.3 48.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.54 -0.725 . . . . 0.0 109.6 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pp -106.41 145.41 31.77 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.5 0.667 . . . . 0.0 109.833 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.34 123.92 44.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.373 -0.83 . . . . 0.0 109.635 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -93.94 37.93 1.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 109.157 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.46 HE21 HD11 ' A' ' 55' ' ' LEU . 78.5 mt-30 55.93 -168.09 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.718 0.77 . . . . 0.0 111.034 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 62.76 -141.37 0.39 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.526 0.679 . . . . 0.0 110.667 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 93.4 mt -113.57 127.82 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.741 -0.599 . . . . 0.0 109.705 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.1 m -120.84 124.95 46.29 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.502 0.668 . . . . 0.0 109.27 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.5 m -94.42 161.63 14.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.518 -0.739 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.57 151.68 31.31 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.606 0.717 . . . . 0.0 109.848 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.85 -58.02 1.53 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -77.62 145.83 36.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -1.091 . . . . 0.0 110.691 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.495 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -86.02 -47.35 0.57 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.505 -0.747 . . . . 0.0 109.742 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 72.9 Cg_exo -51.97 133.71 46.89 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.325 2.017 . . . . 0.0 113.172 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' PRO . 45.7 t0 41.8 49.88 3.96 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.726 0.774 . . . . 0.0 109.718 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 t -157.01 114.25 3.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.62 -37.66 88.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.533 -0.73 . . . . 0.0 109.9 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 mm -73.22 131.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.416 -0.802 . . . . 0.0 110.12 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -129.78 86.54 2.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.705 -0.622 . . . . 0.0 109.541 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -123.12 93.52 3.98 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 97.2 m-20 -94.68 104.18 16.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.431 -0.793 . . . . 0.0 109.468 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 62.3 m-20 -159.52 168.58 25.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.243 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 93' ' ' THR . 17.4 m -67.34 -35.99 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.507 0.67 . . . . 0.0 109.827 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.421 ' N ' HG23 ' A' ' 92' ' ' VAL . 59.2 p -65.77 -26.78 67.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.41 128.83 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.487 -0.758 . . . . 0.0 109.499 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.4 m -88.95 -164.07 1.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.605 0.717 . . . . 0.0 110.03 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -62.92 -43.64 98.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.497 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' A' ' 99' ' ' ALA . 84.7 mtp180 -108.39 -57.83 2.07 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 57.69 -73.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.864 -0.522 . . . . 0.0 109.655 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -132.12 155.24 48.5 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.651 0.738 . . . . 0.0 109.439 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -139.37 146.25 39.98 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' A' ' 110' ' ' VAL . 99.0 m-85 -113.05 139.18 48.9 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -128.85 139.26 52.24 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.02 121.53 36.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.493 -0.754 . . . . 0.0 109.541 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -99.44 -124.99 0.16 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -84.59 88.18 7.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.829 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 52.71 27.0 4.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.64 -0.663 . . . . 0.0 110.051 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -142.19 131.12 23.02 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.019 -1.051 . . . . 0.0 110.02 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -76.73 147.75 37.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.636 -0.665 . . . . 0.0 110.206 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -139.67 159.78 41.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.104 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.446 HG23 ' CE1' ' A' ' 101' ' ' PHE . 9.0 p -126.44 132.73 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.702 -0.624 . . . . 0.0 109.435 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.9 135.82 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.509 0.671 . . . . 0.0 109.244 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -85.3 115.29 22.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.496 -0.753 . . . . 0.0 109.378 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 m . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.617 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.2 m . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.489 0.661 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.37 149.95 49.81 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 122' ' ' ASN . 9.9 p -130.52 156.69 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.604 -0.685 . . . . 0.0 110.009 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 121' ' ' VAL . 97.5 m-20 -40.61 173.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.995 0.902 . . . . 0.0 111.063 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 60.46 -105.12 0.2 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.856 -0.528 . . . . 0.0 109.992 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -125.62 145.5 51.6 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.779 -0.576 . . . . 0.0 109.602 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -49.24 139.12 28.35 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.355 2.037 . . . . 0.0 113.053 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -137.85 160.08 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.489 -0.757 . . . . 0.0 109.977 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -69.13 -37.68 78.45 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.661 -0.649 . . . . 0.0 109.525 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p -156.28 161.83 40.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.048 -1.032 . . . . 0.0 110.456 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.33 165.55 31.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.45 -0.781 . . . . 0.0 109.579 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.0 t -93.46 130.24 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.441 -0.787 . . . . 0.0 109.719 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.6 mt -77.33 147.2 36.31 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.645 0.736 . . . . 0.0 110.467 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.88 164.17 34.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.614 0.721 . . . . 0.0 109.698 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.414 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 18.5 p30 -64.0 127.34 30.97 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.66 0.743 . . . . 0.0 110.714 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.41 16.33 69.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 145' ' ' VAL . 44.8 t0 -85.69 160.23 19.61 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.154 -1.204 . . . . 0.0 109.928 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -112.15 124.37 52.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.522 -0.736 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.1 t -127.35 132.67 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -121.7 113.96 20.46 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.5 130.05 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.462 0.648 . . . . 0.0 109.795 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 142' ' ' PHE . . . 67.29 36.01 88.84 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 140' ' ' GLY . 15.0 tptp 71.37 -19.18 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.677 -0.896 . . . . 0.0 109.475 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 140' ' ' GLY . 95.6 m-85 -73.96 143.34 45.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.882 . . . . 0.0 109.961 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -99.71 120.68 40.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 109.17 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.33 153.39 47.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.6 -0.687 . . . . 0.0 109.944 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 135' ' ' ASP . 9.9 p -127.09 138.72 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.581 0.705 . . . . 0.0 109.554 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -89.9 120.34 31.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.675 . . . . 0.0 109.397 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 66.3 mt -134.72 152.87 52.1 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.396 0.617 . . . . 0.0 109.878 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.569 0.699 . . . . 0.0 109.567 179.988 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.488 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 55' ' ' LEU . 11.0 mp -100.72 149.76 23.46 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.158 -1.201 . . . . 0.0 110.178 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -149.05 165.85 30.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.444 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.04 155.16 47.35 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.67 0.748 . . . . 0.0 109.818 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -116.14 136.69 52.79 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -120.48 135.28 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.672 0.749 . . . . 0.0 109.744 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.3 116.52 20.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.527 -0.733 . . . . 0.0 110.007 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -66.76 -45.15 79.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.43 -0.794 . . . . 0.0 109.918 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -154.29 151.55 29.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.017 . . . . 0.0 110.396 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.42 -176.53 28.11 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.53 -38.37 74.94 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.894 2.396 . . . . 0.0 112.274 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 11.2 m120 -82.17 -76.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.572 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . 70.27 118.07 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.563 0.697 . . . . 0.0 110.249 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.27 -15.65 62.87 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.8 t -67.21 145.46 55.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -1.144 . . . . 0.0 110.546 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -133.4 151.81 51.86 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.667 -0.645 . . . . 0.0 109.676 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -128.17 142.05 51.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.505 -0.747 . . . . 0.0 109.052 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.4 tp -102.27 128.29 48.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.608 -0.683 . . . . 0.0 109.969 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -92.5 75.02 5.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 109.161 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -95.07 5.52 51.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 109.134 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -115.09 139.43 49.89 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.512 -0.742 . . . . 0.0 109.81 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.61 -50.72 72.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.589 -0.695 . . . . 0.0 110.004 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.9 mm -110.14 120.87 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.346 -0.847 . . . . 0.0 108.828 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.4 m -125.69 115.04 19.48 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.369 0.604 . . . . 0.0 109.688 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.1 m -84.31 151.52 24.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.37 -0.831 . . . . 0.0 109.022 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.61 162.23 13.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.216 -0.928 . . . . 0.0 110.348 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.8 -132.18 11.0 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.545 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 94.9 mtt180 -102.97 131.32 50.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.477 -1.013 . . . . 0.0 110.226 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 23.9 m-70 -172.92 153.93 2.67 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.17 -54.38 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.33 2.02 . . . . 0.0 111.305 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 50.3 p-10 -96.79 88.7 4.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.453 -0.78 . . . . 0.0 109.806 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.6 p -166.33 126.79 1.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.991 . . . . 0.0 109.381 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.11 -39.95 95.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.847 . . . . 0.0 109.649 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.6 mt -87.76 127.45 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.104 -0.997 . . . . 0.0 109.594 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -129.28 85.75 2.35 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.2 mt -101.51 94.53 5.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 108.808 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -88.47 85.52 6.87 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.498 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 12.2 p-10 -155.29 170.11 22.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.36 -0.838 . . . . 0.0 109.655 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 93' ' ' THR . 4.1 t -71.9 171.9 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.597 -0.689 . . . . 0.0 110.504 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.55 ' H ' HG12 ' A' ' 92' ' ' VAL . 2.7 p 66.24 -5.93 0.53 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.668 -0.645 . . . . 0.0 109.627 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 92' ' ' VAL . 94.4 t -109.44 -19.2 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 94' ' ' VAL . 1.4 m 44.5 -173.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.826 0.822 . . . . 0.0 110.827 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -70.11 -43.79 70.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.932 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.424 ' CG ' ' NE2' ' A' ' 82' ' ' HIS . 79.3 mtp85 -140.91 88.98 2.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.836 . . . . 0.0 109.421 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -99.53 -30.57 12.08 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.92 151.44 33.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -140.85 150.32 43.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.478 -0.763 . . . . 0.0 109.503 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.34 145.66 37.09 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -132.99 136.28 45.97 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 57.4 tp -96.78 124.75 40.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 109.743 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 105' ' ' ASN . 80.6 tt0 -107.18 -109.93 0.3 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.518 -0.739 . . . . 0.0 109.571 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.402 ' N ' ' HG2' ' A' ' 104' ' ' GLU . 82.1 m-20 -91.84 79.35 5.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.065 . . . . 0.0 109.38 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.0 m120 55.89 34.68 24.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.558 -0.713 . . . . 0.0 109.538 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.24 131.51 13.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.912 . . . . 0.0 109.044 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -83.73 150.35 25.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.172 -0.955 . . . . 0.0 110.357 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -122.31 157.77 31.03 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.9 p -120.87 127.73 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.593 -0.692 . . . . 0.0 109.222 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -130.72 137.55 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.755 -0.59 . . . . 0.0 109.543 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 49.4 p-10 -84.55 95.68 8.92 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.275 -0.891 . . . . 0.0 109.277 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.429 -179.823 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.316 0.579 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -146.22 158.81 43.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.98 . . . . 0.0 109.245 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.55 133.85 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.717 -0.615 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 124' ' ' GLU . 97.7 m-20 57.69 38.43 27.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.779 -0.575 . . . . 0.0 110.006 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 56.79 0.06 0.07 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.525 -0.734 . . . . 0.0 110.634 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 122' ' ' ASN . 72.3 mt-10 -107.28 147.65 35.61 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.266 -0.896 . . . . 0.0 109.44 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.92 148.08 0.23 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.265 1.977 . . . . 0.0 112.227 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 12.9 p -124.69 135.15 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.769 0.795 . . . . 0.0 109.663 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 128' ' ' SER . 65.7 t0 -148.58 59.85 1.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 128' ' ' SER . 2.8 p 80.97 95.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.526 0.679 . . . . 0.0 109.506 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.09 151.22 49.45 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.397 -0.814 . . . . 0.0 109.501 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.6 t -81.5 131.49 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.47 -0.769 . . . . 0.0 109.957 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.03 151.7 35.45 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.478 -0.764 . . . . 0.0 110.267 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.543 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -152.63 153.8 34.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -0.899 . . . . 0.0 109.934 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -49.23 129.84 18.61 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.66 0.743 . . . . 0.0 111.383 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.16 15.13 61.23 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 92.2 m-20 -91.08 150.86 21.24 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.744 -1.445 . . . . 0.0 109.86 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -108.84 130.86 55.42 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.473 -0.767 . . . . 0.0 109.122 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -124.45 133.1 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.604 -0.685 . . . . 0.0 109.248 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.456 ' OE1' ' CZ ' ' A' ' 143' ' ' ARG . 57.3 tt0 -121.07 124.66 45.35 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.49 129.84 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.49 0.662 . . . . 0.0 110.027 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 50.46 -98.38 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -127.4 -19.3 4.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.623 -0.928 . . . . 0.0 108.888 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.498 ' CE1' ' OD2' ' A' ' 91' ' ' ASP . 13.6 m-85 -74.82 143.31 43.99 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.406 -0.809 . . . . 0.0 109.874 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.456 ' CZ ' ' OE1' ' A' ' 138' ' ' GLN . 28.1 mmt180 -103.32 137.17 41.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.496 -0.753 . . . . 0.0 109.653 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.86 151.96 44.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.809 -0.557 . . . . 0.0 109.794 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.0 p -124.28 134.28 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 67.2 t80 -93.04 108.63 20.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.5 mt -140.22 150.75 44.53 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.622 0.725 . . . . 0.0 109.414 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 13.5 p . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.519 -0.738 . . . . 0.0 110.062 -179.398 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.478 ' O ' HD22 ' A' ' 55' ' ' LEU . . . . . . . . 0 N--CA 1.494 2.512 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.666 HD12 HD11 ' A' ' 71' ' ' LEU . 3.9 mm? -114.24 131.69 56.39 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.621 -0.929 . . . . 0.0 110.098 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.15 155.03 44.48 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.4 153.27 48.07 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.827 0.823 . . . . 0.0 110.399 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -114.35 127.08 55.68 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.54 134.05 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.661 0.743 . . . . 0.0 109.809 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.77 128.95 34.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.581 -0.699 . . . . 0.0 109.789 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -88.45 -35.56 16.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.166 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -150.18 132.49 15.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.636 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 66' ' ' ALA . . . 141.43 169.48 11.92 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.12 -39.42 70.82 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.755 2.303 . . . . 0.0 111.816 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -81.81 30.63 0.37 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 63' ' ' GLY . . . -63.17 134.26 55.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.524 -0.735 . . . . 0.0 110.278 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.73 -15.61 58.61 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -65.57 144.53 56.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.525 -0.985 . . . . 0.0 110.076 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -136.87 148.9 47.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.642 -0.661 . . . . 0.0 109.698 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -128.79 153.5 47.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.603 -0.686 . . . . 0.0 109.181 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.666 HD11 HD12 ' A' ' 55' ' ' LEU . 53.8 tp -110.16 143.57 40.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.835 -0.541 . . . . 0.0 109.903 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.9 mt -116.59 78.96 1.25 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.513 -0.742 . . . . 0.0 109.686 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 67.1 t0 -110.31 41.01 1.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -135.93 150.33 49.26 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.704 . . . . 0.0 109.428 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.85 79.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.409 -0.807 . . . . 0.0 109.67 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.62 127.51 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.8 m -122.8 124.98 44.54 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.0 t -97.63 168.16 10.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.335 -0.853 . . . . 0.0 110.443 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB3' ' H ' ' A' ' 99' ' ' ALA . . . -116.16 -178.93 3.52 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.652 0.739 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.34 -134.74 39.25 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.588 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 38.1 mmt180 -74.58 133.9 42.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.436 -1.037 . . . . 0.0 109.818 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 1.2 m80 166.96 85.92 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.15 -36.47 66.65 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.992 1.795 . . . . 0.0 110.964 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -94.82 72.34 3.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.351 -0.843 . . . . 0.0 109.591 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.4 t -169.13 148.3 3.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.072 -1.018 . . . . 0.0 109.41 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.29 -41.5 98.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.354 -0.842 . . . . 0.0 109.681 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.85 123.64 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 109.912 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CZ ' ' OD2' ' A' ' 90' ' ' ASP . 89.3 t80 -130.4 85.73 2.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.12 128.61 53.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.376 -0.828 . . . . 0.0 109.694 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD2' ' CZ ' ' A' ' 88' ' ' PHE . 94.6 m-20 -135.1 86.06 2.22 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 63.3 m-20 -158.92 178.99 9.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.88 . . . . 0.0 110.032 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 94' ' ' VAL . 2.8 t -63.42 166.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.611 -0.681 . . . . 0.0 110.847 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.417 ' H ' HG12 ' A' ' 92' ' ' VAL . 3.0 p 66.06 -4.76 0.62 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 92' ' ' VAL . 55.3 t -123.99 129.5 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.3 m -107.59 -139.24 0.37 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 109.958 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -63.42 -42.53 98.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.546 -0.721 . . . . 0.0 110.662 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -156.89 94.02 1.4 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 109.005 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -61.29 -39.04 88.95 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.438 -0.789 . . . . 0.0 109.438 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 79' ' ' ALA . . . -152.55 162.08 41.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 110.573 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -133.39 145.56 50.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -113.87 141.89 46.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.333 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.71 135.81 50.68 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.748 0.785 . . . . 0.0 109.834 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 107' ' ' GLU . 47.2 tp -98.42 128.49 44.82 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.39 -126.62 0.15 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.152 -0.967 . . . . 0.0 110.94 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 8.0 m120 -64.53 -48.91 73.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 110.529 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 5.5 m120 -168.82 21.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.33 -0.856 . . . . 0.0 109.665 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.466 ' O ' ' CD1' ' A' ' 103' ' ' LEU . 96.8 mt-10 -116.37 -126.92 0.29 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.35 -0.844 . . . . 0.0 109.057 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.439 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 13.7 m-85 -164.23 155.35 15.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.017 -1.052 . . . . 0.0 108.933 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 58.6 m-20 -143.45 149.51 37.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.149 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.32 130.51 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.44 131.54 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.355 0.597 . . . . 0.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -100.25 118.16 35.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.53 -0.731 . . . . 0.0 109.356 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.355 -0.841 . . . . 0.0 110.215 -179.091 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.227 0.537 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -124.12 142.15 51.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.61 -0.681 . . . . 0.0 109.188 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 126' ' ' VAL . 5.9 p -124.13 132.08 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.606 0.717 . . . . 0.0 109.622 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.433 ' C ' ' H ' ' A' ' 124' ' ' GLU . 98.1 m-20 52.6 -171.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.819 0.819 . . . . 0.0 110.894 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -71.37 6.84 1.56 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.394 -0.817 . . . . 0.0 108.871 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 122' ' ' ASN . 3.9 pt-20 -120.44 84.74 36.22 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.45 134.38 60.84 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.373 2.049 . . . . 0.0 112.009 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.513 HG22 HG12 ' A' ' 121' ' ' VAL . 27.3 m -151.04 156.15 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.132 -0.98 . . . . 0.0 109.809 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.45 -41.88 96.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.1 p -158.11 143.5 16.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.399 -0.813 . . . . 0.0 109.546 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -172.93 167.52 5.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.289 -0.882 . . . . 0.0 110.056 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.8 t -78.05 144.31 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.981 0.896 . . . . 0.0 109.96 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.83 ' H ' HD13 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -136.8 158.06 45.31 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.544 0.688 . . . . 0.0 110.444 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.06 -172.02 4.06 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.629 0.728 . . . . 0.0 109.201 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 47.2 p-10 -50.78 141.52 12.96 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.834 0.826 . . . . 0.0 111.538 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.17 21.36 57.2 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -110.08 151.88 26.67 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.446 -1.032 . . . . 0.0 109.267 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -113.46 138.09 50.6 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.8 t -125.61 132.27 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -118.71 125.45 49.7 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.46 128.95 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.65 0.738 . . . . 0.0 109.518 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.67 -120.98 4.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -98.45 -16.31 19.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.421 -1.046 . . . . 0.0 108.808 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -80.37 145.47 32.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 0.0 110.214 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -115.85 126.68 54.29 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.03 158.43 36.98 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.65 -0.656 . . . . 0.0 109.762 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.83 135.47 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -90.24 109.87 20.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.924 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.44 143.59 39.74 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.401 0.62 . . . . 0.0 109.374 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 79.8 p . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 110.396 -179.54 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 95.4 mt -131.57 154.01 49.28 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.118 0.961 . . . . 0.0 110.535 179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.77 158.89 42.94 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.16 151.0 51.16 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.309 1.052 . . . . 0.0 110.929 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -115.25 136.4 53.14 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.221 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.8 t -121.75 132.97 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.855 0.836 . . . . 0.0 109.859 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.7 t -69.8 102.82 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.927 0.87 . . . . 0.0 109.538 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.07 -43.87 86.11 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.632 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -130.97 136.82 48.89 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.945 0.879 . . . . 0.0 109.797 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.9 168.62 16.45 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.11 -34.66 68.63 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.88 2.387 . . . . 0.0 111.471 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 66' ' ' ALA . 87.3 m-20 -66.89 -45.52 77.77 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . 31.52 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.455 0.645 . . . . 0.0 110.838 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.01 -24.62 4.5 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.4 p -70.02 160.68 31.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.779 -0.836 . . . . 0.0 110.849 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.566 ' CD ' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -152.46 164.04 38.35 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.937 0.875 . . . . 0.0 110.556 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -128.24 142.35 51.19 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.887 0.851 . . . . 0.0 109.723 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -104.48 127.52 52.2 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.822 0.82 . . . . 0.0 110.406 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.3 mt -91.37 116.49 28.88 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.898 0.856 . . . . 0.0 109.966 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -157.69 19.7 0.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -129.65 138.89 51.46 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.895 0.855 . . . . 0.0 109.821 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.79 134.62 51.28 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.78 0.8 . . . . 0.0 110.458 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 mm 53.09 93.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.6 m -106.08 118.13 35.81 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.029 0.918 . . . . 0.0 110.169 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.2 m -85.67 159.33 19.84 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.639 0.733 . . . . 0.0 109.909 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 96' ' ' ARG . . . -106.89 170.09 8.15 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.865 0.841 . . . . 0.0 110.388 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.5 -70.67 2.62 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.621 ' NH1' ' NH2' ' A' ' 96' ' ' ARG . 79.7 mtp85 -71.74 142.59 49.77 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.714 0.769 . . . . 0.0 110.118 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.525 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -86.43 -46.07 0.56 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.837 -0.539 . . . . 0.0 109.91 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 54.3 Cg_exo -54.24 135.0 63.43 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.257 1.971 . . . . 0.0 112.725 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 54.48 33.21 18.31 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t -159.65 117.63 2.72 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.932 0.872 . . . . 0.0 109.876 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.23 -37.85 88.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.57 125.36 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.58 0.705 . . . . 0.0 109.702 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.4 ' CD1' ' CB ' ' A' ' 82' ' ' HIS . 57.4 t80 -130.01 86.19 2.38 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.965 0.888 . . . . 0.0 109.566 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 90' ' ' ASP . 96.8 mt -79.7 146.71 32.28 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.763 0.792 . . . . 0.0 109.787 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 89' ' ' LEU . 64.7 t0 -55.88 -109.12 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.454 0.645 . . . . 0.0 110.267 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 93' ' ' THR . 58.6 m-20 -162.23 -103.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.461 0.648 . . . . 0.0 109.486 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 t 53.01 -77.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.151 0.501 . . . . 0.0 109.904 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 91' ' ' ASP . 11.8 p -115.17 9.23 15.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.656 -0.653 . . . . 0.0 109.375 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.1 131.09 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 121.918 0.866 . . . . 0.0 109.862 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.5 t -89.33 -155.74 0.37 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.813 0.816 . . . . 0.0 110.94 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.621 ' NH2' ' NH1' ' A' ' 81' ' ' ARG . 79.3 mtp85 -63.7 -41.22 98.14 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.312 0.577 . . . . 0.0 109.894 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -166.41 56.36 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.433 0.635 . . . . 0.0 109.593 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -62.85 -6.42 3.74 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.56 147.49 34.51 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.939 0.876 . . . . 0.0 109.673 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -143.93 138.94 28.87 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.057 0.932 . . . . 0.0 109.925 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -106.38 145.81 31.25 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.717 0.77 . . . . 0.0 109.302 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -132.93 143.98 49.84 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.985 0.897 . . . . 0.0 110.177 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.0 tp -106.83 121.77 45.05 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.839 0.828 . . . . 0.0 109.569 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 104' ' ' GLU . 9.8 pm0 -107.12 -116.51 0.26 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.444 0.64 . . . . 0.0 109.876 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.43 ' H ' ' CG ' ' A' ' 104' ' ' GLU . 47.7 p-10 -87.38 80.82 8.04 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.604 0.716 . . . . 0.0 110.437 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 54.22 31.42 14.07 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.421 0.629 . . . . 0.0 109.508 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -141.4 130.41 23.24 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.66 0.743 . . . . 0.0 109.562 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -93.31 148.72 21.79 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.465 0.65 . . . . 0.0 109.647 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -147.25 172.34 13.99 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.637 0.732 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.3 p -124.66 131.65 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-O 121.966 0.888 . . . . 0.0 109.576 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.97 133.29 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.712 0.768 . . . . 0.0 109.5 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -89.05 113.82 24.98 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.553 0.692 . . . . 0.0 109.515 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 C--N 1.302 -1.466 0 CA-C-O 121.718 0.771 . . . . 0.0 109.578 -179.731 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.455 0.645 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -121.7 144.15 48.94 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.825 0.821 . . . . 0.0 109.611 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 122' ' ' ASN . 3.2 p -101.99 154.4 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.42 0.628 . . . . 0.0 109.954 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 123' ' ' ARG . 37.9 p-10 -34.04 -45.3 0.2 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.106 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 122' ' ' ASN . 99.8 mtt180 -74.5 -114.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.64 -0.662 . . . . 0.0 110.919 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -102.36 147.29 33.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.679 -0.638 . . . . 0.0 109.989 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.77 137.7 78.39 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.793 2.329 . . . . 0.0 113.022 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.07 161.23 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.789 0.804 . . . . 0.0 110.558 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.46 -18.35 61.13 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.8 p -158.16 159.24 35.94 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.721 0.772 . . . . 0.0 109.901 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.69 155.28 31.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.88 0.847 . . . . 0.0 110.219 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.5 t -99.64 128.91 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.708 0.765 . . . . 0.0 109.622 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.24 143.21 35.52 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.789 0.804 . . . . 0.0 110.552 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.53 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -153.25 150.36 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.611 0.72 . . . . 0.0 109.635 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -39.95 122.87 1.54 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.773 0.797 . . . . 0.0 111.145 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.44 13.11 68.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 28.0 m-20 -85.9 149.15 25.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.516 -0.991 . . . . 0.0 109.861 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -112.47 141.96 45.59 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.867 0.842 . . . . 0.0 110.219 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.2 t -121.74 133.66 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.804 0.812 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -128.45 112.66 14.61 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.829 0.823 . . . . 0.0 109.472 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.13 128.59 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.871 0.843 . . . . 0.0 109.654 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 56.07 -134.46 50.27 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -95.45 -13.59 24.46 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.56 130.53 35.86 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.832 0.825 . . . . 0.0 110.073 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -105.99 135.56 47.22 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.714 0.768 . . . . 0.0 109.752 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.69 149.33 51.49 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.658 0.742 . . . . 0.0 109.714 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.32 132.18 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.721 0.772 . . . . 0.0 109.239 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -94.49 111.94 23.7 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.941 0.877 . . . . 0.0 110.008 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.7 mt -138.14 150.52 46.89 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.805 0.812 . . . . 0.0 109.989 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 7.8 p . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.702 0.763 . . . . 0.0 110.354 -179.723 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.52 136.81 42.55 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.512 -0.993 . . . . 0.0 109.46 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.64 160.64 26.7 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.38 150.22 50.2 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.486 -0.759 . . . . 0.0 109.858 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.34 136.08 53.47 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.5 133.79 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.11 112.46 3.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.425 -0.797 . . . . 0.0 109.464 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.52 ' O ' ' NE ' ' A' ' 62' ' ' ARG . 24.2 tptp -64.71 -47.07 79.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.453 -0.78 . . . . 0.0 109.505 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 61' ' ' LYS . 4.7 mmp_? -143.61 155.26 44.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 109.847 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.43 167.18 11.55 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.56 -19.51 54.39 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.544 2.163 . . . . 0.0 111.873 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -106.25 33.44 3.84 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.452 -0.78 . . . . 0.0 109.192 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.79 145.88 11.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 109.922 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.21 53.68 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.3 m -69.96 145.89 51.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -1.053 . . . . 0.0 109.907 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -141.81 156.1 45.57 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -129.51 146.97 51.27 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.449 -0.782 . . . . 0.0 109.511 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.519 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 53.9 tp -106.44 124.93 50.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.541 -0.724 . . . . 0.0 109.114 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.7 68.73 5.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.152 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.3 p30 -98.75 5.84 47.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.438 -0.789 . . . . 0.0 109.727 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -119.45 135.55 54.7 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.457 -0.777 . . . . 0.0 109.335 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.68 136.06 54.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.514 -0.741 . . . . 0.0 110.659 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.1 mm 60.23 85.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.439 0.637 . . . . 0.0 109.992 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.4 m -102.93 121.84 43.34 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.418 ' O ' ' OG ' ' A' ' 85' ' ' SER . 11.5 m -85.52 162.17 19.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.711 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.37 127.08 44.94 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.86 -141.9 9.64 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -104.48 132.47 50.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.437 -1.037 . . . . 0.0 110.401 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.653 ' N ' ' ND1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 174.15 151.1 0.25 Allowed Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.63 -23.29 49.51 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.14 1.893 . . . . 0.0 112.104 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 85' ' ' SER . 73.0 m-20 -103.3 -146.84 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 109.732 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 84' ' ' ASP . 8.7 t 59.6 128.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.612 0.72 . . . . 0.0 110.389 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 71' ' ' LEU . 48.0 t0 -64.7 -39.69 94.09 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.03 124.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.422 -0.799 . . . . 0.0 109.223 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -130.2 86.25 2.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.723 -0.61 . . . . 0.0 109.482 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.65 99.68 11.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -84.39 92.57 8.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.658 -0.651 . . . . 0.0 109.766 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -154.38 151.76 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 109.593 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 m -71.21 -26.91 27.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.314 -0.867 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.1 p -65.7 -33.85 76.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.499 -0.751 . . . . 0.0 109.737 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.97 121.53 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.293 -0.879 . . . . 0.0 109.374 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.8 m -77.3 179.77 6.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 0.0 110.34 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -58.03 -44.27 87.23 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -135.68 78.63 1.73 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.49 -0.757 . . . . 0.0 109.03 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -94.68 -18.93 20.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.518 -0.739 . . . . 0.0 109.219 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.488 ' HB2' ' OG1' ' A' ' 119' ' ' THR . . . -153.13 152.32 31.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.483 -0.76 . . . . 0.0 109.184 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -139.6 139.6 36.81 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -106.43 119.79 40.19 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.578 -0.702 . . . . 0.0 109.165 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -107.61 134.93 49.89 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 109.398 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.9 tp -103.4 126.68 50.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.386 -0.821 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -99.57 -131.2 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.512 -0.743 . . . . 0.0 109.08 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -65.54 -49.43 68.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.402 -0.811 . . . . 0.0 109.902 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.421 ' CG ' ' O ' ' A' ' 106' ' ' ASN . 2.5 t-20 177.51 46.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 108' ' ' PHE . 80.5 mm-40 -134.32 -6.25 2.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.981 -1.074 . . . . 0.0 109.251 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 107' ' ' GLU . 62.3 m-85 56.71 151.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.724 0.773 . . . . 0.0 110.209 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 88.8 m-20 -143.49 159.89 41.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.379 -0.826 . . . . 0.0 109.487 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.85 137.42 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 112' ' ' ASP . 30.8 t -133.8 157.27 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.405 -0.809 . . . . 0.0 109.763 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.422 ' N ' HG12 ' A' ' 111' ' ' VAL . 36.5 p-10 -84.7 13.63 5.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.674 -0.641 . . . . 0.0 109.582 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.504 ' O ' HG22 ' A' ' 113' ' ' VAL . 9.4 p . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 121.419 0.628 . . . . 0.0 110.394 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 99' ' ' ALA . 17.5 m . . . . . 0 N--CA 1.495 1.802 0 CA-C-O 121.442 0.639 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -141.91 160.36 40.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 121' ' ' VAL . 14.1 p -112.17 129.2 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.293 -0.88 . . . . 0.0 110.486 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.502 ' CG ' ' H ' ' A' ' 123' ' ' ARG . 5.9 t-20 59.47 -167.44 0.16 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.682 0.753 . . . . 0.0 110.824 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.502 ' H ' ' CG ' ' A' ' 122' ' ' ASN . 96.0 mtt-85 -72.71 -12.75 61.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.884 -0.51 . . . . 0.0 109.9 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -86.41 116.53 66.22 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.27 -0.894 . . . . 0.0 109.2 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.22 121.63 5.8 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.507 1.472 . . . . 0.0 111.768 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.53 156.74 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 128' ' ' SER . 38.4 p-10 -72.96 -36.76 67.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.416 -0.803 . . . . 0.0 109.606 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.53 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 99.5 p -160.55 161.83 32.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.413 -0.805 . . . . 0.0 108.852 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -165.53 157.68 15.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.918 -1.114 . . . . 0.0 110.386 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 87.3 t -81.31 134.0 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.462 -0.774 . . . . 0.0 109.638 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.9 mt -80.8 148.07 30.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 109.696 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.548 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -146.28 160.72 41.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.345 -0.847 . . . . 0.0 109.611 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.423 ' OD1' ' OG1' ' A' ' 148' ' ' THR . 51.3 m-20 -57.54 136.79 56.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.737 . . . . 0.0 110.628 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.561 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 80.53 18.62 70.49 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 84.8 m-20 -93.5 155.25 17.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.162 -1.199 . . . . 0.0 109.642 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 56.4 mp0 -113.33 137.43 51.52 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.4 t -122.94 133.6 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -124.12 116.71 23.2 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.592 -0.692 . . . . 0.0 109.304 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.31 128.07 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.612 -0.68 . . . . 0.0 109.811 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 52.82 -134.23 39.85 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -95.49 -4.59 44.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.6 -0.941 . . . . 0.0 109.076 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -95.84 132.34 41.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.553 -0.717 . . . . 0.0 109.506 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -103.36 133.8 47.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.34 154.88 47.2 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.9 134.18 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.687 -0.633 . . . . 0.0 109.368 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -92.0 112.44 24.38 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 134' ' ' GLY . 94.2 mt -134.2 148.65 50.92 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.457 0.646 . . . . 0.0 110.101 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 133' ' ' ASN . 35.8 p . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.796 -0.565 . . . . 0.0 109.984 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.492 0.663 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -84.37 2.24 41.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.253 -0.904 . . . . 0.0 109.288 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 63.6 ttm-85 -159.71 119.76 2.99 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 0.0 109.108 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.54 154.06 39.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.805 . . . . 0.0 109.756 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -69.42 61.45 0.14 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.47 -0.769 . . . . 0.0 109.359 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.555 ' O ' ' N ' ' A' ' 31' ' ' SER . 7.2 p90 -112.99 125.31 54.27 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.305 -0.872 . . . . 0.0 109.12 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 71.8 mt 45.86 13.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.138 -0.976 . . . . 0.0 110.047 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.555 ' N ' ' O ' ' A' ' 29' ' ' PHE . 13.5 m -73.1 146.15 45.97 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.172 -0.955 . . . . 0.0 110.03 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 33' ' ' LEU . 97.2 mt-10 53.48 25.93 5.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.302 -0.874 . . . . 0.0 109.762 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.618 ' H ' HD22 ' A' ' 33' ' ' LEU . 3.4 mm? 40.48 -111.35 0.12 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.721 -0.612 . . . . 0.0 110.42 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -125.39 -59.18 1.4 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.545 -0.722 . . . . 0.0 109.342 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.461 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . -179.31 53.02 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.529 -0.732 . . . . 0.0 109.393 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 35.4 Cg_endo -64.33 146.86 90.61 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.671 2.247 . . . . 0.0 112.379 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.41 -75.68 0.36 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.381 -0.825 . . . . 0.0 109.959 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -82.74 152.83 25.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -0.774 . . . . 0.0 110.186 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -173.95 -33.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.71 58.35 8.53 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 66.0 p -82.0 166.79 19.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.239 -1.153 . . . . 0.0 109.974 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -133.59 -86.44 0.43 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.494 -0.754 . . . . 0.0 109.788 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 p -76.25 154.97 34.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.212 -0.93 . . . . 0.0 110.263 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -175.91 -73.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.3 m -106.24 -4.9 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.575 -0.703 . . . . 0.0 109.31 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.4 m -149.2 86.04 1.48 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.185 -0.947 . . . . 0.0 109.436 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -89.51 4.93 84.1 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.455 ' O ' HG12 ' A' ' 48' ' ' VAL . 37.3 t -71.56 -0.46 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.358 -1.084 . . . . 0.0 108.945 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -51.34 -80.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.486 -0.759 . . . . 0.0 110.031 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' O ' ' C ' ' A' ' 51' ' ' LEU . . . -130.66 -2.66 4.8 Favored Glycine 0 N--CA 1.498 2.788 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.505 ' C ' ' O ' ' A' ' 50' ' ' GLY . 0.4 OUTLIER 23.79 66.58 0.38 Allowed Pre-proline 0 N--CA 1.506 2.344 0 CA-C-O 121.07 0.462 . . . . 0.0 111.015 -179.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 19.3 Cg_exo -48.91 -41.81 38.83 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.934 1.756 . . . . 0.0 112.72 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.538 ' O ' ' N ' ' A' ' 55' ' ' LEU . 27.7 Cg_exo -61.64 150.79 84.07 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 122.152 1.901 . . . . 0.0 112.354 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -58.17 80.23 0.01 OUTLIER Glycine 0 N--CA 1.494 2.531 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 53' ' ' PRO . 67.0 mt -128.16 151.12 49.62 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.513 -0.992 . . . . 0.0 109.702 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.629 ' C ' HD12 ' A' ' 57' ' ' LEU . . . -137.65 143.48 41.39 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.629 HD12 ' C ' ' A' ' 56' ' ' ALA . 11.1 mp -120.23 150.72 40.22 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.335 -0.853 . . . . 0.0 109.868 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.3 mt -117.11 132.58 56.64 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 t -119.08 132.11 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.406 -0.809 . . . . 0.0 109.887 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.8 t -68.78 102.83 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.542 -0.724 . . . . 0.0 109.134 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.71 -42.91 97.89 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.342 -0.849 . . . . 0.0 109.679 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -150.21 136.93 19.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.165 -0.96 . . . . 0.0 109.888 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 160.87 173.27 29.27 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.07 -43.17 60.75 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.224 1.949 . . . . 0.0 112.39 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -102.81 66.15 0.92 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.36 144.75 49.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.47 -0.769 . . . . 0.0 110.278 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.49 -9.7 66.87 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.8 m -66.13 145.64 55.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.404 -1.057 . . . . 0.0 109.665 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.61 146.96 51.42 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.58 -0.7 . . . . 0.0 109.475 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -125.33 134.49 52.2 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 tt -101.98 124.23 47.25 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.504 -0.748 . . . . 0.0 109.471 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.2 mt -98.56 111.74 24.01 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.32 -0.862 . . . . 0.0 109.271 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.9 p30 -86.22 55.42 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.177 -0.952 . . . . 0.0 109.612 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 88.0 mt-30 51.26 -169.09 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.655 0.74 . . . . 0.0 110.855 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 74' ' ' GLN . . . 68.57 -142.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.491 0.663 . . . . 0.0 110.32 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.6 mt -113.45 127.85 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.2 m -121.61 116.64 24.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.559 -0.713 . . . . 0.0 109.123 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.4 p -83.09 165.33 19.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.359 -0.838 . . . . 0.0 109.553 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.51 140.86 51.14 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.309 -0.869 . . . . 0.0 109.413 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.55 -27.25 16.35 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -67.85 143.71 55.64 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -1.108 . . . . 0.0 109.864 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.59 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -92.14 -40.43 0.36 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.651 -0.655 . . . . 0.0 109.857 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 65.8 Cg_exo -53.32 -133.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.92 0 C-N-CA 122.785 2.323 . . . . 0.0 113.356 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -73.83 101.37 3.73 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.283 -0.885 . . . . 0.0 109.751 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.9 m -166.54 129.25 1.88 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.884 . . . . 0.0 109.25 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -61.75 -41.17 97.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.343 -0.848 . . . . 0.0 109.992 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.68 126.01 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.732 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -129.5 86.94 2.48 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 89.0 mt -102.18 96.16 6.8 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.354 -0.841 . . . . 0.0 109.514 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 65.9 t0 -87.92 97.3 10.86 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.317 -0.865 . . . . 0.0 109.62 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 62.9 m-20 -159.97 173.22 16.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.127 -0.983 . . . . 0.0 109.661 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 93' ' ' THR . 31.5 m -63.61 -41.42 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.26 -0.9 . . . . 0.0 109.464 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.518 ' OG1' ' N ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -79.32 -178.11 6.06 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.37 -0.831 . . . . 0.0 110.211 -179.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.518 ' N ' ' OG1' ' A' ' 93' ' ' THR . 4.8 t 61.64 93.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 121.63 0.728 . . . . 0.0 109.597 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 65.4 m -62.87 -167.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.628 -0.67 . . . . 0.0 109.897 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -63.48 -40.5 97.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.0 109.836 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -132.28 40.93 3.27 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.474 -0.766 . . . . 0.0 109.265 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.3 t60 -44.06 -35.75 2.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.749 . . . . 0.0 110.03 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -147.16 152.58 38.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.203 -0.936 . . . . 0.0 109.351 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -139.88 149.29 43.21 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.488 -0.758 . . . . 0.0 109.039 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.24 140.63 49.11 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.471 -0.768 . . . . 0.0 109.057 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -131.28 137.12 48.7 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.377 -0.827 . . . . 0.0 109.061 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 36.6 tp -95.66 127.65 41.87 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.244 -0.91 . . . . 0.0 109.789 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.414 ' O ' ' CG ' ' A' ' 105' ' ' ASN . 40.6 tt0 -142.11 145.11 33.91 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.202 -0.936 . . . . 0.0 109.142 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' OD1' ' CG ' ' A' ' 107' ' ' GLU . 11.2 p30 45.39 41.39 6.42 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.493 -0.754 . . . . 0.0 109.571 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.6 m120 56.8 33.98 23.94 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.536 -0.727 . . . . 0.0 109.994 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.443 ' CG ' ' OD1' ' A' ' 105' ' ' ASN . 73.9 mm-40 -138.47 129.87 27.45 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.273 -0.892 . . . . 0.0 109.264 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -71.27 148.16 47.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.454 -0.779 . . . . 0.0 109.953 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -139.91 166.66 24.03 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.349 -0.845 . . . . 0.0 109.511 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 110' ' ' VAL . 10.3 p -123.77 131.12 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.5 t -123.68 136.8 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 122.238 1.018 . . . . 0.0 109.065 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -101.93 112.92 25.72 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.124 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.1 m -96.09 0.55 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 120.829 -1.169 . . . . 0.0 108.246 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -71.63 142.73 34.18 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.412 ' O ' ' C ' ' A' ' 116' ' ' LEU . 9.7 m -69.73 144.44 52.77 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.332 -1.099 . . . . 0.0 110.117 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 116' ' ' LEU . 9.1 mp 38.2 -98.85 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.744 -0.598 . . . . 0.0 110.92 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 117' ' ' ASN . 32.4 p30 -78.31 152.71 32.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 170.13 -140.54 6.09 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -61.97 138.15 58.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.267 -1.137 . . . . 0.0 110.255 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -141.11 161.41 37.92 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.363 -0.836 . . . . 0.0 108.86 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.9 p -122.39 134.99 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.353 -0.842 . . . . 0.0 109.334 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 56.97 36.54 27.91 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.59 -0.694 . . . . 0.0 109.539 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 58.33 45.83 16.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 109.522 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -144.71 119.86 5.92 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 120.999 -1.063 . . . . 0.0 108.679 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.58 115.99 4.19 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.537 1.492 . . . . 0.0 111.771 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 34.0 m -136.55 158.68 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.086 0 O-C-N 121.322 -0.861 . . . . 0.0 109.975 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.18 -42.09 99.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 42.7 t -162.85 157.64 21.6 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.309 -0.869 . . . . 0.0 109.1 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.2 156.04 40.86 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.999 -1.063 . . . . 0.0 109.712 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 71.0 t -90.82 129.71 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.228 -0.92 . . . . 0.0 109.53 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.1 mt -80.76 153.32 27.85 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 0.0 110.105 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.54 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.22 156.01 40.79 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.411 -0.805 . . . . 0.0 109.131 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -54.86 134.03 48.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.34 -0.85 . . . . 0.0 110.742 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.571 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 85.72 14.68 67.23 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 83.5 m-20 -91.66 152.4 20.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.135 -1.215 . . . . 0.0 109.711 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -114.02 131.15 56.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.602 -0.686 . . . . 0.0 109.24 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.435 ' O ' ' O ' ' A' ' 144' ' ' LEU . 55.2 t -122.29 132.59 70.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -120.64 120.65 36.37 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.465 -0.772 . . . . 0.0 109.299 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.14 128.63 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.58 -0.7 . . . . 0.0 109.842 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 53.61 -128.9 40.35 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.374 -1.09 . . . . 0.0 110.374 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -99.1 -1.43 39.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.577 -0.955 . . . . 0.0 109.291 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -97.09 145.16 26.25 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.457 -0.777 . . . . 0.0 109.262 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -116.22 126.12 53.18 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 137' ' ' VAL . 5.2 mp -128.62 154.55 46.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.573 -0.705 . . . . 0.0 109.437 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.8 p -119.72 130.97 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.577 -0.702 . . . . 0.0 109.156 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -87.22 119.41 27.43 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 134' ' ' GLY . 95.9 mt -132.98 150.92 52.12 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.791 -0.568 . . . . 0.0 109.468 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 74.0 p -127.99 160.0 33.26 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.568 -0.707 . . . . 0.0 109.269 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -74.06 100.53 1.14 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.546 ' N ' ' ND1' ' A' ' 150' ' ' HIS . 0.0 OUTLIER -80.9 157.18 25.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.26 -1.141 . . . . 0.0 109.929 179.88 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 16.1 mtpp -87.46 -3.42 59.01 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.543 HE21 ' CE1' ' A' ' 150' ' ' HIS . 88.4 mt-30 50.49 18.37 0.45 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.533 -0.73 . . . . 0.0 109.358 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -73.4 -125.45 0.1 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.67 135.36 57.66 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.3 -1.117 . . . . 0.0 110.552 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.9 p30 -94.62 10.94 32.86 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.416 -0.802 . . . . 0.0 109.424 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.84 133.4 47.34 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.537 -0.727 . . . . 0.0 109.861 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -148.26 -88.91 0.08 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.385 -0.822 . . . . 0.0 108.88 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' A' ' 158' ' ' HIS . 0.3 OUTLIER -152.7 117.58 5.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.132 -0.98 . . . . 0.0 109.571 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -163.61 138.16 6.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.268 -0.895 . . . . 0.0 108.833 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.448 ' NE2' ' O ' ' A' ' 162' ' ' HIS . 76.9 t60 -113.14 107.42 15.91 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.433 -0.792 . . . . 0.0 109.285 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.505 ' CD2' ' H ' ' A' ' 161' ' ' HIS . 8.5 p80 -107.5 45.85 0.97 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.479 -0.763 . . . . 0.0 108.954 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.448 ' O ' ' NE2' ' A' ' 160' ' ' HIS . 62.8 t-80 -146.3 140.19 26.28 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.362 -0.836 . . . . 0.0 110.098 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 N--CA 1.493 1.705 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.644 179.843 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 26' ' ' ARG . 14.3 p . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 74.5 t80 57.57 -77.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.716 -0.615 . . . . 0.0 109.846 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 24' ' ' VAL . 60.0 ttt85 -148.89 105.79 3.58 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.145 -0.972 . . . . 0.0 109.414 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 46.02 -147.68 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.382 -0.824 . . . . 0.0 110.076 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -135.12 -30.19 1.06 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.601 -0.687 . . . . 0.0 109.154 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -97.47 -8.97 28.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.286 -0.884 . . . . 0.0 109.576 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.8 mt -93.01 -4.07 53.27 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.217 -0.927 . . . . 0.0 108.796 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 39.6 t -66.3 146.18 54.89 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 110.172 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -147.94 98.47 2.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.306 -0.871 . . . . 0.0 108.754 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.17 149.9 40.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.506 -0.746 . . . . 0.0 110.211 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.0 t0 64.41 79.2 0.26 Allowed 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.659 0.742 . . . . 0.0 109.587 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.598 ' HB1' ' HD2' ' A' ' 36' ' ' PRO . . . -51.49 165.79 0.4 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.698 -0.626 . . . . 0.0 109.535 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.598 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 73.2 Cg_endo -76.1 -6.11 16.98 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.704 2.269 . . . . 0.0 111.352 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.34 128.34 1.85 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.819 . . . . 0.0 110.0 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.469 ' C ' ' H ' ' A' ' 40' ' ' GLY . 56.1 tt0 -74.35 -79.03 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.569 -0.707 . . . . 0.0 109.588 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.9 1.17 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.385 -0.822 . . . . 0.0 108.999 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 38' ' ' GLN . . . 70.68 59.12 5.39 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 p -95.26 -2.36 49.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -1.157 . . . . 0.0 108.73 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -52.67 140.03 24.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.416 -0.802 . . . . 0.0 110.038 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.7 t -66.22 144.18 56.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 110.716 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -150.89 14.53 0.73 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 73.2 t -65.52 -43.39 94.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.399 -0.813 . . . . 0.0 109.316 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.7 m -62.08 141.76 57.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.32 -0.863 . . . . 0.0 109.924 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.55 174.69 20.46 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.74 130.52 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.473 -1.016 . . . . 0.0 109.269 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -78.43 146.52 34.45 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.454 -0.779 . . . . 0.0 110.492 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 51' ' ' LEU . . . 78.27 -119.65 5.22 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.586 ' N ' ' HD3' ' A' ' 52' ' ' PRO . 0.2 OUTLIER 77.04 46.59 0.12 Allowed Pre-proline 0 C--N 1.299 -1.627 0 O-C-N 121.971 -0.723 . . . . 0.0 109.733 -178.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.586 ' HD3' ' N ' ' A' ' 51' ' ' LEU . 27.3 Cg_exo -51.36 -42.84 52.88 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 C-N-CA 121.512 1.474 . . . . 0.0 111.687 177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.498 ' C ' ' H ' ' A' ' 55' ' ' LEU . 43.1 Cg_exo -56.76 145.71 81.45 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 121.65 1.567 . . . . 0.0 112.802 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.97 28.68 0.94 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 55' ' ' LEU . 10.9 mp -95.08 157.08 16.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.277 -1.131 . . . . 0.0 109.304 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -127.18 166.91 16.8 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -137.39 159.68 41.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.466 -0.771 . . . . 0.0 109.758 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.0 mt -112.35 135.47 53.0 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -123.36 137.48 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.57 0.7 . . . . 0.0 109.509 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.45 131.32 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.485 -0.759 . . . . 0.0 109.896 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -96.35 -32.53 12.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -0.871 . . . . 0.0 109.172 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -132.21 155.35 48.41 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.762 0.791 . . . . 0.0 110.221 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.35 164.82 14.44 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -68.76 -15.6 40.92 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.686 2.257 . . . . 0.0 111.001 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -92.05 13.94 17.37 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.17 135.15 13.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.397 -0.814 . . . . 0.0 110.369 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.73 -18.5 47.01 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.7 t -65.7 144.26 57.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -1.153 . . . . 0.0 109.824 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -138.79 148.72 44.15 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.358 -0.839 . . . . 0.0 109.904 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.99 137.29 50.22 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.544 -0.722 . . . . 0.0 109.175 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.429 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 40.8 tp -98.76 128.89 45.14 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.339 -0.85 . . . . 0.0 109.794 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 85.5 mt -85.97 78.91 9.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.248 -0.907 . . . . 0.0 108.986 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -98.21 10.89 39.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.469 -0.769 . . . . 0.0 109.074 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -125.11 148.43 48.55 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.5 -0.75 . . . . 0.0 109.817 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.68 -39.98 95.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.542 -0.724 . . . . 0.0 109.91 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -123.53 126.15 72.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.465 -0.772 . . . . 0.0 109.058 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.5 m -123.85 119.45 29.72 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.626 -0.671 . . . . 0.0 109.249 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.3 m -82.86 153.87 24.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.478 -0.764 . . . . 0.0 109.482 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -110.22 177.2 4.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.578 -0.701 . . . . 0.0 109.984 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 69.94 -129.1 20.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -98.99 122.03 41.71 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.347 -1.09 . . . . 0.0 110.241 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.533 ' ND1' ' OG ' ' A' ' 85' ' ' SER . 4.8 t-80 -174.15 94.63 0.32 Allowed Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 38.4 Cg_exo -53.87 150.78 28.79 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.504 2.136 . . . . 0.0 112.995 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.418 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 1.2 m-20 77.24 -19.12 0.45 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.533 ' OG ' ' ND1' ' A' ' 82' ' ' HIS . 11.2 m -74.69 148.01 40.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 110.825 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.429 ' OD2' ' O ' ' A' ' 71' ' ' LEU . 34.2 t70 -62.92 -46.35 88.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.465 -0.772 . . . . 0.0 109.445 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -100.99 112.0 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.355 -0.84 . . . . 0.0 109.348 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 22.9 p90 -130.91 90.13 2.85 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.3 94.94 7.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.419 -0.801 . . . . 0.0 109.063 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 43.7 t0 -87.02 98.94 11.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.459 -0.776 . . . . 0.0 109.413 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 64.5 m-20 -158.32 172.88 17.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.353 -0.842 . . . . 0.0 109.586 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.77 -44.67 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.506 -0.746 . . . . 0.0 109.818 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.6 p -78.28 -171.0 2.21 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.992 -1.068 . . . . 0.0 110.509 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 5.8 t 62.5 115.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.618 0.723 . . . . 0.0 109.9 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 p -69.84 170.71 10.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.6 -0.687 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -58.19 -32.99 68.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 0.0 109.291 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -140.51 59.8 1.55 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -63.55 -40.16 96.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.513 -0.742 . . . . 0.0 109.262 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -151.4 156.0 39.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.215 -0.928 . . . . 0.0 110.075 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -137.03 140.6 42.21 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -103.6 146.87 27.91 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -136.18 147.24 47.58 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.285 -0.884 . . . . 0.0 109.817 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.406 HD13 ' CZ ' ' A' ' 108' ' ' PHE . 55.5 tp -101.97 127.25 48.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.611 -0.681 . . . . 0.0 109.407 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -157.29 144.41 18.5 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.488 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 56.36 35.12 25.35 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.736 -0.603 . . . . 0.0 109.704 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 58.14 31.99 21.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.492 -0.755 . . . . 0.0 109.748 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -142.63 143.13 32.25 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.363 -0.835 . . . . 0.0 109.455 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.406 ' CZ ' HD13 ' A' ' 103' ' ' LEU . 64.8 m-85 -92.45 149.16 21.56 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.383 -0.823 . . . . 0.0 109.64 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -144.11 170.75 15.36 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.351 -0.843 . . . . 0.0 109.554 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 110' ' ' VAL . 14.6 p -125.79 131.04 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.6 t -126.95 130.52 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.53 ' CB ' ' H ' ' A' ' 119' ' ' THR . 26.9 t0 -103.38 128.55 50.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.568 -0.708 . . . . 0.0 109.509 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.9 m -91.68 10.28 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -64.12 148.58 50.94 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.7 m -82.62 -88.05 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.513 -0.992 . . . . 0.0 110.117 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 116' ' ' LEU . 3.5 tt -62.96 -48.12 80.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.427 -0.796 . . . . 0.0 109.729 -179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -92.86 175.41 6.81 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.184 -0.947 . . . . 0.0 110.102 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -176.68 160.22 27.47 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.53 ' H ' ' CB ' ' A' ' 112' ' ' ASP . 26.0 m -63.59 142.48 58.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.357 -1.084 . . . . 0.0 109.871 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.3 p90 -124.76 157.29 36.1 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.67 -0.644 . . . . 0.0 109.542 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.7 p -120.82 134.55 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.509 0.671 . . . . 0.0 109.939 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.0 m120 47.47 -108.11 0.21 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.759 -0.588 . . . . 0.0 109.934 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -128.32 17.13 6.56 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.611 -0.681 . . . . 0.0 109.329 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -124.32 83.31 57.09 Favored Pre-proline 0 N--CA 1.501 2.103 0 O-C-N 121.524 -0.735 . . . . 0.0 109.449 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.81 136.4 75.13 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 122.609 2.206 . . . . 0.0 112.466 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.9 m -151.37 159.28 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.188 -0.945 . . . . 0.0 110.071 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -62.87 -43.66 98.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.503 -0.748 . . . . 0.0 109.584 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 46.6 m -135.85 151.25 49.84 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.324 -0.86 . . . . 0.0 109.223 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -149.73 152.45 35.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.095 -1.003 . . . . 0.0 110.128 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.6 t -95.95 132.14 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.509 -0.744 . . . . 0.0 109.317 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.9 mt -75.52 146.56 40.44 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.961 . . . . 0.0 109.769 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.493 ' H ' ' HB2' ' A' ' 135' ' ' ASP . . . -135.43 153.49 51.76 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.702 . . . . 0.0 109.517 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.665 ' N ' HD22 ' A' ' 133' ' ' ASN . 0.0 OUTLIER -45.41 104.33 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.516 -0.74 . . . . 0.0 110.591 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 92.32 44.52 4.03 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.493 ' HB2' ' H ' ' A' ' 132' ' ' ALA . 15.1 t0 -87.87 163.51 16.36 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.213 -1.169 . . . . 0.0 109.656 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -113.35 116.99 30.55 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.9 t -124.62 133.95 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -132.51 118.96 19.92 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.8 mt -124.0 128.22 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.589 -0.694 . . . . 0.0 109.961 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 53.52 -128.99 40.24 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -95.72 -9.76 31.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.485 -1.009 . . . . 0.0 109.019 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -94.45 142.68 27.15 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 0.0 109.79 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -118.16 130.53 56.16 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.19 149.26 46.55 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.622 -0.674 . . . . 0.0 109.785 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.4 p -124.94 136.88 59.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.422 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 77.0 t80 -83.01 117.66 22.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.657 -0.652 . . . . 0.0 109.73 -179.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 70.7 mt -135.34 146.53 48.5 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.419 0.628 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 44.9 p -111.21 131.79 54.84 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -72.71 2.85 29.67 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -123.9 108.96 13.0 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.551 -0.97 . . . . 0.0 109.494 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -83.61 143.18 30.29 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.392 -0.818 . . . . 0.0 109.756 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -173.49 166.38 4.67 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.393 -0.817 . . . . 0.0 109.67 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 100.69 -17.83 55.94 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.149 -1.581 . . . . 0.0 109.149 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -135.02 -11.86 2.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.472 -1.017 . . . . 0.0 109.036 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 155' ' ' ASP . 53.4 p-10 -70.43 145.33 51.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.913 . . . . 0.0 110.085 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.579 HD12 ' N ' ' A' ' 156' ' ' LEU . 10.1 mp -77.72 142.83 38.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 110.271 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -87.37 -9.48 54.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.59 -0.694 . . . . 0.0 109.467 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -82.58 137.41 34.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 0.0 109.962 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 32.3 p-80 -145.32 137.61 25.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.093 -1.005 . . . . 0.0 109.269 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -85.29 165.21 17.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.274 -0.891 . . . . 0.0 110.207 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -64.2 -12.35 39.7 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.527 -0.733 . . . . 0.0 109.566 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.617 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 60.8 t-80 -70.55 173.41 7.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.334 -0.854 . . . . 0.0 110.658 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.617 ' N ' ' ND1' ' A' ' 162' ' ' HIS . 66.0 m80 . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 118.093 -0.956 . . . . 0.0 109.908 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.449 0.643 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -73.87 150.14 41.11 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.704 0.764 . . . . 0.0 110.809 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.9 ptt-85 -67.34 144.78 55.65 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.597 0.713 . . . . 0.0 110.257 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.87 138.74 53.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 0.0 110.235 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -87.77 109.84 20.03 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 110.025 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.44 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 38.9 p90 -171.47 -26.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.44 HD23 ' CZ ' ' A' ' 29' ' ' PHE . 2.2 pp -105.8 -25.81 12.03 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 t -101.66 72.17 1.36 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.423 -0.798 . . . . 0.0 109.42 -179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 19.1 pt-20 -96.47 124.09 40.35 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 121.795 0.807 . . . . 0.0 109.524 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.469 ' O ' ' N ' ' A' ' 35' ' ' ALA . 83.1 mt -87.45 -3.45 59.01 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 68.1 t0 56.63 -83.61 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.547 -0.721 . . . . 0.0 110.552 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . -92.25 151.74 41.86 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.659 -178.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.93 144.76 77.88 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.501 2.134 . . . . 0.0 112.373 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 42.5 -141.31 0.13 Allowed 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.611 0.719 . . . . 0.0 110.504 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 39' ' ' ALA . 1.5 pp0? -100.57 -4.56 28.32 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' O ' ' O ' ' A' ' 38' ' ' GLN . . . 43.73 97.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.65 0.738 . . . . 0.0 110.253 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.16 149.5 50.15 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 43' ' ' SER . 73.6 m -83.51 -76.1 0.3 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.431 -1.04 . . . . 0.0 109.87 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 69.7 tt0 60.47 -1.05 0.23 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.525 -0.735 . . . . 0.0 109.144 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.67 ' H ' HG22 ' A' ' 41' ' ' THR . 12.4 p -71.63 158.02 36.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.038 -1.038 . . . . 0.0 110.412 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -175.02 27.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.0 m -79.13 137.69 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.409 -0.807 . . . . 0.0 109.952 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.1 m -71.34 150.97 44.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.226 -0.921 . . . . 0.0 110.499 -179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.58 -87.0 0.07 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 49' ' ' GLU . 3.5 m -60.63 -108.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.366 -1.079 . . . . 0.0 110.835 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.503 ' H ' HG23 ' A' ' 48' ' ' VAL . 64.7 tt0 58.99 37.4 24.54 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 167.38 97.05 0.11 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.9 tp -172.1 71.14 0.45 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.243 -1.151 . . . . 0.0 108.95 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.43 179.26 0.14 Allowed 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 122.656 2.237 . . . . 0.0 112.105 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.07 147.16 91.64 Favored 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.397 2.065 . . . . 0.0 112.81 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.35 -20.86 43.8 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 55' ' ' LEU . 7.5 mp -105.27 143.23 33.73 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.417 -1.049 . . . . 0.0 110.054 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.22 159.36 42.8 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.3 OUTLIER -137.64 163.35 31.46 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.461 -0.774 . . . . 0.0 109.786 -179.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -120.14 136.49 54.59 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 85.8 t -123.11 133.47 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-O 121.571 0.701 . . . . 0.0 109.989 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.96 113.43 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.533 -0.729 . . . . 0.0 109.57 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -65.81 -45.6 81.75 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.589 -0.694 . . . . 0.0 109.555 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -156.95 144.43 18.95 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.197 -0.939 . . . . 0.0 109.781 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.426 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . 157.2 -176.62 34.36 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -54.4 -38.79 89.4 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.993 2.462 . . . . 0.0 112.004 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -106.17 22.32 15.91 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.426 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . -39.69 107.62 0.07 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.789 -0.569 . . . . 0.0 110.427 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 138.6 -20.59 3.1 Favored Glycine 0 N--CA 1.497 2.738 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.2 p -69.06 158.09 35.51 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.042 -1.269 . . . . 0.0 110.977 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -143.44 158.14 43.89 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.472 -0.767 . . . . 0.0 109.713 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -129.62 143.75 50.97 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.56 -0.713 . . . . 0.0 109.648 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.4 tp -108.42 126.54 53.0 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.9 mt -98.68 112.16 24.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.342 -0.849 . . . . 0.0 109.355 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 66.7 t0 -132.34 36.47 3.6 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -140.0 155.06 47.27 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.273 -0.892 . . . . 0.0 109.885 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.57 -46.04 91.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.551 -0.718 . . . . 0.0 110.203 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.5 mt -128.31 129.09 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.342 -0.849 . . . . 0.0 109.852 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.9 m -124.66 125.96 44.95 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.5 m -87.31 161.61 17.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -0.842 . . . . 0.0 109.527 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 99' ' ' ALA . . . -120.41 152.54 37.78 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.621 -0.674 . . . . 0.0 109.962 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.5 -130.37 10.2 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.522 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 96.7 mtt180 -100.43 134.39 43.45 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -1.06 . . . . 0.0 110.043 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 50.6 m-70 -165.4 152.23 9.22 Favored Pre-proline 0 C--N 1.302 -1.46 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.07 -15.88 47.78 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.126 1.884 . . . . 0.0 110.893 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.445 ' CG ' ' H ' ' A' ' 85' ' ' SER . 34.5 t70 -142.13 -124.8 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.564 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.445 ' H ' ' CG ' ' A' ' 84' ' ' ASP . 3.5 m 59.02 138.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.765 0.793 . . . . 0.0 110.179 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.18 -41.13 99.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.459 -0.776 . . . . 0.0 109.87 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -88.11 120.47 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.233 -0.917 . . . . 0.0 109.561 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -129.97 86.75 2.44 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.593 -0.692 . . . . 0.0 109.208 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.9 mt -96.52 99.63 11.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.287 -0.883 . . . . 0.0 109.163 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -90.76 94.92 9.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -153.75 152.52 30.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.282 -0.886 . . . . 0.0 109.805 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 93' ' ' THR . 13.6 p -66.42 -34.72 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.482 -0.761 . . . . 0.0 109.809 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.401 ' N ' HG13 ' A' ' 92' ' ' VAL . 42.0 p -64.97 -31.42 72.64 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.858 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.4 t -98.16 126.26 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.111 -0.993 . . . . 0.0 110.196 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 28.9 t -76.58 168.52 19.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.591 -0.693 . . . . 0.0 110.242 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.9 ttp180 -60.84 -42.87 98.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.452 -0.78 . . . . 0.0 109.819 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -124.06 54.31 1.35 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.42 -0.8 . . . . 0.0 109.08 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -64.01 -41.72 97.37 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.557 -0.714 . . . . 0.0 109.551 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -151.73 157.44 42.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.05 -1.031 . . . . 0.0 109.971 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -136.11 149.18 48.58 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.691 . . . . 0.0 109.45 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -112.14 144.03 42.2 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -132.86 138.18 46.95 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.537 -0.727 . . . . 0.0 109.247 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.491 ' CD1' ' O ' ' A' ' 107' ' ' GLU . 39.3 tp -88.99 129.79 35.58 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.44 -0.787 . . . . 0.0 109.997 -179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -169.54 158.66 7.95 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.402 -0.811 . . . . 0.0 108.928 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 59.24 31.81 21.49 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.591 -0.693 . . . . 0.0 109.652 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 52.47 32.53 11.55 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.444 -0.785 . . . . 0.0 109.607 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.555 ' O ' ' CG ' ' A' ' 108' ' ' PHE . 77.3 mm-40 -143.75 -119.71 0.09 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.322 -0.861 . . . . 0.0 108.852 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 107' ' ' GLU . 56.5 m-85 -162.92 150.98 13.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.42 -0.8 . . . . 0.0 109.222 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -137.26 151.2 48.43 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 179.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 110' ' ' VAL . 13.7 p -123.08 131.62 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.5 t -126.17 131.08 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.478 0.656 . . . . 0.0 109.31 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.611 ' CG ' ' H ' ' A' ' 119' ' ' THR . 89.2 m-20 -90.78 147.08 23.45 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.794 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.7 m -133.17 3.1 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -90.41 -136.72 6.61 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 110.796 -0.921 . . . . 0.0 110.796 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 116' ' ' LEU . 28.6 t -55.84 179.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.537 -0.978 . . . . 0.0 110.724 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.459 ' O ' HD13 ' A' ' 116' ' ' LEU . 0.2 OUTLIER -62.38 -50.47 71.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.504 -0.747 . . . . 0.0 109.493 -179.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -65.18 -40.97 94.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 109.511 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.06 -140.51 22.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.611 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 33.4 m -64.3 163.69 12.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.068 . . . . 0.0 109.789 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.583 ' N ' ' CD1' ' A' ' 120' ' ' TYR . 1.6 m-85 -127.22 138.84 53.19 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.598 -0.688 . . . . 0.0 109.452 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.1 p -127.9 134.24 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 m120 47.76 -171.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.433 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.2 ttp180 -65.4 -18.82 65.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.2 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -104.99 104.47 46.88 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.568 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.84 142.13 28.01 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.043 1.828 . . . . 0.0 112.447 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 129' ' ' ALA . 3.8 m -139.6 163.09 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.252 -0.905 . . . . 0.0 110.454 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -66.76 -38.58 86.88 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 37.1 p -158.45 160.17 36.5 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.981 -1.074 . . . . 0.0 109.8 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -169.05 164.3 11.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.061 -1.025 . . . . 0.0 110.315 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.65 130.46 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.583 -0.698 . . . . 0.0 109.447 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.97 150.06 34.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.33 -0.856 . . . . 0.0 110.731 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.54 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -147.05 152.18 38.12 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.735 . . . . 0.0 109.358 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -55.52 134.36 50.72 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.669 0.747 . . . . 0.0 111.183 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.479 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 87.5 13.69 64.96 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 84.4 m-20 -89.99 163.88 14.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.253 -1.145 . . . . 0.0 110.17 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -121.12 132.95 55.16 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -123.58 131.67 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -114.53 119.02 35.41 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 35.1 mm -111.66 124.16 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.654 0.74 . . . . 0.0 109.638 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.72 -124.6 7.1 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -96.56 -1.9 46.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.515 -0.991 . . . . 0.0 108.59 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -95.51 142.48 27.8 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.575 -0.703 . . . . 0.0 109.847 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -107.44 133.74 51.5 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.637 -0.664 . . . . 0.0 109.882 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -138.34 161.14 37.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.422 -0.799 . . . . 0.0 109.132 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -124.95 132.39 71.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -90.03 117.56 28.92 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.479 HD23 ' H ' ' A' ' 134' ' ' GLY . 97.1 mt -134.86 163.64 29.37 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.716 -0.615 . . . . 0.0 110.125 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 150' ' ' HIS . 25.6 p -137.43 -162.01 1.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.633 -0.667 . . . . 0.0 109.897 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -62.43 74.54 0.02 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 148' ' ' THR . 12.7 p80 -76.19 129.47 36.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.171 -1.193 . . . . 0.0 110.24 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -78.28 139.27 38.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -0.835 . . . . 0.0 110.209 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -115.96 -71.44 0.74 Allowed 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 57.34 63.2 5.52 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -64.28 144.59 57.03 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.093 -1.24 . . . . 0.0 109.846 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 157' ' ' GLU . 46.6 t0 57.34 22.21 7.58 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.485 -0.759 . . . . 0.0 109.442 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.487 ' O ' ' ND1' ' A' ' 158' ' ' HIS . 74.4 mt 38.98 27.61 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.066 0 CA-C-O 121.441 0.639 . . . . 0.0 109.82 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 155' ' ' ASP . 10.5 tm-20 -72.72 127.48 32.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.347 -0.845 . . . . 0.0 110.205 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 156' ' ' LEU . 35.5 p-80 -174.23 44.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -60.08 -44.29 94.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.504 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 44.2 p-80 -155.06 151.7 28.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.071 -1.018 . . . . 0.0 109.953 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.6 p80 -154.04 148.92 26.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.241 -0.912 . . . . 0.0 109.591 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.455 ' O ' ' OXT' ' A' ' 163' ' ' HIS . 33.9 t-80 -151.41 140.24 20.9 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.219 -0.926 . . . . 0.0 109.682 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.455 ' OXT' ' O ' ' A' ' 162' ' ' HIS . 58.0 t-80 . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 117.753 -1.118 . . . . 0.0 110.205 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.715 0.769 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -82.64 -76.38 0.27 Allowed 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 121.765 0.793 . . . . 0.0 109.666 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -72.67 136.31 45.6 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.359 -0.838 . . . . 0.0 110.383 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.34 147.79 52.82 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.926 0.87 . . . . 0.0 110.439 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -75.77 -4.42 40.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.523 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.505 ' CE1' ' O ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -88.74 162.57 16.17 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.954 -1.091 . . . . 0.0 109.701 -179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.505 ' O ' ' CE1' ' A' ' 29' ' ' PHE . 33.9 mt -58.78 81.8 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.474 -0.767 . . . . 0.0 109.8 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.496 ' N ' ' O ' ' A' ' 29' ' ' PHE . 7.0 t -103.45 -134.98 0.33 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.802 0.811 . . . . 0.0 109.832 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' OE1' ' OG ' ' A' ' 31' ' ' SER . 39.9 mp0 -80.04 106.88 12.38 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.019 0.914 . . . . 0.0 109.996 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 33' ' ' LEU . 10.1 mp -70.65 143.36 51.45 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.817 0.818 . . . . 0.0 109.585 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -48.88 113.54 0.81 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.299 -0.875 . . . . 0.0 110.86 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.412 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . -171.72 56.32 0.23 Allowed Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.443 -0.785 . . . . 0.0 109.063 179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 35' ' ' ALA . 49.7 Cg_endo -68.96 156.15 66.26 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.851 2.367 . . . . 0.0 112.184 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.86 144.75 56.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.317 -0.864 . . . . 0.0 110.629 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -158.6 -68.44 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.765 0.793 . . . . 0.0 109.287 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -44.3 112.69 0.44 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.099 0.952 . . . . 0.0 110.559 -179.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 41' ' ' THR . . . -85.61 -0.73 87.88 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 40' ' ' GLY . 3.1 p 38.33 55.36 1.79 Allowed 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.907 0.86 . . . . 0.0 110.167 -179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.85 134.96 55.18 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.838 0.828 . . . . 0.0 110.336 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.4 m 49.32 -111.15 0.45 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.634 -0.666 . . . . 0.0 110.052 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -175.31 -27.77 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.15 139.18 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 0.0 110.483 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.3 m 56.07 87.53 0.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.966 0.889 . . . . 0.0 110.078 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.09 -60.77 0.83 Allowed Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.4 HG11 HD22 ' A' ' 51' ' ' LEU . 98.8 t -64.83 -45.67 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.214 -1.168 . . . . 0.0 110.296 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 43.99 79.21 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.139 -0.976 . . . . 0.0 110.397 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 63.14 117.24 0.01 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.576 HD11 ' H ' ' A' ' 149' ' ' GLY . 0.3 OUTLIER -110.66 139.59 21.77 Favored Pre-proline 0 N--CA 1.497 1.907 0 O-C-N 121.616 -0.931 . . . . 0.0 109.819 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -50.36 160.29 1.62 Allowed 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.532 2.155 . . . . 0.0 112.09 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.45 144.2 49.68 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.666 2.244 . . . . 0.0 112.976 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.61 14.05 68.84 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.67 151.6 42.93 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.446 -1.032 . . . . 0.0 109.847 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.84 156.19 42.45 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.295 -0.878 . . . . 0.0 109.492 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.42 153.55 49.58 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.98 0.895 . . . . 0.0 110.13 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.63 134.9 54.76 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -122.97 135.36 63.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 CA-C-O 121.875 0.845 . . . . 0.0 109.902 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.1 t -67.37 135.6 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 CA-C-O 121.676 0.75 . . . . 0.0 110.101 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -84.65 -74.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 109.399 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.685 HH21 ' NH1' ' A' ' 143' ' ' ARG . 88.2 mtm180 -129.11 147.65 50.99 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.433 -0.792 . . . . 0.0 110.0 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.97 177.66 26.78 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -65.83 -19.04 58.93 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.664 2.243 . . . . 0.0 110.922 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 66' ' ' ALA . 35.5 m120 -84.47 -80.77 0.19 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.301 -0.875 . . . . 0.0 109.508 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 58.8 131.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.974 0.892 . . . . 0.0 110.901 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.29 -21.62 41.43 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 66.8 m -69.87 146.3 51.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.253 -1.145 . . . . 0.0 111.011 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 35.2 ptt-85 -145.5 156.53 43.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.887 . . . . 0.0 109.786 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -129.54 144.35 51.23 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.519 -0.738 . . . . 0.0 109.519 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.5 tp -104.06 127.94 51.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.685 -0.634 . . . . 0.0 109.301 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -100.07 74.04 1.76 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.025 -1.047 . . . . 0.0 109.177 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 32.1 p-10 -94.67 3.87 54.54 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -106.6 153.07 22.89 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.281 -0.887 . . . . 0.0 110.059 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.84 -45.06 94.35 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.454 -0.779 . . . . 0.0 109.808 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.2 mt -125.55 126.86 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 86' ' ' ASP . 96.6 m -126.46 120.66 30.31 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.7 p -84.76 166.49 16.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.324 -0.86 . . . . 0.0 109.962 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.38 170.89 7.64 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.932 0.872 . . . . 0.0 110.215 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.29 -131.3 29.91 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -110.77 130.65 55.52 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.398 -1.06 . . . . 0.0 110.104 -179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -170.08 136.14 1.27 Allowed Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -42.57 -58.47 1.26 Allowed 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.485 2.123 . . . . 0.0 112.653 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -96.1 92.72 6.56 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.205 -0.935 . . . . 0.0 109.88 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.48 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 82.9 p -171.13 121.09 0.53 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 108.972 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.466 ' H ' HG23 ' A' ' 77' ' ' THR . 59.3 m-20 -68.1 -34.32 76.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.421 -0.799 . . . . 0.0 109.298 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.94 130.19 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.861 -1.149 . . . . 0.0 109.761 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.48 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 62.4 m-85 -129.07 89.33 2.85 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.427 -0.796 . . . . 0.0 109.401 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 92.7 mt -101.18 103.35 14.39 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -92.52 87.66 6.05 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.626 0.727 . . . . 0.0 109.881 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.46 ' OD2' ' CZ ' ' A' ' 142' ' ' PHE . 65.2 m-20 -150.22 149.53 30.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.16 -0.963 . . . . 0.0 109.757 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.2 m -72.79 -26.27 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.733 0.778 . . . . 0.0 109.568 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.2 p -71.66 -17.21 62.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 0.0 109.382 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.0 t -110.94 126.78 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.325 -0.859 . . . . 0.0 109.415 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 p -77.08 168.63 19.76 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.797 0.808 . . . . 0.0 110.667 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -63.67 -38.08 89.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.477 -0.764 . . . . 0.0 109.878 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 85.6 mtp180 -129.97 50.56 2.17 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.117 -0.989 . . . . 0.0 109.115 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 22.9 t-160 -62.63 -40.8 98.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.078 -1.014 . . . . 0.0 108.969 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.99 159.89 43.8 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.898 -1.126 . . . . 0.0 110.107 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -134.55 150.53 50.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.498 -0.751 . . . . 0.0 109.436 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -114.27 140.05 48.91 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.575 -0.703 . . . . 0.0 109.312 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -134.56 136.86 43.31 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.433 -0.792 . . . . 0.0 109.189 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 38.5 tp -102.63 127.68 49.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -155.66 143.74 19.95 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.19 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 56.24 39.73 30.15 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.547 0.689 . . . . 0.0 110.135 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.2 m120 55.22 31.79 17.2 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.597 0.713 . . . . 0.0 109.382 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -139.79 130.96 26.5 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.237 -0.914 . . . . 0.0 109.753 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -83.62 146.27 28.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.306 -0.871 . . . . 0.0 109.987 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 43.4 p30 -147.58 167.15 25.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.152 -0.967 . . . . 0.0 109.379 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.21 135.59 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.9 t -125.63 130.84 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 119' ' ' THR . 15.0 m-20 -95.23 134.35 38.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.37 -3.91 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.529 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -88.44 129.86 9.82 Favored Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.442 ' C ' ' N ' ' A' ' 117' ' ' ASN . 2.9 t 39.87 24.53 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.075 0.94 . . . . 0.0 109.791 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.529 ' N ' ' O ' ' A' ' 114' ' ' GLY . 4.6 tp 55.81 9.56 0.45 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.927 0.87 . . . . 0.0 108.78 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' N ' ' C ' ' A' ' 115' ' ' SER . 66.1 t30 -155.98 114.77 3.46 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.341 -0.85 . . . . 0.0 109.188 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.501 ' O ' ' CZ ' ' A' ' 120' ' ' TYR . . . -149.11 -67.18 0.01 OUTLIER Glycine 0 N--CA 1.496 2.654 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.572 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 29.0 m -67.44 137.03 55.58 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.331 -1.099 . . . . 0.0 110.489 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.501 ' CZ ' ' O ' ' A' ' 118' ' ' GLY . 22.5 m-85 -127.89 145.34 50.98 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.443 -0.786 . . . . 0.0 109.379 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.452 HG22 ' N ' ' A' ' 122' ' ' ASN . 9.4 p -109.59 157.05 10.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 121.847 0.832 . . . . 0.0 109.752 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.464 ' ND2' ' CD ' ' A' ' 136' ' ' GLU . 90.8 m-20 -53.21 -39.6 63.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.828 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -57.41 -83.41 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.941 -1.099 . . . . 0.0 109.631 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -143.35 147.39 39.94 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.076 -1.015 . . . . 0.0 109.553 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.18 120.73 8.31 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.603 2.202 . . . . 0.0 111.894 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.0 m -137.69 163.18 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.186 -0.946 . . . . 0.0 110.203 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 128' ' ' SER . 47.8 p-10 -66.94 -33.03 74.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.55 -0.719 . . . . 0.0 109.487 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.548 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 86.4 p -152.23 160.19 43.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.024 -1.047 . . . . 0.0 109.278 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.39 156.51 30.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 0.0 110.029 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 72.7 t -89.1 130.15 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.491 -0.755 . . . . 0.0 109.941 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 78.6 mt -76.49 151.38 36.45 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.849 0.833 . . . . 0.0 110.209 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.553 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.77 155.71 39.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.507 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -51.33 124.02 10.91 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.921 0.867 . . . . 0.0 110.972 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.07 16.22 59.71 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.553 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 28.9 m-20 -87.75 155.48 19.89 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.925 -1.338 . . . . 0.0 110.565 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.547 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 56.6 mp0 -113.61 128.2 56.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.661 -0.649 . . . . 0.0 109.499 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.415 ' O ' ' O ' ' A' ' 144' ' ' LEU . 54.8 t -125.45 131.48 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.403 ' O ' ' NE2' ' A' ' 138' ' ' GLN . 4.9 pp0? -123.2 132.83 54.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.706 -0.621 . . . . 0.0 109.776 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.18 117.08 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.668 0.747 . . . . 0.0 109.052 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 61.26 -127.84 43.07 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -93.27 -5.33 50.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -1.161 . . . . 0.0 109.02 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.46 ' CZ ' ' OD2' ' A' ' 91' ' ' ASP . 57.8 m-85 -96.13 133.7 40.1 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.184 -0.947 . . . . 0.0 109.375 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.685 ' NH1' HH21 ' A' ' 62' ' ' ARG . 83.3 mtp180 -103.27 139.4 38.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.592 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 137' ' ' VAL . 4.7 mp -135.51 166.47 23.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 0.0 109.47 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.0 p -128.69 133.67 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-O 121.652 0.739 . . . . 0.0 109.567 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -96.1 115.52 27.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.375 -0.828 . . . . 0.0 109.249 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.57 147.88 51.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.626 0.727 . . . . 0.0 109.668 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 150' ' ' HIS . 6.3 p -134.41 167.46 20.71 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.541 0.686 . . . . 0.0 109.632 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.576 ' H ' HD11 ' A' ' 51' ' ' LEU . . . -69.84 34.26 0.38 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.522 ' H ' ' C ' ' A' ' 148' ' ' THR . 84.9 t60 58.02 146.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.598 -0.943 . . . . 0.0 111.039 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.435 ' O ' ' CD2' ' A' ' 150' ' ' HIS . 98.8 mttt -77.1 147.94 36.34 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.875 0.845 . . . . 0.0 110.616 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -70.24 165.05 23.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.922 0.868 . . . . 0.0 111.045 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -154.14 111.22 0.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -150.83 -35.07 0.15 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.281 -1.129 . . . . 0.0 108.292 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.5 p-10 -68.15 148.08 51.41 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.247 -0.908 . . . . 0.0 110.53 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 74.5 mt -69.27 141.9 54.25 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.92 0.867 . . . . 0.0 110.524 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -76.79 143.66 39.68 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.986 0.898 . . . . 0.0 110.107 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -74.51 141.31 44.89 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.695 0.759 . . . . 0.0 110.514 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -152.78 -158.81 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.319 -0.863 . . . . 0.0 109.979 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 55.4 79.3 0.16 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.977 0.894 . . . . 0.0 109.862 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -154.64 146.55 23.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.549 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -144.6 124.6 13.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.265 -0.897 . . . . 0.0 108.994 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 163' ' ' HIS . 61.3 t-80 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.457 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' ' O ' ' A' ' 26' ' ' ARG . 43.5 p90 -87.33 -11.68 48.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.466 -0.771 . . . . 0.0 109.241 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 25' ' ' PHE . 91.1 mtm-85 55.62 116.26 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.632 0.729 . . . . 0.0 110.892 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.409 ' H ' HD12 ' A' ' 30' ' ' LEU . . . -66.14 -136.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.582 -0.699 . . . . 0.0 110.41 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -78.94 -3.46 44.99 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.267 -0.896 . . . . 0.0 109.663 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 3.0 p90 -148.64 -125.4 0.05 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.17 -0.956 . . . . 0.0 109.559 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 32' ' ' GLU . 89.6 mt 60.42 130.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.663 0.744 . . . . 0.0 110.384 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.5 t 47.86 -86.94 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.18 0.514 . . . . 0.0 110.079 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' LEU . 45.7 tp10 56.46 72.18 0.52 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.326 -0.859 . . . . 0.0 110.086 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 mt 58.08 -178.3 0.07 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.715 0.769 . . . . 0.0 111.494 178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -86.86 111.6 20.94 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.427 0.632 . . . . 0.0 109.643 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.673 ' HB1' ' CD ' ' A' ' 36' ' ' PRO . . . -78.29 -178.23 1.01 Allowed Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.434 -0.791 . . . . 0.0 109.587 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.673 ' CD ' ' HB1' ' A' ' 35' ' ' ALA . 35.8 Cg_exo -59.84 144.83 99.39 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.918 2.412 . . . . 0.0 112.944 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.566 ' O ' ' N ' ' A' ' 39' ' ' ALA . . . -86.53 -11.12 52.53 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 51.8 -83.24 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.583 -0.698 . . . . 0.0 110.127 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . -62.74 -21.28 65.69 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.284 -0.885 . . . . 0.0 109.472 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.91 25.36 41.51 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 98.7 m -63.23 -43.37 98.26 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.407 -1.055 . . . . 0.0 109.711 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -50.35 139.83 14.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.902 . . . . 0.0 110.992 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 p 45.63 70.25 0.38 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.684 -0.635 . . . . 0.0 110.188 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -102.76 -64.46 1.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.703 -0.623 . . . . 0.0 109.379 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.3 t -87.48 128.23 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.215 -0.928 . . . . 0.0 109.931 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.1 p -78.63 162.85 25.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.444 -0.785 . . . . 0.0 110.545 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.61 -174.49 48.19 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.474 ' O ' ' N ' ' A' ' 50' ' ' GLY . 15.1 t -85.17 118.32 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.549 -0.971 . . . . 0.0 109.827 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 48' ' ' VAL . 46.0 tt0 39.7 -93.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.779 -0.576 . . . . 0.0 110.668 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . -107.64 -44.38 1.23 Allowed Glycine 0 N--CA 1.497 2.754 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 50' ' ' GLY . 0.4 OUTLIER 42.72 78.5 0.38 Allowed Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 121.327 -1.102 . . . . 0.0 109.566 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -77.38 169.94 20.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.108 1.872 . . . . 0.0 112.485 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -56.82 147.42 72.72 Favored 'Trans proline' 0 N--CA 1.501 1.923 0 C-N-CA 122.395 2.063 . . . . 0.0 112.872 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 103.24 -15.02 54.85 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 88.2 mt -122.37 142.97 49.95 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.558 -0.966 . . . . 0.0 109.223 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.13 155.18 41.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.17 -0.956 . . . . 0.0 110.198 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.532 ' N ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -127.38 157.12 40.82 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.186 0.517 . . . . 0.0 109.733 -179.544 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 6.4 mt -117.04 128.7 55.42 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.7 t -112.01 134.08 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.642 0.734 . . . . 0.0 109.538 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.6 t -78.36 111.69 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.677 -0.64 . . . . 0.0 109.898 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -64.88 -43.62 92.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.577 -0.702 . . . . 0.0 110.219 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -137.21 151.77 49.13 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.534 -0.729 . . . . 0.0 110.287 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.06 172.29 22.61 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -66.21 -20.83 55.81 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.956 2.437 . . . . 0.0 112.006 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.427 ' O ' ' C ' ' A' ' 66' ' ' ALA . 93.1 m-20 -98.65 -35.74 10.09 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.446 -0.784 . . . . 0.0 109.357 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . 35.42 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.313 0.578 . . . . 0.0 110.789 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.48 -15.13 3.66 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.9 m -62.86 144.49 56.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.487 -1.008 . . . . 0.0 110.766 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 40.1 ptt180 -137.57 156.04 48.53 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.603 -0.686 . . . . 0.0 109.354 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -126.32 146.75 49.91 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.626 -0.671 . . . . 0.0 109.315 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.665 HD13 ' N ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -104.78 126.56 51.97 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.665 ' N ' HD13 ' A' ' 71' ' ' LEU . 79.3 mt -100.53 124.47 46.12 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-O 121.452 0.644 . . . . 0.0 109.669 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -154.39 56.63 0.7 Allowed 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.429 ' CD ' ' N ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -161.08 175.57 12.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.491 -0.756 . . . . 0.0 109.547 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.13 -65.53 1.0 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.495 -0.753 . . . . 0.0 110.297 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 29.2 mm -108.56 124.56 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.765 . . . . 0.0 110.212 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.411 ' OG1' ' CD ' ' A' ' 74' ' ' GLN . 31.5 m -127.97 127.08 42.62 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 p -84.65 165.02 18.27 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.562 -0.711 . . . . 0.0 109.936 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 98' ' ' HIS . . . -109.79 164.93 12.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.631 -0.668 . . . . 0.0 110.026 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.445 ' N ' ' NE2' ' A' ' 98' ' ' HIS . . . 70.99 -127.73 15.51 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.535 ' O ' ' ND1' ' A' ' 82' ' ' HIS . 96.9 mtt180 -101.87 137.01 40.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.399 -1.059 . . . . 0.0 110.491 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.535 ' ND1' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 173.13 153.79 0.25 Allowed Pre-proline 0 N--CA 1.49 1.531 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.3 144.41 51.07 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.733 2.289 . . . . 0.0 113.059 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 55.5 t0 57.09 28.6 15.17 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.451 -0.781 . . . . 0.0 109.348 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.475 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 18.3 t -98.19 119.81 37.49 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.34 -0.85 . . . . 0.0 109.572 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -65.03 -36.45 84.41 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.42 -0.8 . . . . 0.0 109.318 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.2 mm -78.24 128.45 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.272 -0.892 . . . . 0.0 110.212 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.475 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 91.6 m-85 -126.85 86.98 2.58 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 64.8 mt -108.21 106.45 16.64 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.619 0.723 . . . . 0.0 109.641 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 55.6 t0 -86.51 90.82 8.35 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.501 ' OD2' ' CE2' ' A' ' 142' ' ' PHE . 71.1 m-20 -151.33 130.66 12.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.286 -0.884 . . . . 0.0 109.876 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.9 p -69.14 -24.9 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.4 p -75.18 -13.81 60.49 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.554 -0.717 . . . . 0.0 109.182 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 95' ' ' SER . 89.5 t -101.75 -15.1 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 94' ' ' VAL . 79.4 p 50.23 174.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.592 0.71 . . . . 0.0 110.792 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -59.88 -65.66 0.64 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 109.935 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -102.17 134.53 45.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.648 -0.658 . . . . 0.0 109.779 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.484 ' CE1' ' HB1' ' A' ' 79' ' ' ALA . 4.8 p80 -154.3 -35.42 0.1 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.432 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -151.67 158.52 43.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.823 . . . . 0.0 109.928 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -137.16 151.2 48.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.653 -0.654 . . . . 0.0 109.67 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -111.5 142.63 43.53 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 79.0 mtp85 -134.65 141.03 46.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.473 -0.767 . . . . 0.0 109.796 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 56.9 tp -102.44 127.13 49.6 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.683 -0.635 . . . . 0.0 109.32 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' A' ' 106' ' ' ASN . 80.5 tt0 -155.99 -70.69 0.11 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.557 -0.714 . . . . 0.0 109.355 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -72.05 32.71 0.06 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.497 -0.752 . . . . 0.0 109.529 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.499 ' H ' ' C ' ' A' ' 104' ' ' GLU . 16.2 p30 44.02 30.19 0.4 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.658 0.742 . . . . 0.0 109.53 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 108' ' ' PHE . 96.1 mt-10 -144.47 10.24 1.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 107' ' ' GLU . 94.1 m-85 58.17 144.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.255 0.55 . . . . 0.0 110.494 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -133.76 163.7 28.88 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.3 132.18 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.737 -0.602 . . . . 0.0 109.487 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.7 t -128.65 133.6 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -83.98 114.67 21.87 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.317 -0.864 . . . . 0.0 109.487 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.04 -177.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 111.006 -179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.2 -3.64 65.92 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 12.7 p -74.09 158.89 33.42 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.493 -1.004 . . . . 0.0 110.429 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.522 HD23 ' C ' ' A' ' 116' ' ' LEU . 3.5 tt -69.86 106.58 3.2 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.404 -0.81 . . . . 0.0 109.854 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.406 ' N ' HD23 ' A' ' 116' ' ' LEU . 63.2 t-20 -155.24 110.17 3.0 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.346 -0.846 . . . . 0.0 108.902 179.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -84.38 48.52 4.06 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.3 m -63.81 136.06 57.11 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.358 -1.084 . . . . 0.0 110.402 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.423 ' OH ' ' NH1' ' A' ' 123' ' ' ARG . 31.4 p90 -141.54 157.98 44.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.513 -0.742 . . . . 0.0 109.12 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.446 ' O ' HG13 ' A' ' 121' ' ' VAL . 9.1 p -121.02 128.86 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 121.451 0.643 . . . . 0.0 109.888 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 54.35 38.54 29.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.65 -0.656 . . . . 0.0 109.614 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.423 ' NH1' ' OH ' ' A' ' 120' ' ' TYR . 31.0 mmt180 60.47 44.01 12.45 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.436 0.636 . . . . 0.0 110.21 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -147.63 87.21 6.01 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.522 -0.736 . . . . 0.0 109.127 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.4 130.45 38.61 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.378 2.052 . . . . 0.0 112.076 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.5 m -147.34 154.4 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 0.0 110.326 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.89 -39.81 94.11 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 88.6 p -157.26 157.35 34.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.229 -0.919 . . . . 0.0 109.582 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -162.37 149.99 14.04 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.288 -0.883 . . . . 0.0 109.806 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.0 t -80.65 135.98 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.501 -0.749 . . . . 0.0 110.434 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 94.8 mt -76.28 148.89 37.25 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.358 -0.839 . . . . 0.0 109.856 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.03 154.72 44.28 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.571 0.701 . . . . 0.0 109.773 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.608 ' ND2' ' H ' ' A' ' 148' ' ' THR . 24.4 t-20 -55.97 115.07 2.19 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-O 121.581 0.705 . . . . 0.0 110.751 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 146' ' ' PHE . . . 84.13 15.34 69.78 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 136' ' ' GLU . 67.7 t0 -64.23 145.74 55.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.142 -1.211 . . . . 0.0 109.996 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 135' ' ' ASP . 98.4 mt-10 -93.49 122.12 35.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.235 -0.916 . . . . 0.0 109.5 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 52.8 t -122.05 132.89 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -122.67 124.92 44.52 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.437 ' O ' ' N ' ' A' ' 141' ' ' LYS . 96.6 mt -124.42 129.95 73.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.307 0.575 . . . . 0.0 109.947 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.69 -88.47 0.01 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 139' ' ' ILE . 63.3 mttp -141.88 -4.33 1.07 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.461 -1.023 . . . . 0.0 108.624 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.501 ' CE2' ' OD2' ' A' ' 91' ' ' ASP . 62.2 m-85 -96.94 140.49 31.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.472 -0.767 . . . . 0.0 109.924 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -105.0 129.48 53.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.658 -0.651 . . . . 0.0 109.992 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.07 149.68 50.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 2.6 p -120.22 129.06 75.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 121.6 0.714 . . . . 0.0 109.119 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.469 ' O ' ' N ' ' A' ' 134' ' ' GLY . 76.0 t80 -90.08 127.67 36.13 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.764 -0.585 . . . . 0.0 109.582 -179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.911 HD23 ' N ' ' A' ' 147' ' ' LEU . 0.6 OUTLIER -143.41 174.95 10.29 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.823 0.821 . . . . 0.0 110.06 -179.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.608 ' H ' ' ND2' ' A' ' 133' ' ' ASN . 18.9 p -145.34 -151.58 0.38 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.525 0.678 . . . . 0.0 109.482 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -73.69 8.35 11.0 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 86.1 t60 54.03 77.12 0.2 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.216 -1.167 . . . . 0.0 109.919 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -85.69 143.09 28.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.28 -0.888 . . . . 0.0 110.591 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.36 143.06 53.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.563 -0.711 . . . . 0.0 110.238 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -74.88 -124.65 0.14 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 54.91 -165.77 0.1 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.625 -0.927 . . . . 0.0 110.84 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 -61.55 149.11 40.03 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 121.803 0.811 . . . . 0.0 110.92 -178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 74.1 mt -67.03 144.97 55.85 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.604 0.716 . . . . 0.0 110.669 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -61.81 148.73 42.23 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.515 -0.741 . . . . 0.0 110.299 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -76.34 155.28 34.3 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.723 -0.611 . . . . 0.0 110.307 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -133.88 138.14 45.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.513 -0.742 . . . . 0.0 109.416 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 62.3 t60 -90.46 129.76 36.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.441 -0.787 . . . . 0.0 110.221 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -66.53 -35.56 80.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.6 -0.687 . . . . 0.0 109.617 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 82.8 t60 58.11 86.63 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.49 -0.757 . . . . 0.0 109.716 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 82.4 t60 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.63 -179.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 25' ' ' PHE . 7.5 p . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.461 ' O ' ' O ' ' A' ' 26' ' ' ARG . 72.1 t80 54.13 108.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.371 -0.831 . . . . 0.0 110.225 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' O ' ' O ' ' A' ' 25' ' ' PHE . 62.8 ttm-85 56.89 149.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.71 0.767 . . . . 0.0 110.251 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -63.02 137.75 58.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.877 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 28' ' ' ASP . 9.7 p-10 -95.35 -0.74 52.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 0.0 109.602 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.585 ' CD1' ' N ' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -105.16 -17.66 14.4 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.5 mt -94.44 -10.39 32.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.169 -0.957 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -89.9 -12.97 37.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 109.971 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -111.38 117.06 32.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.449 -0.782 . . . . 0.0 109.335 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.69 -41.96 98.07 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.762 -0.586 . . . . 0.0 110.617 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -88.92 114.12 25.2 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.117 -0.99 . . . . 0.0 109.973 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.651 ' HB3' ' CD ' ' A' ' 36' ' ' PRO . . . -166.09 -62.95 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.447 -0.783 . . . . 0.0 109.399 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.651 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 22.4 Cg_endo -59.51 -28.7 88.14 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.073 1.849 . . . . 0.0 111.45 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.477 ' HB1' ' NE2' ' A' ' 38' ' ' GLN . . . 39.27 -153.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.6 0.714 . . . . 0.0 110.926 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.661 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 2.9 pm0 -95.51 10.96 34.71 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.433 -0.792 . . . . 0.0 109.136 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 38' ' ' GLN . . . 63.29 18.92 11.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.456 -0.778 . . . . 0.0 109.938 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.427 ' H ' ' HG2' ' A' ' 38' ' ' GLN . . . -87.16 -135.4 4.45 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 82.5 p 48.09 -162.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.997 . . . . 0.0 110.817 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -68.38 -168.74 0.12 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.689 0.757 . . . . 0.0 111.163 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.418 ' O ' ' OG ' ' A' ' 43' ' ' SER . 7.8 t 51.38 22.12 1.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.714 . . . . 0.0 109.252 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.94 -5.42 59.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.404 -0.81 . . . . 0.0 109.368 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.7 m -72.88 138.49 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.322 -0.861 . . . . 0.0 109.877 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.1 p -75.95 162.16 28.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.55 -0.719 . . . . 0.0 110.202 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.18 95.77 0.98 Allowed Glycine 0 N--CA 1.495 2.593 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 50' ' ' GLY . 33.6 m -77.61 138.35 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.31 -1.112 . . . . 0.0 109.509 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -50.69 88.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.411 -0.805 . . . . 0.0 110.661 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . 58.63 165.06 0.1 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.444 HD22 ' O ' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -154.75 85.61 3.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.454 -1.027 . . . . 0.0 108.54 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -55.58 -42.43 67.83 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 122.44 2.094 . . . . 0.0 113.783 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -73.6 23.7 0.33 Allowed 'Trans proline' 0 N--CA 1.489 1.242 0 CA-C-N 120.058 1.056 . . . . 0.0 112.048 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.479 ' O ' HD12 ' A' ' 55' ' ' LEU . . . 49.76 81.68 0.05 OUTLIER Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.479 HD12 ' O ' ' A' ' 54' ' ' GLY . 7.2 mp -116.52 160.75 20.17 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.509 -0.995 . . . . 0.0 109.526 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.81 154.93 51.04 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.35 152.66 48.67 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.454 -0.779 . . . . 0.0 109.616 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.0 mt -113.7 134.41 54.76 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.38 -0.971 . . . . 0.0 108.38 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -120.8 134.98 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 t -71.62 110.84 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.576 -0.703 . . . . 0.0 109.632 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -64.55 -44.98 89.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.323 -0.861 . . . . 0.0 109.68 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -141.88 148.34 38.59 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.363 -0.835 . . . . 0.0 109.898 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 152.52 178.69 27.43 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.68 -40.48 84.22 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.326 2.017 . . . . 0.0 111.497 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.8 p-10 -114.02 48.24 1.11 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.09 95.78 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.512 -0.743 . . . . 0.0 109.387 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.53 -17.04 0.58 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.969 -1.653 . . . . 0.0 108.969 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 41.2 t -62.56 150.23 41.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.492 -1.005 . . . . 0.0 109.513 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.8 ptt85 -130.3 156.2 45.05 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.633 -0.667 . . . . 0.0 109.292 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -128.17 146.07 50.83 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.533 -0.73 . . . . 0.0 109.286 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 tp -105.66 125.36 50.9 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.642 -0.661 . . . . 0.0 109.557 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.0 mt -96.54 77.85 2.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.406 -0.809 . . . . 0.0 109.0 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -91.01 12.85 18.42 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.409 -0.807 . . . . 0.0 109.405 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -126.51 140.63 52.31 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.588 -0.695 . . . . 0.0 109.43 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.26 -46.93 88.09 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.521 -0.737 . . . . 0.0 110.446 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 mm -106.18 118.47 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 O-C-N 121.303 -0.873 . . . . 0.0 109.764 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.9 m -123.22 122.85 39.41 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.5 t -87.65 167.3 14.01 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.175 -0.953 . . . . 0.0 109.543 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 99' ' ' ALA . . . -122.51 146.88 46.99 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.556 -0.715 . . . . 0.0 109.097 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 106.71 -125.22 8.01 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.533 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 99.8 mtt180 -103.32 133.33 48.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.436 -1.037 . . . . 0.0 110.556 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.533 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 0.7 OUTLIER 175.11 120.12 0.12 Allowed Pre-proline 0 N--CA 1.489 1.495 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -74.08 -14.76 23.44 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 121.59 1.526 . . . . 0.0 111.287 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 66.5 t0 -96.74 -24.13 16.09 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.537 -0.727 . . . . 0.0 109.453 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.5 t -74.55 139.92 44.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.446 -0.784 . . . . 0.0 110.659 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.59 -41.29 96.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 109.687 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -84.74 129.51 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.344 -0.848 . . . . 0.0 110.303 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CZ ' ' OD2' ' A' ' 90' ' ' ASP . 84.4 t80 -129.25 84.84 2.25 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 75.7 mt -108.54 109.34 20.55 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.559 -0.713 . . . . 0.0 109.916 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.517 ' OD2' ' CZ ' ' A' ' 88' ' ' PHE . 97.9 m-20 -99.95 -93.38 0.27 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.511 -0.743 . . . . 0.0 109.352 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.468 ' CG ' ' CE1' ' A' ' 142' ' ' PHE . 1.5 p30 39.75 -165.45 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.645 0.736 . . . . 0.0 110.783 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.9 m -71.84 161.55 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.312 -0.867 . . . . 0.0 110.057 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.5 p 54.56 -139.77 0.98 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.279 0.562 . . . . 0.0 110.676 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 9.2 t 42.72 89.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.493 -0.754 . . . . 0.0 109.649 -179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.9 t -69.36 173.33 5.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.47 -0.769 . . . . 0.0 110.816 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -60.39 -43.91 96.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.48 -0.762 . . . . 0.0 109.358 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 92.1 mtm-85 -123.23 64.14 1.0 Allowed 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -83.36 -35.08 25.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.536 -0.728 . . . . 0.0 109.69 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -150.45 149.62 30.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.233 -0.917 . . . . 0.0 109.803 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -141.49 134.23 28.68 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -100.98 145.8 28.23 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.507 -0.746 . . . . 0.0 109.786 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -131.63 132.18 43.81 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 44.9 tp -90.75 130.57 36.72 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.307 -0.871 . . . . 0.0 109.622 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.544 ' O ' ' N ' ' A' ' 106' ' ' ASN . 49.1 tp10 -131.97 140.81 49.1 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.582 -0.699 . . . . 0.0 109.319 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 51.63 -85.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.469 -0.769 . . . . 0.0 110.085 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.544 ' N ' ' O ' ' A' ' 104' ' ' GLU . 16.9 t-20 -155.75 20.57 0.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.323 -0.861 . . . . 0.0 109.456 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -134.02 139.95 46.37 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.548 -0.72 . . . . 0.0 109.373 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -77.34 147.13 36.31 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.513 -0.742 . . . . 0.0 109.981 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -124.85 160.89 27.74 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.33 134.15 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.8 t -127.33 135.48 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.553 ' CG ' ' H ' ' A' ' 119' ' ' THR . 50.2 t0 -84.0 111.73 19.54 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.188 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.0 t -94.23 109.48 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.425 -0.797 . . . . 0.0 109.304 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 164.12 -177.9 39.68 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.439 ' O ' ' O ' ' A' ' 116' ' ' LEU . 39.6 t -69.7 135.49 49.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -1.095 . . . . 0.0 109.907 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.525 ' N ' HD22 ' A' ' 116' ' ' LEU . 3.8 mm? 43.93 -170.85 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.327 -0.858 . . . . 0.0 110.684 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 118' ' ' GLY . 58.6 t-20 -71.95 147.75 46.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.769 . . . . 0.0 110.341 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 117' ' ' ASN . . . -148.98 -72.59 0.01 OUTLIER Glycine 0 N--CA 1.496 2.665 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.553 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 23.8 m -62.28 139.59 58.51 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.174 -1.192 . . . . 0.0 109.874 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -132.9 157.62 44.63 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.462 -0.774 . . . . 0.0 109.223 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.456 ' O ' HG13 ' A' ' 121' ' ' VAL . 8.8 p -118.94 128.42 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.561 -0.712 . . . . 0.0 109.375 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 54.55 38.24 29.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.918 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 63.1 46.69 4.53 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.506 0.67 . . . . 0.0 109.833 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -148.6 88.98 5.15 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.091 -1.005 . . . . 0.0 109.24 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.446 ' C ' HD21 ' A' ' 117' ' ' ASN . 37.1 Cg_exo -55.06 132.35 51.8 Favored 'Trans proline' 0 N--CA 1.498 1.761 0 C-N-CA 122.226 1.951 . . . . 0.0 112.393 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.471 ' N ' HD21 ' A' ' 117' ' ' ASN . 22.1 m -151.5 156.12 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.276 -0.89 . . . . 0.0 109.863 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.29 -40.63 96.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.824 . . . . 0.0 109.379 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 30.7 t -161.51 156.0 22.87 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.258 -0.901 . . . . 0.0 109.347 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -153.43 156.47 38.28 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.162 -0.961 . . . . 0.0 109.679 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.6 t -88.6 130.19 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.342 -0.849 . . . . 0.0 109.247 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 87.4 mt -77.52 149.2 34.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.838 . . . . 0.0 110.218 -179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.526 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -150.41 163.81 37.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.416 -0.802 . . . . 0.0 109.267 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.572 ' ND2' ' H ' ' A' ' 148' ' ' THR . 18.1 m120 -56.53 138.49 51.76 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.285 -0.884 . . . . 0.0 110.43 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.549 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 80.36 13.55 81.6 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 27.5 m-20 -83.03 145.15 29.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.075 -1.25 . . . . 0.0 109.623 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 11.8 tm-20 -112.87 126.53 55.56 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.1 t -123.42 132.47 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.6 -0.688 . . . . 0.0 109.333 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 140' ' ' GLY . 13.3 tm0? -119.42 127.8 53.44 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.57 127.46 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-O 121.531 0.681 . . . . 0.0 110.052 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.506 ' O ' ' NE2' ' A' ' 138' ' ' GLN . . . 54.51 -104.65 0.27 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -116.78 -24.85 7.52 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.616 -0.932 . . . . 0.0 109.465 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.468 ' CE1' ' CG ' ' A' ' 91' ' ' ASP . 25.2 m-85 -76.33 142.77 41.14 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.347 -0.846 . . . . 0.0 110.077 -179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -107.85 137.08 46.5 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -136.54 155.49 49.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.389 -0.819 . . . . 0.0 109.415 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 145' ' ' VAL . 12.3 p -119.82 131.14 73.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -94.8 120.54 35.18 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.397 -0.814 . . . . 0.0 109.985 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.549 HD23 ' H ' ' A' ' 134' ' ' GLY . 16.3 mt -134.18 150.43 51.08 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.572 ' H ' ' ND2' ' A' ' 133' ' ' ASN . 4.5 p -128.37 159.93 33.8 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.434 ' H ' HD21 ' A' ' 51' ' ' LEU . . . -82.87 86.95 1.47 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.611 ' CG ' ' H ' ' A' ' 151' ' ' LYS . 86.3 t60 -85.95 177.2 7.68 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.445 -1.032 . . . . 0.0 109.482 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.611 ' H ' ' CG ' ' A' ' 150' ' ' HIS . 99.0 mttt -68.85 157.91 35.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 110.396 -179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 55.83 164.45 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.679 . . . . 0.0 110.741 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.37 -147.43 4.83 Favored Glycine 0 N--CA 1.496 2.662 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 155' ' ' ASP . 79.1 mm-40 48.51 -124.42 1.83 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.275 -1.132 . . . . 0.0 109.772 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' ' 154' ' ' GLU . 99.7 m-20 54.49 167.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.287 -0.883 . . . . 0.0 110.012 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.558 ' N ' HD22 ' A' ' 156' ' ' LEU . 3.8 mm? -90.8 129.27 36.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.41 -0.806 . . . . 0.0 109.913 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -145.09 -49.58 0.25 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.402 -0.812 . . . . 0.0 108.899 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -152.48 165.65 34.42 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.27 -0.894 . . . . 0.0 109.815 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -60.89 111.11 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.375 -0.828 . . . . 0.0 109.363 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -86.03 134.04 33.87 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.301 -0.875 . . . . 0.0 109.649 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -78.65 119.47 21.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.455 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 163' ' ' HIS . 58.2 t-80 -85.58 164.82 17.52 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.309 -0.869 . . . . 0.0 110.172 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 162' ' ' HIS . 84.7 t60 . . . . . 0 N--CA 1.494 1.738 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.037 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.691 0.758 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' CG ' ' N ' ' A' ' 26' ' ' ARG . 14.0 t80 -153.11 -163.76 1.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.68 0.752 . . . . 0.0 110.024 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.434 ' N ' ' CG ' ' A' ' 25' ' ' PHE . 96.4 mtt180 55.79 179.04 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.548 0.689 . . . . 0.0 110.292 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.522 ' C ' ' H ' ' A' ' 29' ' ' PHE . . . -67.95 151.26 47.4 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.654 0.74 . . . . 0.0 109.991 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -58.04 -0.67 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 27' ' ' ALA . 32.8 p90 -145.04 -160.13 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.498 -0.751 . . . . 0.0 109.711 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.475 ' N ' ' CD2' ' A' ' 29' ' ' PHE . 51.8 mt -61.46 88.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.763 0.792 . . . . 0.0 110.277 -178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.7 t -66.93 -15.87 63.96 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 58.54 84.48 0.1 Allowed 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.606 0.717 . . . . 0.0 110.175 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.1 tp -63.95 -42.53 97.28 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -85.71 110.18 19.13 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.733 0.777 . . . . 0.0 109.711 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -87.95 152.35 50.87 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.832 -0.542 . . . . 0.0 110.565 -179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.425 ' O ' ' O ' ' A' ' 37' ' ' ALA . 26.4 Cg_endo -63.49 146.67 93.2 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.463 2.108 . . . . 0.0 112.847 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 36' ' ' PRO . . . 50.32 103.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.544 0.687 . . . . 0.0 109.993 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -65.85 175.22 2.04 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.809 0.814 . . . . 0.0 110.385 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.07 139.88 54.84 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 121.804 0.812 . . . . 0.0 110.063 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.99 174.99 31.5 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.6 p -98.02 -13.32 21.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.743 -0.857 . . . . 0.0 108.897 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.1 pm0 -111.08 -109.57 0.34 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.575 -0.703 . . . . 0.0 109.639 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.533 ' O ' ' HB3' ' A' ' 44' ' ' ALA . 96.2 p -164.82 -32.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 43' ' ' SER . . . 70.14 -39.34 0.44 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.729 -0.607 . . . . 0.0 109.64 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.505 ' H ' ' C ' ' A' ' 43' ' ' SER . 10.5 t 51.68 106.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.686 0.755 . . . . 0.0 110.28 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.7 p -73.91 162.57 28.93 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.732 0.777 . . . . 0.0 110.209 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . -170.43 -156.94 11.77 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.565 HG11 HH22 ' A' ' 69' ' ' ARG . 24.9 m -74.32 30.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.913 -0.757 . . . . 0.0 109.608 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.495 ' H ' ' C ' ' A' ' 47' ' ' GLY . 80.1 mm-40 -69.71 -4.2 18.64 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 159.25 141.13 3.06 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -141.51 76.26 21.14 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.75 -0.853 . . . . 0.0 109.293 179.63 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' A' ' 51' ' ' LEU . 50.4 Cg_exo -47.64 -176.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.373 2.049 . . . . 0.0 111.396 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 52' ' ' PRO . 33.7 Cg_exo -60.15 146.33 96.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.381 2.054 . . . . 0.0 113.07 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.6 -0.01 82.41 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 81.9 mt -124.6 145.96 49.32 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.654 -0.91 . . . . 0.0 110.36 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.37 166.51 31.64 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.588 0.708 . . . . 0.0 109.85 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -125.83 146.19 49.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.843 0.83 . . . . 0.0 110.236 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 10.6 mt -125.43 140.9 52.39 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.672 0.749 . . . . 0.0 109.575 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -140.99 143.37 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.745 0.784 . . . . 0.0 110.341 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.6 t -73.76 131.09 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-O 121.792 0.806 . . . . 0.0 109.631 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 35.2 tptt -95.22 -32.0 13.23 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.5 ttt-85 -151.71 140.55 20.95 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.781 0.8 . . . . 0.0 109.966 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.37 167.48 11.66 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.05 -17.71 40.67 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.823 2.349 . . . . 0.0 111.384 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -97.38 19.52 13.11 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -46.43 143.05 2.72 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.865 0.84 . . . . 0.0 110.369 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.96 -14.28 61.6 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 30.4 t -68.16 138.61 55.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.644 -0.915 . . . . 0.0 110.892 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.565 HH22 HG11 ' A' ' 48' ' ' VAL . 85.8 mtp180 -134.52 143.48 47.46 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.74 0.781 . . . . 0.0 110.231 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -128.91 136.58 50.6 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.633 0.73 . . . . 0.0 109.652 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.513 HD23 ' C ' ' A' ' 71' ' ' LEU . 6.6 tt -110.25 123.52 49.93 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.885 0.85 . . . . 0.0 109.74 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 71' ' ' LEU . 57.5 mt -90.3 113.38 25.22 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.552 0.691 . . . . 0.0 109.59 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -147.21 70.88 1.2 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.674 0.75 . . . . 0.0 109.197 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 75' ' ' ALA . 54.3 tp60 -171.07 -121.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.651 -0.656 . . . . 0.0 109.763 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.408 ' N ' ' HG3' ' A' ' 74' ' ' GLN . . . -167.14 127.6 1.51 Allowed 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.751 0.786 . . . . 0.0 109.805 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mm 63.57 82.84 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.632 0.729 . . . . 0.0 109.385 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 98.4 m -99.41 123.38 43.64 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.781 0.801 . . . . 0.0 110.136 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.1 t -91.44 166.43 12.87 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.538 0.685 . . . . 0.0 109.411 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.54 154.95 26.27 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.774 0.797 . . . . 0.0 110.019 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 101.83 -118.97 6.31 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.551 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 84.9 mtp180 -124.08 130.62 52.86 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.78 -0.835 . . . . 0.0 110.352 -179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.551 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 3.1 m-70 176.3 149.37 0.31 Allowed Pre-proline 0 N--CA 1.488 1.447 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.05 -30.99 20.09 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.88 2.386 . . . . 0.0 112.158 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.4 p30 -93.0 -0.25 57.25 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.0 t -94.74 118.93 32.53 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.717 0.77 . . . . 0.0 109.803 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -65.01 -39.94 94.17 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.335 0.588 . . . . 0.0 109.44 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.714 ' N ' HD12 ' A' ' 87' ' ' ILE . 1.9 mp -82.56 125.57 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.552 -0.718 . . . . 0.0 109.987 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CE2' ' OD1' ' A' ' 90' ' ' ASP . 34.0 t80 -124.82 102.3 7.5 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.811 0.815 . . . . 0.0 108.922 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.8 mt -107.34 112.67 25.61 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.821 0.819 . . . . 0.0 110.038 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD1' ' CE2' ' A' ' 88' ' ' PHE . 99.9 m-20 -91.52 81.31 5.37 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.496 0.665 . . . . 0.0 109.435 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 92' ' ' VAL . 66.9 t0 -156.16 140.76 16.91 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.71 0.767 . . . . 0.0 110.071 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.542 ' N ' ' OD1' ' A' ' 91' ' ' ASP . 33.4 m -67.62 -22.64 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.9 p -65.72 -29.08 69.56 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.575 -0.703 . . . . 0.0 109.165 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 69.0 t -103.34 128.84 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 CA-C-O 121.887 0.851 . . . . 0.0 110.033 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 17.1 p -72.66 172.41 10.7 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.881 0.848 . . . . 0.0 111.03 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -59.19 -43.75 92.22 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.911 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.565 ' O ' ' N ' ' A' ' 99' ' ' ALA . 95.1 mtt-85 -108.29 -51.81 2.85 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.424 ' CE1' HD22 ' A' ' 117' ' ' ASN . 64.6 t-80 59.5 -72.56 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.423 0.63 . . . . 0.0 109.951 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -142.32 163.51 32.65 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.712 0.768 . . . . 0.0 109.919 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -132.03 146.11 51.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.803 0.811 . . . . 0.0 110.062 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -114.35 140.51 48.59 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.432 0.634 . . . . 0.0 109.392 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -128.1 142.91 51.07 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.805 0.812 . . . . 0.0 110.212 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 52.6 tp -103.56 123.1 46.31 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.548 0.69 . . . . 0.0 109.361 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -92.25 -127.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.444 0.64 . . . . 0.0 110.141 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.64 -40.8 92.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.805 -0.559 . . . . 0.0 109.641 -179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 46.5 p-10 -174.82 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -140.91 136.59 32.42 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.653 0.74 . . . . 0.0 109.478 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -79.41 146.88 32.57 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.694 0.759 . . . . 0.0 110.228 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -129.26 160.87 31.63 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.426 0.631 . . . . 0.0 109.488 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.3 p -123.82 127.06 73.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-O 121.885 0.85 . . . . 0.0 109.595 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 54.1 t -132.74 133.95 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-O 121.685 0.755 . . . . 0.0 109.404 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -80.61 151.84 28.85 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.635 0.731 . . . . 0.0 110.451 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.8 m -102.83 11.7 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.12 15.3 69.91 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.9 t -59.04 172.7 0.53 Allowed 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.784 0.802 . . . . 0.0 110.767 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 116' ' ' LEU . 4.0 mm? -62.53 -41.14 98.67 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.424 HD22 ' CE1' ' A' ' 98' ' ' HIS . 57.1 t30 -86.41 114.98 23.63 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.612 0.72 . . . . 0.0 109.513 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -82.85 104.84 2.59 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.0 m -63.51 137.74 58.25 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.914 0.864 . . . . 0.0 110.748 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -138.97 160.71 39.11 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.379 0.609 . . . . 0.0 109.584 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.521 ' O ' ' N ' ' A' ' 123' ' ' ARG . 10.4 p -105.92 128.24 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 CA-C-O 121.858 0.837 . . . . 0.0 109.99 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 53.42 -83.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.321 0.581 . . . . 0.0 109.707 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 121' ' ' VAL . 64.3 ttt180 -156.91 42.49 0.35 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -147.64 85.15 6.76 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -56.94 133.95 61.36 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.44 2.093 . . . . 0.0 112.177 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 18.5 m -145.92 162.98 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 121.905 0.86 . . . . 0.0 110.574 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -65.44 -34.08 77.46 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.2 p -153.2 159.9 42.73 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.571 0.7 . . . . 0.0 109.754 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.62 155.91 30.92 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.709 0.766 . . . . 0.0 110.388 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.3 t -105.78 130.12 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 CA-C-O 121.852 0.834 . . . . 0.0 109.641 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.9 mt -75.79 146.35 40.04 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 121.625 0.726 . . . . 0.0 109.835 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.546 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.58 155.35 40.15 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 122.019 0.914 . . . . 0.0 110.289 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -48.41 122.93 5.88 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.937 0.875 . . . . 0.0 110.755 -178.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.527 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 88.62 18.79 54.11 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.546 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 16.1 m-20 -87.66 151.93 22.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.694 -0.886 . . . . 0.0 110.301 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -114.86 129.92 56.79 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.734 0.778 . . . . 0.0 109.721 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.0 t -124.64 131.03 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-O 121.709 0.766 . . . . 0.0 109.133 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -117.26 126.69 53.15 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.795 0.807 . . . . 0.0 109.883 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 97.6 mt -121.18 129.1 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.573 0.701 . . . . 0.0 109.619 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 48.0 -107.28 0.23 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -111.31 -21.05 12.05 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -78.51 148.14 33.56 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.684 0.754 . . . . 0.0 110.76 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -115.33 126.98 55.11 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.718 0.77 . . . . 0.0 109.453 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.11 155.92 44.7 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.625 0.726 . . . . 0.0 110.173 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.9 p -126.75 135.37 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.715 0.769 . . . . 0.0 109.763 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -92.73 118.77 31.42 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-O 121.861 0.838 . . . . 0.0 109.673 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 134' ' ' GLY . 93.0 mt -134.58 148.83 50.53 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.627 0.727 . . . . 0.0 109.498 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.537 ' O ' ' N ' ' A' ' 150' ' ' HIS . 5.1 p -130.93 110.6 11.39 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.624 0.726 . . . . 0.0 109.759 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 59.79 -74.31 0.01 OUTLIER Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.537 ' N ' ' O ' ' A' ' 148' ' ' THR . 86.5 t60 54.97 88.26 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.946 -0.738 . . . . 0.0 109.735 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -61.7 135.5 57.64 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.729 0.776 . . . . 0.0 110.406 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -73.12 146.23 45.86 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.931 0.872 . . . . 0.0 110.448 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -71.43 168.21 51.23 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 56.32 14.37 1.56 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 122.092 -0.652 . . . . 0.0 109.395 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.564 ' O ' ' N ' ' A' ' 157' ' ' GLU . 65.5 t0 -81.3 -80.67 0.15 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.669 -0.644 . . . . 0.0 110.077 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 53.6 mt 58.94 -71.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.459 0.647 . . . . 0.0 110.007 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.564 ' N ' ' O ' ' A' ' 155' ' ' ASP . 80.3 mm-40 -43.31 149.4 0.24 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.779 0.8 . . . . 0.0 110.499 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 159' ' ' HIS . 80.7 m80 -111.34 162.43 15.04 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.916 0.865 . . . . 0.0 110.065 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 158' ' ' HIS . 97.8 m-70 57.97 153.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.685 0.755 . . . . 0.0 110.598 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -82.8 149.08 27.41 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.861 0.839 . . . . 0.0 110.264 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -60.01 -43.85 94.98 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.498 ' O ' ' ND1' ' A' ' 162' ' ' HIS . 32.0 p80 -92.74 123.74 36.24 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.874 0.845 . . . . 0.0 110.036 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.876 -1.059 . . . . 0.0 109.997 179.832 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.342 0.591 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -150.23 -21.52 0.25 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.301 -0.874 . . . . 0.0 108.869 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.444 ' O ' ' CE2' ' A' ' 29' ' ' PHE . 36.1 ttm180 -95.24 -11.04 28.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.348 -0.845 . . . . 0.0 108.842 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 46.43 -140.18 0.48 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 110.102 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -156.66 76.42 0.88 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.408 -0.807 . . . . 0.0 109.605 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.444 ' CE2' ' O ' ' A' ' 26' ' ' ARG . 0.7 OUTLIER -105.0 -55.07 2.38 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.713 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.1 pp -103.35 -13.3 16.73 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.483 -0.761 . . . . 0.0 109.199 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.465 ' N ' HD12 ' A' ' 30' ' ' LEU . 82.6 p -72.4 160.42 32.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.375 -0.828 . . . . 0.0 109.736 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' A' ' 33' ' ' LEU . 81.4 tt0 -126.64 -27.57 3.1 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 32' ' ' GLU . 83.9 mt 40.47 87.28 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.553 0.692 . . . . 0.0 110.093 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.445 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 48.5 p-10 -70.19 138.62 51.93 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.445 -0.784 . . . . 0.0 109.93 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -173.2 80.74 0.4 Allowed Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.414 -0.804 . . . . 0.0 109.054 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -57.83 147.07 83.14 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.6 2.2 . . . . 0.0 112.269 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.11 145.4 55.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.469 -0.769 . . . . 0.0 110.599 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -103.9 -66.8 0.93 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.517 0.675 . . . . 0.0 109.551 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.14 140.98 58.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.384 -0.822 . . . . 0.0 110.271 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.87 -5.85 73.26 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 41' ' ' THR . 0.1 OUTLIER -78.0 149.4 34.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.255 -1.144 . . . . 0.0 109.391 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 44' ' ' ALA . 46.9 tp10 -163.12 124.59 2.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.232 -0.918 . . . . 0.0 109.478 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 94.4 p -76.69 20.42 0.24 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.388 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' H ' ' HG3' ' A' ' 42' ' ' GLU . . . -78.52 2.66 18.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.306 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.9 t -75.81 135.69 26.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.412 -0.805 . . . . 0.0 110.191 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 8.4 t 61.1 143.55 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.645 0.736 . . . . 0.0 110.573 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 168.16 30.43 0.02 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 72.6 t -65.45 -43.06 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.355 -1.085 . . . . 0.0 109.61 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -48.64 140.13 8.63 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.638 0.732 . . . . 0.0 110.679 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 65.88 -88.47 0.11 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.453 ' HG ' ' H ' ' A' ' 149' ' ' GLY . 0.2 OUTLIER 70.26 83.24 0.16 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.717 -0.873 . . . . 0.0 109.675 -179.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.85 170.81 19.13 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.922 1.748 . . . . 0.0 111.731 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -57.08 147.23 76.53 Favored 'Trans proline' 0 N--CA 1.503 2.048 0 C-N-CA 122.316 2.011 . . . . 0.0 113.524 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.58 -16.77 43.92 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.25 146.1 46.39 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.396 -1.061 . . . . 0.0 109.942 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.58 157.15 40.63 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.3 pp -141.49 157.67 44.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.225 -0.922 . . . . 0.0 109.673 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 mp -116.18 151.75 35.07 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.17 133.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 62' ' ' ARG . 53.7 t -67.37 134.59 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.409 -0.807 . . . . 0.0 110.398 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -112.23 50.72 0.84 Allowed 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.654 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 3.6 tpt180 -120.42 173.43 7.15 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.72 -57.63 3.04 Favored Glycine 0 N--CA 1.49 2.241 0 O-C-N 120.92 -1.112 . . . . 0.0 111.443 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -85.07 12.67 3.0 Favored 'Trans proline' 0 N--CA 1.515 2.761 0 C-N-CA 123.917 3.078 . . . . 0.0 114.366 -177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.414 ' O ' HG11 ' A' ' 60' ' ' VAL . 57.4 t30 -148.62 17.08 1.02 Allowed 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.335 -1.478 . . . . 0.0 108.663 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . -77.78 153.39 32.92 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.382 0.611 . . . . 0.0 109.896 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.47 -21.63 43.34 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.7 m -66.17 141.24 58.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.29 -1.123 . . . . 0.0 109.263 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 92.3 mtm-85 -133.81 146.95 51.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.679 -0.638 . . . . 0.0 109.359 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -137.18 102.24 4.77 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.41 -0.806 . . . . 0.0 108.878 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pp -85.63 137.72 32.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.423 -0.798 . . . . 0.0 109.4 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.3 mt -95.91 97.45 9.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.526 -0.734 . . . . 0.0 109.82 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.428 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 51.5 t0 -109.92 17.54 21.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -127.35 152.92 46.85 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.505 -0.747 . . . . 0.0 109.997 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.41 -47.89 83.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.636 -0.665 . . . . 0.0 110.452 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.24 126.12 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.299 -0.876 . . . . 0.0 109.618 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 92.6 m -121.96 120.95 35.92 Favored 'General case' 0 N--CA 1.5 2.051 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.8 p -85.29 163.13 18.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.387 -0.82 . . . . 0.0 109.853 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.58 177.83 4.5 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.478 -0.764 . . . . 0.0 109.56 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.88 -129.64 10.4 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.367 -0.92 . . . . 0.0 110.887 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.558 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 85.1 mtt85 -96.63 114.75 26.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.447 -1.031 . . . . 0.0 110.231 -178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.558 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 32.3 m-70 -170.58 80.33 0.57 Allowed Pre-proline 0 N--CA 1.49 1.574 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.81 -38.39 67.43 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.282 1.988 . . . . 0.0 111.266 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.56 -39.85 95.47 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.441 -0.787 . . . . 0.0 109.28 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.1 t -72.09 158.27 36.25 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.442 -0.786 . . . . 0.0 110.352 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -62.45 -40.55 96.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.514 -0.741 . . . . 0.0 109.883 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 93.2 mt -94.49 117.09 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.07 -1.019 . . . . 0.0 109.671 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 16.5 p90 -130.33 88.26 2.62 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 85.7 mt -88.19 92.33 9.11 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.029 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -95.71 92.65 6.68 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.419 -0.801 . . . . 0.0 109.488 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 p30 -159.99 176.93 11.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.263 -0.898 . . . . 0.0 109.531 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 79.6 t -61.82 -44.38 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.312 -0.867 . . . . 0.0 109.994 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.6 p -71.61 173.6 7.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.297 -0.877 . . . . 0.0 110.63 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.0 t 61.81 108.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 121.679 0.752 . . . . 0.0 109.707 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 8.7 t -61.1 -150.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.551 0.691 . . . . 0.0 110.752 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -60.31 -45.69 92.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.483 -0.76 . . . . 0.0 109.364 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.583 ' O ' ' N ' ' A' ' 99' ' ' ALA . 36.4 ptt85 179.99 -54.11 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.532 ' ND1' ' O ' ' A' ' 97' ' ' ARG . 46.8 p-80 43.09 15.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.675 -0.641 . . . . 0.0 110.141 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.583 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -154.7 143.13 20.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.199 -0.938 . . . . 0.0 109.861 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -149.42 147.67 28.54 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -109.34 143.31 39.02 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.51 -0.744 . . . . 0.0 109.547 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -128.71 137.59 51.68 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.655 -0.653 . . . . 0.0 109.509 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 43.2 tp -91.64 126.89 36.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.382 -0.824 . . . . 0.0 108.78 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.549 ' O ' ' N ' ' A' ' 106' ' ' ASN . 83.7 tt0 -119.83 129.87 54.63 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.467 -0.771 . . . . 0.0 109.763 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 11.9 m120 50.79 -86.47 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.518 -0.739 . . . . 0.0 109.957 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 104' ' ' GLU . 9.0 m120 -148.35 23.6 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.171 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -134.97 139.05 44.59 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.583 -0.698 . . . . 0.0 109.561 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -75.5 149.0 38.54 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.646 -0.659 . . . . 0.0 109.716 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -135.92 165.33 25.9 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.5 -0.75 . . . . 0.0 109.092 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 p -125.69 132.28 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 50.3 t -129.78 132.73 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.563 ' CG ' ' H ' ' A' ' 119' ' ' THR . 88.8 m-20 -103.71 139.28 39.18 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.432 -0.792 . . . . 0.0 109.391 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 113' ' ' VAL . 3.0 m -89.4 131.7 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.247 -0.908 . . . . 0.0 110.309 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 77.33 -176.54 53.37 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.6 m -126.27 64.78 1.24 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.718 -0.872 . . . . 0.0 109.176 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.488 HD13 ' N ' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -156.25 111.81 2.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.027 -1.045 . . . . 0.0 109.0 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.488 ' N ' HD13 ' A' ' 116' ' ' LEU . 6.7 m120 55.79 35.19 24.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.734 -0.604 . . . . 0.0 109.847 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.6 168.36 39.45 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.563 ' H ' ' CG ' ' A' ' 112' ' ' ASP . 21.3 m -62.93 138.66 58.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.396 -1.061 . . . . 0.0 109.952 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -119.62 150.25 40.62 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.623 -0.673 . . . . 0.0 109.326 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.7 p -120.37 130.84 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.595 -0.69 . . . . 0.0 110.01 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.448 ' C ' ' H ' ' A' ' 124' ' ' GLU . 91.0 m-20 45.58 -172.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.637 0.732 . . . . 0.0 110.781 179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.3 ptt180 -59.67 -2.0 0.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.59 -0.694 . . . . 0.0 110.051 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 122' ' ' ASN . 27.1 mt-10 -109.6 95.16 18.49 Favored Pre-proline 0 N--CA 1.499 1.996 0 O-C-N 121.421 -0.799 . . . . 0.0 109.436 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.28 127.82 8.54 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.834 1.69 . . . . 0.0 111.795 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 129' ' ' ALA . 35.5 m -139.04 162.25 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.309 -0.869 . . . . 0.0 110.363 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -74.66 -22.44 58.89 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.531 -0.731 . . . . 0.0 109.553 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 94.4 p -162.54 160.34 25.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 109.632 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.414 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -173.06 166.14 4.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.166 -0.959 . . . . 0.0 109.677 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 65.2 t -90.79 130.66 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.453 -0.779 . . . . 0.0 109.516 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.73 148.7 34.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.321 -0.862 . . . . 0.0 109.91 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.537 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -151.02 152.74 33.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.362 -0.836 . . . . 0.0 108.945 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.493 HD21 ' CE1' ' A' ' 150' ' ' HIS . 64.4 t30 -51.87 134.13 31.52 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.371 -0.831 . . . . 0.0 110.441 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.19 11.4 64.82 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 79.4 m-20 -89.09 148.64 23.59 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.269 -1.136 . . . . 0.0 109.724 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -112.22 128.06 56.14 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 84.7 t -124.93 130.6 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.645 -0.659 . . . . 0.0 109.301 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -126.01 122.45 35.9 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.595 -0.691 . . . . 0.0 109.214 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 95.4 mt -123.82 129.73 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.638 -0.664 . . . . 0.0 109.914 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.36 -108.02 2.34 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.527 ' O ' ' NH1' ' A' ' 62' ' ' ARG . 88.7 tttt -126.16 -26.1 3.44 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.913 . . . . 0.0 109.255 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -74.34 146.58 42.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -103.84 139.7 38.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.493 -0.754 . . . . 0.0 109.269 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.8 mp -136.53 137.43 40.26 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.397 -0.814 . . . . 0.0 109.589 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 145' ' ' VAL . 12.8 p -109.49 130.18 62.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -89.72 111.45 22.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.224 -0.923 . . . . 0.0 109.971 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 32.8 mt -140.12 159.85 41.26 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.612 0.72 . . . . 0.0 109.813 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.451 ' OG1' ' CE1' ' A' ' 150' ' ' HIS . 60.0 p -96.33 168.58 10.49 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.543 -0.723 . . . . 0.0 110.356 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.453 ' H ' ' HG ' ' A' ' 51' ' ' LEU . . . -77.49 96.91 1.29 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.493 ' CE1' HD21 ' A' ' 133' ' ' ASN . 76.5 m80 -87.79 147.26 25.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.43 -1.041 . . . . 0.0 110.131 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -90.42 -8.1 51.44 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.412 -0.805 . . . . 0.0 109.505 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -88.69 144.25 26.4 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.291 -0.881 . . . . 0.0 110.136 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 157.93 -35.7 0.53 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -140.97 71.08 1.36 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.4 -1.059 . . . . 0.0 109.434 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.545 ' C ' ' H ' ' A' ' 157' ' ' GLU . 96.7 m-20 -89.49 -1.7 58.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 0.0 108.97 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 61.8 mt 59.74 -2.86 0.12 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.545 ' H ' ' C ' ' A' ' 155' ' ' ASP . 97.7 mt-10 -98.31 -3.88 36.24 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.326 -0.859 . . . . 0.0 108.909 179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 60.7 m80 -60.32 -41.65 93.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.407 -0.808 . . . . 0.0 109.527 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -72.27 130.26 40.37 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.881 . . . . 0.0 109.383 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -111.39 142.03 44.16 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.551 -0.718 . . . . 0.0 109.784 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -65.34 -38.36 89.89 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.537 -0.727 . . . . 0.0 109.807 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.509 ' ND1' ' OXT' ' A' ' 163' ' ' HIS . 64.6 t-80 -145.5 138.89 26.42 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.11 -0.994 . . . . 0.0 109.775 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.509 ' OXT' ' ND1' ' A' ' 162' ' ' HIS . 75.5 m80 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.934 -1.032 . . . . 0.0 109.745 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 25' ' ' PHE . 16.2 m . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 121.4 0.619 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.401 ' N ' HG23 ' A' ' 24' ' ' VAL . 0.8 OUTLIER -63.47 -43.76 96.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.218 -0.926 . . . . 0.0 109.636 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.4 mtt85 -73.68 144.9 45.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.275 -0.89 . . . . 0.0 110.726 -178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.428 ' H ' ' HB3' ' A' ' 31' ' ' SER . . . -52.76 -175.82 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 122.037 0.922 . . . . 0.0 110.649 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -71.14 -2.32 15.39 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.506 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 28.3 p90 -149.31 -160.67 1.2 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.011 -1.056 . . . . 0.0 109.93 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 29' ' ' PHE . 56.4 mt -62.89 91.69 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.899 0.857 . . . . 0.0 109.651 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.428 ' HB3' ' H ' ' A' ' 27' ' ' ALA . 83.1 p -81.71 -6.57 59.16 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 tp10 -92.02 97.99 11.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.062 -1.024 . . . . 0.0 109.571 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.6 mt 50.43 -171.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.034 0.921 . . . . 0.0 110.956 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 34' ' ' ASP . 20.3 p-10 -98.67 -61.15 1.41 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.48 -0.763 . . . . 0.0 109.317 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.476 ' H ' ' CG ' ' A' ' 34' ' ' ASP . . . -178.15 80.2 0.23 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.448 -0.782 . . . . 0.0 108.922 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.72 145.05 97.34 Favored 'Trans proline' 0 N--CA 1.496 1.623 0 C-N-CA 122.798 2.332 . . . . 0.0 112.382 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -164.63 125.68 2.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.072 -1.017 . . . . 0.0 109.736 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -77.08 140.71 40.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.397 -0.814 . . . . 0.0 109.901 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.94 165.29 21.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.252 -0.905 . . . . 0.0 110.809 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.87 -176.77 49.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.8 m 42.75 83.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.697 -0.884 . . . . 0.0 110.359 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -164.9 126.11 2.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.231 -0.918 . . . . 0.0 109.223 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -73.47 150.91 41.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.282 -0.886 . . . . 0.0 110.309 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -156.74 -35.43 0.08 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.025 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.0 m -94.88 37.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.218 -0.926 . . . . 0.0 109.134 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 91.2 p -81.88 -3.51 54.31 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.293 -0.879 . . . . 0.0 108.812 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.36 43.68 4.24 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.6 m -83.2 -8.28 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -1.112 . . . . 0.0 109.072 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -95.85 -76.54 0.5 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.31 -0.869 . . . . 0.0 109.747 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -92.73 94.46 1.89 Allowed Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.522 ' O ' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -100.95 153.08 37.94 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.538 -0.978 . . . . 0.0 109.142 -179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.439 ' O ' ' O ' ' A' ' 51' ' ' LEU . 84.8 Cg_exo -39.56 166.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.302 2.002 . . . . 0.0 112.283 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -54.75 139.51 77.42 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.066 1.844 . . . . 0.0 112.801 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 43.89 84.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 72' ' ' LEU . 1.9 tp -149.95 141.65 23.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.92 -1.341 . . . . 0.0 109.237 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.17 165.93 23.64 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.55 0.69 . . . . 0.0 109.739 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.03 154.75 47.88 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.623 0.725 . . . . 0.0 109.744 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 75.3 mt -114.37 136.81 52.58 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -124.35 131.56 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.609 0.719 . . . . 0.0 109.782 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 76.0 t -73.21 133.63 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-O 121.593 0.711 . . . . 0.0 109.72 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -86.29 -74.02 0.44 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.906 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -121.61 149.24 43.45 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-O 121.757 0.789 . . . . 0.0 110.09 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.54 175.09 25.3 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -68.42 -18.43 43.87 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.864 2.376 . . . . 0.0 111.727 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 66' ' ' ALA . 92.5 m-20 -88.93 -74.93 0.45 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.186 -0.947 . . . . 0.0 109.38 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 60.59 132.78 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.473 -0.767 . . . . 0.0 110.521 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.99 -20.24 50.85 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 m -71.54 144.79 49.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -1.143 . . . . 0.0 110.777 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -146.69 151.66 37.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.307 -0.87 . . . . 0.0 109.64 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -130.32 145.66 51.81 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.367 -0.833 . . . . 0.0 109.552 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pp -109.66 146.25 35.14 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.563 -0.71 . . . . 0.0 109.22 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.453 ' O ' HD11 ' A' ' 55' ' ' LEU . 66.6 mt -97.65 115.82 28.66 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.29 -0.882 . . . . 0.0 110.17 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -89.45 53.33 2.58 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.963 0.887 . . . . 0.0 108.693 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 43.31 -165.74 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 122.174 0.988 . . . . 0.0 111.199 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 59.95 -144.5 0.52 Allowed 'General case' 0 N--CA 1.488 1.425 0 CA-C-O 121.663 0.745 . . . . 0.0 110.479 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.12 127.21 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.734 -0.604 . . . . 0.0 109.5 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 96.6 m -120.24 120.58 36.51 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.2 p -83.03 162.29 21.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.429 -0.795 . . . . 0.0 109.885 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -107.73 -179.46 3.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.34 -0.85 . . . . 0.0 110.137 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.45 -124.17 28.91 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -105.62 127.26 52.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.43 -1.041 . . . . 0.0 109.963 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 83' ' ' PRO . 36.6 t-80 -173.94 135.09 0.62 Allowed Pre-proline 0 C--N 1.298 -1.639 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.478 ' O ' ' ND1' ' A' ' 82' ' ' HIS . 49.3 Cg_endo -68.92 150.32 73.1 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.391 2.061 . . . . 0.0 113.394 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t0 65.24 -8.3 0.26 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.821 -0.549 . . . . 0.0 110.087 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 83' ' ' PRO . 46.7 t -73.84 133.98 43.25 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.991 -1.068 . . . . 0.0 110.191 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.26 -41.1 97.1 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 0.0 109.544 179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.84 126.02 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.722 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -129.66 85.87 2.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.511 -0.743 . . . . 0.0 109.148 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.2 mt -104.83 93.66 4.85 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.455 -0.778 . . . . 0.0 109.331 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.3 p-10 -99.96 83.34 2.7 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.526 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 24.3 p30 -155.4 172.57 17.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.127 -0.983 . . . . 0.0 109.958 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.499 HG12 ' N ' ' A' ' 93' ' ' THR . 5.3 t -62.81 169.13 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.534 -0.729 . . . . 0.0 110.703 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.499 ' N ' HG12 ' A' ' 92' ' ' VAL . 4.4 p 65.74 -7.38 0.36 Allowed 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.498 ' H ' ' C ' ' A' ' 92' ' ' VAL . 82.2 t -125.87 122.19 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.475 -0.766 . . . . 0.0 109.254 179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.3 p -86.65 -162.09 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.824 0.821 . . . . 0.0 110.498 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 79.1 mtp85 -62.57 -38.65 90.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.36 -0.837 . . . . 0.0 109.556 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -152.81 81.69 1.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.077 -1.015 . . . . 0.0 108.947 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -65.95 -39.76 90.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.737 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -135.62 160.97 36.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.355 -0.841 . . . . 0.0 109.621 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -137.88 144.96 41.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.506 -0.746 . . . . 0.0 109.196 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -113.52 140.35 48.21 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -136.95 142.15 42.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.397 -0.815 . . . . 0.0 109.625 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 53.8 tp -95.53 126.9 41.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.514 -0.742 . . . . 0.0 109.385 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 53.5 tt0 -94.12 -128.46 0.12 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.236 -0.915 . . . . 0.0 110.012 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -64.48 -41.57 96.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.825 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -174.05 25.83 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.02 -1.05 . . . . 0.0 109.092 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -137.41 142.4 41.67 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.234 -0.917 . . . . 0.0 110.059 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -76.64 145.63 38.71 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.499 -0.75 . . . . 0.0 110.05 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -139.27 162.16 35.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.279 -0.888 . . . . 0.0 109.221 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.0 p -126.57 132.57 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 47.6 t -127.37 132.84 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 CA-C-O 121.669 0.747 . . . . 0.0 109.475 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' A' ' 112' ' ' ASP . 1.5 m-20 -78.01 138.06 38.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.561 -0.712 . . . . 0.0 109.584 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 18.7 m -114.27 12.33 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.05 123.93 1.23 Allowed Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.769 -1.205 . . . . 0.0 110.125 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.9 p 61.4 116.67 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.535 -0.98 . . . . 0.0 110.542 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 116' ' ' LEU . 10.5 mp -64.17 -40.02 95.23 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.582 -0.699 . . . . 0.0 109.821 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -80.02 5.46 14.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.06 -1.025 . . . . 0.0 108.583 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -58.94 -101.78 0.01 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.5 m -64.85 138.38 58.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -1.141 . . . . 0.0 110.267 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -140.46 157.67 45.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.27 -0.894 . . . . 0.0 109.181 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 122' ' ' ASN . 7.6 p -107.29 156.71 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.69 -0.631 . . . . 0.0 109.638 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.446 ' N ' HG22 ' A' ' 121' ' ' VAL . 6.5 m120 -41.23 -39.35 1.32 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.517 0.675 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -65.63 -90.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.125 -0.984 . . . . 0.0 109.967 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -142.62 146.39 38.22 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.297 -0.877 . . . . 0.0 109.8 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -49.96 133.88 34.9 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 122.257 1.971 . . . . 0.0 112.636 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.6 m -144.24 157.31 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.082 -1.011 . . . . 0.0 110.64 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -72.96 -16.85 61.52 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.679 0.752 . . . . 0.0 109.049 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.6 p -158.61 161.23 37.19 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.152 -0.968 . . . . 0.0 109.434 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -158.63 153.96 25.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.942 -1.099 . . . . 0.0 109.84 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.2 t -98.78 126.81 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.386 -0.821 . . . . 0.0 109.57 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 76.8 mt -79.53 146.44 32.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.471 -0.768 . . . . 0.0 110.303 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.526 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -151.96 151.17 30.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.234 -0.916 . . . . 0.0 109.175 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.468 HD22 ' H ' ' A' ' 148' ' ' THR . 22.1 t-20 -46.93 124.99 6.87 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.461 -0.774 . . . . 0.0 110.998 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.473 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 90.53 13.6 59.57 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.526 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 32.9 m-20 -87.57 154.68 20.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.043 -1.269 . . . . 0.0 109.693 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -115.35 135.86 53.7 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.446 -0.784 . . . . 0.0 109.553 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.07 132.1 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.565 -0.709 . . . . 0.0 109.144 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -120.27 122.19 40.32 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 0.0 109.445 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.62 126.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 121.52 0.676 . . . . 0.0 109.232 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.2 -134.3 48.46 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -91.86 -7.95 47.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.446 -1.032 . . . . 0.0 109.38 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.526 ' CE1' ' OD2' ' A' ' 91' ' ' ASP . 82.5 m-85 -95.28 143.86 26.33 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 0.0 110.516 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -108.16 136.9 47.06 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.622 -0.674 . . . . 0.0 109.202 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.29 154.27 51.4 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.267 -0.895 . . . . 0.0 109.59 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.89 136.53 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 121.436 0.636 . . . . 0.0 109.289 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -92.46 113.48 25.76 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.677 -0.639 . . . . 0.0 109.297 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 134' ' ' GLY . 94.4 mt -137.06 147.77 46.34 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.689 0.756 . . . . 0.0 109.784 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 150' ' ' HIS . 68.3 p -90.53 168.05 12.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.598 -0.689 . . . . 0.0 110.016 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.438 ' O ' ' O ' ' A' ' 150' ' ' HIS . . . -59.67 79.94 0.01 OUTLIER Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.136 -1.186 . . . . 0.0 110.136 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.519 ' N ' ' O ' ' A' ' 148' ' ' THR . 98.4 m-70 49.24 178.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.401 -1.058 . . . . 0.0 110.928 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.472 ' C ' ' H ' ' A' ' 153' ' ' GLY . 51.5 mtmt -96.66 -0.17 48.84 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.468 ' C ' ' H ' ' A' ' 154' ' ' GLU . 98.3 mm-40 -65.14 3.12 0.65 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 109.12 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . -74.31 36.16 0.96 Allowed Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.468 ' H ' ' C ' ' A' ' 152' ' ' GLN . 79.9 mm-40 -64.48 139.72 58.79 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.173 -1.193 . . . . 0.0 110.44 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -70.04 152.38 44.45 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.832 0.825 . . . . 0.0 110.826 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 68.5 mt -61.67 143.24 56.45 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.819 0.819 . . . . 0.0 110.791 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -71.32 102.51 2.61 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.812 0.815 . . . . 0.0 109.997 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 45.5 p-80 -83.51 -17.3 42.4 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.476 -0.765 . . . . 0.0 108.965 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.566 ' CG ' ' N ' ' A' ' 160' ' ' HIS . 53.3 t-80 -151.33 170.95 18.29 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.163 -0.961 . . . . 0.0 110.01 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.566 ' N ' ' CG ' ' A' ' 159' ' ' HIS . 60.7 m170 -68.74 139.62 55.35 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.929 0.871 . . . . 0.0 111.131 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -79.41 154.77 28.73 Favored 'General case' 0 N--CA 1.487 1.386 0 CA-C-O 121.856 0.836 . . . . 0.0 110.935 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 47.27 91.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.953 0.882 . . . . 0.0 110.093 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 78.4 m80 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.703 179.774 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.486 ' CD2' ' O ' ' A' ' 26' ' ' ARG . 47.1 p90 -106.9 -159.6 0.7 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.41 -0.806 . . . . 0.0 110.309 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.486 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 56.4 ttp180 -62.76 139.52 58.69 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.569 -0.707 . . . . 0.0 110.13 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -146.6 -111.5 0.09 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.487 -0.758 . . . . 0.0 109.432 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -101.42 -21.12 14.89 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.493 -0.754 . . . . 0.0 109.769 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.41 ' O ' ' C ' ' A' ' 30' ' ' LEU . 1.3 p90 -82.17 -21.02 36.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.179 -0.951 . . . . 0.0 109.364 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 30' ' ' LEU . 7.4 mp 38.45 60.13 1.37 Allowed 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.607 0.718 . . . . 0.0 110.254 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.53 ' C ' ' H ' ' A' ' 33' ' ' LEU . 20.7 t 38.84 -163.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.77 0.795 . . . . 0.0 111.143 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 33' ' ' LEU . 24.4 tp10 62.5 -4.36 0.23 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.591 -0.693 . . . . 0.0 109.512 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 35' ' ' ALA . 76.5 mt 48.4 -179.49 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.418 -0.801 . . . . 0.0 110.55 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.452 ' O ' ' HB3' ' A' ' 35' ' ' ALA . 67.9 t0 45.67 -88.89 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.651 -0.656 . . . . 0.0 110.223 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 33' ' ' LEU . . . 64.43 68.76 0.77 Allowed Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.426 -0.796 . . . . 0.0 109.585 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -77.58 145.87 23.69 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.762 2.308 . . . . 0.0 112.316 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.09 -12.8 22.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.45 -0.782 . . . . 0.0 109.565 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 38' ' ' GLN . 5.1 pp0? -84.1 139.44 32.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.316 -0.865 . . . . 0.0 110.367 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.42 -19.48 1.66 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.05 -133.05 49.13 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.2 m 48.09 73.83 0.19 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.568 -0.96 . . . . 0.0 109.89 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -100.13 0.16 40.09 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.312 -0.868 . . . . 0.0 109.157 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 m -65.35 147.35 53.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.554 -0.716 . . . . 0.0 110.156 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -167.95 79.89 0.17 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.453 HG22 ' H ' ' A' ' 45' ' ' VAL . 5.4 m -82.88 142.27 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.343 -0.848 . . . . 0.0 110.606 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 54.4 p 40.93 -162.67 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.482 0.658 . . . . 0.0 110.651 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.69 -98.67 0.15 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 48' ' ' VAL . 17.8 m -89.31 127.89 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.025 -1.279 . . . . 0.0 110.343 -178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' CG ' ' N ' ' A' ' 50' ' ' GLY . 18.1 pt-20 -163.47 -42.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 0.0 109.38 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.488 ' O ' ' C ' ' A' ' 51' ' ' LEU . . . -104.73 0.83 42.11 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 50' ' ' GLY . 0.3 OUTLIER -27.83 92.34 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.434 0 CA-C-N 117.412 0.606 . . . . 0.0 110.6 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.461 ' N ' ' O ' ' A' ' 50' ' ' GLY . 42.8 Cg_exo -53.81 156.61 11.78 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.326 2.017 . . . . 0.0 112.436 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.28 149.48 75.74 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.801 2.334 . . . . 0.0 112.236 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.27 -2.19 88.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.34 151.79 33.98 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.497 -1.001 . . . . 0.0 109.846 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.449 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -146.4 156.25 43.17 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.4 OUTLIER -137.99 171.75 13.95 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.805 . . . . 0.0 109.326 -179.502 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 14.9 mt -118.76 134.3 55.24 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.4 t -116.77 130.05 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' ' 62' ' ' ARG . 42.3 t -70.07 134.91 29.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.537 -0.727 . . . . 0.0 109.986 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.9 tptp -104.55 36.3 2.45 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.626 -0.672 . . . . 0.0 109.338 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.75 ' H ' HG12 ' A' ' 60' ' ' VAL . 77.8 mtp85 -126.85 144.27 51.02 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.429 -0.794 . . . . 0.0 109.93 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.76 -57.21 15.09 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -46.43 -36.93 18.8 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.314 2.009 . . . . 0.0 111.781 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.401 ' ND2' ' CE1' ' A' ' 142' ' ' PHE . 41.0 m-20 -119.66 25.31 10.09 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.581 -0.699 . . . . 0.0 109.18 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' ARG . . . -66.46 140.52 58.03 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.313 -0.867 . . . . 0.0 109.801 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.413 ' O ' ' NH1' ' A' ' 69' ' ' ARG . . . 101.21 -18.87 53.48 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.0 m -64.12 136.55 57.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.38 -1.071 . . . . 0.0 109.739 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.413 ' NH1' ' O ' ' A' ' 67' ' ' GLY . 90.6 mtm-85 -140.58 146.82 38.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.728 . . . . 0.0 109.098 179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.425 ' O ' ' CB ' ' A' ' 57' ' ' LEU . 88.0 m-85 -129.01 136.58 50.5 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.511 -0.743 . . . . 0.0 109.324 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 49.0 tp -103.84 129.73 51.34 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.494 -0.754 . . . . 0.0 109.163 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.0 mt -94.55 70.46 3.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -0.91 . . . . 0.0 109.357 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.442 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 67.1 t0 -95.18 34.67 1.37 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -141.52 150.81 42.65 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.341 -0.85 . . . . 0.0 109.96 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.03 -47.76 81.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.684 -0.635 . . . . 0.0 110.299 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.39 125.27 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.407 -0.808 . . . . 0.0 109.32 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 99.0 m -122.65 122.14 38.09 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.1 m -87.15 153.12 21.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 109.727 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -118.34 122.38 42.73 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.637 -0.665 . . . . 0.0 109.341 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.22 -124.38 2.52 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.476 ' C ' ' CG ' ' A' ' 82' ' ' HIS . 62.8 ttm-85 -119.72 121.92 40.28 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.532 -0.981 . . . . 0.0 109.222 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.614 ' CD2' ' N ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -170.05 161.54 6.67 Favored Pre-proline 0 N--CA 1.494 1.734 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.12 -78.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 122.45 2.1 . . . . 0.0 112.077 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -81.37 97.41 7.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.325 -0.86 . . . . 0.0 109.743 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 17.8 p -166.51 126.96 1.65 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.472 -0.767 . . . . 0.0 109.019 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.35 -37.72 84.36 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.834 . . . . 0.0 109.48 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 19.3 mm -87.86 120.31 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.471 -0.768 . . . . 0.0 109.649 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CE2' ' OD2' ' A' ' 90' ' ' ASP . 69.3 t80 -130.28 85.72 2.32 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.6 mt -104.19 107.86 18.96 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.444 -0.785 . . . . 0.0 109.507 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.492 ' OD2' ' CE2' ' A' ' 88' ' ' PHE . 97.9 m-20 -90.38 87.32 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.37 -0.831 . . . . 0.0 109.276 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -151.71 150.1 29.83 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.379 -0.826 . . . . 0.0 109.641 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.8 m -70.37 -25.05 26.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.311 -0.868 . . . . 0.0 109.041 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.0 p -65.27 -33.94 77.17 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.479 -0.763 . . . . 0.0 109.647 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.1 t -101.68 118.02 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.3 -0.875 . . . . 0.0 109.516 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 72.7 m -70.81 174.7 5.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.56 -0.713 . . . . 0.0 110.342 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -60.67 -43.72 97.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.564 -0.71 . . . . 0.0 109.356 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -127.04 55.23 1.58 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.564 -0.71 . . . . 0.0 109.114 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -60.7 -41.87 96.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.5 -0.75 . . . . 0.0 109.761 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.45 158.58 44.3 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.357 -0.839 . . . . 0.0 109.08 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -133.13 148.63 52.12 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.518 -0.739 . . . . 0.0 109.227 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -113.84 135.48 53.92 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -128.59 141.26 51.42 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.465 -0.772 . . . . 0.0 109.655 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 40.1 tp -98.93 127.23 44.81 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' A' ' 106' ' ' ASN . 49.2 tp10 -123.39 132.76 54.07 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.578 -0.701 . . . . 0.0 109.701 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.6 t-20 51.97 -84.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.654 -0.654 . . . . 0.0 109.859 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' GLU . 63.8 t30 -153.51 25.74 0.52 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.297 -0.877 . . . . 0.0 109.137 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -134.73 138.58 44.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.489 -0.757 . . . . 0.0 109.55 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -77.04 146.98 37.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.454 -0.779 . . . . 0.0 109.74 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -132.92 157.62 44.66 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.29 136.54 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.6 t -127.35 133.5 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 44.5 p-10 -95.87 115.69 27.8 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.247 -0.908 . . . . 0.0 109.769 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 20.4 m -110.37 7.51 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.466 -0.772 . . . . 0.0 108.935 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.1 101.61 1.73 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 7.5 t -64.14 -40.19 95.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.493 -1.004 . . . . 0.0 109.895 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 54.3 tp -61.55 -43.29 99.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.266 -0.896 . . . . 0.0 109.481 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -138.71 -73.73 0.39 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 92.94 153.5 30.3 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.453 HG22 ' N ' ' A' ' 120' ' ' TYR . 93.8 m -75.63 158.46 32.39 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.513 -0.993 . . . . 0.0 109.777 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.453 ' N ' HG22 ' A' ' 119' ' ' THR . 40.4 p90 -147.49 162.7 38.54 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.7 p -120.74 128.13 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.435 -0.791 . . . . 0.0 109.844 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 10.1 m120 55.38 38.5 30.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.509 -0.745 . . . . 0.0 110.01 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.1 ttt85 59.26 40.16 21.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.459 -0.776 . . . . 0.0 109.492 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -144.59 87.36 7.58 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.109 -0.994 . . . . 0.0 108.494 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -55.1 135.09 67.3 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 122.498 2.132 . . . . 0.0 112.202 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.3 m -141.79 162.96 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.307 -0.871 . . . . 0.0 110.014 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.64 -40.54 97.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.503 -0.748 . . . . 0.0 109.366 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 33.2 p -157.58 161.35 38.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.439 -0.788 . . . . 0.0 109.098 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -157.37 150.58 23.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.006 -1.058 . . . . 0.0 109.908 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 57.6 t -95.0 132.26 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.494 -0.754 . . . . 0.0 109.239 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.64 151.44 37.77 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.389 -0.819 . . . . 0.0 109.943 -179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.544 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -147.4 159.34 43.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.345 -0.847 . . . . 0.0 109.636 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 43.1 p-10 -57.25 132.36 52.77 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.349 -0.844 . . . . 0.0 110.637 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.496 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 83.34 14.93 72.9 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 29.4 m-20 -83.18 148.84 27.21 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.242 -1.152 . . . . 0.0 109.581 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -113.29 128.12 56.37 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.2 t -121.42 131.73 72.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -120.06 118.45 30.65 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.539 -0.725 . . . . 0.0 109.229 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.31 129.36 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.611 -0.68 . . . . 0.0 109.744 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 59.98 -131.41 50.32 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -102.43 -16.32 16.22 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.587 -0.949 . . . . 0.0 109.18 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.401 ' CE1' ' ND2' ' A' ' 65' ' ' ASN . 79.0 m-85 -80.47 147.81 30.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.455 -0.778 . . . . 0.0 109.895 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -105.16 137.24 43.24 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.476 -0.765 . . . . 0.0 109.2 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -138.5 150.67 46.64 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.336 -0.853 . . . . 0.0 109.24 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 10.2 p -125.02 132.78 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.463 -0.773 . . . . 0.0 108.943 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.449 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 74.1 t80 -93.29 117.48 30.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 109.513 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.496 HD23 ' H ' ' A' ' 134' ' ' GLY . 94.0 mt -129.06 139.76 51.89 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 150' ' ' HIS . 69.7 p -100.03 167.03 10.74 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.446 -0.784 . . . . 0.0 109.993 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.76 83.32 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.451 ' N ' ' O ' ' A' ' 148' ' ' THR . 98.0 m-70 47.02 -161.52 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.444 -1.033 . . . . 0.0 110.866 178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -66.12 135.22 54.27 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.566 -0.708 . . . . 0.0 110.213 -179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -85.51 141.33 29.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.472 -0.767 . . . . 0.0 110.106 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.07 51.75 0.4 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.5 131.1 45.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.355 -1.085 . . . . 0.0 110.258 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -151.18 106.27 3.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.484 -0.76 . . . . 0.0 108.995 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 87.5 mt -90.37 127.57 36.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -76.91 131.17 38.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.464 -0.772 . . . . 0.0 110.237 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.529 ' O ' ' CG ' ' A' ' 159' ' ' HIS . 84.6 t60 -165.59 133.89 3.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.489 -0.757 . . . . 0.0 109.247 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' A' ' 158' ' ' HIS . 99.1 m-70 -158.48 -63.25 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 108.955 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.493 ' ND1' ' N ' ' A' ' 161' ' ' HIS . 53.0 t-80 41.11 -96.32 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.809 -0.557 . . . . 0.0 110.218 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.493 ' N ' ' ND1' ' A' ' 160' ' ' HIS . 85.0 t60 42.73 85.25 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.642 -0.661 . . . . 0.0 109.666 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -71.64 142.55 49.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.472 -0.768 . . . . 0.0 110.058 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.367 179.583 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.364 0.602 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.631 ' O ' ' N ' ' A' ' 27' ' ' ALA . 8.4 p90 -149.18 -14.35 0.3 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.674 ' O ' ' HB3' ' A' ' 27' ' ' ALA . 45.9 mtp180 53.58 -74.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 120.93 0.395 . . . . 0.0 110.278 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 26' ' ' ARG . . . 86.09 146.9 0.06 Allowed 'General case' 0 N--CA 1.497 1.906 0 CA-C-O 121.465 0.65 . . . . 0.0 109.947 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.3 t0 62.06 36.14 15.52 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.208 0.527 . . . . 0.0 109.672 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.61 ' CG ' ' N ' ' A' ' 30' ' ' LEU . 2.6 p90 -142.31 -142.12 0.14 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.216 -0.928 . . . . 0.0 109.337 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.61 ' N ' ' CG ' ' A' ' 29' ' ' PHE . 6.2 mp -62.12 -42.29 99.09 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.443 -0.786 . . . . 0.0 108.928 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.7 p 45.34 41.06 5.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.406 -0.809 . . . . 0.0 109.343 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -64.63 -24.48 67.6 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 tp -63.0 -41.67 99.64 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.559 -0.713 . . . . 0.0 109.378 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -83.17 114.87 21.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.372 -0.83 . . . . 0.0 110.099 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -156.18 78.6 4.2 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.2 147.58 83.17 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 122.735 2.29 . . . . 0.0 112.552 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.43 150.27 27.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.474 -0.766 . . . . 0.0 110.248 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -60.43 147.8 39.72 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.711 0.767 . . . . 0.0 110.379 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.36 176.94 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.524 0.678 . . . . 0.0 110.696 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' O ' ' OG1' ' A' ' 41' ' ' THR . . . -175.67 -172.8 40.83 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 40' ' ' GLY . 6.7 p 60.7 139.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.606 -0.938 . . . . 0.0 110.535 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -66.4 138.29 57.47 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.584 -0.698 . . . . 0.0 110.134 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -72.95 147.82 44.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.459 -0.776 . . . . 0.0 110.364 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -159.65 34.79 0.19 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 55.5 t -109.57 130.89 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.491 -0.755 . . . . 0.0 109.004 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 96.3 p -75.29 167.04 22.68 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.395 -0.816 . . . . 0.0 110.514 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.65 -165.29 35.04 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.704 ' H ' HH22 ' A' ' 69' ' ' ARG . 95.9 t -83.28 132.08 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.493 -1.004 . . . . 0.0 109.979 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -112.25 -92.6 0.47 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.515 -0.741 . . . . 0.0 110.361 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.39 151.99 37.15 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 120.536 -0.84 . . . . 0.0 111.332 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.64 74.4 5.23 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.466 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 24.7 Cg_exo -53.04 -41.93 68.18 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.07 1.846 . . . . 0.0 112.112 179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 32.4 Cg_exo -56.23 -4.17 0.68 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 C-N-CA 121.553 1.502 . . . . 0.0 111.31 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 52' ' ' PRO . . . 75.39 62.59 2.69 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 83.3 mt -96.54 172.31 8.0 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.155 -1.203 . . . . 0.0 110.243 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.71 157.66 43.65 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.618 ' CD2' HH21 ' A' ' 69' ' ' ARG . 5.1 mp -131.87 150.3 52.19 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.341 -0.849 . . . . 0.0 110.022 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.5 mt -117.39 134.89 54.3 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -121.61 132.53 70.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.654 0.74 . . . . 0.0 109.259 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.1 t -74.1 132.53 33.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.491 -0.755 . . . . 0.0 109.779 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -93.31 -15.12 26.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.373 -0.829 . . . . 0.0 109.284 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -165.87 141.77 5.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.046 -1.034 . . . . 0.0 109.925 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 150.91 176.82 24.18 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -54.23 -40.23 83.13 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.423 2.082 . . . . 0.0 111.764 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -108.43 53.58 0.68 Allowed 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.96 143.47 42.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.463 -0.773 . . . . 0.0 110.13 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.13 1.56 75.64 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 16.2 m -71.84 152.33 42.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.466 -1.02 . . . . 0.0 109.941 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.704 HH22 ' H ' ' A' ' 48' ' ' VAL . 17.8 ptm180 -133.81 144.37 48.95 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.516 -0.74 . . . . 0.0 109.279 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -121.16 138.31 54.27 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.487 -0.758 . . . . 0.0 109.385 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.4 tp -99.48 125.71 45.28 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.388 -0.82 . . . . 0.0 109.13 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -99.34 75.05 1.96 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.282 -0.886 . . . . 0.0 109.13 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 64.3 t0 -99.07 17.3 20.12 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.392 -0.817 . . . . 0.0 109.053 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -119.26 144.45 46.77 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.562 -0.711 . . . . 0.0 109.658 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.82 99.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.51 -0.744 . . . . 0.0 110.076 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.4 mt -124.81 126.78 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.431 -0.793 . . . . 0.0 109.012 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 m -124.52 124.05 41.44 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.564 -0.71 . . . . 0.0 109.364 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.5 m -96.67 156.57 16.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.38 -0.825 . . . . 0.0 109.334 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -111.91 147.81 35.04 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.369 -0.832 . . . . 0.0 109.496 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.69 -48.44 1.01 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -88.01 141.11 28.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.151 -1.205 . . . . 0.0 109.989 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.615 ' CD2' ' N ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -88.72 -44.49 0.45 Allowed Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.419 -0.801 . . . . 0.0 109.817 -179.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 32.5 Cg_exo -57.25 137.19 80.59 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.374 2.049 . . . . 0.0 112.701 -178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 44.76 46.43 8.65 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.603 -0.686 . . . . 0.0 109.709 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.9 m -156.07 116.89 3.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.325 -0.859 . . . . 0.0 109.74 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.24 -38.29 90.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.3 mm -78.2 128.09 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.427 -0.796 . . . . 0.0 109.819 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -129.99 85.92 2.35 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.0 mt -105.4 98.05 7.81 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 46.7 p-10 -91.46 94.62 9.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.378 -0.826 . . . . 0.0 109.701 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -154.3 158.14 39.72 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.18 -0.95 . . . . 0.0 109.926 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.7 m -69.13 -32.47 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.534 -0.729 . . . . 0.0 109.761 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.7 p -65.83 -29.96 70.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.901 . . . . 0.0 110.341 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -99.84 125.9 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.11 -0.994 . . . . 0.0 109.562 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.0 m -79.39 -170.15 2.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.643 -0.661 . . . . 0.0 110.19 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -60.28 -45.45 93.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.488 -0.758 . . . . 0.0 109.614 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.589 ' O ' ' N ' ' A' ' 99' ' ' ALA . 79.7 mtp85 -108.17 -47.83 3.47 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 113' ' ' VAL . 85.8 t60 52.81 -80.68 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.619 -0.675 . . . . 0.0 110.074 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.589 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -127.71 155.8 43.4 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.541 -0.724 . . . . 0.0 109.131 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -136.02 154.23 51.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.42 -0.8 . . . . 0.0 109.094 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -118.73 143.66 46.75 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 95.3 mtt-85 -130.19 144.29 51.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.4 -0.813 . . . . 0.0 109.511 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 54.6 tp -104.46 123.96 48.4 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.511 -0.743 . . . . 0.0 109.437 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -95.19 -117.36 0.11 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.37 -0.831 . . . . 0.0 109.63 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 92.5 m-20 -65.07 -50.3 66.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.169 -0.957 . . . . 0.0 110.13 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 68.6 m-20 -169.03 23.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.572 -0.705 . . . . 0.0 109.282 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -134.54 136.68 43.22 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -77.0 146.62 37.3 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.49 -0.756 . . . . 0.0 110.126 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -123.37 156.62 35.06 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 110' ' ' VAL . 11.7 p -117.75 131.15 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.76 143.13 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.485 -0.759 . . . . 0.0 109.731 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -99.58 112.82 24.99 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 0.0 108.938 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 98' ' ' HIS . 16.6 m -77.73 150.21 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.172 -0.955 . . . . 0.0 110.742 -178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.97 17.79 64.55 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.435 ' OG ' ' N ' ' A' ' 116' ' ' LEU . 44.4 t 45.39 -147.8 0.11 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.55 -0.971 . . . . 0.0 110.135 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.435 ' N ' ' OG ' ' A' ' 115' ' ' SER . 49.0 tp 59.29 150.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.426 0.631 . . . . 0.0 110.283 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -66.45 141.91 57.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.714 -0.616 . . . . 0.0 109.945 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -172.13 -93.94 0.09 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.5 m -63.87 136.49 57.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.317 -1.108 . . . . 0.0 110.211 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -138.78 153.19 48.4 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.429 -0.794 . . . . 0.0 109.387 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.1 p -120.25 129.36 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-O 121.664 0.745 . . . . 0.0 109.52 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.489 ' CG ' ' H ' ' A' ' 123' ' ' ARG . 6.8 t-20 55.37 -167.09 0.1 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.585 0.707 . . . . 0.0 110.229 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.489 ' H ' ' CG ' ' A' ' 122' ' ' ASN . 11.0 mmp_? -72.6 -4.63 31.99 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.691 -0.631 . . . . 0.0 109.299 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -107.81 99.53 30.46 Favored Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -76.19 128.46 10.58 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.021 1.814 . . . . 0.0 112.056 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 129' ' ' ALA . 4.8 m -136.59 160.79 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.299 -0.876 . . . . 0.0 110.478 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.89 -42.21 97.51 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.556 -0.715 . . . . 0.0 109.266 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.4 m -157.94 158.43 34.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.375 -0.828 . . . . 0.0 109.467 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -168.05 159.09 10.9 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.035 -1.041 . . . . 0.0 109.859 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 98.9 t -82.19 131.53 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.763 . . . . 0.0 109.954 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 86.7 mt -76.6 150.31 36.48 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.866 . . . . 0.0 109.864 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -140.96 156.76 46.01 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.418 -0.801 . . . . 0.0 109.567 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -55.83 135.03 52.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.52 -0.737 . . . . 0.0 110.667 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 81.99 19.16 65.77 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 136' ' ' GLU . 64.4 t0 -96.76 133.73 40.96 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.308 -1.113 . . . . 0.0 109.986 -179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.488 ' N ' ' OD1' ' A' ' 135' ' ' ASP . 98.4 mt-10 -94.35 130.45 40.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.319 -0.863 . . . . 0.0 109.224 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.5 t -124.51 132.53 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 O-C-N 121.565 -0.71 . . . . 0.0 109.126 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -126.22 127.53 45.81 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.42 127.47 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.496 -0.753 . . . . 0.0 109.698 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 55.48 -95.35 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -128.43 -18.37 4.01 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.643 -0.916 . . . . 0.0 109.123 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -74.76 141.44 44.4 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.326 -0.859 . . . . 0.0 109.63 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -105.28 131.83 52.25 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.432 -0.792 . . . . 0.0 109.814 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -134.75 152.62 51.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.506 -0.746 . . . . 0.0 109.161 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -122.43 131.39 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -92.5 111.39 22.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.44 -0.788 . . . . 0.0 109.271 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.77 143.17 50.55 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.467 0.651 . . . . 0.0 109.715 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 82.2 p -86.46 170.9 11.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.409 -0.807 . . . . 0.0 109.775 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -43.94 -79.4 0.06 OUTLIER Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.636 -0.986 . . . . 0.0 110.636 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.538 ' ND1' ' N ' ' A' ' 151' ' ' LYS . 52.4 t-80 -162.62 -123.4 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -1.151 . . . . 0.0 109.556 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.538 ' N ' ' ND1' ' A' ' 150' ' ' HIS . 68.9 mttm 51.05 -93.22 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.382 -0.824 . . . . 0.0 110.186 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 150' ' ' HIS . 14.5 pt20 -74.03 148.35 42.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.4 -0.813 . . . . 0.0 110.682 -178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 145.31 -10.05 1.73 Allowed Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.86 -1.696 . . . . 0.0 108.86 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 155' ' ' ASP . 57.2 mp0 -63.86 140.99 58.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.498 -1.001 . . . . 0.0 110.234 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 154' ' ' GLU . 98.0 m-20 56.69 123.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.964 0.887 . . . . 0.0 109.997 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 156' ' ' LEU . 3.6 mm? -74.63 139.48 43.63 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.404 -0.81 . . . . 0.0 110.146 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -71.01 84.18 0.69 Allowed 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.569 -0.707 . . . . 0.0 109.801 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 160' ' ' HIS . 86.2 t60 -67.33 -40.34 85.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.574 -0.704 . . . . 0.0 109.888 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 80.4 m80 -43.38 91.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.517 -0.74 . . . . 0.0 110.42 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 158' ' ' HIS . 81.1 m-70 -95.44 -10.39 30.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.584 -0.697 . . . . 0.0 109.245 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -78.51 148.51 33.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.88 . . . . 0.0 109.763 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -62.04 -39.63 92.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.393 -0.817 . . . . 0.0 109.779 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.294 -179.731 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.453 ' CE2' ' O ' ' A' ' 26' ' ' ARG . 89.1 t80 -65.87 133.4 50.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.411 -0.806 . . . . 0.0 109.85 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' O ' ' CE2' ' A' ' 25' ' ' PHE . 95.9 mtt-85 -72.25 146.67 47.09 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.35 -0.844 . . . . 0.0 110.424 -179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.39 168.44 20.02 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.666 0.746 . . . . 0.0 110.54 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -64.0 -37.14 86.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.617 -0.677 . . . . 0.0 110.2 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -80.83 -164.15 0.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.063 -1.023 . . . . 0.0 110.581 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' CD2' ' H ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -76.29 92.63 3.33 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.494 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.0 t -69.32 144.97 53.38 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.517 0.675 . . . . 0.0 109.978 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -163.1 25.64 0.09 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.399 -0.813 . . . . 0.0 108.842 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 79.0 mt -71.22 140.65 50.51 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.955 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -89.78 114.5 26.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.8 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.89 154.43 91.0 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.7 -10.73 27.02 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.522 2.148 . . . . 0.0 111.377 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.06 140.68 54.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.432 -0.793 . . . . 0.0 109.894 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.412 ' O ' ' O ' ' A' ' 39' ' ' ALA . 27.2 mt-30 -108.44 -100.56 0.37 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.497 -0.752 . . . . 0.0 109.473 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' A' ' 38' ' ' GLN . . . 59.3 151.36 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.451 -0.781 . . . . 0.0 110.17 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.1 -122.27 0.94 Allowed Glycine 0 N--CA 1.495 2.581 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.7 p -89.47 117.1 28.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.218 -1.166 . . . . 0.0 110.038 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' O ' ' A' ' 43' ' ' SER . 49.1 tp10 -87.91 141.01 28.92 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.374 -0.829 . . . . 0.0 110.262 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 42' ' ' GLU . 26.1 t 46.37 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.697 0.76 . . . . 0.0 110.343 179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.28 -5.62 59.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.577 -0.702 . . . . 0.0 109.116 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.48 ' O ' ' CB ' ' A' ' 46' ' ' SER . 27.7 m -79.61 158.54 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.361 -0.837 . . . . 0.0 110.097 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 45' ' ' VAL . 2.4 p 80.17 136.98 0.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.524 0.678 . . . . 0.0 109.993 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.41 -80.51 0.1 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 48' ' ' VAL . 22.0 m -83.65 129.03 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.132 -1.217 . . . . 0.0 110.025 -179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -96.97 -47.92 5.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.35 -0.844 . . . . 0.0 109.315 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 163.7 95.14 0.1 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -93.44 153.85 41.35 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.253 -1.145 . . . . 0.0 108.881 -179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.9 160.88 48.0 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.187 1.925 . . . . 0.0 111.408 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.33 144.54 80.74 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.57 2.18 . . . . 0.0 112.635 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.425 ' C ' HD12 ' A' ' 55' ' ' LEU . . . 98.15 -23.06 37.72 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.425 HD12 ' C ' ' A' ' 54' ' ' GLY . 11.1 mp -104.92 148.21 26.93 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.187 -1.184 . . . . 0.0 109.931 -179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -132.26 176.87 8.02 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.614 0.721 . . . . 0.0 109.315 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.714 ' C ' HD22 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -157.33 172.58 18.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.291 -0.88 . . . . 0.0 109.886 -178.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 57' ' ' LEU . 4.6 mp -130.47 149.3 52.21 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 68.2 t -124.61 131.56 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.571 -0.705 . . . . 0.0 109.804 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.6 t -73.05 119.88 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.487 -0.758 . . . . 0.0 109.333 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -92.92 -16.64 24.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.296 -0.877 . . . . 0.0 109.122 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -155.5 132.68 10.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.386 -0.821 . . . . 0.0 109.599 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.15 172.14 22.52 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.97 -42.44 66.76 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.518 2.146 . . . . 0.0 112.003 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -100.66 49.71 0.89 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.471 -0.768 . . . . 0.0 109.09 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.09 141.98 26.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.539 -0.726 . . . . 0.0 110.234 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.65 -18.48 56.86 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 m -68.64 149.88 48.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.284 -1.127 . . . . 0.0 110.695 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -139.06 135.81 34.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -111.58 115.46 29.2 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.416 -0.802 . . . . 0.0 109.07 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 tt -94.5 133.23 38.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.414 -0.804 . . . . 0.0 110.244 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.402 HD21 HD11 ' A' ' 87' ' ' ILE . 81.3 mt -89.75 131.17 35.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.578 -0.701 . . . . 0.0 109.608 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -136.33 26.74 3.17 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.61 155.46 47.43 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.299 -0.876 . . . . 0.0 109.783 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.69 84.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.932 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.14 126.31 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 O-C-N 121.419 -0.801 . . . . 0.0 109.156 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.4 m -119.69 124.03 45.24 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.56 -0.712 . . . . 0.0 109.549 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 m -86.87 155.43 20.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.476 -0.765 . . . . 0.0 109.193 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -123.41 131.7 53.73 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.448 -0.783 . . . . 0.0 109.364 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 155.3 -138.91 6.31 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 72.7 ttp85 -113.37 125.58 54.42 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.509 -0.995 . . . . 0.0 110.042 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.531 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 11.8 m-70 -168.94 152.17 5.17 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.14 -19.5 50.91 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.201 1.934 . . . . 0.0 111.589 179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 85' ' ' SER . 84.5 m-20 -117.95 -129.95 0.3 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.543 -0.723 . . . . 0.0 109.744 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.44 ' O ' ' O ' ' A' ' 84' ' ' ASP . 6.1 m 57.87 138.18 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.74 0.781 . . . . 0.0 110.602 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.34 -43.53 97.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.492 -0.755 . . . . 0.0 109.355 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.402 HD11 HD21 ' A' ' 72' ' ' LEU . 93.5 mt -100.81 115.25 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.332 -0.855 . . . . 0.0 109.228 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.516 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 26.3 p90 -130.23 98.1 4.62 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 96.9 mt -97.0 123.8 40.81 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.318 -0.864 . . . . 0.0 109.367 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.545 ' CG ' ' H ' ' A' ' 91' ' ' ASP . 31.0 t0 -95.25 -151.62 0.34 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.538 -0.726 . . . . 0.0 109.8 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.545 ' H ' ' CG ' ' A' ' 90' ' ' ASP . 34.5 t70 58.82 171.53 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.686 0.755 . . . . 0.0 110.351 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.447 ' N ' ' CG ' ' A' ' 91' ' ' ASP . 71.9 t -91.25 114.21 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.599 -0.688 . . . . 0.0 110.151 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER 172.29 -31.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.099 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 49.9 t -115.52 131.99 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 121.704 0.764 . . . . 0.0 109.689 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -77.06 -175.78 3.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.589 -0.695 . . . . 0.0 110.424 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -62.11 -39.16 91.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.49 -0.756 . . . . 0.0 109.65 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.9 mtm-85 -139.77 57.81 1.62 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.155 -0.966 . . . . 0.0 109.16 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.746 ' CE1' ' H ' ' A' ' 118' ' ' GLY . 57.0 t-80 -61.66 -40.11 93.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.452 -0.78 . . . . 0.0 109.639 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -145.39 156.33 43.71 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.106 -0.996 . . . . 0.0 110.097 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -137.25 145.9 44.12 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -111.57 145.65 38.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.542 -0.724 . . . . 0.0 109.181 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 80.2 mtp85 -130.78 144.65 51.6 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.6 -0.687 . . . . 0.0 109.283 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 51.0 tp -105.17 126.44 52.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.589 -0.694 . . . . 0.0 109.686 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -158.05 149.89 21.75 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.367 -0.833 . . . . 0.0 109.014 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 55.51 35.2 24.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.446 -0.784 . . . . 0.0 109.415 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 54.9 31.62 16.21 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.677 -0.639 . . . . 0.0 109.716 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -143.53 138.97 29.54 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -77.08 145.69 37.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.528 -0.733 . . . . 0.0 109.618 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -130.94 159.0 38.73 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.566 -0.708 . . . . 0.0 109.195 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 110' ' ' VAL . 8.6 p -122.28 128.05 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.1 t -125.96 132.81 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 112' ' ' ASP . 53.3 p-10 -95.9 144.94 25.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.326 -0.859 . . . . 0.0 109.435 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 113' ' ' VAL . 3.5 m -77.71 75.92 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.247 -0.908 . . . . 0.0 109.969 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.07 167.0 22.24 Favored Glycine 0 N--CA 1.498 2.831 0 N-CA-C 110.604 -0.998 . . . . 0.0 110.604 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 71.2 m -60.93 -41.28 95.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.726 -0.867 . . . . 0.0 109.677 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 39.0 tp -79.4 125.84 30.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 0.0 109.966 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.522 ' ND2' ' OG1' ' A' ' 119' ' ' THR . 65.1 t30 -174.1 164.31 4.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.545 -0.722 . . . . 0.0 109.571 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.746 ' H ' ' CE1' ' A' ' 98' ' ' HIS . . . -95.57 -5.97 59.91 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.522 ' OG1' ' ND2' ' A' ' 117' ' ' ASN . 45.2 m -67.55 130.58 43.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -1.152 . . . . 0.0 109.945 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 119' ' ' THR . 38.4 m-85 -144.28 152.11 40.34 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.214 -0.929 . . . . 0.0 109.585 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.511 HG12 HG11 ' A' ' 126' ' ' VAL . 9.4 p -129.08 138.91 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.48 -0.763 . . . . 0.0 109.454 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 58.98 38.34 24.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.596 -0.69 . . . . 0.0 109.839 -179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 90.3 mtm180 48.58 35.9 6.77 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.0 109.945 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -145.49 148.22 36.33 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 108.642 179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.427 ' O ' ' OE2' ' A' ' 124' ' ' GLU . 25.7 Cg_endo -61.43 139.9 84.8 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.367 2.044 . . . . 0.0 112.095 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.511 HG11 HG12 ' A' ' 121' ' ' VAL . 2.0 p -147.76 161.19 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.33 -0.856 . . . . 0.0 108.996 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 128' ' ' SER . 67.3 t0 -124.73 66.83 1.09 Allowed 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.52 ' CB ' ' O ' ' A' ' 127' ' ' ASP . 3.5 p 84.82 116.87 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 CA-C-O 121.15 0.5 . . . . 0.0 109.809 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -150.02 160.84 43.32 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.25 -0.906 . . . . 0.0 109.931 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.1 t -79.21 133.23 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -0.779 . . . . 0.0 110.519 -179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 92.3 mt -76.52 147.88 37.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.384 -0.823 . . . . 0.0 109.617 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.537 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -142.15 148.42 38.24 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.254 -0.903 . . . . 0.0 109.186 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 49.9 p-10 -48.48 132.23 17.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.466 -0.772 . . . . 0.0 111.021 -178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.518 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 87.23 13.1 66.56 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.537 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 79.8 m-20 -89.48 150.28 22.55 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.097 -1.237 . . . . 0.0 110.042 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -111.74 136.99 50.24 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.599 -0.688 . . . . 0.0 109.515 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.2 t -128.27 134.74 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.515 -0.741 . . . . 0.0 109.221 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -124.15 117.4 24.56 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -131.84 128.35 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.479 -0.763 . . . . 0.0 109.524 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 142' ' ' PHE . . . 61.62 45.29 96.61 Favored Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.587 -1.292 . . . . 0.0 110.541 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? 70.2 -29.33 0.18 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.571 -0.958 . . . . 0.0 110.119 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.522 ' H ' ' C ' ' A' ' 140' ' ' GLY . 72.8 m-85 -66.64 137.12 56.49 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.65 -0.656 . . . . 0.0 110.273 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -106.85 124.61 49.87 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.287 -0.883 . . . . 0.0 109.191 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.7 mp -126.37 147.64 49.72 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.533 -0.729 . . . . 0.0 109.327 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 145' ' ' VAL . 10.4 p -108.59 126.61 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -89.76 120.49 31.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.557 -0.714 . . . . 0.0 109.879 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.518 HD23 ' H ' ' A' ' 134' ' ' GLY . 96.8 mt -131.89 150.46 52.15 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.463 0.649 . . . . 0.0 109.762 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 30.1 p -118.65 124.53 47.62 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.695 -0.628 . . . . 0.0 109.377 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -91.96 102.37 2.91 Favored Glycine 0 N--CA 1.497 2.726 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 151' ' ' LYS . 53.5 p-80 -154.38 14.3 0.44 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.275 -1.132 . . . . 0.0 108.854 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.431 ' O ' ' O ' ' A' ' 150' ' ' HIS . 55.7 mtpt 40.95 -166.2 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.677 0.751 . . . . 0.0 111.326 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -66.78 129.94 41.53 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.479 0.657 . . . . 0.0 110.324 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 154.87 93.89 0.1 OUTLIER Glycine 0 N--CA 1.493 2.48 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -69.41 140.67 54.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -1.189 . . . . 0.0 109.988 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -92.9 8.66 38.76 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.298 -0.876 . . . . 0.0 109.584 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 91.9 mt -76.71 122.83 25.27 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.284 -0.885 . . . . 0.0 110.034 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -174.51 -63.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -67.11 -39.67 86.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.378 -0.826 . . . . 0.0 109.519 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -69.62 141.56 53.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.376 -0.828 . . . . 0.0 110.112 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -130.03 86.29 2.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.524 -0.735 . . . . 0.0 109.04 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -89.49 -10.65 45.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.436 -0.79 . . . . 0.0 108.916 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 -83.39 -12.72 56.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.424 -0.797 . . . . 0.0 109.071 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.71 179.65 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.823 0.821 . . . . 0.0 108.802 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -64.3 169.25 4.77 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.824 0.821 . . . . 0.0 110.622 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -141.57 116.88 10.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.455 -0.778 . . . . 0.0 109.799 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 43.87 -129.12 0.86 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.413 0.625 . . . . 0.0 110.552 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -124.87 -41.29 2.12 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -100.08 -164.02 1.08 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.329 -0.857 . . . . 0.0 111.002 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.489 ' H ' HD23 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -82.67 99.24 9.48 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.983 0.896 . . . . 0.0 109.819 -179.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.9 p -65.63 160.76 21.9 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 122.032 0.92 . . . . 0.0 110.68 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 55.58 71.55 0.54 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.788 0.804 . . . . 0.0 109.704 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.11 -41.32 99.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.663 -0.648 . . . . 0.0 109.309 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 35' ' ' ALA . 91.8 m-20 57.71 50.87 10.09 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 34' ' ' ASP . . . -37.58 154.64 0.11 Allowed Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.893 -0.504 . . . . 0.0 110.397 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.23 152.99 75.53 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.78 2.32 . . . . 0.0 112.779 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.423 ' H ' ' H ' ' A' ' 38' ' ' GLN . . . -167.63 -18.61 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.51 ' H ' ' CD ' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -92.53 0.08 57.39 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.155 -0.966 . . . . 0.0 109.289 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -69.77 2.73 3.06 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.148 -0.97 . . . . 0.0 109.274 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.39 5.46 15.16 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.534 HG22 ' H ' ' A' ' 43' ' ' SER . 16.0 m -61.85 137.02 58.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.308 -1.113 . . . . 0.0 110.081 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -68.19 -0.18 4.38 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.6 0.714 . . . . 0.0 109.296 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.534 ' H ' HG22 ' A' ' 41' ' ' THR . 62.2 p -85.74 -8.69 58.0 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.314 -0.866 . . . . 0.0 109.77 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.21 -12.32 24.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.096 -1.003 . . . . 0.0 108.922 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 39.9 t -100.5 -17.41 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 121.219 -0.925 . . . . 0.0 108.887 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.2 t -66.75 143.86 56.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.367 -0.833 . . . . 0.0 110.358 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.33 -173.91 52.57 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.1 t 42.98 86.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 CA-C-O 121.939 0.876 . . . . 0.0 110.373 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -152.67 101.37 2.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.434 -0.791 . . . . 0.0 109.824 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.32 146.97 21.53 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD1' ' ND1' ' A' ' 150' ' ' HIS . 20.0 tp -173.65 74.55 0.38 Allowed Pre-proline 0 N--CA 1.486 1.356 0 O-C-N 121.891 -0.77 . . . . 0.0 109.441 178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.445 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 44.1 Cg_exo -54.13 -43.28 59.81 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.894 2.396 . . . . 0.0 112.619 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 58.7 Cg_endo -78.72 156.98 27.94 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.1 1.867 . . . . 0.0 112.98 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.34 84.67 0.95 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.141 -1.183 . . . . 0.0 110.141 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 94.1 mt -138.55 163.61 31.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.456 -1.026 . . . . 0.0 109.636 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.73 156.83 42.52 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.508 -0.745 . . . . 0.0 109.949 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.671 ' C ' HD12 ' A' ' 57' ' ' LEU . 3.9 pp -142.7 169.9 16.7 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.355 -0.841 . . . . 0.0 110.626 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.9 mt -124.49 144.01 50.34 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.1 t -130.42 132.49 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 CA-C-O 121.743 0.782 . . . . 0.0 109.61 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 89.3 t -75.71 132.62 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.69 0.757 . . . . 0.0 109.993 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.527 ' NZ ' ' OE2' ' A' ' 136' ' ' GLU . 51.9 mtmt -86.78 -73.78 0.45 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.724 -0.61 . . . . 0.0 110.017 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.603 HH21 ' NH1' ' A' ' 143' ' ' ARG . 61.7 ttp180 -117.33 134.69 54.52 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.433 -0.792 . . . . 0.0 110.356 -179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.26 173.9 21.6 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -67.47 -19.74 48.63 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.882 2.388 . . . . 0.0 111.726 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -97.37 19.77 12.68 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.207 -0.933 . . . . 0.0 109.047 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.22 139.32 29.65 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.389 -0.819 . . . . 0.0 110.373 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.78 -22.27 40.18 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 64.3 m -71.9 149.39 45.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.367 -1.078 . . . . 0.0 110.831 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -145.78 152.31 39.35 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.327 -0.858 . . . . 0.0 110.232 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -121.55 131.76 54.31 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-O 121.463 0.649 . . . . 0.0 109.444 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.43 ' O ' ' OD2' ' A' ' 86' ' ' ASP . 46.8 tp -100.42 128.87 46.37 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.61 -0.681 . . . . 0.0 109.263 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.08 128.27 42.83 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.836 0.826 . . . . 0.0 110.428 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.403 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 67.6 t0 -155.24 41.03 0.42 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -141.39 152.61 44.47 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.353 -0.842 . . . . 0.0 109.553 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.46 -48.02 83.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.687 -0.633 . . . . 0.0 109.987 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.3 mt -129.42 121.33 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.45 -0.781 . . . . 0.0 109.372 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -116.92 118.9 33.73 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.583 0.706 . . . . 0.0 109.423 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.2 m -86.16 155.28 20.82 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.554 0.692 . . . . 0.0 109.895 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 99' ' ' ALA . . . -103.69 169.75 8.34 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.905 0.859 . . . . 0.0 110.339 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.31 -119.9 5.7 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.532 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 74.1 ttp85 -118.63 121.6 40.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.69 -0.888 . . . . 0.0 109.884 -179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 41.7 m-70 -167.9 151.28 5.79 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -65.82 145.02 79.48 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.787 2.324 . . . . 0.0 112.783 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 54.82 31.1 14.93 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.511 0.672 . . . . 0.0 109.584 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.9 t -99.14 123.45 43.44 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.209 -0.932 . . . . 0.0 110.555 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' OD2' ' O ' ' A' ' 71' ' ' LEU . 54.3 m-20 -65.85 -39.57 90.88 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.9 mt -85.01 125.51 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.135 -0.978 . . . . 0.0 109.841 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -127.19 86.11 2.46 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 94.2 mt -115.26 94.29 4.66 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -92.79 109.68 21.12 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.525 0.679 . . . . 0.0 109.622 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -158.58 163.1 37.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.958 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 95.2 t -66.3 -44.21 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.63 0.729 . . . . 0.0 110.285 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 75.5 p -68.22 -29.4 68.23 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.344 -0.848 . . . . 0.0 109.996 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.4 t -92.46 112.1 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.131 -0.981 . . . . 0.0 109.97 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.9 m -77.58 176.73 8.67 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.686 0.755 . . . . 0.0 110.444 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.53 -41.84 99.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.646 -0.658 . . . . 0.0 110.017 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -124.18 49.2 1.81 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.377 -0.827 . . . . 0.0 109.005 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.08 -39.93 94.1 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.511 0.672 . . . . 0.0 109.45 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -147.99 154.89 40.89 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.957 -1.089 . . . . 0.0 110.272 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -136.58 151.6 49.55 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.497 0.665 . . . . 0.0 109.848 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.435 ' CE1' HG23 ' A' ' 110' ' ' VAL . 97.0 m-85 -121.09 138.83 54.0 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.3 mtp180 -130.71 141.21 50.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.635 0.731 . . . . 0.0 109.718 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.06 123.87 38.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 106' ' ' ASN . 80.7 tt0 -115.13 120.38 39.58 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.862 0.839 . . . . 0.0 109.867 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.464 ' OD1' ' ND2' ' A' ' 106' ' ' ASN . 21.3 t-20 52.09 -84.52 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.426 0.631 . . . . 0.0 110.372 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -144.03 20.36 1.77 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.081 -1.012 . . . . 0.0 108.503 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -130.16 137.47 50.13 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.714 0.769 . . . . 0.0 109.721 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -82.08 147.47 29.09 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.433 0.635 . . . . 0.0 109.76 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -136.06 157.87 45.77 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.518 -0.739 . . . . 0.0 109.769 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.6 p -125.84 127.35 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 53.1 t -131.03 131.26 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.549 ' OD2' ' N ' ' A' ' 119' ' ' THR . 42.9 t0 -100.38 126.48 46.75 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.697 0.76 . . . . 0.0 109.447 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.5 m -85.43 3.29 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.644 0.735 . . . . 0.0 109.228 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' A' ' 116' ' ' LEU . . . -79.35 -1.29 85.8 Favored Glycine 0 N--CA 1.495 2.624 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.8 m 48.62 -88.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.541 -0.976 . . . . 0.0 109.966 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.544 ' N ' ' O ' ' A' ' 114' ' ' GLY . 46.5 tp -73.09 133.62 44.23 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.877 0.846 . . . . 0.0 111.368 -178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 57.2 38.42 28.82 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.746 0.784 . . . . 0.0 109.725 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.6 -163.59 20.56 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.324 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.549 ' N ' ' OD2' ' A' ' 112' ' ' ASP . 28.4 m -60.84 137.16 58.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.904 . . . . 0.0 110.582 -179.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.434 ' OH ' ' NE2' ' A' ' 138' ' ' GLN . 22.7 p90 -119.57 150.51 40.17 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.579 0.704 . . . . 0.0 109.905 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.426 ' O ' ' O ' ' A' ' 122' ' ' ASN . 9.6 p -121.28 130.07 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-O 121.974 0.892 . . . . 0.0 109.29 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.466 ' C ' ' H ' ' A' ' 124' ' ' GLU . 14.0 m120 41.9 -168.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 122.098 0.951 . . . . 0.0 111.324 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.05 -0.24 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.757 -0.59 . . . . 0.0 110.163 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 122' ' ' ASN . 17.2 tt0 -113.25 93.09 24.6 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.384 -0.822 . . . . 0.0 109.42 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -78.04 122.36 5.74 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.74 2.293 . . . . 0.0 112.361 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 23.0 m -136.72 165.07 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.447 -0.783 . . . . 0.0 109.891 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.83 -37.81 88.78 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.591 0.71 . . . . 0.0 109.3 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 97.4 p -155.54 161.34 40.91 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.254 -0.903 . . . . 0.0 110.065 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -161.06 156.26 24.34 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.597 0.713 . . . . 0.0 110.166 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 92.2 t -82.36 129.75 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 CA-C-O 121.624 0.726 . . . . 0.0 110.098 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 85.5 mt -77.88 143.04 38.08 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.906 0.86 . . . . 0.0 110.592 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.544 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.86 147.18 27.65 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.596 0.712 . . . . 0.0 109.279 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 20.5 p30 -43.17 130.19 4.65 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 122.057 0.932 . . . . 0.0 111.667 -179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.06 13.47 68.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 81.2 m-20 -89.95 150.03 22.33 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.986 -1.302 . . . . 0.0 109.673 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.527 ' OE2' ' NZ ' ' A' ' 61' ' ' LYS . 84.0 tt0 -108.5 129.25 55.29 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.696 0.76 . . . . 0.0 110.05 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.9 t -126.11 131.25 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.434 ' NE2' ' OH ' ' A' ' 120' ' ' TYR . 56.6 tt0 -121.5 120.92 36.31 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.465 0.65 . . . . 0.0 109.772 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 39.7 mm -110.71 122.2 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 CA-C-O 121.75 0.786 . . . . 0.0 109.284 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 56.3 -129.74 48.54 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -95.06 -6.59 41.74 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.544 -0.974 . . . . 0.0 109.059 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -89.88 139.92 30.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.327 -0.858 . . . . 0.0 109.519 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.603 ' NH1' HH21 ' A' ' 62' ' ' ARG . 85.0 mtt85 -102.95 136.52 42.61 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.674 0.75 . . . . 0.0 110.027 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 mp -137.53 157.37 46.69 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.8 p -126.55 133.52 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 CA-C-O 121.671 0.748 . . . . 0.0 109.431 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 68.2 t80 -87.27 111.51 21.11 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.595 0.712 . . . . 0.0 109.978 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.7 mt -136.19 157.7 46.19 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.426 0.631 . . . . 0.0 109.335 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.4 p -112.79 130.23 56.15 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.496 0.665 . . . . 0.0 109.718 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.26 77.16 0.02 OUTLIER Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.503 ' ND1' ' CD1' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -88.53 140.2 29.7 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.345 -1.091 . . . . 0.0 109.998 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.594 ' C ' ' H ' ' A' ' 153' ' ' GLY . 17.8 mmmt -69.76 -85.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.609 -0.682 . . . . 0.0 110.568 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 62.21 -13.1 0.06 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.443 0.64 . . . . 0.0 110.028 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 151' ' ' LYS . . . 77.29 149.78 3.63 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -143.01 -26.41 0.59 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.687 -0.89 . . . . 0.0 109.033 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -82.35 115.21 21.29 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.884 . . . . 0.0 109.846 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 156' ' ' LEU . 9.5 mp -80.89 -78.37 0.18 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.889 0.852 . . . . 0.0 109.847 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 158' ' ' HIS . 97.3 mt-10 47.21 23.0 0.27 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.81 0.814 . . . . 0.0 109.341 -178.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.457 ' O ' ' O ' ' A' ' 157' ' ' GLU . 77.5 m80 51.27 168.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 CA-C-O 121.776 0.798 . . . . 0.0 111.234 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.506 ' C ' ' H ' ' A' ' 161' ' ' HIS . 84.3 t60 -153.53 143.04 21.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.301 -0.874 . . . . 0.0 110.261 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 56.11 4.93 0.14 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.653 0.74 . . . . 0.0 109.562 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.602 ' CD2' ' NE2' ' A' ' 162' ' ' HIS . 9.4 t60 -66.52 -40.83 89.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.501 -0.75 . . . . 0.0 109.666 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.602 ' NE2' ' CD2' ' A' ' 161' ' ' HIS . 97.7 m-70 -130.64 143.17 50.57 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.304 -0.873 . . . . 0.0 109.999 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.258 -179.962 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.522 HG13 ' N ' ' A' ' 25' ' ' PHE . 10.5 p . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.47 0.653 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.522 ' N ' HG13 ' A' ' 24' ' ' VAL . 84.0 t80 -156.95 114.69 3.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.36 -0.837 . . . . 0.0 109.342 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 35.0 ptt-85 -76.8 144.53 39.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 109.6 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.05 -179.6 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.827 0.822 . . . . 0.0 110.631 -179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -80.65 -0.27 37.36 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.631 0.729 . . . . 0.0 109.093 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 31' ' ' SER . 48.8 p90 -140.96 -160.02 1.03 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.495 -0.753 . . . . 0.0 109.551 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.445 ' O ' ' O ' ' A' ' 31' ' ' SER . 18.6 mt -37.26 96.45 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.929 0.871 . . . . 0.0 110.31 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 29' ' ' PHE . 33.5 t -38.9 162.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.538 0.685 . . . . 0.0 110.918 -179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 31' ' ' SER . 97.5 mt-10 59.3 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.924 0.868 . . . . 0.0 110.308 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 33' ' ' LEU . 3.7 mm? -74.1 152.75 39.84 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.873 0.844 . . . . 0.0 110.196 -179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 34' ' ' ASP . 54.5 p-10 -58.77 146.42 36.98 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.911 0.862 . . . . 0.0 110.755 -179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.67 71.72 20.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -75.72 -9.27 19.72 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.657 2.238 . . . . 0.0 110.985 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 52.49 -139.24 1.02 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.606 0.717 . . . . 0.0 110.39 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.467 ' N ' ' CD ' ' A' ' 38' ' ' GLN . 2.7 pm0 -146.81 12.43 1.12 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 47.55 -97.73 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.698 0.761 . . . . 0.0 110.508 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.81 139.91 35.62 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 31.8 m -68.3 134.62 50.63 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.778 -0.836 . . . . 0.0 110.729 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -82.21 -80.74 0.16 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 121.666 0.746 . . . . 0.0 109.772 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 59.0 p -151.24 -31.53 0.17 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.338 -0.851 . . . . 0.0 109.274 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 42.62 89.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.669 0.747 . . . . 0.0 110.411 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 59.8 t -107.99 -40.79 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.626 0.727 . . . . 0.0 109.262 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 t 45.0 -164.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.836 0.827 . . . . 0.0 111.158 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.82 -91.13 0.22 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.1 t -76.87 131.27 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.523 -0.987 . . . . 0.0 110.494 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -112.35 -25.95 8.98 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -79.46 96.03 1.49 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.527 HD11 ' N ' ' A' ' 149' ' ' GLY . 0.6 OUTLIER -177.47 79.48 0.24 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.805 -0.821 . . . . 0.0 109.545 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.421 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 47.3 Cg_exo -50.17 -175.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.451 2.101 . . . . 0.0 111.612 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 52' ' ' PRO . 31.5 Cg_exo -59.77 140.25 92.44 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.428 2.085 . . . . 0.0 112.429 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.475 ' C ' HD22 ' A' ' 55' ' ' LEU . . . 146.32 -87.68 0.16 Allowed Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 55' ' ' LEU . 2.6 mm? -102.09 167.54 9.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.563 -0.963 . . . . 0.0 110.272 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.19 176.96 7.5 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -130.55 146.6 52.1 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.023 0.916 . . . . 0.0 110.712 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mt -116.4 134.33 55.0 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 89.2 t -122.43 135.08 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 CA-C-O 121.586 0.708 . . . . 0.0 109.187 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.3 t -69.18 133.39 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.58 0.705 . . . . 0.0 110.184 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -95.17 -28.61 14.96 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.548 0.689 . . . . 0.0 109.196 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -147.73 138.19 23.1 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.194 -0.941 . . . . 0.0 110.072 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.65 174.4 15.9 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.17 -13.1 25.84 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.958 2.439 . . . . 0.0 111.132 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' ALA . 97.9 m-20 -97.88 16.69 20.1 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . -39.78 133.04 1.62 Allowed 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.884 0.849 . . . . 0.0 110.924 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.34 -14.24 65.42 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.4 t -66.39 146.71 54.25 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.437 -1.037 . . . . 0.0 110.971 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -134.96 142.11 46.42 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.269 0.557 . . . . 0.0 109.604 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -118.98 125.42 49.36 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.621 0.724 . . . . 0.0 109.95 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 tt -102.16 132.97 47.74 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.281 0.563 . . . . 0.0 110.044 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -87.72 157.74 18.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.512 -0.743 . . . . 0.0 110.344 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 66.7 t0 -173.51 33.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -156.58 147.17 21.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.452 -0.78 . . . . 0.0 109.88 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.23 136.81 46.46 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.802 0.811 . . . . 0.0 110.83 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 85.3 mt 55.11 100.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.542 0.687 . . . . 0.0 109.873 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.2 m -103.7 126.06 50.59 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.607 0.717 . . . . 0.0 109.571 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 30.7 t -92.94 143.64 26.05 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.491 0.662 . . . . 0.0 109.923 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -101.97 170.06 8.37 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.75 0.786 . . . . 0.0 110.282 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 89' ' ' LEU . . . 92.02 -129.47 9.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.921 -1.272 . . . . 0.0 109.921 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.52 ' O ' ' CD2' ' A' ' 82' ' ' HIS . 8.7 ptp180 -103.8 110.83 23.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.615 -0.932 . . . . 0.0 109.612 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 81' ' ' ARG . 80.3 m-70 -161.87 90.56 1.43 Allowed Pre-proline 0 N--CA 1.486 1.341 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.5 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 58.6 Cg_exo -52.12 145.72 33.13 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.679 2.253 . . . . 0.0 112.507 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 7.0 t0 81.5 -22.32 0.27 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.7 t -71.97 146.98 47.39 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.79 0.805 . . . . 0.0 110.891 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -62.62 -42.86 99.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.64 -0.663 . . . . 0.0 109.845 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.9 mm -106.03 114.05 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 109.563 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.501 ' CD2' ' O ' ' A' ' 88' ' ' PHE . 22.0 p90 -129.85 97.87 4.62 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.577 0.703 . . . . 0.0 109.414 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' A' ' 80' ' ' GLY . 96.1 mt -102.03 96.75 7.22 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.763 0.792 . . . . 0.0 108.871 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 30.0 p30 -85.34 90.61 7.97 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.515 0.674 . . . . 0.0 109.764 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -146.06 150.05 35.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.485 -0.759 . . . . 0.0 109.477 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.08 -32.32 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.551 0.691 . . . . 0.0 109.912 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.6 p -66.43 -32.51 73.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.459 -0.776 . . . . 0.0 109.786 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 20.4 t -93.32 128.47 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.306 -0.871 . . . . 0.0 109.917 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 96' ' ' ARG . 25.2 t -78.29 -170.96 2.2 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.666 0.745 . . . . 0.0 110.594 -179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.503 ' N ' ' OG ' ' A' ' 95' ' ' SER . 95.3 mtt180 -61.66 -41.62 97.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.516 -0.74 . . . . 0.0 109.036 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -142.21 62.41 1.43 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -62.3 -40.81 97.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.507 -0.745 . . . . 0.0 109.084 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -140.32 151.07 44.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 0.0 109.777 -179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -140.83 136.57 32.52 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.656 0.741 . . . . 0.0 109.608 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -99.43 146.69 26.05 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.396 0.617 . . . . 0.0 109.356 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -130.81 131.74 44.82 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.483 0.659 . . . . 0.0 109.342 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 50.1 tp -102.93 123.51 46.7 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 105' ' ' ASN . 44.6 tt0 -93.18 -132.04 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.625 -0.672 . . . . 0.0 109.827 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.427 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 90.9 m-20 -64.35 -44.34 91.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.321 -0.862 . . . . 0.0 109.616 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.427 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 3.9 m120 -169.79 24.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -126.78 131.53 51.27 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.654 0.74 . . . . 0.0 109.514 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.409 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 63.9 m-85 -78.94 146.43 33.48 Favored 'General case' 0 N--CA 1.487 1.417 0 CA-C-O 121.486 0.66 . . . . 0.0 109.836 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 93.4 m-20 -144.61 159.38 42.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.8 p -126.93 131.98 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.483 0.658 . . . . 0.0 109.343 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.9 t -127.04 133.46 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.633 0.73 . . . . 0.0 109.414 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -96.53 114.09 25.72 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.569 0.699 . . . . 0.0 109.215 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 35.8 m -77.72 130.32 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.649 0.738 . . . . 0.0 110.385 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 89.44 161.32 37.38 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 82.8 p -88.56 -148.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.617 -0.931 . . . . 0.0 110.538 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.8 mt 57.03 -168.84 0.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.813 0.816 . . . . 0.0 110.753 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.49 ' OD1' ' N ' ' A' ' 118' ' ' GLY . 63.1 t-20 -66.8 145.8 55.11 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.703 0.763 . . . . 0.0 110.336 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.49 ' N ' ' OD1' ' A' ' 117' ' ' ASN . . . -170.6 -146.92 5.37 Favored Glycine 0 N--CA 1.485 1.914 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.1 m -60.38 137.64 58.11 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.764 -0.845 . . . . 0.0 110.428 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 51.8 p90 -137.57 157.73 45.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.622 -0.674 . . . . 0.0 109.411 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 121' ' ' VAL . 11.2 p -117.86 129.57 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 CA-C-O 121.752 0.787 . . . . 0.0 109.965 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.9 m120 52.65 49.56 20.08 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.701 0.762 . . . . 0.0 109.719 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 52.29 26.17 3.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.968 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -123.95 101.22 35.95 Favored Pre-proline 0 N--CA 1.487 1.389 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -47.82 127.01 13.71 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.323 2.015 . . . . 0.0 112.274 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.425 HG22 ' N ' ' A' ' 128' ' ' SER . 2.4 p -144.36 138.69 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.474 -0.766 . . . . 0.0 109.946 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -66.49 -40.17 89.14 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.474 0.654 . . . . 0.0 109.449 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.425 ' N ' HG22 ' A' ' 126' ' ' VAL . 87.7 p -156.87 154.26 29.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.0 109.832 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.13 157.14 27.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.5 -0.75 . . . . 0.0 109.854 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 82.3 t -91.61 128.13 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 CA-C-O 121.729 0.776 . . . . 0.0 109.796 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 92.4 mt -76.67 152.29 35.84 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.754 0.788 . . . . 0.0 110.411 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.534 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -149.4 155.73 40.92 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 121.51 0.671 . . . . 0.0 109.659 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.405 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 43.0 p-10 -51.77 132.57 31.44 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.883 0.849 . . . . 0.0 111.084 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.515 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 82.45 18.19 66.97 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.534 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 23.5 m-20 -83.57 149.38 26.61 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.223 -1.163 . . . . 0.0 110.073 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 57.6 mp0 -108.84 123.97 49.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.624 -0.672 . . . . 0.0 109.435 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.4 t -125.17 132.32 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -123.38 125.18 44.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.405 ' O ' ' N ' ' A' ' 141' ' ' LYS . 36.3 mm -111.34 127.51 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.737 0.779 . . . . 0.0 109.308 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 54.91 -92.19 0.01 OUTLIER Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 139' ' ' ILE . 60.8 pttt -129.9 -18.46 3.4 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -76.99 142.61 39.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.512 -0.742 . . . . 0.0 110.036 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -105.65 132.49 51.73 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.684 0.754 . . . . 0.0 110.13 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -134.54 155.35 50.56 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.446 0.641 . . . . 0.0 109.578 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.39 134.39 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.559 0.695 . . . . 0.0 109.802 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -94.12 120.73 34.79 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 134' ' ' GLY . 84.0 mt -132.74 152.85 51.65 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.799 0.809 . . . . 0.0 109.613 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 t -142.61 164.41 30.2 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.587 0.708 . . . . 0.0 109.693 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.527 ' N ' HD11 ' A' ' 51' ' ' LEU . . . -61.88 -68.65 1.57 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.976 -1.249 . . . . 0.0 109.976 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 149' ' ' GLY . 23.2 m80 -159.38 151.64 21.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.447 -1.031 . . . . 0.0 109.766 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -100.18 142.29 31.87 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.508 0.671 . . . . 0.0 109.781 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -107.59 -40.63 5.27 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.695 0.759 . . . . 0.0 109.189 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 79.45 -69.59 2.97 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 154' ' ' GLU . 57.9 mp0 -71.62 144.77 49.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.718 -0.872 . . . . 0.0 110.758 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 52.8 p-10 -68.69 150.01 48.42 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 121.704 0.764 . . . . 0.0 110.375 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.534 ' CD2' ' H ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -71.04 129.09 38.08 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.865 0.84 . . . . 0.0 110.123 -179.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.655 ' H ' ' CD ' ' A' ' 157' ' ' GLU . 1.2 pm0 -75.34 137.9 41.41 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.693 0.759 . . . . 0.0 110.313 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -67.19 -38.08 84.75 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.633 0.73 . . . . 0.0 109.723 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -66.06 174.04 2.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.445 -0.784 . . . . 0.0 110.632 -179.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -146.53 163.52 35.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.44 -0.788 . . . . 0.0 110.047 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -107.14 131.03 54.58 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.68 0.752 . . . . 0.0 110.44 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.408 ' H ' ' CD2' ' A' ' 162' ' ' HIS . 0.3 OUTLIER -85.32 149.84 25.18 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.523 0.678 . . . . 0.0 109.945 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 85.8 t60 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 117.829 -1.082 . . . . 0.0 109.857 179.856 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -70.44 130.6 42.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 0.0 110.13 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -73.28 145.67 45.92 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.693 0.758 . . . . 0.0 110.79 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -167.14 -39.59 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.567 -0.708 . . . . 0.0 109.181 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -144.62 -64.43 0.35 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.513 0.673 . . . . 0.0 109.837 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.572 ' O ' ' N ' ' A' ' 31' ' ' SER . 1.6 p90 -60.83 165.0 4.29 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.359 -0.838 . . . . 0.0 110.124 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.474 HD12 ' CE2' ' A' ' 29' ' ' PHE . 78.9 mt 58.32 -70.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 121.459 0.647 . . . . 0.0 109.926 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 29' ' ' PHE . 7.9 m -67.32 147.29 53.15 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.377 -0.827 . . . . 0.0 110.5 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -148.57 -69.18 0.22 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 tp -133.33 -35.16 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -84.59 108.11 17.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 110.031 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.661 ' H ' ' CD ' ' A' ' 36' ' ' PRO . . . -110.4 -43.34 0.1 Allowed Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.82 -0.55 . . . . 0.0 109.689 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.661 ' CD ' ' H ' ' A' ' 35' ' ' ALA . 25.1 Cg_exo -60.93 143.39 99.34 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.253 1.969 . . . . 0.0 112.411 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.13 -13.11 21.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.447 -0.783 . . . . 0.0 109.277 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -160.22 -33.11 0.06 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 0.0 109.089 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 57.9 6.4 0.47 Allowed 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.341 0.591 . . . . 0.0 110.332 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.39 158.78 31.95 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -106.44 125.31 50.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.669 -0.9 . . . . 0.0 109.576 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -168.49 130.0 1.32 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.868 . . . . 0.0 109.608 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 m -71.63 146.5 48.28 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.483 -0.76 . . . . 0.0 110.097 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -166.36 22.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -98.06 -14.03 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.426 -0.796 . . . . 0.0 108.99 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.4 t -64.87 145.0 56.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.48 -0.762 . . . . 0.0 110.503 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . 164.64 -84.48 0.1 Allowed Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.8 t 66.13 -41.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 122.201 -0.587 . . . . 0.0 109.666 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.474 ' H ' ' C ' ' A' ' 47' ' ' GLY . 98.5 mt-10 -54.82 138.84 41.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.345 -0.847 . . . . 0.0 110.857 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 52.38 90.94 0.01 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -135.99 78.15 48.08 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.677 -0.896 . . . . 0.0 109.033 179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.437 ' CB ' ' CD ' ' A' ' 53' ' ' PRO . 22.6 Cg_exo -64.38 -175.9 0.36 Allowed 'Trans proline' 0 C--N 1.299 -2.072 0 C-N-CA 122.181 1.921 . . . . 0.0 111.84 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 52' ' ' PRO . 23.2 Cg_exo -65.48 156.05 65.58 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 123.108 2.539 . . . . 0.0 113.285 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.36 -25.43 28.32 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 86.4 mt -125.56 149.58 48.22 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.433 -1.039 . . . . 0.0 110.636 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.459 ' HB3' HD12 ' A' ' 72' ' ' LEU . . . -151.43 156.31 40.39 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.6 mp -122.39 151.47 41.18 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 122.097 0.951 . . . . 0.0 110.188 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 67.0 mt -117.88 142.51 47.25 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 81.2 t -127.32 130.7 70.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.56 -0.713 . . . . 0.0 109.816 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 70.2 t -79.41 130.58 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 121.649 0.738 . . . . 0.0 110.061 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -73.21 -76.47 0.12 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.559 -0.713 . . . . 0.0 109.756 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -123.62 148.53 46.34 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.625 0.726 . . . . 0.0 110.16 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 159.53 175.28 30.31 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.89 -21.23 50.64 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 C-N-CA 122.887 2.391 . . . . 0.0 111.346 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 51.1 p-10 -110.31 23.8 13.82 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -39.96 145.94 0.13 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.643 0.735 . . . . 0.0 110.923 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.6 -1.3 88.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 18.6 m -72.38 146.23 47.17 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -1.073 . . . . 0.0 110.742 -179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 78.1 mtp85 -134.38 147.6 50.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.608 -0.682 . . . . 0.0 109.571 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -128.77 146.92 50.77 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.492 -0.755 . . . . 0.0 109.55 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.1 tp -105.25 127.64 53.04 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.559 0.695 . . . . 0.0 109.756 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 56' ' ' ALA . 84.9 mt -92.88 77.81 4.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.385 -0.822 . . . . 0.0 109.301 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 54.8 t0 -108.59 16.81 22.63 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -124.51 140.02 53.34 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.571 0.7 . . . . 0.0 109.622 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.47 -47.54 85.67 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.618 -0.676 . . . . 0.0 109.869 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 97.1 mt -112.91 121.09 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.531 -0.731 . . . . 0.0 109.354 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 93.6 m -126.83 124.0 38.62 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 70.4 m -97.67 155.25 17.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.448 -0.782 . . . . 0.0 109.625 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.6 158.37 20.9 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.672 0.748 . . . . 0.0 110.219 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.68 -120.95 5.29 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -93.87 111.32 23.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.342 -1.093 . . . . 0.0 109.944 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -175.05 88.71 0.31 Allowed Pre-proline 0 N--CA 1.486 1.371 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 84' ' ' ASP . 46.1 Cg_exo -54.91 148.27 47.75 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 122.574 2.183 . . . . 0.0 112.526 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 83' ' ' PRO . 10.3 t0 82.14 -7.75 1.32 Allowed 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.492 ' O ' ' CZ ' ' A' ' 88' ' ' PHE . 66.7 m -78.48 147.12 34.03 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.345 -0.847 . . . . 0.0 110.618 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -64.17 -38.71 92.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.511 -0.743 . . . . 0.0 109.153 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -83.08 126.75 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.341 -0.849 . . . . 0.0 109.907 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CZ ' ' O ' ' A' ' 85' ' ' SER . 50.3 m-85 -125.2 98.78 5.79 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.413 0.625 . . . . 0.0 109.316 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 91' ' ' ASP . 49.0 mt -107.87 146.81 31.8 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.61 -0.681 . . . . 0.0 109.608 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 41.4 t0 -60.48 -1.16 0.32 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 89' ' ' LEU . 2.6 p30 47.22 31.92 1.9 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.643 0.735 . . . . 0.0 110.444 179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.9 m -68.88 -24.79 28.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 109.885 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 140' ' ' GLY . 60.6 p -138.22 13.27 2.83 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.392 -0.817 . . . . 0.0 109.234 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -106.73 131.35 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.584 0.706 . . . . 0.0 109.582 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.3 p -66.67 -162.89 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.636 0.731 . . . . 0.0 110.887 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -60.38 -40.85 92.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 109.77 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.553 ' O ' ' N ' ' A' ' 99' ' ' ALA . 93.3 mtm-85 -133.24 -41.7 0.89 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.0 t60 60.6 -67.27 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.954 -0.466 . . . . 0.0 109.939 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -140.99 154.3 45.97 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.079 -1.013 . . . . 0.0 109.412 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -138.7 142.34 38.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.555 -0.715 . . . . 0.0 109.551 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -99.88 140.31 34.29 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.421 -0.799 . . . . 0.0 109.446 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.406 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 50.5 mmm-85 -130.48 141.53 50.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.636 -0.665 . . . . 0.0 109.547 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 55.8 tp -115.24 119.54 36.69 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.571 0.7 . . . . 0.0 109.183 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -160.16 -34.04 0.06 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.562 -0.712 . . . . 0.0 109.124 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 107' ' ' GLU . 13.7 m120 -88.58 41.85 1.04 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.351 -0.843 . . . . 0.0 109.232 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 57.48 1.64 0.12 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.622 -0.674 . . . . 0.0 109.973 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.488 ' H ' ' C ' ' A' ' 105' ' ' ASN . 96.1 mt-10 -142.99 157.22 44.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.167 -0.958 . . . . 0.0 109.906 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -74.25 141.65 45.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.515 -0.741 . . . . 0.0 110.14 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 102' ' ' ARG . 39.6 p30 -139.66 173.76 11.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.458 -0.776 . . . . 0.0 109.548 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.7 p -126.3 134.64 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.687 -0.633 . . . . 0.0 109.847 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.7 t -127.02 130.81 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.72 155.19 24.44 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.414 -0.804 . . . . 0.0 110.127 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.541 HG23 ' H ' ' A' ' 115' ' ' SER . 13.0 m -94.95 -7.94 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 64.34 3.88 10.74 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.541 ' H ' HG23 ' A' ' 113' ' ' VAL . 78.2 p -61.84 -42.29 98.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.128 -1.219 . . . . 0.0 109.045 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.2 pp -173.06 135.93 0.62 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.799 0.809 . . . . 0.0 110.532 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 57.27 90.47 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.646 0.736 . . . . 0.0 110.71 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -63.08 140.1 45.13 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.451 -1.059 . . . . 0.0 110.451 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 120' ' ' TYR . 44.2 m -76.69 161.99 28.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.509 -0.995 . . . . 0.0 110.327 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.528 ' N ' HG22 ' A' ' 119' ' ' THR . 44.2 p90 -142.48 162.28 35.88 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.545 -0.722 . . . . 0.0 109.956 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 123' ' ' ARG . 8.4 p -114.68 131.42 66.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.654 0.74 . . . . 0.0 109.722 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 43.59 -91.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.582 -0.699 . . . . 0.0 110.385 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 121' ' ' VAL . 15.0 ptp180 -143.68 41.64 1.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 109.059 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -146.71 82.43 8.68 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.369 -0.832 . . . . 0.0 109.185 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -55.58 128.9 32.31 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.806 2.338 . . . . 0.0 112.811 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.3 m -150.81 161.87 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.321 -0.862 . . . . 0.0 109.945 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.62 -38.01 89.52 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -0.827 . . . . 0.0 109.557 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.8 t -153.22 152.65 31.44 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.148 -0.97 . . . . 0.0 109.511 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -151.5 152.13 32.56 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.212 -0.93 . . . . 0.0 110.072 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.27 130.16 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.461 -0.775 . . . . 0.0 109.913 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.96 148.93 34.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.793 0.806 . . . . 0.0 110.272 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.431 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -148.98 156.36 42.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.494 -0.754 . . . . 0.0 109.317 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.766 ' ND2' ' H ' ' A' ' 148' ' ' THR . 31.8 t-20 -57.72 136.14 56.85 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.776 0.798 . . . . 0.0 111.301 -179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 85.3 10.46 77.55 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.431 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 89.5 m-20 -89.62 156.42 18.6 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.228 -1.16 . . . . 0.0 110.275 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -108.78 136.57 48.12 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.704 -0.623 . . . . 0.0 109.376 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.6 t -124.72 133.25 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.647 -0.658 . . . . 0.0 109.458 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -123.14 114.77 20.76 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 140' ' ' GLY . 96.7 mt -132.78 122.43 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.448 -0.782 . . . . 0.0 109.74 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.516 ' O ' ' N ' ' A' ' 142' ' ' PHE . . . 35.14 72.8 0.11 Allowed Glycine 0 N--CA 1.5 2.921 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 142' ' ' PHE . 6.2 tmtt? 64.16 -63.43 0.15 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.911 -0.758 . . . . 0.0 110.066 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.516 ' N ' ' O ' ' A' ' 140' ' ' GLY . 33.1 m-85 -36.31 123.19 0.76 Allowed 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.504 0.669 . . . . 0.0 110.595 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -101.56 132.46 47.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.725 -0.609 . . . . 0.0 109.46 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 mp -138.06 156.43 47.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.56 -0.712 . . . . 0.0 109.423 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.09 137.9 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.619 -0.676 . . . . 0.0 109.424 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -90.82 114.48 26.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.589 -0.694 . . . . 0.0 109.262 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.6 mt -134.01 149.4 51.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.774 0.797 . . . . 0.0 109.417 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.766 ' H ' ' ND2' ' A' ' 133' ' ' ASN . 82.4 p -141.27 98.72 3.42 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.568 -0.707 . . . . 0.0 109.52 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 148' ' ' THR . . . 36.36 -110.5 0.09 OUTLIER Glycine 0 N--CA 1.497 2.739 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 45.07 92.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.779 -0.836 . . . . 0.0 109.946 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -92.05 112.95 25.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.363 -0.836 . . . . 0.0 109.761 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -168.4 100.76 0.42 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.545 ' O ' HD21 ' A' ' 156' ' ' LEU . . . -87.49 -2.94 81.88 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.086 -1.606 . . . . 0.0 109.086 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -77.49 152.48 34.14 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.55 -0.97 . . . . 0.0 111.008 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 56.03 58.14 4.59 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.622 0.725 . . . . 0.0 109.421 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.545 HD21 ' O ' ' A' ' 153' ' ' GLY . 86.2 mt -70.97 144.88 50.37 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.712 0.768 . . . . 0.0 110.333 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.0 tt0 50.43 25.48 1.94 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.677 0.751 . . . . 0.0 109.108 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -148.2 137.4 22.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.421 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -144.1 121.53 11.68 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 109.293 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -67.46 -40.21 85.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.409 -0.807 . . . . 0.0 109.708 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -80.52 144.2 32.67 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 110.803 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -76.94 141.43 40.48 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.742 0.782 . . . . 0.0 110.402 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.862 -1.066 . . . . 0.0 109.986 179.793 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -83.58 161.87 21.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.341 -0.849 . . . . 0.0 110.431 -179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 27' ' ' ALA . 69.8 ttt180 -150.87 115.76 5.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -0.841 . . . . 0.0 109.604 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 26' ' ' ARG . . . 57.33 154.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.78 0.8 . . . . 0.0 110.776 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -81.43 -4.56 56.17 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 109.037 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.493 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 31.3 p90 -156.17 -160.03 0.96 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.306 -0.872 . . . . 0.0 110.168 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.493 ' N ' ' CD2' ' A' ' 29' ' ' PHE . 59.6 mt -60.95 97.77 0.06 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.93 0.871 . . . . 0.0 109.917 -179.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.4 ' O ' ' O ' ' A' ' 30' ' ' LEU . 69.5 m -48.03 -95.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.674 -0.641 . . . . 0.0 109.904 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 33' ' ' LEU . 47.9 tp10 -173.72 -48.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.438 ' O ' ' O ' ' A' ' 32' ' ' GLU . 50.4 tp 57.1 116.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.839 0.828 . . . . 0.0 110.297 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.678 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 44.4 t0 -63.37 -49.73 72.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 0.0 109.549 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 34' ' ' ASP . . . 163.08 154.2 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.708 -0.62 . . . . 0.0 109.354 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -64.13 146.75 91.13 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 123.011 2.474 . . . . 0.0 112.966 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.76 143.3 55.93 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.707 0.765 . . . . 0.0 110.152 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 39' ' ' ALA . 5.0 pp0? -173.13 -25.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 38' ' ' GLN . . . 39.82 -105.9 0.05 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.526 0.679 . . . . 0.0 110.429 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.16 2.58 87.94 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.8 m -103.96 119.58 39.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.375 -1.074 . . . . 0.0 109.693 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -106.59 -15.57 14.74 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -65.64 138.64 58.14 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.508 -0.745 . . . . 0.0 110.252 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -172.74 24.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.3 t -107.17 -19.98 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.6 t -166.4 130.1 2.05 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 109.809 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 49' ' ' GLU . . . -164.45 -148.41 5.43 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 48' ' ' VAL . 17.8 t -67.56 3.44 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.47 -1.018 . . . . 0.0 109.458 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 47' ' ' GLY . 98.1 mt-10 -58.96 -39.19 80.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.305 -0.872 . . . . 0.0 109.62 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 172.17 94.89 0.1 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -96.26 150.55 37.3 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.195 -1.18 . . . . 0.0 109.772 -179.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.77 166.08 28.8 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 122.56 2.174 . . . . 0.0 111.905 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -53.22 140.1 62.13 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 C-N-CA 121.891 1.727 . . . . 0.0 112.277 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 144.81 -76.19 0.29 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.492 ' N ' HD12 ' A' ' 55' ' ' LEU . 10.7 mp -96.13 151.77 19.16 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.399 -1.06 . . . . 0.0 110.289 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -127.02 162.63 25.56 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.23 153.8 45.66 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.917 0.865 . . . . 0.0 110.509 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.7 mt -114.3 141.21 47.89 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -126.8 132.72 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-O 121.585 0.707 . . . . 0.0 109.794 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.8 t -72.06 132.54 33.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.606 0.717 . . . . 0.0 109.686 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -81.9 -77.16 0.23 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.543 -0.723 . . . . 0.0 109.188 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.4 tpt85 -133.94 139.16 45.95 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.806 0.813 . . . . 0.0 109.836 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 161.62 -177.74 37.77 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.51 -38.63 90.07 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.758 2.305 . . . . 0.0 111.919 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.425 ' O ' ' O ' ' A' ' 66' ' ' ALA . 98.7 m-20 -75.53 -78.82 0.1 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.662 -0.648 . . . . 0.0 110.102 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 65' ' ' ASN . . . 59.63 122.46 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.442 -0.787 . . . . 0.0 110.391 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 99.14 -19.58 53.55 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 40.6 t -67.63 144.78 55.37 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.295 -1.121 . . . . 0.0 110.554 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -134.54 145.07 48.38 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.627 -0.671 . . . . 0.0 109.732 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -132.22 139.3 48.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.54 -0.725 . . . . 0.0 109.6 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pp -106.41 145.41 31.77 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.5 0.667 . . . . 0.0 109.833 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.34 123.92 44.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.373 -0.83 . . . . 0.0 109.635 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -93.94 37.93 1.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 109.157 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.46 HE21 HD11 ' A' ' 55' ' ' LEU . 78.5 mt-30 55.93 -168.09 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.718 0.77 . . . . 0.0 111.034 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . 62.76 -141.37 0.39 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.526 0.679 . . . . 0.0 110.667 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 93.4 mt -113.57 127.82 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.741 -0.599 . . . . 0.0 109.705 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 97.1 m -120.84 124.95 46.29 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.502 0.668 . . . . 0.0 109.27 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.5 m -94.42 161.63 14.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.518 -0.739 . . . . 0.0 109.436 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -113.57 151.68 31.31 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.606 0.717 . . . . 0.0 109.848 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.85 -58.02 1.53 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -77.62 145.83 36.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -1.091 . . . . 0.0 110.691 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.495 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -86.02 -47.35 0.57 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.505 -0.747 . . . . 0.0 109.742 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 72.9 Cg_exo -51.97 133.71 46.89 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.325 2.017 . . . . 0.0 113.172 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 83' ' ' PRO . 45.7 t0 41.8 49.88 3.96 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.726 0.774 . . . . 0.0 109.718 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 9.5 t -157.01 114.25 3.1 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.369 -0.832 . . . . 0.0 109.397 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -64.62 -37.66 88.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.533 -0.73 . . . . 0.0 109.9 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.5 mm -73.22 131.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.416 -0.802 . . . . 0.0 110.12 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -129.78 86.54 2.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.705 -0.622 . . . . 0.0 109.541 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 87.9 mt -123.12 93.52 3.98 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.426 ' O ' ' OD1' ' A' ' 91' ' ' ASP . 97.2 m-20 -94.68 104.18 16.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.431 -0.793 . . . . 0.0 109.468 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 62.3 m-20 -159.52 168.58 25.81 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.266 -0.896 . . . . 0.0 110.243 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 93' ' ' THR . 17.4 m -67.34 -35.99 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 CA-C-O 121.507 0.67 . . . . 0.0 109.827 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.421 ' N ' HG23 ' A' ' 92' ' ' VAL . 59.2 p -65.77 -26.78 67.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.841 . . . . 0.0 109.944 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.41 128.83 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.487 -0.758 . . . . 0.0 109.499 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.4 m -88.95 -164.07 1.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.605 0.717 . . . . 0.0 110.03 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -62.92 -43.64 98.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.516 -0.74 . . . . 0.0 109.497 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.6 ' O ' ' N ' ' A' ' 99' ' ' ALA . 84.7 mtp180 -108.39 -57.83 2.07 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 57.69 -73.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.864 -0.522 . . . . 0.0 109.655 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . -132.12 155.24 48.5 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.651 0.738 . . . . 0.0 109.439 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -139.37 146.25 39.98 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' A' ' 110' ' ' VAL . 99.0 m-85 -113.05 139.18 48.9 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -128.85 139.26 52.24 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 42.5 tp -95.02 121.53 36.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.493 -0.754 . . . . 0.0 109.541 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.0 tp10 -99.44 -124.99 0.16 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -84.59 88.18 7.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.829 -179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 58.1 t-20 52.71 27.0 4.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.64 -0.663 . . . . 0.0 110.051 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -142.19 131.12 23.02 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.019 -1.051 . . . . 0.0 110.02 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -76.73 147.75 37.17 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.636 -0.665 . . . . 0.0 110.206 -179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -139.67 159.78 41.37 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.411 -0.806 . . . . 0.0 109.104 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.446 HG23 ' CE1' ' A' ' 101' ' ' PHE . 9.0 p -126.44 132.73 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.702 -0.624 . . . . 0.0 109.435 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 55.4 t -125.9 135.82 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.509 0.671 . . . . 0.0 109.244 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.425 ' OD2' ' OD1' ' A' ' 117' ' ' ASN . 68.0 m-20 -85.3 115.29 22.98 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.496 -0.753 . . . . 0.0 109.378 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.5 m -107.65 -2.12 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.66 137.99 14.93 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 38.5 t -63.27 -42.59 99.14 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.432 -1.04 . . . . 0.0 109.838 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.438 HD12 ' N ' ' A' ' 118' ' ' GLY . 2.2 pp -65.1 -36.8 85.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 109.861 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.425 ' OD1' ' OD2' ' A' ' 112' ' ' ASP . 55.2 t30 68.35 81.4 0.19 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.674 0.75 . . . . 0.0 109.945 -179.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.438 ' N ' HD12 ' A' ' 116' ' ' LEU . . . -94.24 -10.28 58.51 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.2 m -76.1 132.45 40.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.328 -1.101 . . . . 0.0 110.196 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -135.37 149.95 49.81 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.534 ' O ' ' O ' ' A' ' 122' ' ' ASN . 9.9 p -130.52 156.69 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.604 -0.685 . . . . 0.0 110.009 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.534 ' O ' ' O ' ' A' ' 121' ' ' VAL . 97.5 m-20 -40.61 173.96 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.995 0.902 . . . . 0.0 111.063 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 60.46 -105.12 0.2 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.856 -0.528 . . . . 0.0 109.992 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -125.62 145.5 51.6 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.779 -0.576 . . . . 0.0 109.602 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -49.24 139.12 28.35 Favored 'Trans proline' 0 N--CA 1.499 1.81 0 C-N-CA 122.355 2.037 . . . . 0.0 113.053 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 m -137.85 160.08 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.489 -0.757 . . . . 0.0 109.977 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -69.13 -37.68 78.45 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.661 -0.649 . . . . 0.0 109.525 178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 99.8 p -156.28 161.83 40.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.048 -1.032 . . . . 0.0 110.456 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -160.33 165.55 31.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.45 -0.781 . . . . 0.0 109.579 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.0 t -93.46 130.24 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.441 -0.787 . . . . 0.0 109.719 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 80.6 mt -77.33 147.2 36.31 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.645 0.736 . . . . 0.0 110.467 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.88 164.17 34.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 121.614 0.721 . . . . 0.0 109.698 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 133' ' ' ASN . 18.5 p30 -64.0 127.34 30.97 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.66 0.743 . . . . 0.0 110.714 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 83.41 16.33 69.18 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 145' ' ' VAL . 44.8 t0 -85.69 160.23 19.61 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.154 -1.204 . . . . 0.0 109.928 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -112.15 124.37 52.29 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.522 -0.736 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.1 t -127.35 132.67 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -121.7 113.96 20.46 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -131.5 130.05 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 CA-C-O 121.462 0.648 . . . . 0.0 109.795 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.505 ' C ' ' H ' ' A' ' 142' ' ' PHE . . . 67.29 36.01 88.84 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 140' ' ' GLY . 15.0 tptp 71.37 -19.18 0.26 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.677 -0.896 . . . . 0.0 109.475 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 140' ' ' GLY . 95.6 m-85 -73.96 143.34 45.7 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.882 . . . . 0.0 109.961 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -99.71 120.68 40.1 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.377 -0.827 . . . . 0.0 109.17 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.33 153.39 47.89 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.6 -0.687 . . . . 0.0 109.944 -179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 135' ' ' ASP . 9.9 p -127.09 138.72 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 121.581 0.705 . . . . 0.0 109.554 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -89.9 120.34 31.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.619 -0.675 . . . . 0.0 109.397 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 66.3 mt -134.72 152.87 52.1 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.396 0.617 . . . . 0.0 109.878 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 68.7 p -128.1 158.81 36.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.569 0.699 . . . . 0.0 109.567 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 150' ' ' HIS . . . -45.75 -78.61 0.08 OUTLIER Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 149' ' ' GLY . 56.4 t-80 48.29 97.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.474 -1.015 . . . . 0.0 110.058 -179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -76.7 156.19 32.72 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.721 0.772 . . . . 0.0 110.581 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -62.02 138.6 58.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.577 -0.702 . . . . 0.0 110.433 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 172.01 178.37 42.22 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -98.24 88.76 4.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.429 -1.042 . . . . 0.0 109.388 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 156' ' ' LEU . 65.8 t0 -79.29 151.41 31.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.392 -0.817 . . . . 0.0 109.793 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.563 ' N ' ' OD1' ' A' ' 155' ' ' ASP . 86.1 mt -69.58 -79.07 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.336 -0.853 . . . . 0.0 109.636 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' A' ' 156' ' ' LEU . 97.0 mt-10 46.9 97.97 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.862 0.839 . . . . 0.0 110.01 -179.282 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -60.13 -39.99 88.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.533 -0.729 . . . . 0.0 109.7 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -101.64 138.44 38.63 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.552 -0.718 . . . . 0.0 109.573 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -148.86 79.71 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 80.2 m80 44.82 88.42 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.753 0.787 . . . . 0.0 110.064 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -90.78 125.62 35.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.471 -0.768 . . . . 0.0 110.217 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.599 ' CD2' ' H ' ' A' ' 163' ' ' HIS . 7.9 p80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.882 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.526 0.679 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -70.21 135.65 49.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 110.201 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -73.43 143.87 46.56 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.351 -0.843 . . . . 0.0 110.252 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.519 ' C ' ' H ' ' A' ' 29' ' ' PHE . . . -92.9 81.37 4.63 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.229 -0.919 . . . . 0.0 109.755 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.2 t0 66.93 -16.33 0.14 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.581 -0.699 . . . . 0.0 109.923 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.573 ' CD2' ' N ' ' A' ' 30' ' ' LEU . 16.5 p90 -171.8 -161.83 0.2 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.944 -1.098 . . . . 0.0 110.16 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.573 ' N ' ' CD2' ' A' ' 29' ' ' PHE . 71.3 mt -69.99 85.35 0.52 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.546 0.689 . . . . 0.0 109.614 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 97.7 p -63.21 150.34 43.25 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.404 -0.81 . . . . 0.0 110.612 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -174.35 137.49 0.51 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.182 -0.949 . . . . 0.0 110.02 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 43.5 tp -64.06 -40.6 96.63 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.45 -0.781 . . . . 0.0 109.961 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -64.4 144.26 57.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.232 -0.917 . . . . 0.0 111.095 -178.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -169.54 57.8 0.31 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.328 -0.857 . . . . 0.0 109.402 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.5 155.93 62.47 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.754 2.303 . . . . 0.0 112.26 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.57 -107.33 0.14 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.195 -0.941 . . . . 0.0 109.161 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -105.87 -25.71 12.03 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.78 135.85 38.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 110.586 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 40.97 87.67 0.01 OUTLIER Glycine 0 N--CA 1.498 2.784 0 N-CA-C 110.473 -1.051 . . . . 0.0 110.473 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -68.77 136.09 52.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.025 -1.279 . . . . 0.0 110.343 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -85.46 142.56 29.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 110.033 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 44' ' ' ALA . 41.9 t -59.08 -82.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.31 -0.869 . . . . 0.0 110.205 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 43' ' ' SER . . . 42.02 49.36 4.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.523 -0.736 . . . . 0.0 109.941 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.9 m -93.29 -4.62 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.306 -0.871 . . . . 0.0 108.71 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 16.0 p -73.52 155.53 39.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.369 -0.832 . . . . 0.0 110.63 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.15 144.65 0.12 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.4 t -91.32 -5.65 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.239 -1.154 . . . . 0.0 108.611 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 59.75 106.79 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.518 0.675 . . . . 0.0 110.717 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 51' ' ' LEU . . . 102.55 -49.91 0.96 Allowed Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.444 HD23 ' HA3' ' A' ' 149' ' ' GLY . 0.3 OUTLIER 40.99 80.63 0.27 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.635 -0.921 . . . . 0.0 109.72 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -56.38 127.43 25.95 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.94 1.76 . . . . 0.0 111.139 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -47.75 138.67 19.88 Favored 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 121.968 1.779 . . . . 0.0 112.695 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 100.5 -18.64 54.95 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.5 ' N ' HD12 ' A' ' 55' ' ' LEU . 11.0 mp -100.72 149.76 23.46 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.158 -1.201 . . . . 0.0 110.178 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.42 ' CB ' ' CZ ' ' A' ' 146' ' ' PHE . . . -149.05 165.85 30.47 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.444 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.04 155.16 47.35 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.67 0.748 . . . . 0.0 109.818 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.2 mt -116.14 136.69 52.79 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.0 t -120.48 135.28 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.672 0.749 . . . . 0.0 109.744 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.3 116.52 20.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.527 -0.733 . . . . 0.0 110.007 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -66.76 -45.15 79.45 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.43 -0.794 . . . . 0.0 109.918 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -154.29 151.55 29.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.017 . . . . 0.0 110.396 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.42 -176.53 28.11 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.53 -38.37 74.94 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.894 2.396 . . . . 0.0 112.274 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 11.2 m120 -82.17 -76.62 0.25 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.283 -0.886 . . . . 0.0 109.572 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . 70.27 118.07 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.563 0.697 . . . . 0.0 110.249 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.27 -15.65 62.87 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 43.8 t -67.21 145.46 55.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.254 -1.144 . . . . 0.0 110.546 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -133.4 151.81 51.86 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.667 -0.645 . . . . 0.0 109.676 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -128.17 142.05 51.29 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.505 -0.747 . . . . 0.0 109.052 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 41.4 tp -102.27 128.29 48.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.608 -0.683 . . . . 0.0 109.969 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 75.2 mt -92.5 75.02 5.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.218 -0.926 . . . . 0.0 109.161 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.6 p-10 -95.07 5.52 51.65 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 0.0 109.134 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -115.09 139.43 49.89 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.512 -0.742 . . . . 0.0 109.81 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.61 -50.72 72.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.589 -0.695 . . . . 0.0 110.004 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 22.9 mm -110.14 120.87 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.346 -0.847 . . . . 0.0 108.828 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 81.4 m -125.69 115.04 19.48 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.369 0.604 . . . . 0.0 109.688 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.1 m -84.31 151.52 24.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.37 -0.831 . . . . 0.0 109.022 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.61 162.23 13.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.216 -0.928 . . . . 0.0 110.348 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.8 -132.18 11.0 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.545 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 94.9 mtt180 -102.97 131.32 50.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.477 -1.013 . . . . 0.0 110.226 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 23.9 m-70 -172.92 153.93 2.67 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.17 -54.38 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.33 2.02 . . . . 0.0 111.305 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 84' ' ' ASP . 50.3 p-10 -96.79 88.7 4.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.453 -0.78 . . . . 0.0 109.806 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 96.6 p -166.33 126.79 1.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.991 . . . . 0.0 109.381 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.11 -39.95 95.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.344 -0.847 . . . . 0.0 109.649 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.6 mt -87.76 127.45 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.104 -0.997 . . . . 0.0 109.594 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -129.28 85.75 2.35 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 91.2 mt -101.51 94.53 5.94 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.343 -0.848 . . . . 0.0 108.808 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -88.47 85.52 6.87 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.498 ' OD2' ' CE1' ' A' ' 142' ' ' PHE . 12.2 p-10 -155.29 170.11 22.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.36 -0.838 . . . . 0.0 109.655 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.55 HG12 ' H ' ' A' ' 93' ' ' THR . 4.1 t -71.9 171.9 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.597 -0.689 . . . . 0.0 110.504 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.55 ' H ' HG12 ' A' ' 92' ' ' VAL . 2.7 p 66.24 -5.93 0.53 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.668 -0.645 . . . . 0.0 109.627 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 92' ' ' VAL . 94.4 t -109.44 -19.2 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 94' ' ' VAL . 1.4 m 44.5 -173.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.826 0.822 . . . . 0.0 110.827 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -70.11 -43.79 70.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.932 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.424 ' CG ' ' NE2' ' A' ' 82' ' ' HIS . 79.3 mtp85 -140.91 88.98 2.22 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.362 -0.836 . . . . 0.0 109.421 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -99.53 -30.57 12.08 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.92 151.44 33.4 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.175 -0.953 . . . . 0.0 109.868 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -140.85 150.32 43.1 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.478 -0.763 . . . . 0.0 109.503 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.34 145.66 37.09 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -132.99 136.28 45.97 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 57.4 tp -96.78 124.75 40.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.329 -0.857 . . . . 0.0 109.743 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 105' ' ' ASN . 80.6 tt0 -107.18 -109.93 0.3 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.518 -0.739 . . . . 0.0 109.571 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.402 ' N ' ' HG2' ' A' ' 104' ' ' GLU . 82.1 m-20 -91.84 79.35 5.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.997 -1.065 . . . . 0.0 109.38 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.0 m120 55.89 34.68 24.03 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.558 -0.713 . . . . 0.0 109.538 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.24 131.51 13.63 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.912 . . . . 0.0 109.044 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -83.73 150.35 25.89 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.172 -0.955 . . . . 0.0 110.357 -179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -122.31 157.77 31.03 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 110' ' ' VAL . 7.9 p -120.87 127.73 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.593 -0.692 . . . . 0.0 109.222 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.2 t -130.72 137.55 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.755 -0.59 . . . . 0.0 109.543 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.479 ' OD2' HD23 ' A' ' 116' ' ' LEU . 49.4 p-10 -84.55 95.68 8.92 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.275 -0.891 . . . . 0.0 109.277 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.41 -42.99 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.429 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.52 -151.17 1.31 Allowed Glycine 0 N--CA 1.489 2.188 0 C-N-CA 120.275 -0.965 . . . . 0.0 110.966 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.5 t -62.0 149.52 40.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.449 -1.03 . . . . 0.0 110.717 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.479 HD23 ' OD2' ' A' ' 112' ' ' ASP . 84.1 mt -62.8 -40.09 96.29 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.601 -0.687 . . . . 0.0 109.531 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -79.95 131.4 35.82 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.867 -1.146 . . . . 0.0 110.307 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 133.41 -72.24 0.48 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 48.7 m -82.02 129.58 34.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.973 -1.31 . . . . 0.0 109.749 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -146.22 158.81 43.9 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.133 -0.98 . . . . 0.0 109.245 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.55 133.85 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.717 -0.615 . . . . 0.0 109.484 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.494 ' C ' ' H ' ' A' ' 124' ' ' GLU . 97.7 m-20 57.69 38.43 27.58 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.779 -0.575 . . . . 0.0 110.006 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 56.79 0.06 0.07 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.525 -0.734 . . . . 0.0 110.634 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 122' ' ' ASN . 72.3 mt-10 -107.28 147.65 35.61 Favored Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.266 -0.896 . . . . 0.0 109.44 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.92 148.08 0.23 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.265 1.977 . . . . 0.0 112.227 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 12.9 p -124.69 135.15 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 121.769 0.795 . . . . 0.0 109.663 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 128' ' ' SER . 65.7 t0 -148.58 59.85 1.08 Allowed 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.464 ' O ' ' OG ' ' A' ' 128' ' ' SER . 2.8 p 80.97 95.6 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.526 0.679 . . . . 0.0 109.506 -179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -128.09 151.22 49.45 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.397 -0.814 . . . . 0.0 109.501 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.6 t -81.5 131.49 33.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.47 -0.769 . . . . 0.0 109.957 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 97.4 mt -77.03 151.7 35.45 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.478 -0.764 . . . . 0.0 110.267 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.543 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -152.63 153.8 34.06 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -0.899 . . . . 0.0 109.934 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -49.23 129.84 18.61 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.66 0.743 . . . . 0.0 111.383 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 88.16 15.13 61.23 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.543 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 92.2 m-20 -91.08 150.86 21.24 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.744 -1.445 . . . . 0.0 109.86 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -108.84 130.86 55.42 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.473 -0.767 . . . . 0.0 109.122 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 55.6 t -124.45 133.1 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.604 -0.685 . . . . 0.0 109.248 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.456 ' OE1' ' CZ ' ' A' ' 143' ' ' ARG . 57.3 tt0 -121.07 124.66 45.35 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.49 129.84 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 CA-C-O 121.49 0.662 . . . . 0.0 110.027 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 50.46 -98.38 0.02 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -127.4 -19.3 4.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.623 -0.928 . . . . 0.0 108.888 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.498 ' CE1' ' OD2' ' A' ' 91' ' ' ASP . 13.6 m-85 -74.82 143.31 43.99 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.406 -0.809 . . . . 0.0 109.874 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.456 ' CZ ' ' OE1' ' A' ' 138' ' ' GLN . 28.1 mmt180 -103.32 137.17 41.81 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.496 -0.753 . . . . 0.0 109.653 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 mp -140.86 151.96 44.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.809 -0.557 . . . . 0.0 109.794 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 15.0 p -124.28 134.28 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.42 ' CZ ' ' CB ' ' A' ' 56' ' ' ALA . 67.2 t80 -93.04 108.63 20.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.5 mt -140.22 150.75 44.53 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.622 0.725 . . . . 0.0 109.414 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 150' ' ' HIS . 13.5 p -87.58 172.39 9.78 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.519 -0.738 . . . . 0.0 110.062 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.444 ' HA3' HD23 ' A' ' 51' ' ' LEU . . . -62.34 3.46 0.82 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' A' ' 148' ' ' THR . 80.8 t60 41.77 90.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.485 -1.009 . . . . 0.0 110.353 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -82.67 157.51 23.33 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.738 0.78 . . . . 0.0 110.233 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.1 tp60 -59.88 142.9 52.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.328 -0.857 . . . . 0.0 110.41 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -64.75 143.95 47.51 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.961 -0.856 . . . . 0.0 110.961 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -78.97 166.49 22.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.569 -0.959 . . . . 0.0 110.659 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 53.3 p-10 -57.3 -162.08 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.79 0.805 . . . . 0.0 110.748 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 75.3 mt -70.25 146.17 50.84 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.686 0.755 . . . . 0.0 110.686 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.25 52.5 1.83 Allowed 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.43 -0.793 . . . . 0.0 109.137 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' HIS . 61.7 t-80 45.69 86.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.663 0.744 . . . . 0.0 110.378 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 160' ' ' HIS . 80.3 m80 54.01 165.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.511 0.672 . . . . 0.0 111.097 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 159' ' ' HIS . 79.4 m80 58.02 140.3 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 121.448 0.642 . . . . 0.0 110.706 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.419 ' O ' ' N ' ' A' ' 163' ' ' HIS . 58.5 t-80 -120.17 123.6 43.69 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.607 -0.683 . . . . 0.0 109.709 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 163' ' ' HIS . 53.3 t-80 49.72 -93.89 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.44 -0.788 . . . . 0.0 110.496 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.427 ' N ' ' ND1' ' A' ' 162' ' ' HIS . 46.7 t-80 . . . . . 0 N--CA 1.488 1.436 0 O-C-N 120.878 -1.138 . . . . 0.0 109.097 -179.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.463 0.649 . . . . 0.0 109.713 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -70.77 128.99 37.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.443 -0.786 . . . . 0.0 110.199 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -143.93 -6.16 0.77 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 52.55 -138.27 1.13 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.706 0.765 . . . . 0.0 110.479 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -152.29 65.76 0.83 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.38 -0.825 . . . . 0.0 109.049 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.417 ' CZ ' HD23 ' A' ' 30' ' ' LEU . 49.7 p90 -172.74 -29.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.417 HD23 ' CZ ' ' A' ' 29' ' ' PHE . 2.1 pp -92.68 -28.94 16.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.133 -0.979 . . . . 0.0 109.359 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.5 t -91.11 99.74 12.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.935 . . . . 0.0 109.481 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -87.77 97.77 11.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.475 -0.766 . . . . 0.0 109.66 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 33' ' ' LEU . 9.9 mp -72.18 -171.81 0.8 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.645 0.735 . . . . 0.0 110.646 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -62.81 140.45 58.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.442 -0.786 . . . . 0.0 110.288 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -157.68 60.62 2.0 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.47 -0.769 . . . . 0.0 109.273 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.7 155.83 65.12 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 122.801 2.334 . . . . 0.0 112.629 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.28 141.37 58.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 110.235 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -99.22 154.39 18.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.459 -0.775 . . . . 0.0 110.264 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.55 18.2 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.44 -179.57 53.42 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.35 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.8 m -87.52 127.61 35.25 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.599 -0.942 . . . . 0.0 109.994 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -175.34 -87.24 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 80.6 p 45.5 -131.93 0.99 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.537 -0.727 . . . . 0.0 110.12 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -169.66 50.08 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.0 m -90.68 -7.19 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -69.52 140.42 53.92 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.433 -0.792 . . . . 0.0 110.567 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.22 174.92 11.27 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 48' ' ' VAL . 10.3 p -89.34 2.89 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.577 -0.954 . . . . 0.0 109.02 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' O ' ' C ' ' A' ' 50' ' ' GLY . 80.5 mm-40 -39.6 155.02 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.448 0.642 . . . . 0.0 110.809 -179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 49' ' ' GLU . . . -35.16 109.29 0.06 OUTLIER Glycine 0 N--CA 1.497 2.754 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.625 ' H ' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -102.22 158.27 32.09 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -179.256 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -73.47 167.59 26.89 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.019 1.813 . . . . 0.0 111.992 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.85 148.14 85.37 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.435 2.09 . . . . 0.0 112.866 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.478 ' O ' HD22 ' A' ' 55' ' ' LEU . . . 88.1 15.81 60.29 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.666 HD12 HD11 ' A' ' 71' ' ' LEU . 3.9 mm? -114.24 131.69 56.39 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.621 -0.929 . . . . 0.0 110.098 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.15 155.03 44.48 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -129.4 153.27 48.07 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.827 0.823 . . . . 0.0 110.399 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -114.35 127.08 55.68 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.3 t -119.54 134.05 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 121.661 0.743 . . . . 0.0 109.809 -179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 71.9 t -70.77 128.95 34.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.581 -0.699 . . . . 0.0 109.789 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -88.45 -35.56 16.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.166 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -150.18 132.49 15.52 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.636 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 66' ' ' ALA . . . 141.43 169.48 11.92 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 178.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.12 -39.42 70.82 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.755 2.303 . . . . 0.0 111.816 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -81.81 30.63 0.37 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 63' ' ' GLY . . . -63.17 134.26 55.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.524 -0.735 . . . . 0.0 110.278 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.73 -15.61 58.61 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 22.8 t -65.57 144.53 56.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.525 -0.985 . . . . 0.0 110.076 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 52.5 ptt85 -136.87 148.9 47.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.642 -0.661 . . . . 0.0 109.698 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -128.79 153.5 47.34 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.603 -0.686 . . . . 0.0 109.181 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.666 HD11 HD12 ' A' ' 55' ' ' LEU . 53.8 tp -110.16 143.57 40.06 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.835 -0.541 . . . . 0.0 109.903 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 86.9 mt -116.59 78.96 1.25 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.513 -0.742 . . . . 0.0 109.686 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.427 ' O ' ' OD1' ' A' ' 73' ' ' ASP . 67.1 t0 -110.31 41.01 1.83 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -135.93 150.33 49.26 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.573 -0.704 . . . . 0.0 109.428 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.09 -48.85 79.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.409 -0.807 . . . . 0.0 109.67 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 96.6 mt -127.62 127.51 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 86.8 m -122.8 124.98 44.54 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 27.0 t -97.63 168.16 10.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.335 -0.853 . . . . 0.0 110.443 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB3' ' H ' ' A' ' 99' ' ' ALA . . . -116.16 -178.93 3.52 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.652 0.739 . . . . 0.0 109.753 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 64.34 -134.74 39.25 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.588 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 38.1 mmt180 -74.58 133.9 42.18 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.436 -1.037 . . . . 0.0 109.818 -178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.588 ' CG ' ' O ' ' A' ' 81' ' ' ARG . 1.2 m80 166.96 85.92 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.15 -36.47 66.65 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.992 1.795 . . . . 0.0 110.964 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -94.82 72.34 3.53 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.351 -0.843 . . . . 0.0 109.591 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 45.4 t -169.13 148.3 3.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.072 -1.018 . . . . 0.0 109.41 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.29 -41.5 98.98 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.354 -0.842 . . . . 0.0 109.681 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.85 123.64 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.398 -0.814 . . . . 0.0 109.912 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.524 ' CZ ' ' OD2' ' A' ' 90' ' ' ASP . 89.3 t80 -130.4 85.73 2.32 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 93.5 mt -105.12 128.61 53.44 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.376 -0.828 . . . . 0.0 109.694 -179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.524 ' OD2' ' CZ ' ' A' ' 88' ' ' PHE . 94.6 m-20 -135.1 86.06 2.22 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 90' ' ' ASP . 63.3 m-20 -158.92 178.99 9.49 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.88 . . . . 0.0 110.032 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 94' ' ' VAL . 2.8 t -63.42 166.52 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.611 -0.681 . . . . 0.0 110.847 -179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.417 ' H ' HG12 ' A' ' 92' ' ' VAL . 3.0 p 66.06 -4.76 0.62 Allowed 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.489 ' H ' ' C ' ' A' ' 92' ' ' VAL . 55.3 t -123.99 129.5 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.3 m -107.59 -139.24 0.37 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 109.958 -179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 21.8 mmt85 -63.42 -42.53 98.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.546 -0.721 . . . . 0.0 110.662 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -156.89 94.02 1.4 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.02 -1.05 . . . . 0.0 109.005 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -61.29 -39.04 88.95 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.438 -0.789 . . . . 0.0 109.438 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 79' ' ' ALA . . . -152.55 162.08 41.7 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 110.573 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -133.39 145.56 50.43 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -113.87 141.89 46.79 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.624 -0.673 . . . . 0.0 109.333 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -127.71 135.81 50.68 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.748 0.785 . . . . 0.0 109.834 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 107' ' ' GLU . 47.2 tp -98.42 128.49 44.82 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -97.39 -126.62 0.15 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.152 -0.967 . . . . 0.0 110.94 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 106' ' ' ASN . 8.0 m120 -64.53 -48.91 73.32 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.11 -0.994 . . . . 0.0 110.529 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' ASN . 5.5 m120 -168.82 21.47 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.33 -0.856 . . . . 0.0 109.665 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.466 ' O ' ' CD1' ' A' ' 103' ' ' LEU . 96.8 mt-10 -116.37 -126.92 0.29 Allowed 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.35 -0.844 . . . . 0.0 109.057 179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.439 ' O ' ' OD1' ' A' ' 109' ' ' ASN . 13.7 m-85 -164.23 155.35 15.63 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.017 -1.052 . . . . 0.0 108.933 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.439 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 58.6 m-20 -143.45 149.51 37.7 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.194 -0.941 . . . . 0.0 109.149 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.2 p -124.32 130.51 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 56.0 t -128.44 131.54 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.355 0.597 . . . . 0.0 109.461 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -100.25 118.16 35.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.53 -0.731 . . . . 0.0 109.356 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 115' ' ' SER . 25.3 m -75.66 -157.85 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.355 -0.841 . . . . 0.0 110.215 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -73.93 28.43 0.94 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 113' ' ' VAL . 17.0 m -71.87 150.99 43.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -1.171 . . . . 0.0 110.671 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 116' ' ' LEU . 10.5 mp -60.03 176.0 0.35 Allowed 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.825 0.822 . . . . 0.0 111.02 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 118' ' ' GLY . 50.0 t30 58.17 -116.27 0.88 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.291 0.567 . . . . 0.0 110.367 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.476 ' O ' ' CZ ' ' A' ' 120' ' ' TYR . . . 162.16 125.31 0.76 Allowed Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.7 m -72.09 138.79 48.03 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.422 -1.046 . . . . 0.0 109.856 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.476 ' CZ ' ' O ' ' A' ' 118' ' ' GLY . 11.2 m-85 -124.12 142.15 51.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.61 -0.681 . . . . 0.0 109.188 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 126' ' ' VAL . 5.9 p -124.13 132.08 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.606 0.717 . . . . 0.0 109.622 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.433 ' C ' ' H ' ' A' ' 124' ' ' GLU . 98.1 m-20 52.6 -171.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.819 0.819 . . . . 0.0 110.894 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -71.37 6.84 1.56 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.394 -0.817 . . . . 0.0 108.871 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 122' ' ' ASN . 3.9 pt-20 -120.44 84.74 36.22 Favored Pre-proline 0 N--CA 1.497 1.917 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -58.45 134.38 60.84 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.373 2.049 . . . . 0.0 112.009 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.513 HG22 HG12 ' A' ' 121' ' ' VAL . 27.3 m -151.04 156.15 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.132 -0.98 . . . . 0.0 109.809 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -64.45 -41.88 96.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 96.1 p -158.11 143.5 16.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.399 -0.813 . . . . 0.0 109.546 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -172.93 167.52 5.05 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.289 -0.882 . . . . 0.0 110.056 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 70.8 t -78.05 144.31 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.981 0.896 . . . . 0.0 109.96 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.83 ' H ' HD13 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -136.8 158.06 45.31 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 121.544 0.688 . . . . 0.0 110.444 -179.072 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -150.06 -172.02 4.06 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.629 0.728 . . . . 0.0 109.201 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 133' ' ' ASN . 47.2 p-10 -50.78 141.52 12.96 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.834 0.826 . . . . 0.0 111.538 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 84.17 21.36 57.2 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -110.08 151.88 26.67 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.446 -1.032 . . . . 0.0 109.267 179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -113.46 138.09 50.6 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 72.8 t -125.61 132.27 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -118.71 125.45 49.7 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.7 mt -120.46 128.95 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.65 0.738 . . . . 0.0 109.518 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 45.67 -120.98 4.68 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -98.45 -16.31 19.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.421 -1.046 . . . . 0.0 108.808 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -80.37 145.47 32.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 0.0 110.214 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -115.85 126.68 54.29 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.03 158.43 36.98 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.65 -0.656 . . . . 0.0 109.762 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.0 p -123.83 135.47 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -90.24 109.87 20.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.924 -178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -138.44 143.59 39.74 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.401 0.62 . . . . 0.0 109.374 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 79.8 p -86.47 167.27 14.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.346 -0.846 . . . . 0.0 110.396 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -82.87 -3.28 90.56 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -88.1 117.25 26.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.099 -1.236 . . . . 0.0 109.752 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -172.03 -26.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.42 ' HG3' ' H ' ' A' ' 152' ' ' GLN . 0.0 OUTLIER -69.87 158.12 36.12 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.814 0.816 . . . . 0.0 110.518 -179.336 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 91.71 128.69 4.37 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 54.8 20.02 2.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.636 -0.92 . . . . 0.0 109.353 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -86.81 56.63 4.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.261 -0.899 . . . . 0.0 109.346 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 79.1 mt -80.43 133.05 35.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.381 -0.825 . . . . 0.0 110.025 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -87.23 122.96 31.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.388 -0.82 . . . . 0.0 109.889 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -110.15 118.25 35.86 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.537 -0.727 . . . . 0.0 109.661 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.496 ' CE1' ' OXT' ' A' ' 163' ' ' HIS . 59.3 t-80 -86.17 -7.52 58.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.481 -0.762 . . . . 0.0 108.965 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 159' ' ' HIS . 70.2 m80 58.42 133.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 122.085 0.945 . . . . 0.0 110.909 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 162' ' ' HIS . 60.1 t-80 48.55 86.05 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.784 0.802 . . . . 0.0 110.291 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.423 ' O ' ' O ' ' A' ' 161' ' ' HIS . 74.0 m80 46.93 -176.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.726 0.774 . . . . 0.0 110.762 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.496 ' OXT' ' CE1' ' A' ' 159' ' ' HIS . 86.7 t60 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.93 -1.033 . . . . 0.0 109.857 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.666 0.746 . . . . 0.0 109.911 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -75.97 148.23 38.29 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.925 0.869 . . . . 0.0 110.457 -179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -78.53 144.54 35.55 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.648 0.737 . . . . 0.0 110.512 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 28' ' ' ASP . . . -177.28 153.19 0.92 Allowed 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.179 0.514 . . . . 0.0 109.675 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 27' ' ' ALA . 8.1 t70 75.3 16.15 2.74 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.325 0.583 . . . . 0.0 109.448 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 30' ' ' LEU . 41.7 p90 -174.05 -38.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.575 ' N ' ' CD1' ' A' ' 29' ' ' PHE . 71.9 mt 54.19 110.56 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.895 0.855 . . . . 0.0 110.041 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.6 t 57.23 82.57 0.12 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.577 0.703 . . . . 0.0 109.999 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -69.3 -35.2 75.75 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.605 HD23 ' N ' ' A' ' 34' ' ' ASP . 4.0 tt -91.36 116.74 29.09 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.845 0.831 . . . . 0.0 109.364 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.605 ' N ' HD23 ' A' ' 33' ' ' LEU . 97.3 m-20 -66.96 142.82 57.13 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.938 0.875 . . . . 0.0 111.015 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.439 ' N ' ' CD ' ' A' ' 36' ' ' PRO . . . -171.73 54.11 0.2 Allowed Pre-proline 0 N--CA 1.493 1.704 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.528 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' O ' ' N ' ' A' ' 38' ' ' GLN . 37.7 Cg_endo -66.32 146.24 80.19 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.881 2.387 . . . . 0.0 112.574 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 36' ' ' PRO . . . 40.5 -91.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.106 0.479 . . . . 0.0 110.128 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 36' ' ' PRO . 1.8 mm100 -74.91 148.74 39.82 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.882 0.848 . . . . 0.0 110.333 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.12 -8.15 58.75 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.03 -167.05 34.92 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.359 -1.097 . . . . 0.0 110.359 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 43' ' ' SER . 87.3 m -61.5 131.8 51.31 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.691 0.758 . . . . 0.0 110.431 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -90.82 -15.72 29.54 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.476 ' H ' HG22 ' A' ' 41' ' ' THR . 16.4 m -73.98 147.15 43.26 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.923 0.868 . . . . 0.0 110.49 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -154.98 -39.22 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.2 t -78.9 -78.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.478 -0.764 . . . . 0.0 109.62 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 95.5 p -76.9 161.46 28.38 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.766 0.793 . . . . 0.0 110.36 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -171.43 -170.02 35.02 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.1 m -84.19 -8.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.842 -0.799 . . . . 0.0 109.179 -179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -83.59 107.14 15.86 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.907 0.86 . . . . 0.0 109.827 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 60.77 132.64 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.621 -0.991 . . . . 0.0 110.621 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.415 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 0.3 OUTLIER -156.62 68.4 4.54 Favored Pre-proline 0 N--CA 1.488 1.432 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.557 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 45.5 Cg_exo -47.59 -41.89 29.82 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.408 2.072 . . . . 0.0 112.101 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 35.0 Cg_exo -60.86 146.79 97.0 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.867 2.378 . . . . 0.0 112.837 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -51.27 83.5 0.01 OUTLIER Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 53' ' ' PRO . 95.4 mt -131.57 154.01 49.28 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.118 0.961 . . . . 0.0 110.535 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -152.77 158.89 42.94 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.16 151.0 51.16 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 122.309 1.052 . . . . 0.0 110.929 -179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 13.8 mt -115.25 136.4 53.14 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.221 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.8 t -121.75 132.97 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 CA-C-O 121.855 0.836 . . . . 0.0 109.859 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.7 t -69.8 102.82 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 121.927 0.87 . . . . 0.0 109.538 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.07 -43.87 86.11 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.632 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -130.97 136.82 48.89 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.945 0.879 . . . . 0.0 109.797 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 151.9 168.62 16.45 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.11 -34.66 68.63 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.88 2.387 . . . . 0.0 111.471 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 66' ' ' ALA . 87.3 m-20 -66.89 -45.52 77.77 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' 65' ' ' ASN . . . 31.52 94.36 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.455 0.645 . . . . 0.0 110.838 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.01 -24.62 4.5 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 88.4 p -70.02 160.68 31.51 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.779 -0.836 . . . . 0.0 110.849 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.566 ' N ' ' CD ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -152.46 164.04 38.35 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.937 0.875 . . . . 0.0 110.556 -179.706 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -128.24 142.35 51.19 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.887 0.851 . . . . 0.0 109.723 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 tt -104.48 127.52 52.2 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.822 0.82 . . . . 0.0 110.406 -179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.3 mt -91.37 116.49 28.88 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.898 0.856 . . . . 0.0 109.966 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -157.69 19.7 0.27 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -129.65 138.89 51.46 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.895 0.855 . . . . 0.0 109.821 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.79 134.62 51.28 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.78 0.8 . . . . 0.0 110.458 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.5 mm 53.09 93.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.6 m -106.08 118.13 35.81 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-O 122.029 0.918 . . . . 0.0 110.169 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.2 m -85.67 159.33 19.84 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.639 0.733 . . . . 0.0 109.909 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.427 ' O ' ' O ' ' A' ' 96' ' ' ARG . . . -106.89 170.09 8.15 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.865 0.841 . . . . 0.0 110.388 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.5 -70.67 2.62 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.621 ' NH1' ' NH2' ' A' ' 96' ' ' ARG . 79.7 mtp85 -71.74 142.59 49.77 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.714 0.769 . . . . 0.0 110.118 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.525 ' N ' ' CD ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -86.43 -46.07 0.56 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.837 -0.539 . . . . 0.0 109.91 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 82' ' ' HIS . 54.3 Cg_exo -54.24 135.0 63.43 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.257 1.971 . . . . 0.0 112.725 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 54.48 33.21 18.31 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t -159.65 117.63 2.72 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.932 0.872 . . . . 0.0 109.876 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -64.23 -37.85 88.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.57 125.36 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.58 0.705 . . . . 0.0 109.702 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.4 ' CD1' ' CB ' ' A' ' 82' ' ' HIS . 57.4 t80 -130.01 86.19 2.38 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.965 0.888 . . . . 0.0 109.566 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 90' ' ' ASP . 96.8 mt -79.7 146.71 32.28 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.763 0.792 . . . . 0.0 109.787 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.403 ' O ' ' O ' ' A' ' 89' ' ' LEU . 64.7 t0 -55.88 -109.12 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.454 0.645 . . . . 0.0 110.267 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.595 ' O ' ' N ' ' A' ' 93' ' ' THR . 58.6 m-20 -162.23 -103.66 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.461 0.648 . . . . 0.0 109.486 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 t 53.01 -77.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.151 0.501 . . . . 0.0 109.904 -179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 91' ' ' ASP . 11.8 p -115.17 9.23 15.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.656 -0.653 . . . . 0.0 109.375 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.2 t -113.1 131.09 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 CA-C-O 121.918 0.866 . . . . 0.0 109.862 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.5 t -89.33 -155.74 0.37 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.813 0.816 . . . . 0.0 110.94 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.621 ' NH2' ' NH1' ' A' ' 81' ' ' ARG . 79.3 mtp85 -63.7 -41.22 98.14 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.312 0.577 . . . . 0.0 109.894 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -166.41 56.36 0.09 Allowed 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.433 0.635 . . . . 0.0 109.593 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -62.85 -6.42 3.74 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.56 147.49 34.51 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.939 0.876 . . . . 0.0 109.673 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -143.93 138.94 28.87 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.057 0.932 . . . . 0.0 109.925 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -106.38 145.81 31.25 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.717 0.77 . . . . 0.0 109.302 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -132.93 143.98 49.84 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.985 0.897 . . . . 0.0 110.177 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 60.0 tp -106.83 121.77 45.05 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.839 0.828 . . . . 0.0 109.569 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 104' ' ' GLU . 9.8 pm0 -107.12 -116.51 0.26 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.444 0.64 . . . . 0.0 109.876 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.43 ' H ' ' CG ' ' A' ' 104' ' ' GLU . 47.7 p-10 -87.38 80.82 8.04 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.604 0.716 . . . . 0.0 110.437 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 54.22 31.42 14.07 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.421 0.629 . . . . 0.0 109.508 179.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -141.4 130.41 23.24 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.66 0.743 . . . . 0.0 109.562 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -93.31 148.72 21.79 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.465 0.65 . . . . 0.0 109.647 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 29.5 p30 -147.25 172.34 13.99 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.637 0.732 . . . . 0.0 110.425 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.3 p -124.66 131.65 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-O 121.966 0.888 . . . . 0.0 109.576 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 52.5 t -127.97 133.29 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 121.712 0.768 . . . . 0.0 109.5 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -89.05 113.82 24.98 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.553 0.692 . . . . 0.0 109.515 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.4 m -71.48 81.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.718 0.771 . . . . 0.0 109.578 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 115' ' ' SER . . . 90.98 177.84 43.55 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 178.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.429 ' O ' ' O ' ' A' ' 114' ' ' GLY . 5.2 m 56.09 114.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.684 0.754 . . . . 0.0 110.187 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 116' ' ' LEU . 11.0 mp -63.19 -40.21 96.85 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -88.66 109.69 20.33 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.825 0.821 . . . . 0.0 110.266 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.506 ' O ' ' CE1' ' A' ' 120' ' ' TYR . . . -156.92 -116.42 0.51 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.6 m -65.77 133.86 51.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.55 -0.971 . . . . 0.0 110.021 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.506 ' CE1' ' O ' ' A' ' 118' ' ' GLY . 8.9 m-85 -121.7 144.15 48.94 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.825 0.821 . . . . 0.0 109.611 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 122' ' ' ASN . 3.2 p -101.99 154.4 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 121.42 0.628 . . . . 0.0 109.954 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 123' ' ' ARG . 37.9 p-10 -34.04 -45.3 0.2 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.106 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 122' ' ' ASN . 99.8 mtt180 -74.5 -114.6 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.64 -0.662 . . . . 0.0 110.919 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -102.36 147.29 33.78 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.679 -0.638 . . . . 0.0 109.989 -178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.77 137.7 78.39 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.793 2.329 . . . . 0.0 113.022 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.4 m -143.07 161.23 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 CA-C-O 121.789 0.804 . . . . 0.0 110.558 179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -73.46 -18.35 61.13 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.8 p -158.16 159.24 35.94 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.721 0.772 . . . . 0.0 109.901 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -156.69 155.28 31.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.88 0.847 . . . . 0.0 110.219 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.5 t -99.64 128.91 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 121.708 0.765 . . . . 0.0 109.622 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 91.4 mt -79.24 143.21 35.52 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.789 0.804 . . . . 0.0 110.552 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.53 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -153.25 150.36 28.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.611 0.72 . . . . 0.0 109.635 179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 46.1 p-10 -39.95 122.87 1.54 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.773 0.797 . . . . 0.0 111.145 -179.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 86.44 13.11 68.61 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.981 -1.247 . . . . 0.0 109.981 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.53 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 28.0 m-20 -85.9 149.15 25.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.516 -0.991 . . . . 0.0 109.861 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -112.47 141.96 45.59 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.867 0.842 . . . . 0.0 110.219 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.2 t -121.74 133.66 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 CA-C-O 121.804 0.812 . . . . 0.0 109.411 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -128.45 112.66 14.61 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.829 0.823 . . . . 0.0 109.472 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.8 mt -131.13 128.59 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 121.871 0.843 . . . . 0.0 109.654 179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 56.07 -134.46 50.27 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -95.45 -13.59 24.46 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -89.56 130.53 35.86 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.832 0.825 . . . . 0.0 110.073 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 85.7 mtp180 -105.99 135.56 47.22 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.714 0.768 . . . . 0.0 109.752 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.69 149.33 51.49 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.658 0.742 . . . . 0.0 109.714 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 14.4 p -118.32 132.18 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.721 0.772 . . . . 0.0 109.239 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -94.49 111.94 23.7 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.941 0.877 . . . . 0.0 110.008 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 19.7 mt -138.14 150.52 46.89 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.805 0.812 . . . . 0.0 109.989 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.546 ' O ' ' N ' ' A' ' 150' ' ' HIS . 7.8 p -88.18 -170.1 2.83 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.702 0.763 . . . . 0.0 110.354 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.498 ' C ' ' H ' ' A' ' 151' ' ' LYS . . . -39.9 90.57 0.01 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.546 ' N ' ' O ' ' A' ' 148' ' ' THR . 80.6 m80 -49.84 -11.54 0.06 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 149' ' ' GLY . 4.5 tppt? -79.01 101.48 7.83 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.739 0.78 . . . . 0.0 110.226 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -105.2 139.9 39.16 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.809 0.814 . . . . 0.0 110.088 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 169.6 43.29 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 24.6 tp10 -131.77 39.55 3.46 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.43 -1.041 . . . . 0.0 109.504 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -173.9 173.81 3.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.502 -0.749 . . . . 0.0 109.747 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 65.2 mt -70.0 148.25 49.12 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.698 0.761 . . . . 0.0 110.298 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.21 145.14 52.23 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.636 0.732 . . . . 0.0 110.93 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -88.89 169.38 11.62 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.8 0.81 . . . . 0.0 110.978 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 55.0 p-80 -68.04 142.95 55.73 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.641 0.734 . . . . 0.0 110.641 -179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -75.77 146.18 40.21 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.674 0.75 . . . . 0.0 110.301 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -144.62 140.1 28.48 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 121.803 0.811 . . . . 0.0 110.126 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.472 ' ND1' ' OXT' ' A' ' 163' ' ' HIS . 61.3 t-80 -82.47 129.58 34.94 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.84 0.829 . . . . 0.0 110.222 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.472 ' OXT' ' ND1' ' A' ' 162' ' ' HIS . 97.8 m-70 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.805 -1.093 . . . . 0.0 109.935 -179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.429 ' O ' ' O ' ' A' ' 25' ' ' PHE . 11.4 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.335 0.588 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.593 ' CG ' ' N ' ' A' ' 26' ' ' ARG . 74.5 t80 48.08 -179.86 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.571 0.701 . . . . 0.0 110.272 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.593 ' N ' ' CG ' ' A' ' 25' ' ' PHE . 85.0 mtt85 -67.91 146.47 53.59 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 0.0 111.105 -178.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.435 ' O ' ' O ' ' A' ' 26' ' ' ARG . . . 41.3 -166.75 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.66 0.743 . . . . 0.0 110.799 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -73.66 -62.92 1.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.785 -0.572 . . . . 0.0 110.193 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -88.19 -163.54 0.97 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.383 -0.823 . . . . 0.0 110.638 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.487 ' CD2' ' H ' ' A' ' 30' ' ' LEU . 0.1 OUTLIER -83.96 97.35 9.21 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.443 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.1 p -76.79 159.18 30.32 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.626 0.727 . . . . 0.0 111.3 -179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.494 ' HG3' ' H ' ' A' ' 34' ' ' ASP . 23.8 tp10 68.38 128.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.611 0.72 . . . . 0.0 110.45 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.9 mt -85.8 -3.07 58.81 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' H ' ' HG3' ' A' ' 32' ' ' GLU . 95.8 m-20 -89.58 2.62 54.42 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.624 ' HB3' ' CD ' ' A' ' 36' ' ' PRO . . . -41.84 -61.5 1.47 Allowed Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.77 -0.582 . . . . 0.0 110.1 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.624 ' CD ' ' HB3' ' A' ' 35' ' ' ALA . 30.5 Cg_endo -61.05 144.91 99.55 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.256 1.97 . . . . 0.0 111.865 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -169.8 130.64 1.03 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.407 -0.808 . . . . 0.0 109.822 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 40' ' ' GLY . 13.6 pt20 -154.59 -26.42 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 45.01 -89.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.872 -0.517 . . . . 0.0 110.177 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 38' ' ' GLN . . . 79.1 25.33 59.86 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.103 -1.599 . . . . 0.0 109.103 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 43' ' ' SER . 70.0 p -87.49 -5.02 58.98 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.391 -1.064 . . . . 0.0 109.243 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -51.36 89.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.56 -0.712 . . . . 0.0 109.863 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.507 ' N ' ' O ' ' A' ' 41' ' ' THR . 70.0 p -86.71 -4.71 59.21 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.439 -0.788 . . . . 0.0 109.537 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 60.39 79.2 0.25 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.404 0.621 . . . . 0.0 109.343 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.4 m -98.89 159.51 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.563 -0.71 . . . . 0.0 110.577 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 68.8 m -53.0 -96.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.646 -0.659 . . . . 0.0 109.3 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' HA2' ' H ' ' A' ' 153' ' ' GLY . . . 76.83 -165.48 53.63 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 50' ' ' GLY . 2.8 t -83.19 118.88 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.616 -0.932 . . . . 0.0 110.007 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 50' ' ' GLY . 13.6 pt-20 36.35 25.83 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.84 -0.538 . . . . 0.0 111.11 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 48' ' ' VAL . . . 52.62 175.75 0.05 OUTLIER Glycine 0 N--CA 1.494 2.557 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.571 ' N ' ' CD ' ' A' ' 52' ' ' PRO . 0.2 OUTLIER -139.44 45.41 0.89 Allowed Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.429 -1.042 . . . . 0.0 109.184 179.578 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 51' ' ' LEU . 2.7 Cg_endo -42.62 -54.44 3.21 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.346 2.031 . . . . 0.0 112.236 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 52' ' ' PRO . 36.0 Cg_endo -60.84 -81.31 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.858 1.705 . . . . 0.0 111.944 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -174.75 57.01 0.12 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 mp -103.52 136.81 42.55 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.512 -0.993 . . . . 0.0 109.46 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -123.64 160.64 26.7 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mp -128.38 150.22 50.2 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.486 -0.759 . . . . 0.0 109.858 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.1 mt -115.34 136.08 53.47 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.9 t -124.5 133.79 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.11 112.46 3.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.425 -0.797 . . . . 0.0 109.464 -179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.52 ' O ' ' NE ' ' A' ' 62' ' ' ARG . 24.2 tptp -64.71 -47.07 79.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.453 -0.78 . . . . 0.0 109.505 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 61' ' ' LYS . 4.7 mmp_? -143.61 155.26 44.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.303 -0.873 . . . . 0.0 109.847 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 143.43 167.18 11.55 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.56 -19.51 54.39 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 C-N-CA 122.544 2.163 . . . . 0.0 111.873 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 53.8 p30 -106.25 33.44 3.84 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.452 -0.78 . . . . 0.0 109.192 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.79 145.88 11.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.549 -0.719 . . . . 0.0 109.922 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.36 -19.21 53.68 Favored Glycine 0 N--CA 1.497 2.717 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 68.3 m -69.96 145.89 51.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -1.053 . . . . 0.0 109.907 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -141.81 156.1 45.57 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -129.51 146.97 51.27 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.449 -0.782 . . . . 0.0 109.511 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.519 ' N ' ' OD2' ' A' ' 86' ' ' ASP . 53.9 tp -106.44 124.93 50.35 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.541 -0.724 . . . . 0.0 109.114 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.7 68.73 5.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.152 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 35.3 p30 -98.75 5.84 47.3 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.438 -0.789 . . . . 0.0 109.727 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -119.45 135.55 54.7 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.457 -0.777 . . . . 0.0 109.335 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.68 136.06 54.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.514 -0.741 . . . . 0.0 110.659 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.1 mm 60.23 85.76 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 121.439 0.637 . . . . 0.0 109.992 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 56.4 m -102.93 121.84 43.34 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.418 ' O ' ' OG ' ' A' ' 85' ' ' SER . 11.5 m -85.52 162.17 19.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.438 -0.789 . . . . 0.0 109.711 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -126.37 127.08 44.94 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.86 -141.9 9.64 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -104.48 132.47 50.69 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.437 -1.037 . . . . 0.0 110.401 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.653 ' N ' ' ND1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 174.15 151.1 0.25 Allowed Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.63 -23.29 49.51 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 C-N-CA 122.14 1.893 . . . . 0.0 112.104 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 85' ' ' SER . 73.0 m-20 -103.3 -146.84 0.37 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.453 -0.779 . . . . 0.0 109.732 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.431 ' O ' ' O ' ' A' ' 84' ' ' ASP . 8.7 t 59.6 128.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.612 0.72 . . . . 0.0 110.389 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 71' ' ' LEU . 48.0 t0 -64.7 -39.69 94.09 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.7 mt -82.03 124.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.422 -0.799 . . . . 0.0 109.223 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -130.2 86.25 2.38 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.723 -0.61 . . . . 0.0 109.482 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.65 99.68 11.28 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -84.39 92.57 8.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.658 -0.651 . . . . 0.0 109.766 -179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -154.38 151.76 29.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.294 -0.879 . . . . 0.0 109.593 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.3 m -71.21 -26.91 27.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.314 -0.867 . . . . 0.0 109.254 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.1 p -65.7 -33.85 76.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.499 -0.751 . . . . 0.0 109.737 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 22.0 t -96.97 121.53 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.293 -0.879 . . . . 0.0 109.374 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 26.8 m -77.3 179.77 6.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 0.0 110.34 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 57.4 ttt85 -58.03 -44.27 87.23 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 90.1 mtm180 -135.68 78.63 1.73 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.49 -0.757 . . . . 0.0 109.03 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -94.68 -18.93 20.87 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.518 -0.739 . . . . 0.0 109.219 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.488 ' HB2' ' OG1' ' A' ' 119' ' ' THR . . . -153.13 152.32 31.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.483 -0.76 . . . . 0.0 109.184 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -139.6 139.6 36.81 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -106.43 119.79 40.19 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.578 -0.702 . . . . 0.0 109.165 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -107.61 134.93 49.89 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 109.398 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 39.9 tp -103.4 126.68 50.69 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.386 -0.821 . . . . 0.0 109.617 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -99.57 -131.2 0.23 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.512 -0.743 . . . . 0.0 109.08 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -65.54 -49.43 68.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.402 -0.811 . . . . 0.0 109.902 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.421 ' CG ' ' O ' ' A' ' 106' ' ' ASN . 2.5 t-20 177.51 46.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.462 ' O ' ' O ' ' A' ' 108' ' ' PHE . 80.5 mm-40 -134.32 -6.25 2.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.981 -1.074 . . . . 0.0 109.251 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.462 ' O ' ' O ' ' A' ' 107' ' ' GLU . 62.3 m-85 56.71 151.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.724 0.773 . . . . 0.0 110.209 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 108' ' ' PHE . 88.8 m-20 -143.49 159.89 41.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.379 -0.826 . . . . 0.0 109.487 -179.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 9.6 p -129.85 137.42 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 112' ' ' ASP . 30.8 t -133.8 157.27 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.405 -0.809 . . . . 0.0 109.763 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 114' ' ' GLY . 36.5 p-10 -84.7 13.63 5.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.674 -0.641 . . . . 0.0 109.582 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.504 ' O ' HG22 ' A' ' 113' ' ' VAL . 9.4 p 37.12 26.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.419 0.628 . . . . 0.0 110.394 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 112' ' ' ASP . . . 102.96 -155.69 18.17 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 114' ' ' GLY . 46.4 m 58.99 141.94 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.748 -0.854 . . . . 0.0 110.164 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 46.2 tp -78.54 134.74 37.22 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.643 -0.66 . . . . 0.0 110.489 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 62.7 t30 58.04 40.07 25.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.587 -0.695 . . . . 0.0 109.714 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -76.17 -130.04 0.33 Allowed Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.488 ' OG1' ' HB2' ' A' ' 99' ' ' ALA . 17.5 m -62.87 138.98 58.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.419 -1.048 . . . . 0.0 110.599 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -141.91 160.36 40.35 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 121' ' ' VAL . 14.1 p -112.17 129.2 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.293 -0.88 . . . . 0.0 110.486 -179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.502 ' CG ' ' H ' ' A' ' 123' ' ' ARG . 5.9 t-20 59.47 -167.44 0.16 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.682 0.753 . . . . 0.0 110.824 179.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.502 ' H ' ' CG ' ' A' ' 122' ' ' ASN . 96.0 mtt-85 -72.71 -12.75 61.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.884 -0.51 . . . . 0.0 109.9 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -86.41 116.53 66.22 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.27 -0.894 . . . . 0.0 109.2 -179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.22 121.63 5.8 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.507 1.472 . . . . 0.0 111.768 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 31.1 m -136.53 156.74 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 121.272 -0.892 . . . . 0.0 110.173 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 128' ' ' SER . 38.4 p-10 -72.96 -36.76 67.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.416 -0.803 . . . . 0.0 109.606 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.53 ' N ' ' OD1' ' A' ' 127' ' ' ASP . 99.5 p -160.55 161.83 32.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.413 -0.805 . . . . 0.0 108.852 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -165.53 157.68 15.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.918 -1.114 . . . . 0.0 110.386 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 87.3 t -81.31 134.0 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.462 -0.774 . . . . 0.0 109.638 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 75.9 mt -80.8 148.07 30.19 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.187 -0.946 . . . . 0.0 109.696 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.548 ' N ' ' OD2' ' A' ' 135' ' ' ASP . . . -146.28 160.72 41.63 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.345 -0.847 . . . . 0.0 109.611 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.423 ' OD1' ' OG1' ' A' ' 148' ' ' THR . 51.3 m-20 -57.54 136.79 56.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.52 -0.737 . . . . 0.0 110.628 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.561 ' H ' HD23 ' A' ' 147' ' ' LEU . . . 80.53 18.62 70.49 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.548 ' OD2' ' N ' ' A' ' 132' ' ' ALA . 84.8 m-20 -93.5 155.25 17.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.162 -1.199 . . . . 0.0 109.642 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 136' ' ' GLU . 56.4 mp0 -113.33 137.43 51.52 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 50.4 t -122.94 133.6 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -124.12 116.71 23.2 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.592 -0.692 . . . . 0.0 109.304 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.31 128.07 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.612 -0.68 . . . . 0.0 109.811 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 52.82 -134.23 39.85 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.0 tptp -95.49 -4.59 44.65 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.6 -0.941 . . . . 0.0 109.076 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -95.84 132.34 41.2 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.553 -0.717 . . . . 0.0 109.506 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -103.36 133.8 47.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.34 154.88 47.2 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 8.7 p -124.9 134.18 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.687 -0.633 . . . . 0.0 109.368 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -92.0 112.44 24.38 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 134' ' ' GLY . 94.2 mt -134.2 148.65 50.92 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.457 0.646 . . . . 0.0 110.101 -179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.423 ' OG1' ' OD1' ' A' ' 133' ' ' ASN . 35.8 p -117.82 122.23 42.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.796 -0.565 . . . . 0.0 109.984 -179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 50.23 -94.73 0.01 OUTLIER Glycine 0 N--CA 1.495 2.607 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.523 ' CG ' ' N ' ' A' ' 151' ' ' LYS . 49.0 t-80 47.72 -110.57 0.34 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.383 -1.069 . . . . 0.0 110.48 -179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.523 ' N ' ' CG ' ' A' ' 150' ' ' HIS . 10.9 ttmm -60.9 135.84 57.9 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.613 0.721 . . . . 0.0 110.629 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -68.55 128.17 35.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.607 -0.683 . . . . 0.0 109.558 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.431 ' H ' ' HA2' ' A' ' 47' ' ' GLY . . . -77.86 165.53 52.45 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.499 ' OE2' HD21 ' A' ' 156' ' ' LEU . 47.2 tp10 -157.81 -79.41 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.424 -1.044 . . . . 0.0 108.996 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 45.38 81.36 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.432 -0.793 . . . . 0.0 109.483 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.499 HD21 ' OE2' ' A' ' 154' ' ' GLU . 86.0 mt -68.5 143.31 55.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.543 -0.723 . . . . 0.0 109.742 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -173.34 -128.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.638 ' ND1' ' N ' ' A' ' 159' ' ' HIS . 56.4 t-80 44.16 -110.46 0.18 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.42 -0.8 . . . . 0.0 110.418 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.638 ' N ' ' ND1' ' A' ' 158' ' ' HIS . 23.0 t60 44.8 -170.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.597 -0.689 . . . . 0.0 110.473 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 0.625 ' H ' ' CG ' ' A' ' 159' ' ' HIS . 49.4 m170 55.06 174.91 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.497 0.665 . . . . 0.0 110.269 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -106.04 138.16 42.71 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.595 -0.691 . . . . 0.0 109.574 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -73.27 139.16 45.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.533 -0.73 . . . . 0.0 110.05 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.69 -179.873 . . . . . . . . 0 0 . 1 stop_ save_